

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-4,6-dichloropyrimidine
C4H3Cl2N3
5413-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 Cl 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-4,5-pyrimidinediamine
C5H7ClN4
52602-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 N 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5413-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52602-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9040274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Chloro-N4-methylpyrimidine-4.5-diamine: A 50 mL 3-necked flask fitted
with a thermometer was charged with 1,4-dioxane (20 mL) and
4,5-dichloropyrimdine-5-amine (5.00 g, 30.5 mmol). The reaction mixture
was then stirred for 30 minutes at room temperature to ensure complete
dissolution of the 4,5-dichloropyrimidine-5-amine, after which a solution
of methylamine in water (40% by weight, 120 mmol, 9.3 mL) was added over
a period of 30 minutes by means of a pressure-equalized dropping funnel.
Upon completion of addition, the dropping funnel was replaced with a
reflux condenser. The stirred reaction mixture was then heated to 75 °C
over a period of 40 minutes, and the progress was monitored by LCMS. The
reaction was complete after 16 hours. The resulting mixture was then
cooled to 50°C and poured into 120 mL of ice and water (approximetely 1 :
1 by volume), which resulted in the rapid precipitation of a solid. The
resulting suspension was then for a period of 2 hours. The precipitated
solids were collected by vacuum filtration, washed with ice-cold water
(20 mL) and dried on the filter to give
6-chloro-N4-memylpyrimidine-4,5-diamine. Light yellow solid, yield 4.76
g, 98.4%. 1H-NMR (400 MHz, DMSO-d6): δ 7.73 (s, 1H), 6.87 (d, 1H), 4.94
(broad s, 2H), 2.86 (d, 3H). MS (EI) for C5H7ClN4: 159 (MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl-substituted purine derivatives as inhibitors
of PI3k-delta for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patrick, Kearney
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012037226 A1 2012-03-22

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6,8,9,11,12-Octahydro-15-nitro-1,4,7,10,13-benzopentaoxacyclopentadecin
C14H19NO7
60835-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7008 5.0624 0.0 0 VAL=5
M  V30 2 O 10.7008 6.6024 0.0 0
M  V30 3 O 12.0347 4.2923 0.0 0
M  V30 4 C 6.6999 4.2923 0.0 0
M  V30 5 C 6.6999 2.7523 0.0 0
M  V30 6 C 8.0335 5.0624 0.0 0
M  V30 7 O 5.3661 5.0624 0.0 0
M  V30 8 C 8.0335 1.9823 0.0 0
M  V30 9 O 5.3661 1.9823 0.0 0
M  V30 10 C 9.3672 4.2923 0.0 0
M  V30 11 C 5.0459 6.5687 0.0 0
M  V30 12 C 9.3672 2.7523 0.0 0
M  V30 13 C 5.0459 0.4760 0.0 0
M  V30 14 C 3.5813 7.0447 0.0 0
M  V30 15 C 3.5813 0.0000 0.0 0
M  V30 16 O 2.4368 6.0141 0.0 0
M  V30 17 O 2.4368 1.0306 0.0 0
M  V30 18 C 0.9052 6.1752 0.0 0
M  V30 19 C 0.9052 0.8695 0.0 0
M  V30 20 C 0.0000 4.9291 0.0 0
M  V30 21 C 0.0000 2.1155 0.0 0
M  V30 22 O 0.6265 3.5223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-[2-[2-(Methylamino)-5-nitrophenoxy]ethoxy]ethoxy]ethoxy]ethanol
C15H24N2O7
194923-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 9.2400 6.6684 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 11.5500 8.0020 0.0 0
M  V30 7 O 13.0900 8.0020 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 15.4000 9.3358 0.0 0
M  V30 10 O 16.1700 10.6694 0.0 0
M  V30 11 C 17.7100 10.6694 0.0 0
M  V30 12 C 18.4800 12.0031 0.0 0
M  V30 13 O 20.0200 12.0031 0.0 0
M  V30 14 N 4.6200 1.3336 0.0 0
M  V30 15 C 3.8500 0.0000 0.0 0
M  V30 16 N 1.5400 6.6684 0.0 0 VAL=5
M  V30 17 O 0.0000 6.6684 0.0 0
M  V30 18 O 2.3100 8.0020 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 2.6673 0.0 0
M  V30 21 C 3.8500 5.3347 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 20
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60835-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-90-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10112553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Earlier, we have found that the opening of
nitrobenzocrown ethers 1a-c on heating them with MeNH2 gives
nitrogen-containing podands 2a-c in 92-98% yields.8,9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nitrobenzoazacrown compounds by ring transformations of
nitrobenzo crown ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, S. P.; Dmitrieva, S. N.; Churakova, M. V.; Turchanov, A. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2002), 51(7), 1335-1336

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromopyridine
C5H3Br2N
624-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Br 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinamine
C6H7BrN2
84539-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84539-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35688106
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, thermal in stage 1,autoclave used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bulky ligands protect molecular ruby from oxygen quenching
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stein, Laura; Wang, Cui; Foerster, Christoph; Resch-Genger, Ute; Heinze,
Katja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2022), 51(46), 17664-17670

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)thieno[2,3-d]pyrimidine-6-carboxaldehyde
C8H6N2OS2
655253-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6211 3.9554 0.0 0
M  V30 4 O 8.9550 3.1854 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 C 4.8807 3.8119 0.0 0
M  V30 9 S 6.1265 1.6538 0.0 0
M  V30 10 N 3.8501 0.0000 0.0 0
M  V30 11 N 1.5400 1.3337 0.0 0
M  V30 12 C 6.2875 3.1854 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Methylthio)thieno[2,3-d]pyrimidin-6-yl]methylene]methanamine
C9H9N3S2
655253-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6212 3.9554 0.0 0
M  V30 4 N 8.9550 3.1854 0.0 0
M  V30 5 C 10.2887 3.9554 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.8807 3.8119 0.0 0
M  V30 10 S 6.1266 1.6538 0.0 0
M  V30 11 N 3.8501 0.0000 0.0 0
M  V30 12 N 1.5400 1.3337 0.0 0
M  V30 13 C 6.2875 3.1854 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 655253-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 655253-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11484847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed pyridines and pyrimidines as Tie2 receptor
tyrosine kinase inhibitors and their anti-angiogenic effect
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luke, Richard William Arthur; Jones, Clifford David; McCoull, William;
Hayter, Barry Raymond
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004013141 A1 2004-02-12

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8957839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 52: tert-Butyl 4-(methylamino)piperidine-1-carboxylate. 10%
Pd/C (2 g) was added to a solution of tert-butyl
4-oxopiperidine-1-carboxylate (20 g, 100 mmol) in methylamine (33% in
ethanol, 10 mL) and the mixture was stirred at room temperature, under 60
psi of hydrogen, for 18 hours. The reaction mixture was then filtered
through Arbocel.RTM. and the filtrate was concentrated in vacuo. The
residue was azeotroped with dichloromethane ( x 3) and the dried under
vacuum for 72 hours to afford the title compound as a solid, yield, 21.1
g, 98%. LRMS APCI m/z 215 [M+H]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted triazoles as oxytocin antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Alan Daniel; Calabrese, Andrew Antony; Ellis, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060160786 A1 2006-07-20

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-924888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of thienopyrimidine derivatives as
GPR119 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeon, Moon-Kook; Lee, Kyu Myung; Kim, Il Hyang; Jang, Yoon Kyung; Kang,
Seung Kyu; Lee, Jun Mi; Jung, Kwan-Young; Kumar, Jaladi Ashok; Rhee, Sang
Dal; Jung, Won Hoon; Song, Jin Sook; Bae, Myung Ae; Kim, Kwang Rok; Ahn,
Jin Hee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(17), 4281-4285

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7945288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-heteroaryl-N'-heterocyclylureas as neuropeptide Y Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stamford, Andrew; Dong, Youhao; McCombie, Stuart W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040006086 A1 2004-01-08

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13693085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a mixture of N-t-butoxycarbonyl4-piperidone (10.0 g, 50 mmol) and
aqueous methylamine (40% w/w, 10 ml) in 1,2-dichloroethane (125 ml) was
added NaBH(OAc)3 (16.0 g, 75 mmol). The reaction mixture was stirred
overnight, then 1 M NaOH (250 ml) was added and the whole was extracted
with ether (700 ml). The organic layer was washed with sat'd NaCl, dried
(MgSO4), filtered, and concentrated to give the product as an oil, yield
10.5 g, 97%. 1H NMR (CDCl3, 400 MHz) δ 4.09 (2H, m), 2.86 (2H, m), 2.55
(1H, m), 2.50 (3H, s), 1.90 (2H, m), 1.51 (9H, s), 1.30 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030114517 A1 2003-06-19

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3352175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 1 To a mixture of N-t-butoxycarbonyl-4-piperidone (10 g, 50
mmol) and aqueous methylamine (40% w/w, 10 ml) in 1,2-dichloroethane (125
ml) was added NaBH(OAc)3 (16.0 g, 75 mmol). The reaction mixture was
stirred overnight, then 1M NaOH (250 ml) was added and the whole was
extracted with ether (700 ml). The organic layer was washed with sat'd
NaCl, dried (MgSO4), filtered, and concentrated. The product (10.5 g,
97%) as an oil. 1H NMR (CDCl3, 400 MHz) δ 4.09 (2H, m), 2.86 (2H, m),
2.55 (1H, m), 2.50 (3H, s), 1.90 (2H, m), 1.51 (9H, s), 1.30 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-heteroaryl-N'-heterocyclylureas as neuropeptide Y Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stamford, Andrew W.; Dong, Youhao; McCombie, Stuart W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002049648 A1 2002-06-27

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17628547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002022592 A2 2002-03-21

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7780330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a mixture of N-t-butoxycarbony4-piperidone (10.0 g, 0.050 mol) and
aqueous CH3NH2 (40% w/w, 10 ml) in 1,2-dichloroethane (125 ml) was added
NaBH(OAc)3 (16.0 g, 0.075 mol). The reaction mixture was stirred
overnight, then 1M NaOH (250 ml) was added and the whole was extracted
with Et2O (700 ml). The organic layer was washed with sat'd NaCl, dried
(MgSO4), filtered, and concentrated to give the product, that was used
directly in Step 2. Oil, yield 10.5 g, 97%. 1H NMR (CDCl3, 400 MHz) δ
4.09 (2H, m), 2.86 (2H, m), 2.55 (1H, m), 2.50 (3H, s), 1.90 (2H, m),
1.51 (9H, s), 1.30 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl amides and ureas as neuropeptide Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dugar, Sundeep; Neustadt, Bernard R.; Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6329395 B1 2001-12-11

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-969312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for production of sertraline hydrochloride free from isomeric and
dehalogenated impurities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanganabhatla, Shankar; Ranade, Prasad Vasudeo; Koduru, Ramanarasimha
Moorthy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2005MU00741 A 2005-10-28

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7624270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 4-(Methylamino)-3-nitrobenzoic acid 300 g (1.49 mol) of
4-chloro-3-nitrobenzoic acid were suspended in 836 mL of a 25-30% aqueous
solution of methylamine. After heating to reflux temperature, an orange
solution was obtained. The solution was kept at reflux temperature for 4
hours. The solution was cooled to room temperature, and pH was adjusted
to about 2 by addition of 2M aqueous sulphuric acid. Precipitation of an
orange solid was observed, which was isolated by filtration. The filtered
cake was washed with 1.5 L of water and subsequently with 750 mL of
ethanol. The solid was suspended in 1.6 L of ethanol and stirred at
reflux temperature for 30 minutes. After cooling to room temperature, the
solid was filtered and dried at 60°C under vacuum to obtain
4-(methylamino)-3-nitrobenzoic acid. Orange powder, yield 285 g, 97.5 %.
Purity (HPLC, method 2): 97.7%
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate method may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dabigatran etexilate and related substances, processes and compositions,
and use of the substances as reference standards and markers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serra Miralles, Judit; Duran Lopez, Ernesto; Rao, Lingxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012152855 A1 2012-11-15

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenesulfonyl chloride
C6H4BrClO2S
98-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
703-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Br 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 703-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzenesulfonyl chloride
C7H7ClO3S
98-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
7010-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 1.3337 0.0 0 VAL=6
M  V30 2 N 1.3337 0.5637 0.0 0
M  V30 3 O 1.8975 2.6673 0.0 0
M  V30 4 O 3.4375 0.0000 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 8.0023 4.4137 0.0 0
M  V30 7 C 9.3360 3.6437 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 4.0012 3.6437 0.0 0
M  V30 10 C 5.3348 1.3337 0.0 0
M  V30 11 C 5.3348 4.4137 0.0 0
M  V30 12 C 6.6685 2.1037 0.0 0
M  V30 13 C 6.6685 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7010-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13744800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydrazonodiaminopyrazoles as integrin-linked kinase
inhibitors with antiproliferative activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zaihui; Daynard, Timothy S.; Chafeev, Mikhail A.; Wang, Shisen;
Chopiuk, Greg B.; Sviridov, Serguei V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003045379 A1 2003-06-05

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Nitrophenyl)methylene]methanamine
C8H8N2O2
121004-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121004-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13233247
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiazolidinones Derived from Dynamic Systemic Resolution of Complex
Reversible-Reaction Networks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yan; Ramstroem, Olof
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(12), 3288-3291

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
6-Chloronicotinic acid
C6H4ClNO2
5326-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5326-23-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2621981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 6-Chloro-N-methynicotinamide To 50 g (317 mmol) of 2-chloronicotinic
acid was added 230 ml (3.16 mol) thionyl chloride at 0 °C. After heating
the mixture at reflux for 2 h excess thionyl chloride was removed by
distation. The oily brown residue was dissolved in 250 ml
dichloromethane. The solution was treated with methylamine gas at 0 °C
until no exothermic reaction was observed any longer. The resulting
suspension was diluted with 1000 ml dichloromethane/water. The layers
were separated and the aqueous layer extracted with three 300 ml portions
of dichloromethane. Drying of the organic layer with sodium sulfate and
concentration gave the title compound Light yellow solid, yield 53.2 g,
98 % MS m/e (%): 171 (M+H+, 15).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylpyridines as neurokinin-1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Godel, Thierry; Hoffmann, Torsten; Schnider, Patrick; Stadler, Heinz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002016324 A1 2002-02-28

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
6-Chloronicotinic acid
C6H4ClNO2
5326-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5326-23-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17646805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylpyridine derivatives as neurokinin-1 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffmann, Torsten; Schnider, Patrick; Stadler, Heinz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002008232 A1 2002-01-31

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
6-Chloronicotinic acid
C6H4ClNO2
5326-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5326-23-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11204463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 6-Chloro-N-methynicotinamide To 50 g (317 mmol) of 2-chloronicotinic
acid were added 230 ml (3.16 mol) thionyl chloride at 0 °C. After heating
the mixture at reflux for 2 h excess thionyl chloride was removed by
distation. The oily brown residue was dissolved in 250 ml
dichloromethane. The solution was treated with methylamine gas at 0 °C
until no exothermic reaction was observed any longer. The resulting
suspension was diluted with 1000 ml dichloromethane/water. The layers
were separated and the aqueous layer extracted with three 300-ml portions
of dichloromethane. Drying of the combined organic layers with sodium
sulfate and concentration gave of the title compound Light yellow solid,
yield 53.2 g (98 %) MS m/e (%): 171 (M+H+, 15).
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine gas used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-oxides as NK1 receptor antagonist prodrugs of
4-phenylpyridine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffmann, Torsten; Poli, Sonia Maria; Schnider, Patrick; Sleight, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002006236 A1 2002-01-24

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzo-18-crown-6
C16H23NO8
53408-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 5.3901 0.0 0 VAL=5
M  V30 2 O 13.3370 4.6201 0.0 0
M  V30 3 O 12.0033 6.9302 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 9.3360 5.3901 0.0 0
M  V30 7 O 6.6685 5.3901 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 6.6685 2.3101 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 C 6.6685 6.9302 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 5.3348 7.7002 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 O 4.0010 6.9302 0.0 0
M  V30 17 O 4.0010 0.7700 0.0 0
M  V30 18 C 2.6673 7.7002 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0
M  V30 22 O 1.3337 5.3901 0.0 0
M  V30 23 O 1.3337 2.3101 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 25 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
14-[2-(Methylamino)-5-nitrophenoxy]-3,6,9,12-tetraoxatetradecan-1-ol
C17H28N2O8
194923-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 5.3901 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 5.3901 0.0 0
M  V30 4 O 8.0022 4.6201 0.0 0
M  V30 5 C 9.3360 5.3901 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 O 12.0033 5.3901 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 C 14.6708 5.3901 0.0 0
M  V30 10 O 16.0045 4.6201 0.0 0
M  V30 11 C 17.3382 5.3901 0.0 0
M  V30 12 C 18.6718 4.6201 0.0 0
M  V30 13 O 20.0057 5.3901 0.0 0
M  V30 14 C 21.3393 4.6201 0.0 0
M  V30 15 C 22.6730 5.3901 0.0 0
M  V30 16 O 24.0067 4.6201 0.0 0
M  V30 17 N 1.3337 6.9302 0.0 0
M  V30 18 C 0.0000 7.7002 0.0 0
M  V30 19 N 1.3337 0.7700 0.0 0 VAL=5
M  V30 20 O 0.0000 0.0000 0.0 0
M  V30 21 O 2.6673 0.0000 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 2.6673 3.0801 0.0 0
M  V30 25 C 0.0000 4.6201 0.0 0
M  V30 26 C 1.3337 2.3101 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 23
M  V30 19 2 19 20
M  V30 20 2 19 21
M  V30 21 1 19 26
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53408-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-994007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Earlier, we have found that the opening of
nitrobenzocrown ethers 1a-c on heating them with MeNH2 gives
nitrogen-containing podands 2a-c in 92-98% yields.8,9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nitrobenzoazacrown compounds by ring transformations of
nitrobenzo crown ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, S. P.; Dmitrieva, S. N.; Churakova, M. V.; Turchanov, A. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2002), 51(7), 1335-1336

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6,8,9-Hexahydro-12-nitro-1,4,7,10-benzotetraoxacyclododecin
C12H15NO6
78554-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3359 2.3100 0.0 0 VAL=5
M  V30 2 O 9.3359 0.7700 0.0 0
M  V30 3 O 10.6695 3.0800 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6684 2.3100 0.0 0
M  V30 7 O 4.0011 2.3100 0.0 0
M  V30 8 C 6.6684 5.3901 0.0 0
M  V30 9 O 4.0011 5.3901 0.0 0
M  V30 10 C 8.0022 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 O 1.3337 0.7700 0.0 0
M  V30 17 O 0.0000 4.6201 0.0 0
M  V30 18 C 1.3337 2.3100 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-[2-(Methylamino)-5-nitrophenoxy]ethoxy]ethoxy]ethanol
C13H20N2O6
194923-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 9.2400 6.6684 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 11.5500 8.0021 0.0 0
M  V30 7 O 13.0900 8.0021 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 15.4000 9.3358 0.0 0
M  V30 10 O 16.1700 10.6694 0.0 0
M  V30 11 N 4.6200 1.3336 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 N 1.5400 6.6684 0.0 0 VAL=5
M  V30 14 O 0.0000 6.6684 0.0 0
M  V30 15 O 2.3100 8.0021 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 20
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78554-67-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14099484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Earlier, we have found that the opening of nitrobenzocrown ethers 1a-c on
heating them with MeNH2 gives nitrogen-containing podands 2a-c in 92-98%
yields.8,9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nitrobenzoazacrown compounds by ring transformations of
nitrobenzo crown ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, S. P.; Dmitrieva, S. N.; Churakova, M. V.; Turchanov, A. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2002), 51(7), 1335-1336

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,5-Dimethoxyphenyl)methylene]methanamine
C10H13NO2
114943-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 114943-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9526291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) Ν-(2,5-dimethoxybenzylidine) methylamine. To a solution of
2,5-dimethoxybenzaldehyde (20.00g, 0.12 mol) in toluene (100 ml) was
added methylamine (22.5 ml of an 8.03M solution in ethanol, 0.18 mol) at
room temperature. The solution became cloudy within 10 min. due to the
condensation of water. The reaction had gone to completion within 30 min.
according to GC analysis and the solvent was then removed in vacuo to
give the required product; (21.17g, 98%) as a yellow oil. δH (CDCl3, 270
MHz) 3.50 (3H, s), 3.80 (3H, s), 3.85 (3H, s), 6.80 (1H, m), 7.00 (1H,
m), 7.50 (1H, m) and 8.70 (1H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing benzodiazepines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hayes, Jerome Francis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000063186 A1 2000-10-26

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-thiazolecarboxylate
C12H18N2O4S
96929-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.3158 5.8826 0.0 0
M  V30 2 O 12.7226 5.2562 0.0 0
M  V30 3 O 11.1547 7.4142 0.0 0
M  V30 4 C 13.9684 6.1614 0.0 0
M  V30 5 C 15.3754 5.5351 0.0 0
M  V30 6 C 6.1600 4.2074 0.0 0
M  V30 7 N 5.3900 2.8736 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 O 3.0800 1.5400 0.0 0
M  V30 10 O 3.0800 4.2074 0.0 0
M  V30 11 C 1.5400 1.5400 0.0 0
M  V30 12 C 1.5400 3.0800 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 10.0699 4.9774 0.0 0
M  V30 16 N 8.6052 5.4533 0.0 0
M  V30 17 C 10.0699 3.4374 0.0 0
M  V30 18 C 7.7000 4.2074 0.0 0
M  V30 19 S 8.6052 2.9616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-[(methylamino)carbonyl]-2-thiazolyl]methyl]carbamate
C11H17N3O3S
1266095-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 O 2.6673 2.3101 0.0 0
M  V30 5 O 4.0010 0.0000 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 2.1037 0.2064 0.0 0
M  V30 10 C 11.9711 2.6672 0.0 0
M  V30 11 N 12.8764 3.9131 0.0 0
M  V30 12 O 12.5976 1.2602 0.0 0
M  V30 13 C 14.4079 3.7521 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 N 9.4091 1.6836 0.0 0
M  V30 16 S 8.1633 3.8416 0.0 0
M  V30 17 C 10.4396 2.8281 0.0 0
M  V30 18 C 9.6696 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96929-05-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266095-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18533998
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the molecular hybrid inspired by Largazole and Psammaplin A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Xiaoling; Zhang, Bingbing; Shan, Guangsheng; Wu, Yue; Yang,
Feng-Ling; Lei, Xinsheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2018), 74(5), 549-555

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
(3S)-2,3-Dihydro-3-(2E)-2-nonen-1-yl-2-oxo-1H-indole-3-acetic acid
C19H25NO3
524932-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4658 3.2896 0.0 0
M  V30 2 C 6.7995 4.0596 0.0 0
M  V30 3 C 8.1332 3.2896 0.0 0
M  V30 4 C 9.4668 4.0596 0.0 0
M  V30 5 C 10.8006 3.2896 0.0 0
M  V30 6 C 12.1343 4.0596 0.0 0
M  V30 7 C 13.4679 3.2896 0.0 0
M  V30 8 C 14.8016 4.0596 0.0 0
M  V30 9 C 16.1354 3.2896 0.0 0
M  V30 10 C 3.5057 2.6528 0.0 0
M  V30 11 C 4.4109 1.4070 0.0 0
M  V30 12 O 5.9425 1.5679 0.0 0
M  V30 13 O 3.7846 0.0000 0.0 0
M  V30 14 O 6.5773 5.3057 0.0 0
M  V30 15 C 4.1320 4.0596 0.0 0 CFG=1
M  V30 16 C 2.6675 4.5357 0.0 0
M  V30 17 C 5.0373 5.3057 0.0 0
M  V30 18 C 2.6675 6.0757 0.0 0
M  V30 19 C 1.3338 3.7657 0.0 0
M  V30 20 N 4.1320 6.5516 0.0 0
M  V30 21 C 1.3338 6.8457 0.0 0
M  V30 22 C 0.0000 4.5357 0.0 0
M  V30 23 C 0.0000 6.0757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 15 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 17
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-2,3-Dihydro-N-methyl-3-(2E)-2-nonen-1-yl-2-oxo-1H-indole-3-acetamide
C20H28N2O2
524932-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4658 4.5356 0.0 0
M  V30 2 C 6.7994 5.3056 0.0 0
M  V30 3 C 8.1331 4.5356 0.0 0
M  V30 4 C 9.4667 5.3056 0.0 0
M  V30 5 C 10.8005 4.5356 0.0 0
M  V30 6 C 12.1342 5.3056 0.0 0
M  V30 7 C 13.4678 4.5356 0.0 0
M  V30 8 C 14.8015 5.3056 0.0 0
M  V30 9 C 16.1353 4.5356 0.0 0
M  V30 10 C 3.5057 3.8987 0.0 0
M  V30 11 C 4.4109 2.6528 0.0 0
M  V30 12 N 3.7846 1.2459 0.0 0
M  V30 13 O 5.9424 2.8137 0.0 0
M  V30 14 C 4.6896 0.0000 0.0 0
M  V30 15 O 6.5772 6.5515 0.0 0
M  V30 16 C 4.1320 5.3056 0.0 0 CFG=1
M  V30 17 C 2.6674 5.7815 0.0 0
M  V30 18 C 5.0372 6.5515 0.0 0
M  V30 19 C 2.6674 7.3215 0.0 0
M  V30 20 C 1.3338 5.0115 0.0 0
M  V30 21 N 4.1320 7.7974 0.0 0
M  V30 22 C 1.3338 8.0915 0.0 0
M  V30 23 C 0.0000 5.7815 0.0 0
M  V30 24 C 0.0000 7.3215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 16 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 2 15 18
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 524932-53-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 524932-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5364274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective total synthesis of (-)-pseudophrynaminol through tandem
olefination, isomerization and asymmetric Claisen rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasaki, Tomomi; Ogawa, Atsuyo; Takashima, Yasuyuki; Sakamoto, Masanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(8), 1591-1593

$RFMT $RIREG SCHEME18 STEP1
$RXN



  3  1
$MOL
2-Methyl-2-nitro-1-propanol
C4H9NO3
76-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 1.3337 0.0 0 VAL=5
M  V30 3 C 3.6437 1.8973 0.0 0
M  V30 4 C 3.0801 4.0010 0.0 0
M  V30 5 C 0.9762 3.4374 0.0 0
M  V30 6 O 2.3101 0.0000 0.0 0
M  V30 7 O 0.0000 1.3337 0.0 0
M  V30 8 O 4.9774 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanol, 2-methyl-2-nitro-, 1-(N-methylcarbamate)
C6H12N2O4
1616537-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 C 3.6439 1.8973 0.0 0
M  V30 3 N 1.5400 1.3337 0.0 0 VAL=5
M  V30 4 C 0.9764 3.4374 0.0 0
M  V30 5 C 3.0801 4.0010 0.0 0
M  V30 6 O 4.9775 2.6673 0.0 0
M  V30 7 O 2.3101 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 9 C 6.3112 1.8973 0.0 0
M  V30 10 N 7.6449 2.6673 0.0 0
M  V30 11 O 6.3112 0.3573 0.0 0
M  V30 12 C 8.9787 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 3 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-39-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616537-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-7172658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Methy2-nitropropyl Methylcarbamate (3). Under an argon atmosphere and
with stirring in a sealed tube, 2-methy2-nitro-1- propanol (1 g, 8.39
mmol), DCI (2.11 g, 16.78 mmol), and DMAP (0.102 g, 0.839 mmol) were
dissolved in THF under an argon atmosphere. After 2 h of stirring at room
temperature, methylamine (1.13 g, 16.78 mmol) was added and the stirring
was continued for 18 h. Then, the mixture was filtered and the solvent
was removed under vacuum. The crude mixture was purified by flash
chromatography (cyclohexane/EtOAc 9/1 v/v) to give compound 3. White
powder, 1.45 g, 8.23 mmol, 98%. Rf = 0.30 (cyclohexane/EtOAc 8/2 v/v); mp
48.3−49.3 °C; 1H NMR (CDCl3, 250 MHz) δ 4.76 (1H, bs), 4.39 (2H, s), 2.78
(3H, d, J = 4.90 Hz), 1.59 (6H, s); 13C NMR (CDCl3, 62.86 MHz) δ 156.0
(CO), 86.7 (C), 68.7 (CH2), 27.6, 23.0 (CH3). HR-MS (ESI+, m/z) calcd for
C6H13N2O4 [(M + H)+] 177.0875, found 177.0878.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivities of Substituted α-Phenyl-N-tert-butyl Nitrones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosselin, Marie; Choteau, Fanny; Zeamari, Kamal; Nash, Kevin M.; Das,
Amlan; Lauricella, Robert; Lojou, Elisabeth; Tuccio, Beatrice; Villamena,
Frederick A.; Durand, Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(14), 6615-6626

$RFMT $RIREG SCHEME19 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-methoxybenzaldehyde 2-(2-pyridinyl)hydrazone
C13H13N3O2
90170-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 N 7.7000 6.6685 0.0 0
M  V30 4 O 0.7700 2.6674 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3336 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 N 10.0100 8.0021 0.0 0
M  V30 16 C 11.5500 5.3347 0.0 0
M  V30 17 C 11.5500 8.0021 0.0 0
M  V30 18 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-[[(methylamino)carbonyl]oxy]benzaldehyde 1-[2-(2-pyridinyl)hydraz...
C15H16N4O3
222620-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5503 4.0012 0.0 0
M  V30 2 C 12.3203 5.3348 0.0 0
M  V30 3 N 13.8603 5.3348 0.0 0
M  V30 4 O 11.5503 6.6685 0.0 0
M  V30 5 C 14.6303 6.6685 0.0 0
M  V30 6 O 10.0102 1.3337 0.0 0
M  V30 7 C 9.2402 0.0000 0.0 0
M  V30 8 C 5.3901 4.0012 0.0 0
M  V30 9 N 4.6201 5.3348 0.0 0
M  V30 10 N 3.0801 5.3348 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 9.2402 2.6675 0.0 0
M  V30 13 C 9.2402 5.3348 0.0 0
M  V30 14 C 7.7002 2.6675 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 6.9302 4.0012 0.0 0
M  V30 17 C 2.3101 6.6685 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 N 3.0801 8.0023 0.0 0
M  V30 20 C 0.0000 8.0023 0.0 0
M  V30 21 C 2.3101 9.3360 0.0 0
M  V30 22 C 0.7700 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9 CFG=2
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90170-19-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 222620-53-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-21299479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminoalkylphenols and related compounds for treatment of
memory dysfunction.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kosley, Raymond W., Jr.; Palermo, Mark G.; Shimshock, Stephen J.; Wolf,
Veronica
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6479495 B1 2002-11-12

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-(1,1-dimethylethyl)benzene
C14H21BrO
53669-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.1037 0.0000 0.0 0
M  V30 3 C 0.0000 0.5637 0.0 0
M  V30 4 C 0.5637 2.6673 0.0 0
M  V30 5 O 6.6685 4.4137 0.0 0
M  V30 6 C 8.0022 3.6437 0.0 0
M  V30 7 C 9.3360 4.4137 0.0 0
M  V30 8 C 10.6697 3.6437 0.0 0
M  V30 9 C 12.0033 4.4137 0.0 0
M  V30 10 Br 13.3370 3.6437 0.0 0
M  V30 11 C 2.6673 2.1037 0.0 0
M  V30 12 C 4.0010 1.3337 0.0 0
M  V30 13 C 2.6673 3.6437 0.0 0
M  V30 14 C 5.3348 2.1037 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(1,1-Dimethylethyl)phenoxy]-N-methyl-1-butanamine
C15H25NO
1195950-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.1037 0.0000 0.0 0
M  V30 3 C 0.0000 0.5637 0.0 0
M  V30 4 C 0.5637 2.6673 0.0 0
M  V30 5 O 6.6685 4.4137 0.0 0
M  V30 6 C 8.0022 3.6437 0.0 0
M  V30 7 C 9.3358 4.4137 0.0 0
M  V30 8 C 10.6697 3.6437 0.0 0
M  V30 9 C 12.0033 4.4137 0.0 0
M  V30 10 N 13.3370 3.6437 0.0 0
M  V30 11 C 14.6707 4.4137 0.0 0
M  V30 12 C 2.6673 2.1037 0.0 0
M  V30 13 C 4.0010 1.3337 0.0 0
M  V30 14 C 2.6673 3.6437 0.0 0
M  V30 15 C 5.3348 2.1037 0.0 0
M  V30 16 C 4.0010 4.4137 0.0 0
M  V30 17 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53669-73-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10772190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophthalic anhydride
C8H3NO5
5466-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 N 7.2706 3.9844 0.0 0 VAL=5
M  V30 4 O 8.0406 5.3182 0.0 0
M  V30 5 O 8.0406 2.6508 0.0 0
M  V30 6 C 3.4206 2.6508 0.0 0
M  V30 7 C 2.6506 3.9844 0.0 0
M  V30 8 C 4.9606 2.6508 0.0 0
M  V30 9 C 2.3902 1.5064 0.0 0
M  V30 10 C 1.1444 3.6643 0.0 0
M  V30 11 C 3.4206 5.3182 0.0 0
M  V30 12 C 5.7306 3.9844 0.0 0
M  V30 13 O 0.9834 2.1327 0.0 0
M  V30 14 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-nitro-1H-isoindole-1,3(2H)-dione
C9H6N2O4
41663-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4210 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 N 7.9108 4.2504 0.0 0 VAL=5
M  V30 4 O 7.9108 5.7904 0.0 0
M  V30 5 O 9.2446 3.4804 0.0 0
M  V30 6 C 0.0000 2.7104 0.0 0
M  V30 7 C 3.9099 3.4804 0.0 0
M  V30 8 C 3.9099 1.9404 0.0 0
M  V30 9 C 5.2436 4.2504 0.0 0
M  V30 10 C 2.4452 3.9564 0.0 0
M  V30 11 C 2.4452 1.4645 0.0 0
M  V30 12 C 5.2436 1.1704 0.0 0
M  V30 13 C 6.5772 3.4804 0.0 0
M  V30 14 N 1.5400 2.7104 0.0 0
M  V30 15 C 6.5772 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5466-84-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41663-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35289719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Insecticidal Activities, and 3D-QASR of N-Pyridylpyrazole
Amide Derivatives Containing a Phthalimide as Potential Ryanodine
Receptor Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Lu; Chen, Ruijia; Li, Xiaoyang; Xu, Xiaoyong; Xu, Zhiping; Cheng,
Jiagao; Wang, Yanli; Li, Yuxin; Shao, XuSheng; Li, Zhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2022), 70(39), 12651-12662

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
trans-4-[4-(Phenylmethoxy)butoxy]cyclohexanecarboxylic acid
C18H26O4
554455-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 12.0035 4.6201 0.0 0
M  V30 6 O 13.3372 3.8501 0.0 0
M  V30 7 C 14.6708 4.6201 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 17 C 16.0045 3.8501 0.0 0
M  V30 18 C 17.3383 4.6201 0.0 0
M  V30 19 C 16.0045 2.3101 0.0 0
M  V30 20 C 18.6720 3.8501 0.0 0
M  V30 21 C 17.3383 1.5400 0.0 0
M  V30 22 C 18.6720 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 16 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-N-Methyl-4-[4-(phenylmethoxy)butoxy]cyclohexanecarboxamide
C19H29NO3
554455-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0033 4.6201 0.0 0
M  V30 2 C 10.6697 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 O 5.3348 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 17.3382 1.5400 0.0 0
M  V30 9 N 18.6720 2.3101 0.0 0
M  V30 10 O 17.3382 0.0000 0.0 0
M  V30 11 C 20.0057 1.5400 0.0 0
M  V30 12 C 13.3372 3.8501 0.0 0 CFG=2
M  V30 13 C 13.3372 2.3101 0.0 0
M  V30 14 C 14.6708 4.6201 0.0 0
M  V30 15 C 14.6708 1.5400 0.0 0
M  V30 16 C 16.0045 3.8501 0.0 0
M  V30 17 C 16.0045 2.3101 0.0 0 CFG=2
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 2.6675 2.3101 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 22 C 1.3337 1.5400 0.0 0
M  V30 23 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 17 8 CFG=1
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 554455-48-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 554455-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3468580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclohexane derivatives as inhibitors of
2,3-oxidosqualene-lanosterol cyclase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ackermann, Jean; Aebi, Johannes; Dehmlow, Henrietta; Hirth, Georges;
Maerki, Hans-Peter; Morand, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003053919 A1 2003-07-03

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-nitrobenzene
C10H12BrNO3
55502-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 Br 13.3370 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(4-nitrophenoxy)-1-butanamine
C11H16N2O3
1195950-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3358 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 N 13.3370 3.8501 0.0 0
M  V30 7 C 14.6707 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55502-03-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-25-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6182254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME24 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonyl chloride
C6H5ClO2S
98-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-methyl-1-propene
C4H7Cl
563-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-(2-methyl-2-propen-1-yl)benzenesulfonamide
C11H15NO2S
860514-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 5.3348 5.3901 0.0 0
M  V30 7 C 8.0023 3.8501 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 8.0023 5.3901 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 563-47-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860514-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31639366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Hydrogen Atom Transfer Hydroarylation of Alkenes toward
δ-Lactams Using Cobalt-Photoredox Dual Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamaguchi, Yuto; Seino, Yusuke; Suzuki, Akihiko; Kamei, Yuji; Yoshino,
Tatsuhiko; Kojima, Masahiro; Matsunaga, Shigeki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(12), 2441-2445

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiomorpholine, 4-[2-fluoro-4-[4-(isothiocyanatomethyl)-1H-1,2,3-triazol-1-yl...
C14H14FN5OS2
565459-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.1600 0.0000 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 14.3957 4.3425 0.0 0
M  V30 4 N 15.8026 3.7162 0.0 0
M  V30 5 C 17.0485 4.6213 0.0 0
M  V30 6 S 18.2944 5.5265 0.0 0
M  V30 7 C 6.1600 2.6673 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 6.9300 4.0009 0.0 0
M  V30 10 C 8.4700 1.3336 0.0 0
M  V30 11 C 8.4700 4.0009 0.0 0
M  V30 12 C 9.2400 2.6673 0.0 0
M  V30 13 N 4.6200 2.6673 0.0 0
M  V30 14 C 3.8500 4.0009 0.0 0
M  V30 15 C 3.8500 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 2.3100 1.3336 0.0 0
M  V30 18 S 1.5400 2.6673 0.0 0 VAL=4
M  V30 19 N 10.7801 2.6673 0.0 0
M  V30 20 C 11.6853 3.9132 0.0 0
M  V30 21 N 11.6853 1.4214 0.0 0
M  V30 22 C 13.1498 3.4373 0.0 0
M  V30 23 N 13.1498 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 18
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 2 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 12 19
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-[3-Fluoro-4-(1-oxido-4-thiomorpholinyl)phenyl]-1H-1,2,3-triazol-4-yl]me...
C15H19FN6OS2
565459-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.1600 6.1529 0.0 0
M  V30 2 C 14.3958 1.8104 0.0 0
M  V30 3 N 15.8026 2.4367 0.0 0
M  V30 4 C 17.0484 1.5315 0.0 0
M  V30 5 N 18.4554 2.1580 0.0 0
M  V30 6 S 16.8875 0.0000 0.0 0
M  V30 7 C 19.7012 1.2528 0.0 0
M  V30 8 O 0.0000 3.4856 0.0 0
M  V30 9 C 9.2400 3.4856 0.0 0
M  V30 10 C 8.4700 4.8193 0.0 0
M  V30 11 C 8.4700 2.1518 0.0 0
M  V30 12 C 6.9300 4.8193 0.0 0
M  V30 13 C 6.9300 2.1518 0.0 0
M  V30 14 C 6.1600 3.4856 0.0 0
M  V30 15 N 10.7800 3.4856 0.0 0
M  V30 16 C 11.6852 2.2396 0.0 0
M  V30 17 N 11.6852 4.7315 0.0 0
M  V30 18 C 13.1498 2.7156 0.0 0
M  V30 19 N 13.1498 4.2556 0.0 0
M  V30 20 N 4.6200 3.4856 0.0 0
M  V30 21 C 3.8500 2.1518 0.0 0
M  V30 22 C 3.8500 4.8193 0.0 0
M  V30 23 C 2.3100 2.1518 0.0 0
M  V30 24 C 2.3100 4.8193 0.0 0
M  V30 25 S 1.5400 3.4856 0.0 0 VAL=4
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 25
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 14 20
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 565459-33-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 565459-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-3756395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolyl-phenyl substituted morpholine/thiomorpholine
derivatives as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Jagattaran; Natesan, Selvakumar; Trehan, Sanjay; Iqbal, Javed;
Magadi, Sitaramkumar; Mamidi, Nagavenkatasrinivasarao; Ramanujam,
Rajagopalan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003059894 A1 2003-07-24

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,5-Trichloropyrimidine
C4HCl3N2
5750-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 N 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dichloro-N-methyl-4-pyrimidinamine
C5H5Cl2N3
940927-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5750-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 940927-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17023649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging
of LRRK2 enzyme in Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Min; Gao, Mingzhang; Xu, Zhidong; Zheng, Qi-Huang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(6), 1351-1355

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzoyl chloride
C7H4BrClO
586-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14467037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Bromo-N-methyl-benzamide 4-Bromo benzoyl chloride (5.0g, 22.8 mmol) was
added to DCM (100 ml), to this was added TEA (7.0 ml, 50.2 mmol) followed
by the slow addition of methylamine (20 ml, 2.0N in THF). The reaction
was stirred for 1 hour before being quenched with HCl (2.0 N; 50 ml), the
reaction was extracted with DCM (2 x 100 ml), dried and the solvent was
removed in vacuo to yield a white solid, yield 4.8 g, 98%. NMR (299.954
MHz, CDCl3) 7.62 (d, 2H), 7.55 (d, 2H), 6.16 (s, 3H), 3.00 (d, 6H); m/z
215
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(4-(imidazol-4-yl)-pyrimidin-2-ylamino)benzamides as CDK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006064251 A1 2006-06-22

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
4-Bromobenzoic acid
C7H5BrO2
586-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-76-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7669895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed synthesis of phosphonium salts from aryl halides and
triphenylphosphine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marcoux, David; Charette, Andre B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2008), 350(18), 2967-2974

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
4-Bromobenzoic acid
C7H5BrO2
586-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-76-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20517635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Bond Directed ortho-Selective C-H Borylation of Secondary
Aromatic Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bai, Shao-Tao; Bheeter, Charles B.; Reek, Joost N. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(37), 13039-13043

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromopropoxy)benzene
C9H11BrO
588-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 Br 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-phenoxy-1-propanamine
C10H15NO
132424-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 588-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132424-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-470198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Antifungal Activity of Novel Conformationally
Restricted Triazole Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Miao, Zhenyuan;
Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2009), 342(12), 732-739

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-threo-Pentonoperoxoic acid, 2,3-anhydro-4,5-dideoxy-5-phenyl-, 1,1-dimethyl...
C15H20O4
590410-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5422 2.3101 0.0 0
M  V30 2 O 10.8760 3.0801 0.0 0
M  V30 3 O 9.5422 0.7700 0.0 0
M  V30 4 O 12.2097 2.3101 0.0 0
M  V30 5 C 13.5434 3.0801 0.0 0
M  V30 6 C 14.3134 1.7464 0.0 0
M  V30 7 C 14.8770 3.8501 0.0 0
M  V30 8 C 12.7733 4.4137 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 8.2085 3.0801 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 13 O 7.4385 4.4137 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 12 9 CFG=3
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3-Anhydro-4,5-dideoxy-N-methyl-5-phenyl-L-threo-pentonamide
C12H15NO2
485809-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5424 2.3101 0.0 0
M  V30 2 N 10.8760 3.0801 0.0 0
M  V30 3 O 9.5424 0.7700 0.0 0
M  V30 4 C 12.2097 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 8.2085 3.0801 0.0 0 CFG=2
M  V30 8 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 9 O 7.4385 4.4137 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 8 5 CFG=3
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590410-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 485809-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27145288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic asymmetric epoxidation of α,β-unsaturated carboxylic acid
imidazolides and amides by lanthanide-BINOL complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohshima, Takashi; Nemoto, Tetsuhiro; Tosaki, Shin-ya; Kakei, Hiroyuki;
Gnanadesikan, Vijay; Shibasaki, Masakatsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(52), 10485-10497

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-threo-Pentonoperoxoic acid, 2,3-anhydro-4,5-dideoxy-5-phenyl-, 1,1-dimethyl...
C15H20O4
590410-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5422 2.3101 0.0 0
M  V30 2 O 10.8760 3.0801 0.0 0
M  V30 3 O 9.5422 0.7700 0.0 0
M  V30 4 O 12.2097 2.3101 0.0 0
M  V30 5 C 13.5434 3.0801 0.0 0
M  V30 6 C 14.3134 1.7464 0.0 0
M  V30 7 C 14.8770 3.8501 0.0 0
M  V30 8 C 12.7733 4.4137 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 8.2085 3.0801 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 13 O 7.4385 4.4137 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 12 9 CFG=3
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3-Anhydro-4,5-dideoxy-N-methyl-5-phenyl-L-threo-pentonamide
C12H15NO2
485809-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5424 2.3101 0.0 0
M  V30 2 N 10.8760 3.0801 0.0 0
M  V30 3 O 9.5424 0.7700 0.0 0
M  V30 4 C 12.2097 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 8.2085 3.0801 0.0 0 CFG=2
M  V30 8 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 9 O 7.4385 4.4137 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 8 5 CFG=3
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590410-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 485809-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27364271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unique reactivity of α,β-unsaturated carboxylic acid imidazolides:
catalytic asymmetric synthesis of α,β-epoxy esters and α,β-epoxy
carboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nemoto, Tetsuhiro; Tosaki, Shin-Ya; Ohshima, Takashi; Shibasaki,
Masakatsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chirality (2003), 15(4), 306-311

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isobutyl isothiocyanate
C5H9NS
591-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0
M  V30 4 C 1.3338 0.0000 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 S 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-(2-methylpropyl)thiourea
C6H14N2S
59814-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 N 4.0011 1.5400 0.0 0
M  V30 3 N 6.6686 1.5400 0.0 0
M  V30 4 S 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-82-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59814-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-10674115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of xanthinethione derivatives as myeloperoxidase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanson, Sverker; Nordvall, Gunnar; Tiden, Anna-Karin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003089430 A1 2003-10-30

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxylic acid, 4-hydroxy-, 1,3-dimethyl ester
C10H10O5
5985-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 O 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 O 8.0023 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-hydroxy-3-[(methylamino)carbonyl]benzoate
C10H11NO4
2306054-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 N 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 O 8.0023 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5985-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2306054-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23796791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent,
Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET)
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucas, Simon C. C.; Atkinson, Stephen J.; Chung, Chun-wa; Davis, Rob;
Gordon, Laurie; Grandi, Paola; Gray, James J. R.; Grimes, Thomas;
Phillipou, Alexander; Preston, Alex G.; Prinjha, Rab K.; Rioja,
Inmaculada; Taylor, Simon; Tomkinson, Nicholas C. O.; Wall, Ian; Watson,
Robert J.; Woolven, James; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 10711-10741

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxylic acid, 4-hydroxy-, 1,3-dimethyl ester
C10H10O5
5985-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 O 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 O 8.0023 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-hydroxy-3-[(methylamino)carbonyl]benzoate
C10H11NO4
2306054-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 N 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 O 8.0023 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5985-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2306054-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21473205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurans as bromodomain inhibitors useful in treatment
of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Lucas, Simon Christopher Cranko; Preston, Alexander G.; Seal, Jonathan
Thomas; Wall, Ian David; Watson, Robert J.; Woolven, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019068783 A1 2019-04-11

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-chloro-3-methylimidazo[1,2-a]pyrazine
C7H5BrClN3
615535-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 C 6.6520 4.5603 0.0 0
M  V30 3 Br 2.6675 0.0000 0.0 0
M  V30 4 C 2.6675 4.6201 0.0 0
M  V30 5 N 4.0012 3.8501 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 N 2.9877 6.1264 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.1456 4.8805 0.0 0
M  V30 10 N 1.3337 2.3101 0.0 0
M  V30 11 C 4.5192 6.2873 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N,3-dimethylimidazo[1,2-a]pyrazin-8-amine
C8H9BrN4
615535-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 4.6201 0.0 0
M  V30 2 C 7.9857 3.8501 0.0 0
M  V30 3 C 0.0000 4.5603 0.0 0
M  V30 4 Br 3.9845 0.0000 0.0 0
M  V30 5 C 3.9845 4.6201 0.0 0
M  V30 6 N 2.6509 3.8501 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 N 3.6644 6.1264 0.0 0
M  V30 9 C 1.5065 4.8805 0.0 0
M  V30 10 C 2.6509 2.3101 0.0 0
M  V30 11 N 5.3182 2.3101 0.0 0
M  V30 12 C 2.1328 6.2873 0.0 0
M  V30 13 C 3.9845 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615535-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615535-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12605899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazothienopyrazines for treatment of inflammatory and
immune diseases.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belema, Makonen; Bunker, Amy; Nguyen, Van; Beaulieu, Francis; Ouellet,
Carl; Marinier, Anne; Roy, Stephan; Yang, Xuejie; Qiu, Yuping; Zhang,
Yunhui; Martel, Alain; Zusi, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003084959 A1 2003-10-16

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonimidic acid, N-[(methylsulfonyl)oxy]-2,3,4,6-tetrakis-O-(phenylmethyl...
C35H37NO8S
620946-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 9.3358 0.0 0
M  V30 2 C 5.3901 9.3358 0.0 0
M  V30 3 O 10.0102 9.3358 0.0 0
M  V30 4 C 9.2402 10.6697 0.0 0
M  V30 5 O 5.3901 6.6685 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 C 11.5503 6.6685 0.0 0
M  V30 8 O 12.3203 8.0022 0.0 0
M  V30 9 C 13.8603 8.0022 0.0 0
M  V30 10 N 6.9302 4.0010 0.0 0
M  V30 11 O 7.7002 2.6673 0.0 0
M  V30 12 S 6.9302 1.3337 0.0 0 VAL=6
M  V30 13 C 8.2638 0.5637 0.0 0
M  V30 14 O 6.1601 0.0000 0.0 0
M  V30 15 O 5.5965 2.1037 0.0 0
M  V30 16 C 7.7002 8.0022 0.0 0 CFG=2
M  V30 17 C 9.2402 8.0022 0.0 0 CFG=2
M  V30 18 C 6.9302 6.6685 0.0 0 CFG=2
M  V30 19 C 10.0102 6.6685 0.0 0 CFG=1
M  V30 20 C 7.7002 5.3348 0.0 0
M  V30 21 O 9.2402 5.3348 0.0 0
M  V30 22 C 4.6201 10.6697 0.0 0
M  V30 23 C 5.3901 12.0033 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 4.6201 13.3370 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 3.0801 13.3370 0.0 0
M  V30 28 C 10.0102 12.0033 0.0 0
M  V30 29 C 9.2402 13.3370 0.0 0
M  V30 30 C 11.5503 12.0033 0.0 0
M  V30 31 C 10.0102 14.6707 0.0 0
M  V30 32 C 12.3203 13.3370 0.0 0
M  V30 33 C 11.5503 14.6707 0.0 0
M  V30 34 C 3.0801 5.3348 0.0 0
M  V30 35 C 2.3101 6.6685 0.0 0
M  V30 36 C 2.3101 4.0010 0.0 0
M  V30 37 C 0.7700 6.6685 0.0 0
M  V30 38 C 0.7700 4.0010 0.0 0
M  V30 39 C 0.0000 5.3348 0.0 0
M  V30 40 C 14.6303 6.6685 0.0 0
M  V30 41 C 13.8603 5.3348 0.0 0
M  V30 42 C 16.1704 6.6685 0.0 0
M  V30 43 C 14.6303 4.0010 0.0 0
M  V30 44 C 16.9404 5.3348 0.0 0
M  V30 45 C 16.1704 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 17 3 CFG=3
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 18 5 CFG=1
M  V30 9 1 6 34
M  V30 10 1 7 8
M  V30 11 1 19 7 CFG=1
M  V30 12 1 8 9
M  V30 13 1 9 40
M  V30 14 1 10 11
M  V30 15 2 10 20 CFG=2
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 2 12 14
M  V30 19 2 12 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,5R,6R,7S,8S)-1-Methyl-6,7,8-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]...
C35H38N2O5
620946-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0102 0.0 0
M  V30 2 C 5.3348 11.5503 0.0 0
M  V30 3 C 10.1060 12.1139 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 C 4.0012 7.7002 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 O 12.0035 7.7002 0.0 0
M  V30 8 C 13.3372 6.9302 0.0 0
M  V30 9 O 8.0023 5.3901 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 8.0023 10.0102 0.0 0 CFG=2
M  V30 12 C 6.6687 9.2402 0.0 0 CFG=1
M  V30 13 N 8.7723 11.3439 0.0 0
M  V30 14 N 7.2323 11.3439 0.0 0
M  V30 15 O 9.3360 9.2402 0.0 0
M  V30 16 C 6.6687 7.7002 0.0 0 CFG=1
M  V30 17 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 18 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 19 C 4.0012 12.3203 0.0 0
M  V30 20 C 4.0012 13.8603 0.0 0
M  V30 21 C 2.6675 11.5503 0.0 0
M  V30 22 C 2.6675 14.6303 0.0 0
M  V30 23 C 1.3338 12.3203 0.0 0
M  V30 24 C 1.3338 13.8603 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 26 C 1.3338 7.7002 0.0 0
M  V30 27 C 2.6675 5.3901 0.0 0
M  V30 28 C 0.0000 6.9302 0.0 0
M  V30 29 C 1.3338 4.6201 0.0 0
M  V30 30 C 0.0000 5.3901 0.0 0
M  V30 31 C 9.3360 3.0801 0.0 0
M  V30 32 C 8.0023 2.3101 0.0 0
M  V30 33 C 10.6697 2.3101 0.0 0
M  V30 34 C 8.0023 0.7700 0.0 0
M  V30 35 C 10.6697 0.7700 0.0 0
M  V30 36 C 9.3360 0.0000 0.0 0
M  V30 37 C 14.6708 7.7002 0.0 0
M  V30 38 C 14.6708 9.2402 0.0 0
M  V30 39 C 16.0045 6.9302 0.0 0
M  V30 40 C 16.0045 10.0102 0.0 0
M  V30 41 C 17.3383 7.7002 0.0 0
M  V30 42 C 17.3383 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 19
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 1 17 6 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 37
M  V30 12 1 9 10
M  V30 13 1 18 9 CFG=1
M  V30 14 1 10 31
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 14 CFG=1
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620946-62-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620946-94-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26551400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonimidic acid, 2,3:4,6-bis-O-(1-methylethylidene)-N-[(methylsulfonyl)ox...
C13H21NO8S
620946-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1097 4.8480 0.0 0
M  V30 2 O 8.8797 6.1816 0.0 0
M  V30 3 S 10.4197 6.1816 0.0 0 VAL=6
M  V30 4 C 10.4197 4.6416 0.0 0
M  V30 5 O 11.9598 6.1816 0.0 0
M  V30 6 O 10.4197 7.7216 0.0 0
M  V30 7 C 3.9993 0.0000 0.0 0
M  V30 8 C 6.0603 0.0000 0.0 0
M  V30 9 C 0.0000 7.1715 0.0 0
M  V30 10 C 0.0000 5.1917 0.0 0
M  V30 11 C 4.2597 3.5143 0.0 0 CFG=1
M  V30 12 C 5.7997 3.5143 0.0 0 CFG=2
M  V30 13 C 3.4897 4.8480 0.0 0 CFG=2
M  V30 14 O 3.7838 2.0496 0.0 0
M  V30 15 C 6.5697 4.8480 0.0 0
M  V30 16 O 6.2756 2.0496 0.0 0
M  V30 17 C 4.2597 6.1816 0.0 0 CFG=1
M  V30 18 O 1.9497 4.8480 0.0 0
M  V30 19 C 5.0297 1.1444 0.0 0
M  V30 20 O 5.7997 6.1816 0.0 0
M  V30 21 C 3.4897 7.5153 0.0 0
M  V30 22 C 1.1797 6.1816 0.0 0
M  V30 23 O 1.9497 7.5153 0.0 0
M  V30 24 H 2.9397 2.7211 0.0 0
M  V30 25 H 7.3312 3.3532 0.0 0
M  V30 26 H 2.4007 3.7590 0.0 0
M  V30 27 H 5.0297 7.5153 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 15 CFG=2
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 19
M  V30 8 1 8 19
M  V30 9 1 9 22
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 24 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 25 CFG=3
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 13 26 CFG=1
M  V30 21 1 14 19
M  V30 22 1 15 20
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 1 17 21
M  V30 26 1 17 27 CFG=3
M  V30 27 1 18 22
M  V30 28 1 21 23
M  V30 29 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,3′aS,5′aR,9′aR,9′bS)-Tetrahydro-1,2′,2′,8′,8′-pentamethylspiro[diaziridin...
C13H22N2O5
620946-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5271 0.0000 0.0 0
M  V30 2 C 9.2409 5.7390 0.0 0
M  V30 3 C 8.2104 7.5238 0.0 0
M  V30 4 C 1.7146 8.3915 0.0 0
M  V30 5 C 0.0000 7.4015 0.0 0
M  V30 6 C 5.2971 2.8738 0.0 0 CFG=2
M  V30 7 C 6.0671 4.2074 0.0 0 CFG=1
M  V30 8 O 3.7571 2.8738 0.0 0
M  V30 9 N 5.2971 1.3338 0.0 0
M  V30 10 N 6.6309 2.1038 0.0 0
M  V30 11 C 5.2971 5.5411 0.0 0 CFG=1
M  V30 12 O 7.5736 4.5276 0.0 0
M  V30 13 C 2.9871 4.2074 0.0 0 CFG=2
M  V30 14 C 3.7571 5.5411 0.0 0 CFG=2
M  V30 15 O 6.3277 6.6856 0.0 0
M  V30 16 C 7.7345 6.0591 0.0 0
M  V30 17 C 1.4471 4.2074 0.0 0
M  V30 18 O 2.9871 6.8747 0.0 0
M  V30 19 O 0.6771 5.5411 0.0 0
M  V30 20 C 1.4471 6.8747 0.0 0
M  V30 21 H 6.9724 2.9616 0.0 0
M  V30 22 H 5.3241 7.0809 0.0 0
M  V30 23 H 2.2171 2.8738 0.0 0
M  V30 24 H 4.1558 7.0286 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 16
M  V30 3 1 3 16
M  V30 4 1 4 20
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10 CFG=1
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 21 CFG=1
M  V30 13 1 8 13
M  V30 14 1 9 10
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 22 CFG=1
M  V30 18 1 12 16
M  V30 19 1 13 14
M  V30 20 1 13 17
M  V30 21 1 13 23 CFG=1
M  V30 22 1 14 18
M  V30 23 1 14 24 CFG=3
M  V30 24 1 15 16
M  V30 25 1 17 19
M  V30 26 1 18 20
M  V30 27 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 11 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620946-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620946-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28955774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Gluconimidic-15N acid, N-[(methylsulfonyl)oxy]-2,3,4,6-tetrakis-O-(phenylme...
C35H37NO8S
620946-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 5.3348 0.0 0
M  V30 2 C 9.2402 4.0010 0.0 0
M  V30 3 O 6.9302 5.3348 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 O 11.5503 8.0022 0.0 0
M  V30 6 C 12.3203 9.3358 0.0 0
M  V30 7 C 5.3901 8.0022 0.0 0
M  V30 8 O 4.6201 9.3358 0.0 0
M  V30 9 C 3.0801 9.3358 0.0 0
M  V30 10 N 10.0102 10.6697 0.0 0 MASS=15
M  V30 11 O 9.2402 12.0033 0.0 0
M  V30 12 S 10.0102 13.3370 0.0 0 VAL=6
M  V30 13 C 8.6766 14.1070 0.0 0
M  V30 14 O 10.7802 14.6707 0.0 0
M  V30 15 O 11.3439 12.5670 0.0 0
M  V30 16 C 9.2402 6.6685 0.0 0 CFG=2
M  V30 17 C 7.7002 6.6685 0.0 0 CFG=2
M  V30 18 C 10.0102 8.0022 0.0 0 CFG=1
M  V30 19 C 6.9302 8.0022 0.0 0 CFG=1
M  V30 20 C 9.2402 9.3358 0.0 0
M  V30 21 O 7.7002 9.3358 0.0 0
M  V30 22 C 10.0102 2.6673 0.0 0
M  V30 23 C 11.5503 2.6673 0.0 0
M  V30 24 C 9.2402 1.3337 0.0 0
M  V30 25 C 12.3203 1.3337 0.0 0
M  V30 26 C 10.0102 0.0000 0.0 0
M  V30 27 C 11.5503 0.0000 0.0 0
M  V30 28 C 4.6201 4.0010 0.0 0
M  V30 29 C 3.0801 4.0010 0.0 0
M  V30 30 C 5.3901 2.6673 0.0 0
M  V30 31 C 2.3101 2.6673 0.0 0
M  V30 32 C 4.6201 1.3337 0.0 0
M  V30 33 C 3.0801 1.3337 0.0 0
M  V30 34 C 13.8603 9.3358 0.0 0
M  V30 35 C 14.6303 10.6697 0.0 0
M  V30 36 C 14.6303 8.0022 0.0 0
M  V30 37 C 16.1704 10.6697 0.0 0
M  V30 38 C 16.1704 8.0022 0.0 0
M  V30 39 C 16.9404 9.3358 0.0 0
M  V30 40 C 2.3101 10.6697 0.0 0
M  V30 41 C 0.7700 10.6697 0.0 0
M  V30 42 C 3.0801 12.0033 0.0 0
M  V30 43 C 0.0000 12.0033 0.0 0
M  V30 44 C 2.3101 13.3370 0.0 0
M  V30 45 C 0.7700 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 17 3 CFG=3
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 18 5 CFG=3
M  V30 9 1 6 34
M  V30 10 1 7 8
M  V30 11 1 19 7 CFG=1
M  V30 12 1 8 9
M  V30 13 1 9 40
M  V30 14 1 10 11
M  V30 15 2 10 20 CFG=2
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 2 12 14
M  V30 19 2 12 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Oxa-1,2-diazaspiro[2.5]octane-1-15N, 1-methyl-6,7,8-tris(phenylmethoxy)-5-[...
C35H38N2O5
620946-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0102 0.0 0
M  V30 2 C 5.3348 11.5503 0.0 0
M  V30 3 C 10.1060 12.1139 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 C 4.0012 7.7002 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 O 12.0035 7.7002 0.0 0
M  V30 8 C 13.3372 6.9302 0.0 0
M  V30 9 O 8.0023 5.3901 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 8.0023 10.0102 0.0 0 CFG=2
M  V30 12 C 6.6687 9.2402 0.0 0 CFG=2
M  V30 13 N 8.7723 11.3439 0.0 0
M  V30 14 N 7.2323 11.3439 0.0 0 MASS=15
M  V30 15 O 9.3360 9.2402 0.0 0
M  V30 16 C 6.6687 7.7002 0.0 0 CFG=1
M  V30 17 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 18 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 19 C 4.0012 12.3203 0.0 0
M  V30 20 C 4.0012 13.8603 0.0 0
M  V30 21 C 2.6675 11.5503 0.0 0
M  V30 22 C 2.6675 14.6303 0.0 0
M  V30 23 C 1.3338 12.3203 0.0 0
M  V30 24 C 1.3338 13.8603 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 26 C 2.6675 5.3901 0.0 0
M  V30 27 C 1.3338 7.7002 0.0 0
M  V30 28 C 1.3338 4.6201 0.0 0
M  V30 29 C 0.0000 6.9302 0.0 0
M  V30 30 C 0.0000 5.3901 0.0 0
M  V30 31 C 9.3360 3.0801 0.0 0
M  V30 32 C 8.0023 2.3101 0.0 0
M  V30 33 C 10.6697 2.3101 0.0 0
M  V30 34 C 8.0023 0.7700 0.0 0
M  V30 35 C 10.6697 0.7700 0.0 0
M  V30 36 C 9.3360 0.0000 0.0 0
M  V30 37 C 14.6708 7.7002 0.0 0
M  V30 38 C 16.0045 6.9302 0.0 0
M  V30 39 C 14.6708 9.2402 0.0 0
M  V30 40 C 17.3383 7.7002 0.0 0
M  V30 41 C 16.0045 10.0102 0.0 0
M  V30 42 C 17.3383 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 19
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 1 17 6 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 37
M  V30 12 1 9 10
M  V30 13 1 18 9 CFG=1
M  V30 14 1 10 31
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 14 CFG=1
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620946-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620946-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27568789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-methoxybenzene
C10H13BrO2
6267-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 Br 12.0033 3.0801 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methoxyphenoxy)-N-methyl-1-propanamine
C11H17NO2
303104-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 N 12.0033 3.0801 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6267-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 303104-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4728775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-3-methylbenzene
C10H13BrO
6291-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Br 10.6697 3.0801 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(3-methylphenoxy)-1-propanamine
C11H17NO
915923-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6291-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915923-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8704144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
(αS)-1,3-Dihydro-α-(1-methylethyl)-1,3-dioxo-2H-isoindole-2-acetic acid
C13H13NO4
6306-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.7106 0.0 0 CFG=2
M  V30 2 C 1.5400 4.0442 0.0 0
M  V30 3 C 1.5400 1.3769 0.0 0
M  V30 4 C 2.3100 5.3780 0.0 0
M  V30 5 C 0.0000 4.0442 0.0 0
M  V30 6 O 0.0000 1.3769 0.0 0
M  V30 7 O 2.3100 0.0431 0.0 0
M  V30 8 O 4.2792 0.0000 0.0 0
M  V30 9 O 4.2792 5.4211 0.0 0
M  V30 10 N 3.8500 2.7106 0.0 0
M  V30 11 C 4.7551 1.4647 0.0 0
M  V30 12 C 4.7551 3.9564 0.0 0
M  V30 13 C 6.2198 1.9406 0.0 0
M  V30 14 C 6.2198 3.4806 0.0 0
M  V30 15 C 7.5534 1.1706 0.0 0
M  V30 16 C 7.5534 4.2506 0.0 0
M  V30 17 C 8.8870 1.9406 0.0 0
M  V30 18 C 8.8870 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 2 8 11
M  V30 9 2 9 12
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-1,3-Dihydro-N-methyl-α-(1-methylethyl)-1,3-dioxo-2H-isoindole-2-acetamide
C14H16N2O3
512827-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 2.3101 0.0 0 CFG=1
M  V30 2 C 7.4148 3.0801 0.0 0
M  V30 3 C 6.0811 0.7700 0.0 0
M  V30 4 N 8.7486 2.3101 0.0 0
M  V30 5 O 7.4148 4.6201 0.0 0
M  V30 6 C 4.7475 0.0000 0.0 0
M  V30 7 C 7.4148 0.0000 0.0 0
M  V30 8 C 10.0823 3.0801 0.0 0
M  V30 9 O 3.0203 0.9473 0.0 0
M  V30 10 O 5.7309 5.6421 0.0 0
M  V30 11 N 4.7475 3.0801 0.0 0
M  V30 12 C 3.3405 2.4536 0.0 0
M  V30 13 C 4.5865 4.6116 0.0 0
M  V30 14 C 2.3101 3.5981 0.0 0
M  V30 15 C 3.0801 4.9318 0.0 0
M  V30 16 C 0.7700 3.5981 0.0 0
M  V30 17 C 2.3101 6.2655 0.0 0
M  V30 18 C 0.0000 4.9318 0.0 0
M  V30 19 C 0.7700 6.2655 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 2 9 12
M  V30 10 2 10 13
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6306-54-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 512827-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13417045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane).
(S)-N,3-Dimethyl-2-(1,3-dioxoisoindolin-2-yl)butanamide (3i)
[PhtN-L-Val-NHMe]. Following GP-III, from PhtN-L-Val- OH 2i (1.24 g, 5
mmol) gives title compound 3i as a white solid (1.28 g, > 98 %); mp 137°C
(EtOAc/cyclohexane); [α]D -28.9 (c 1.0, CH2Cl2); δH (400.14 MHz, CDCl3):
0.85 (d, 3 H, 3JHH = 6.5 Hz), 1.10 (d, 3 H, 3JHH = 6.5 Hz), 2.82 (d, 3 H,
3JHH = 6.5 Hz), 4.42 (d, 1 H, 3JHH = 11.5 Hz), 6.97 (bs, 1 H), 7.77
(2×dd, 2 H, 4JHH = 3.0 Hz, 3JHH = 5.7 Hz), 7.86 (2×dd, 2 H, 4JHH = 3.3
Hz, 3JHH = 5.2 Hz); δC (100.63 MHz, CDCl3): 19.44 (q), 19.75 (q), 26.22
(q), 27.57 (d), 63.10 (d), 123.56 (2×d), 131.34 (2×s), 134.35 (2×d),
168.39 (2×s), 169.39 (s); GC-MS-CI, m/z: 260 [M+H], 277 [M+NH3]; EI, m/z
(%): 260 (3) [M], 218 (65) [M-C3H6], 202 (100) [M-C2H5NO], 188 (11)
[218-CH5N], 160 (31) [202-C3H6], 148 (57) [M-C6H11NO], 130 (44)
[M-C8H4O2], 104 (17) [148-CHNO], 76 (13), 55 (25). Analytical and
spectral data agree with literature.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(chlorosulfonyl)-, methyl ester
C8H7ClO4S
63555-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 Cl 0.0000 3.8501 0.0 0
M  V30 7 O 2.1037 4.4137 0.0 0
M  V30 8 O 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)sulfonyl]benzoate
C9H11NO4S
1094752-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6673 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 3.4374 4.4137 0.0 0
M  V30 4 O 1.8973 1.7464 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0023 4.6201 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63555-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094752-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24821774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Aroylsulfonamide-Photofragmentation (ASAP)-A Versatile Route to Biaryls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wessig, Pablo; Krebs, Saskia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(46), 6367-6374

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
6-Methoxy-1-methyl-2-(trifluoromethyl)-1H-indole-3-carboxylic acid
C12H10F3NO3
638218-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 1.1444 0.0 0
M  V30 2 O 2.0029 0.8242 0.0 0
M  V30 3 O 4.5398 0.0000 0.0 0
M  V30 4 C 1.5400 3.8549 0.0 0
M  V30 5 F 1.5400 5.3949 0.0 0
M  V30 6 F 0.0000 3.8549 0.0 0
M  V30 7 F 1.5400 2.3149 0.0 0
M  V30 8 C 3.5094 6.5653 0.0 0
M  V30 9 O 9.4508 5.3949 0.0 0
M  V30 10 C 10.7846 4.6249 0.0 0
M  V30 11 C 3.9852 2.6091 0.0 0
M  V30 12 C 3.0800 3.8549 0.0 0
M  V30 13 C 5.4499 3.0849 0.0 0
M  V30 14 N 3.9852 5.1008 0.0 0
M  V30 15 C 5.4499 4.6249 0.0 0
M  V30 16 C 6.7835 2.3149 0.0 0
M  V30 17 C 6.7835 5.3949 0.0 0
M  V30 18 C 8.1172 3.0849 0.0 0
M  V30 19 C 8.1172 4.6249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 15
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N,1-dimethyl-2-(trifluoromethyl)-1H-indole-3-carboxamide
C13H13F3N2O2
638218-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 2.6091 0.0 0
M  V30 2 N 4.5398 1.4647 0.0 0
M  V30 3 O 2.0029 2.2889 0.0 0
M  V30 4 C 4.0639 0.0000 0.0 0
M  V30 5 C 1.5400 5.3196 0.0 0
M  V30 6 F 1.5400 6.8596 0.0 0
M  V30 7 F 0.0000 5.3196 0.0 0
M  V30 8 F 1.5400 3.7796 0.0 0
M  V30 9 C 3.5094 8.0302 0.0 0
M  V30 10 O 9.4508 6.8596 0.0 0
M  V30 11 C 10.7846 6.0896 0.0 0
M  V30 12 C 3.9852 4.0738 0.0 0
M  V30 13 C 5.4499 4.5496 0.0 0
M  V30 14 C 3.0800 5.3196 0.0 0
M  V30 15 C 5.4499 6.0896 0.0 0
M  V30 16 C 6.7835 3.7796 0.0 0
M  V30 17 N 3.9852 6.5655 0.0 0
M  V30 18 C 6.7835 6.8596 0.0 0
M  V30 19 C 8.1172 4.5496 0.0 0
M  V30 20 C 8.1172 6.0896 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 20
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 638218-43-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638218-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-751705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofused heteroaryl amide derivatives of thienopyridines
as tyrosine kinase inhibitors useful against hyperproliferative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romines, William Henry, III; Kania, Robert Steven; Lou, Jihong; Collins,
Michael Raymond; Cripps, Stephan James; He, Mingying; Zhou, Ru; Palmer,
Cynthia Louise; Deal, Judith Gail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003106462 A1 2003-12-24

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Bromoethyl)benzenesulfonyl chloride
C8H8BrClO2S
64062-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 Br 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Bromoethyl)-N-methylbenzenesulfonamide
C9H12BrNO2S
811806-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 0.2064 0.0 0
M  V30 6 C 8.4700 1.5400 0.0 0
M  V30 7 C 9.2400 2.8736 0.0 0
M  V30 8 Br 10.7800 2.8736 0.0 0
M  V30 9 C 3.8500 1.5400 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 4.6200 0.2064 0.0 0
M  V30 12 C 6.1600 2.8736 0.0 0
M  V30 13 C 6.1600 0.2064 0.0 0
M  V30 14 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64062-91-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811806-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-1937566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(N-methylsulfamoyl)phenethyl bromide To a solution of
4-(chlorosulfonyl)phenethyl bromide (10.00 g, 35.2 mmol) in
tetrahydrofuran (200 ml) was added 40% aqueous methylamine solution (9.14
ml, 105.6 mmol) under stirring, and the resulting mixture was stirred at
room temperature for one hour. After evaporating the reaction mixture in
vacuo, water was added to the residue, and the resulting mixture was
extracted with dichloromethane. The extract was washed with water, dried
over anhydrous magnesium sulfate and evaporated in vacuo to afford the
title compound. Title compound (9.63 g) in a yield of 98% as a white
powder. 1H-NMR (500 MHz, CDCl3) δppm: 7.82 (2H, d, J=8 Hz), 7.38 (2H, d,
J=8 Hz), 4.40-4.30 (1H, m), 3.60 (2H, t, J=8 Hz), 3.25 (2H, t, J=8 Hz),
2.68 (3H, d, J=5 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic tertiary amine compounds that inhibit inflammatory
cytokine production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Shimozato, Takaichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070049620 A1 2007-03-01

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,8-Naphthyridine-2,7-dicarboxaldehyde
C10H6N2O2
65896-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 N 4.0012 3.0801 0.0 0
M  V30 8 N 6.6685 3.0801 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H12N4
2757498-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 N 12.0033 2.3101 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 N 5.3348 3.0801 0.0 0
M  V30 10 N 8.0022 3.0801 0.0 0
M  V30 11 C 8.0022 0.0000 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 9.3360 0.7700 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65896-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757498-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32425460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rigid chelating dicarbene ligands based on naphthyridine-fused
bisimidazolium salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yan; She, Zhijie; Zheng, Qinze; Zheng, Xuesong; Wang, Tianbao; Gao,
Ge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(6), 2993-2996

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzaldehyde
C7H5BrO
6630-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzylamine
C8H10BrN
698-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6630-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4144121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves 3A used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New coupling reaction of phenacylamine derivatives with silylstannane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iwai, Yasumasa; Kita, Kumiko; Matsushita, Yoko; Yamauchi, Aiko; Kihara,
Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2002), 50(3), 441-443

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-phenyl-4H-3,1-benzoxazin-4-one
C14H8BrNO2
66387-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 0.0000 0.0 0
M  V30 2 Br 11.5500 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 9.2400 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 9.2400 5.3349 0.0 0
M  V30 11 O 5.3900 1.3338 0.0 0
M  V30 12 C 10.0100 4.0011 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.7700 1.3338 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-(benzoylamino)-5-bromo-N-methyl-
C15H13BrN2O2
2919020-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 O 5.3900 8.0021 0.0 0
M  V30 4 C 6.9300 2.6674 0.0 0
M  V30 5 N 7.7000 1.3336 0.0 0
M  V30 6 O 5.3900 2.6674 0.0 0
M  V30 7 C 6.9300 0.0000 0.0 0
M  V30 8 Br 11.5500 5.3347 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66387-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919020-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35751409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of New Quinazolin-4-one Derivatives with Negative
mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaczorowska, Katarzyna; Stankiewicz, Anna; Bugno, Ryszard; Paluchowska,
Maria H.; Burnat, Grzegorz; Branski, Piotr; Cieslik, Paulina; Wieronska,
Joanna M.; Milik, Mariusz; Nowak, Mateusz; Przybylowicz, Agnieszka;
Koziol, Aneta; Hogendorf, Agata; Hogendorf, Adam S.; Kalinowska-Tluscik,
Justyna; Duszynska, Beata; Pilc, Andrzej; Bojarski, Andrzej J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2023), 24(3), 1981

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Dinitroguanidine
CH3N5O4
666736-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 N 5.3347 2.3100 0.0 0
M  V30 5 N 4.0011 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 9 O 6.6685 0.0000 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine, N,N′-dinitro-, compd. with methanamine (1:1)
CH5N.CH3N5O4
666736-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 3.8500 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 N 1.3336 3.0800 0.0 0 VAL=5
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 N 4.0011 1.5400 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 1.3336 1.5400 0.0 0
M  V30 8 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 8.0021 3.8500 0.0 0
M  V30 11 C 3.2311 0.0000 0.0 0
M  V30 12 N 4.7711 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 666736-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 666736-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26778393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and some properties of 1,2-dinitroguanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Astrat'yev, A. A.; Dashko, D. V.; Kuznetsov, L. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (Translation of Zhurnal
Organicheskoi Khimii) (2003), 39(4), 501-512

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (αR)-α-[[(1,1-dimethylethoxy)carbonyl]amino]-1-naphthalenepropanoate
C20H25NO4
677005-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 6.6684 0.0 0
M  V30 2 C 6.9301 6.6684 0.0 0 CFG=2
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 C 7.7001 8.0022 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 O 9.2401 8.0022 0.0 0
M  V30 7 O 6.9301 9.3359 0.0 0
M  V30 8 O 7.7001 2.6673 0.0 0
M  V30 9 O 5.3901 4.0011 0.0 0
M  V30 10 C 10.0101 9.3359 0.0 0
M  V30 11 C 6.9301 1.3337 0.0 0
M  V30 12 C 11.5501 9.3359 0.0 0
M  V30 13 C 5.5964 2.1037 0.0 0
M  V30 14 C 6.1601 0.0000 0.0 0
M  V30 15 C 8.2637 0.5636 0.0 0
M  V30 16 C 3.0800 8.0022 0.0 0
M  V30 17 C 4.6201 8.0022 0.0 0
M  V30 18 C 2.3100 9.3359 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 5.3901 9.3359 0.0 0
M  V30 21 C 3.0800 10.6695 0.0 0
M  V30 22 C 0.7700 9.3359 0.0 0
M  V30 23 C 0.7700 6.6684 0.0 0
M  V30 24 C 4.6201 10.6695 0.0 0
M  V30 25 C 0.0000 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 2 22 25
M  V30 26 1 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R)-2-(methylamino)-1-(1-naphthalenylmethyl)-2-oxoethyl]-, 1...
C19H24N2O3
677005-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 3 N 6.9302 4.0012 0.0 0
M  V30 4 C 4.6201 2.6675 0.0 0
M  V30 5 C 7.7002 5.3348 0.0 0
M  V30 6 N 5.3901 1.3337 0.0 0
M  V30 7 O 3.0801 2.6675 0.0 0
M  V30 8 O 9.2402 5.3348 0.0 0
M  V30 9 O 6.9302 6.6685 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 10.0102 6.6685 0.0 0
M  V30 12 C 8.6766 7.4385 0.0 0
M  V30 13 C 10.7802 8.0023 0.0 0
M  V30 14 C 11.3439 5.8985 0.0 0
M  V30 15 C 2.3101 6.6685 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 3.0801 8.0023 0.0 0
M  V30 19 C 2.3101 4.0012 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 21 C 0.0000 8.0023 0.0 0
M  V30 22 C 2.3101 9.3360 0.0 0
M  V30 23 C 0.7700 4.0012 0.0 0
M  V30 24 C 0.7700 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 677005-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 677005-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5965198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly enantioselective alkylation of glycine methyl and ethyl ester
derivatives under phase-transfer conditions: its synthetic advantage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ooi, Takashi; Uematsu, Yukitaka; Maruoka, Keiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(8), 1675-1678

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-2-Phenyl-4-(1-phenylethylidene)-5(4H)-oxazolone
C17H13NO2
69015-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.7106 0.0 0
M  V30 2 C 2.3100 1.3769 0.0 0
M  V30 3 O 5.0494 0.0000 0.0 0
M  V30 4 C 6.9898 3.4806 0.0 0
M  V30 5 N 5.5252 3.9564 0.0 0
M  V30 6 O 6.9898 1.9406 0.0 0
M  V30 7 C 4.6200 2.7106 0.0 0
M  V30 8 C 5.5252 1.4647 0.0 0
M  V30 9 C 8.2357 4.3858 0.0 0
M  V30 10 C 9.6426 3.7593 0.0 0
M  V30 11 C 8.0747 5.9173 0.0 0
M  V30 12 C 10.8885 4.6645 0.0 0
M  V30 13 C 9.3206 6.8225 0.0 0
M  V30 14 C 10.7275 6.1961 0.0 0
M  V30 15 C 2.3100 4.0442 0.0 0
M  V30 16 C 3.0800 5.3779 0.0 0
M  V30 17 C 0.7700 4.0442 0.0 0
M  V30 18 C 2.3100 6.7117 0.0 0
M  V30 19 C 0.0000 5.3779 0.0 0
M  V30 20 C 0.7700 6.7117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 1 15
M  V30 4 2 3 8
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 9
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-[(Methylamino)carbonyl]-2-phenyl-1-propen-1-yl]benzamide
C18H18N2O2
1174066-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6685 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 5.3900 6.6685 0.0 0
M  V30 7 N 0.7700 6.6685 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 O 4.6200 8.0021 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 11
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 6 9
M  V30 10 1 6 17
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69015-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1174066-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18006745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-2-Phenyl-4-(1-phenylethylidene)-5(4H)-oxazolone
C17H13NO2
69015-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.7106 0.0 0
M  V30 2 C 2.3100 1.3769 0.0 0
M  V30 3 O 5.0494 0.0000 0.0 0
M  V30 4 C 6.9898 3.4806 0.0 0
M  V30 5 N 5.5252 3.9564 0.0 0
M  V30 6 O 6.9898 1.9406 0.0 0
M  V30 7 C 4.6200 2.7106 0.0 0
M  V30 8 C 5.5252 1.4647 0.0 0
M  V30 9 C 8.2357 4.3858 0.0 0
M  V30 10 C 9.6426 3.7593 0.0 0
M  V30 11 C 8.0747 5.9173 0.0 0
M  V30 12 C 10.8885 4.6645 0.0 0
M  V30 13 C 9.3206 6.8225 0.0 0
M  V30 14 C 10.7275 6.1961 0.0 0
M  V30 15 C 2.3100 4.0442 0.0 0
M  V30 16 C 3.0800 5.3779 0.0 0
M  V30 17 C 0.7700 4.0442 0.0 0
M  V30 18 C 2.3100 6.7117 0.0 0
M  V30 19 C 0.0000 5.3779 0.0 0
M  V30 20 C 0.7700 6.7117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 1 15
M  V30 4 2 3 8
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 9
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-[(Methylamino)carbonyl]-2-phenyl-1-propen-1-yl]benzamide
C18H18N2O2
1174066-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6685 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 5.3900 6.6685 0.0 0
M  V30 7 N 0.7700 6.6685 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 O 4.6200 8.0021 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 11
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 6 9
M  V30 10 1 6 17
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69015-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1174066-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16404839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloro-5-(trifluoromethyl)pyridine
C6H2Cl2F3N
69045-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-5-(trifluoromethyl)-2-pyridinamine
C7H6ClF3N2
89810-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 N 7.7000 2.6673 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 N 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69045-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89810-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25100862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Hastelloy autoclave reactor used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amination of halo substituted trihalomethyl pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Ram; Balaji, Prabhu; Singh, Avaneesh Kumar; Jain, Anurag; Kumar,
Kapil; Dinda, Milan; Kumar, Vimal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202011002826 A 2021-08-27

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6R,6aR)-6-(6-Chloro-9H-purin-9-yl)-3a,5,6,6a-tetrahydro-3-phenyl-...
C17H14ClN5O2
696614-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.2792 2.1075 0.0 0
M  V30 2 Cl 14.4138 2.4581 0.0 0
M  V30 3 C 5.5252 4.5527 0.0 0 CFG=2
M  V30 4 C 6.9898 5.0286 0.0 0 CFG=2
M  V30 5 C 4.6200 5.7986 0.0 0
M  V30 6 C 5.5252 3.0127 0.0 0 CFG=2
M  V30 7 C 7.8950 3.7827 0.0 0 CFG=1
M  V30 8 O 6.9898 6.5686 0.0 0
M  V30 9 N 5.5252 7.0446 0.0 0
M  V30 10 C 6.9898 2.5368 0.0 0
M  V30 11 C 3.0800 5.7986 0.0 0
M  V30 12 C 2.3100 4.4649 0.0 0
M  V30 13 C 2.3100 7.1324 0.0 0
M  V30 14 C 0.7700 4.4649 0.0 0
M  V30 15 C 0.7700 7.1324 0.0 0
M  V30 16 C 0.0000 5.7986 0.0 0
M  V30 17 N 9.4350 3.7827 0.0 0
M  V30 18 C 10.3402 2.5368 0.0 0
M  V30 19 C 10.3402 5.0286 0.0 0
M  V30 20 C 11.8047 3.0127 0.0 0
M  V30 21 N 10.0200 1.0306 0.0 0
M  V30 22 N 11.8047 4.5527 0.0 0
M  V30 23 C 12.9492 1.9823 0.0 0
M  V30 24 C 11.1644 0.0000 0.0 0
M  V30 25 N 12.6291 0.4759 0.0 0
M  V30 26 H 4.0605 4.0768 0.0 0
M  V30 27 H 8.4544 5.5046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 26 CFG=1
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 27 CFG=1
M  V30 10 2 5 9
M  V30 11 1 5 11
M  V30 12 1 6 10
M  V30 13 1 7 10
M  V30 14 1 7 17 CFG=1
M  V30 15 1 8 9
M  V30 16 2 11 12
M  V30 17 1 11 13
M  V30 18 1 12 14
M  V30 19 2 13 15
M  V30 20 2 14 16
M  V30 21 1 15 16
M  V30 22 1 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 18 21
M  V30 26 2 19 22
M  V30 27 1 20 22
M  V30 28 2 20 23
M  V30 29 1 21 24
M  V30 30 1 23 25
M  V30 31 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6R,6aR)-3a,5,6,6a-Tetrahydro-6-[6-(methylamino)-9H-purin-9-yl]-3-...
C18H18N6O2
696615-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9533 0.6299 0.0 0
M  V30 2 N 14.7938 3.0800 0.0 0
M  V30 3 C 16.1274 2.3100 0.0 0
M  V30 4 C 6.9972 4.0507 0.0 0 CFG=1
M  V30 5 C 8.1418 3.0203 0.0 0 CFG=1
M  V30 6 C 5.6636 3.2807 0.0 0 CFG=2
M  V30 7 O 6.6771 5.5572 0.0 0
M  V30 8 C 7.5153 1.6135 0.0 0
M  V30 9 C 4.5192 4.3113 0.0 0
M  V30 10 C 5.9838 1.7744 0.0 0 CFG=2
M  V30 11 N 5.1455 5.7181 0.0 0
M  V30 12 N 9.6481 3.3405 0.0 0
M  V30 13 C 10.7926 2.3100 0.0 0
M  V30 14 C 10.2746 4.7474 0.0 0
M  V30 15 C 12.1263 3.0800 0.0 0
M  V30 16 N 10.7926 0.7700 0.0 0
M  V30 17 N 11.8061 4.5863 0.0 0
M  V30 18 C 13.4600 2.3100 0.0 0
M  V30 19 C 12.1263 0.0000 0.0 0
M  V30 20 N 13.4600 0.7700 0.0 0
M  V30 21 C 3.0127 3.9911 0.0 0
M  V30 22 C 1.9823 5.1355 0.0 0
M  V30 23 C 2.5369 2.5264 0.0 0
M  V30 24 C 0.4759 4.8153 0.0 0
M  V30 25 C 1.0306 2.2062 0.0 0
M  V30 26 C 0.0000 3.3506 0.0 0
M  V30 27 H 8.3311 4.8207 0.0 0
M  V30 28 H 4.3299 2.5107 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 27 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 12 CFG=1
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 28 CFG=1
M  V30 13 1 7 11
M  V30 14 1 8 10
M  V30 15 2 9 11
M  V30 16 1 9 21
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 17
M  V30 23 2 15 18
M  V30 24 1 16 19
M  V30 25 1 18 20
M  V30 26 2 19 20
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696614-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 696615-27-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15134140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From cyclopentadiene to isoxazoline-carbocyclic nucleosides: a rapid
access to biological molecules through nitrosocarbonyl chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadrelli, Paolo; Scrocchi, Roberto; Caramella, Pierluigi; Rescifina,
Antonio; Piperno, Anna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(16), 3643-3651

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 9-methyl-9H-purine-6-carboximidate
C8H9N5O
705956-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 O 7.9857 2.3101 0.0 0
M  V30 3 N 6.6520 4.6201 0.0 0
M  V30 4 C 9.3194 3.0801 0.0 0
M  V30 5 C 0.0000 3.0203 0.0 0
M  V30 6 C 3.9845 3.0801 0.0 0
M  V30 7 C 2.6509 2.3101 0.0 0
M  V30 8 C 5.3182 2.3101 0.0 0
M  V30 9 N 3.6644 4.5864 0.0 0
M  V30 10 N 1.5063 3.3405 0.0 0
M  V30 11 N 2.6509 0.7700 0.0 0
M  V30 12 N 5.3182 0.7700 0.0 0
M  V30 13 C 2.1328 4.7473 0.0 0
M  V30 14 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,9-Dimethyl-9H-purine-6-carboximidamide
C8H10N6
705956-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 N 7.9857 2.3101 0.0 0
M  V30 3 N 6.6520 4.6201 0.0 0
M  V30 4 C 9.3194 3.0801 0.0 0
M  V30 5 C 0.0000 3.0203 0.0 0
M  V30 6 C 3.9845 3.0801 0.0 0
M  V30 7 C 2.6509 2.3101 0.0 0
M  V30 8 C 5.3182 2.3101 0.0 0
M  V30 9 N 3.6644 4.5864 0.0 0
M  V30 10 N 1.5063 3.3405 0.0 0
M  V30 11 N 2.6509 0.7700 0.0 0
M  V30 12 N 5.3182 0.7700 0.0 0
M  V30 13 C 2.1328 4.7473 0.0 0
M  V30 14 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705956-57-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705956-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5286174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient conversion of 6-cyanopurines into 6-alkoxyformimidoylpurines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carvalho, M. Alice; Esteves, Teresa M.; Proenca, M. Fernanda; Booth,
Brian L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 1019-1024

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[3-(1,3-dioxan-2-ylmethyl)-4-nitrophenoxy]acetate
C15H19NO7
705961-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 N 4.6200 1.3336 0.0 0 VAL=5
M  V30 3 O 3.0800 1.3336 0.0 0
M  V30 4 O 5.3900 0.0000 0.0 0
M  V30 5 O 7.7000 6.6684 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 C 10.0100 8.0021 0.0 0
M  V30 8 O 11.5500 8.0021 0.0 0
M  V30 9 O 9.2400 9.3358 0.0 0
M  V30 10 C 12.3200 9.3358 0.0 0
M  V30 11 C 13.8600 9.3358 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 O 3.0800 6.6684 0.0 0
M  V30 20 O 0.7700 5.3347 0.0 0
M  V30 21 C 2.3100 8.0021 0.0 0
M  V30 22 C 0.0000 6.6684 0.0 0
M  V30 23 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, 2-[3-(1,3-dioxan-2-ylmethyl)-4-nitrophenoxy]-N-methyl-
C14H18N2O6
705961-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 N 4.6200 1.3336 0.0 0 VAL=5
M  V30 3 O 3.0800 1.3336 0.0 0
M  V30 4 O 5.3900 0.0000 0.0 0
M  V30 5 O 7.7000 6.6684 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 C 10.0100 8.0021 0.0 0
M  V30 8 N 11.5500 8.0021 0.0 0
M  V30 9 O 9.2400 9.3358 0.0 0
M  V30 10 C 12.3200 9.3358 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 O 3.0800 6.6684 0.0 0
M  V30 19 O 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705961-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705961-48-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3962553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 9037-24-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel phase-switching protecting group for multi-step parallel solution
phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xin; Abell, Chris; Congreve, Miles S.; Warrington, Brian H.; Ladlow,
Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 989-998

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[(4-Methoxyphenyl)methylene]-2-methyl-5(4H)-oxazolone
C12H11NO3
71198-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.3628 0.0 0
M  V30 2 O 0.7103 0.0000 0.0 0
M  V30 3 C 0.1435 5.3914 0.0 0
M  V30 4 O 9.1059 4.4428 0.0 0
M  V30 5 C 10.4396 3.6728 0.0 0
M  V30 6 C 2.4374 2.1328 0.0 0
M  V30 7 C 1.0304 1.5063 0.0 0
M  V30 8 N 2.2763 3.6644 0.0 0
M  V30 9 O 0.0000 2.6509 0.0 0
M  V30 10 C 0.7700 3.9845 0.0 0
M  V30 11 C 5.1048 2.1328 0.0 0
M  V30 12 C 5.1048 3.6728 0.0 0
M  V30 13 C 6.4384 1.3628 0.0 0
M  V30 14 C 6.4384 4.4428 0.0 0
M  V30 15 C 7.7722 2.1328 0.0 0
M  V30 16 C 7.7722 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3,5-Dihydro-5-[(4-methoxyphenyl)methylene]-2,3-dimethyl-4H-imidazol-4-one
C13H14N2O2
101820-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 C 1.6752 5.3914 0.0 0
M  V30 5 O 10.6375 4.4428 0.0 0
M  V30 6 C 11.9713 3.6728 0.0 0
M  V30 7 C 3.9690 2.1328 0.0 0
M  V30 8 C 2.5622 1.5063 0.0 0
M  V30 9 N 3.8080 3.6644 0.0 0
M  V30 10 N 1.5316 2.6509 0.0 0
M  V30 11 C 2.3016 3.9845 0.0 0
M  V30 12 C 6.6365 2.1328 0.0 0
M  V30 13 C 7.9701 1.3628 0.0 0
M  V30 14 C 6.6365 3.6728 0.0 0
M  V30 15 C 9.3038 2.1328 0.0 0
M  V30 16 C 7.9701 4.4428 0.0 0
M  V30 17 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 1 12
M  V30 3 2 2 8
M  V30 4 1 3 10
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71198-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101820-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16287801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild, Efficient, One-Pot Synthesis of Imidazolones Promoted by
N,O-Bistrimethylsilylacetamide (BSA)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muselli, Mickael; Colombeau, Ludovic; Hedouin, Jonathan; Hoarau,
Christophe; Bischoff, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2819-2825

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 4-[4-(trifluoromethyl)phenyl]-1,3-piperidinedicarboxylate
C18H22F3NO4
721958-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 O 8.4700 0.0000 0.0 0
M  V30 4 C 12.3200 4.0011 0.0 0
M  V30 5 O 13.0900 5.3349 0.0 0
M  V30 6 O 13.0900 2.6674 0.0 0
M  V30 7 C 14.6300 5.3349 0.0 0
M  V30 8 C 14.6300 6.8749 0.0 0
M  V30 9 C 16.1700 5.3349 0.0 0
M  V30 10 C 14.6300 3.7949 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 F 1.5400 5.5411 0.0 0
M  V30 13 F 0.0000 4.0011 0.0 0
M  V30 14 F 1.5400 2.4611 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3349 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 10.0100 5.3349 0.0 0
M  V30 20 N 10.7800 4.0011 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 5.3900 5.3349 0.0 0
M  V30 23 C 5.3900 2.6674 0.0 0
M  V30 24 C 3.8500 5.3349 0.0 0
M  V30 25 C 3.8500 2.6674 0.0 0
M  V30 26 C 3.0800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 26
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[(methylamino)carbonyl]-4-[4-(trifluoromethyl)phenyl]-1-p...
C19H25F3N2O3
721958-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 N 8.4700 1.3338 0.0 0
M  V30 3 O 6.1600 2.6674 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 C 12.3200 5.3347 0.0 0
M  V30 6 O 13.0900 6.6685 0.0 0
M  V30 7 O 13.0900 4.0011 0.0 0
M  V30 8 C 14.6300 6.6685 0.0 0
M  V30 9 C 14.6300 5.1285 0.0 0
M  V30 10 C 16.1700 6.6685 0.0 0
M  V30 11 C 14.6300 8.2085 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 F 1.5400 3.7947 0.0 0
M  V30 14 F 0.0000 5.3347 0.0 0
M  V30 15 F 1.5400 6.8747 0.0 0
M  V30 16 C 7.7000 5.3347 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 8.4700 6.6685 0.0 0
M  V30 19 C 10.0100 4.0011 0.0 0
M  V30 20 C 10.0100 6.6685 0.0 0
M  V30 21 N 10.7800 5.3347 0.0 0
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 5.3900 6.6685 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 3.8500 6.6685 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 27
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 721958-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 721958-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11831260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The acid from Step 4 (60 mg, 0.16 mmol) was dissolved in DCM, and amine
(0.12 mL, 0.24 mmol), EDCI (60.48 mg, 0.32 mmol), HOBT (42.63 mg, 0.32
mmol), and TEA (0.07 mL, 0.47 mmol) were added. The mixture was stirred
at rt overnight, and purified by flash chromatography with 50% EtOAc /
Hex to provide amide. Yield 61 mg, 98%. Rf 0.38 (50% EtOAc / Hex).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 3,5-dihydro-4H-imidazol-4-ones for the
treatment of obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Yuanwei; O'Connor, Stephen James; Gunn, David; Newcom, Jason; Chen,
Jianqing; Yi, Lin; Zhang, Hai-jun; Hunyadi, Laszlo Matyas; Natero, Reina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004058727 A1 2004-07-15

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)cyclopropanecarboxylic acid
C10H9ClO2
72934-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 0.9899 0.0 0
M  V30 2 O 0.0000 0.4632 0.0 0
M  V30 3 O 2.6269 0.0000 0.0 0
M  V30 4 Cl 7.8746 2.5065 0.0 0
M  V30 5 C 1.7146 2.5065 0.0 0
M  V30 6 C 0.2675 3.0332 0.0 0
M  V30 7 C 1.4471 4.0231 0.0 0
M  V30 8 C 3.2546 2.5065 0.0 0
M  V30 9 C 4.0246 3.8401 0.0 0
M  V30 10 C 4.0246 1.1729 0.0 0
M  V30 11 C 5.5646 3.8401 0.0 0
M  V30 12 C 5.5646 1.1729 0.0 0
M  V30 13 C 6.3346 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester
C11H11ClO2
117252-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3246 2.6268 0.0 0
M  V30 2 O 7.8413 2.3593 0.0 0
M  V30 3 O 5.7979 4.0740 0.0 0
M  V30 4 C 8.8311 3.5391 0.0 0
M  V30 5 Cl 0.0000 4.5271 0.0 0
M  V30 6 C 5.3348 1.4470 0.0 0
M  V30 7 C 6.3246 0.2673 0.0 0
M  V30 8 C 4.8080 0.0000 0.0 0
M  V30 9 C 4.0010 2.2170 0.0 0
M  V30 10 C 2.6673 1.4470 0.0 0
M  V30 11 C 4.0010 3.7570 0.0 0
M  V30 12 C 1.3337 2.2170 0.0 0
M  V30 13 C 2.6673 4.5271 0.0 0
M  V30 14 C 1.3337 3.7570 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72934-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117252-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
γ-Oxo-3-pyridinebutanal
C9H9NO2
76014-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 O 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 N 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Nicotyrine
C10H10N2
487-19-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9406 0.0000 0.0 0
M  V30 2 C 2.3698 2.7105 0.0 0
M  V30 3 N 1.4646 1.4646 0.0 0
M  V30 4 C 1.4646 3.9563 0.0 0
M  V30 5 C 0.0000 1.9404 0.0 0
M  V30 6 C 0.0000 3.4805 0.0 0
M  V30 7 C 3.9098 2.7105 0.0 0
M  V30 8 C 4.6799 1.3768 0.0 0
M  V30 9 C 4.6799 4.0441 0.0 0
M  V30 10 C 6.2199 1.3768 0.0 0
M  V30 11 N 6.2199 4.0441 0.0 0
M  V30 12 C 6.9899 2.7105 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 7
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76014-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 487-19-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-400983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nornicotine, nicotine and other functionalized derivatives
using solid-supported reagents and scavengers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxendale, Ian R.; Brusotti, Gloria; Matsuoka, Masato; Ley, Steven V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chemical Society, Perkin Transactions 1 (2002), (2),
143-154

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentafluorobenzonitrile
C7F5N
773-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 F 4.6200 0.0000 0.0 0
M  V30 4 F 4.6200 5.3349 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6-Tetrafluoro-4-(methylamino)benzonitrile
C8H4F4N2
28012-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 N 8.4700 2.6674 0.0 0
M  V30 3 F 5.3900 0.0000 0.0 0
M  V30 4 F 5.3900 5.3349 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 F 2.3100 5.3349 0.0 0
M  V30 7 N 0.7700 2.6674 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 12
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 773-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28012-05-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14027060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Trifluoromethyl)benzenesulfonyl chloride
C7H4ClF3O2S
776-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3246 3.5506 0.0 0
M  V30 2 F 4.4412 4.8122 0.0 0
M  V30 3 F 6.2078 2.2892 0.0 0
M  V30 4 F 6.5860 4.4340 0.0 0
M  V30 5 S 1.2614 3.5506 0.0 0 VAL=6
M  V30 6 Cl 0.0000 4.4340 0.0 0
M  V30 7 O 2.1448 4.8122 0.0 0
M  V30 8 O 0.3782 2.2892 0.0 0
M  V30 9 C 4.0630 2.6674 0.0 0
M  V30 10 C 2.5230 2.6674 0.0 0
M  V30 11 C 4.8330 1.3336 0.0 0
M  V30 12 C 1.7530 1.3336 0.0 0
M  V30 13 C 4.0630 0.0000 0.0 0
M  V30 14 C 2.5230 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(trifluoromethyl)benzenesulfonamide
C8H8F3NO2S
633697-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3246 3.5506 0.0 0 VAL=6
M  V30 2 N 6.5861 4.4340 0.0 0
M  V30 3 O 6.2079 2.2892 0.0 0
M  V30 4 O 4.4412 4.8122 0.0 0
M  V30 5 C 7.9818 3.7832 0.0 0
M  V30 6 C 1.2616 3.5506 0.0 0
M  V30 7 F 2.1449 4.8122 0.0 0
M  V30 8 F 0.0000 4.4340 0.0 0
M  V30 9 F 0.3782 2.2892 0.0 0
M  V30 10 C 4.0630 2.6674 0.0 0
M  V30 11 C 2.5230 2.6674 0.0 0
M  V30 12 C 4.8330 1.3336 0.0 0
M  V30 13 C 1.7530 1.3336 0.0 0
M  V30 14 C 4.0630 0.0000 0.0 0
M  V30 15 C 2.5230 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 776-04-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 633697-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9467496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Regio- and Chemo-selective Reactions of 2-Bromobenzyl
Bromides: Expanding the Scope for the Synthesis of Biaryls Fused to a
Seven-Membered Sultam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Sharma, Shubhra; Dayal, Neetu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(36), 7885-7891

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-cyclohexene-1-propanoate
C10H16O2
78640-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-cyclohexene-1-propanamide
C10H17NO
1061341-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78640-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1061341-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15355440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A. 3-Cyclohex-3-enyl-N-methyl-propionamide Methyl amine (8 M in
EtOH, 75 ml, 600 mmol) was added to a mixture of
3-cyclohex-3-enyl-propionic acid methyl ester (German patent DE 4023848
A1 19920130) (20.0 g, 119 mmol) in 75 mL of methanol. The mixture was
stirred at room temperature for one day. Additional Methyl amine (8 M in
EtOH, 40 ml, 320 mmol) was added to the mixture and stirring continued
for one more day. The mixture was concentrated and the residue was taken
up in ethyl acetate, washed with 0.5 M aqueous HCl, dried and stripped of
the solvent to give the title compound (19.50 g, 98% yield, uncorrected)
as a pale orange solid. 1H NMR (CDCl3, 200 MHz, δ, ppm): 5.58 (s, 2H,
olefinic H), 5.57 (m, 1H, NH), 2.74 (d, 3H, NCH3, J = 5Hz), 2.20 -1.90
(m, 5H), 1.75 -1.40 (m, 5H), 1.15 (m, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine and ethanol
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pleuromutilin derivatives for the treatment of diseases
mediated by microbes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mang, Rosemarie; Heilmayer, Werner; Badegruber, Rudolf; Strickmann, Dirk;
Novak, Rodger; Ferencic, Mathias; Bulusu, Atchyuta Rama Chandra Murty
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008113089 A1 2008-09-25

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-3-methylbenzene
C11H15BrO
81368-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(3-methylphenoxy)-1-butanamine
C12H19NO
361395-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81368-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361395-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12903059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-4′-methyl-2,2′-bipyridine
C12H11BrN2
81998-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 2.3100 0.0 0
M  V30 2 Br 10.6695 3.0800 0.0 0
M  V30 3 C 0.0000 3.0800 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0
M  V30 8 C 6.6684 5.3901 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 N 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4′-Dimethyl[2,2′-bipyridine]-4-methanamine
C13H15N3
330649-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 5.3348 0.7700 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 8.0022 0.7700 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 4.0012 4.6201 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 14
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81998-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330649-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4123542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(M ethylaminom ethyl)-4'-m ethylbipyridine (bpyCH2MeH). A stream of
MeNH2 gas was bubbled through a solution of bpyCH2Br (1.52 g, 5.76 mm ol)
in 75 m L of THF at 0°C. for 15 min to give a cloudy colorless solution.
The solution w as allowed to w arm to ambient temperature and stirring
continued for 16 hours. The solvent w as removed to give an oily white
solid. A pale yellow solution w as extracted from a white powder with
diethyl ether and the solvent removed under vacuum to give bpyCH2NMeH
Pale yellow liquid, Yield 1.20 (98%) 1H NMR: δ = 8.62 (d, 1H, J=4.9 Hz),
8.53 (d, 1H, J=4.9 Hz), 8.33 (s, 1H), 8.23 (s, 1H), 7.31 (d, 1H, J=4.3
Hz), 7.13 (d, 1H, J=4.4 Hz), 3.86 (s, 2H), 2.48 (s, 3H), 2.44 (s, 3H),
1.44 (br s, 1H). 13C i 1H j N M R : V d V 156.3, 155.9,150.3, 149.2,
148.9, 148.1, 124.7, 122.9, 122.0, 120.4, 54.9, 36.1, 21.2. GC/EIMS: m/z
212 (M -H )+, 184 (bpyMe)+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Saccharide sensing molecules having enhanced fluorescent properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satcher, Joe H.; Lane, Stephen M.; Darrow, Christopher B.; Cary, Douglas
R.; Tran, Joe Anh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020010279 A1 2002-01-24

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-4′-methyl-2,2′-bipyridine
C12H11BrN2
81998-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 2.3100 0.0 0
M  V30 2 Br 10.6695 3.0800 0.0 0
M  V30 3 C 0.0000 3.0800 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0
M  V30 8 C 6.6684 5.3901 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 N 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4′-Dimethyl[2,2′-bipyridine]-4-methanamine
C13H15N3
330649-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 5.3348 0.7700 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 8.0022 0.7700 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 4.0012 4.6201 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 14
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81998-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330649-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17462982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Saccharide sensing molecules having enhanced fluorescent properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satcher, Joe H., Jr.; Lane, Stephen M.; Darrow, Christopher B.; Cary,
Douglas R.; Tran, Joe Anh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001074968 A2 2001-10-11

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-4′-methyl-2,2′-bipyridine
C12H11BrN2
81998-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 2.3100 0.0 0
M  V30 2 Br 10.6695 3.0800 0.0 0
M  V30 3 C 0.0000 3.0800 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0
M  V30 8 C 6.6684 5.3901 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 N 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4′-Dimethyl[2,2′-bipyridine]-4-methanamine
C13H15N3
330649-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 5.3348 0.7700 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 8.0022 0.7700 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 4.0012 4.6201 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 14
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81998-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330649-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8208463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(Methylaminomethyl)-4′-methylbipyridine (bpyCH2NMeH). A stream of MeNH2
gas was bubbled through a solution of bpyCH2Br (1.52 g, 5.76 mmol) in 75
mL of THF at 0° C. for 15 min to give a cloudy colorless solution. The
solution was allowed to warm to ambient temperature and stirring
continued for 16 hours. The solvent was removed to give an oily white
solid. A pale yellow solution was extracted from a white powder with
diethyl ether and the solvent removed under vacuum, bpyCH2NMeH (1.20 g,
98%) as a pale yellow liquid. 1H NMR: δ 8.62 (d, 1H, J=4.9 Hz), 8.53 (d,
1H, J=4.9 Hz), 8.33 (s, 1H), 8.23 (s, 1H), 7.31 (d, 1H, J=4.3 Hz), 7.13
(d, 1H, J=4.4 Hz), 3.86 (s, 2H), 2.48 (s, 3H), 2.44 (s, 3H), 1.44 (br s,
1H). 13C{1H} NMR: δ 156.3, 155.9, 150.3, 149.2, 148.9, 148.1, 124.7,
122.9, 122.0, 120.4, 54.9, 36.1, 21.2. GC/EIMS: m/z 212 (M-H)+, 184
(bpyMe)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glucose sensing molecules having selected fluorescent properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satcher, Joe H., Jr.; Lane, Stephen M.; Darrow, Christopher B.; Cary,
Douglas R.; Tran, Joe Anh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001020334 A1 2001-03-22

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dibromobutanoyl chloride
C4H5Br2ClO
82820-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 Br 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 Cl 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 Br 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dibromo-N-methylbutanamide
C5H9Br2NO
132996-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 2.3100 0.0 0
M  V30 4 Br 4.0011 0.0000 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 Br 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82820-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132996-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-8850669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 5: 2,4-dibromo-N-methyl-butanamide 2,4-Dibromobutanoyl
chloride (CAS no. 82820-87-9) (16.9 g, 64 mmol) in DCM (20 mL) was added
dropwise to a solution of methylamine (20 mL) in water (30 mL) and DCM
(30 mL) at 10-15&#x00B0; C, then warmed to 30&#x00B0; C and stirred for
30 minutes. The organic layer was separated and the aqueous layer
re-extracted with DCM (2×10 mL), the combined organic layers were washed
with brine (20 mL), dried (MgSO4) and evaporated to afford the product
(16.3 g, 98%). 1H NMR &#x03B4; (400 MHz, CDCl3) 2.35-2.45 (m, 1H),
2.57-2.67 (m, 1H), 2.81 (d, 3H), 3.44-3.54 (m, 2H), 4.46 (q, 1H), 6.34
(s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoyl amino heterocyclyl compounds as glucokinase
activators for treating type 2 diabetes and other diseases mediated by
GLK
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campbell, Leonie; Pike, Kurt Gordon; Suleman, Abid; Waring, Michael James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008050101 A2 2008-05-02

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 4-chloro-5-nitro-6-phenyl-, ethyl ester
C14H11ClN2O4
842145-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0801 1.3338 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Cl 7.7002 1.3338 0.0 0
M  V30 5 C 9.2402 4.0012 0.0 0
M  V30 6 O 10.0102 5.3348 0.0 0
M  V30 7 O 10.0102 2.6675 0.0 0
M  V30 8 C 11.5503 5.3348 0.0 0
M  V30 9 C 12.3203 6.6687 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 N 5.3901 5.3348 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 6.9302 5.3348 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 3.0801 4.0012 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 2.3101 2.6675 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.7700 2.6675 0.0 0
M  V30 21 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 4-(methylamino)-5-nitro-6-phenyl-, ethyl ester
C15H15N3O4
842145-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0 VAL=5
M  V30 2 O 5.3901 0.0000 0.0 0
M  V30 3 O 3.0801 1.3338 0.0 0
M  V30 4 N 7.7002 1.3338 0.0 0
M  V30 5 C 9.2402 1.3338 0.0 0
M  V30 6 C 9.2402 4.0012 0.0 0
M  V30 7 O 10.0102 5.3348 0.0 0
M  V30 8 O 10.0102 2.6675 0.0 0
M  V30 9 C 11.5503 5.3348 0.0 0
M  V30 10 C 12.3203 6.6687 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 C 4.6201 4.0012 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 N 5.3901 5.3348 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 6.9302 5.3348 0.0 0
M  V30 17 C 3.0801 4.0012 0.0 0
M  V30 18 C 2.3101 2.6675 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 0.7700 2.6675 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 842145-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 842145-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8550376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM e) Ethyl 4-(methylamino)-5-nitro-6-phenyl-3-pyridinecarboxylate To the
compound of Example 98(d) and Et3N (0.75 mL, 3.60 mmol) in ethanol (30
mL) was added a solution of MeNH2 in THF (1.80 mL, 2.0 M, 3.60 mmol).
After stirring at RT for 16 h, the solvent was removed in vacuo. The
residue was dissolved in EtOAc and passed through a plug of silica gel
eluting with 5% EtOAc/hexane. The solvent was removed to give the desired
product as a solid (0.88 g, 98%). MS(ES)+ m/e 302 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-imidazo[4,5-c]pyridin-2-yl derivatives as inhibitors of
Akt activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heerding, Dirk A.; Clark, Tammy J.; Drewry, David H.; Leber, Jack Dale;
Safonov, Igor; Yamashita, Dennis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005011700 A1 2005-02-10

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Acetyloxy)-3-[3-(acetyloxy)propyl]-5-chloro-7-methyl-6H-2-benzopyran-6,8(7...
C17H17ClO7
853247-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3569 0.0493 0.0 0
M  V30 2 Cl 5.3569 6.2094 0.0 0
M  V30 3 O 2.5066 2.6268 0.0 0
M  V30 4 C 1.5166 1.4470 0.0 0
M  V30 5 C 0.0000 1.7145 0.0 0
M  V30 6 O 2.0433 0.0000 0.0 0
M  V30 7 C 3.4965 0.9123 0.0 0
M  V30 8 O 2.6895 4.6694 0.0 0
M  V30 9 C 10.6917 4.6694 0.0 0
M  V30 10 C 12.0254 3.8994 0.0 0
M  V30 11 C 13.3592 4.6694 0.0 0
M  V30 12 O 14.6928 3.8994 0.0 0
M  V30 13 C 16.0265 4.6694 0.0 0
M  V30 14 C 16.0265 6.2094 0.0 0
M  V30 15 O 17.3602 3.8994 0.0 0
M  V30 16 C 6.6905 2.3593 0.0 0
M  V30 17 C 6.6905 3.8994 0.0 0
M  V30 18 C 5.3569 1.5893 0.0 0
M  V30 19 C 8.0243 1.5893 0.0 0
M  V30 20 C 5.3569 4.6694 0.0 0
M  V30 21 C 8.0243 4.6694 0.0 0
M  V30 22 C 4.0232 2.3593 0.0 0
M  V30 23 O 9.3580 2.3593 0.0 0
M  V30 24 C 4.0232 3.8994 0.0 0
M  V30 25 C 9.3580 3.8994 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 22
M  V30 8 2 8 24
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Acetyloxy)-3-[3-(acetyloxy)propyl]-5-chloro-2,7-dimethyl-6,8(2H,7H)-isoqui...
C18H20ClNO6
853247-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.8866 6.6685 0.0 0
M  V30 2 O 3.8066 1.3338 0.0 0
M  V30 3 O 3.8066 6.6685 0.0 0
M  V30 4 C 10.7366 2.6674 0.0 0
M  V30 5 C 11.5066 4.0011 0.0 0
M  V30 6 C 13.0466 4.0011 0.0 0
M  V30 7 O 13.8166 5.3347 0.0 0
M  V30 8 C 15.3566 5.3347 0.0 0
M  V30 9 C 16.1266 4.0011 0.0 0
M  V30 10 O 16.1266 6.6685 0.0 0
M  V30 11 O 2.6268 3.0112 0.0 0
M  V30 12 C 1.1798 3.5378 0.0 0
M  V30 13 C 0.0000 2.5481 0.0 0
M  V30 14 O 0.9123 5.0546 0.0 0
M  V30 15 C 2.6268 4.9910 0.0 0
M  V30 16 C 9.1966 0.0000 0.0 0
M  V30 17 C 6.8866 4.0011 0.0 0
M  V30 18 C 6.1166 2.6674 0.0 0
M  V30 19 C 6.1166 5.3347 0.0 0
M  V30 20 C 8.4266 4.0011 0.0 0
M  V30 21 C 4.5766 2.6674 0.0 0
M  V30 22 C 6.8866 1.3338 0.0 0
M  V30 23 C 4.5766 5.3347 0.0 0
M  V30 24 C 9.1966 2.6674 0.0 0
M  V30 25 C 3.8066 4.0011 0.0 0
M  V30 26 N 8.4266 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 2 2 21
M  V30 3 2 3 23
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 25
M  V30 16 1 16 26
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853247-20-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853247-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-13753005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of 26a-i
and 27a-c. A solution of substrate 25 (0.1 mmol, 1.0 equiv) in
dichloromethane (5 mL) was treated with amine (1.1 equiv) at ambient
temperature. After the completion of the reaction, the solvent was
removed under reduced pressure, and the residue was purified directly by
flash chromatography on silica gel. The isolated yields are shown in
Table 1 of the text. Acetic acid
3-(7-acetoxy-5-chloro-2,7-dimethyl-6,8-dioxo-
2,6,7,8-tetrahydroisoquinolin-3-yl)propyl ester (26b): orange solid; mp
187-189 °C dec; 1H NMR (300 MHz, CDCl3) δ 7.71 (1H, s), 6.71 (1H, s),
4.14 (2H, t, J = 6.0 Hz), 3.57 (3H, s), 2.62 (2H, t, J = 7.8 Hz), 2.11
(3H, s), 2.04 (3H, s), 2.02-1.94 (2H, m), 1.47 (3H, s); 13C NMR (75.0
MHz, CDCl3) δ 193.5, 184.5, 170.8, 170.0, 149.9, 144.3, 142.2, 114.7,
113.0, 101.8, 84.8, 62.8, 41.0, 28.8, 26.8, 23.0, 20.8, 20.2; IR (KBr) v
max 1733, 1705, 1652, 1611, 1508, 1368, 1250, 1212, 1084, 854, 502 cm-1;
HRMS m/z (EI) calcd for C18H20ClNO6 (M+ + H) 382.1052, found 382.1048.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis Studies toward Chloroazaphilone and Vinylogous γ-Pyridones: Two
Common Natural Product Core Structures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Wan-Guo; Yao, Zhu-Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(12), 4585-4590

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Methoxy-4-(phenylmethoxy)phenyl]cyclopropanecarboxaldehyde
C18H18O3
853765-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0443 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3347 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 16 C 10.1846 5.3347 0.0 0
M  V30 17 C 10.9546 4.0011 0.0 0
M  V30 18 C 10.9546 6.6685 0.0 0
M  V30 19 C 12.4946 4.0011 0.0 0
M  V30 20 C 12.4946 6.6685 0.0 0
M  V30 21 C 13.2646 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-[3-Methoxy-4-(phenylmethoxy)phenyl]cyclopropyl]methylene]methanamine
C19H21NO2
853765-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7145 5.5177 0.0 0
M  V30 2 N 0.2675 6.0443 0.0 0
M  V30 3 C 0.0000 7.5611 0.0 0
M  V30 4 O 6.6020 1.3338 0.0 0
M  V30 5 C 5.8320 0.0000 0.0 0
M  V30 6 O 8.1420 4.0011 0.0 0
M  V30 7 C 8.9120 5.3347 0.0 0
M  V30 8 C 1.9820 4.0011 0.0 0
M  V30 9 C 0.5348 3.4744 0.0 0
M  V30 10 C 1.7145 2.4845 0.0 0
M  V30 11 C 3.5220 4.0011 0.0 0
M  V30 12 C 4.2920 2.6674 0.0 0
M  V30 13 C 4.2920 5.3347 0.0 0
M  V30 14 C 5.8320 2.6674 0.0 0
M  V30 15 C 5.8320 5.3347 0.0 0
M  V30 16 C 6.6020 4.0011 0.0 0
M  V30 17 C 10.4520 5.3347 0.0 0
M  V30 18 C 11.2220 4.0011 0.0 0
M  V30 19 C 11.2220 6.6685 0.0 0
M  V30 20 C 12.7620 4.0011 0.0 0
M  V30 21 C 12.7620 6.6685 0.0 0
M  V30 22 C 13.5320 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853765-86-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853765-87-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10733870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4 Methylamine (13 ml, 26.0 mmol, 2 M in THF) was added to a
suspension of 1-[4-(benzyloxy)-3-methoxyphenyl]cyclopropanecarbaldehyde
(3.64 g, 12.89 mmol) and Na2SO4 (10 g) in DCE (13 ml) and the mixture
stirred at ambient temperature overnight. Mixture was filtered and salts
washed with Et2O to give
N-{1-[4-(benzyloxy)-3-methoxyphenyl]cyclopropyl}methylene)-N-methylamine
Yield 3.73 g (98%) yellow oil. 1H NMR (400 MHz, CDCl3) δ 1.11-1.14 (m, 2
H) 1.23-1.25 (m, 2 H) 3.22 (d, J=1.51 Hz, 3 H) 3.88 (s, 3 H) 5.13 (s, 2
H) 6.79-6.86 (m, 3 H) 7.28-7.44 (m, 5 H) 7.54 (d, J=1.51 Hz, 1 H). 13C
NMR (100 MHz, CDCl3) δ 14.91,29.96,47.58,55.95, 70.98, 113.61, 113.69,
121.72, 127.19, 127.73, 128.48, 134.70, 137.30, 147.13, 149.31, 169.28.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted urea-octahydroindoles as antagonists of
melanin concentrating hormone receptor 1 (MCH1R)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Browning, Andrew; Nilsson, Jonas; Scobie, Martin; Angbrant, Johan;
Ringom, Rune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005051381 A1 2005-06-09

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (1R,2R)-2-[(1R)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-2-(3...
C15H24N2O5S
856894-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5907 4.6799 0.0 0 CFG=2
M  V30 2 C 4.2569 3.9099 0.0 0
M  V30 3 N 6.9243 3.9099 0.0 0
M  V30 4 O 2.9232 4.6799 0.0 0
M  V30 5 C 8.2579 4.6799 0.0 0
M  V30 6 O 9.5916 3.9099 0.0 0
M  V30 7 O 8.2579 6.2199 0.0 0
M  V30 8 C 10.9254 4.6799 0.0 0
M  V30 9 C 11.6954 3.3461 0.0 0
M  V30 10 C 12.2590 5.4499 0.0 0
M  V30 11 C 10.1554 6.0135 0.0 0
M  V30 12 C 2.6269 5.9606 0.0 0
M  V30 13 O 1.4471 6.9505 0.0 0
M  V30 14 O 2.3594 4.4440 0.0 0
M  V30 15 C 0.0000 6.4238 0.0 0
M  V30 16 C 5.5907 6.2199 0.0 0 CFG=1
M  V30 17 C 4.0739 6.4872 0.0 0 CFG=1
M  V30 18 C 5.0638 7.6670 0.0 0
M  V30 19 N 4.2569 2.3699 0.0 0
M  V30 20 C 5.5027 1.4647 0.0 0
M  V30 21 C 3.0110 1.4647 0.0 0
M  V30 22 C 5.0269 0.0000 0.0 0
M  V30 23 S 3.4869 0.0000 0.0 0
M  V30 24 H 7.1073 6.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 17 12 CFG=1
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 24
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 1 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R)-1-[(1R,2R)-2-[(methylamino)carbonyl]cyclopropyl]-2-oxo-2...
C15H25N3O4S
856894-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5907 4.6799 0.0 0 CFG=2
M  V30 2 C 4.2569 3.9099 0.0 0
M  V30 3 N 6.9243 3.9099 0.0 0
M  V30 4 O 2.9232 4.6799 0.0 0
M  V30 5 C 8.2579 4.6799 0.0 0
M  V30 6 O 9.5916 3.9099 0.0 0
M  V30 7 O 8.2579 6.2199 0.0 0
M  V30 8 C 10.9254 4.6799 0.0 0
M  V30 9 C 10.1554 6.0135 0.0 0
M  V30 10 C 12.2590 5.4499 0.0 0
M  V30 11 C 11.6954 3.3461 0.0 0
M  V30 12 C 2.6269 5.9606 0.0 0
M  V30 13 N 1.4471 6.9505 0.0 0
M  V30 14 O 2.3594 4.4440 0.0 0
M  V30 15 C 0.0000 6.4238 0.0 0
M  V30 16 C 5.5907 6.2199 0.0 0 CFG=1
M  V30 17 C 4.0739 6.4872 0.0 0 CFG=1
M  V30 18 C 5.0638 7.6670 0.0 0
M  V30 19 N 4.2569 2.3699 0.0 0
M  V30 20 C 3.0110 1.4647 0.0 0
M  V30 21 C 5.5027 1.4647 0.0 0
M  V30 22 C 3.4869 0.0000 0.0 0
M  V30 23 S 5.0269 0.0000 0.0 0
M  V30 24 H 7.1073 6.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 17 12 CFG=1
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 24
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 1 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 856894-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 856894-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8791721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 19. Methyl
(1RS,2RS)-2-((1RS)-1-(tert-butoxycarbonyl)amino-2-oxo-2-(1,3thiazolan-yl)
ethyl)cyclopropane-1-carboxylate. N-methylmorpholine (389 mg, 3.84 mmol)
and pivaloyl chloride (243 mg, 2.01 mmoles) were added successively to a
stirred and cooled (10°C) solution of Intermediate 2 (500 mg, 1.83 mmol)
in ethyl acetate(10 ml) to result a white precipitate. The mixture was
further stirred at the same temperature for 30 min. Thiazolidine (180 mg,
2.01 mmol) was then added and the temperature was gradually allowed to
come to room temperature and stirring was continued for another 1.5 h.
The reaction mixture was diluted with ethyl acetate (200 ml), washed
successively with 1N HCl solution, saturated NaHC0 3 solution, and brine
and dried over anhy Na2SO4 . The solvent was evaporated under reduced
pressure to afford a yellow residue. The residue was purified by silica
gel column chromatography using 0.5 % methanol in dichloromethane to give
451 mg (71 %) the product as a white solid. Example 24.
N1-Methyl-(1RS,2RS)-2-[(1RS)-1-amino-2-oxo-2-(1,3-thiazolan-3-yl)ethyl]cycloprop-ane-L-carboxamlde
hydrochloride. Step1:
N1-methyl-(1RS,2RS)-2-[(1RS)-1-(tert-butoxycarbonyl)amino-2-oxo-2-(1,3-thiazolan-3-yl)ethyl]cyclopropane-1-carboxamide:
To a stirred solution of Intermediate 19 (240 mg, 0.70 mmol) in THF (5
ml) was added a 40 % aqueous solution of methyl amine (5 ml) at room
temperature. Stirring was continued overnight THF and water were removed
under reduced pressure to afford the product as a yellow solid (235 mg,
98 %). IR (KBr) 3345, 2929, 1691, 1645, 1164 cm-1; 1H NMR (300 MHz,
CDCl3) δ 0.82-0.88 (m, 1H), 1.19-1.25 (m, 1H), 1.43 (s, 9H), 1.66- 1.68
(m, 1H), 1.99-2.01 (m, 2H), 2.81 (s, 3H) 3.02-3.14 (m, 2H), 3.78-3.92 (m,
2H), 4.44-4.68 (m, 2H), 4.64-4.67 (m, 1H), 5.38-5.41 (d, J= 9.0 Hz, 1H),
5.72 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclopropylglycine dipeptides as inhibitors of dipeptidyl
peptidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joshi, Hemant Vasant; Gopalan, Balasubramanian; Shah, Daisy Manish;
Thomas, Abraham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005058849 A1 2005-06-30

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, methyl 3-deoxy-3-[4-(methoxycarbonyl)-1H-1,2,3-triazol...
C17H23N3O9S
862670-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.9302 0.0 0
M  V30 2 C 5.3348 7.7002 0.0 0
M  V30 3 C 4.0010 6.9302 0.0 0
M  V30 4 O 5.3348 9.2402 0.0 0
M  V30 5 O 9.3358 2.3101 0.0 0
M  V30 6 C 9.3358 0.7700 0.0 0
M  V30 7 C 10.6697 0.0000 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 O 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 1.3337 6.9302 0.0 0
M  V30 13 O 0.0000 4.6201 0.0 0
M  V30 14 S 6.6685 0.7700 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 C 13.3048 5.7473 0.0 0
M  V30 17 O 14.2100 6.9931 0.0 0
M  V30 18 O 13.9313 4.3403 0.0 0
M  V30 19 C 15.7416 6.8322 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0 CFG=2
M  V30 21 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 22 C 8.0022 3.0801 0.0 0 CFG=1
M  V30 23 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 24 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 25 O 5.3348 3.0801 0.0 0
M  V30 26 N 9.3358 5.3901 0.0 0
M  V30 27 C 10.7428 4.7638 0.0 0
M  V30 28 N 9.4969 6.9217 0.0 0
M  V30 29 C 11.7733 5.9082 0.0 0
M  V30 30 N 11.0032 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 24 14 CFG=3
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 29
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 26 CFG=3
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-deoxy-3-[4-[(methylamino)carbonyl]-1H-1,2,3-triazol-1-yl]-1-thio-β-D...
C11H18N4O5S
862670-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.9300 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 O 0.0000 4.6200 0.0 0
M  V30 5 S 4.0011 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 10.6373 5.7471 0.0 0
M  V30 8 N 11.5425 6.9930 0.0 0
M  V30 9 O 11.2636 4.3402 0.0 0
M  V30 10 C 13.0740 6.8321 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 12 C 4.0011 5.3900 0.0 0 CFG=1
M  V30 13 C 5.3347 3.0800 0.0 0 CFG=1
M  V30 14 C 2.6673 4.6200 0.0 0 CFG=1
M  V30 15 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 16 O 2.6673 3.0800 0.0 0
M  V30 17 N 6.6684 5.3900 0.0 0
M  V30 18 C 8.0753 4.7635 0.0 0
M  V30 19 N 6.8293 6.9215 0.0 0
M  V30 20 C 9.1057 5.9081 0.0 0
M  V30 21 N 8.3357 7.2417 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 13 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 14 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 15 5 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17 CFG=3
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862670-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862670-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-13943472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity
galectin-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salameh, Bader A.; Cumpstey, Ian; Sundin, Anders; Leffler, Hakon;
Nilsson, Ulf J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(14), 5367-5378

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, methyl 3-deoxy-3-[4-(methoxycarbonyl)-1H-1,2,3-triazol...
C17H23N3O9S
862670-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.9302 0.0 0
M  V30 2 C 5.3348 7.7002 0.0 0
M  V30 3 C 4.0010 6.9302 0.0 0
M  V30 4 O 5.3348 9.2402 0.0 0
M  V30 5 O 9.3358 2.3101 0.0 0
M  V30 6 C 9.3358 0.7700 0.0 0
M  V30 7 C 10.6697 0.0000 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 O 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 1.3337 6.9302 0.0 0
M  V30 13 O 0.0000 4.6201 0.0 0
M  V30 14 S 6.6685 0.7700 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 C 13.3048 5.7473 0.0 0
M  V30 17 O 14.2100 6.9931 0.0 0
M  V30 18 O 13.9313 4.3403 0.0 0
M  V30 19 C 15.7416 6.8322 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0 CFG=2
M  V30 21 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 22 C 8.0022 3.0801 0.0 0 CFG=1
M  V30 23 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 24 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 25 O 5.3348 3.0801 0.0 0
M  V30 26 N 9.3358 5.3901 0.0 0
M  V30 27 C 10.7428 4.7638 0.0 0
M  V30 28 N 9.4969 6.9217 0.0 0
M  V30 29 C 11.7733 5.9082 0.0 0
M  V30 30 N 11.0032 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 24 14 CFG=3
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 29
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 26 CFG=3
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-deoxy-3-[4-[(methylamino)carbonyl]-1H-1,2,3-triazol-1-yl]-1-thio-β-D...
C11H18N4O5S
862670-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.9300 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 O 0.0000 4.6200 0.0 0
M  V30 5 S 4.0011 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 10.6373 5.7471 0.0 0
M  V30 8 N 11.5425 6.9930 0.0 0
M  V30 9 O 11.2636 4.3402 0.0 0
M  V30 10 C 13.0740 6.8321 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 12 C 4.0011 5.3900 0.0 0 CFG=1
M  V30 13 C 5.3347 3.0800 0.0 0 CFG=1
M  V30 14 C 2.6673 4.6200 0.0 0 CFG=1
M  V30 15 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 16 O 2.6673 3.0800 0.0 0
M  V30 17 N 6.6684 5.3900 0.0 0
M  V30 18 C 8.0753 4.7635 0.0 0
M  V30 19 N 6.8293 6.9215 0.0 0
M  V30 20 C 9.1057 5.9081 0.0 0
M  V30 21 N 8.3357 7.2417 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 13 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 14 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 15 5 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17 CFG=3
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862670-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862670-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-10699940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for the preparation of amides 14-18 The ester 4 (10 mg,
0.023 mmol) was stirred with the amine (x, 0.25 mL) in water or methanol
(1.0 mL) for (t) time and at (T) temperature. The residue obtained after
the evaporation of the solvent was purified by column chromatography
using the eluent indicated. Methyl
3-(4-methylaminocarbonyl-1H-[1,2,3]-triazol-1-yl)-3-deoxy-1-thio-β-D-galactopyranoside
(14) x= Methyl amine, t= 12 hours, Column SiO2, CH2Cl2:MeOH 15:1, yield:
7.0 mg, 98%. 1H NMR (400 MHz, MeOD) δ 8.43 (a, 1H, H-5') , 4.84 (dd, 1H,
J 2,3 = 10.6, J 3,4=3.0, H-3) , 4.46(d, 1H, J 1,2=9.2, H-1) , 4.19(dd,
1H, H-2) , 4.10(d, 1H, H-4) , 3.80-3.67(m, 3H, H-5, 2H-6) , 2.92 (s, 3H,
CH3N) , 2.25 (a, 3H, CH3S) . 13C NMR (100.6 MHz, MeOD) δ 163.4(C=O) ,
143.5(C-4') , 126.6 (C-5') , 88.6(C-1) , 81.0(C-5) , 69.6(C-4) ,
69.1(C-3) , 67.7(C-2) , 62.4 (C-6) , 26.1(CH3N) , 12.0(CH3S) . FAB HRMS
Calcd. for C11H18N4O5SNa [M+Na] + 341.0896; found 341.0892.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-(1,2,3-triazol-1-yl)-1-thio-galactosides as antitumor
and anti-inflammatory agents and for use as hydrolytically stable
inhibitors of galectin-3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leffler, Hakon; Salameh, Bader Abdalraheem Bader
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005113569 A1 2005-12-01

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, methyl 3-deoxy-3-[4-(methoxycarbonyl)-1H-1,2,3-triazol...
C17H23N3O9S
862670-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.9302 0.0 0
M  V30 2 C 5.3348 7.7002 0.0 0
M  V30 3 C 4.0010 6.9302 0.0 0
M  V30 4 O 5.3348 9.2402 0.0 0
M  V30 5 O 9.3358 2.3101 0.0 0
M  V30 6 C 9.3358 0.7700 0.0 0
M  V30 7 C 10.6697 0.0000 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 O 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 1.3337 6.9302 0.0 0
M  V30 13 O 0.0000 4.6201 0.0 0
M  V30 14 S 6.6685 0.7700 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 C 13.3048 5.7473 0.0 0
M  V30 17 O 14.2100 6.9931 0.0 0
M  V30 18 O 13.9313 4.3403 0.0 0
M  V30 19 C 15.7416 6.8322 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0 CFG=2
M  V30 21 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 22 C 8.0022 3.0801 0.0 0 CFG=1
M  V30 23 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 24 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 25 O 5.3348 3.0801 0.0 0
M  V30 26 N 9.3358 5.3901 0.0 0
M  V30 27 C 10.7428 4.7638 0.0 0
M  V30 28 N 9.4969 6.9217 0.0 0
M  V30 29 C 11.7733 5.9082 0.0 0
M  V30 30 N 11.0032 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 24 14 CFG=3
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 29
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 26 CFG=3
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-deoxy-3-[4-[(methylamino)carbonyl]-1H-1,2,3-triazol-1-yl]-1-thio-β-D...
C11H18N4O5S
862670-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.9300 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 O 0.0000 4.6200 0.0 0
M  V30 5 S 4.0011 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 10.6373 5.7471 0.0 0
M  V30 8 N 11.5425 6.9930 0.0 0
M  V30 9 O 11.2636 4.3402 0.0 0
M  V30 10 C 13.0740 6.8321 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 12 C 4.0011 5.3900 0.0 0 CFG=1
M  V30 13 C 5.3347 3.0800 0.0 0 CFG=1
M  V30 14 C 2.6673 4.6200 0.0 0 CFG=1
M  V30 15 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 16 O 2.6673 3.0800 0.0 0
M  V30 17 N 6.6684 5.3900 0.0 0
M  V30 18 C 8.0753 4.7635 0.0 0
M  V30 19 N 6.8293 6.9215 0.0 0
M  V30 20 C 9.1057 5.9081 0.0 0
M  V30 21 N 8.3357 7.2417 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 13 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 14 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 15 5 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17 CFG=3
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862670-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862670-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-11509428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and
hydrolytically stable inhibitors of galectin-3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salameh, Bader A.; Leffler, Hakon; Nilsson, Ulf J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(14), 3344-3346

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[2-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethyl...
C19H16ClF3N4O3
863910-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.9145 2.8737 0.0 0
M  V30 2 O 20.6845 4.2074 0.0 0
M  V30 3 O 20.6845 1.5400 0.0 0
M  V30 4 C 22.2245 4.2074 0.0 0
M  V30 5 C 12.0035 1.3337 0.0 0
M  V30 6 C 10.6697 2.1037 0.0 0
M  V30 7 N 9.3360 1.3337 0.0 0
M  V30 8 C 8.0023 2.1037 0.0 0
M  V30 9 N 6.6687 1.3337 0.0 0
M  V30 10 O 8.0023 3.6437 0.0 0
M  V30 11 C 1.3338 1.3337 0.0 0
M  V30 12 F 2.1038 0.0000 0.0 0
M  V30 13 F 0.0000 0.5637 0.0 0
M  V30 14 F 0.5638 2.6673 0.0 0
M  V30 15 Cl 1.3338 4.4137 0.0 0
M  V30 16 C 16.0045 3.6437 0.0 0
M  V30 17 C 16.0045 2.1037 0.0 0
M  V30 18 N 17.4692 4.1196 0.0 0
M  V30 19 C 14.6708 4.4137 0.0 0
M  V30 20 N 17.4692 1.6278 0.0 0
M  V30 21 C 14.6708 1.3337 0.0 0
M  V30 22 C 18.3744 2.8737 0.0 0
M  V30 23 C 13.3372 3.6437 0.0 0
M  V30 24 C 13.3372 2.1037 0.0 0
M  V30 25 C 5.3348 2.1037 0.0 0
M  V30 26 C 4.0012 1.3337 0.0 0
M  V30 27 C 5.3348 3.6437 0.0 0
M  V30 28 C 2.6675 2.1037 0.0 0
M  V30 29 C 4.0012 4.4137 0.0 0
M  V30 30 C 2.6675 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 28
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethyl]-N-met...
C19H17ClF3N5O2
863910-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.9145 2.8737 0.0 0
M  V30 2 N 20.6845 4.2074 0.0 0
M  V30 3 O 20.6845 1.5400 0.0 0
M  V30 4 C 22.2245 4.2074 0.0 0
M  V30 5 C 12.0035 1.3337 0.0 0
M  V30 6 C 10.6697 2.1037 0.0 0
M  V30 7 N 9.3360 1.3337 0.0 0
M  V30 8 C 8.0023 2.1037 0.0 0
M  V30 9 N 6.6687 1.3337 0.0 0
M  V30 10 O 8.0023 3.6437 0.0 0
M  V30 11 C 1.3338 1.3337 0.0 0
M  V30 12 F 2.1038 0.0000 0.0 0
M  V30 13 F 0.0000 0.5637 0.0 0
M  V30 14 F 0.5638 2.6673 0.0 0
M  V30 15 Cl 1.3338 4.4137 0.0 0
M  V30 16 C 16.0045 3.6437 0.0 0
M  V30 17 C 16.0045 2.1037 0.0 0
M  V30 18 N 17.4692 4.1196 0.0 0
M  V30 19 C 14.6708 4.4137 0.0 0
M  V30 20 N 17.4692 1.6278 0.0 0
M  V30 21 C 14.6708 1.3337 0.0 0
M  V30 22 C 18.3744 2.8737 0.0 0
M  V30 23 C 13.3372 3.6437 0.0 0
M  V30 24 C 13.3372 2.1037 0.0 0
M  V30 25 C 5.3348 2.1037 0.0 0
M  V30 26 C 4.0012 1.3337 0.0 0
M  V30 27 C 5.3348 3.6437 0.0 0
M  V30 28 C 2.6675 2.1037 0.0 0
M  V30 29 C 4.0012 4.4137 0.0 0
M  V30 30 C 2.6675 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 28
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863910-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863910-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9855914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of isoquinolines and benzimidazoles as RAF kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchstaller, Hans-Peter; Burgdorf, Lars; Finsinger, Dirk; Stieber, Frank;
Sirrenberg, Christian; Amendt, Christiane; Grell, Matthias; Zenke, Frank;
Krier, Mireille
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(8), 2264-2269

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[2-[[[[2-methoxy-5-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethy...
C20H19F3N4O4
863910-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.4528 4.6200 0.0 0
M  V30 2 O 18.2228 3.2864 0.0 0
M  V30 3 O 18.2228 5.9536 0.0 0
M  V30 4 C 19.7628 3.2864 0.0 0
M  V30 5 C 9.5420 6.1600 0.0 0
M  V30 6 C 8.2084 5.3900 0.0 0
M  V30 7 N 6.8747 6.1600 0.0 0
M  V30 8 C 5.5409 5.3900 0.0 0
M  V30 9 N 4.2073 6.1600 0.0 0
M  V30 10 O 5.5409 3.8500 0.0 0
M  V30 11 O 1.5400 7.7000 0.0 0
M  V30 12 C 0.2062 8.4700 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 F 3.0800 1.5400 0.0 0
M  V30 15 F 1.5400 0.0000 0.0 0
M  V30 16 F 0.0000 1.5400 0.0 0
M  V30 17 C 13.5431 3.8500 0.0 0
M  V30 18 C 13.5431 5.3900 0.0 0
M  V30 19 N 15.0076 3.3741 0.0 0
M  V30 20 C 12.2094 3.0800 0.0 0
M  V30 21 N 15.0076 5.8659 0.0 0
M  V30 22 C 12.2094 6.1600 0.0 0
M  V30 23 C 15.9128 4.6200 0.0 0
M  V30 24 C 10.8756 3.8500 0.0 0
M  V30 25 C 10.8756 5.3900 0.0 0
M  V30 26 C 2.8736 5.3900 0.0 0
M  V30 27 C 1.5400 6.1600 0.0 0
M  V30 28 C 2.8736 3.8500 0.0 0
M  V30 29 C 0.2062 5.3900 0.0 0
M  V30 30 C 1.5400 3.0800 0.0 0
M  V30 31 C 0.2062 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 30
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-[[[[2-Methoxy-5-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethyl]-N-me...
C20H20F3N5O3
863910-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.4528 4.6200 0.0 0
M  V30 2 N 18.2228 3.2864 0.0 0
M  V30 3 O 18.2228 5.9536 0.0 0
M  V30 4 C 19.7628 3.2864 0.0 0
M  V30 5 C 9.5420 6.1600 0.0 0
M  V30 6 C 8.2084 5.3900 0.0 0
M  V30 7 N 6.8747 6.1600 0.0 0
M  V30 8 C 5.5409 5.3900 0.0 0
M  V30 9 N 4.2073 6.1600 0.0 0
M  V30 10 O 5.5409 3.8500 0.0 0
M  V30 11 O 1.5400 7.7000 0.0 0
M  V30 12 C 0.2062 8.4700 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 F 0.0000 1.5400 0.0 0
M  V30 15 F 1.5400 0.0000 0.0 0
M  V30 16 F 3.0800 1.5400 0.0 0
M  V30 17 C 13.5431 3.8500 0.0 0
M  V30 18 C 13.5431 5.3900 0.0 0
M  V30 19 N 15.0076 3.3741 0.0 0
M  V30 20 C 12.2094 3.0800 0.0 0
M  V30 21 N 15.0076 5.8659 0.0 0
M  V30 22 C 12.2094 6.1600 0.0 0
M  V30 23 C 15.9128 4.6200 0.0 0
M  V30 24 C 10.8756 3.8500 0.0 0
M  V30 25 C 10.8756 5.3900 0.0 0
M  V30 26 C 2.8736 5.3900 0.0 0
M  V30 27 C 1.5400 6.1600 0.0 0
M  V30 28 C 2.8736 3.8500 0.0 0
M  V30 29 C 0.2062 5.3900 0.0 0
M  V30 30 C 1.5400 3.0800 0.0 0
M  V30 31 C 0.2062 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 30
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863910-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863910-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7721410
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of isoquinolines and benzimidazoles as RAF kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchstaller, Hans-Peter; Burgdorf, Lars; Finsinger, Dirk; Stieber, Frank;
Sirrenberg, Christian; Amendt, Christiane; Grell, Matthias; Zenke, Frank;
Krier, Mireille
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(8), 2264-2269

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1,3-bis(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-acetic acid
C20H25NO3
864924-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2896 4.0011 0.0 0
M  V30 2 C 4.0596 2.6673 0.0 0
M  V30 3 C 3.2896 1.3336 0.0 0
M  V30 4 C 4.0596 0.0000 0.0 0
M  V30 5 C 1.7496 1.3336 0.0 0
M  V30 6 C 2.6528 5.9611 0.0 0
M  V30 7 C 1.4070 5.0558 0.0 0
M  V30 8 O 0.0000 5.6823 0.0 0
M  V30 9 O 1.5679 3.5243 0.0 0
M  V30 10 O 5.3056 2.8895 0.0 0
M  V30 11 C 8.0160 4.8589 0.0 0
M  V30 12 C 9.1606 5.8893 0.0 0
M  V30 13 C 10.6251 5.4134 0.0 0
M  V30 14 C 11.7697 6.4439 0.0 0
M  V30 15 C 10.9453 3.9070 0.0 0
M  V30 16 C 4.0596 5.3347 0.0 0
M  V30 17 C 4.5356 6.7994 0.0 0
M  V30 18 C 5.3056 4.4295 0.0 0
M  V30 19 C 6.0756 6.7994 0.0 0
M  V30 20 C 3.7656 8.1331 0.0 0
M  V30 21 N 6.5515 5.3347 0.0 0
M  V30 22 C 6.8456 8.1331 0.0 0
M  V30 23 C 4.5356 9.4667 0.0 0
M  V30 24 C 6.0756 9.4667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 18
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-1,3-bis(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-acetamide
C21H28N2O2
864924-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 5.9611 0.0 0
M  V30 2 C 2.6528 5.0558 0.0 0
M  V30 3 N 1.2459 5.6823 0.0 0
M  V30 4 O 2.8137 3.5243 0.0 0
M  V30 5 C 0.0000 4.7771 0.0 0
M  V30 6 C 4.5355 4.0011 0.0 0
M  V30 7 C 5.3055 2.6673 0.0 0
M  V30 8 C 4.5355 1.3336 0.0 0
M  V30 9 C 2.9955 1.3336 0.0 0
M  V30 10 C 5.3055 0.0000 0.0 0
M  V30 11 O 6.5515 2.8895 0.0 0
M  V30 12 C 9.2619 4.8589 0.0 0
M  V30 13 C 10.4064 5.8893 0.0 0
M  V30 14 C 11.8710 5.4134 0.0 0
M  V30 15 C 13.0155 6.4439 0.0 0
M  V30 16 C 12.1912 3.9070 0.0 0
M  V30 17 C 5.3055 5.3347 0.0 0
M  V30 18 C 5.7815 6.7994 0.0 0
M  V30 19 C 6.5515 4.4295 0.0 0
M  V30 20 C 7.3215 6.7994 0.0 0
M  V30 21 C 5.0115 8.1331 0.0 0
M  V30 22 N 7.7974 5.3347 0.0 0
M  V30 23 C 8.0915 8.1331 0.0 0
M  V30 24 C 5.7815 9.4667 0.0 0
M  V30 25 C 7.3215 9.4667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 19
M  V30 12 1 12 13
M  V30 13 1 12 22
M  V30 14 2 13 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 864924-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864924-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-811845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (3aS-cis)-(-)- and (3aR-cis)-(+)-debromoflustramine B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2005), 16(14), 2493-2499

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,8aS)-3,3a,8,8a-Tetrahydro-3a,8-bis(3-methyl-2-buten-1-yl)-2H-furo[2,3-b]...
C20H25NO2
864924-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7113 0.0 0
M  V30 7 C 10.3497 4.8558 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3320 3.0710 0.0 0
M  V30 11 O 4.0467 0.0000 0.0 0
M  V30 12 C 5.3348 3.7711 0.0 0 CFG=2
M  V30 13 C 6.6685 3.0010 0.0 0 CFG=2
M  V30 14 C 5.6550 5.2775 0.0 0
M  V30 15 C 4.1902 2.7406 0.0 0
M  V30 16 N 7.8130 4.0316 0.0 0
M  V30 17 O 6.3483 1.4947 0.0 0
M  V30 18 C 7.1865 5.4384 0.0 0
M  V30 19 C 4.7497 6.5234 0.0 0
M  V30 20 C 4.8167 1.3338 0.0 0
M  V30 21 C 7.8130 6.8454 0.0 0
M  V30 22 C 5.3762 7.9302 0.0 0
M  V30 23 C 6.9078 8.0913 0.0 0
M  V30 24 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 24 CFG=3
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,8aS)-3,3a,8,8a-Tetrahydro-1-methyl-3a,8-bis(3-methyl-2-buten-1-yl)pyrrol...
C21H28N2O
864924-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7115 0.0 0
M  V30 7 C 10.3497 4.8559 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3321 3.0710 0.0 0
M  V30 11 C 7.3787 0.3502 0.0 0
M  V30 12 O 4.0467 0.0000 0.0 0
M  V30 13 C 5.3348 3.7711 0.0 0 CFG=2
M  V30 14 C 6.6685 3.0010 0.0 0 CFG=2
M  V30 15 C 5.6550 5.2775 0.0 0
M  V30 16 C 4.1903 2.7406 0.0 0
M  V30 17 N 7.8130 4.0316 0.0 0
M  V30 18 N 6.3483 1.4947 0.0 0
M  V30 19 C 7.1865 5.4384 0.0 0
M  V30 20 C 4.7497 6.5234 0.0 0
M  V30 21 C 4.8167 1.3338 0.0 0
M  V30 22 C 7.8130 6.8454 0.0 0
M  V30 23 C 5.3762 7.9302 0.0 0
M  V30 24 C 6.9078 8.0913 0.0 0
M  V30 25 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 18
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 25 CFG=3
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 864924-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864924-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7479317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (3aS-cis)-(-)- and (3aR-cis)-(+)-debromoflustramine B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2005), 16(14), 2493-2499

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aR,8aR)-3,3a,8,8a-Tetrahydro-3a,8-bis(3-methyl-2-buten-1-yl)-2H-furo[2,3-b]...
C20H25NO2
864924-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7113 0.0 0
M  V30 7 C 10.3497 4.8558 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3320 3.0710 0.0 0
M  V30 11 O 4.0467 0.0000 0.0 0
M  V30 12 C 5.3348 3.7711 0.0 0 CFG=1
M  V30 13 C 6.6685 3.0010 0.0 0 CFG=1
M  V30 14 C 5.6550 5.2775 0.0 0
M  V30 15 C 4.1902 2.7406 0.0 0
M  V30 16 N 7.8130 4.0316 0.0 0
M  V30 17 O 6.3483 1.4947 0.0 0
M  V30 18 C 7.1865 5.4384 0.0 0
M  V30 19 C 4.7497 6.5234 0.0 0
M  V30 20 C 4.8167 1.3338 0.0 0
M  V30 21 C 7.8130 6.8454 0.0 0
M  V30 22 C 5.3762 7.9302 0.0 0
M  V30 23 C 6.9078 8.0913 0.0 0
M  V30 24 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 24 CFG=1
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a,8-bis(3-methyl-2-buten-1-yl)pyrrol...
C21H28N2O
377725-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7115 0.0 0
M  V30 7 C 10.3497 4.8559 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3321 3.0710 0.0 0
M  V30 11 C 7.3787 0.3502 0.0 0
M  V30 12 O 4.0467 0.0000 0.0 0
M  V30 13 C 5.3348 3.7711 0.0 0 CFG=1
M  V30 14 C 6.6685 3.0010 0.0 0 CFG=1
M  V30 15 C 5.6550 5.2775 0.0 0
M  V30 16 C 4.1903 2.7406 0.0 0
M  V30 17 N 7.8130 4.0316 0.0 0
M  V30 18 N 6.3483 1.4947 0.0 0
M  V30 19 C 7.1865 5.4384 0.0 0
M  V30 20 C 4.7497 6.5234 0.0 0
M  V30 21 C 4.8167 1.3338 0.0 0
M  V30 22 C 7.8130 6.8454 0.0 0
M  V30 23 C 5.3762 7.9302 0.0 0
M  V30 24 C 6.9078 8.0913 0.0 0
M  V30 25 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 18
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 25 CFG=1
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 864924-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 377725-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9607316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (3aS-cis)-(-)- and (3aR-cis)-(+)-debromoflustramine B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2005), 16(14), 2493-2499

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S,2R)-3-[[[3-(bromomethyl)-1,2-benzisoxazol-5-yl]sulfonyl](...
C29H36BrN3O8S
869988-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.8053 9.9592 0.0 0
M  V30 2 Br 20.2699 10.4351 0.0 0
M  V30 3 S 13.0745 8.0022 0.0 0 VAL=6
M  V30 4 N 12.3045 6.6684 0.0 0
M  V30 5 O 14.4082 7.2322 0.0 0
M  V30 6 O 11.7407 8.7722 0.0 0
M  V30 7 C 10.7645 6.6684 0.0 0
M  V30 8 C 13.0745 5.3347 0.0 0
M  V30 9 C 9.9945 5.3347 0.0 0 CFG=1
M  V30 10 C 14.6145 5.3347 0.0 0
M  V30 11 C 8.4545 5.3347 0.0 0 CFG=1
M  V30 12 O 10.7645 4.0011 0.0 0
M  V30 13 C 15.3845 4.0011 0.0 0
M  V30 14 C 15.3845 6.6684 0.0 0
M  V30 15 C 7.6845 4.0011 0.0 0
M  V30 16 N 7.6845 6.6684 0.0 0
M  V30 17 C 6.1445 6.6684 0.0 0
M  V30 18 O 5.3745 8.0022 0.0 0
M  V30 19 O 5.3745 5.3347 0.0 0
M  V30 20 C 16.1545 10.6695 0.0 0
M  V30 21 C 15.3845 12.0031 0.0 0
M  V30 22 C 17.6608 10.9896 0.0 0
M  V30 23 C 15.3845 9.3358 0.0 0
M  V30 24 C 13.8445 12.0031 0.0 0
M  V30 25 O 16.4149 13.1477 0.0 0
M  V30 26 N 17.8217 12.5213 0.0 0
M  V30 27 C 13.8445 9.3358 0.0 0
M  V30 28 C 13.0745 10.6695 0.0 0
M  V30 29 C 8.4545 2.6674 0.0 0
M  V30 30 C 7.6845 1.3336 0.0 0
M  V30 31 C 9.9945 2.6674 0.0 0
M  V30 32 C 8.4545 0.0000 0.0 0
M  V30 33 C 10.7645 1.3336 0.0 0
M  V30 34 C 9.9945 0.0000 0.0 0
M  V30 35 C 3.8345 8.0022 0.0 0 CFG=1
M  V30 36 C 2.9292 9.2481 0.0 0 CFG=2
M  V30 37 C 2.9292 6.7562 0.0 0
M  V30 38 C 1.4645 8.7722 0.0 0 CFG=2
M  V30 39 C 2.9292 10.7881 0.0 0
M  V30 40 O 1.4645 7.2322 0.0 0
M  V30 41 O 0.5593 10.0181 0.0 0
M  V30 42 C 1.4645 11.2639 0.0 0
M  V30 43 H 4.3938 9.7239 0.0 0
M  V30 44 H 0.0000 8.2962 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 27
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15 CFG=3
M  V30 16 1 11 16
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 35 18 CFG=1
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 36 39
M  V30 42 1 36 43 CFG=3
M  V30 43 1 37 40
M  V30 44 1 38 40
M  V30 45 1 38 41
M  V30 46 1 38 44 CFG=3
M  V30 47 1 39 42
M  V30 48 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 11 35 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S,2R)-2-hydroxy-3-[[[3-[(methylamino)methyl]-1,2-benzisoxaz...
C30H40N4O8S
869988-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.8053 9.9592 0.0 0
M  V30 2 N 20.2700 10.4351 0.0 0
M  V30 3 C 21.4144 9.4047 0.0 0
M  V30 4 S 13.0745 8.0022 0.0 0 VAL=6
M  V30 5 N 12.3045 6.6684 0.0 0
M  V30 6 O 11.7409 8.7722 0.0 0
M  V30 7 O 14.4082 7.2322 0.0 0
M  V30 8 C 10.7645 6.6684 0.0 0
M  V30 9 C 13.0745 5.3347 0.0 0
M  V30 10 C 9.9945 5.3347 0.0 0 CFG=1
M  V30 11 C 14.6145 5.3347 0.0 0
M  V30 12 C 8.4545 5.3347 0.0 0 CFG=1
M  V30 13 O 10.7645 4.0011 0.0 0
M  V30 14 C 15.3845 4.0011 0.0 0
M  V30 15 C 15.3845 6.6684 0.0 0
M  V30 16 C 7.6845 4.0011 0.0 0
M  V30 17 N 7.6845 6.6684 0.0 0
M  V30 18 C 6.1445 6.6684 0.0 0
M  V30 19 O 5.3745 8.0022 0.0 0
M  V30 20 O 5.3745 5.3347 0.0 0
M  V30 21 C 16.1545 10.6695 0.0 0
M  V30 22 C 15.3845 12.0031 0.0 0
M  V30 23 C 17.6608 10.9896 0.0 0
M  V30 24 C 15.3845 9.3358 0.0 0
M  V30 25 C 13.8445 12.0031 0.0 0
M  V30 26 O 16.4149 13.1477 0.0 0
M  V30 27 N 17.8219 12.5213 0.0 0
M  V30 28 C 13.8445 9.3358 0.0 0
M  V30 29 C 13.0745 10.6695 0.0 0
M  V30 30 C 8.4545 2.6674 0.0 0
M  V30 31 C 7.6845 1.3336 0.0 0
M  V30 32 C 9.9945 2.6674 0.0 0
M  V30 33 C 8.4545 0.0000 0.0 0
M  V30 34 C 10.7645 1.3336 0.0 0
M  V30 35 C 9.9945 0.0000 0.0 0
M  V30 36 C 3.8345 8.0022 0.0 0 CFG=1
M  V30 37 C 2.9292 9.2481 0.0 0 CFG=2
M  V30 38 C 2.9292 6.7562 0.0 0
M  V30 39 C 1.4647 8.7722 0.0 0 CFG=2
M  V30 40 C 2.9292 10.7881 0.0 0
M  V30 41 O 1.4647 7.2322 0.0 0
M  V30 42 O 0.5595 10.0181 0.0 0
M  V30 43 C 1.4647 11.2639 0.0 0
M  V30 44 H 4.3940 9.7239 0.0 0
M  V30 45 H 0.0000 8.2962 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 4 7
M  V30 7 1 4 28
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=3
M  V30 17 1 12 17
M  V30 18 1 16 30
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 36 19 CFG=1
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 37 40
M  V30 43 1 37 44 CFG=3
M  V30 44 1 38 41
M  V30 45 1 39 41
M  V30 46 1 39 42
M  V30 47 1 39 45 CFG=3
M  V30 48 1 40 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 36 37 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869988-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869988-85-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13832579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound: 252 Yield 98%. MH+=617
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl sulfonylaminobenzylhydroxypropylcarbamates as
HIV protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eissenstat, Michael; Delahanty, Greg; Topin, Andrey; Rajendran, Gnana
Ravi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005110428 A2 2005-11-24

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Indole-3-acetic acid
C10H9NO2
87-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 3.1885 0.0 0
M  V30 2 C 7.1954 2.7126 0.0 0
M  V30 3 O 7.5156 1.2061 0.0 0
M  V30 4 O 8.3398 3.7430 0.0 0
M  V30 5 C 3.0800 2.4782 0.0 0
M  V30 6 C 2.3100 1.1444 0.0 0
M  V30 7 C 4.5863 2.1580 0.0 0
M  V30 8 C 2.3100 3.8118 0.0 0
M  V30 9 N 3.3405 0.0000 0.0 0
M  V30 10 C 0.7700 1.1444 0.0 0
M  V30 11 C 4.7473 0.6263 0.0 0
M  V30 12 C 0.7700 3.8118 0.0 0
M  V30 13 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-acetamide
C11H12N2O
132906-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 1.6412 0.0 0
M  V30 2 C 7.0869 2.4112 0.0 0
M  V30 3 N 8.4206 1.6412 0.0 0
M  V30 4 O 7.0869 3.9512 0.0 0
M  V30 5 C 9.7544 2.4112 0.0 0
M  V30 6 C 3.0127 1.7849 0.0 0
M  V30 7 C 4.4196 2.4112 0.0 0
M  V30 8 C 1.9823 2.9292 0.0 0
M  V30 9 C 2.5368 0.3202 0.0 0
M  V30 10 C 4.2586 3.9429 0.0 0
M  V30 11 N 2.7523 4.2630 0.0 0
M  V30 12 C 0.4759 2.6091 0.0 0
M  V30 13 C 1.0306 0.0000 0.0 0
M  V30 14 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87-51-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132906-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35434525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bioinspired intramolecular Diels-Alder cycloaddition for the total
synthesis of ophiorrhine A via ophiorrhine G and ophiorrhiside E
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Wei; Dou, Yingchao; Kouklovsky, Cyrille; Vincent, Guillaume
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(38), e202209135

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-[(2-ethyl-6-methylphenyl)methyl]-3-nitro-4-pyridinamine
C15H15Cl2N3O2
875769-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 6.1600 5.3347 0.0 0
M  V30 3 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 4 O 2.3100 6.6684 0.0 0
M  V30 5 O 0.0000 5.3347 0.0 0
M  V30 6 Cl 0.0000 2.6674 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 10.7800 5.3347 0.0 0
M  V30 10 C 4.6200 8.0021 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 15 C 3.8500 1.3336 0.0 0
M  V30 16 N 2.3100 1.3336 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 C 8.4700 6.6684 0.0 0
M  V30 19 C 6.1600 8.0021 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 6 14
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 1 8 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-[(2-ethyl-6-methylphenyl)methyl]-N2-methyl-3-nitro-2,4-pyridinedi...
C16H19ClN4O2
890307-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0
M  V30 3 N 8.0021 6.1601 0.0 0 VAL=5
M  V30 4 O 6.6684 6.9301 0.0 0
M  V30 5 O 9.3359 6.9301 0.0 0
M  V30 6 N 10.6695 4.6201 0.0 0
M  V30 7 C 12.0032 3.8500 0.0 0
M  V30 8 Cl 8.0021 0.0000 0.0 0
M  V30 9 C 1.3337 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 4.0011 6.9301 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 8.0021 4.6201 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 9.3359 3.8500 0.0 0
M  V30 16 C 8.0021 1.5400 0.0 0
M  V30 17 N 9.3359 2.3100 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8500 0.0 0
M  V30 20 C 2.6673 6.1601 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 1.3337 6.9301 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875769-58-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890307-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12409659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM B.
6-Chloro-4-(2-ethyl-6-methylbenzyl)amino-2-methylamino-3-nitro-pyridine A
solution of methylamine in ethanol (33%) (4.50 ml, 36.0 mmol) and
triethylamine (4.50 ml) were added to a suspension of
2,6-dichloro-4-(2-ethyl-6-methylbenzyl)amino-3-nitro-pyridine (5.10 g,
15.0 mmol) in 2-methoxyethanol (90 ml). The reaction mixture was heated
to 55 °C for 1 h forming a clear solution. The solution was concentrated
in vacuum, diluted with a small amount of ethanol, and poured onto ice
(600 ml). An orange precipitate was formed which was filtered off, washed
with water and dried at 40 °C in vacuum for 12h. 4.93 g (98 %) of the
title compound were obtained as an orange solid.
6-Chloro-4-(2-ethyl-6-methylbenzyl)amino-2-methylamino-3-nitro-pyridine ,
Yield 4.93 g (98 %) m.p. 152-157°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazo[4,5-b]pyridines as gastric acid secretion
inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brehm, Christof; Buhr, Wilm; Chiesa, M. Vittoria; Palmer, Andreas;
Zimmermann, Peter Jan; Simon, Wolfgang-Alexander; Postius, Stefan;
Kromer, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006061380 A2 2006-06-15

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-[2-[4-(2-methyl-5-quinolinyl)-1-piperidinyl]ethyl]imidazo[1,5-a]quino...
C31H32N4O2
876923-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.8208 8.6254 0.0 0
M  V30 2 O 20.2855 9.1014 0.0 0
M  V30 3 O 18.5006 7.1191 0.0 0
M  V30 4 C 21.4299 8.0708 0.0 0
M  V30 5 C 22.8946 8.5467 0.0 0
M  V30 6 C 10.7800 8.0020 0.0 0
M  V30 7 C 9.2400 8.0020 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 N 15.4000 10.6694 0.0 0
M  V30 10 C 13.8600 10.6694 0.0 0
M  V30 11 C 16.1700 9.3358 0.0 0
M  V30 12 C 16.4306 11.8138 0.0 0
M  V30 13 C 13.0900 9.3358 0.0 0
M  V30 14 C 13.0900 12.0031 0.0 0
M  V30 15 C 17.6764 9.6560 0.0 0
M  V30 16 C 15.4000 8.0020 0.0 0
M  V30 17 N 17.8374 11.1875 0.0 0
M  V30 18 C 11.5500 9.3358 0.0 0
M  V30 19 C 13.8600 8.0020 0.0 0
M  V30 20 C 11.5500 12.0031 0.0 0
M  V30 21 C 10.7800 10.6694 0.0 0
M  V30 22 N 8.4700 6.6684 0.0 0
M  V30 23 C 6.9300 6.6684 0.0 0
M  V30 24 C 9.2400 5.3347 0.0 0
M  V30 25 C 6.1600 5.3347 0.0 0
M  V30 26 C 8.4700 4.0011 0.0 0
M  V30 27 C 6.9300 4.0011 0.0 0
M  V30 28 C 6.1600 2.6673 0.0 0
M  V30 29 C 4.6200 2.6673 0.0 0
M  V30 30 C 6.9300 1.3336 0.0 0
M  V30 31 C 3.8500 1.3336 0.0 0
M  V30 32 C 3.8500 4.0011 0.0 0
M  V30 33 C 6.1600 0.0000 0.0 0
M  V30 34 C 4.6200 0.0000 0.0 0
M  V30 35 N 2.3100 1.3336 0.0 0
M  V30 36 C 2.3100 4.0011 0.0 0
M  V30 37 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 22
M  V30 9 1 8 37
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 2 12 17
M  V30 18 2 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 17
M  V30 22 2 16 19
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 31 34
M  V30 38 1 31 35
M  V30 39 2 32 36
M  V30 40 2 33 34
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[2-[4-(2-methyl-5-quinolinyl)-1-piperidinyl]ethyl]imidazo[1,5-a]qu...
C30H31N5O
876924-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.8206 8.6254 0.0 0
M  V30 2 N 20.2853 9.1014 0.0 0
M  V30 3 O 18.5005 7.1191 0.0 0
M  V30 4 C 21.4297 8.0708 0.0 0
M  V30 5 C 10.7800 8.0020 0.0 0
M  V30 6 C 9.2400 8.0020 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 N 15.4000 10.6694 0.0 0
M  V30 9 C 13.8600 10.6694 0.0 0
M  V30 10 C 16.1700 9.3358 0.0 0
M  V30 11 C 16.4304 11.8138 0.0 0
M  V30 12 C 13.0900 9.3358 0.0 0
M  V30 13 C 13.0900 12.0031 0.0 0
M  V30 14 C 17.6763 9.6560 0.0 0
M  V30 15 C 15.4000 8.0020 0.0 0
M  V30 16 N 17.8372 11.1875 0.0 0
M  V30 17 C 11.5500 9.3358 0.0 0
M  V30 18 C 13.8600 8.0020 0.0 0
M  V30 19 C 11.5500 12.0031 0.0 0
M  V30 20 C 10.7800 10.6694 0.0 0
M  V30 21 N 8.4700 6.6684 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 6.9300 6.6684 0.0 0
M  V30 24 C 8.4700 4.0011 0.0 0
M  V30 25 C 6.1600 5.3347 0.0 0
M  V30 26 C 6.9300 4.0011 0.0 0
M  V30 27 C 6.1600 2.6673 0.0 0
M  V30 28 C 4.6200 2.6673 0.0 0
M  V30 29 C 6.9300 1.3336 0.0 0
M  V30 30 C 3.8500 1.3336 0.0 0
M  V30 31 C 3.8500 4.0011 0.0 0
M  V30 32 C 6.1600 0.0000 0.0 0
M  V30 33 C 4.6200 0.0000 0.0 0
M  V30 34 N 2.3100 1.3336 0.0 0
M  V30 35 C 2.3100 4.0011 0.0 0
M  V30 36 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 21
M  V30 8 1 7 36
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 10 15
M  V30 16 2 11 16
M  V30 17 2 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 14 16
M  V30 21 2 15 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 28 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 30 34
M  V30 38 2 31 35
M  V30 39 2 32 33
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 876923-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876924-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1772250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-6-{2-[4-(2-methyl-5-quinolinyl}-1-piperidinyl]ethyl}imidazo[1,5-a]quinoline-3-carboxamide
dihydrochloride (E89). A solution of trimethylaluminium (0.1 ml of a 2.0M
sol. in hexanes, 0.2 mmol) and methylamine (0.1 ml of a 2.0M sol. in THF,
0.2 mmol) in dry DCM (0.5 ml) was stirred at room temperature for 15 min.
Ethyl 6-{2-[4-(2-methyl-5-quinolinyl)-1-
piperidinyijethyl}imidazo[1,5-a]quinoline-3-carboxylate (free base of
E86) (20mg, 0.04 mmol) in dry DCM (1 ml) was added and stirring was
continued for another 8 hours at 60°C. After reaction was completed,
water was added dropwise at 0°C followed by 1M NaOH until the organic and
aqueous phase separated. The mixture was extracted with DCM (3 × 10 ml)
and the combined organic phases dried (Na2SO4) and then evaporated in
vacuo. The residue was triturated with diethyl ether affording the free
base of the title compound as a white solid (19 mg, 98%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic imidazobenzoxazines, imidazoquinolines,
triazolobenzoxazines and their analogs for the treatment of psychotic
disorders and related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bentley, Jonathan; Bergauer, Markus; Bertani, Barbara; Biagetti, Matteo;
Borriello, Manuela; Bromidge, Steven Mark; Gianotti, Massimo; Granci,
Enrica; Leslie, Colin Philip; Pasquarello, Alessandra; Zucchelli, Valeria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006024517 A1 2006-03-09

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-4-(phenylmethylene)-5(4H)-oxazolone
C11H9NO2
881-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.7106 0.0 0
M  V30 2 O 5.0492 0.0000 0.0 0
M  V30 3 C 8.2357 4.3858 0.0 0
M  V30 4 C 4.6200 2.7106 0.0 0
M  V30 5 C 5.5252 1.4647 0.0 0
M  V30 6 N 5.5252 3.9564 0.0 0
M  V30 7 O 6.9898 1.9406 0.0 0
M  V30 8 C 6.9898 3.4806 0.0 0
M  V30 9 C 2.3100 4.0442 0.0 0
M  V30 10 C 0.7700 4.0442 0.0 0
M  V30 11 C 3.0800 5.3779 0.0 0
M  V30 12 C 0.0000 5.3779 0.0 0
M  V30 13 C 2.3100 6.7117 0.0 0
M  V30 14 C 0.7700 6.7117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4 CFG=2
M  V30 2 1 1 9
M  V30 3 2 2 5
M  V30 4 1 3 8
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-N-methyl-3-phenyl-2-propenamide
C12H14N2O2
91566-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 N 5.3900 1.3338 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 7.7000 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 6.9300 6.6685 0.0 0
M  V30 10 O 9.2400 5.3347 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 881-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91566-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14624648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-arylidene-5-imidazolinones as synthetic analogs of
fluorescent protein chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng-Yu; Chen, Yun-Chung; Lin, Hao-Chun; Jhong, Yuandong; Chang,
Chih-Wei; Tsai, Ching-Hua; Kao, Chai-Lin; Chien, Tun-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(29), 5898-5907

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methyl 2,3-dihydro-3-hydroxy-1-(methoxycarbonyl)-2-oxo-1H-indole-3-acetate
C13H13NO6
885117-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7849 4.6079 0.0 0
M  V30 2 O 1.4647 6.1141 0.0 0
M  V30 3 O 0.6403 3.5773 0.0 0
M  V30 4 C 0.0000 6.5900 0.0 0
M  V30 5 C 7.1481 3.5055 0.0 0
M  V30 6 C 8.3940 4.4107 0.0 0
M  V30 7 O 9.8009 3.7844 0.0 0
M  V30 8 O 8.2330 5.9423 0.0 0
M  V30 9 C 11.0468 4.6896 0.0 0
M  V30 10 O 6.5113 5.4656 0.0 0
M  V30 11 O 4.4953 6.5771 0.0 0
M  V30 12 C 3.7253 2.6673 0.0 0
M  V30 13 C 5.2653 2.6673 0.0 0
M  V30 14 N 3.2494 4.1320 0.0 0
M  V30 15 C 2.9553 1.3336 0.0 0
M  V30 16 C 5.7413 4.1320 0.0 0
M  V30 17 C 6.0353 1.3336 0.0 0
M  V30 18 C 4.4953 5.0371 0.0 0
M  V30 19 C 3.7253 0.0000 0.0 0
M  V30 20 C 5.2653 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 18
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-hydroxy-N-methyl-1-[(methylamino)carbonyl]-2-oxo-1H-indole-3-ac...
C13H15N3O4
885117-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7849 4.6079 0.0 0
M  V30 2 N 1.4647 6.1141 0.0 0
M  V30 3 O 0.6403 3.5773 0.0 0
M  V30 4 C 0.0000 6.5900 0.0 0
M  V30 5 C 7.1481 3.5055 0.0 0
M  V30 6 C 8.3940 4.4107 0.0 0
M  V30 7 N 9.8009 3.7844 0.0 0
M  V30 8 O 8.2330 5.9423 0.0 0
M  V30 9 C 11.0468 4.6896 0.0 0
M  V30 10 O 6.5113 5.4656 0.0 0
M  V30 11 O 4.4953 6.5771 0.0 0
M  V30 12 C 3.7253 2.6673 0.0 0
M  V30 13 C 5.2653 2.6673 0.0 0
M  V30 14 N 3.2494 4.1320 0.0 0
M  V30 15 C 2.9553 1.3336 0.0 0
M  V30 16 C 5.7413 4.1320 0.0 0
M  V30 17 C 6.0353 1.3336 0.0 0
M  V30 18 C 4.4953 5.0371 0.0 0
M  V30 19 C 3.7253 0.0000 0.0 0
M  V30 20 C 5.2653 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 18
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 885117-62-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 885117-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10742064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-hydroxyoxindoles with dimethyldioxirane and their use
for the synthesis of natural products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suarez-Castillo, Oscar R.; Sanchez-Zavala, Maricruz; Melendez-Rodriguez,
Myriam; Castelan-Duarte, Luis E.; Morales-Rios, Martha S.; Joseph-Nathan,
Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(13), 3040-3051

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methyl 2,3-dihydro-3-hydroxy-1-(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-acetate
C16H19NO4
885117-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5655 3.9094 0.0 0
M  V30 2 C 9.8992 4.6794 0.0 0
M  V30 3 O 11.2329 3.9094 0.0 0
M  V30 4 O 9.8992 6.2194 0.0 0
M  V30 5 C 12.5667 4.6794 0.0 0
M  V30 6 O 8.1369 5.9253 0.0 0
M  V30 7 C 4.0434 2.2890 0.0 0
M  V30 8 C 2.5369 2.6091 0.0 0
M  V30 9 C 1.5065 1.4647 0.0 0
M  V30 10 C 0.0000 1.7849 0.0 0
M  V30 11 C 1.9823 0.0000 0.0 0
M  V30 12 O 7.3754 1.9387 0.0 0
M  V30 13 C 6.0873 5.7098 0.0 0
M  V30 14 C 4.7536 4.9398 0.0 0
M  V30 15 C 7.2318 4.6794 0.0 0
M  V30 16 C 6.0873 7.2499 0.0 0
M  V30 17 N 5.0738 3.4334 0.0 0
M  V30 18 C 3.4200 5.7098 0.0 0
M  V30 19 C 6.6054 3.2724 0.0 0
M  V30 20 C 4.7536 8.0199 0.0 0
M  V30 21 C 3.4200 7.2499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 12 19
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-hydroxy-N-methyl-1-(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-ac...
C16H20N2O3
885117-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5655 3.9094 0.0 0
M  V30 2 C 9.8992 4.6794 0.0 0
M  V30 3 N 11.2329 3.9094 0.0 0
M  V30 4 O 9.8992 6.2194 0.0 0
M  V30 5 C 12.5667 4.6794 0.0 0
M  V30 6 O 8.1369 5.9253 0.0 0
M  V30 7 C 4.0434 2.2890 0.0 0
M  V30 8 C 2.5369 2.6091 0.0 0
M  V30 9 C 1.5065 1.4647 0.0 0
M  V30 10 C 0.0000 1.7849 0.0 0
M  V30 11 C 1.9823 0.0000 0.0 0
M  V30 12 O 7.3754 1.9387 0.0 0
M  V30 13 C 6.0873 5.7098 0.0 0
M  V30 14 C 4.7536 4.9398 0.0 0
M  V30 15 C 7.2318 4.6794 0.0 0
M  V30 16 C 6.0873 7.2499 0.0 0
M  V30 17 N 5.0738 3.4334 0.0 0
M  V30 18 C 3.4200 5.7098 0.0 0
M  V30 19 C 6.6054 3.2724 0.0 0
M  V30 20 C 4.7536 8.0199 0.0 0
M  V30 21 C 3.4200 7.2499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 12 19
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 885117-71-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 885117-73-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12863500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-hydroxyoxindoles with dimethyldioxirane and their use
for the synthesis of natural products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suarez-Castillo, Oscar R.; Sanchez-Zavala, Maricruz; Melendez-Rodriguez,
Myriam; Castelan-Duarte, Luis E.; Morales-Rios, Martha S.; Joseph-Nathan,
Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(13), 3040-3051

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneethanol, 3-chloro-4-[[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinyl]...
C20H18ClN5O3S
886548-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7546 1.8517 0.0 0
M  V30 2 Cl 12.4219 0.3117 0.0 0
M  V30 3 C 15.0894 4.9318 0.0 0
M  V30 4 C 16.4231 4.1618 0.0 0
M  V30 5 O 17.7567 4.9318 0.0 0
M  V30 6 S 19.0904 4.1618 0.0 0 VAL=6
M  V30 7 C 19.8604 5.4955 0.0 0
M  V30 8 O 20.4242 3.3918 0.0 0
M  V30 9 O 18.3204 2.8281 0.0 0
M  V30 10 C 4.4197 1.8517 0.0 0
M  V30 11 C 3.0128 2.4781 0.0 0
M  V30 12 C 4.2587 0.3202 0.0 0
M  V30 13 C 1.9823 1.3337 0.0 0
M  V30 14 C 2.5369 3.9428 0.0 0
M  V30 15 N 2.7523 0.0000 0.0 0
M  V30 16 N 0.4759 1.6538 0.0 0
M  V30 17 C 1.0306 4.2630 0.0 0
M  V30 18 C 0.0000 3.1186 0.0 0
M  V30 19 C 5.7534 2.6218 0.0 0
M  V30 20 N 7.0871 1.8517 0.0 0
M  V30 21 C 5.7534 4.1618 0.0 0
M  V30 22 C 8.4208 2.6218 0.0 0
M  V30 23 C 7.0871 4.9318 0.0 0
M  V30 24 N 8.4208 4.1618 0.0 0
M  V30 25 C 11.0882 2.6218 0.0 0
M  V30 26 C 12.4219 1.8517 0.0 0
M  V30 27 C 11.0882 4.1618 0.0 0
M  V30 28 C 13.7556 2.6218 0.0 0
M  V30 29 C 12.4219 4.9318 0.0 0
M  V30 30 C 13.7556 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 1 25
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 30
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 19
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Chloro-4-[2-(methylamino)ethyl]phenyl]-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)...
C20H19ClN6
886547-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7545 1.8517 0.0 0
M  V30 2 Cl 12.4218 0.3117 0.0 0
M  V30 3 C 15.0892 4.9317 0.0 0
M  V30 4 C 16.4229 4.1617 0.0 0
M  V30 5 N 17.7565 4.9317 0.0 0
M  V30 6 C 19.0904 4.1617 0.0 0
M  V30 7 C 4.4197 1.8517 0.0 0
M  V30 8 C 3.0127 2.4782 0.0 0
M  V30 9 C 4.2588 0.3202 0.0 0
M  V30 10 C 1.9823 1.3337 0.0 0
M  V30 11 C 2.5369 3.9428 0.0 0
M  V30 12 N 2.7523 0.0000 0.0 0
M  V30 13 N 0.4760 1.6538 0.0 0
M  V30 14 C 1.0306 4.2629 0.0 0
M  V30 15 C 0.0000 3.1185 0.0 0
M  V30 16 C 5.7533 2.6217 0.0 0
M  V30 17 N 7.0870 1.8517 0.0 0
M  V30 18 C 5.7533 4.1617 0.0 0
M  V30 19 C 8.4208 2.6217 0.0 0
M  V30 20 C 7.0870 4.9317 0.0 0
M  V30 21 N 8.4208 4.1617 0.0 0
M  V30 22 C 11.0881 2.6217 0.0 0
M  V30 23 C 12.4218 1.8517 0.0 0
M  V30 24 C 11.0881 4.1617 0.0 0
M  V30 25 C 13.7556 2.6217 0.0 0
M  V30 26 C 12.4218 4.9317 0.0 0
M  V30 27 C 13.7556 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 22
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886548-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886547-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4430051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of compound 19a (200 mg) and
pyrrolidine (200 mg) was heated at 60 °C for 4 hrs. The reaction was
quenched with water and extracted with ethyl acetate, then the organic
phase was washed with brine and concentrated. The residue was purified on
silica gel column and eluted with ~3-5% methanol (with NH3) in DCM to
afford compound 19 (112 mg, 60%). Using the procedure of example 19,
compound 53a (50 mg) was reacted with methylamine (17 mg) to provide
compound 53 (40 mg, 94%). 1H NMR (400 MHz, CD3OD/CDCl3) δ 8.70 (d, 1H),
8.33 (d, 1H), 8.30 (s, 1H), 8.24 (d, 1H), 8.20 (s, 1H)7.40 (d, IE), 7.28
(d, 1H), 7.18 (dd, 1H), 6.95 (d, 1H), 4.35 (t, 2H), 2.78 (t, 2H), 2.60
(s, 3H). MS (ESI) m/z: 379 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinyl-substituted fused pyrroles for treatment of
kinase disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Shenlin; Lin, Ronghui; Connolly, Peter J.; Emanuel, Stuart L.;
Middleton, Steven A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006050076 A1 2006-05-11

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Inosine, 3′,5′-O-[bis(1,1-dimethylethyl)silylene]-2′-O-[(1,1-dimethylethyl)di...
C24H42N4O5Si2
896131-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.8552 2.8738 0.0 0
M  V30 2 Si 6.5213 2.1038 0.0 0
M  V30 3 C 5.1877 1.3338 0.0 0
M  V30 4 C 7.2914 0.7700 0.0 0
M  V30 5 C 5.7513 3.4375 0.0 0
M  V30 6 C 5.9577 0.0000 0.0 0
M  V30 7 C 3.8540 0.5638 0.0 0
M  V30 8 C 4.4177 2.6675 0.0 0
M  V30 9 C 13.5341 3.7162 0.0 0
M  V30 10 C 14.7476 4.6642 0.0 0
M  V30 11 C 14.4821 2.5025 0.0 0
M  V30 12 C 12.3206 2.7680 0.0 0
M  V30 13 C 14.3574 7.5892 0.0 0
M  V30 14 C 13.6344 8.9490 0.0 0
M  V30 15 C 15.7171 8.3122 0.0 0
M  V30 16 C 15.0803 6.2295 0.0 0
M  V30 17 O 0.0000 4.5643 0.0 0
M  V30 18 C 7.8552 4.4138 0.0 0 CFG=1
M  V30 19 C 9.1010 5.3189 0.0 0 CFG=2
M  V30 20 C 6.6091 5.3189 0.0 0 CFG=2
M  V30 21 C 8.6252 6.7836 0.0 0 CFG=1
M  V30 22 O 10.6073 4.9987 0.0 0
M  V30 23 O 7.0851 6.7836 0.0 0
M  V30 24 C 9.6556 7.9280 0.0 0
M  V30 25 Si 11.6379 6.1433 0.0 0
M  V30 26 O 11.1619 7.6078 0.0 0
M  V30 27 N 5.1446 4.8430 0.0 0
M  V30 28 C 3.8987 5.7483 0.0 0
M  V30 29 C 4.6687 3.3785 0.0 0
M  V30 30 C 2.6528 4.8430 0.0 0
M  V30 31 N 3.7376 7.2798 0.0 0
M  V30 32 N 3.1287 3.3785 0.0 0
M  V30 33 C 1.2459 5.4695 0.0 0
M  V30 34 C 2.3308 7.9063 0.0 0
M  V30 35 N 1.0849 7.0011 0.0 0
M  V30 36 H 9.4212 3.8126 0.0 0
M  V30 37 H 7.9987 8.1904 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 25
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 25
M  V30 17 2 17 33
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=3
M  V30 23 1 20 23
M  V30 24 1 20 27 CFG=3
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 1 21 37 CFG=1
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 1 28 31
M  V30 35 2 29 32
M  V30 36 1 30 32
M  V30 37 1 30 33
M  V30 38 1 31 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′,5′-O-[Bis(1,1-dimethylethyl)silylene]-2′-O-[(1,1-dimethylethyl)dimethylsil...
C25H45N5O4Si2
1679353-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.1830 3.7162 0.0 0
M  V30 2 C 0.9694 4.6642 0.0 0
M  V30 3 C 1.2349 2.5025 0.0 0
M  V30 4 C 3.3966 2.7680 0.0 0
M  V30 5 C 1.3598 7.5892 0.0 0
M  V30 6 C 0.6368 6.2295 0.0 0
M  V30 7 C 0.0000 8.3122 0.0 0
M  V30 8 C 2.0827 8.9490 0.0 0
M  V30 9 O 7.8620 2.8738 0.0 0
M  V30 10 Si 9.1957 2.1038 0.0 0
M  V30 11 C 10.5293 1.3338 0.0 0
M  V30 12 C 8.4257 0.7700 0.0 0
M  V30 13 C 9.9657 3.4375 0.0 0
M  V30 14 C 9.7593 0.0000 0.0 0
M  V30 15 C 11.8630 0.5638 0.0 0
M  V30 16 C 11.2993 2.6674 0.0 0
M  V30 17 N 15.7170 4.5643 0.0 0
M  V30 18 C 17.1240 5.1906 0.0 0
M  V30 19 Si 4.0793 6.1432 0.0 0
M  V30 20 O 5.1097 4.9987 0.0 0
M  V30 21 O 4.5552 7.6078 0.0 0
M  V30 22 C 6.6160 5.3189 0.0 0 CFG=2
M  V30 23 C 6.0615 7.9280 0.0 0
M  V30 24 C 7.8620 4.4138 0.0 0 CFG=1
M  V30 25 C 7.0920 6.7836 0.0 0 CFG=2
M  V30 26 C 9.1079 5.3189 0.0 0 CFG=2
M  V30 27 O 8.6321 6.7836 0.0 0
M  V30 28 N 10.5725 4.8430 0.0 0
M  V30 29 C 11.8185 5.7482 0.0 0
M  V30 30 C 11.0485 3.3785 0.0 0
M  V30 31 C 13.0643 4.8430 0.0 0
M  V30 32 N 11.9794 7.2798 0.0 0
M  V30 33 N 12.5885 3.3785 0.0 0
M  V30 34 C 14.4711 5.4695 0.0 0
M  V30 35 C 13.3862 7.9062 0.0 0
M  V30 36 N 14.6321 7.0010 0.0 0
M  V30 37 H 6.2959 3.8126 0.0 0
M  V30 38 H 7.7184 8.1904 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 19
M  V30 9 1 9 10
M  V30 10 1 24 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 17 18
M  V30 18 1 17 34
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 22 37 CFG=1
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 38 CFG=3
M  V30 30 1 26 27
M  V30 31 1 26 28 CFG=1
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 2 30 33
M  V30 37 1 31 33
M  V30 38 2 31 34
M  V30 39 1 32 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 22 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 896131-05-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679353-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37479920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of Selective Fat Mass and Obesity Associated
Protein (FTO) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shishodia, Shifali; Demetriades, Marina; Zhang, Dong; Tam, Nok Yin;
Maheswaran, Pratheesh; Clunie-O'Connor, Caitlin; Tumber, Anthony; Leung,
Ivanhoe K. H.; Ng, Yi Min; Leissing, Thomas M.; El-Sagheer, Afaf H.;
Salah, Eidarus; Brown, Tom; Aik, Wei Shen; McDonough, Michael A.;
Schofield, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(22), 16609-16625

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-4-oxopyrrolo[1,2-a]quinoxaline-5(4H)-butanoic acid
C15H13FN2O3
903169-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 5.3348 0.0 0
M  V30 2 C 7.0573 6.6685 0.0 0
M  V30 3 C 8.5973 6.6685 0.0 0
M  V30 4 C 9.3674 8.0023 0.0 0
M  V30 5 O 10.9074 8.0023 0.0 0
M  V30 6 O 8.5973 9.3359 0.0 0
M  V30 7 O 4.7473 8.0023 0.0 0
M  V30 8 F 4.7473 0.0000 0.0 0
M  V30 9 C 3.9773 4.0011 0.0 0
M  V30 10 C 2.4372 4.0011 0.0 0
M  V30 11 N 4.7473 5.3348 0.0 0
M  V30 12 C 4.7473 2.6675 0.0 0
M  V30 13 N 1.6672 5.3348 0.0 0
M  V30 14 C 1.6672 2.6675 0.0 0
M  V30 15 C 3.9773 6.6685 0.0 0
M  V30 16 C 3.9773 1.3337 0.0 0
M  V30 17 C 2.4372 6.6685 0.0 0
M  V30 18 C 0.1609 5.6550 0.0 0
M  V30 19 C 2.4372 1.3337 0.0 0
M  V30 20 C 1.4068 7.8130 0.0 0
M  V30 21 C 0.0000 7.1865 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 15
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 17
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-N-methyl-4-oxopyrrolo[1,2-a]quinoxaline-5(4H)-butanamide
C16H16FN3O2
2752469-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 10.6697 3.8501 0.0 0
M  V30 6 O 9.3360 6.1601 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 O 5.3348 6.9302 0.0 0
M  V30 9 F 1.3337 0.0000 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 N 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 N 1.3337 6.1601 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 0.1893 7.1906 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 21 C 2.3472 8.4365 0.0 0
M  V30 22 C 0.8156 8.5974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 16
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 2 19 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 903169-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2752469-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30631896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazoloquinoxalines and related heterocyclic compounds as
imaging agents for imaging of huntingtin protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Longbin; Lee, Matthew; Dominguez, Celia; Johnson, Peter David;
Greenaway, Catherine Jane; Khurana, Kanika; Mills, Matthew Robert; Rota,
Filippo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252775 A1 2021-12-16

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Tricyclo[3.3.0.03,7]octane-1,5-dicarboxylic acid, 3,7-diiodo-
C10H10I2O4
908124-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0851 1.6829 0.0 0
M  V30 2 O 9.5425 2.5243 0.0 0
M  V30 3 O 8.0851 0.0000 0.0 0
M  V30 4 C 1.4574 5.5093 0.0 0
M  V30 5 O 0.0000 4.6677 0.0 0
M  V30 6 O 1.4574 7.1922 0.0 0
M  V30 7 I 3.5882 1.5294 0.0 0
M  V30 8 I 5.9691 5.6542 0.0 0
M  V30 9 C 6.6278 2.5243 0.0 0
M  V30 10 C 2.9147 4.6679 0.0 0
M  V30 11 C 5.3596 1.9583 0.0 0
M  V30 12 C 6.4837 3.9057 0.0 0
M  V30 13 C 4.1910 5.2362 0.0 0
M  V30 14 C 3.0608 3.2784 0.0 0
M  V30 15 C 4.4274 2.9879 0.0 0
M  V30 16 C 5.1260 4.1979 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 1 7 15
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3a,6:5,7a-Dimethano-1H-isoindole-1,3(2H)-dione, tetrahydro-5,6-diiodo-2-methyl-
C11H11I2NO2
909007-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.8396 0.0000 0.0 0
M  V30 2 O 3.7124 5.3027 0.0 0
M  V30 3 I 4.6033 4.9284 0.0 0
M  V30 4 I 0.0000 2.9529 0.0 0
M  V30 5 C 6.2023 3.0608 0.0 0
M  V30 6 C 2.5380 1.4946 0.0 0
M  V30 7 C 2.2178 3.0011 0.0 0
M  V30 8 C 3.3892 2.4383 0.0 0
M  V30 9 C 1.3763 2.0105 0.0 0
M  V30 10 C 4.0696 1.3337 0.0 0
M  V30 11 C 0.8667 4.3822 0.0 0
M  V30 12 C 2.8903 4.8123 0.0 0
M  V30 13 C 3.5515 3.7711 0.0 0
M  V30 14 C 2.7567 3.5407 0.0 0
M  V30 15 C 1.5060 3.2750 0.0 0
M  V30 16 N 4.6959 2.7407 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 13
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 908124-51-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 909007-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3179104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Generation and trapping of tricyclo[3.3.0.03,7]oct-1(5)-ene derivatives
containing carbonyl functionalities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camps, Pelayo; Munoz, M. Rosa; Vazquez, Santiago
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(33), 7645-7652

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-(phenylmethoxy)benzene
C17H19BrO2
90816-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 O 10.6697 5.3901 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 5.3901 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 C 16.0045 5.3901 0.0 0
M  V30 8 Br 17.3383 4.6201 0.0 0
M  V30 9 C 6.6687 3.0801 0.0 0
M  V30 10 C 6.6687 4.6201 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 8.0023 5.3901 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 1.3338 3.0801 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3338 0.0000 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-(phenylmethoxy)phenoxy]-1-butanamine
C18H23NO2
1195950-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 O 10.6697 5.3901 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 5.3901 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 C 16.0045 5.3901 0.0 0
M  V30 8 N 17.3383 4.6201 0.0 0
M  V30 9 C 18.6720 5.3901 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0023 5.3901 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 1.3337 3.0801 0.0 0
M  V30 19 C 1.3337 0.0000 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90816-68-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1924932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-(4-bromobutoxy)benzene
C10H12Br2O
90869-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 Br 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenoxy)-N-methyl-1-butanamine
C11H16BrNO
1195950-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 Br 0.0000 0.0000 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90869-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11045026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-[(1,1-dimethylethoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.7]dodec-1...
C18H28N2O5
914264-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9556 0.0 0
M  V30 8 O 9.0947 1.4672 0.0 0
M  V30 9 C 10.6346 3.7078 0.0 0
M  V30 10 C 11.6651 4.8523 0.0 0
M  V30 11 O 13.1714 4.5322 0.0 0
M  V30 12 O 11.1891 6.3169 0.0 0
M  V30 13 C 14.2019 5.6766 0.0 0
M  V30 14 C 6.7417 2.4782 0.0 0 CFG=1
M  V30 15 N 5.3348 1.8517 0.0 0
M  V30 16 C 8.2560 2.7588 0.0 0
M  V30 17 C 7.7721 1.3337 0.0 0
M  V30 18 C 5.4725 3.3505 0.0 0
M  V30 19 C 5.4958 0.3202 0.0 0
M  V30 20 N 9.1282 4.0280 0.0 0
M  V30 21 C 7.0021 0.0000 0.0 0
M  V30 22 C 5.1919 4.8647 0.0 0
M  V30 23 C 8.8475 5.5423 0.0 0
M  V30 24 C 6.0642 6.1340 0.0 0
M  V30 25 C 7.5784 6.4145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (5R)-7-[2-(methylamino)-2-oxoethyl]-6-oxo-1,7-diazaspiro[4....
C18H29N3O4
914265-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 2.1037 3.9556 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 0.5637 1.2881 0.0 0
M  V30 8 O 9.0947 1.4672 0.0 0
M  V30 9 C 10.6346 3.7078 0.0 0
M  V30 10 C 11.6651 4.8523 0.0 0
M  V30 11 N 13.1714 4.5322 0.0 0
M  V30 12 O 11.1891 6.3169 0.0 0
M  V30 13 C 14.2019 5.6766 0.0 0
M  V30 14 C 6.7417 2.4782 0.0 0 CFG=1
M  V30 15 N 5.3348 1.8517 0.0 0
M  V30 16 C 8.2560 2.7588 0.0 0
M  V30 17 C 7.7721 1.3337 0.0 0
M  V30 18 C 5.4725 3.3505 0.0 0
M  V30 19 C 5.4958 0.3202 0.0 0
M  V30 20 N 9.1282 4.0280 0.0 0
M  V30 21 C 7.0021 0.0000 0.0 0
M  V30 22 C 5.1919 4.8647 0.0 0
M  V30 23 C 8.8475 5.5423 0.0 0
M  V30 24 C 6.0642 6.1340 0.0 0
M  V30 25 C 7.5784 6.4145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914264-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6449404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-acetyl-6-oxo-1,7-diazaspiro[4.6]undec-9-ene-7-acetate
C14H20N2O4
914264-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5399 3.7898 0.0 0
M  V30 2 C 0.0000 3.8129 0.0 0
M  V30 3 O 2.3297 5.1118 0.0 0
M  V30 4 O 5.5199 0.2841 0.0 0
M  V30 5 C 7.8965 1.9045 0.0 0
M  V30 6 C 9.2303 2.6746 0.0 0
M  V30 7 O 10.5639 1.9045 0.0 0
M  V30 8 O 9.2303 4.2146 0.0 0
M  V30 9 C 11.8976 2.6746 0.0 0
M  V30 10 C 3.8188 2.2609 0.0 0 CFG=1
M  V30 11 N 2.2899 2.4448 0.0 0
M  V30 12 C 5.2904 1.8069 0.0 0
M  V30 13 C 4.1165 0.7498 0.0 0
M  V30 14 C 3.2562 3.6945 0.0 0
M  V30 15 C 1.6424 1.0474 0.0 0
M  V30 16 N 6.5628 2.6746 0.0 0
M  V30 17 C 2.7714 0.0000 0.0 0
M  V30 18 C 4.0262 5.0282 0.0 0
M  V30 19 C 6.6778 4.2103 0.0 0
M  V30 20 C 5.5490 5.2576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11 CFG=3
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-1-Acetyl-N-methyl-6-oxo-1,7-diazaspiro[4.6]undec-9-ene-7-acetamide
C14H21N3O3
914265-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5399 3.7898 0.0 0
M  V30 2 C 0.0000 3.8129 0.0 0
M  V30 3 O 2.3297 5.1118 0.0 0
M  V30 4 O 5.5199 0.2841 0.0 0
M  V30 5 C 7.8965 1.9045 0.0 0
M  V30 6 C 9.2303 2.6746 0.0 0
M  V30 7 N 10.5639 1.9045 0.0 0
M  V30 8 O 9.2303 4.2146 0.0 0
M  V30 9 C 11.8976 2.6746 0.0 0
M  V30 10 C 3.8188 2.2609 0.0 0 CFG=1
M  V30 11 N 2.2899 2.4448 0.0 0
M  V30 12 C 5.2904 1.8069 0.0 0
M  V30 13 C 4.1165 0.7498 0.0 0
M  V30 14 C 3.2562 3.6945 0.0 0
M  V30 15 C 1.6424 1.0474 0.0 0
M  V30 16 N 6.5628 2.6746 0.0 0
M  V30 17 C 2.7714 0.0000 0.0 0
M  V30 18 C 4.0262 5.0282 0.0 0
M  V30 19 C 6.6778 4.2103 0.0 0
M  V30 20 C 5.5490 5.2576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11 CFG=3
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914264-94-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12840420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-[(1,1-dimethylethoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.6]undec-9...
C17H26N2O5
914264-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 3.7710 0.0 0
M  V30 2 O 2.1036 3.7710 0.0 0
M  V30 3 O 4.4136 5.1048 0.0 0
M  V30 4 C 1.3336 5.1048 0.0 0
M  V30 5 C 0.0000 4.3348 0.0 0
M  V30 6 C 0.5636 6.4384 0.0 0
M  V30 7 C 2.6673 5.8748 0.0 0
M  V30 8 O 7.6757 0.3254 0.0 0
M  V30 9 C 10.0277 1.9811 0.0 0
M  V30 10 C 11.3498 2.7709 0.0 0
M  V30 11 O 12.6949 2.0209 0.0 0
M  V30 12 O 11.3267 4.3108 0.0 0
M  V30 13 C 14.0168 2.8108 0.0 0
M  V30 14 C 5.9452 2.2764 0.0 0 CFG=1
M  V30 15 N 4.4136 2.4374 0.0 0
M  V30 16 C 7.4234 1.8445 0.0 0
M  V30 17 C 6.2653 0.7700 0.0 0
M  V30 18 C 5.3612 3.7014 0.0 0
M  V30 19 C 3.7873 1.0306 0.0 0
M  V30 20 N 8.6827 2.7310 0.0 0
M  V30 21 C 4.9317 0.0000 0.0 0
M  V30 22 C 6.1112 5.0464 0.0 0
M  V30 23 C 8.7748 4.2683 0.0 0
M  V30 24 C 7.6304 5.2987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (5R)-7-[2-(methylamino)-2-oxoethyl]-6-oxo-1,7-diazaspiro[4....
C17H27N3O4
914265-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 3.7710 0.0 0
M  V30 2 O 2.1036 3.7710 0.0 0
M  V30 3 O 4.4136 5.1048 0.0 0
M  V30 4 C 1.3336 5.1048 0.0 0
M  V30 5 C 2.6673 5.8748 0.0 0
M  V30 6 C 0.5636 6.4384 0.0 0
M  V30 7 C 0.0000 4.3348 0.0 0
M  V30 8 O 7.6757 0.3254 0.0 0
M  V30 9 C 10.0277 1.9811 0.0 0
M  V30 10 C 11.3498 2.7709 0.0 0
M  V30 11 N 12.6949 2.0209 0.0 0
M  V30 12 O 11.3267 4.3108 0.0 0
M  V30 13 C 14.0168 2.8108 0.0 0
M  V30 14 C 5.9452 2.2764 0.0 0 CFG=1
M  V30 15 N 4.4136 2.4374 0.0 0
M  V30 16 C 7.4234 1.8445 0.0 0
M  V30 17 C 6.2653 0.7700 0.0 0
M  V30 18 C 5.3612 3.7014 0.0 0
M  V30 19 C 3.7873 1.0306 0.0 0
M  V30 20 N 8.6827 2.7310 0.0 0
M  V30 21 C 4.9317 0.0000 0.0 0
M  V30 22 C 6.1112 5.0464 0.0 0
M  V30 23 C 8.7748 4.2683 0.0 0
M  V30 24 C 7.6304 5.2987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914264-96-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-01-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4305936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-ethyl-6-oxo-1,7-diazaspiro[4.6]undec-9-ene-7-acetate
C14H22N2O3
914264-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5399 3.7898 0.0 0
M  V30 2 C 0.0000 3.8129 0.0 0
M  V30 3 O 5.5199 0.2841 0.0 0
M  V30 4 C 7.8964 1.9045 0.0 0
M  V30 5 C 9.2302 2.6745 0.0 0
M  V30 6 O 10.5639 1.9045 0.0 0
M  V30 7 O 9.2302 4.2146 0.0 0
M  V30 8 C 11.8975 2.6745 0.0 0
M  V30 9 C 3.8188 2.2609 0.0 0 CFG=1
M  V30 10 N 2.2898 2.4448 0.0 0
M  V30 11 C 5.2904 1.8069 0.0 0
M  V30 12 C 4.1165 0.7498 0.0 0
M  V30 13 C 3.2562 3.6945 0.0 0
M  V30 14 C 1.6424 1.0474 0.0 0
M  V30 15 N 6.5628 2.6745 0.0 0
M  V30 16 C 2.7714 0.0000 0.0 0
M  V30 17 C 4.0262 5.0282 0.0 0
M  V30 18 C 6.6778 4.2102 0.0 0
M  V30 19 C 5.5490 5.2576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 11
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10 CFG=3
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-1-Ethyl-N-methyl-6-oxo-1,7-diazaspiro[4.6]undec-9-ene-7-acetamide
C14H23N3O2
914265-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5399 3.7898 0.0 0
M  V30 2 C 0.0000 3.8129 0.0 0
M  V30 3 O 5.5199 0.2841 0.0 0
M  V30 4 C 7.8964 1.9045 0.0 0
M  V30 5 C 9.2302 2.6745 0.0 0
M  V30 6 N 10.5639 1.9045 0.0 0
M  V30 7 O 9.2302 4.2146 0.0 0
M  V30 8 C 11.8975 2.6745 0.0 0
M  V30 9 C 3.8188 2.2609 0.0 0 CFG=1
M  V30 10 N 2.2898 2.4448 0.0 0
M  V30 11 C 5.2904 1.8069 0.0 0
M  V30 12 C 4.1165 0.7498 0.0 0
M  V30 13 C 3.2562 3.6945 0.0 0
M  V30 14 C 1.6424 1.0474 0.0 0
M  V30 15 N 6.5628 2.6745 0.0 0
M  V30 16 C 2.7714 0.0000 0.0 0
M  V30 17 C 4.0262 5.0282 0.0 0
M  V30 18 C 6.6778 4.2102 0.0 0
M  V30 19 C 5.5490 5.2576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 11
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10 CFG=3
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914264-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-11-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14969527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-[(1,1-dimethylethoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.5]dec-9-e...
C16H24N2O5
914265-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6812 3.4208 0.0 0
M  V30 2 O 2.1748 3.1006 0.0 0
M  V30 3 O 4.1571 4.8855 0.0 0
M  V30 4 C 1.1444 4.2450 0.0 0
M  V30 5 C 0.0000 3.2146 0.0 0
M  V30 6 C 0.1140 5.3895 0.0 0
M  V30 7 C 2.2889 5.2756 0.0 0
M  V30 8 O 8.5532 1.1037 0.0 0
M  V30 9 C 10.0932 3.7710 0.0 0
M  V30 10 C 10.8632 5.1048 0.0 0
M  V30 11 O 12.4032 5.1048 0.0 0
M  V30 12 O 10.0932 6.4384 0.0 0
M  V30 13 C 13.1732 6.4384 0.0 0
M  V30 14 C 6.2432 2.4374 0.0 0 CFG=1
M  V30 15 N 4.7116 2.2764 0.0 0
M  V30 16 C 7.7832 2.4374 0.0 0
M  V30 17 C 6.8696 1.0306 0.0 0
M  V30 18 C 5.4732 3.7710 0.0 0
M  V30 19 C 4.3915 0.7700 0.0 0
M  V30 20 N 8.5532 3.7710 0.0 0
M  V30 21 C 5.7251 0.0000 0.0 0
M  V30 22 C 6.2432 5.1048 0.0 0
M  V30 23 C 7.7832 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (5R)-7-[2-(methylamino)-2-oxoethyl]-6-oxo-1,7-diazaspiro[4....
C16H25N3O4
914264-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6812 3.4208 0.0 0
M  V30 2 O 2.1748 3.1006 0.0 0
M  V30 3 O 4.1571 4.8855 0.0 0
M  V30 4 C 1.1444 4.2450 0.0 0
M  V30 5 C 2.2889 5.2756 0.0 0
M  V30 6 C 0.1140 5.3895 0.0 0
M  V30 7 C 0.0000 3.2146 0.0 0
M  V30 8 O 8.5532 1.1037 0.0 0
M  V30 9 C 10.0932 3.7710 0.0 0
M  V30 10 C 10.8632 5.1048 0.0 0
M  V30 11 N 12.4032 5.1048 0.0 0
M  V30 12 O 10.0932 6.4384 0.0 0
M  V30 13 C 13.1732 6.4384 0.0 0
M  V30 14 C 6.2432 2.4374 0.0 0 CFG=1
M  V30 15 N 4.7116 2.2764 0.0 0
M  V30 16 C 7.7832 2.4374 0.0 0
M  V30 17 C 6.8696 1.0306 0.0 0
M  V30 18 C 5.4732 3.7710 0.0 0
M  V30 19 C 4.3915 0.7700 0.0 0
M  V30 20 N 8.5532 3.7710 0.0 0
M  V30 21 C 5.7251 0.0000 0.0 0
M  V30 22 C 6.2432 5.1048 0.0 0
M  V30 23 C 7.7832 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914265-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914264-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2169796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-[(1,1-dimethylethoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.8]tridec-...
C19H30N2O5
914265-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.2880 0.0 0
M  V30 2 O 2.6673 5.0580 0.0 0
M  V30 3 O 4.0011 2.7480 0.0 0
M  V30 4 C 1.3336 4.2880 0.0 0
M  V30 5 C 0.5636 5.6216 0.0 0
M  V30 6 C 0.0000 3.5180 0.0 0
M  V30 7 C 2.1036 2.9542 0.0 0
M  V30 8 O 8.9896 5.5770 0.0 0
M  V30 9 C 10.7249 3.6496 0.0 0
M  V30 10 C 11.9384 2.7016 0.0 0
M  V30 11 O 13.3663 3.2785 0.0 0
M  V30 12 O 11.7240 1.1766 0.0 0
M  V30 13 C 14.5798 2.3303 0.0 0
M  V30 14 C 6.7415 4.4315 0.0 0 CFG=1
M  V30 15 N 5.3347 5.0580 0.0 0
M  V30 16 C 8.2666 4.2173 0.0 0
M  V30 17 C 7.7721 5.5760 0.0 0
M  V30 18 C 5.4356 3.6155 0.0 0
M  V30 19 C 5.4956 6.5895 0.0 0
M  V30 20 N 9.2970 3.0728 0.0 0
M  V30 21 C 7.0021 6.9097 0.0 0
M  V30 22 C 4.9597 2.1509 0.0 0
M  V30 23 C 9.3507 1.5337 0.0 0
M  V30 24 C 5.5366 0.7230 0.0 0
M  V30 25 C 8.4027 0.3202 0.0 0
M  V30 26 C 6.8963 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15 CFG=1
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24 CFG=2
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (5R)-7-[2-(methylamino)-2-oxoethyl]-6-oxo-1,7-diazaspiro[4....
C19H31N3O4
914265-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.2880 0.0 0
M  V30 2 O 2.6673 5.0580 0.0 0
M  V30 3 O 4.0011 2.7480 0.0 0
M  V30 4 C 1.3336 4.2880 0.0 0
M  V30 5 C 2.1036 2.9542 0.0 0
M  V30 6 C 0.0000 3.5180 0.0 0
M  V30 7 C 0.5636 5.6216 0.0 0
M  V30 8 O 8.9896 5.5770 0.0 0
M  V30 9 C 10.7249 3.6496 0.0 0
M  V30 10 C 11.9384 2.7016 0.0 0
M  V30 11 N 13.3663 3.2785 0.0 0
M  V30 12 O 11.7240 1.1766 0.0 0
M  V30 13 C 14.5798 2.3303 0.0 0
M  V30 14 C 6.7415 4.4315 0.0 0 CFG=1
M  V30 15 N 5.3347 5.0580 0.0 0
M  V30 16 C 8.2666 4.2173 0.0 0
M  V30 17 C 7.7721 5.5760 0.0 0
M  V30 18 C 5.4356 3.6155 0.0 0
M  V30 19 C 5.4956 6.5895 0.0 0
M  V30 20 N 9.2970 3.0728 0.0 0
M  V30 21 C 7.0021 6.9097 0.0 0
M  V30 22 C 4.9597 2.1509 0.0 0
M  V30 23 C 9.3507 1.5337 0.0 0
M  V30 24 C 5.5366 0.7230 0.0 0
M  V30 25 C 8.4027 0.3202 0.0 0
M  V30 26 C 6.8963 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15 CFG=1
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 24 CFG=2
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914265-45-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-05-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8579254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-1-[(1,1-dimethylethoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.6]undec-9...
C18H28N2O5
914265-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 2.6674 0.0 0
M  V30 2 O 2.1036 2.6674 0.0 0
M  V30 3 O 4.4136 1.3336 0.0 0
M  V30 4 C 1.3336 1.3336 0.0 0
M  V30 5 C 2.6673 0.5636 0.0 0
M  V30 6 C 0.5636 0.0000 0.0 0
M  V30 7 C 0.0000 2.1036 0.0 0
M  V30 8 O 7.6757 6.1130 0.0 0
M  V30 9 C 10.0277 4.4574 0.0 0
M  V30 10 C 11.3498 3.6675 0.0 0
M  V30 11 C 12.6949 4.4175 0.0 0
M  V30 12 O 14.0168 3.6276 0.0 0
M  V30 13 O 12.7178 5.9573 0.0 0
M  V30 14 C 15.3618 4.3776 0.0 0
M  V30 15 C 5.9452 4.1620 0.0 0 CFG=1
M  V30 16 N 4.4136 4.0011 0.0 0
M  V30 17 C 7.4234 4.5940 0.0 0
M  V30 18 C 6.2653 5.6684 0.0 0
M  V30 19 C 5.3612 2.7370 0.0 0
M  V30 20 C 3.7873 5.4079 0.0 0
M  V30 21 N 8.6827 3.7074 0.0 0
M  V30 22 C 4.9317 6.4384 0.0 0
M  V30 23 C 6.1112 1.3920 0.0 0
M  V30 24 C 8.7748 2.1702 0.0 0
M  V30 25 C 7.6304 1.1398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 15 16 CFG=1
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 1 21 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (5R)-7-[3-(methylamino)-3-oxopropyl]-6-oxo-1,7-diazaspiro[4...
C18H29N3O4
914265-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 2.6674 0.0 0
M  V30 2 O 2.1036 2.6674 0.0 0
M  V30 3 O 4.4136 1.3336 0.0 0
M  V30 4 C 1.3336 1.3336 0.0 0
M  V30 5 C 2.6673 0.5636 0.0 0
M  V30 6 C 0.5636 0.0000 0.0 0
M  V30 7 C 0.0000 2.1036 0.0 0
M  V30 8 O 7.6757 6.1130 0.0 0
M  V30 9 C 10.0277 4.4574 0.0 0
M  V30 10 C 11.3498 3.6675 0.0 0
M  V30 11 C 12.6949 4.4175 0.0 0
M  V30 12 N 14.0168 3.6276 0.0 0
M  V30 13 O 12.7178 5.9573 0.0 0
M  V30 14 C 15.3618 4.3776 0.0 0
M  V30 15 C 5.9452 4.1620 0.0 0 CFG=1
M  V30 16 N 4.4136 4.0011 0.0 0
M  V30 17 C 7.4234 4.5940 0.0 0
M  V30 18 C 6.2653 5.6684 0.0 0
M  V30 19 C 5.3612 2.7370 0.0 0
M  V30 20 C 3.7873 5.4079 0.0 0
M  V30 21 N 8.6827 3.7074 0.0 0
M  V30 22 C 4.9317 6.4384 0.0 0
M  V30 23 C 6.1112 1.3920 0.0 0
M  V30 24 C 8.7748 2.1702 0.0 0
M  V30 25 C 7.6304 1.1398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 15 16 CFG=1
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 1 21 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 914265-47-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 914265-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10708709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly practical RCM approach towards a molecular building kit of
spirocyclic reverse turn mimics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Boeckler, Frank; Einsiedel, Juergen; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2006), 12(24), 6315-6322

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
4-Nitro-3-[(tetrahydro-3-furanyl)oxy]benzoic acid
C11H11NO6
917909-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6217 4.0011 0.0 0
M  V30 2 N 4.1618 1.3337 0.0 0 VAL=5
M  V30 3 O 4.9318 0.0000 0.0 0
M  V30 4 O 2.6217 1.3337 0.0 0
M  V30 5 C 7.2418 6.6686 0.0 0
M  V30 6 O 6.4718 8.0023 0.0 0
M  V30 7 O 8.7818 6.6686 0.0 0
M  V30 8 C 4.1618 4.0011 0.0 0
M  V30 9 C 4.9318 2.6675 0.0 0
M  V30 10 C 4.9318 5.3348 0.0 0
M  V30 11 C 6.4718 2.6675 0.0 0
M  V30 12 C 6.4718 5.3348 0.0 0
M  V30 13 C 7.2418 4.0011 0.0 0
M  V30 14 C 1.8517 5.3348 0.0 0
M  V30 15 C 2.4782 6.7418 0.0 0
M  V30 16 C 0.3202 5.4959 0.0 0
M  V30 17 C 1.3337 7.7722 0.0 0
M  V30 18 O 0.0000 7.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 9
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitro-3-[(tetrahydro-3-furanyl)oxy]benzamide
C12H14N2O5
917909-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 4.6200 0.0 0
M  V30 2 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 C 6.6684 4.6200 0.0 0
M  V30 6 N 8.0022 3.8500 0.0 0
M  V30 7 O 6.6684 6.1600 0.0 0
M  V30 8 C 9.3358 4.6200 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 C 2.5797 7.0652 0.0 0
M  V30 17 C 0.0878 7.0652 0.0 0
M  V30 18 C 2.1036 8.5298 0.0 0
M  V30 19 O 0.5636 8.5298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 917909-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 917909-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-844669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 241d: 4-Nitro-3-(tetrahydro-furan-3-yloxy)-N-methyl-benzamide A
solution of 4-Nitro-3-(tetrahydro-furan-3-yloxy)-benzoic acid (82 mg,
0.32 mmol, 1.0 eq), EDC (47 mg, 0.64 mmol, 2.0 eq) and HOBT (43 mg, 0.64
mmol, 2.0 eq) in DCM (5 ml) was stirred at room temperature for 15
minutes, methylamine as a 2.0M solution in THF (0.32 ml, 0.64 mmol, 2.0
eq) was added. The reaction was stirred at room temperature for 18 hours,
the solvent was removed in vacuo, and the resultant residue was purified
by column chromatography using 7% MeOH/DCM as eluent to give the title
compound (84 mg, 0.32 mmol, 98%). Compound 241d:
4-Nitro-3-(tetrahydro-furan-3-yloxy)-N-methyl-benzamide, yield (84 mg,
0.32 mmol, 98%). 1H NMR indicates desired product in ca. 95% purity.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyrimidines for pharmaceutical compositions and their preparation
and use as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jaekel, Stefan; Murfin, Stefen; Taylor, Steven; Aicher, Babette; Kelter,
Arnd-Rene; Coulter, Thomasstefen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006136402 A1 2006-12-28

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-(3,5-difluorophenyl)-2-formyl-4-methoxybenzenepropanoate
C19H18F2O4
921220-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 13.3370 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 O 6.6685 0.0000 0.0 0
M  V30 10 F 9.3360 9.2402 0.0 0
M  V30 11 F 4.0010 9.2402 0.0 0
M  V30 12 O 1.3337 1.5400 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 4.0010 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 6.6685 6.1601 0.0 0
M  V30 21 C 8.0022 6.9302 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 8.0022 8.4702 0.0 0
M  V30 24 C 5.3348 8.4702 0.0 0
M  V30 25 C 6.6685 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 15
M  V30 11 1 10 23
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-(3,5-difluorophenyl)-4-methoxy-2-[(methylamino)methyl]benzenepropanoate
C20H23F2NO3
921220-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 O 10.6697 4.6201 0.0 0
M  V30 5 O 9.3360 6.9302 0.0 0
M  V30 6 C 12.0033 5.3901 0.0 0
M  V30 7 C 13.3370 4.6201 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 N 6.6685 0.7700 0.0 0
M  V30 10 C 8.0022 0.0000 0.0 0
M  V30 11 F 9.3360 10.0102 0.0 0
M  V30 12 F 4.0010 10.0102 0.0 0
M  V30 13 O 1.3337 2.3101 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 2.6673 3.0801 0.0 0
M  V30 21 C 6.6685 6.9302 0.0 0
M  V30 22 C 8.0022 7.7002 0.0 0
M  V30 23 C 5.3348 7.7002 0.0 0
M  V30 24 C 8.0022 9.2402 0.0 0
M  V30 25 C 5.3348 9.2402 0.0 0
M  V30 26 C 6.6685 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 9 10
M  V30 12 1 11 24
M  V30 13 1 12 25
M  V30 14 1 13 14
M  V30 15 1 13 20
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 921220-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921220-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7670876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0892] Step G: To a solution of methylamine (0.60 mL, 4.9 mmol, 33% in
ethanol) and the aldehyde (1.6 g, 3.9 mmol) from step F above was added
titanium(IV) isopropoxide (1.5 mL, 5.1 mmol). The resultant reaction
solution was stirred at room temperature for 16 h and then sodium
borohydride (0.16 g, 4.3 mmol) was added to it. The reaction solution was
stirred at room temperature for 1 hour, and then quenched with water. The
precipitate formed was removed by filtration, and the filtrate obtained
was diluted with dichloromethane, washed with water, dried over sodium
sulfate and concentrated in vacuo to give the crude amine (1.4 g, 98%) as
a light yellow oil, which was used in the next step without purification.
1H NMR (CDCl3, 500 MHz) δ 7.13 (d, J=8.5 Hz, 1H), 6.90 (d, J=3.0 Hz, 1H),
6.80 (dd, J=8.5, 3.0 Hz, 1H), 6.78-6.75 (m, 2H), 6.61 (tt, J=9.0, 2.5 Hz,
1H), 4.87 (t, J=8.0 Hz, 1H), 4.05 (q, J=7.0 Hz, 2H), 3.79 (s, 3H), 3.75
(d, J=13.0 Hz, 1H), 3.67 (d, J=13.0 Hz, 1H), 3.04-2.92 (m, 2H), 2.45 (s,
3H), 1.70-1.30 (br, 1H), 1.14 (t, J=7.0 Hz, 3H); ESI MS m/z 364 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof
to block reuptake of norepinephrine, dopamine, and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Liu, Shuang; Sambandam, Aruna; Guzzo, Peter R.; Hu,
Min; Zha, Congxiang; Nacro, Kassoum; Manning, David D.; Isherwood,
Matthew L.; Fleming, Kristen N.; Cui, Wenge; Olson, Richard E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007011820 A2 2007-01-25

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
5-Bromo-4-methyl-2-pyrimidinecarboxylic acid
C6H5BrN2O2
933745-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 N 3.0801 1.3337 0.0 0
M  V30 8 N 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,4-dimethyl-2-pyrimidinecarboxamide
C7H8BrN3O
2246365-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 933745-86-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2246365-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22096157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinolines as inhibitors of HPK1 useful for treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chan, Bryan; Drobnick, Joy; Gazzard, Lewis; Heffron, Timothy; Liang, Jun;
Malhotra, Sushant; Mendonca, Rohan; Rajapaksa, Naomi; Stivala, Craig;
Tellis, John; Wang, Weiru; Wei, Binqing; Zhou, Aihe; Cartwright, Matthew
W.; Lainchbury, Michael; Gancia, Emanuela; Seward, Eileen; Madin, Andrew;
Favor, David; Fong, Kin Chiu; Hu, Yonghan; Good, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018183964 A1 2018-10-04

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6,8-dideoxy-7-S-[5-(4,5-difluoro-2-nitrophenyl)-1,3,4-thiadiazol-2-yl]...
C26H35F2N5O7S3
941586-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 10.1979 0.0 0 VAL=5
M  V30 2 O 3.8500 11.5316 0.0 0
M  V30 3 O 6.1600 10.1979 0.0 0
M  V30 4 F 1.5400 4.8632 0.0 0
M  V30 5 S 9.7757 5.8554 0.0 0
M  V30 6 C 11.1826 6.4817 0.0 0 CFG=1
M  V30 7 C 12.4285 5.5765 0.0 0 CFG=2
M  V30 8 C 11.3435 8.0133 0.0 0
M  V30 9 N 13.8353 6.2030 0.0 0
M  V30 10 C 13.9964 7.7345 0.0 0
M  V30 11 O 12.7505 8.6398 0.0 0
M  V30 12 F 0.0000 7.5306 0.0 0
M  V30 13 O 10.0561 2.5533 0.0 0
M  V30 14 S 16.2012 2.9831 0.0 0
M  V30 15 C 17.0624 1.7063 0.0 0
M  V30 16 O 11.7784 0.0000 0.0 0
M  V30 17 O 14.8511 0.2148 0.0 0
M  V30 18 C 14.6929 11.0117 0.0 0
M  V30 19 C 19.3876 8.3011 0.0 0
M  V30 20 C 20.4182 9.4456 0.0 0
M  V30 21 C 21.9245 9.1255 0.0 0
M  V30 22 C 4.6200 7.5306 0.0 0
M  V30 23 C 3.8500 8.8643 0.0 0
M  V30 24 C 3.8500 6.1968 0.0 0
M  V30 25 C 2.3100 8.8643 0.0 0
M  V30 26 C 2.3100 6.1968 0.0 0
M  V30 27 C 1.5400 7.5306 0.0 0
M  V30 28 C 6.1600 7.5306 0.0 0
M  V30 29 S 7.0652 6.2846 0.0 0
M  V30 30 N 7.0652 8.7765 0.0 0
M  V30 31 C 8.5298 6.7606 0.0 0
M  V30 32 N 8.5298 8.3006 0.0 0
M  V30 33 C 12.2675 4.0450 0.0 0 CFG=2
M  V30 34 O 13.8037 4.1525 0.0 0
M  V30 35 C 11.5924 2.6608 0.0 0 CFG=2
M  V30 36 C 14.6649 2.8757 0.0 0 CFG=2
M  V30 37 C 12.4536 1.3842 0.0 0 CFG=2
M  V30 38 C 13.9899 1.4915 0.0 0 CFG=2
M  V30 39 C 15.4032 8.3609 0.0 0 CFG=1
M  V30 40 C 16.7368 7.5909 0.0 0
M  V30 41 N 15.7233 9.8673 0.0 0
M  V30 42 C 17.8813 8.6213 0.0 0 CFG=1
M  V30 43 C 17.2550 10.0282 0.0 0
M  V30 44 H 10.7871 4.4694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 4 26
M  V30 5 1 5 6
M  V30 6 1 5 31
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9 CFG=1
M  V30 10 1 7 33
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 39 10 CFG=1
M  V30 14 1 12 27
M  V30 15 1 35 13 CFG=1
M  V30 16 1 14 15
M  V30 17 1 36 14 CFG=3
M  V30 18 1 37 16 CFG=1
M  V30 19 1 38 17 CFG=3
M  V30 20 1 18 41
M  V30 21 1 19 20
M  V30 22 1 42 19 CFG=3
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 22 28
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 33 44 CFG=3
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 6 7 33 35 36 37 38 39 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 6,8-dideoxy-7-S-[5-[4-fluoro-5-(methylamino)-2-nitrophenyl]-1,3,4-thia...
C27H39FN6O7S3
941586-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 10.1979 0.0 0 VAL=5
M  V30 2 O 3.8500 11.5315 0.0 0
M  V30 3 O 6.1600 10.1979 0.0 0
M  V30 4 N 1.5400 4.8632 0.0 0
M  V30 5 C 0.0000 4.8632 0.0 0
M  V30 6 S 9.7756 5.8554 0.0 0
M  V30 7 C 11.1826 6.4817 0.0 0 CFG=1
M  V30 8 C 12.4284 5.5765 0.0 0 CFG=2
M  V30 9 C 11.3435 8.0133 0.0 0
M  V30 10 N 13.8352 6.2030 0.0 0
M  V30 11 C 13.9963 7.7345 0.0 0
M  V30 12 O 12.7505 8.6397 0.0 0
M  V30 13 F 0.0000 7.5306 0.0 0
M  V30 14 O 10.0561 2.5533 0.0 0
M  V30 15 S 16.2011 2.9831 0.0 0
M  V30 16 C 17.0623 1.7063 0.0 0
M  V30 17 O 11.7784 0.0000 0.0 0
M  V30 18 O 14.8510 0.2148 0.0 0
M  V30 19 C 14.6929 11.0116 0.0 0
M  V30 20 C 19.3876 8.3011 0.0 0
M  V30 21 C 20.4181 9.4456 0.0 0
M  V30 22 C 21.9244 9.1254 0.0 0
M  V30 23 C 4.6200 7.5306 0.0 0
M  V30 24 C 3.8500 8.8643 0.0 0
M  V30 25 C 3.8500 6.1968 0.0 0
M  V30 26 C 2.3100 8.8643 0.0 0
M  V30 27 C 2.3100 6.1968 0.0 0
M  V30 28 C 1.5400 7.5306 0.0 0
M  V30 29 C 6.1600 7.5306 0.0 0
M  V30 30 S 7.0652 6.2846 0.0 0
M  V30 31 N 7.0652 8.7765 0.0 0
M  V30 32 C 8.5298 6.7606 0.0 0
M  V30 33 N 8.5298 8.3006 0.0 0
M  V30 34 C 12.2675 4.0450 0.0 0 CFG=2
M  V30 35 O 13.8037 4.1525 0.0 0
M  V30 36 C 11.5924 2.6608 0.0 0 CFG=2
M  V30 37 C 14.6648 2.8756 0.0 0 CFG=2
M  V30 38 C 12.4535 1.3842 0.0 0 CFG=2
M  V30 39 C 13.9899 1.4915 0.0 0 CFG=2
M  V30 40 C 15.4031 8.3608 0.0 0 CFG=1
M  V30 41 C 16.7368 7.5908 0.0 0
M  V30 42 N 15.7233 9.8673 0.0 0
M  V30 43 C 17.8813 8.6212 0.0 0 CFG=1
M  V30 44 C 17.2550 10.0282 0.0 0
M  V30 45 H 10.7871 4.4694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 6 7
M  V30 7 1 6 32
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10 CFG=1
M  V30 11 1 8 34
M  V30 12 1 10 11
M  V30 13 2 11 12
M  V30 14 1 40 11 CFG=1
M  V30 15 1 13 28
M  V30 16 1 36 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 37 15 CFG=3
M  V30 19 1 38 17 CFG=1
M  V30 20 1 39 18 CFG=3
M  V30 21 1 19 42
M  V30 22 1 20 21
M  V30 23 1 43 20 CFG=3
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 23 29
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 34 45 CFG=3
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 7 8 34 36 37 38 39 40 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 941586-45-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 941586-79-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18877964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antibacterial activity of novel lincomycin derivatives.
III. Optimization of a phenyl thiadiazole moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumura, Ko; Wakiyama, Yoshinari; Ueda, Kazutaka; Umemura, Eijiro;
Watanabe, Takashi; Yamamoto, Mikio; Yoshida, Takuji; Ajito, Keiichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Antibiotics (2018), 71(1), 104-112

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[[4-(Dimethylamino)phenyl]methylene]-2-methyl-5(4H)-oxazolone
C13H14N2O2
944261-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.3626 0.0 0
M  V30 2 O 0.7103 0.0000 0.0 0
M  V30 3 C 0.1435 5.3913 0.0 0
M  V30 4 N 9.1059 4.4427 0.0 0
M  V30 5 C 10.4395 3.6727 0.0 0
M  V30 6 C 9.1059 5.9827 0.0 0
M  V30 7 C 2.4374 2.1326 0.0 0
M  V30 8 N 2.2763 3.6643 0.0 0
M  V30 9 C 1.0304 1.5063 0.0 0
M  V30 10 C 0.7700 3.9845 0.0 0
M  V30 11 O 0.0000 2.6509 0.0 0
M  V30 12 C 5.1047 2.1326 0.0 0
M  V30 13 C 5.1047 3.6727 0.0 0
M  V30 14 C 6.4384 1.3626 0.0 0
M  V30 15 C 6.4384 4.4427 0.0 0
M  V30 16 C 7.7722 2.1326 0.0 0
M  V30 17 C 7.7722 3.6727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 1 12
M  V30 3 2 2 9
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-5-[[4-(Dimethylamino)phenyl]methylene]-3,5-dihydro-2,3-dimethyl-4H-imida...
C14H17N3O
1241390-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.3626 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 C 1.6752 5.3913 0.0 0
M  V30 5 N 10.6375 4.4427 0.0 0
M  V30 6 C 11.9713 3.6727 0.0 0
M  V30 7 C 10.6375 5.9827 0.0 0
M  V30 8 C 3.9690 2.1326 0.0 0
M  V30 9 C 2.5622 1.5063 0.0 0
M  V30 10 N 3.8080 3.6644 0.0 0
M  V30 11 N 1.5316 2.6509 0.0 0
M  V30 12 C 2.3016 3.9845 0.0 0
M  V30 13 C 6.6365 2.1326 0.0 0
M  V30 14 C 6.6365 3.6727 0.0 0
M  V30 15 C 7.9701 1.3626 0.0 0
M  V30 16 C 7.9701 4.4427 0.0 0
M  V30 17 C 9.3038 2.1326 0.0 0
M  V30 18 C 9.3038 3.6727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 1 13
M  V30 3 2 2 9
M  V30 4 1 3 11
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944261-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1241390-26-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16287812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild, Efficient, One-Pot Synthesis of Imidazolones Promoted by
N,O-Bistrimethylsilylacetamide (BSA)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muselli, Mickael; Colombeau, Ludovic; Hedouin, Jonathan; Hoarau,
Christophe; Bischoff, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2819-2825

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[6-(1-Piperidinylmethyl)-2-pyridinyl]oxy]benzaldehyde
C18H20N2O2
956593-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 3.0800 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 C 14.6707 3.0800 0.0 0
M  V30 4 O 16.0045 2.3100 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 N 6.6686 3.0800 0.0 0
M  V30 7 C 8.0022 0.7700 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 6.6686 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 10.6697 2.3100 0.0 0
M  V30 12 C 12.0034 3.0800 0.0 0
M  V30 13 C 10.6697 0.7700 0.0 0
M  V30 14 C 13.3370 2.3100 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 C 13.3370 0.7700 0.0 0
M  V30 17 N 2.6675 2.3100 0.0 0
M  V30 18 C 1.3338 3.0800 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 C 1.3338 0.0000 0.0 0
M  V30 22 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 2 17
M  V30 5 2 3 4
M  V30 6 1 3 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[[6-(1-piperidinylmethyl)-2-pyridinyl]oxy]benzenemethanamine
C19H25N3O
956593-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 3.0800 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 C 14.6705 3.0800 0.0 0
M  V30 4 N 16.0041 2.3100 0.0 0
M  V30 5 C 17.3379 3.0800 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 N 6.6685 3.0800 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 10.6694 2.3100 0.0 0
M  V30 13 C 12.0032 3.0800 0.0 0
M  V30 14 C 10.6694 0.7700 0.0 0
M  V30 15 C 13.3369 2.3100 0.0 0
M  V30 16 C 12.0032 0.0000 0.0 0
M  V30 17 C 13.3369 0.7700 0.0 0
M  V30 18 N 2.6674 2.3100 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 1.3338 3.0800 0.0 0
M  V30 21 C 1.3338 0.0000 0.0 0
M  V30 22 C 0.0000 2.3100 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 9
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 3 15
M  V30 7 1 4 5
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 956593-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956593-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10942403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual serotonin transporter inhibitor/histamine H3 antagonists:
Development of rigidified H3 pharmacophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, John M.; Barbier, Ann J.; Wilson, Sandy J.; Miller, Kirstin;
Boggs, Jamin D.; Fraser, Ian C.; Mazur, Curt; Lovenberg, Timothy W.;
Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(19), 5325-5329

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-(3-methoxy-3-oxopropyl)-N-methyl-, methyl ester
C9H17NO4
105-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 O 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-24026332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acridin-9-yl-amine, quinolin-9-yl-amine, 1-amino-9H-thioxanthene-9-one
and benzo[b][1,5]naphthyridin-10-yl-amine derivatives as autophagy
inhibitors for treating cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hou, Frank Shujie; Xue, Jian; Zhao, Yushan; Miao, Dezu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021142065 A1 2021-07-15

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-(3-methoxy-3-oxopropyl)-N-methyl-, methyl ester
C9H17NO4
105-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 O 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2373149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General
Procedure Reactions were typically carried out as follows: 1.40 mol of
alkyl acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Yield 98.0 %. Bp
[°C/mmHg] or mp 134/12 °C Refractive index nD20 1.4430 Molecular formula
C9H17NO4 Elemental analysis calcd. (wt%): C, 53.19; H, 8.43; N, 6.89.
found (wt%): C, 53.15; H, 8.45; N, 6.90.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dichlorobenzenesulfonyl chloride
C6H3Cl3O2S
98-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dichloro-N-methylbenzenesulfonamide
C7H7Cl2NO2S
5836-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Cl 1.5400 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5836-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzenesulfonyl chloride
C6H4Cl2O2S
98-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenesulfonamide
C7H8ClNO2S
6333-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Cl 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6333-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzenesulfonyl chloride
C6H4Cl2O2S
98-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenesulfonamide
C7H8ClNO2S
6333-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Cl 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6333-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14329131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Regio- and Chemo-selective Reactions of 2-Bromobenzyl
Bromides: Expanding the Scope for the Synthesis of Biaryls Fused to a
Seven-Membered Sultam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Sharma, Shubhra; Dayal, Neetu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(36), 7885-7891

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzoic acid
C7H6O3
99-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-N-methylbenzamide
C8H9NO2
15788-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38672807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(difluoromethyl)-1,3,4-oxadiazol-2-yl substituted
pyrimidine and pyridine compounds for inhibiting histone deacetylase 6
(HDAC6)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wagner, Florence Fevrier; Yates, Christopher M.; Richardson, Tom
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023196605 A1 2023-10-12

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzoic acid
C7H6O3
99-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-N-methylbenzamide
C8H9NO2
15788-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15788-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37973151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazole HDAC6 inhibitors and its uses in treating
neurological disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wagner, Florence Fevrier; Richardson, Tom
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023196601 A1 2023-10-12

$RFMT $RIREG SCHEME103 STEP1
$RXN



  1  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, nitrate (1:1)
CH5N.HNO3
22113-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 O 2.6673 3.8501 0.0 0
M  V30 4 O 1.3337 1.5400 0.0 0
M  V30 5 C 0.5637 0.0000 0.0 0
M  V30 6 N 2.1037 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22113-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41063142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7697-37-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Replacement of Toxic Hydrazines in Satellite Propulsion with Greener
Dinitramide-Based Energetic Ionic Liquid Candidates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le, Duc-Minh; Renault, Anne; Delage, Arthur; Ducos, Paul; Miro-Sabate,
Carlos; Pelletier, Nicolas; Lacote, Emmanuel; Jacob, Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2024), 30(31), e202303965

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzenesulfonyl chloride
C7H7ClO3S
10130-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
1538358-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 1.8975 1.7464 0.0 0
M  V30 4 O 3.4375 4.4137 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10130-74-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538358-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5261756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Regio- and Chemo-selective Reactions of 2-Bromobenzyl
Bromides: Expanding the Scope for the Synthesis of Biaryls Fused to a
Seven-Membered Sultam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Sharma, Shubhra; Dayal, Neetu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(36), 7885-7891

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14360002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 84 Preparation
of Benzo[1,3]dioxol-5-ylmethyl-methylamine [0839] According to the
procedure of Preparation 67, except substituting
benzo[1,3]dioxole-5-carbaldehyde for 1-propyl-naphthalene-2-carbaldehyde,
the title compound (3.23 g, 97%) was prepared as a yellow oil. 1H NMR
(300 MHz, DMSO-d6) δ 6.88-6.75 (m, 3H), 5.96 (s, 2H), 3.52 (s, 2H), 2.20
(s, 3H), 1.95 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5968286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5667788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
Benzo[1,3]dioxol-5-ylmethyl-methylamine According to the procedure of
Preparation 1, except substituting benzo[1,3]dioxole-5-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (3.23 g, 97%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.88-6.75 (m, 3H),
5.96 (s, 2H), 3.52 (s, 2H), 2.20 (s, 3H), 1.95 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-3-oxetaneacetate
C7H13NO3
1207175-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4375 2.3101 0.0 0
M  V30 2 C 4.7712 1.5400 0.0 0
M  V30 3 O 6.1048 2.3101 0.0 0
M  V30 4 O 4.7712 0.0000 0.0 0
M  V30 5 C 7.4387 1.5400 0.0 0
M  V30 6 C 8.7723 2.3101 0.0 0
M  V30 7 N 2.8737 0.2064 0.0 0
M  V30 8 C 2.1037 1.5400 0.0 0
M  V30 9 C 1.3337 2.8737 0.0 0
M  V30 10 C 0.7700 0.7700 0.0 0
M  V30 11 O 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-3-oxetaneacetamide
C6H12N2O2
1613239-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4375 2.3101 0.0 0
M  V30 2 C 4.7712 1.5400 0.0 0
M  V30 3 N 6.1048 2.3101 0.0 0
M  V30 4 O 4.7712 0.0000 0.0 0
M  V30 5 C 7.4387 1.5400 0.0 0
M  V30 6 N 2.8739 0.2064 0.0 0
M  V30 7 C 2.1038 1.5400 0.0 0
M  V30 8 C 1.3338 2.8737 0.0 0
M  V30 9 C 0.7700 0.7700 0.0 0
M  V30 10 O 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207175-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613239-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7941912
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel pyridine derivatives as cannabinoid receptor 2
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frei, Beat; Gobbi, Luca; Grether, Uwe; Kimbara, Atsushi; Nettekoven,
Matthias; Roever, Stephan; Rogers-Evans, Mark; Schulz-Gasch, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014086705 A1 2014-06-12

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6198770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and in Vitro Evaluation of a Microbicide Gel Formulation for
a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the
N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tintori, Cristina; Brai, Annalaura; Dasso Lang, Maria Chiara; Deodato,
Davide; Greco, Antonia Michela; Bizzarri, Bruno Mattia; Cascone, Lorena;
Casian, Alexandru; Zamperini, Claudio; Dreassi, Elena; Crespan,
Emmanuele; Maga, Giovanni; Vanham, Guido; Ceresola, Elisa; Canducci,
Filippo; Arien, Kevin K.; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2747-2759

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6160415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4-methoxyphenyl)-N-methylmethanamine (15). To a solution of anisaldehyde
(1 mL, 8.22 mmol) in MeOH (10mL), methylamine 33 % in absolute ethanol
(1.22 mL, 9.86 mmol) and sodium hydrogen carbonate (1.38 g, 16.44 mmol)
were added. Mixture was refluxed overnight and then NaBH4 (374 mg, 9.86
mmol) was added at 0°C. Mixture was stirred at r.t for 1 h and then water
was added dropwise at 0°C to quench the reaction. The mixture was
concentrate under reduced pressure to remove MeOH, and the residual
acqueous solution was acidified with HCl 1N, washed with CH2Cl2 (x1),
basified with NaOH 1N and then exctracted with CH2Cl2 (x3). The combined
organic layers were dried over Na2SO4, washed with brine and
concentrated. 1.21 g (97%) of 15 as uncoloured oil. 1H NMR (400 MHz,
CDCl3-d) δ (ppm) 7.13-7.11 (d, 2H, J = 8.3 Hz), 6.77-6.75 (d, 2H, J = 8.3
Hz), 3.67 (s, 3H), 3.57 (s, 2H), 2.32 (s, 3H). MS (ESI) m/z: 152 [M+H]+.
Anal. (C9H13NO) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A domino microwave-assisted protocol for the synthesis of
2,6-disubstituted pyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Radi, Marco; Casaluce, Gianni; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2011), (14), 1997-2000

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31453001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antibacterial alkylguanidino ureas: Molecular simplification approach,
searching for membrane-based MoA
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Agostino, Ilaria; Ardino, Claudia; Poli, Giulio; Sannio, Filomena;
Lucidi, Massimiliano; Poggialini, Federica; Visaggio, Daniela; Rango,
Enrico; Filippi, Silvia; Petricci, Elena; Visca, Paolo; Botta, Lorenzo;
Docquier, Jean-Denis; Dreassi, Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 231114158

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl acrylate
C7H12O2
141-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Butoxy-3-oxopropyl)-N-methyl-β-alanine butyl ester
C15H29NO4
1123109-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 1.5400 0.0 0
M  V30 2 C 12.0033 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 10.6697 0.0000 0.0 0
M  V30 5 C 13.3370 1.5400 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 C 14.6708 2.3101 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 O 14.6708 3.8501 0.0 0
M  V30 11 O 5.3348 1.5400 0.0 0
M  V30 12 O 6.6685 3.8501 0.0 0
M  V30 13 C 17.3382 2.3101 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 18.6720 1.5400 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 20.0057 2.3101 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 21.3393 1.5400 0.0 0
M  V30 20 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11307851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound
N-methyl-N,N-bis[2-(butoxycarbonyl)ethyl]amine (4c) Product
CH3N(CH2CH2COOC4H9)2 Yield 97.0 %. Bp [°C/mmHg] or mp 166/1.6 °C
Refractive index nD20 1.4420 Molecular formula C15H29NO4 Elemental
analysis calcd. (wt%): C, 62.69; H, 10.17; N, 4.87. found (wt%): C,
62.65; H, 10.15; N, 4.85. Chemical shifts δ [ppm] (J [Hz]): 1H NMR: 0.90
(t, 6 H, J = 7.50, CH3CH2CH2CH2O); 1.34 (sext, 4 H, J = 6.50,
CH3CH2CH2CH2O); 1.57 (q, 4 H, J = 6.5, CH3CH2CH2CH2O); 2.21 (s, 3 H,
CH3N); 2.43 (t, 4 H, J = 7.0, NCH2CH2COO); 2.67 (t, 4 H, J = 7.0,
NCH2CH2COO); 4.04 (t, 4 H, J = 6.5, CH3CH2CH2CH2O) 13C NMR: 13.63
(CH3CH2CH2CH2O); 19.08 (CH3CH2CH2CH2O); 30.61 (CH3CH2CH2CH2O); 32.61
(NCH2CH2COO); 41.68 (CH3N); 52.55 (NCH2CH2COO); 64.21 (CH3CH2CH2CH2O;
172.50 (C=O) IR: 3452, 2960, 1737, 1466, 1176, 1032.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6897177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Mediated Synthesis of Indolequinones from Bromoquinones and
Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(11), 2179-2187

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13866216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Z)-tert-Butyl 3-(methylamino)but-2-enoate. A solution of methylamine
(25% w/v in water; 3.72 mL, 30 mmol) was added in a single portion to a
stirred suspension of silica gel (0.3 g) and tert-butyl acetoacetate
(3.95 g, 25 mmol) at room temperature, and the resulting mixture was
stirred at room temperature for 15 h. The mixture was extracted with
dichloromethane (3 × 15 mL), and the combined organic phases were dried
(MgSO4), filtered and concentrated in vacuo to give the title compound as
a pale yellow oil (4.15 g, 97%). Found: M+H+, 172.1342. C9H18NO2 requires
172.1332); νmax (CHCl3)/cm-1 3306, 3005, 2980, 2931, 1595, 1293; δH (400
MHz; CDCl3) 8.45 (1H, br s, NH), 4.41 (1H, s, CH), 2.89 (3H, d, J4.8,
NMe), 1.89 (3H, s, Me), 1.47 (9H, s, tBu); δC(75 MHz; CDCl3) 170.9,
162.2, 83.5 (CH), 77.7, 29.5 (Me), 28.6 (Me), 19.0 (Me); m/z (EI) 365
(2M+Na+, 100%), 172 (M+H+, 79).
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indolequinones from Bromoquinones and Enamines Mediated by
Cu(OAc)2·H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(17), 6023-6026

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4662264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Z)-tert-Butyl 3-(methylamino)but-2-enoate. A solution of methylamine
(25% w/v in water; 3.72 mL, 30 mmol) was added in a single portion to a
stirred suspension of silica gel (0.3 g) and tert-butyl acetoacetate
(3.95 g, 25 mmol) at room temperature, and the resulting mixture was
stirred at room temperature for 15 h. The mixture was extracted with
dichloromethane (3 × 15 mL), and the combined organic phases were dried
(MgSO4), filtered and concentrated in vacuo to give the title compound as
a pale yellow oil (4.15 g, 97%). (Found: M+H+, 172.1342. C9H18NO2
requires 172.1332); νmax (CHCl3)/cm-1 3306, 3005, 2980, 2931, 1595, 1293;
δH (400 MHz; CDCl3) 8.45 (1H, br s, NH), 4.41 (1H, s, CH), 2.89 (3H, d,
J4.8, NMe), 1.89 (3H, s, Me), 1.47 (9H, s, tBu); δC (75 MHz; CDCl3)
170.9, 162.2, 83.5 (CH), 77.7, 29.5 (Me), 28.6 (Me), 19.0 (Me); m/z (EI)
365 (2M+Na+, 100%), 172 (M+H+, 79).
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indolequinones from Bromoquinones and Enamines Mediated by
Cu(OAc)2·H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(17), 6023-6026

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P-[2-Oxo-1-(phenylmethoxy)-3-piperidinyl]phosphonic acid
C12H16NO5P
2004714-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 1.3337 3.0801 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 O 6.6685 3.0801 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 12.0033 3.0801 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-P-[2-oxo-1-(phenylmethoxy)-3-piperidinyl]phosphonamidic acid
C13H19N2O4P
2414317-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 10.6697 3.0801 0.0 0 VAL=5
M  V30 2 N 12.0033 3.8501 0.0 0
M  V30 3 O 11.4397 1.7464 0.0 0
M  V30 4 O 9.8996 4.4137 0.0 0
M  V30 5 C 13.3370 3.0801 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 O 5.3348 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 8.0022 0.0000 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 1.3337 5.3901 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2004714-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414317-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24568378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2446-83-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,in-situ generated reagent in
stage 1,Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the monoamidation of phosphates and phosphonates under
Mitsunobu conditions and use of the phosphoramidates and
phosphonoamidates as inhibitors of the enolase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yan, Victoria; Pham, Cong-Dat; Muller, Florian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021202886 A1 2021-10-07

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31526291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Environmentally friendly catechol-based synthesis of dibenzosultams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liljenberg, Sara; Nain-Perez, Amalyn; Nilsson, Oscar; Matic, Josipa;
Groetli, Morten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2022), 46(12), 5593-5605

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,4-dichloropyrimidine
C4HBrCl2N2
36082-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 N 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methyl-4-pyrimidinamine
C5H5BrClN3
205672-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36082-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205672-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34731728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diazepanone-fused pyrimidine compounds as EGFR and HER2
inhibitors, their compositions and medicinal applications thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hallur, Gurulingappa; Roth, Bruce; Pandey, Anjali; Saxton, Tracy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022212538 A1 2022-10-06

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14730434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 95
3-(Isopropyl(methyl)amino)-2-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)quinoxaline-6-carboxylic
acid Step 1. 4-Bromo-N-methyl-2-nitroaniline To a solution of
4-bromo-1-fluoro-2-nitrobenzene (6 g, 27.27 mmol) in dichloromethane (100
ml) was added potassium carbonate (7.5 g, 54.27 mmol). This was followed
by the addition of CH3NH2 (20 ml, 33% aqueous), which was added dropwise
with stirring at room temperature. The resulting solution was stirred for
2 h at room temperature, extracted with dichloromethane (2×200 ml) and
the organic layers combined and concentrated under vacuum to afford
4-bromo-N-methyl-2-nitroaniline. Red solid (6.1 g, 97%). LC/MS (ES, m/z):
[M+H]+ 231.1 1H-NMR (300 MHz, CDCl3) δ 8.34 (d, J=2.4 Hz, 1H), 8.05 (s,
1H), 7.47-7.56 (m, 1H), 6.79 (d, J=3.3 Hz, 1H), 3.03 (d, J=8.1 Hz, 3H)
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinoxaline-6-carboxylic acid derivatives as modulators of
PAS kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McCall, John M.; Romero, Donna L.; Kelly, Robert C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012119046 A2 2012-09-07

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-methyl-1-nitrobenzene
C7H6FNO2
446-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-2-nitrobenzenamine
C8H10N2O2
65081-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65081-42-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14880390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as ACSS2 modulators and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Darryl David; Grina, Jonas; Josey, John A.; Rizzi, James P.;
Schlachter, Stephen T.; Wallace, Eli M.; Wang, Bin; Wehn, Paul; Yang,
Hanbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015175845 A1 2015-11-19

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-methoxy-1-nitrobenzene
C7H6FNO3
446-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N-methyl-2-nitrobenzenamine
C8H10N2O3
69397-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69397-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3306680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Luminescent bimetallic lanthanide bioprobes for cellular imaging with
excitation in the visible-light range
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deiters, Emmanuel; Song, Bo; Chauvin, Anne-Sophie; Vandevyver, Caroline
D. B.; Gumy, Frederic; Bunzli, Jean-Claude G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(4), 885-900

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4895796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methylamine in ethanol (33%, 35 mL, 280 mmol) was slowly added to a
solution of ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate (20 g, 86
mmol) in 250 mL of dichloromethane at 0 °C. The solution was stirred for
30 min.Then 150 mL of water was added, and the layers were separated. The
organic layer was dried over MgSO4, filtered, and concentrated to 19 g
(97%) of ethyl 4-methylamino-2-methylthiopyrimidine-5-carboxylate (3a) as
a white solid. ethyl 4-methylamino-2-methylthiopyrimidine-5-carboxylate
(3a), yield 19 g (97%) 1H NMR (300 MHz, DMSO-d6) δ ppm 1.30 (t, J= 7.25
Hz, 3H), 2.49 (s, 3H), 2.98 (d, J= 4.58Hz, 3H), 4.28 (q, J= 7.25 Hz, 2H),
8.19-8.28 (m, 1 H), 8.52 (s, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one
(Pamapimod) and
6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
(R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α
Mitogen-Activated Protein Kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goldstein, David M.; Soth, Michael; Gabriel, Tobias; Dewdney, Nolan;
Kuglstatter, Andreas; Arzeno, Humberto; Chen, Jeffrey; Bingenheimer,
William; Dalrymple, Stacie A.; Dunn, James; Farrell, Robert; Frauchiger,
Sandra; La Fargue, JoAnn; Ghate, Manjiri; Graves, Bradford; Hill, Ronald
J.; Li, Fujun; Litman, Renee; Loe, Brad; McIntosh, Joel; McWeeney,
Daniel; Papp, Eva; Park, Jaehyeon; Reese, Harlan F.; Roberts, Richard T.;
Rotstein, David; San Pablo, Bong; Sarma, Keshab; Stahl, Martin; Sung,
Man-Ling; Suttman, Rebecca T.; Sjogren, Eric B.; Tan, Yunchou; Trejo,
Alejandra; Welch, Mary; Weller, Paul; Wong, Brian R.; Zecic, Hasim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(7), 2255-2265

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12716266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ethyl 4-(Methylamino)-2-(methylthio)pyrimidine-5-carboxylate (6). To a
solution of compound 5 (1.0 g, 4.3 mmol) in THF (14.3 mL) was added 2.0 M
methylamine solution in THF (5.37 mL, 10.7 mmol) at 0 °C, and the
reaction mixture was stirred at room temperature for 1 h. The reaction
mixture was partitioned between ethyl acetate (50 mL) and saturated
NaHCO3 (30 mL). The organic layer was washed with brine, dried over
MgSO4, filtered through a pad of celite, and concentrated under reduced
pressure. The resulting white solid title compound (950 mg, 97% yield)
was used for the next step without further purification. Rf = 0.47 (1/4
ethyl acetate/hexane).1H NMR 600 MHz (CDCl3) δ 8.60 (s, 1H), 8.16 (bs,
1H), 4.32 (q, J = 7.2 Hz, J = 13.8 Hz, 2H), 3.07 (d, J = 5.4 Hz, 3H),
2.54 (s, 3H), 1.36 (t, J = 7.2 Hz, 3H). 1H 400 MHz (DMSO-d6) δ 8.49 (s,
1H), 8.23 (bs, 1H), 4.26 (q, J = 7.1 Hz, J = 14.1 Hz, 2H), 2.96 (d, J =
4.8 Hz, 3H), 2.48 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR 100 MHz
(DMSO-d6) δ 175.49, 166.22, 160.14, 158.13, 101.26. 61.01, 27.80, 14.53,
14.04. HRMS (ESI) m/z[M + Na]+ calcd 250.0626, found 250.0628.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Type-II Kinase Inhibitor Capable of Inhibiting the T315I "Gatekeeper"
Mutant of Bcr-Abl
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Hwan Geun; Ren, Pingda; Adrian, Francisco; Sun, Fangxian; Lee, Hyun
Soo; Wang, Xia; Ding, Qiang; Zhang, Guobao; Xie, Yongping; Zhang,
Jianming; Liu, Yi; Tuntland, Tove; Warmuth, Markus; Manley, Paul W.;
Mestan, Jurgen; Gray, Nathanael S.; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(15), 5439-5448

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17612282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic pyridine and pyrimidine derivatives, e.g.,
thieno[2,3-d]pyrimidines and analogs, active as p38 kinase inhibitors,
and their preparation, pharmaceutical compositions, and uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jian Jeffrey; Dewdney, Nolan James; Stahl, Christoph Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003074530 A1 2003-09-12

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3736047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1 Preparation of ethyl
4-methylamino-2-methylthiopyrimidine-5-carboxylate, To a 0 °C solution of
20 g ( 8 6 mmol) of ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate
(Aldrich Chemical Co., Milwaukee, Wisconsin, USA) in 250 mL of
dichloromethane was slowly added 35 mL (281 mmol) of a 33% solution of m
ethylamine in ethanol. After stirring for 30 minutes, 150 mL of water was
added and the phases were separated. The organic phase was dried over
magnesium sulfate and filtered. The filtrate was evaporated under reduced
pressure to give ethyl
4-methylamino-2-methylthiopyrimidine-5-carboxylate. White solild; Yield:
(19 g, 97%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-Oxopyridopyrimidines as inhibitors of cellular proliferation, and
particularly as inhibitors of p38 kinase, for treatment of p38-related
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jian Jeffrey; Dunn, James Patrick; Goldstein, David Michael; Lim,
Julie Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002018380 A1 2002-03-07

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9481466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1.1 Preparation of ethyl
4-methylamino-2-methylthiopyrimidine-5-carboxylate. A solution of 20 g
(86 mmol) of ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate (Aldrich
Chemical Co., Milwaukee, Wisconsin, USA) in 250 mL of dichloromethane was
cooled to 0 °C and treated slowly with 35 mL (281 mmol) of a 33% solution
of methylamine in ethanol. After stirring for 30 minutes, 150 mL of water
was added and the phases were separated. The organic phase was dried over
magnesium sulfate and filtered. The filtrate was evaporated under reduced
pressure to give ethyl
4-methylarmino-2-methylthiopyrimidine-5-carboxylate. White solid, yield
97%, 19 g.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-oxopyridopyrimidines as p38 MAP kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arzeno, Humberto Bartolome; Chen, Jian Jeffrey; Dunn, James Patrick;
Goldstein, David Michael; Lim, Julie Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002018379 A2 2002-03-07

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19276525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alkylamino substituted bicyclic nitrogen heterocycles for
pharmaceutical use as inhibitors of p38 protein kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dunn, James Patrick; Fisher, Lawrence Emerson; Goldstein, David Michael;
Harris, William; Hill, Christopher Huw; Smith, Ian Edward David; Welch,
Teresa Rosanne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001029042 A1 2001-04-26

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17745732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidopyrimidinones as T-cell tyrosine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harris, William; Hill, Christopher Huw; Smith, Ian Edward David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000024744 A1 2000-05-04

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Pantolactone
C6H10O3
599-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6527 0.0000 0.0 0
M  V30 2 C 0.0000 3.0715 0.0 0
M  V30 3 C 0.6368 1.1114 0.0 0
M  V30 4 O 5.3632 1.9692 0.0 0
M  V30 5 C 2.6527 1.5400 0.0 0 CFG=1
M  V30 6 C 1.4068 2.4452 0.0 0
M  V30 7 C 3.8987 2.4452 0.0 0
M  V30 8 C 1.8827 3.9098 0.0 0
M  V30 9 O 3.4227 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 2 6
M  V30 3 1 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Butanamide, 2,4-dihydroxy-N,3,3-trimethyl-, (R)-
C7H15NO3
88308-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6438 1.5400 0.0 0 CFG=1
M  V30 2 C 2.3100 2.3100 0.0 0
M  V30 3 C 4.9775 2.3100 0.0 0
M  V30 4 O 3.6438 0.0000 0.0 0
M  V30 5 C 1.5400 0.9764 0.0 0
M  V30 6 C 3.0800 3.6437 0.0 0
M  V30 7 C 0.9764 3.0800 0.0 0
M  V30 8 N 6.3111 1.5400 0.0 0
M  V30 9 O 4.9775 3.8500 0.0 0
M  V30 10 O 0.0000 0.9764 0.0 0
M  V30 11 C 7.6450 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 2 3 9
M  V30 9 1 5 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 599-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88308-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37838432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of Coenzyme A analogues as Aurora kinase A
inhibitors: An exploration of the roles of the pyrophosphate and
pantetheine moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bellany, Fiona; Tsuchiya, Yugo; Tran, Trang M.; Chan, A. W. Edith; Allan,
Helen; Gout, Ivan; Tabor, Alethea B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(22), 115740

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36521867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small Schiff base molecules derived from salicylaldehyde as colorimetric
and fluorescent neutral-to-basic pH sensors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silva, Renan C.; Canisares, Felipe S. M.; Mutti, Alessandra M. G.; Pires,
Ana M.; Lima, Sergio A. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2023), 213111191

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16410435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Modular Synthesis of N-Benzotriazole Ureas Using Alkylation of
5-Nitrobenzotriazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Machara, Ales; Konvalinka, Jan; Kotora, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2016), 1(1), 101-107

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-tert-Butylsalicylaldehyde
C11H14O2
24623-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl)-6-[(methylimino)methyl]phenol
C12H17NO
479507-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 8.0023 2.3101 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24623-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479507-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19397986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable Fe(III) phenoxyimines as selective and robust CO2/epoxide coupling
catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fazekas, Eszter; Nichol, Gary S.; Shaver, Michael P.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2018), 47(37), 13106-13112

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34512402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mi-2beta inhibitor as an immunotherapy agent for treating cancer and
combination with other agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hong-Yu; Wang, Zhengyu; Shao, Jingwei; Cui, Rutao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20220304990 A1 2022-09-29

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6E)-2,3-Anhydro-6,7,8,9-tetradeoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-8...
C19H30N2O5
847779-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1663 5.4513 0.0 0
M  V30 2 N 9.5000 6.2213 0.0 0
M  V30 3 O 8.1663 3.9113 0.0 0
M  V30 4 C 4.4628 4.0739 0.0 0
M  V30 5 C 3.9361 2.6269 0.0 0
M  V30 6 C 4.9260 1.4471 0.0 0
M  V30 7 C 4.3993 0.0000 0.0 0
M  V30 8 C 6.4426 1.7146 0.0 0
M  V30 9 C 0.4987 7.8509 0.0 0
M  V30 10 C 0.0000 5.8511 0.0 0
M  V30 11 O 11.8765 7.8415 0.0 0
M  V30 12 C 5.2927 6.2213 0.0 0 CFG=1
M  V30 13 C 6.8327 6.2213 0.0 0 CFG=1
M  V30 14 O 6.0627 7.5549 0.0 0
M  V30 15 C 3.8455 6.7480 0.0 0 CFG=1
M  V30 16 C 3.4729 5.2537 0.0 0 CFG=1
M  V30 17 O 2.5395 7.5640 0.0 0
M  V30 18 O 1.9367 5.1462 0.0 0
M  V30 19 C 1.3598 6.5741 0.0 0
M  V30 20 C 10.8336 5.4513 0.0 0 CFG=1
M  V30 21 C 12.1061 6.3188 0.0 0
M  V30 22 C 10.7186 3.9156 0.0 0
M  V30 23 N 13.5776 5.8648 0.0 0
M  V30 24 C 11.8474 2.8681 0.0 0
M  V30 25 C 14.1403 4.4314 0.0 0
M  V30 26 C 13.3703 3.0976 0.0 0
M  V30 27 H 5.0252 4.7047 0.0 0
M  V30 28 H 4.5205 8.1321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 20 2 CFG=3
M  V30 5 2 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 19
M  V30 11 1 10 19
M  V30 12 2 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 27
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 28 CFG=1
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 15 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6E)-2,6,7,8,9-Pentadeoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-8-methyl-2-...
C20H35N3O5
847779-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2766 5.9716 0.0 0 CFG=1
M  V30 2 C 6.6102 6.7416 0.0 0 CFG=1
M  V30 3 O 5.2766 4.4316 0.0 0
M  V30 4 C 7.9439 5.9716 0.0 0
M  V30 5 N 6.6102 8.2816 0.0 0
M  V30 6 N 9.2777 6.7416 0.0 0
M  V30 7 O 7.9439 4.4316 0.0 0
M  V30 8 C 7.9439 9.0516 0.0 0
M  V30 9 C 4.0864 4.0011 0.0 0
M  V30 10 C 3.3164 2.6673 0.0 0
M  V30 11 C 4.0864 1.3337 0.0 0
M  V30 12 C 3.3164 0.0000 0.0 0
M  V30 13 C 5.6265 1.3337 0.0 0
M  V30 14 C 0.8384 8.4090 0.0 0
M  V30 15 C 0.0000 6.5261 0.0 0
M  V30 16 O 11.6542 8.3620 0.0 0
M  V30 17 C 3.9429 6.7416 0.0 0 CFG=1
M  V30 18 C 3.3164 5.3348 0.0 0 CFG=1
M  V30 19 O 2.7984 7.7722 0.0 0
M  V30 20 O 1.7849 5.4957 0.0 0
M  V30 21 C 1.4647 7.0021 0.0 0
M  V30 22 C 10.6113 5.9716 0.0 0 CFG=1
M  V30 23 C 11.8837 6.8391 0.0 0
M  V30 24 C 10.4963 4.4359 0.0 0
M  V30 25 N 13.3553 6.3852 0.0 0
M  V30 26 C 11.6251 3.3883 0.0 0
M  V30 27 C 13.9181 4.9516 0.0 0
M  V30 28 C 13.1480 3.6180 0.0 0
M  V30 29 H 4.8481 7.9875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 22 6 CFG=3
M  V30 10 2 9 10
M  V30 11 1 18 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 21
M  V30 16 1 15 21
M  V30 17 2 16 23
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 29 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 2 17 18 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847779-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847779-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-1835880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 2-Amino Derivatives 50-52. General procedure.
Epoxy amide 49 (20 mg, 0.055 mmol, 1.0 equiv) was suspended in a 30-40%
v/w solution of the selected amine, and MeOH was added to achieve
complete solution. The mixture was stirred at room temperature overnight.
The reaction was followed by TLC (silica gel, AcOEt 70% in hexanes) until
reaction was complete. Then, the crude was dried under high vacuum to
obtain the corresponding amines 50, 51 and 52 practically pure, not
requiring further purification, and in almost quantitative yields
(95-97%). [51]: R f = 0.23 (silica gel, 4% MeOH in AcOEt); [α]25 D =+18.5
(c 1.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.94 (d, J= 2.7 Hz, 3H),
0.96 (d, J= 2.7 Hz, 3H), 1.40 (s, 6H), 1.41-1.50 (m, 2H), 1.73-1.88 (m,
2H), 1.94- 2.09 (m, 1H), 2.22-2.32 (m, 1H), 2.45-2.55 (m, 3H), 3.20- 3.31
(m, 2H), 3.77-3.85 (m, 2H), 4.37-4.39 (m, 1H), 4.56 (dd, J= 5.9, 10.2 Hz,
1H), 5.31 (dd, J= 8.1, 15.6 Hz, 1H), 5.81 (dd, J= 6.5, 15.6 Hz, 1H); 1H
NMR (400 MHz, DMSO-d 6): δ = 8.11 (bd, J= 6.5 Hz, 1H), 7.84 (bt,J= 6.5
Hz, 1H), 5.71 (dd, J= 6.5, 15.6 Hz, 1H), 5.31 (dd, J= 8.1, 15.6 Hz, 1H),
4.41 (m, 1H), 4.28 (dd, J= 8.1 Hz, 1H), 3.78 (dd, J= 8.1, 10.7 Hz, 1H),
3.44-3.36 (m, 1H), 3.24-3.13 (m, 1H), 3.12-3.00 (m, 2H), 2.34-2.23 (m,
1H), 2.23 (s, 3H), 1.91-1.56 (m, 4H), 1.41-1.12 (m, 2H), 1.30 (s, 6H),
0.95 (d, J= 7.0 Hz, 3H), 0.94 (d,J= 7.0 Hz, 3H); 13C NMR (100 MHz,
CDCl3): δ = 175.1, 144.8, 122.8, 109.4, 80.1, 78.5, 68.0, 66.3, 52.4,
41.9, 34.3, 31.1, 30.8, 28.7, 27.9, 27.4, 26.6, 22.1, 21.9; 13C NMR (100
MHz, DMSO-d 6): δ = 174.1, 141.9, 124.5, 107.8, 79.8, 77.6, 72.3, 67.9,
40.5, 34.5, 30.9, 30.1, 28.8, 27.6, 27.2, 26.6, 23.1, 22.0, 21.9; FAB
HRMS (NBA) m/e 398.2675, M+H+ calcd for C20H35N3O5 398.2655.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Bengamide E and Analogues by Modification at C-2 and
at Terminal Olefinic Positions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sarabia, Francisco; Sanchez-Ruiz, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(23), 9514-9520

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-phenylthiourea
C8H10N2S
2724-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 3.0800 0.0 0
M  V30 4 S 5.3347 0.7700 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2724-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-15550182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antiplatelet activity of antithrombotic thiourea compounds:
biological and structure-activity relationship studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lourenco, Andre Luiz; Saito, Max Seidy; Dorneles, Luis Eduardo Gomes;
Viana, Gil Mendes; Sathler, Plinio Cunha; Aguiar, Lucia Cruz de Sequeira;
de Padula, Marcelo; Domingos, Thaisa Francielle Souza; Fraga, Aline
Guerra Manssour; Rodrigues, Carlos Rangel; Pereira de Sousa, Valeria;
Castro, Helena Carla; Cabral, Lucio Mendes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2015), 20(4), 7174-7200

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-445021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-oxo-3-(1-oxo-1H-isoquinolin-2-ylacetylamino)-pentanoic
acid ester and amide derivatives as caspase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charrier, Jean-Damien; Mortimore, Michael; Studley, John R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004058718 A1 2004-07-15

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7118880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Chloro-N-methyl-benzamide To a 0°C solution of the 4-chlorobenzoyl
chloride (4.50 g) in dichloromethane (10 mL) was added an 8M solution of
methylamine in ethanol dropwise. The solution was stirred for 16 h and
then evaporated to dryness. The residue was diluted with saturated sodium
bicarbonate solution (10 mL) and extracted three times with ethyl acetate
(3×20 mL), the organics washed with brine (10 mL), dried (MgSO4) and
concentrated in vacuo. The sub-title compound as a white solid (4.33 g;
97%). 1H NMR (400 MHz, CDCl3) δ 3.00 (3H, s), 7.40 (1H, br) 7.40 (1H, d),
7.70 (1H, d) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinolinone and quinazolinone peptide derivatives as
caspase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Knegtel, Ronald; Mortimore, Michael; Studley, John; Millan, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004002961 A1 2004-01-08

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzenesulfonyl chloride
C7H4ClNO2S
49584-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyano-N-methylbenzenesulfonamide
C8H8N2O2S
56236-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 C 8.4700 1.5400 0.0 0
M  V30 7 N 10.0100 1.5400 0.0 0
M  V30 8 C 3.8500 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 6.1600 0.2064 0.0 0
M  V30 12 C 6.1600 2.8736 0.0 0
M  V30 13 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49584-26-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56236-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15927595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoindoline inhibitors of RORγ
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Claremon, David A.; Dillard, Lawrence Wayne; Dong, Chengguo; Fan, Yi;
Jia, Lanqi; Lotesta, Stephen D.; Marcus, Andrew; Singh, Suresh B.; Tice,
Colin M.; Yuan, Jing; Zhao, Wei; Zheng, Yajun; Zhuang, Linghang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160122318 A1 2016-05-05

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1,3-benzenedimethanol
C8H9ClO2
1000342-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 Cl 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N1,N3-dimethyl-1,3-benzenedimethanamine
C10H15ClN2
2757338-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 N 9.3360 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 N 1.3337 3.8501 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 Cl 5.3348 0.0000 0.0 0
M  V30 8 C 6.6685 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000342-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757338-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25872943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1239695-08-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, conversion = 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Synthesis of Bisdimethylamine Derivatives from Diols and an
Aqueous Solution of Dimethylamine through Iridium-Catalyzed Borrowing
Hydrogen Pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeong, Jaeyoung; Fujita, Ken-ichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2022), 14(3), e202101499

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
4-Methoxybenzoic acid
C8H8O3
100-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzamide
C9H11NO2
3400-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20517630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Bond Directed ortho-Selective C-H Borylation of Secondary
Aromatic Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bai, Shao-Tao; Bheeter, Charles B.; Reek, Joost N. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(37), 13039-13043

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrole-2-carboxaldehyde
C5H5NO
1003-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 N 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1H-Pyrrol-2-ylmethylene)methanamine
C6H8N2
15191-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1003-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15191-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42032200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anionic N-Heterocyclic Carbenes from Mesoionic Imidazolium-4-pyrrolides:
The Influence of Substituents, Solvents, and Charge on their 77Se NMR
Chemical Shifts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pruschinski, Lucas; Namyslo, Jan C.; Schmidt, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(20), 15003-15019

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrole-2-carboxaldehyde
C5H5NO
1003-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 N 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1H-Pyrrol-2-ylmethylene)methanamine
C6H8N2
15191-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1003-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15191-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2104330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Water as an ideal solvent for the synthesis of easily hydrolyzable
compounds: High-yield preparation of 2-pyrrolecarbaldimines and their
CVD/ALD-relevant Cu(II) derivatives in H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grushin, Vladimir V.; Marshall, William J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2004), 346(12), 1457-1460

$RFMT $RIREG SCHEME129 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-Sulfonylbis[1-(4-chlorophenyl)ethanone]
C16H12Cl2O4S
58881-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 S 8.4700 2.6674 0.0 0 VAL=6
M  V30 5 C 10.0100 2.6674 0.0 0
M  V30 6 O 8.4700 4.2074 0.0 0
M  V30 7 O 8.4700 1.1274 0.0 0
M  V30 8 C 10.7800 1.3338 0.0 0
M  V30 9 O 10.0100 0.0000 0.0 0
M  V30 10 Cl 0.0000 4.0011 0.0 0
M  V30 11 Cl 16.9400 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 3.8500 5.3349 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 17 C 1.5400 4.0011 0.0 0
M  V30 18 C 12.3200 1.3338 0.0 0
M  V30 19 C 13.0900 0.0000 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 14.6300 0.0000 0.0 0
M  V30 22 C 14.6300 2.6674 0.0 0
M  V30 23 C 15.4000 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 8 9
M  V30 10 1 8 18
M  V30 11 1 10 17
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C31H25Cl2NO4S
2200244-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 4.6200 0.0 0
M  V30 2 O 8.0020 3.0800 0.0 0
M  V30 3 O 8.1849 6.6627 0.0 0
M  V30 4 O 7.1950 8.3771 0.0 0
M  V30 5 C 2.6673 4.6200 0.0 0
M  V30 6 C 5.3347 9.2400 0.0 0
M  V30 7 O 4.0009 10.0100 0.0 0
M  V30 8 Cl 13.3367 7.7000 0.0 0
M  V30 9 Cl 10.6694 12.3200 0.0 0
M  V30 10 C 6.6684 5.3900 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 S 6.6684 6.9300 0.0 0 VAL=6
M  V30 13 N 4.0009 5.3900 0.0 0
M  V30 14 C 5.3347 7.7000 0.0 0
M  V30 15 C 4.0009 6.9300 0.0 0
M  V30 16 C 5.3347 3.0800 0.0 0
M  V30 17 C 6.6684 2.3100 0.0 0
M  V30 18 C 4.0009 2.3100 0.0 0
M  V30 19 C 6.6684 0.7700 0.0 0
M  V30 20 C 4.0009 0.7700 0.0 0
M  V30 21 C 5.3347 0.0000 0.0 0
M  V30 22 C 9.3358 5.3900 0.0 0
M  V30 23 C 10.6694 4.6200 0.0 0
M  V30 24 C 9.3358 6.9300 0.0 0
M  V30 25 C 12.0031 5.3900 0.0 0
M  V30 26 C 10.6694 7.7000 0.0 0
M  V30 27 C 12.0031 6.9300 0.0 0
M  V30 28 C 2.6673 7.7000 0.0 0
M  V30 29 C 1.3336 6.9300 0.0 0
M  V30 30 C 2.6673 9.2400 0.0 0
M  V30 31 C 0.0000 7.7000 0.0 0
M  V30 32 C 1.3336 10.0100 0.0 0
M  V30 33 C 0.0000 9.2400 0.0 0
M  V30 34 C 6.6684 10.0100 0.0 0
M  V30 35 C 8.0020 9.2400 0.0 0
M  V30 36 C 6.6684 11.5500 0.0 0
M  V30 37 C 9.3358 10.0100 0.0 0
M  V30 38 C 8.0020 12.3200 0.0 0
M  V30 39 C 9.3358 11.5500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 22
M  V30 4 2 3 12
M  V30 5 2 4 12
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 1 6 14
M  V30 9 1 6 34
M  V30 10 1 8 27
M  V30 11 1 9 39
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 11 16
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 15 28
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 58881-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2200244-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-18498307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, PASS prediction and docking studies of anti-inflammatory
activity of novel series of 2,6-bis(p-chlorobenzoyl)
3,5-diphenyl-4-methylthiamorpholine 1,1-dioxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhavani, P.; Sasikala, R. P.; Meena, K. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences Review and Research
(2016), 41(1), 188-193

$RFMT $RIREG SCHEME130 STEP1
$RXN



  3  1
$MOL
L-Alanine methyl ester
C4H9NO2
10065-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0 CFG=1
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 N 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3R)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3-diphenylcyclopropanecarbo...
C21H23NO4
214492-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 O 7.2557 7.9970 0.0 0
M  V30 11 O 4.6289 8.4603 0.0 0
M  V30 12 C 5.5412 5.9537 0.0 0 CFG=1
M  V30 13 C 4.7712 4.6201 0.0 0 CFG=1
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=1
M  V30 15 C 4.7712 3.0800 0.0 0
M  V30 16 C 3.4375 2.3100 0.0 0
M  V30 17 C 6.1048 2.3100 0.0 0
M  V30 18 C 3.4375 0.7700 0.0 0
M  V30 19 C 6.1048 0.7700 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 2.6675 6.7237 0.0 0
M  V30 22 C 2.6675 8.2638 0.0 0
M  V30 23 C 1.3337 5.9537 0.0 0
M  V30 24 C 1.3337 9.0338 0.0 0
M  V30 25 C 0.0000 6.7237 0.0 0
M  V30 26 C 0.0000 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 12 9 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=1
M  V30 16 1 14 21 CFG=3
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(2R,3R)-1-[[[(1S)-1-methyl-2-(methylamino)-2-oxoethyl]amino]c...
C25H31N3O4
876727-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0463 4.9863 0.0 0
M  V30 2 C 7.0564 3.8066 0.0 0
M  V30 3 O 7.5831 2.3595 0.0 0
M  V30 4 O 5.5398 4.0740 0.0 0
M  V30 5 C 6.5932 1.1797 0.0 0
M  V30 6 C 7.7730 0.1899 0.0 0
M  V30 7 C 5.6034 0.0000 0.0 0
M  V30 8 C 5.4135 2.1696 0.0 0
M  V30 9 C 6.0030 6.1661 0.0 0
M  V30 10 N 5.0131 7.3458 0.0 0
M  V30 11 O 5.4763 4.7189 0.0 0
M  V30 12 C 3.4965 7.0784 0.0 0 CFG=1
M  V30 13 C 2.5065 8.2581 0.0 0
M  V30 14 C 2.9698 5.6313 0.0 0
M  V30 15 N 0.9899 7.9907 0.0 0
M  V30 16 O 3.0332 9.7052 0.0 0
M  V30 17 C 0.0000 9.1704 0.0 0
M  V30 18 C 7.5196 6.4335 0.0 0 CFG=2
M  V30 19 C 8.8533 7.2035 0.0 0 CFG=1
M  V30 20 C 7.5196 7.9735 0.0 0 CFG=1
M  V30 21 C 10.3933 7.2035 0.0 0
M  V30 22 C 11.1633 5.8698 0.0 0
M  V30 23 C 11.1633 8.5371 0.0 0
M  V30 24 C 12.7034 5.8698 0.0 0
M  V30 25 C 12.7034 8.5371 0.0 0
M  V30 26 C 13.4734 7.2035 0.0 0
M  V30 27 C 6.7496 9.3071 0.0 0
M  V30 28 C 7.5196 10.6410 0.0 0
M  V30 29 C 5.2096 9.3071 0.0 0
M  V30 30 C 6.7496 11.9746 0.0 0
M  V30 31 C 4.4396 10.6410 0.0 0
M  V30 32 C 5.2096 11.9746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 18 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14 CFG=1
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 21 1 19 21 CFG=3
M  V30 22 1 20 27 CFG=1
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10065-72-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 214492-28-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876727-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10283010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM Boc removed by mild acidolysis, EDCI/HOAt or HATU/HOAt in DCM used, no
exptl. detail, reactant assumed, stepwise peptide solution synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preferred 3D-structure of peptides rich in a severely conformationally
restricted cyclopropane analog of phenylalanine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crisma, Marco; De Borggraeve, Wim M.; Peggion, Cristina; Formaggio,
Fernando; Royo, Soledad; Jimenez, Ana I.; Cativiela, Carlos; Toniolo,
Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2005), 12(1), 251-260

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzaldehyde
C7H6O2
100-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]phenol
C8H11NO
123926-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 123926-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1712658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual serotonin transporter inhibitor/histamine H3 antagonists:
Development of rigidified H3 pharmacophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, John M.; Barbier, Ann J.; Wilson, Sandy J.; Miller, Kirstin;
Boggs, Jamin D.; Fraser, Ian C.; Mazur, Curt; Lovenberg, Timothy W.;
Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(19), 5325-5329

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzaldehyde
C7H6O2
100-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]phenol
C8H11NO
123926-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 123926-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23350028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Laccase-catalyzed 1,4-dioxane-mediated synthesis of belladine N-oxides
with anti-influenza A virus activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zippilli, Claudio; Botta, Lorenzo; Bizzarri, Bruno Mattia; Nencioni,
Lucia; De Angelis, Marta; Protto, Virginia; Giorgi, Gianluca; Baratto,
Maria Camilla; Pogni, Rebecca; Saladino, Raffaele
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2021), 22(3), 1337

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Diphenyl-1H-pyrazolo[3,4-c]pyridazine-3-sulfonyl chloride
C17H11ClN4O2S
1022990-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.4645 3.4494 0.0 0 VAL=6
M  V30 2 Cl 0.9887 1.9849 0.0 0
M  V30 3 O 2.9292 2.9736 0.0 0
M  V30 4 O 0.0000 3.9253 0.0 0
M  V30 5 C 4.7387 4.6200 0.0 0
M  V30 6 C 3.4051 5.3900 0.0 0
M  V30 7 C 6.0725 5.3900 0.0 0
M  V30 8 C 3.4051 6.9300 0.0 0
M  V30 9 C 1.9404 4.9141 0.0 0
M  V30 10 N 6.0725 6.9300 0.0 0
M  V30 11 N 4.7387 7.7000 0.0 0
M  V30 12 N 1.9404 7.4059 0.0 0
M  V30 13 N 1.0353 6.1600 0.0 0
M  V30 14 C 4.7387 3.0800 0.0 0
M  V30 15 C 6.0725 2.3100 0.0 0
M  V30 16 C 3.4051 2.3100 0.0 0
M  V30 17 C 6.0725 0.7700 0.0 0
M  V30 18 C 3.4051 0.7700 0.0 0
M  V30 19 C 4.7387 0.0000 0.0 0
M  V30 20 C 7.4062 4.6200 0.0 0
M  V30 21 C 8.7398 5.3900 0.0 0
M  V30 22 C 7.4062 3.0800 0.0 0
M  V30 23 C 10.0734 4.6200 0.0 0
M  V30 24 C 8.7398 2.3100 0.0 0
M  V30 25 C 10.0734 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 20
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 1 10 11
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4,5-diphenyl-1H-pyrazolo[3,4-c]pyridazine-3-sulfonamide
C18H15N5O2S
1022990-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0408 3.1885 0.0 0 VAL=6
M  V30 2 N 9.1854 4.2189 0.0 0
M  V30 3 O 9.0714 2.0439 0.0 0
M  V30 4 O 7.0104 4.3329 0.0 0
M  V30 5 C 10.6499 3.7431 0.0 0
M  V30 6 C 4.6201 3.8119 0.0 0
M  V30 7 C 5.3901 2.4781 0.0 0
M  V30 8 C 3.0801 3.8119 0.0 0
M  V30 9 C 4.6201 1.1444 0.0 0
M  V30 10 C 6.8964 2.1579 0.0 0
M  V30 11 N 2.3101 2.4781 0.0 0
M  V30 12 N 5.6505 0.0000 0.0 0
M  V30 13 N 3.0801 1.1444 0.0 0
M  V30 14 N 7.0574 0.6263 0.0 0
M  V30 15 C 5.3901 5.1456 0.0 0
M  V30 16 C 4.6201 6.4792 0.0 0
M  V30 17 C 6.9302 5.1456 0.0 0
M  V30 18 C 5.3901 7.8129 0.0 0
M  V30 19 C 7.7002 6.4792 0.0 0
M  V30 20 C 6.9302 7.8129 0.0 0
M  V30 21 C 2.3101 5.1456 0.0 0
M  V30 22 C 0.7700 5.1456 0.0 0
M  V30 23 C 3.0801 6.4792 0.0 0
M  V30 24 C 0.0000 6.4792 0.0 0
M  V30 25 C 2.3101 7.8129 0.0 0
M  V30 26 C 0.7700 7.8129 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 21
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1022990-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022990-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13901162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Substituted sulfamoyl-4,5-diphenyl-1H-pyrazolo[3,4-c]pyridazines 4c-o
General Procedure To a solution of sulfonylchloride derivative 3 (1.0 g,
2.69 mmoles) in benzene (20 mL), substituted amines (3.0 mmoles) was
added. The reaction mixture was heated under reflux for 3 h. The solvent
was concentrated. The solid product was collected and recrystallized from
ethanol. 4c (R = Me): yield 96.9%. Mp 240-241°C; 3250, 3141 (NH groups),
IR: 3055 (CHarom ), 2967 (CHaliph ), 1653 (C=N), 1302, 1163 (SO2); MS m/z
(%): 365 (M+, 1.5), 271 (M+ - SO2NHCH3, 69). Anal. Calcd. for
Ci8H15N5O2S: C, 59.16; H, 4.14; N, 19.17. Found: C, 58.90; H, 4.00; N,
18.90.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridazine derivatives and related compounds. Part 24. Synthesis and
antimicrobial activity of some sulfamoylpyrazolo[3,4-c]pyridazine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hosny, Mona; El-Mariah, Fatma; Deeb, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2007), 182(7),
1475-1482

$RFMT $RIREG SCHEME133 STEP1
$RXN



  3  1
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isocyanate
C7H5NO
103-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-3-methyl-1-phenyl-2,4,5(3H)-pyrimidinetrione
C11H10N2O3
1872193-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3349 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 N 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 6.9300 1.3338 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 8.4700 1.3338 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 103-71-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1872193-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10984590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound (irradiation (100 W))
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-assisted efficient synthesis of new dihydropyrimidinone and
tetrahydro-2-thioxopyrimidinone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mehrabi, Hossein; Alizadeh-bami, Farzaneh; Zadeh, Ashrafosadat Beheshti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2015), 39(6), 360-362

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,3-dimethyl-4-nitropyridine
C7H7BrN2O2
1038989-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 Br 1.3338 4.6201 0.0 0
M  V30 6 C 6.6686 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 N 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,2,3-trimethyl-4-pyridinamine
C8H11BrN2
1038989-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 Br 5.3348 4.6201 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 1.5400 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 N 1.3338 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1038989-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1038989-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-196-CAS-9240680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of two potential heterocyclic amine food mutagens
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanga, Mary J.; Kozocas, Joseph A.; Tochimoto, Todd K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2008), 45(3), 661-665

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(1-bromoethyl)-3-nitro-, methyl ester
C10H10BrNO4
1039151-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 Br 1.3337 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 6.6684 4.6201 0.0 0
M  V30 8 O 8.0022 3.8500 0.0 0
M  V30 9 O 6.6684 6.1601 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[1-(methylamino)ethyl]-3-nitro-, methyl ester
C11H14N2O4
2259311-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 N 1.5400 5.3349 0.0 0
M  V30 3 C 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 6 O 2.3100 1.3338 0.0 0
M  V30 7 O 4.6200 0.0000 0.0 0
M  V30 8 C 8.4700 4.0011 0.0 0
M  V30 9 O 9.2400 5.3349 0.0 0
M  V30 10 O 9.2400 2.6674 0.0 0
M  V30 11 C 10.7800 5.3349 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1039151-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2259311-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33439197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of potent small molecule cyclic urea activators of STING
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Basu, Sourav; Middya, Sandip; Banerjee, Monali; Ghosh, Rajib; Pryde,
David C.; Yadav, Dharmendra B.; Shrivastava, Ritesh; Surya, Arjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 229114087

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(1-bromoethyl)-3-nitro-, methyl ester
C10H10BrNO4
1039151-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 Br 1.3337 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 6.6684 4.6201 0.0 0
M  V30 8 O 8.0022 3.8500 0.0 0
M  V30 9 O 6.6684 6.1601 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[1-(methylamino)ethyl]-3-nitro-, methyl ester
C11H14N2O4
2259311-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 N 1.5400 5.3349 0.0 0
M  V30 3 C 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 6 O 2.3100 1.3338 0.0 0
M  V30 7 O 4.6200 0.0000 0.0 0
M  V30 8 C 8.4700 4.0011 0.0 0
M  V30 9 O 9.2400 5.3349 0.0 0
M  V30 10 O 9.2400 2.6674 0.0 0
M  V30 11 C 10.7800 5.3349 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1039151-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2259311-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23691770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused (hetero)arylpyrimidine carboxamide compounds as
modulators of human STING and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banerjee, Monali; Middya, Sandip; Basu, Sourav; Ghosh, Rajib; Pryde,
David; Yadav, Dharmendra; Shrivastava, Ritesh; Surya, Arjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018234808 A1 2018-12-27

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
(4-Methoxyphenyl)acetic acid
C9H10O3
104-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 1.3337 0.7700 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 O 8.0023 0.0000 0.0 0
M  V30 6 C 9.3360 0.7700 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzeneacetamide
C10H13NO2
59907-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59907-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12991460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
(4-Nitrophenyl)acetic acid
C8H7NO4
104-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzeneacetamide
C9H10N2O3
98245-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 N 9.3359 4.6201 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-03-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98245-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15133681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthaleneethanol, 6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-1-(1-methylethyl)...
C22H27FO4S
104265-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 0.7700 0.0 0
M  V30 2 C 6.6684 0.0000 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 8.1851 3.3475 0.0 0
M  V30 5 C 8.7118 4.7946 0.0 0
M  V30 6 O 10.2284 5.0620 0.0 0
M  V30 7 S 10.7551 6.5091 0.0 0 VAL=6
M  V30 8 O 11.2817 7.9563 0.0 0
M  V30 9 O 9.3079 7.0358 0.0 0
M  V30 10 O 7.1952 1.6329 0.0 0
M  V30 11 F 0.0000 5.3900 0.0 0
M  V30 12 C 16.5436 4.4022 0.0 0
M  V30 13 C 4.0011 3.0800 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 18 C 5.3347 5.3900 0.0 0
M  V30 19 C 2.6674 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 C 6.6684 4.6200 0.0 0
M  V30 22 C 1.3336 4.6200 0.0 0
M  V30 23 C 12.2022 5.9824 0.0 0
M  V30 24 C 13.3818 6.9724 0.0 0
M  V30 25 C 12.4695 4.4658 0.0 0
M  V30 26 C 14.8290 6.4455 0.0 0
M  V30 27 C 13.9167 3.9390 0.0 0
M  V30 28 C 15.0965 4.9289 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 4 5
M  V30 5 1 17 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 17 10 CFG=1
M  V30 12 1 11 22
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2S)-6-Fluoro-1,2,3,4-tetrahydro-2-[2-(methylamino)ethyl]-1-(1-methylethyl...
C16H24FNO
193464-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 C 8.1851 3.3474 0.0 0
M  V30 5 C 8.7119 4.7946 0.0 0
M  V30 6 N 10.2285 5.0619 0.0 0
M  V30 7 C 10.7552 6.5091 0.0 0
M  V30 8 O 7.1953 1.6329 0.0 0
M  V30 9 F 0.0000 5.3901 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0 CFG=2
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 6.6685 3.0800 0.0 0 CFG=1
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 2.6675 5.3901 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 4 5
M  V30 5 1 14 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 14 8 CFG=1
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104265-58-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 193464-87-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20428771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carbamate analogs of Mibefradil as calcium channel
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richardson, Thomas E.; Higgin, Michelle; MacDonald, Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018152317 A1 2018-08-23

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Ribofuranuronic acid, 1,2-O-(1-methylethylidene)-, methyl ester, 3-acetate
C11H16O7
1076189-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6687 2.3100 0.0 0
M  V30 2 C 3.3349 1.5400 0.0 0
M  V30 3 C 3.3349 0.0000 0.0 0
M  V30 4 O 2.0012 2.3100 0.0 0
M  V30 5 C 7.3791 4.2792 0.0 0
M  V30 6 O 8.5236 5.3096 0.0 0
M  V30 7 O 7.6992 2.7729 0.0 0
M  V30 8 C 9.9881 4.8338 0.0 0
M  V30 9 C 0.0000 5.5934 0.0 0
M  V30 10 C 0.6368 7.5534 0.0 0
M  V30 11 C 4.6687 3.8500 0.0 0 CFG=2
M  V30 12 C 3.4226 4.7551 0.0 0 CFG=1
M  V30 13 C 5.9145 4.7551 0.0 0 CFG=1
M  V30 14 C 3.8987 6.2198 0.0 0 CFG=1
M  V30 15 O 1.8826 4.7551 0.0 0
M  V30 16 O 5.4387 6.2198 0.0 0
M  V30 17 O 2.6526 7.1250 0.0 0
M  V30 18 C 1.4068 6.2198 0.0 0
M  V30 19 H 2.9468 3.2905 0.0 0
M  V30 20 H 4.3745 7.6843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 13 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 9 18
M  V30 10 1 10 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 19 CFG=3
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 20 CFG=3
M  V30 20 1 15 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,2-O-(1-methylethylidene)-α-D-ribofuranuronamide
C9H15NO5
1076189-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.4547 0.0000 0.0 0
M  V30 2 C 7.4240 2.7104 0.0 0
M  V30 3 N 8.1940 4.0442 0.0 0
M  V30 4 O 8.1940 1.3768 0.0 0
M  V30 5 C 9.7340 4.0442 0.0 0
M  V30 6 C 0.0000 1.6800 0.0 0
M  V30 7 C 0.0000 3.7410 0.0 0
M  V30 8 C 3.5143 3.4804 0.0 0 CFG=1
M  V30 9 C 3.5143 1.9404 0.0 0 CFG=2
M  V30 10 O 4.9788 3.9564 0.0 0
M  V30 11 O 2.0496 3.9564 0.0 0
M  V30 12 C 4.9788 1.4645 0.0 0 CFG=2
M  V30 13 O 2.0496 1.4645 0.0 0
M  V30 14 C 5.8840 2.7104 0.0 0 CFG=2
M  V30 15 C 1.1444 2.7104 0.0 0
M  V30 16 H 3.5143 5.0204 0.0 0
M  V30 17 H 3.5143 0.4004 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 14 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 16 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 17 CFG=3
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1076189-26-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1076189-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-4765094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl-D-ribopyranuronamide nucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Shiqiong; Busson, Roger; Herdewijn, Piet
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2008), 64(43), 10062-10067

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[[(1,1-dimethylethoxy)carbonyl]amino](methylthio)methyle...
C12H22N2O4S
107819-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7236 4.0011 0.0 0
M  V30 2 C 5.9536 2.6674 0.0 0
M  V30 3 C 8.2636 4.0011 0.0 0
M  V30 4 N 4.4136 2.6674 0.0 0
M  V30 5 S 6.7236 1.3338 0.0 0
M  V30 6 O 9.0336 5.3349 0.0 0
M  V30 7 O 9.0336 2.6674 0.0 0
M  V30 8 C 3.6436 4.0011 0.0 0
M  V30 9 C 5.9536 0.0000 0.0 0
M  V30 10 C 10.5736 5.3349 0.0 0
M  V30 11 O 2.1036 4.0011 0.0 0
M  V30 12 O 4.4136 5.3349 0.0 0
M  V30 13 C 10.5736 3.7949 0.0 0
M  V30 14 C 12.1136 5.3349 0.0 0
M  V30 15 C 10.5736 6.8749 0.0 0
M  V30 16 C 1.3336 5.3349 0.0 0
M  V30 17 C 2.6673 6.1049 0.0 0
M  V30 18 C 0.5636 6.6685 0.0 0
M  V30 19 C 0.0000 4.5649 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
C,C′-Bis(1,1-dimethylethyl) N,N′-(methylcarbonimidoyl)bis[carbamate]
C12H23N3O4
1337971-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7236 4.0011 0.0 0
M  V30 2 C 5.9536 2.6674 0.0 0
M  V30 3 C 8.2636 4.0011 0.0 0
M  V30 4 N 4.4136 2.6674 0.0 0
M  V30 5 N 6.7236 1.3338 0.0 0
M  V30 6 O 9.0336 5.3349 0.0 0
M  V30 7 O 9.0336 2.6674 0.0 0
M  V30 8 C 3.6436 4.0011 0.0 0
M  V30 9 C 5.9536 0.0000 0.0 0
M  V30 10 C 10.5736 5.3349 0.0 0
M  V30 11 O 2.1036 4.0011 0.0 0
M  V30 12 O 4.4136 5.3349 0.0 0
M  V30 13 C 10.5736 3.7949 0.0 0
M  V30 14 C 12.1136 5.3349 0.0 0
M  V30 15 C 10.5736 6.8749 0.0 0
M  V30 16 C 1.3336 5.3349 0.0 0
M  V30 17 C 2.6673 6.1049 0.0 0
M  V30 18 C 0.5636 6.6685 0.0 0
M  V30 19 C 0.0000 4.5649 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107819-90-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1337971-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40724630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis
Phosphopantetheinyl Transferase PptT by Amidinoureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ottavi, Samantha; Scarry, Sarah M.; Mosior, John; Ling, Yan; Roberts,
Julia; Singh, Amrita; Zhang, David; Goullieux, Laurent; Roubert,
Christine; Bacque, Eric; Lagiakos, H. Rachel; Vendome, Jeremie; Moraca,
Francesca; Li, Kelin; Perkowski, Andrew J.; Ramesh, Remya; Bowler,
Matthew M.; Tracy, William; Feher, Victoria A.; Sacchettini, James C.;
Gold, Ben S.; Nathan, Carl F.; Aube, Jeffrey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(3), 1996-2022

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-butyl-1H-indole-2-carboxylate
C15H19NO2
108797-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0431 5.7308 0.0 0
M  V30 2 C 2.5367 5.4106 0.0 0
M  V30 3 C 1.5063 6.5552 0.0 0
M  V30 4 C 0.0000 6.2350 0.0 0
M  V30 5 C 7.3751 6.0810 0.0 0
M  V30 6 O 8.9151 6.0810 0.0 0
M  V30 7 O 6.6051 7.4148 0.0 0
M  V30 8 C 9.6851 7.4148 0.0 0
M  V30 9 C 11.2251 7.4148 0.0 0
M  V30 10 C 4.7534 3.0800 0.0 0
M  V30 11 N 5.0735 4.5864 0.0 0
M  V30 12 C 6.0870 2.3100 0.0 0
M  V30 13 C 3.4197 2.3100 0.0 0
M  V30 14 C 6.6051 4.7474 0.0 0
M  V30 15 C 7.2315 3.3406 0.0 0
M  V30 16 C 6.0870 0.7700 0.0 0
M  V30 17 C 3.4197 0.7700 0.0 0
M  V30 18 C 4.7534 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butyl-N-methyl-1H-indole-2-carboxamide
C14H18N2O
2242452-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6420 5.7308 0.0 0
M  V30 2 C 7.1484 5.4107 0.0 0
M  V30 3 C 8.1789 6.5552 0.0 0
M  V30 4 C 9.6851 6.2350 0.0 0
M  V30 5 C 2.3100 6.0810 0.0 0
M  V30 6 N 0.7700 6.0810 0.0 0
M  V30 7 O 3.0800 7.4149 0.0 0
M  V30 8 C 0.0000 7.4149 0.0 0
M  V30 9 N 4.6116 4.5865 0.0 0
M  V30 10 C 4.9317 3.0800 0.0 0
M  V30 11 C 3.0800 4.7474 0.0 0
M  V30 12 C 3.5981 2.3100 0.0 0
M  V30 13 C 6.2654 2.3100 0.0 0
M  V30 14 C 2.4535 3.3406 0.0 0
M  V30 15 C 3.5981 0.7700 0.0 0
M  V30 16 C 6.2654 0.7700 0.0 0
M  V30 17 C 4.9317 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108797-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242452-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19045898
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-metal-free [3 + 3] annulation of indol-2-ylmethyl carbanions
to nitroarenes. A novel synthesis of indolo[3,2-b]quinolines
(quindolines)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowacki, Michal; Wojciechowski, Krzysztof
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14194-202

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloropyridine
C5H4ClN
109-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)pyridine
C6H8N2
4597-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-09-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4597-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14673061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12131-44-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1219080-77-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: In an inert atmosphere glovebox,
[Pd(cinnamyl)Cl]2 (0.67 mg, 0.0013 mmol, from a toluene stock solution)
and L2 (2.2 mg, 0.0052 mmol) were mixed in a total of 2.000 mL toluene
for 10 minutes. From this stock solution, 383 μL was added to a vial
containing NaOtBu (135 mg, 1.4 mmol), followed by 600 μL of additional
toluene. The vial was sealed with a cap containing a PTFE septum and
removed from the glovebox. Chlorobenzene (103 μL, 1.0 mmol) and
octylamine (200 μL, 1.2 mmol) were added by use of a microlitre syringe.
The reaction mixture was heated at 110 °C and periodically monitored by
use of TLC or gas chromatography. Upon completion of the reaction, the
product was purified by column chromatography on silica (20:1 Hex:EtOAc)
and isolated as a colorless oil (0.203 g, 99% yield). Alternatively,
samples of [Pd(cinnamyl)Cl]2, ligand, and NaOtBu stored under N 2 could
be weighed out on the benchtop into a vial. Following addition of
chlorobenzene, octylamine and anhydrous toluene, the vial was sealed with
a cap containing a PTFE septum, purged with N2 and heated at 110 °C, with
results similar to those obtained from reactions setup in a glovebox (99%
conversion on the basis of GC data at 0.1 mol% Pd). Compound 3-35, Yield
(%): 97(1), CON 3 - 48 hours, 65 °C.
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig cross-coupling, alternative catalyst and ligand may also
be used ([Pd(allyl)Cl]2 and
di-tert-butyl(2-dimethylaminophenyl)phosphine), alternative preparation
shown, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amines, hydrazones, hydrazines, and indazoles by
hydroamination or cross-coupling reactions catalyzed by palladium or gold
in the presence of a phosphine ligand
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lundgren, Rylan J.; Stradiotto, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012068335 A2 2012-05-24

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloropyridine
C5H4ClN
109-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)pyridine
C6H8N2
4597-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-09-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4597-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9686541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1219080-77-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative cinnamyl palladium catalyst gave similar yield, in-situ
generated catalyst, Buchwald-Hartwig coupling, alternative di-tert-butyl
ligand gave similar yield, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Versatile Catalyst System for the Cross-Coupling of Aryl
Chlorides and Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lundgren, Rylan J.; Sappong-Kumankumah, Antonia; Stradiotto, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(6), 1983-1991,
S1983/1-S1983/198

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(2S)-2-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]benzoyl]amino]-1-o...
C23H27N3O6
1094297-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 8.0020 0.0 0
M  V30 2 N 7.7000 8.0020 0.0 0
M  V30 3 O 10.0100 6.6684 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 5 C 5.3900 6.6684 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 N 4.6200 5.3347 0.0 0
M  V30 8 O 4.6200 8.0020 0.0 0
M  V30 9 N 12.3200 8.0020 0.0 0
M  V30 10 C 13.8600 8.0020 0.0 0
M  V30 11 O 14.6300 6.6684 0.0 0
M  V30 12 O 14.6300 9.3358 0.0 0
M  V30 13 C 16.1700 6.6684 0.0 0
M  V30 14 C 16.1700 5.1284 0.0 0
M  V30 15 C 17.7100 6.6684 0.0 0
M  V30 16 C 16.1700 8.2084 0.0 0
M  V30 17 C 3.0800 2.6673 0.0 0
M  V30 18 O 2.3100 1.3336 0.0 0
M  V30 19 O 4.6200 2.6673 0.0 0
M  V30 20 C 3.0800 0.0000 0.0 0
M  V30 21 C 10.0100 9.3358 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 C 9.2400 10.6694 0.0 0
M  V30 24 C 12.3200 10.6694 0.0 0
M  V30 25 C 10.0100 12.0031 0.0 0
M  V30 26 C 11.5500 12.0031 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 0.7700 4.0011 0.0 0
M  V30 31 C 0.7700 6.6684 0.0 0
M  V30 32 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 27
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 28
M  V30 21 1 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[[(1S)-1-methyl-2-[[2-[(methylamino)carbonyl]phenyl]a...
C23H28N4O5
1094297-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 8.0020 0.0 0
M  V30 2 N 7.7000 8.0020 0.0 0
M  V30 3 O 10.0100 6.6684 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 5 C 5.3900 6.6684 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 N 4.6200 5.3347 0.0 0
M  V30 8 O 4.6200 8.0020 0.0 0
M  V30 9 N 12.3200 8.0020 0.0 0
M  V30 10 C 13.8600 8.0020 0.0 0
M  V30 11 O 14.6300 6.6684 0.0 0
M  V30 12 O 14.6300 9.3358 0.0 0
M  V30 13 C 16.1700 6.6684 0.0 0
M  V30 14 C 16.1700 5.1284 0.0 0
M  V30 15 C 17.7100 6.6684 0.0 0
M  V30 16 C 16.1700 8.2084 0.0 0
M  V30 17 C 3.0800 2.6673 0.0 0
M  V30 18 N 2.3100 1.3336 0.0 0
M  V30 19 O 4.6200 2.6673 0.0 0
M  V30 20 C 3.0800 0.0000 0.0 0
M  V30 21 C 10.0100 9.3358 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 C 9.2400 10.6694 0.0 0
M  V30 24 C 12.3200 10.6694 0.0 0
M  V30 25 C 10.0100 12.0031 0.0 0
M  V30 26 C 11.5500 12.0031 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 0.7700 4.0011 0.0 0
M  V30 31 C 0.7700 6.6684 0.0 0
M  V30 32 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 27
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 28
M  V30 21 1 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1094297-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094297-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1249303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
2-(1-(2-(methylcarbamoyl)phenylamino)-1oxopropan-2-ylcarbamoyl) phenyl
carbamate 4: The ester 10 (0.5 g, 1.1 mmol) was taken in saturated
methanolic methylamine solution (5 mL) and stirred at room temperature
for 6 h. The solvent was removed under reduced pressure, and the product
was purified by column chromatography (50% AcOEt/ pet. Ether, Rf: 0.3)
furnishing 4 as a white solid (0.49 g, 97%). white solid. mp: 185-186 ºC;
[α]24 D: 110° (c = 0.1, CHCl3); IR (CHCl3) ν (cm- 1): 3308, 3018, 1717,
1647, 1637, 1587, 1522, 1508, 1447, 1217, 1159, 1047, 1024; 1H NMR (400
MHz, CDCl3) δ : 11.70 (s, 1H), 10.16 (s, 1H), 8.60-8.58 (d, J = 8.04 Hz,
1H), 8.38-8.36 (d, J = 8.43 Hz, 1H), 7.69-7.67 (d, J = 6.89 Hz, 1H),
7.51-7.43 (m, 3H), 7.12-7.08 (m, 1H), 7.04-6.99 (m, 2H), 6.28 (bs, 1H),
4.84-4.77 (m, 1H), 2.97-2.95 (d, J = 4.78 Hz, 3H), 1.64-1.63 (d, J = 7.13
Hz, 3H), 1.51 (s, 9H); 13C NMR (100 MHz, CDCl3) δ: 170.9, 169.3, 168.6,
153.1, 140.3, 139.0, 132.7, 132.5, 127.2, 126.4, 123.2, 121.4, 121.4,
120.4, 119.7, 119.3, 80.2, 50.7, 28.3, 26.7, 19.0; ESI-MS: 463.5 (M+Na)+;
479.55 (M+K)+; Elemental analysis calculated for C23H28N4O5: C, 62.71; H,
6.41; N, 12.72. Found: 62.84, H, 6.52, N, 12.60.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sequence-specific unusual (1→2)-type helical turns in α/β-hybrid peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prabhakaran, Panchami; Kale, Sangram S.; Puranik, Vedavati G.;
Rajamohanan, P. R.; Chetina, Olga; Howard, Judith. A. K.; Hofmann,
Hans-Jorg; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(52), 17743-17754

$RFMT $RIREG SCHEME144 STEP1
$RXN



  4  1
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-(phenylmethyl)alanine
C25H23NO4
540483-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 3.0800 5.3347 0.0 0
M  V30 5 O 5.3900 6.6685 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 C 0.7700 6.6685 0.0 0
M  V30 9 C 3.0800 8.0021 0.0 0
M  V30 10 O 0.0000 8.0021 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2315 5.4958 0.0 0
M  V30 14 C 7.0735 6.7417 0.0 0
M  V30 15 C 9.5517 7.0021 0.0 0
M  V30 16 C 10.3759 4.4652 0.0 0
M  V30 17 C 8.2181 7.7721 0.0 0
M  V30 18 C 5.6090 7.2175 0.0 0
M  V30 19 C 11.0164 7.4779 0.0 0
M  V30 20 C 11.8406 4.9411 0.0 0
M  V30 21 C 7.8979 9.2785 0.0 0
M  V30 22 C 5.2888 8.7238 0.0 0
M  V30 23 C 12.1608 6.4475 0.0 0
M  V30 24 C 6.4332 9.7544 0.0 0
M  V30 25 C 3.0800 2.6674 0.0 0
M  V30 26 C 2.3100 1.3338 0.0 0
M  V30 27 C 4.6200 2.6674 0.0 0
M  V30 28 C 3.0800 0.0000 0.0 0
M  V30 29 C 5.3900 1.3338 0.0 0
M  V30 30 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxyethylamine
C3H9NO
109-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 N 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H27N3O5
2172815-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 5.3348 0.0 0
M  V30 2 C 6.1601 4.0011 0.0 0
M  V30 3 C 6.1601 6.6684 0.0 0
M  V30 4 C 8.4701 5.3348 0.0 0
M  V30 5 C 4.6201 6.6684 0.0 0
M  V30 6 C 6.9301 8.0022 0.0 0
M  V30 7 C 9.2401 6.6684 0.0 0
M  V30 8 O 9.2401 4.0011 0.0 0
M  V30 9 N 3.8500 8.0022 0.0 0
M  V30 10 O 3.8500 5.3348 0.0 0
M  V30 11 N 10.7801 6.6684 0.0 0
M  V30 12 C 2.3100 8.0022 0.0 0
M  V30 13 C 4.6201 9.3359 0.0 0
M  V30 14 C 11.5501 8.0022 0.0 0
M  V30 15 C 1.5400 9.3359 0.0 0
M  V30 16 C 13.0901 8.0022 0.0 0
M  V30 17 O 0.0000 9.3359 0.0 0
M  V30 18 O 2.3100 10.6695 0.0 0
M  V30 19 O 13.8602 9.3359 0.0 0
M  V30 20 C 15.4002 9.3359 0.0 0
M  V30 21 C 6.9301 2.6673 0.0 0
M  V30 22 C 8.4701 2.6673 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 C 9.2401 1.3337 0.0 0
M  V30 25 C 6.9301 0.0000 0.0 0
M  V30 26 C 8.4701 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 540483-59-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 109-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172815-31-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18429977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to 2-chlorotrityl resin in stage
1,solid phase peptoide synthesis,cleavage step repeated twice,further
bromoacetic acid-amine coupling carried out by DIC in DMF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic peptoids as topological templates: Synthesis via central to
conformational chirality induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Amato, Assunta; Pierri, Giovanni; Costabile, Chiara; Della Sala,
Giorgio; Tedesco, Consiglia; Izzo, Irene; De Riccardis, Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(3), 640-643

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methyl (7R)-14-cyclohexyl-7-[[(1,1-dimethylethoxy)carbonyl](5-hydroxy-3,3-dim...
C37H50N2O6
1104195-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.5810 9.8520 0.0 0
M  V30 2 C 11.3510 8.5182 0.0 0
M  V30 3 C 11.3510 11.1856 0.0 0
M  V30 4 C 12.8910 8.5182 0.0 0
M  V30 5 O 10.5810 12.5193 0.0 0
M  V30 6 O 12.8910 11.1856 0.0 0
M  V30 7 C 13.6611 7.1845 0.0 0
M  V30 8 C 11.3510 13.8529 0.0 0
M  V30 9 C 14.9947 7.9545 0.0 0
M  V30 10 C 14.4311 5.8508 0.0 0
M  V30 11 C 12.3274 6.4145 0.0 0
M  V30 12 C 10.0174 14.6230 0.0 0
M  V30 13 C 12.1210 15.1868 0.0 0
M  V30 14 C 12.6847 13.0829 0.0 0
M  V30 15 C 16.3284 7.1845 0.0 0
M  V30 16 O 17.6622 7.9545 0.0 0
M  V30 17 C 8.5908 2.5937 0.0 0
M  V30 18 O 8.1533 1.1171 0.0 0
M  V30 19 O 10.0882 2.9533 0.0 0
M  V30 20 C 9.2135 0.0000 0.0 0
M  V30 21 C 5.6060 8.4291 0.0 0
M  V30 22 C 4.6059 7.2581 0.0 0
M  V30 23 N 7.0288 7.8398 0.0 0
M  V30 24 C 5.0168 9.8520 0.0 0
M  V30 25 C 5.4106 5.9449 0.0 0
M  V30 26 C 6.9081 6.3045 0.0 0
M  V30 27 C 8.4516 8.4291 0.0 0
M  V30 28 C 5.6060 11.2746 0.0 0
M  V30 29 C 3.4898 9.6508 0.0 0
M  V30 30 C 4.9732 4.4684 0.0 0
M  V30 31 C 7.9681 5.1874 0.0 0
M  V30 32 C 9.0410 9.8520 0.0 0 CFG=1
M  V30 33 O 7.0288 11.8640 0.0 0
M  V30 34 C 4.6686 12.4965 0.0 0
M  V30 35 C 2.5524 10.8727 0.0 0
M  V30 36 C 6.0332 3.3512 0.0 0
M  V30 37 C 7.5307 3.7108 0.0 0
M  V30 38 C 8.4516 11.2746 0.0 0
M  V30 39 C 3.1416 12.2955 0.0 0
M  V30 40 C 3.0706 7.3789 0.0 0
M  V30 41 C 2.4077 8.7689 0.0 0
M  V30 42 C 2.1984 6.1097 0.0 0
M  V30 43 C 0.8723 8.8898 0.0 0
M  V30 44 C 0.6631 6.2306 0.0 0
M  V30 45 C 0.0000 7.6206 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 32 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 37
M  V30 20 1 18 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 40
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 24 29
M  V30 30 1 25 26
M  V30 31 2 25 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 1 28 33
M  V30 35 2 28 34
M  V30 36 1 29 35
M  V30 37 1 30 36
M  V30 38 1 31 37
M  V30 39 1 32 38
M  V30 40 1 33 38
M  V30 41 1 34 39
M  V30 42 2 35 39
M  V30 43 2 36 37
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (7R)-14-cyclohexyl-7-[[(1,1-dimethylethoxy)carbonyl][3,3-dimethyl-5-(m...
C38H53N3O5
1104195-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.5807 9.8518 0.0 0
M  V30 2 C 11.3507 11.1855 0.0 0
M  V30 3 C 11.3507 8.5180 0.0 0
M  V30 4 O 10.5807 12.5191 0.0 0
M  V30 5 O 12.8907 11.1855 0.0 0
M  V30 6 C 12.8907 8.5180 0.0 0
M  V30 7 C 11.3507 13.8528 0.0 0
M  V30 8 C 13.6607 7.1844 0.0 0
M  V30 9 C 10.0171 14.6228 0.0 0
M  V30 10 C 12.1207 15.1866 0.0 0
M  V30 11 C 12.6844 13.0828 0.0 0
M  V30 12 C 14.4307 8.5180 0.0 0
M  V30 13 C 12.1207 7.1844 0.0 0
M  V30 14 C 14.4307 5.8508 0.0 0
M  V30 15 C 15.9707 8.5180 0.0 0
M  V30 16 N 16.7407 9.8518 0.0 0
M  V30 17 C 18.2807 9.8518 0.0 0
M  V30 18 C 8.5906 2.5937 0.0 0
M  V30 19 O 8.1532 1.1171 0.0 0
M  V30 20 O 10.0881 2.9533 0.0 0
M  V30 21 C 9.2132 0.0000 0.0 0
M  V30 22 C 5.6059 8.4290 0.0 0
M  V30 23 C 4.6057 7.2580 0.0 0
M  V30 24 N 7.0287 7.8397 0.0 0
M  V30 25 C 5.0166 9.8518 0.0 0
M  V30 26 C 5.4103 5.9449 0.0 0
M  V30 27 C 6.9078 6.3045 0.0 0
M  V30 28 C 8.4514 8.4290 0.0 0
M  V30 29 C 5.6059 11.2745 0.0 0
M  V30 30 C 3.4898 9.6507 0.0 0
M  V30 31 C 4.9730 4.4683 0.0 0
M  V30 32 C 7.9680 5.1873 0.0 0
M  V30 33 C 9.0407 9.8518 0.0 0 CFG=1
M  V30 34 O 7.0287 11.8639 0.0 0
M  V30 35 C 4.6684 12.4963 0.0 0
M  V30 36 C 2.5522 10.8726 0.0 0
M  V30 37 C 6.0331 3.3512 0.0 0
M  V30 38 C 7.5304 3.7108 0.0 0
M  V30 39 C 8.4514 11.2745 0.0 0
M  V30 40 C 3.1416 12.2954 0.0 0
M  V30 41 C 3.0705 7.3788 0.0 0
M  V30 42 C 2.4075 8.7688 0.0 0
M  V30 43 C 2.1982 6.1096 0.0 0
M  V30 44 C 0.8723 8.8897 0.0 0
M  V30 45 C 0.6630 6.2305 0.0 0
M  V30 46 C 0.0000 7.6205 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 33 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 12 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 38
M  V30 21 1 19 21
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 23 41
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 25 30
M  V30 31 1 26 27
M  V30 32 2 26 31
M  V30 33 2 27 32
M  V30 34 1 28 33
M  V30 35 1 29 34
M  V30 36 2 29 35
M  V30 37 1 30 36
M  V30 38 1 31 37
M  V30 39 1 32 38
M  V30 40 1 33 39
M  V30 41 1 34 39
M  V30 42 1 35 40
M  V30 43 2 36 40
M  V30 44 2 37 38
M  V30 45 1 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1104195-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1104195-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-12190346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as inhibitors of viral proteases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Conte, Immacolata; Habermann, Joerg; MacKay, Angela; Narjes, Frank; Rico
Ferreira, Maria del Rosario; Stansfield, Ian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090048239 A1 2009-02-19

$RFMT $RIREG SCHEME146 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-bromo-2-butenoate
C5H7BrO2
1117-71-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 Br 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-methyl-2-thioxo-4-thiazolidineacetate
C7H11NO2S2
2624299-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.3628 0.0 0
M  V30 2 C 6.6363 2.1328 0.0 0
M  V30 3 O 7.9700 1.3628 0.0 0
M  V30 4 O 6.6363 3.6728 0.0 0
M  V30 5 C 9.3037 2.1328 0.0 0
M  V30 6 C 2.2418 0.0000 0.0 0
M  V30 7 S 0.0000 2.4899 0.0 0
M  V30 8 C 3.9688 2.1328 0.0 0
M  V30 9 N 2.5620 1.5065 0.0 0
M  V30 10 C 3.8079 3.6644 0.0 0
M  V30 11 C 1.5316 2.6509 0.0 0
M  V30 12 S 2.3016 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 2 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1117-71-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624299-00-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-24330465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alkylation/intramolecular Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Alkylation/Michael Addition Reaction of Dithiocarbamic Acids with
Alkyl γ-Bromocrotonates: Access to Functionalized
1,3-Thiazolidine-2-thiones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalili Foumeshi, Maryam; Ziyaei Halimehjani, Azim; Alaei, Ali;
Klepetarova, Blanka; Beier, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2021), 53(13), 2219-2228

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-2-cyclohexyl-, (2S)-
C19H34N2O5
1134826-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 7.7000 4.0011 0.0 0
M  V30 4 C 7.7000 6.6685 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 C 9.0336 5.8985 0.0 0
M  V30 9 C 8.4700 8.0021 0.0 0
M  V30 10 C 6.3664 7.4385 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 12 O 10.0100 2.6674 0.0 0
M  V30 13 O 10.0100 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 11.5500 2.6674 0.0 0
M  V30 16 O 0.7700 5.3347 0.0 0
M  V30 17 O 3.0800 6.6685 0.0 0
M  V30 18 C 11.5500 4.2074 0.0 0
M  V30 19 C 13.0900 2.6674 0.0 0
M  V30 20 C 11.5500 1.1274 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 3.0800 1.3336 0.0 0
M  V30 23 C 0.7700 2.6674 0.0 0
M  V30 24 C 2.3100 0.0000 0.0 0
M  V30 25 C 0.0000 1.3336 0.0 0
M  V30 26 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 11 14
M  V30 14 1 11 21 CFG=1
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-2-cyclohexyl-N-methylg...
C20H37N3O4
862118-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0009 4.6200 0.0 0 CFG=1
M  V30 2 N 5.3347 5.3900 0.0 0
M  V30 3 C 2.6673 5.3900 0.0 0
M  V30 4 C 5.3347 6.9300 0.0 0
M  V30 5 N 1.3336 4.6200 0.0 0
M  V30 6 O 2.6673 6.9300 0.0 0
M  V30 7 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 8 O 4.0009 7.7000 0.0 0
M  V30 9 C 0.0000 5.3900 0.0 0
M  V30 10 N 8.0020 6.9300 0.0 0
M  V30 11 C 6.6684 9.2400 0.0 0
M  V30 12 C 9.3358 7.7000 0.0 0
M  V30 13 C 8.2084 9.2400 0.0 0
M  V30 14 C 6.6684 10.7800 0.0 0
M  V30 15 C 5.1284 9.2400 0.0 0
M  V30 16 O 10.6694 6.9300 0.0 0
M  V30 17 O 9.3358 9.2400 0.0 0
M  V30 18 C 12.0031 7.7000 0.0 0
M  V30 19 C 11.2331 9.0336 0.0 0
M  V30 20 C 13.3367 8.4700 0.0 0
M  V30 21 C 12.7731 6.3664 0.0 0
M  V30 22 C 4.0009 3.0800 0.0 0
M  V30 23 C 2.6673 2.3100 0.0 0
M  V30 24 C 5.3347 2.3100 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 5.3347 0.7700 0.0 0
M  V30 27 C 4.0009 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 7 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1134826-23-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862118-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4135353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2. Preparation of (S)-N-((S)-1-cyclohexyl-2-
(methylamino)-2-oxoethyl)-2-(BOC-amino)-3,3- dimethylbutanamide (Compound
13), Compound 12 (1.0 g, 2.7 mol) is dissolved in DCM 30 (ml) and treated
with EDCI-HCl (0.52 g, 2.7 mmol) and HOBt-H2O (0.41 g, 2.7 mmol). The mix
is stirred at room temperature for 10 min, and methyl amine aqueous
solution (40%, 0.71 ml, 8.1 mmol) is then added. After 3 hr, the mix is
concentrated and extracted with ethyl acetate (50 ml). The compound 13
(1.01 g, 97%) is obtained as a white powder.
(S)-N-((S)-1-cyclohexyl-2-(methylamino)-2-oxoethyl)-2-(BOC-amino)-3,3-dimethylbutanamide
(Compound 13), yield (1.01 g, 97%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea-containing peptides as inhibitors of viral
replication
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Dawei; Deshpande, Milind; Phadke, Avinash
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090082261 A1 2009-03-26

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 1-(2,6-difluorophenyl)-5-(phenylsulfonyl)-, et...
C18H14F2N2O4S
1138037-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.3755 4.0011 0.0 0 VAL=6
M  V30 2 O 3.0418 4.7711 0.0 0
M  V30 3 O 5.7091 3.2311 0.0 0
M  V30 4 F 3.5673 9.6709 0.0 0
M  V30 5 F 2.4582 4.4528 0.0 0
M  V30 6 C 8.4041 7.6284 0.0 0
M  V30 7 O 9.6500 6.7232 0.0 0
M  V30 8 O 8.5651 9.1601 0.0 0
M  V30 9 C 11.0569 7.3497 0.0 0
M  V30 10 C 12.3028 6.4445 0.0 0
M  V30 11 N 4.5192 6.7417 0.0 0
M  V30 12 C 5.1455 5.3347 0.0 0
M  V30 13 N 5.6635 7.7721 0.0 0
M  V30 14 C 6.6770 5.4958 0.0 0
M  V30 15 C 6.9972 7.0021 0.0 0
M  V30 16 C 3.0127 7.0619 0.0 0
M  V30 17 C 2.5369 8.5264 0.0 0
M  V30 18 C 1.9823 5.9173 0.0 0
M  V30 19 C 1.0306 8.8466 0.0 0
M  V30 20 C 0.4759 6.2375 0.0 0
M  V30 21 C 0.0000 7.7022 0.0 0
M  V30 22 C 3.6055 2.6674 0.0 0
M  V30 23 C 4.3755 1.3336 0.0 0
M  V30 24 C 2.0655 2.6674 0.0 0
M  V30 25 C 3.6055 0.0000 0.0 0
M  V30 26 C 1.2955 1.3336 0.0 0
M  V30 27 C 2.0655 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 22
M  V30 5 1 4 17
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 1-(2,6-difluorophenyl)-N-methyl-5-(phenylsulfonyl)-
C17H13F2N3O3S
1138038-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 5.8690 0.0 0 VAL=6
M  V30 2 O 3.2311 4.5352 0.0 0
M  V30 3 O 4.7711 7.2026 0.0 0
M  V30 4 F 2.5664 4.5191 0.0 0
M  V30 5 F 6.1361 0.5546 0.0 0
M  V30 6 C 9.3036 4.7418 0.0 0
M  V30 7 N 9.9301 6.1486 0.0 0
M  V30 8 O 10.2088 3.4960 0.0 0
M  V30 9 C 11.4616 6.3097 0.0 0
M  V30 10 N 5.4958 3.5673 0.0 0
M  V30 11 C 5.3347 5.0990 0.0 0
M  V30 12 N 7.0021 3.2471 0.0 0
M  V30 13 C 6.7417 5.7253 0.0 0
M  V30 14 C 7.7721 4.5809 0.0 0
M  V30 15 C 4.3513 2.5368 0.0 0
M  V30 16 C 2.8866 3.0127 0.0 0
M  V30 17 C 4.6714 1.0306 0.0 0
M  V30 18 C 1.7422 1.9823 0.0 0
M  V30 19 C 3.5271 0.0000 0.0 0
M  V30 20 C 2.0624 0.4760 0.0 0
M  V30 21 C 2.6674 6.6390 0.0 0
M  V30 22 C 1.3336 5.8690 0.0 0
M  V30 23 C 2.6674 8.1790 0.0 0
M  V30 24 C 0.0000 6.6390 0.0 0
M  V30 25 C 1.3336 8.9490 0.0 0
M  V30 26 C 0.0000 8.1790 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 21
M  V30 5 1 4 16
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138038-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7121641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 331
1-(2,6-difluorophenyl)-N-methyl-5-(phenylsulfonyl)-1H-pyrazole-3-carboxamide
To a solution of ethyl
1-(2,6-difluorophenyl)-5-(phenylsulfonyl)-1H-pyrazole-3-carboxylate (300
mg) in methanol (1 mL) was added 40% methylamine-methanol solution (1
mL), and the mixture was stirred at room temperature for 2 hr, and
concentrated under reduced pressure to give the title compound as a white
solid (279 mg, yield 97%). 1H-NMR (CDCl3) &#x03B4; : 2.96 (3H, d, J=4.9
Hz), 6.73-6.80 (1H, m), 6.98-7.06 (2H, m), 7.42-7.50 (2H, m), 7.51-7.57
(1H, m), 7.58 (1H, s), 7.59-7.67 (3H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 6-Oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
C9H15NO3
114214-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 7.7598 2.1037 0.0 0
M  V30 9 C 7.7598 3.6437 0.0 0
M  V30 10 O 9.0934 2.8737 0.0 0
M  V30 11 C 6.2952 1.6278 0.0 0
M  V30 12 C 6.2952 4.1195 0.0 0
M  V30 13 N 5.3900 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3R,4R)-3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate
C10H20N2O3
203503-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0287 0.0 0
M  V30 2 O 2.6673 3.2587 0.0 0
M  V30 3 O 4.0012 5.5688 0.0 0
M  V30 4 C 1.3337 4.0287 0.0 0
M  V30 5 C 2.1037 5.3624 0.0 0
M  V30 6 C 0.0000 4.7987 0.0 0
M  V30 7 C 0.5637 2.6951 0.0 0
M  V30 8 N 9.3038 2.9016 0.0 0
M  V30 9 C 9.9301 4.3086 0.0 0
M  V30 10 O 7.6286 0.0000 0.0 0
M  V30 11 N 5.3348 3.2587 0.0 0
M  V30 12 C 6.7417 3.8850 0.0 0
M  V30 13 C 5.4958 1.7271 0.0 0
M  V30 14 C 7.7722 2.7406 0.0 0 CFG=1
M  V30 15 C 7.0022 1.4070 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 14 8 CFG=1
M  V30 10 1 15 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114214-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 203503-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-84322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (±)-trans-1-(5-Bromo-pyridin-2-yl)-4-methylamino-pyrrolidin-3-ol.
Dissolve 6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid
tert-butylester(1.50 g, 8.10 mmol) in methylamine (15 ml., 40% solution
in water). Warm to 50°C and stir in a sealed vessel overnight. Dilute the
mixture with saturated sodium bicarbonate and extract with
dichloromethane (3x). Dry the organics over sodium sulfate, filter, and
evaporate. Purify by silica gel chromatography, eluting with 0-10%
methanol (2N NH3)/CH2Cl2 to give 1.87 g (97%) of
3-hydroxy-4-methylamino-pyrrolidine-1-carboxylic acid tert-butyl ester as
a yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thieno[2,3-c]pyridine derivatives as MCH receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amegadzie, Albert Kudzovi; Dao, Yen; Gardinier, Kevin Matthew; Garmene,
David Joseph; Green, Steven James; Hembre, Erik James; Lu, Jianliang;
Spinazze, Patrick Gianpietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007146759 A2 2007-12-21

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-cyano-N′-[2-[(phenylmethyl)thio]ethyl]carbamimidothioate
C12H15N3S2
115414-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 S 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 N 9.3360 3.8501 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 N 10.6697 1.5400 0.0 0
M  V30 8 S 12.0033 3.8501 0.0 0
M  V30 9 C 12.0033 0.7700 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 N 13.3370 0.0000 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 17 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 3 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-methyl-N′′-[2-[(phenylmethyl)thio]ethyl]guanidine
C12H16N4S
83356-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 S 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 N 9.3360 3.8501 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 N 10.6697 1.5400 0.0 0
M  V30 8 N 12.0033 3.8501 0.0 0
M  V30 9 C 12.0033 0.7700 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 N 13.3370 0.0000 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 17 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 3 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115414-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83356-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24543975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of the azole moiety of cimetidine derivatives for the
inhibition of human multidrug and toxin extrusion transporter 1 (hMATE1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinya, Susumu; Kawai, Kentaro; Tarui, Atsushi; Karuo, Yukiko; Sato,
Kazuyuki; Matsuda, Masaya; Kitatani, Kazuyuki; Kobayashi, Naoki; Nabe,
Takeshi; Otsuka, Masato; Omote, Masaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2021), 69(9), 905-912

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(4-Oxo-1-piperidinyl)methyl]benzamide
C13H16N2O2
1181634-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 N 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 12.0032 1.5400 0.0 0
M  V30 6 C 5.3348 3.8500 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 2.6673 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 2.6673 2.3100 0.0 0
M  V30 12 N 8.0021 3.8500 0.0 0
M  V30 13 C 9.3359 4.6201 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 15 C 10.6695 3.8500 0.0 0
M  V30 16 C 9.3359 1.5400 0.0 0
M  V30 17 C 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-(Methylamino)-1-piperidinyl]methyl]benzamide
C14H21N3O
1080651-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 N 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0010 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 8.0022 3.8501 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 9.3360 1.5400 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1181634-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1080651-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9669822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SUN11602, a Novel Aniline Compound, Mimics the Neuroprotective Mechanisms
of Basic Fibroblast Growth Factor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murayama, Norihito; Kadoshima, Taisuke; Takemoto, Naohiro; Kodama, Shiho;
Toba, Tetsuya; Ogino, Ryoko; Noshita, Takafumi; Oka, Tetsushi; Ueno,
Shinya; Kuroda, Mariko; Shimmyo, Yoshiari; Morita, Yasuhiro; Inoue,
Teruyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Neuroscience (2013), 4(2), 266-276

$RFMT $RIREG SCHEME152 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,5-Dimethoxyphenyl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C17H18N2O3
1547295-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9302 0.0 0
M  V30 2 O 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 4.0012 8.4702 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 N 4.0012 3.8501 0.0 0
M  V30 9 N 5.3348 6.1601 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0012 6.9302 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 8.0022 1.5400 0.0 0
M  V30 21 C 9.3360 3.8501 0.0 0
M  V30 22 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 2 4 11
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 12
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1547295-91-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21403551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloropyrimidine
C4H2Cl2N2
1193-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylpyrimidin-4-amine
C5H6ClN3
65766-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1193-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65766-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17185622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chlorobenzene-substituted azaaryl compounds as anticancer agents and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yen, Yun; Liou, Jing-Ping; Chen, Chun-Han
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017015400 A1 2017-01-26

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromobutoxy)benzene
C10H13BrO
1200-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 Br 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-phenoxy-1-butanamine
C11H17NO
91339-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1200-03-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91339-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9906977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Antifungal Activity of Novel Conformationally
Restricted Triazole Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Miao, Zhenyuan;
Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2009), 342(12), 732-739

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Ethyl 2-[(1S)-2-cyclopropyl-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-...
C15H27NO3S3
1203455-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.2073 0.0 0 CFG=1
M  V30 2 C 6.1600 2.8736 0.0 0
M  V30 3 N 3.8500 4.2073 0.0 0
M  V30 4 S 3.0800 5.5411 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 5.5411 0.0 0
M  V30 6 O 3.8500 6.8747 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 5.5411 0.0 0
M  V30 9 C 1.5400 7.0811 0.0 0
M  V30 10 C 7.4060 4.6359 0.0 0
M  V30 11 O 8.8128 5.2622 0.0 0
M  V30 12 O 7.2449 3.1042 0.0 0
M  V30 13 C 10.0587 4.3570 0.0 0
M  V30 14 C 11.4656 4.9834 0.0 0
M  V30 15 C 6.1600 5.5411 0.0 0
M  V30 16 S 7.1906 6.6854 0.0 0
M  V30 17 S 4.7532 6.1674 0.0 0
M  V30 18 C 6.4206 8.0191 0.0 0
M  V30 19 C 4.9141 7.6989 0.0 0
M  V30 20 C 5.3900 1.5400 0.0 0
M  V30 21 C 4.0564 0.7700 0.0 0
M  V30 22 C 5.3900 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5 CFG=3
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1S)-2-Cyclopropyl-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-N-meth...
C14H26N2O2S3
1203455-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.2073 0.0 0 CFG=1
M  V30 2 C 6.1600 2.8737 0.0 0
M  V30 3 N 3.8500 4.2073 0.0 0
M  V30 4 S 3.0800 5.5411 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 5.5411 0.0 0
M  V30 6 O 3.8500 6.8747 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 5.5411 0.0 0
M  V30 9 C 1.5400 7.0811 0.0 0
M  V30 10 C 7.4059 4.6359 0.0 0
M  V30 11 N 8.8128 5.2622 0.0 0
M  V30 12 O 7.2450 3.1042 0.0 0
M  V30 13 C 10.0587 4.3570 0.0 0
M  V30 14 C 6.1600 5.5411 0.0 0
M  V30 15 S 4.7532 6.1674 0.0 0
M  V30 16 S 7.1905 6.6855 0.0 0
M  V30 17 C 4.9142 7.6990 0.0 0
M  V30 18 C 6.4204 8.0191 0.0 0
M  V30 19 C 5.3900 1.5400 0.0 0
M  V30 20 C 5.3900 0.0000 0.0 0
M  V30 21 C 4.0564 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 4 5 CFG=3
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1203455-76-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1203455-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15271883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Beyond the chiral pool: a general approach to β-amino-α-keto amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Cristian L.; Krawiec, Mariusz; Forslund, Raymond E.; Nugent,
William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(1), 41-47

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-6-chloro-2-methoxypyridine
C6H5BrClNO
1211526-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinamine, 5-bromo-6-methoxy-N-methyl-
C7H9BrN2O
2767036-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 Br 4.6200 0.0000 0.0 0
M  V30 4 N 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 N 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1211526-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2767036-07-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32037051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-azaindole compounds for inhibition of BCR-ABL tyrosine
kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lyssikatos, Joseph P.; Kintz, Samuel; Ren, Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022076973 A1 2022-04-14

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitro-4-(trifluoromethyl)benzene
C7H3ClF3NO2
121-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0 VAL=5
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 Cl 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5638 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-4-(trifluoromethyl)-1,2-benzenediamine
C8H9F3N2
35203-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 N 6.1600 0.0000 0.0 0
M  V30 6 N 7.7000 2.6673 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35203-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19957585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arenoazolylamines as antibiotic compounds and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meo, Paul; Khan, Nawaz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018037223 A1 2018-03-01

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
121-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 N 6.6687 3.0801 0.0 0 VAL=5
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenesulfonamide
C7H8N2O4S
58955-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58955-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-3051269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Regio- and Chemo-selective Reactions of 2-Bromobenzyl
Bromides: Expanding the Scope for the Synthesis of Biaryls Fused to a
Seven-Membered Sultam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Sharma, Shubhra; Dayal, Neetu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(36), 7885-7891

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
121-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 N 6.6687 3.0801 0.0 0 VAL=5
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenesulfonamide
C7H8N2O4S
58955-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58955-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-254949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of N-methyl-3-nitrobenzenesulfonamide. To a solution of 4.42
g (20.0 mmol) of 3-nitrobenzenesulfonyl chloride in 150 mL of dry THF was
added 25.0 mL (50.0 mmol) of methylamine as a 2 M solution in THF under
ice cooling and stirring. The resulting cloudy solution was stirred
overnight at ambient temperature. After this time period, the reaction
mixture was diluted with 150 mL of saturated sodium chloride solution and
50 mL of ethyl acetate, then transferred to a 500 mL separatory funnel,
mixed thoroughly, and the organic phase was separated. The aqueous phase
was extracted twice with 50 mL of ethyl acetate. The combined organic
layers were dried over Na2SO4, filtered, and concentrated under reduced
pressure. The resulting residue was purified by recrytallization from
EtOH. Yield 4.20 g, 19.48 mmol, 97%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydrazonodiaminopyrazoles with antiproliferative activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zaihui; Daynard, Timothy Scott; Sviridov, Serguei V.; Chafeev,
Mikhail A.; Wang, Shisen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030060453 A1 2003-03-27

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-[5-[4-(bromomethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-pyrazinamine
C13H9Br2N5O
1225062-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 6.1600 0.0 0
M  V30 2 Br 1.3336 0.0000 0.0 0
M  V30 3 C 12.5646 4.4942 0.0 0
M  V30 4 Br 13.4698 5.7401 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 O 5.4079 3.9935 0.0 0
M  V30 7 N 4.1620 6.1516 0.0 0
M  V30 8 C 6.4383 5.1381 0.0 0
M  V30 9 N 5.6683 6.4717 0.0 0
M  V30 10 C 2.6673 3.8500 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 N 2.6673 2.3100 0.0 0
M  V30 13 N 0.0000 3.8500 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 7.9700 4.9772 0.0 0
M  V30 17 C 8.8751 6.2230 0.0 0
M  V30 18 C 8.5963 3.5702 0.0 0
M  V30 19 C 10.4068 6.0621 0.0 0
M  V30 20 C 10.1279 3.4093 0.0 0
M  V30 21 C 11.0331 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 16
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-[5-[4-[(methylamino)methyl]phenyl]-1,3,4-oxadiazol-2-yl]-2-pyrazina...
C14H13BrN6O
1225063-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.7844 0.0000 0.0 0
M  V30 2 Br 0.2789 5.6276 0.0 0
M  V30 3 C 12.3669 6.0899 0.0 0
M  V30 4 N 13.7008 5.3199 0.0 0
M  V30 5 C 15.0344 6.0899 0.0 0
M  V30 6 C 4.5948 2.4918 0.0 0
M  V30 7 O 5.6253 3.6363 0.0 0
M  V30 8 N 5.3649 1.1581 0.0 0
M  V30 9 C 7.0321 3.0098 0.0 0
M  V30 10 N 6.8712 1.4783 0.0 0
M  V30 11 C 3.0631 2.6527 0.0 0
M  V30 12 C 2.1580 1.4068 0.0 0
M  V30 13 N 2.4368 4.0597 0.0 0
M  V30 14 N 0.6263 1.5679 0.0 0
M  V30 15 C 0.9052 4.2206 0.0 0
M  V30 16 C 0.0000 2.9747 0.0 0
M  V30 17 C 8.3659 3.7799 0.0 0
M  V30 18 C 9.6996 3.0098 0.0 0
M  V30 19 C 8.3659 5.3199 0.0 0
M  V30 20 C 11.0333 3.7799 0.0 0
M  V30 21 C 9.6996 6.0899 0.0 0
M  V30 22 C 11.0333 5.3199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 17
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1225062-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1225063-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10255437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00719] Example 39:
1-(7-(5-Amino-6-(5-(4-((methylamino)methylphenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-2,7-diazaspiro[4.4]nonan-2-yl)propan-1-one
(Compound 1-342) [00720] Compound I-342 was prepared using Method BF,
Steps 1-2 followed by Method BQ, Steps 1-4 METHOD BQ: Step 1:
5-Bromo-3-(5-(4-((methylamino)methyl)phenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-amine
[00721] A suspension of
5-bromo-3-[5-[4-(bromomethyl)phenyl]-1,3,4-oxadiazol-2-yl]pyrazin-2-amine
(2 g, 4.9 mmol) and Na2CO3 (1.55 g, 14.60 mmol) in tetrahydrofuran (30
mL) was treated with methanamine (3.6 rnL of 2 M, 7.3 mmol) in THF. The
reaction mixture was heated at 60 °C for 1 h. The reaction was cooled,
diluted with water and the organic layer was extracted with
dichloromethane. The organic layer was dried over Na2SO4, filtered and
concentrated in vacuo to yield
5-bromo-3-(5-(4-((methylamino)methyl)phenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-amine
(1.7 g, 97%) as a yellow solid, which was used without purification in
the next step. LC/MS m/z 363.5 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazine compounds as inhibitors of ATR kinase for use in
treating disease and as biological tools
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charrier, Jean-Damien; Durrant, Steven; Kay, David; O'Donnell, Michael;
Knegtel, Ronald; Maccormick, Somhairle; Pinder, Joanne; Virani, Anisa;
Young, Stephen; Binch, Hayley; Cleveland, Thomas; Fanning, Lev T. D.;
Hurley, Dennis; Joshi, Pramod; Sheth, Urvi; Silina, Alina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010054398 A1 2010-05-14

$RFMT $RIREG SCHEME160 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Phenyl-3-buten-2-one
C10H10O
122-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1,2-Ethynediyl)bis[4-methoxybenzene]
C16H14O2
2132-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 1.3337 0.0 0
M  V30 2 C 8.4702 1.3337 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 O 14.6303 1.3337 0.0 0
M  V30 6 C 15.4003 0.0000 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.0801 0.0000 0.0 0
M  V30 11 C 3.0801 2.6673 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 10.0102 1.3337 0.0 0
M  V30 14 C 10.7802 0.0000 0.0 0
M  V30 15 C 10.7802 2.6673 0.0 0
M  V30 16 C 12.3203 0.0000 0.0 0
M  V30 17 C 12.3203 2.6673 0.0 0
M  V30 18 C 13.0903 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 2,3-bis(4-methoxyphenyl)-1,6-dimethyl-4-phenyl-, tetrafluoroborat...
C27H26NO2.BF4
1651170-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 14.6300 0.0 0
M  V30 2 C 5.3347 16.1700 0.0 0
M  V30 3 O 5.3347 5.3900 0.0 0
M  V30 4 C 4.0011 4.6200 0.0 0
M  V30 5 O 12.0031 9.2400 0.0 0
M  V30 6 C 13.3367 10.0100 0.0 0
M  V30 7 C 5.3347 11.5500 0.0 0
M  V30 8 C 6.6684 12.3200 0.0 0
M  V30 9 C 4.0009 12.3200 0.0 0
M  V30 10 N 6.6684 13.8600 0.0 0 CHG=1 VAL=4
M  V30 11 C 4.0009 13.8600 0.0 0
M  V30 12 C 5.3347 14.6300 0.0 0
M  V30 13 C 5.3347 10.0100 0.0 0
M  V30 14 C 4.0009 9.2400 0.0 0
M  V30 15 C 6.6684 9.2400 0.0 0
M  V30 16 C 4.0009 7.7000 0.0 0
M  V30 17 C 6.6684 7.7000 0.0 0
M  V30 18 C 5.3347 6.9300 0.0 0
M  V30 19 C 8.0020 11.5500 0.0 0
M  V30 20 C 8.0020 10.0100 0.0 0
M  V30 21 C 9.3358 12.3200 0.0 0
M  V30 22 C 9.3358 9.2400 0.0 0
M  V30 23 C 10.6694 11.5500 0.0 0
M  V30 24 C 10.6694 10.0100 0.0 0
M  V30 25 C 2.6673 11.5500 0.0 0
M  V30 26 C 1.3336 12.3200 0.0 0
M  V30 27 C 2.6673 10.0100 0.0 0
M  V30 28 C 0.0000 11.5500 0.0 0
M  V30 29 C 1.3336 9.2400 0.0 0
M  V30 30 C 0.0000 10.0100 0.0 0
M  V30 31 B 6.6684 1.5400 0.0 0 CHG=3 VAL=4
M  V30 32 F 5.1284 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 33 F 8.2084 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 34 F 6.6684 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 35 F 6.6684 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 8 19
M  V30 12 2 9 11
M  V30 13 1 9 25
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 31 34
M  V30 37 1 31 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-57-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2132-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1651170-76-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14641783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 13755-29-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Pyridinium Salts from Unsaturated Ketones, Amines and Alkynes A sealed
tube containing [Cp*RhCl2]2 (1.0 mol %), NaBF4 (0.31 mmol) and
Cu(OAc)2.H2O (0.56 mmol) was evacuated and purged with nitrogen gas three
times. Then, vinyl ketone 1 (0.34 mmol), amine 2 (0.28 mmol) and alkyne 3
(0.34 mmol) in MeOH (2.0 mL) were added to the system via syringe under a
nitrogen atmosphere and the reaction was allowed to stir at 80 °C for 24
h. When the reaction was completed, the mixture was diluted with CH2Cl2
(10 mL) and filtered through a Celite pad and the Celite pad was washed
several times with CH2Cl2 (50 mL). The combined filtrate was concentrated
in vacuo and the residue was purified by column chromatography on silica
gel using DCM/MeOH (95:5) as eluent. The desired pure product 4.
1,6-Dimethyl-2,3,4-triphenylpyridin-1-ium tetrafluoroborate (4a)
2,3-Bis(4-methoxyphenyl)-1,6-dimethyl-4-phenylpyridin-1-ium
tetrafluoroborate (4c) Yellow solid (131 mg, 97%). m.p. 113-115 °C; 1H
NMR (400 MHz, CDCl3): δ 7.69 (s, 1 H), 7.25-7.16 (m, 5 H), 7.12 (d, J =
7.2 Hz, 2 H), 6.78 (d, J = 8.4 Hz, 2 H), 6.70 (d, J = 8.4 Hz, 2 H), 6.46
(d, J = 8.4 Hz, 2 H), 3.91 (s, 3 H), 3.73 (s, 3 H), 3.61 (s, 3 H), 2.90
(s, 3 H); 13C NMR (100 MHz, CDCl3): δ 160.4 (C), 158.6 (C), 157.2 (C),
156.0 (C), 154.2 (C), 138.8 (C), 136.4 (C), 131.7 (2 CH), 130.8 (2 CH),
129.2 (CH), 129.1 (2 CH), 128.9 (CH), 128.3 (2 CH), 126.6 (C), 124.3 (C),
114.3 (2 CH), 113.3 (2 CH), 55.2 (CH3), 54.9 (CH3), 42.9 (CH3), 22.0
(CH3); HRMS (FAB+) cal for C27H26O2N+ 396.1958, found 396.1963; IR (KBr):
3000, 2931, 2838, 1612, 1511, 1457, 1295, 1249, 1180, 1056 (ν B-F), 1025
and 840 cm-1.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium(III)-Catalyzed Vinylic C-H Activation: A Direct Route toward
Pyridinium Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Ching-Zong; Jayakumar, Jayachandran; Gandeepan, Parthasarathy; Wu,
Yun-Ching; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(4), 924-927

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9500254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent and selective Bruton's tyrosine kinase
inhibitors: Pyridazinone analogs with improved metabolic stability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Young, Wendy B.; Barbosa, James; Blomgren, Peter; Bremer, Meire C.;
Crawford, James J.; Dambach, Donna; Eigenbrot, Charles; Gallion, Steve;
Johnson, Adam R.; Kropf, Jeffrey E.; Lee, Seung H.; Liu, Lichuan; Lubach,
Joseph W.; Macaluso, Jen; Maciejewski, Pat; Mitchell, Scott A.; Ortwine,
Daniel F.; Di Paolo, Julie; Reif, Karin; Scheerens, Heleen; Schmitt,
Aaron; Wang, Xiaojing; Wong, Harvey; Xiong, Jin-Ming; Xu, Jianjun; Yu,
Christine; Zhao, Zhongdong; Currie, Kevin S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(2), 575-579

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14266522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 113d 5-Methy2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
113d A 1-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL), 113c (10.0 g,
32.2 mmol), 2M methylamine solution in THF ( 113 mL, 225 mmol) and
stirred at room temperature for 72 h. After this time the reaction was
concentrated to dryness under reduced pressure, and the resulting solid
was stirred with a mixture of ethyl acetate (75 mL) and 10% aqueous
potassium carbonate (75 mL). The aqueous layer was separated and
extracted with ethyl acetate (2 x 75 mL). The combined organic extracts
were washed with 10% aqueous potassium carbonate (75 mL), followed by
brine (50 mL) and dried over sodium sulfate. The drying agent was removed
by filtration, and the filtrate concentrated under reduced pressure to
afford 113d. Yellow solid, yield (5.70 g), 97%. 1H NMR (300 MHz, CDCl3) δ
6.62 (s, 1H), 4.28 (t, 2H, J =5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J =5.4
Hz), 2.52 (s, 3H); MS (ESI+) m/z 183.0 (M+H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylpyridone and azapyridone compounds as inhibitors of BTK
activity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Ortwine, Daniel Fred; Wei, Binqing; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013067274 A1 2013-05-10

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14545978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 128a 5-Methy2-nitro-4,5,6,7-tetrahydropyrazolo[ 1,5-a]pyrazine
128a A 1-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL), 124c (10.0 g,
32.2 mmol), 2M methylamine solution in THF (113 mL, 225 mmol) and stirred
at room temperature for 72 h. After this time the reaction was
concentrated to dryness under reduced pressure, and the resulting solid
was stirred with a mixture of ethyl acetate (75 mL) and 10% aqueous
potassium carbonate (75 mL). The aqueous layer was separated and
extracted with ethyl acetate (2 x 75 mL). The combined organic extracts
were washed with 10% aqueous potassium carbonate (75 mL), followed by
brine (50 mL) and dried over sodium sulfate. The drying agent was removed
by filtration, and the filtrate concentrated under reduced pressure to
afford 128a. Yellow solid, yield (5.70 g, 97 %). 1H NMR (300 MHz, CDCl3)
δ 6.62 (S, 1H), 4.28 (t, 2H, J= 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J=
5.4 Hz), 2.52 (s, 3H); MS (ESI+) m/z 183.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 8-Fluorophthalazin-1(2H)-one compounds as inhibitors of BTK activity and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Ortwine, Daniel Fred; Wei, Binqing; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013067264 A1 2013-05-10

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2404775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 124d 5-Methy2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
124d A 1-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL), 124c (10.0
g,32.2 mmol), 2M methylamine solution in THF (113 mL, 225 mmol) and
stirred at room temperature for 72 h. After this time the reaction was
concentrated to dryness under reduced pressure, and the resulting solid
was stirred with a mixture of ethyl acetate (75 mL) and 10% aqueous
potassium carbonate (75 mL). The aqueous layer was separated and
extracted with ethyl acetate (2 x75 mL). The combined organic extracts
were washed with 10% aqueous potassium carbonate (75 mL), followed by
brine (50 mL) and dried over sodium sulfate. The drying agent was removed
by filtration, and the filtrate concentrated under reduced pressure to
afford 124d. Yellow solid, yield 5.70 g, 97%. 1H NMR (300 MHz, CDCl3 ) δ
6.62 (s, 1H), 4.28 (t, 2H, J= 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J= 5.4
Hz),2.52 (s, 3H); MS (ESI+) m/z 183.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic piperazine compounds as BTK inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Ortwine, Daniel Fred; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013067260 A1 2013-05-10

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15358600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 101k 5-Methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
101k A 1-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL),
1-(2-bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole 101j (10.0 g, 32.2
mmol), 2M methylamine solution in THF (113 mL, 225 mmol) and stirred at
room temperature for 72 h. After this time the reaction was concentrated
to dryness under reduced pressure, and the resulting solid was stirred
with a mixture of ethyl acetate (75 mL) and 10% aqueous potassium
carbonate (75 mL). The aqueous layer was separated and extracted with
ethyl acetate (2 x 75 mL). The combined organic extracts were washed with
10% aqueous potassium carbonate (75 mL), followed by brine (50 mL) and
dried over sodium sulfate. The drying agent was removed by filtration,
and the filtrate concentrated under reduced pressure.
5-methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine 101k in a 97%
yield (5.70 g) as a yellow solid. 1H NMR (300 MHz, CDCl3) δ 6.62 (s, 1H),
4.28 (t, 2H, J = 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J = 5.4 Hz), 2.52
(s, 3H); MS (ESI+) m/z 183.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridazinones as Btk kinase inhibitors for treating immune
disorders, cancer, inflammation, and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Currie, Kevin S.; Wang, Xiaojing; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012030990 A1 2012-03-08

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12334765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 103j 5-Methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
103j Al-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL),
1-(2-bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole 103i (10.0 g, 32.2
mmol), 2M methylamine solution in THF (113 mL, 225 mmol) and stirred at
room temperature for 72 h. After this time the reaction was concentrated
to dryness under reduced pressure, and the resulting solid was stirred
with a mixture of ethyl acetate (75 mL) and 10% aqueous potassium
carbonate (75 mL). The aqueous layer was separated and extracted with
ethyl acetate (2 x 75 mL). The combined organic extracts were washed with
10% aqueous potassium carbonate (75 mL), followed by brine (50 mL) and
dried over sodium sulfate. The drying agent was removed by filtration,
and the filtrate concentrated under reduced pressure to afford
5-methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine 103j. Yellow
solid, yield 5.70 g, 97%. 1H NMR (300 MHz, CDCl3) δ 6.62 (s, 1H), 4.28
(t, 2H, J= 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J= 5.4 Hz), 2.52 (s, 3H);
MS (ESI+) m/z 183.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinones and pyrazinones as Btk kinase inhibitors for
treating inflammation, immunological disorders, cancer, and other
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Currie, Kevin S.; Wang, Xiaojing; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012031004 A1 2012-03-08

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14820977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 101d 5-Methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine
101d A 1-L single-neck round-bottomed flask equipped with a magnetic
stirrer and nitrogen inlet was charged with THF (350 mL), 101c (10.0 g,
32.2 mmol), 2M methylamine solution in THF (113 mL, 225 mmol) and stirred
at room temperature for 72 h. After this time the reaction was
concentrated to dryness under reduced pressure, and the resulting solid
was stirred with a mixture of ethyl acetate (75 mL) and 10% aqueous
potassium carbonate (75 mL). The aqueous layer was separated and
extracted with ethyl acetate (2 x 75 mL). The combined organic extracts
were washed with 10% aqueous potassium carbonate (75 mL), followed by
brine (50 mL) and dried over sodium sulfate. The drying agent was removed
by filtration, and the filtrate concentrated under reduced pressure to
afford 101d. Yield 5.70 g, 97%, yellow solid. 1H NMR (300 MHz, CDCl3) δ
6.62 (s, 1H), 4.28 (t, 2H, J= 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J= 5.4
Hz), 2.52 (s, 3H); MS (ESI+) m/z 183.0 (M+H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridone and azapyridone compounds as Btk inhibitors for
treating immune disorders, inflammation, cancer, and other Btk-mediated
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbosa, Antonio J. M.; Blomgren, Peter A.; Currie, Kevin S.;
Krishnamoorthy, Ravi; Kropf, Jeffrey E.; Lee, Seung H.; Mitchell, Scott
A.; Ortwine, Daniel; Schmitt, Aaron C.; Wang, Xiaojing; Xu, Jianjun;
Young, Wendy; Zhang, Honglu; Zhao, Zhongdong; Zhichkin, Pavel E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011140488 A1 2011-11-10

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2967527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine A 1-L
single-neck round-bottomed flask equipped with a magnetic stirrer and
nitrogen inlet was charged with THF (350 mL),
1-(2-bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole (10.0 g, 32.2 mmol),
2M methylamine solution in THF (113 mL, 225 mmol) and stirred at room
temperature for 72 h. After this time the reaction was concentrated to
dryness under reduced pressure, and the resulting solid was stirred with
a mixture of ethyl acetate (75 mL) and 10% aqueous potassium carbonate
(75 mL). The aqueous layer was separated and extracted with ethyl acetate
(2x15 mL). The combined organic extracts were washed with 10% aqueous
potassium carbonate (75 mL), followed by brine (50 mL) and dried over
sodium sulfate. The drying agent was removed by filtration, and the
filtrate concentrated under reduced pressure to afford
5-methyl-2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine. Yellow solid,
yield 5.70 g, 97%. 1H NMR (300 MHz, CDCl3) δ 6.62 (s, 1H), 4.28 (t, 2H, J
= 5.4 Hz), 3.67 (s, 2H), 2.95 (t, 2H, J = 5.4 Hz), 2.52 (s, 3H); MS
(ESI+) m/z 183.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridazinones and their use as Btk inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbosa, Antonio J., Jr.; Blomgren, Peter A.; Currie, Kevin S.; Lee,
Seung H.; Kropf, Jeffrey E.; Mitchell, Scott A.; Ortwine, Daniel;
Rennells, William M.; Schmitt, Aaron C.; Xu, Jianjun; Young, Wendy B.;
Zhao, Zhongdong; Zhichkin, Pavel E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010056875 A1 2010-05-20

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-[[(1,1-dimethylethyl...
C22H37NO6Si
1227750-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 3 N 8.0022 7.7002 0.0 0
M  V30 4 O 4.0010 6.9302 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 C 9.3360 6.9302 0.0 0
M  V30 7 Si 2.6673 7.7002 0.0 0
M  V30 8 O 6.6685 10.0102 0.0 0
M  V30 9 O 4.0010 10.0102 0.0 0
M  V30 10 O 10.6697 7.7002 0.0 0
M  V30 11 O 9.3360 5.3901 0.0 0
M  V30 12 C 1.3337 8.4702 0.0 0
M  V30 13 C 3.4374 9.0338 0.0 0
M  V30 14 C 1.8973 6.3665 0.0 0
M  V30 15 C 6.6685 11.5503 0.0 0
M  V30 16 C 12.0033 6.9302 0.0 0
M  V30 17 C 2.1037 9.8039 0.0 0
M  V30 18 C 0.0000 9.2402 0.0 0
M  V30 19 C 0.5637 7.1365 0.0 0
M  V30 20 C 11.2333 5.5965 0.0 0
M  V30 21 C 13.3370 6.1601 0.0 0
M  V30 22 C 12.7733 8.2638 0.0 0
M  V30 23 O 6.6685 0.7700 0.0 0
M  V30 24 C 5.3348 0.0000 0.0 0
M  V30 25 C 6.6685 5.3901 0.0 0
M  V30 26 C 8.0022 4.6201 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 8.0022 3.0801 0.0 0
M  V30 29 C 5.3348 3.0801 0.0 0
M  V30 30 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 8 15
M  V30 16 1 10 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 23 24
M  V30 24 1 23 30
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2R)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-(4-m...
C22H38N2O5Si
1227750-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 3 N 8.0022 7.7002 0.0 0
M  V30 4 O 4.0010 6.9302 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 C 9.3360 6.9302 0.0 0
M  V30 7 Si 2.6673 7.7002 0.0 0
M  V30 8 N 6.6685 10.0102 0.0 0
M  V30 9 O 4.0010 10.0102 0.0 0
M  V30 10 O 10.6697 7.7002 0.0 0
M  V30 11 O 9.3360 5.3901 0.0 0
M  V30 12 C 1.3337 8.4702 0.0 0
M  V30 13 C 3.4374 9.0338 0.0 0
M  V30 14 C 1.8973 6.3665 0.0 0
M  V30 15 C 6.6685 11.5503 0.0 0
M  V30 16 C 12.0033 6.9302 0.0 0
M  V30 17 C 2.1037 9.8039 0.0 0
M  V30 18 C 0.0000 9.2402 0.0 0
M  V30 19 C 0.5637 7.1365 0.0 0
M  V30 20 C 11.2333 5.5965 0.0 0
M  V30 21 C 13.3370 6.1601 0.0 0
M  V30 22 C 12.7733 8.2638 0.0 0
M  V30 23 O 6.6685 0.7700 0.0 0
M  V30 24 C 5.3348 0.0000 0.0 0
M  V30 25 C 6.6685 5.3901 0.0 0
M  V30 26 C 8.0022 4.6201 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 8.0022 3.0801 0.0 0
M  V30 29 C 5.3348 3.0801 0.0 0
M  V30 30 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 8 15
M  V30 16 1 10 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 23 24
M  V30 24 1 23 30
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227750-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227750-81-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3408768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of the large non-ribosomal peptide polytheonamide B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inoue, Masayuki; Shinohara, Naoki; Tanabe, Shintaro; Takahashi, Tomoaki;
Okura, Ken; Itoh, Hiroaki; Mizoguchi, Yuki; Iida, Maiko; Lee, Nayoung;
Matsuoka, Shigeru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemistry (2010), 2(4), 280-285

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
2-Cyclopentyl-5-[[[3,4-dihydro-6-(trifluoromethoxy)-2H-1,4-benzoxazin-2-yl]ca...
C26H25F3N2O7
1233531-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 9.3358 0.0 0
M  V30 2 C 4.6798 10.6695 0.0 0
M  V30 3 O 3.9098 12.0031 0.0 0
M  V30 4 O 6.2198 10.6695 0.0 0
M  V30 5 C 4.6798 13.3368 0.0 0
M  V30 6 C 6.9898 4.0009 0.0 0
M  V30 7 C 7.7598 2.6673 0.0 0
M  V30 8 C 8.5298 1.3336 0.0 0
M  V30 9 O 7.7598 0.0000 0.0 0
M  V30 10 N 8.5298 6.6684 0.0 0
M  V30 11 C 9.2998 8.0020 0.0 0
M  V30 12 O 8.5298 9.3358 0.0 0
M  V30 13 O 17.7698 9.3357 0.0 0
M  V30 14 C 18.5398 10.6695 0.0 0
M  V30 15 F 17.7698 12.0031 0.0 0
M  V30 16 F 19.3098 12.0031 0.0 0
M  V30 17 F 20.0799 10.6695 0.0 0
M  V30 18 C 3.9098 6.6684 0.0 0
M  V30 19 C 4.6798 8.0020 0.0 0
M  V30 20 C 4.6798 5.3347 0.0 0
M  V30 21 C 6.2198 8.0020 0.0 0
M  V30 22 C 6.2198 5.3347 0.0 0
M  V30 23 C 6.9898 6.6684 0.0 0
M  V30 24 C 2.3698 6.6684 0.0 0
M  V30 25 C 1.4645 5.4225 0.0 0
M  V30 26 C 1.4645 7.9143 0.0 0
M  V30 27 C 0.0000 5.8984 0.0 0
M  V30 28 C 0.0000 7.4384 0.0 0
M  V30 29 C 10.8398 8.0020 0.0 0
M  V30 30 O 11.6098 9.3358 0.0 0
M  V30 31 C 11.6098 6.6684 0.0 0
M  V30 32 C 13.1498 9.3358 0.0 0
M  V30 33 N 13.1498 6.6684 0.0 0
M  V30 34 C 13.9198 8.0020 0.0 0
M  V30 35 C 13.9198 10.6695 0.0 0
M  V30 36 C 15.4598 8.0020 0.0 0
M  V30 37 C 15.4598 10.6695 0.0 0
M  V30 38 C 16.2298 9.3357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 3 6 7
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 2 11 12
M  V30 13 1 11 29
M  V30 14 1 13 14
M  V30 15 1 13 38
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 32 35
M  V30 37 1 33 34
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Cyclopentyl-5-hydroxy-2-[3-(methylamino)-1-propyn-1-yl]phenyl]-3,4-dihyd...
C25H26F3N3O4
1233530-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 8.0020 0.0 0
M  V30 2 C 9.2998 9.3358 0.0 0
M  V30 3 O 8.5298 10.6695 0.0 0
M  V30 4 C 6.9898 5.3347 0.0 0
M  V30 5 C 7.7598 4.0009 0.0 0
M  V30 6 C 8.5298 2.6673 0.0 0
M  V30 7 N 7.7598 1.3336 0.0 0
M  V30 8 C 8.5298 0.0000 0.0 0
M  V30 9 O 3.9098 10.6695 0.0 0
M  V30 10 O 17.7698 10.6695 0.0 0
M  V30 11 C 18.5398 12.0031 0.0 0
M  V30 12 F 17.7698 13.3368 0.0 0
M  V30 13 F 19.3099 13.3368 0.0 0
M  V30 14 F 20.0799 12.0031 0.0 0
M  V30 15 C 6.9898 8.0020 0.0 0
M  V30 16 C 6.2198 6.6684 0.0 0
M  V30 17 C 6.2198 9.3358 0.0 0
M  V30 18 C 4.6798 6.6684 0.0 0
M  V30 19 C 4.6798 9.3358 0.0 0
M  V30 20 C 3.9098 8.0020 0.0 0
M  V30 21 C 10.8398 9.3358 0.0 0
M  V30 22 O 11.6098 10.6695 0.0 0
M  V30 23 C 11.6098 8.0020 0.0 0
M  V30 24 C 13.1498 10.6695 0.0 0
M  V30 25 N 13.1498 8.0020 0.0 0
M  V30 26 C 13.9198 9.3358 0.0 0
M  V30 27 C 13.9198 12.0031 0.0 0
M  V30 28 C 15.4598 9.3358 0.0 0
M  V30 29 C 15.4598 12.0031 0.0 0
M  V30 30 C 16.2298 10.6695 0.0 0
M  V30 31 C 2.3698 8.0020 0.0 0
M  V30 32 C 1.4645 9.2479 0.0 0
M  V30 33 C 1.4645 6.7562 0.0 0
M  V30 34 C 0.0000 8.7720 0.0 0
M  V30 35 C 0.0000 7.2320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 2 21
M  V30 5 3 4 5
M  V30 6 1 4 16
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 20 31
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 26
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1233531-56-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1233530-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-10694841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Cyclopentyl-4-(3-hydroxyprop-1-ynyl)-5-(6-(trifluoromethoxy)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamido)phenyl
methyl carbonate (20 mg, 0.037 mmol) was dissolved in dichloromethane (1
mL) and triethylamine (20 μL, 0.14 mmol) and cooled to 0°C.
Methanesulfonyl chloride (4.3 mg, 2.9 μL, 0.04 mmol) in 1 mL of
dichloromethane was slowly added to the reaction. Conversion to the
mesylate was complete after 10 min. MeNH2 (100 μL of 2 M in THF, 0.20
mmol) was then added and the reaction stirred at room temperature for 10
h. The solution was concentrated in vacuo and purified by HPLC (10-99%
CH3CN/ 0.035% TFA) to provide
N-(4-cyclopentyl-5-hydroxy-2-(3-(methylamino)prop-1-ynyl)phenyl)-6-(trifluoromethoxy)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide
(21 mg, 97% yield).
N-(4-cyclopentyl-5-hydroxy-2-(3-(methylamino)prop-1-ynyl)phenyl)-6-(trifluoromethoxy)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide,
yield (21 mg, 97%). LC/MS m/z 490.4 [M+H]+. LC/RT min; 4.19; 1H NMR
(400.0 MHz, MeOD) δ 7.65 (s, 1H), 7.28 (s, 1H), 6.97 (d, J = 8.7 Hz, 1H),
6.60 (s, 1H), 6.54 (dd, J = 1.8, 8.7 Hz, 1H), 4.78 (dd, J = 3.0, 7.0 Hz,
1H), 4.14 (dd, J = 16.6, 27.1 Hz, 2H), 3.67 (dd, J = 3.0, 12.1 Hz, 1H),
3.49-3.44 (m, 1H), 3.24 (m, 1H), 2.79 (s, 3H), 2.05-1.92 (m, 2H),
1.81-1.77 (m, 2H), 1.71-1.68 (m, 2H), 1.54-1.51 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzo[b][1,4]oxazine-2-carboxamides as modulators of
cystic fibrosis transmembrane conductance regulator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Binch, Hayley; Hurley, Dennis; Fanning, Lev T.D.; Grootenhuis, Peter
D.J.; Botfield, Martyn; Van Goor, Fredrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100168094 A1 2010-07-01

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis[dichloro[η5-(pentamethylcyclopentadienyl)]rhodium]
C20H30Cl4Rh2
12354-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.5489 5.0684 0.0 0 CHG=-1 VAL=1
M  V30 2 C 0.0000 7.6734 0.0 0
M  V30 3 C 4.1079 7.6734 0.0 0
M  V30 4 C 2.3262 7.7870 0.0 0
M  V30 5 C 1.7817 7.7870 0.0 0
M  V30 6 C 2.0432 9.1248 0.0 0
M  V30 7 Cl 5.9946 4.0564 0.0 0 CHG=-1 VAL=1
M  V30 8 C 6.5628 1.4386 0.0 0
M  V30 9 C 2.4570 1.4515 0.0 0
M  V30 10 C 4.2365 1.3357 0.0 0
M  V30 11 C 4.7833 1.3357 0.0 0
M  V30 12 C 4.5002 0.0000 0.0 0
M  V30 13 Rh 2.0432 5.4972 0.0 0 CHG=3 VAL=8
M  V30 14 C 0.7611 7.5104 0.0 0 VAL=5
M  V30 15 C 3.3489 7.5104 0.0 0 CHG=-1 VAL=4
M  V30 16 C 2.5278 7.0366 0.0 0 VAL=5
M  V30 17 C 1.5801 7.0366 0.0 0 VAL=5
M  V30 18 C 2.0432 8.3466 0.0 0 VAL=5
M  V30 19 Cl 4.5002 5.4972 0.0 0 CHG=-1 VAL=2
M  V30 20 Cl 2.0389 3.6276 0.0 0 CHG=-1 VAL=2
M  V30 21 Rh 4.5002 3.6276 0.0 0 CHG=3 VAL=8
M  V30 22 C 5.8059 1.6123 0.0 0 CHG=-1 VAL=4
M  V30 23 C 3.2181 1.6123 0.0 0 VAL=5
M  V30 24 C 4.0350 2.0883 0.0 0 VAL=5
M  V30 25 C 4.9848 2.0883 0.0 0 VAL=5
M  V30 26 C 4.5002 0.7783 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 5 17
M  V30 6 1 6 18
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 23
M  V30 10 1 10 24
M  V30 11 1 11 25
M  V30 12 1 12 26
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 14 17
M  V30 21 2 14 18
M  V30 22 1 15 16
M  V30 23 1 15 18
M  V30 24 2 16 17
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 1 21 24
M  V30 30 1 21 25
M  V30 31 1 21 26
M  V30 32 1 22 25
M  V30 33 1 22 26
M  V30 34 1 23 24
M  V30 35 2 23 26
M  V30 36 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dichloro(methanamine)[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-...
C11H20Cl2NRh
956591-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.6287 0.7712 0.0 0 VAL=4
M  V30 2 C 4.3638 1.1940 0.0 0
M  V30 3 Cl 0.9603 0.7712 0.0 0 CHG=-1 VAL=1
M  V30 4 Cl 2.2945 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 5 C 1.9291 3.7434 0.0 0
M  V30 6 C 2.2945 5.2264 0.0 0
M  V30 7 C 4.5890 3.7116 0.0 0
M  V30 8 C 2.6620 3.7434 0.0 0
M  V30 9 C 0.0000 3.7116 0.0 0
M  V30 10 Rh 2.2945 1.5403 0.0 0 CHG=3 VAL=8
M  V30 11 C 1.7294 2.9977 0.0 0 CHG=-1 VAL=4
M  V30 12 C 2.2945 4.4552 0.0 0 VAL=5
M  V30 13 C 3.8327 3.5650 0.0 0 VAL=5
M  V30 14 C 2.8618 2.9977 0.0 0 VAL=5
M  V30 15 C 0.7563 3.5650 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 13
M  V30 18 2 12 15
M  V30 19 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956591-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-1485762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of [Rh(Cp*)Cl2(NH2R)] [R = Me (2a), To (2b)].To a solution of
[Rh(Cp*)Cl(μ-Cl)]2 (2a: 250 mg, 0.40 mmol; 2b: 102.5 mg, 0.16 mmol) in
CH2Cl2 (15 mL) was added NH2R (2a: R = Me, 100.7 μL, 0.81 mmol; 2b: R =
To, 35.5 mg, 0.33 mmol). After 1 (2a) or 24 (2b) h of being stirred, the
solution was concentrated under a vacuum (1 mL) and Et2O (25 mL) was
added. The resulting suspension was filtered and the solid washed with
Et2O (3 X 5 mL) and dried by suction (2a) or under a vacuum for 12 h (2b)
to give an orange solid. Compound 2a, Yield: 266 mg, 97% mp (dec): 185
°C. 1H NMR (200 MHz, CDCl3): δ 1.71 (s, 15 H, Me, Cp*), 2.64 (t, 3 H, Me,
3JH,H = 6 Hz), 3.01 (br, 2 H, NH2). 13C{1H} APT NMR (50 MHz, CDCl3): δ
9.26 (Me, Cp*), 31.5 (Me), 93.3 (d, C, Cp*, 1JCRh = 9 Hz). IR (cm-1): νNH
3318, 3202, 3126. ^M (Ω-1 cm2 mol-1): 2.5. Anal. Calcd for C11H20Cl2NRh:
C, 38.85; H, 5.93; N, 4.12. Found: C, 38.99; H, 6.15; N, 4.22.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM On the Reactivity Toward Ketones of New Methyl Amino Complexes of Rh(III)
and Ag(I). Synthesis of Ortho-Rhodiated Acetophenone Methyl Imine
Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vicente, Jose; Chicote, Maria Teresa; Vicente-Hernandez, Inmaculada;
Bautista, Delia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2007), 46(21), 8939-8949

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-4-hydroxy-6,7-dimethoxy-2-oxo-1-(2-propen-1-yl)-3-quinolin...
C16H17NO6
1248483-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 C 4.6201 0.0000 0.0 0
M  V30 4 O 7.7001 8.0022 0.0 0
M  V30 5 O 7.7001 2.6673 0.0 0
M  V30 6 O 0.7700 6.6684 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 C 9.2401 5.3348 0.0 0
M  V30 9 O 10.0101 6.6684 0.0 0
M  V30 10 O 10.0101 4.0011 0.0 0
M  V30 11 C 11.5501 6.6684 0.0 0
M  V30 12 O 2.3100 9.3359 0.0 0
M  V30 13 C 3.0800 10.6695 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 5.3901 6.6684 0.0 0
M  V30 16 N 5.3901 4.0011 0.0 0
M  V30 17 C 3.0800 5.3348 0.0 0
M  V30 18 C 6.9301 6.6684 0.0 0
M  V30 19 C 4.6201 8.0022 0.0 0
M  V30 20 C 6.9301 4.0011 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 7.7001 5.3348 0.0 0
M  V30 23 C 3.0800 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 4 18
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 23
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-4-hydroxy-6,7-dimethoxy-N-methyl-2-oxo-1-(2-propen-1-yl)-3-quinol...
C16H18N2O5
876891-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 C 4.6201 0.0000 0.0 0
M  V30 4 O 7.7001 8.0022 0.0 0
M  V30 5 O 7.7001 2.6673 0.0 0
M  V30 6 O 0.7700 6.6684 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 C 9.2401 5.3348 0.0 0
M  V30 9 N 10.0101 6.6684 0.0 0
M  V30 10 O 10.0101 4.0011 0.0 0
M  V30 11 C 11.5501 6.6684 0.0 0
M  V30 12 O 2.3100 9.3359 0.0 0
M  V30 13 C 3.0800 10.6695 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 5.3901 6.6684 0.0 0
M  V30 16 N 5.3901 4.0011 0.0 0
M  V30 17 C 3.0800 5.3348 0.0 0
M  V30 18 C 6.9301 6.6684 0.0 0
M  V30 19 C 4.6201 8.0022 0.0 0
M  V30 20 C 6.9301 4.0011 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 7.7001 5.3348 0.0 0
M  V30 23 C 3.0800 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 4 18
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 23
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1248483-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876891-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4322051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM no exptl. detail, literature prepn.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Hydroxy-2-quinolones. 180*. Synthesis, chemical reactions, and
analgesic activity of
1-allyl-4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3-carboxylic
acid alkylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Mospanova, E. V.; Davidenko, A. A.; Shishkina, S. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2010),
46(9), 1084-1095

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Iodoethyl)-2-[4-methoxy-2-(methoxymethoxy)phenyl]-1-[(4-methylphenyl)sul...
C26H26INO5S
1255648-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.3791 7.3594 0.0 0 VAL=6
M  V30 2 O 9.8550 8.8241 0.0 0
M  V30 3 O 8.9032 5.8948 0.0 0
M  V30 4 C 3.9579 7.3594 0.0 0
M  V30 5 C 2.8135 8.3899 0.0 0
M  V30 6 I 1.3488 7.9139 0.0 0
M  V30 7 O 4.0012 5.3901 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 O 1.3337 5.3901 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 O 6.6685 0.7700 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 15.2377 5.4559 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 N 7.9144 7.8352 0.0 0
M  V30 16 C 5.4226 7.8352 0.0 0
M  V30 17 C 7.4385 9.3000 0.0 0
M  V30 18 C 5.8985 9.3000 0.0 0
M  V30 19 C 8.2085 10.6336 0.0 0
M  V30 20 C 5.1285 10.6336 0.0 0
M  V30 21 C 7.4385 11.9673 0.0 0
M  V30 22 C 5.8985 11.9673 0.0 0
M  V30 23 C 6.6685 5.3901 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 8.0022 4.6201 0.0 0
M  V30 26 C 5.3348 3.0801 0.0 0
M  V30 27 C 8.0022 3.0801 0.0 0
M  V30 28 C 6.6685 2.3101 0.0 0
M  V30 29 C 10.8437 6.8835 0.0 0
M  V30 30 C 11.9882 7.9139 0.0 0
M  V30 31 C 11.1640 5.3772 0.0 0
M  V30 32 C 13.4528 7.4381 0.0 0
M  V30 33 C 12.6286 4.9012 0.0 0
M  V30 34 C 13.7731 5.9317 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 28
M  V30 14 1 13 34
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 23
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-Methoxy-2-(methoxymethoxy)phenyl]-N-methyl-1-[(4-methylphenyl)sulfonyl]-...
C27H30N2O5S
1255648-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.1745 7.3592 0.0 0 VAL=6
M  V30 2 O 8.6987 5.8947 0.0 0
M  V30 3 O 9.6506 8.8239 0.0 0
M  V30 4 C 3.7536 7.3592 0.0 0
M  V30 5 C 2.6091 8.3898 0.0 0
M  V30 6 N 1.1445 7.9138 0.0 0
M  V30 7 C 0.0000 8.9443 0.0 0
M  V30 8 O 3.7967 5.3900 0.0 0
M  V30 9 C 2.4631 4.6200 0.0 0
M  V30 10 O 2.4631 3.0800 0.0 0
M  V30 11 C 1.1294 2.3100 0.0 0
M  V30 12 O 6.4641 0.7700 0.0 0
M  V30 13 C 7.7978 0.0000 0.0 0
M  V30 14 C 15.0332 5.4558 0.0 0
M  V30 15 C 6.4641 6.9300 0.0 0
M  V30 16 N 7.7100 7.8351 0.0 0
M  V30 17 C 5.2181 7.8351 0.0 0
M  V30 18 C 7.2341 9.2998 0.0 0
M  V30 19 C 5.6941 9.2998 0.0 0
M  V30 20 C 8.0041 10.6334 0.0 0
M  V30 21 C 4.9241 10.6334 0.0 0
M  V30 22 C 7.2341 11.9670 0.0 0
M  V30 23 C 5.6941 11.9670 0.0 0
M  V30 24 C 6.4641 5.3900 0.0 0
M  V30 25 C 5.1304 4.6200 0.0 0
M  V30 26 C 7.7978 4.6200 0.0 0
M  V30 27 C 5.1304 3.0800 0.0 0
M  V30 28 C 7.7978 3.0800 0.0 0
M  V30 29 C 6.4641 2.3100 0.0 0
M  V30 30 C 10.6392 6.8833 0.0 0
M  V30 31 C 11.7836 7.9138 0.0 0
M  V30 32 C 10.9594 5.3771 0.0 0
M  V30 33 C 13.2483 7.4379 0.0 0
M  V30 34 C 12.4241 4.9011 0.0 0
M  V30 35 C 13.5685 5.9316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 24
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1255648-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1255648-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10954868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lessons from the total synthesis of (±)-phalarine: insights into the
mechanism of the Pictet-Spengler reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trzupek, John D.; Li, Chaomin; Chan, Collin; Crowley, Brendan M.;
Heimann, Annekatrin C.; Danishefsky, Samuel J.IUPAC Commission
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pure and Applied Chemistry (2010), 82(9), 1735-1748

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromo-3-pyridinesulfonyl chloride
C5H2Br2ClNO2S
1261587-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 Br 1.3338 4.4137 0.0 0
M  V30 6 Br 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 N 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-chloro-N-methyl-3-pyridinesulfonamide
C6H6BrClN2O2S
1383995-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Cl 0.0000 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 N 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1261587-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383995-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-174-CAS-6370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-bromo-5-chloro-N-methyl-3-pyridinesulfonamide To a solution of
2-bromo-5-chloro-3-pyridinesulfonyl chloride (275 mg, 0.95 mmol) prepared
as described in example 158 in anhydrous THF (6 mL) cooled to 0 °C was
added methylamine (1 mL, 2M in THF) and the reaction stirred for 5
minutes. The reaction was poured into ethyl acetate and washed with
water, brine and dried over anhydrous MgSO4 and evaporated to give the
title compound which was used without additional purification. Yield (263
mg, 97%). ES-LCMS: m/z = 284.77 (M + 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinone derivatives as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banka, Anna Lindsey; Botyanszki, Janos; Duan, Maosheng; Leivers, Martin
Robert; Shotwell, John Bradford; Tallant, Matthew David; Dickerson, Scott
Howard; Tai, Vincent W.-F.; McFadyen, Robert Blount; Redman, Aniko Maria;
Yu, Jianjun; Li, Xiofei; Garrido, Dulce Maria; Catalano, John George;
Adjabeng, George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012087938 A1 2012-06-28

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl)-2-(4-thiazolyl)-1H-benzimidazole-5-carboxylic acid
C18H13N3O2S
1277098-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 3.7534 0.0 0
M  V30 2 C 1.3336 8.0040 0.0 0
M  V30 3 O 0.0000 7.2340 0.0 0
M  V30 4 O 1.3336 9.5440 0.0 0
M  V30 5 N 6.7994 5.2181 0.0 0
M  V30 6 C 7.7046 6.4640 0.0 0
M  V30 7 C 5.3347 5.6940 0.0 0
M  V30 8 N 6.7994 7.7099 0.0 0
M  V30 9 C 5.3347 7.2340 0.0 0
M  V30 10 C 4.0011 4.9240 0.0 0
M  V30 11 C 4.0011 8.0040 0.0 0
M  V30 12 C 2.6674 5.6940 0.0 0
M  V30 13 C 2.6674 7.2340 0.0 0
M  V30 14 C 9.2446 6.4640 0.0 0
M  V30 15 C 10.1497 5.2181 0.0 0
M  V30 16 N 10.1497 7.7099 0.0 0
M  V30 17 S 11.6144 5.6940 0.0 0
M  V30 18 C 11.6144 7.2340 0.0 0
M  V30 19 C 6.2449 2.6091 0.0 0
M  V30 20 C 4.7384 2.9292 0.0 0
M  V30 21 C 6.7207 1.1444 0.0 0
M  V30 22 C 3.7080 1.7849 0.0 0
M  V30 23 C 5.6901 0.0000 0.0 0
M  V30 24 C 4.1839 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 9
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(phenylmethyl)-2-(4-thiazolyl)-1H-benzimidazole-5-carboxamide
C19H16N4OS
1277098-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7876 4.5192 0.0 0
M  V30 2 C 10.0585 5.2294 0.0 0
M  V30 3 N 10.8285 6.5631 0.0 0
M  V30 4 O 10.8285 3.8958 0.0 0
M  V30 5 C 12.3685 6.5631 0.0 0
M  V30 6 N 3.9320 5.5496 0.0 0
M  V30 7 C 3.7710 7.0812 0.0 0
M  V30 8 C 5.4384 5.2294 0.0 0
M  V30 9 N 5.1780 7.7076 0.0 0
M  V30 10 C 6.2084 6.5631 0.0 0
M  V30 11 C 6.2084 3.8958 0.0 0
M  V30 12 C 7.7484 6.5631 0.0 0
M  V30 13 C 7.7484 3.8958 0.0 0
M  V30 14 C 8.5185 5.2294 0.0 0
M  V30 15 C 2.4374 7.8512 0.0 0
M  V30 16 C 1.0304 7.2248 0.0 0
M  V30 17 N 2.2765 9.3829 0.0 0
M  V30 18 S 0.0000 8.3692 0.0 0
M  V30 19 C 0.7700 9.7030 0.0 0
M  V30 20 C 3.1078 3.0127 0.0 0
M  V30 21 C 1.9634 1.9823 0.0 0
M  V30 22 C 4.5725 2.5369 0.0 0
M  V30 23 C 2.2835 0.4760 0.0 0
M  V30 24 C 4.8926 1.0306 0.0 0
M  V30 25 C 3.7481 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 10
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1277098-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1277098-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6855684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anti-hepatitis B virus activity of a novel class of
thiazolylbenzimidazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Yu; Yao, Jia-Ping; Yang, Li; Feng, Chun-Lan; Tang, Wei; Wang,
Gui-Feng; Zuo, Jian-Pin; Lu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2011), 344(2), 78-83

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3-dihydro-5-methoxy-1,3-dimethyl-2-oxo-1H-indole-3-acetate
C14H17NO4
129011-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6664 3.6643 0.0 0
M  V30 2 C 8.4364 4.9979 0.0 0
M  V30 3 O 9.9764 4.9979 0.0 0
M  V30 4 O 7.6664 6.3317 0.0 0
M  V30 5 C 10.7464 6.3317 0.0 0
M  V30 6 C 6.2874 5.1958 0.0 0
M  V30 7 O 7.6210 1.3627 0.0 0
M  V30 8 C 4.5602 0.0000 0.0 0
M  V30 9 O 1.5400 6.6519 0.0 0
M  V30 10 C 0.0000 6.6519 0.0 0
M  V30 11 C 4.6200 3.9844 0.0 0
M  V30 12 C 6.1264 3.6643 0.0 0
M  V30 13 C 3.8500 2.6508 0.0 0
M  V30 14 C 3.8500 5.3182 0.0 0
M  V30 15 C 6.2874 2.1327 0.0 0
M  V30 16 N 4.8806 1.5064 0.0 0
M  V30 17 C 2.3100 2.6508 0.0 0
M  V30 18 C 2.3100 5.3182 0.0 0
M  V30 19 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 15
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-5-methoxy-N,1,3-trimethyl-2-oxo-1H-indole-3-acetamide
C14H18N2O3
174418-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6664 3.6643 0.0 0
M  V30 2 C 8.4364 4.9979 0.0 0
M  V30 3 N 9.9764 4.9979 0.0 0
M  V30 4 O 7.6664 6.3317 0.0 0
M  V30 5 C 10.7464 6.3317 0.0 0
M  V30 6 C 6.2874 5.1958 0.0 0
M  V30 7 O 7.6210 1.3627 0.0 0
M  V30 8 C 4.5602 0.0000 0.0 0
M  V30 9 O 1.5400 6.6519 0.0 0
M  V30 10 C 0.0000 6.6519 0.0 0
M  V30 11 C 4.6200 3.9844 0.0 0
M  V30 12 C 6.1264 3.6643 0.0 0
M  V30 13 C 3.8500 2.6508 0.0 0
M  V30 14 C 3.8500 5.3182 0.0 0
M  V30 15 C 6.2874 2.1327 0.0 0
M  V30 16 N 4.8806 1.5064 0.0 0
M  V30 17 C 2.3100 2.6508 0.0 0
M  V30 18 C 2.3100 5.3182 0.0 0
M  V30 19 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 15
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 129011-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 174418-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38003281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Fe-catalyzed radical cyclization for the synthesis of
oxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Tianxiang; Qu, Ruina; Song, Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2023), 21(40), 8089-8093

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromophenyl isothiocyanate
C7H4BrNS
13037-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 3.0800 0.0 0
M  V30 4 Br 1.3338 0.0000 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 1.3338 1.5400 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3338 4.6200 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromophenyl)-N′-methylthiourea
C8H9BrN2S
52599-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 S 5.3347 3.8500 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 Br 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13037-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52599-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-11757813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-substituted benzothiazoles by palladium-catalyzed
intramolecular cyclization of o-bromophenylthioureas and
o-bromophenylthioamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benedi, Carolina; Bravo, Fernando; Uriz, Pedro; Fernandez, Elena; Claver,
Carmen; Castillon, Sergio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(32), 6073-6077

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3a,8-Diethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indol-2-one
C14H17NO2
1312132-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4254 5.6719 0.0 0
M  V30 2 C 5.6714 6.5771 0.0 0
M  V30 3 C 3.0203 0.4760 0.0 0
M  V30 4 C 1.5557 0.0000 0.0 0
M  V30 5 O 8.5554 3.7832 0.0 0
M  V30 6 C 4.5865 4.1403 0.0 0 CFG=2
M  V30 7 C 4.7474 2.6086 0.0 0 CFG=2
M  V30 8 C 3.0800 4.4605 0.0 0
M  V30 9 C 5.9933 4.7666 0.0 0
M  V30 10 N 3.3406 1.9823 0.0 0
M  V30 11 O 6.2538 2.2885 0.0 0
M  V30 12 C 2.3100 3.1267 0.0 0
M  V30 13 C 2.3100 5.7941 0.0 0
M  V30 14 C 7.0238 3.6221 0.0 0
M  V30 15 C 0.7700 3.1267 0.0 0
M  V30 16 C 0.7700 5.7941 0.0 0
M  V30 17 C 0.0000 4.4605 0.0 0
M  V30 18 H 4.9083 1.0771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 18 CFG=1
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 12
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3a,8-Diethyl-3,3a,8,8a-tetrahydro-1-methylpyrrolo[2,3-b]indol-2...
C15H20N2O
1312132-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4254 5.6719 0.0 0
M  V30 2 C 5.6714 6.5771 0.0 0
M  V30 3 C 3.0203 0.4760 0.0 0
M  V30 4 C 1.5557 0.0000 0.0 0
M  V30 5 C 6.8802 0.8817 0.0 0
M  V30 6 O 8.5554 3.7832 0.0 0
M  V30 7 C 4.5865 4.1403 0.0 0 CFG=2
M  V30 8 C 4.7474 2.6086 0.0 0 CFG=2
M  V30 9 C 3.0800 4.4605 0.0 0
M  V30 10 C 5.9933 4.7667 0.0 0
M  V30 11 N 3.3406 1.9823 0.0 0
M  V30 12 N 6.2539 2.2885 0.0 0
M  V30 13 C 2.3100 3.1267 0.0 0
M  V30 14 C 2.3100 5.7942 0.0 0
M  V30 15 C 7.0239 3.6221 0.0 0
M  V30 16 C 0.7700 3.1267 0.0 0
M  V30 17 C 0.7700 5.7942 0.0 0
M  V30 18 C 0.0000 4.4605 0.0 0
M  V30 19 H 4.9084 1.0771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 12
M  V30 6 2 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 19 CFG=1
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-34-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312132-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15428172
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-8-methyl-3a-(3-methyl-2-buten-1-yl)-2H-fur...
C16H19NO2
1312132-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 4.5411 0.0 0
M  V30 2 C 6.6520 3.7711 0.0 0
M  V30 3 C 7.9856 4.5411 0.0 0
M  V30 4 C 7.9856 6.0811 0.0 0
M  V30 5 C 9.3193 3.7711 0.0 0
M  V30 6 C 0.0000 3.7115 0.0 0
M  V30 7 O 5.2726 0.0000 0.0 0
M  V30 8 C 3.9845 3.7711 0.0 0 CFG=1
M  V30 9 C 3.6643 5.2775 0.0 0
M  V30 10 C 2.6508 3.0010 0.0 0 CFG=2
M  V30 11 C 5.1291 2.7406 0.0 0
M  V30 12 C 2.1328 5.4384 0.0 0
M  V30 13 C 4.5696 6.5234 0.0 0
M  V30 14 N 1.5063 4.0316 0.0 0
M  V30 15 O 2.9710 1.4947 0.0 0
M  V30 16 C 4.5026 1.3338 0.0 0
M  V30 17 C 1.5063 6.8454 0.0 0
M  V30 18 C 3.9431 7.9302 0.0 0
M  V30 19 C 2.4115 8.0913 0.0 0
M  V30 20 H 1.3172 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 2 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 20 CFG=1
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1,8-dimethyl-3a-(3-methyl-2-buten-1-yl)pyr...
C17H22N2O
1312132-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 4.5411 0.0 0
M  V30 2 C 6.6520 3.7711 0.0 0
M  V30 3 C 7.9856 4.5411 0.0 0
M  V30 4 C 7.9856 6.0811 0.0 0
M  V30 5 C 9.3193 3.7711 0.0 0
M  V30 6 C 0.0000 3.7115 0.0 0
M  V30 7 C 1.9406 0.3502 0.0 0
M  V30 8 O 5.2726 0.0000 0.0 0
M  V30 9 C 3.9845 3.7711 0.0 0 CFG=2
M  V30 10 C 2.6508 3.0010 0.0 0 CFG=2
M  V30 11 C 3.6643 5.2775 0.0 0
M  V30 12 C 5.1291 2.7406 0.0 0
M  V30 13 N 1.5063 4.0316 0.0 0
M  V30 14 N 2.9710 1.4947 0.0 0
M  V30 15 C 2.1328 5.4384 0.0 0
M  V30 16 C 4.5696 6.5234 0.0 0
M  V30 17 C 4.5026 1.3338 0.0 0
M  V30 18 C 1.5063 6.8454 0.0 0
M  V30 19 C 3.9431 7.9302 0.0 0
M  V30 20 C 2.4115 8.0913 0.0 0
M  V30 21 H 1.3172 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 13
M  V30 7 1 7 14
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 21 CFG=1
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312132-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2035138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-3a-(3-methyl-2-buten-1-yl)-8-(phenylmethyl...
C22H23NO2
1312132-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8025 4.3328 0.0 0
M  V30 2 C 10.3089 4.0126 0.0 0
M  V30 3 C 11.3393 5.1572 0.0 0
M  V30 4 C 12.8458 4.8368 0.0 0
M  V30 5 C 10.8635 6.6217 0.0 0
M  V30 6 C 4.0011 1.9004 0.0 0
M  V30 7 O 10.1625 0.0000 0.0 0
M  V30 8 C 7.7721 3.1884 0.0 0 CFG=2
M  V30 9 C 6.7417 2.0439 0.0 0 CFG=2
M  V30 10 C 7.0021 4.5221 0.0 0
M  V30 11 C 9.1790 2.5619 0.0 0
M  V30 12 N 5.3347 2.6704 0.0 0
M  V30 13 O 7.5117 0.7102 0.0 0
M  V30 14 C 5.4958 4.2019 0.0 0
M  V30 15 C 7.4779 5.9867 0.0 0
M  V30 16 C 9.0179 1.0304 0.0 0
M  V30 17 C 4.4652 5.3463 0.0 0
M  V30 18 C 6.4475 7.1311 0.0 0
M  V30 19 C 4.9411 6.8110 0.0 0
M  V30 20 C 2.6674 2.6704 0.0 0
M  V30 21 C 1.3338 1.9004 0.0 0
M  V30 22 C 2.6674 4.2104 0.0 0
M  V30 23 C 0.0000 2.6704 0.0 0
M  V30 24 C 1.3338 4.9804 0.0 0
M  V30 25 C 0.0000 4.2104 0.0 0
M  V30 26 H 5.7111 0.8995 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 1 6 20
M  V30 8 2 7 16
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 26 CFG=1
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 12 14
M  V30 19 1 13 16
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a-(3-methyl-2-buten-1-yl)-8-(phe...
C23H26N2O
932042-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8023 5.0294 0.0 0
M  V30 2 C 10.3087 4.7092 0.0 0
M  V30 3 C 11.3391 5.8536 0.0 0
M  V30 4 C 12.8455 5.5334 0.0 0
M  V30 5 C 10.8633 7.3183 0.0 0
M  V30 6 C 4.0010 2.5969 0.0 0
M  V30 7 C 6.8851 0.0000 0.0 0
M  V30 8 O 10.1623 0.6967 0.0 0
M  V30 9 C 7.7719 3.8849 0.0 0 CFG=2
M  V30 10 C 6.7415 2.7405 0.0 0 CFG=2
M  V30 11 C 7.0020 5.2187 0.0 0
M  V30 12 C 9.1789 3.2586 0.0 0
M  V30 13 N 5.3346 3.3668 0.0 0
M  V30 14 N 7.5115 1.4069 0.0 0
M  V30 15 C 5.4957 4.8985 0.0 0
M  V30 16 C 7.4778 6.6832 0.0 0
M  V30 17 C 9.0178 1.7271 0.0 0
M  V30 18 C 4.4652 6.0429 0.0 0
M  V30 19 C 6.4474 7.8277 0.0 0
M  V30 20 C 4.9410 7.5075 0.0 0
M  V30 21 C 2.6674 3.3668 0.0 0
M  V30 22 C 1.3338 2.5969 0.0 0
M  V30 23 C 2.6674 4.9068 0.0 0
M  V30 24 C 0.0000 3.3668 0.0 0
M  V30 25 C 1.3338 5.6768 0.0 0
M  V30 26 C 0.0000 4.9068 0.0 0
M  V30 27 H 5.7110 1.5962 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 13
M  V30 7 1 6 21
M  V30 8 1 7 14
M  V30 9 2 8 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 27 CFG=1
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 13 15
M  V30 20 1 14 17
M  V30 21 2 15 18
M  V30 22 1 16 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 932042-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4120861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-8-(phenylmethyl)-3a-(4-pyridinylmethyl)-2H...
C23H20N2O2
1312132-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.2477 0.0 0
M  V30 2 C 8.8109 5.6252 0.0 0
M  V30 3 O 2.3890 6.2031 0.0 0
M  V30 4 C 5.3901 3.5813 0.0 0 CFG=2
M  V30 5 C 6.1601 4.9150 0.0 0 CFG=2
M  V30 6 C 6.4205 2.4369 0.0 0
M  V30 7 C 3.8836 3.9015 0.0 0
M  V30 8 N 7.6664 4.5948 0.0 0
M  V30 9 O 5.1295 6.0595 0.0 0
M  V30 10 C 7.8273 3.0633 0.0 0
M  V30 11 C 6.2596 0.9052 0.0 0
M  V30 12 C 3.7227 5.4331 0.0 0
M  V30 13 C 9.0734 2.1580 0.0 0
M  V30 14 C 7.5055 0.0000 0.0 0
M  V30 15 C 8.9123 0.6265 0.0 0
M  V30 16 C 3.0800 2.2477 0.0 0
M  V30 17 C 2.3100 3.5813 0.0 0
M  V30 18 C 2.3100 0.9139 0.0 0
M  V30 19 C 0.7700 3.5813 0.0 0
M  V30 20 C 0.7700 0.9139 0.0 0
M  V30 21 N 0.0000 2.2477 0.0 0
M  V30 22 C 10.2755 5.1494 0.0 0
M  V30 23 C 10.5957 3.6431 0.0 0
M  V30 24 C 11.4200 6.1800 0.0 0
M  V30 25 C 12.0604 3.1672 0.0 0
M  V30 26 C 12.8846 5.7039 0.0 0
M  V30 27 C 13.2048 4.1976 0.0 0
M  V30 28 H 6.9301 6.2488 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 1 1 16
M  V30 3 1 2 8
M  V30 4 1 2 22
M  V30 5 2 3 12
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 28 CFG=1
M  V30 12 1 6 10
M  V30 13 2 6 11
M  V30 14 1 7 12
M  V30 15 1 8 10
M  V30 16 1 9 12
M  V30 17 2 10 13
M  V30 18 1 11 14
M  V30 19 1 13 15
M  V30 20 2 14 15
M  V30 21 1 16 17
M  V30 22 2 16 18
M  V30 23 2 17 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-8-(phenylmethyl)-3a-(4-pyridinylm...
C24H23N3O
1312132-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3183 0.0 0
M  V30 2 C 8.8108 1.9406 0.0 0
M  V30 3 C 5.4498 0.0000 0.0 0
M  V30 4 O 2.3890 1.3628 0.0 0
M  V30 5 C 5.3900 3.9845 0.0 0 CFG=2
M  V30 6 C 6.1600 2.6508 0.0 0 CFG=2
M  V30 7 C 6.4204 5.1290 0.0 0
M  V30 8 C 3.8836 3.6643 0.0 0
M  V30 9 N 7.6663 2.9710 0.0 0
M  V30 10 N 5.1295 1.5064 0.0 0
M  V30 11 C 7.8272 4.5025 0.0 0
M  V30 12 C 6.2595 6.6605 0.0 0
M  V30 13 C 3.7227 2.1328 0.0 0
M  V30 14 C 9.0733 5.4077 0.0 0
M  V30 15 C 7.5054 7.5658 0.0 0
M  V30 16 C 8.9122 6.9393 0.0 0
M  V30 17 C 3.0800 5.3183 0.0 0
M  V30 18 C 2.3100 3.9845 0.0 0
M  V30 19 C 2.3100 6.6519 0.0 0
M  V30 20 C 0.7700 3.9845 0.0 0
M  V30 21 C 0.7700 6.6519 0.0 0
M  V30 22 N 0.0000 5.3183 0.0 0
M  V30 23 C 10.2754 2.4164 0.0 0
M  V30 24 C 10.5956 3.9229 0.0 0
M  V30 25 C 11.4199 1.3860 0.0 0
M  V30 26 C 12.0603 4.3987 0.0 0
M  V30 27 C 12.8845 1.8619 0.0 0
M  V30 28 C 13.2046 3.3682 0.0 0
M  V30 29 H 6.9300 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 9
M  V30 4 1 2 23
M  V30 5 1 3 10
M  V30 6 2 4 13
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 29 CFG=3
M  V30 13 1 7 11
M  V30 14 2 7 12
M  V30 15 1 8 13
M  V30 16 1 9 11
M  V30 17 1 10 13
M  V30 18 2 11 14
M  V30 19 1 12 15
M  V30 20 1 14 16
M  V30 21 2 15 16
M  V30 22 1 17 18
M  V30 23 2 17 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312132-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6292517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[[(5-Iodo-2-pyridinyl)methylamino]methyl]cyclohexyl]glycine methyl...
C16H24IN3O2
1313366-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 I 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 O 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[trans-4-[[(5-Iodo-2-pyridinyl)methylamino]methyl]cyclohexyl]amino]-N-meth...
C16H25IN4O
1313366-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 I 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 N 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313366-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313366-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12163326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 132.2:
2-(4-{[(5-Iodo-pyridin-2-yl)-methyl-amino]-methyl}-trans-cyclohexyl-amino)-N-methyl-acetamide.
The mixture of intermediate 130.3 (12.9 g, 30.6 mmol) and methylamine
(33% in EtOH) (191 mL, 1.53 mol) was stirred 16 hours at 80° C. The
mixture was concentrated to dryness and the residue was purified by
normal phase column chromatography, eluting with DCM-MeOH-aq. 30% NH4OH
(200:20:1). The title compound as a beige oil (13.0 g, 29.7 mmol, 97%).
HPLC: Dt Ret =0.68 min; LC-MS: m/z 417.3 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isoquinolinone and quinazolinone derivatives as MDM2 and MDM4 inhibitors
and their preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berghausen, Joerg; Buschmann, Nicole; Furet, Pascal; Gessier, Francois;
Hergovich Lisztwan, Joanna; Holzer, Philipp; Jacoby, Edgar; Kallen,
Joerg; Masuya, Keiichi; Pissot Soldermann, Carole; Ren, Haixia; Stutz,
Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011076786 A1 2011-06-30

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethoxy-2-(phenylmethoxy)benzaldehyde
C16H16O3
131866-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 O 7.7000 4.0011 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 C 10.0100 2.6674 0.0 0
M  V30 6 C 3.0800 6.6685 0.0 0
M  V30 7 O 2.3100 8.0021 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 4.6200 6.6685 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 5.3900 8.0021 0.0 0
M  V30 13 C 6.9300 8.0021 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 3.0800 1.3336 0.0 0
M  V30 17 C 0.0000 1.3336 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 10
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethoxy-N-methyl-2-(phenylmethoxy)benzenemethanamine
C17H21NO2
861409-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.3901 0.0 0
M  V30 2 C 4.0012 4.6201 0.0 0
M  V30 3 C 2.6673 6.9302 0.0 0
M  V30 4 N 1.3337 7.7002 0.0 0
M  V30 5 C 0.0000 6.9302 0.0 0
M  V30 6 O 8.0023 6.9302 0.0 0
M  V30 7 C 9.3360 7.7002 0.0 0
M  V30 8 C 10.6697 6.9302 0.0 0
M  V30 9 C 5.3348 6.9302 0.0 0
M  V30 10 C 4.0012 7.7002 0.0 0
M  V30 11 C 6.6685 7.7002 0.0 0
M  V30 12 C 4.0012 9.2402 0.0 0
M  V30 13 C 6.6685 9.2402 0.0 0
M  V30 14 C 5.3348 10.0102 0.0 0
M  V30 15 C 4.0012 3.0801 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 11
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131866-67-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 861409-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23705348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships of aristoyagonine
derivatives as Brd4 bromodomain inhibitors with X-ray co-crystal research
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoo, Minjin; Park, Tae Hyun; Yoo, Miyoun; Kim, Yeongrin; Lee, Joo-Youn;
Lee, Kyu Myung; Ryu, Seong Eon; Lee, Byung Il; Jung, Kwan-Young; Park,
Chi Hoon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(6), 1686

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthaleneethanol, 6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-1-(1-methylethyl)...
C22H27FO4S
133160-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 0.7700 0.0 0
M  V30 2 C 6.6684 0.0000 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 8.1851 3.3475 0.0 0
M  V30 5 C 8.7118 4.7946 0.0 0
M  V30 6 O 10.2284 5.0620 0.0 0
M  V30 7 S 10.7551 6.5091 0.0 0 VAL=6
M  V30 8 O 11.2817 7.9563 0.0 0
M  V30 9 O 9.3079 7.0358 0.0 0
M  V30 10 O 7.1952 1.6329 0.0 0
M  V30 11 F 0.0000 5.3900 0.0 0
M  V30 12 C 16.5436 4.4022 0.0 0
M  V30 13 C 4.0011 3.0800 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 18 C 5.3347 5.3900 0.0 0
M  V30 19 C 2.6674 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 C 6.6684 4.6200 0.0 0
M  V30 22 C 1.3336 4.6200 0.0 0
M  V30 23 C 12.2022 5.9824 0.0 0
M  V30 24 C 13.3818 6.9724 0.0 0
M  V30 25 C 12.4695 4.4658 0.0 0
M  V30 26 C 14.8290 6.4455 0.0 0
M  V30 27 C 13.9167 3.9390 0.0 0
M  V30 28 C 15.0965 4.9289 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 4 5
M  V30 5 1 17 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 17 10 CFG=3
M  V30 12 1 11 22
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2R)-6-Fluoro-1,2,3,4-tetrahydro-2-[2-(methylamino)ethyl]-1-(1-methylethyl...
C16H24FNO
2242888-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 C 8.1851 3.3474 0.0 0
M  V30 5 C 8.7119 4.7946 0.0 0
M  V30 6 N 10.2285 5.0619 0.0 0
M  V30 7 C 10.7552 6.5091 0.0 0
M  V30 8 O 7.1953 1.6329 0.0 0
M  V30 9 F 0.0000 5.3901 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0 CFG=1
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 2.6675 5.3901 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 4 5
M  V30 5 1 14 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 14 8 CFG=3
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133160-38-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242888-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20428788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carbamate analogs of Mibefradil as calcium channel
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richardson, Thomas E.; Higgin, Michelle; MacDonald, Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018152317 A1 2018-08-23

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-6-[(methylsulfonyl)amino]-3-benzofurancarbox...
C19H16ClNO5S
1331943-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 N 1.5400 3.0800 0.0 0
M  V30 5 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 3.0800 1.5400 0.0 0
M  V30 9 Cl 14.0710 4.6200 0.0 0
M  V30 10 C 5.5411 5.3900 0.0 0
M  V30 11 C 5.5411 3.8500 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 C 4.2074 6.1600 0.0 0
M  V30 14 O 7.0058 3.3741 0.0 0
M  V30 15 C 4.2074 3.0800 0.0 0
M  V30 16 C 7.9110 4.6200 0.0 0
M  V30 17 C 2.8738 5.3900 0.0 0
M  V30 18 C 2.8738 3.8500 0.0 0
M  V30 19 C 9.4510 4.6200 0.0 0
M  V30 20 C 10.2210 5.9536 0.0 0
M  V30 21 C 10.2210 3.2864 0.0 0
M  V30 22 C 11.7610 5.9536 0.0 0
M  V30 23 C 11.7610 3.2864 0.0 0
M  V30 24 C 12.5310 4.6200 0.0 0
M  V30 25 C 1.5400 6.1600 0.0 0
M  V30 26 C 0.7700 7.4936 0.0 0
M  V30 27 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-[(methylsulfonyl)amino]benzofuran...
C20H19ClN2O4S
1331943-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0
M  V30 6 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 7 C 1.5400 9.9395 0.0 0
M  V30 8 O 0.0000 8.3995 0.0 0
M  V30 9 O 3.0800 8.3995 0.0 0
M  V30 10 Cl 14.0710 5.3195 0.0 0
M  V30 11 C 5.5411 4.5495 0.0 0
M  V30 12 C 7.0058 4.0736 0.0 0
M  V30 13 C 5.5411 6.0895 0.0 0
M  V30 14 C 4.2074 3.7795 0.0 0
M  V30 15 C 7.9110 5.3195 0.0 0
M  V30 16 O 7.0058 6.5655 0.0 0
M  V30 17 C 4.2074 6.8595 0.0 0
M  V30 18 C 2.8738 4.5495 0.0 0
M  V30 19 C 2.8738 6.0895 0.0 0
M  V30 20 C 9.4510 5.3195 0.0 0
M  V30 21 C 10.2210 3.9858 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 11.7610 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 12.5310 5.3195 0.0 0
M  V30 26 C 1.5400 3.7795 0.0 0
M  V30 27 C 0.0000 3.7795 0.0 0
M  V30 28 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 26
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1331943-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331943-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1182453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 11:
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
To a solution of
5-cyclopropyl-2-(4-chlorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic
acid (5 g, 11.52 mmol) in dry DMF (30 mL) was added DIPEA (3.3 g, 25.34
mmol) and HATU (5.15 g, 13.5 mmol) at 20°C. After 15 minutes, 2M
Methylamine in THF (23.04 mL, 46.08 mmol) was added dropwise and the
mixture was stirred for another 2 hours before water (60 mL) was added.
The mixture was extracted with EA (3×200 mL), washed with water (2×200
mL), dried and concentrated to afford the compound. Yield: (4.7 g, 97%),
a brown solid. 1H NMR (400 MHz, DMSO-d6) δ ppm 9.32 (br. s., 1H) 8.45 (q,
1H) 7.90 (d, 2H) 7.53-7.64 (m, 3H) 7.16 (s, 1H) 3.06 (s, 3H) 2.83 (d, 3H)
2.21-2.37 (m, 1H) 0.94-1.05 (m, 2H) 0.64-0.73 (m, 2H). LCMS (m/z,
ES+)=419 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuranyl boronic acid derivatives for the treatment of
hepatitis C virus infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chong, Pek Yoke; Miller, John F.; Peat, Andrew James; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013028371 A1 2013-02-28

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-6-[(methylsulfonyl)amino]-3-benzofurancarbox...
C19H16ClNO5S
1331943-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 N 1.5400 3.0800 0.0 0
M  V30 5 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 3.0800 1.5400 0.0 0
M  V30 9 Cl 14.0710 4.6200 0.0 0
M  V30 10 C 5.5411 5.3900 0.0 0
M  V30 11 C 5.5411 3.8500 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 C 4.2074 6.1600 0.0 0
M  V30 14 O 7.0058 3.3741 0.0 0
M  V30 15 C 4.2074 3.0800 0.0 0
M  V30 16 C 7.9110 4.6200 0.0 0
M  V30 17 C 2.8738 5.3900 0.0 0
M  V30 18 C 2.8738 3.8500 0.0 0
M  V30 19 C 9.4510 4.6200 0.0 0
M  V30 20 C 10.2210 5.9536 0.0 0
M  V30 21 C 10.2210 3.2864 0.0 0
M  V30 22 C 11.7610 5.9536 0.0 0
M  V30 23 C 11.7610 3.2864 0.0 0
M  V30 24 C 12.5310 4.6200 0.0 0
M  V30 25 C 1.5400 6.1600 0.0 0
M  V30 26 C 0.7700 7.4936 0.0 0
M  V30 27 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-[(methylsulfonyl)amino]benzofuran...
C20H19ClN2O4S
1331943-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0
M  V30 6 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 7 C 1.5400 9.9395 0.0 0
M  V30 8 O 0.0000 8.3995 0.0 0
M  V30 9 O 3.0800 8.3995 0.0 0
M  V30 10 Cl 14.0710 5.3195 0.0 0
M  V30 11 C 5.5411 4.5495 0.0 0
M  V30 12 C 7.0058 4.0736 0.0 0
M  V30 13 C 5.5411 6.0895 0.0 0
M  V30 14 C 4.2074 3.7795 0.0 0
M  V30 15 C 7.9110 5.3195 0.0 0
M  V30 16 O 7.0058 6.5655 0.0 0
M  V30 17 C 4.2074 6.8595 0.0 0
M  V30 18 C 2.8738 4.5495 0.0 0
M  V30 19 C 2.8738 6.0895 0.0 0
M  V30 20 C 9.4510 5.3195 0.0 0
M  V30 21 C 10.2210 3.9858 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 11.7610 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 12.5310 5.3195 0.0 0
M  V30 26 C 1.5400 3.7795 0.0 0
M  V30 27 C 0.0000 3.7795 0.0 0
M  V30 28 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 26
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1331943-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331943-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3536897
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 11:
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide
To a solution of
5-cyclopropyl-2-(4-chlorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic
acid (5 g, 11.52 mmol) in dry DMF (30 mL) was added DIPEA (3.3 g, 25.34
mmol) and HATU (5.15 g, 13.5 mmol) at 20 °C. After 15 minutes, 2M
Methylamine in THF (23.04 mL, 46.08 mmol) was added dropwise and the
mixture was stirred for another 2 hours before water (60 mL) was added.
The mixture was extracted with EA (3x200 mL), washed with water (2x200
mL), dried and concentrated to afford
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
Brown solid, yield 4.7 g, 97%. 1H NMR (400 MHz, DMSO-d6) δ ppm 9.32 (br.
s., 1 H) 8.45 (q, 1 H) 7.90 (d, 2 H) 7.53 - 7.64 (m, 3 H) 7.16 (s, 1 H)
3.06 (s, 3 H) 2.83 (d, 3 H) 2.21 - 2.37 (m, 1 H) 0.94 - 1.05 (m, 2 H)
0.64 - 0.73 (m, 2 H). LCMS (m/z, ES+) = 419 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran NS5B polymerase inhibitors for use in
combination treatment for Hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walker, Jill; Voitenleitner, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013025992 A1 2013-02-21

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-6-[(methylsulfonyl)amino]-3-benzofurancarbox...
C19H16ClNO5S
1331943-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 N 1.5400 3.0800 0.0 0
M  V30 5 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 3.0800 1.5400 0.0 0
M  V30 9 Cl 14.0710 4.6200 0.0 0
M  V30 10 C 5.5411 5.3900 0.0 0
M  V30 11 C 5.5411 3.8500 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 C 4.2074 6.1600 0.0 0
M  V30 14 O 7.0058 3.3741 0.0 0
M  V30 15 C 4.2074 3.0800 0.0 0
M  V30 16 C 7.9110 4.6200 0.0 0
M  V30 17 C 2.8738 5.3900 0.0 0
M  V30 18 C 2.8738 3.8500 0.0 0
M  V30 19 C 9.4510 4.6200 0.0 0
M  V30 20 C 10.2210 5.9536 0.0 0
M  V30 21 C 10.2210 3.2864 0.0 0
M  V30 22 C 11.7610 5.9536 0.0 0
M  V30 23 C 11.7610 3.2864 0.0 0
M  V30 24 C 12.5310 4.6200 0.0 0
M  V30 25 C 1.5400 6.1600 0.0 0
M  V30 26 C 0.7700 7.4936 0.0 0
M  V30 27 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-[(methylsulfonyl)amino]benzofuran...
C20H19ClN2O4S
1331943-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0
M  V30 6 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 7 C 1.5400 9.9395 0.0 0
M  V30 8 O 0.0000 8.3995 0.0 0
M  V30 9 O 3.0800 8.3995 0.0 0
M  V30 10 Cl 14.0710 5.3195 0.0 0
M  V30 11 C 5.5411 4.5495 0.0 0
M  V30 12 C 7.0058 4.0736 0.0 0
M  V30 13 C 5.5411 6.0895 0.0 0
M  V30 14 C 4.2074 3.7795 0.0 0
M  V30 15 C 7.9110 5.3195 0.0 0
M  V30 16 O 7.0058 6.5655 0.0 0
M  V30 17 C 4.2074 6.8595 0.0 0
M  V30 18 C 2.8738 4.5495 0.0 0
M  V30 19 C 2.8738 6.0895 0.0 0
M  V30 20 C 9.4510 5.3195 0.0 0
M  V30 21 C 10.2210 3.9858 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 11.7610 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 12.5310 5.3195 0.0 0
M  V30 26 C 1.5400 3.7795 0.0 0
M  V30 27 C 0.0000 3.7795 0.0 0
M  V30 28 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 26
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1331943-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331943-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10133607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 11:
5-Cyclopropyl-2-(4-chlorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
A solution of
5-cyclopropyl-2-(4-chlorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic
acid (5 g, 11.52 mmol) in dry DMF (30 mL) was added with DIPEA (3.3 g,
25.34 mmol), HATU (5.15 .g, 13.5 mmol) at 20 °C. After 15 minutes, 2M
methylamine in THF(23.04 mL, 46.08 mmol) was added drop wise and the
mixture was stirred for another 2 hours then added water (60ml). The
mixture was extracted with EA (3×200 mL), washed with water (2×200 mL),
dried and concentrated. a brown solid (4.7 g, 97 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Benzofuranyl)aminoalkyl-substituted boronic acid derivatives and their
preparation and use for the treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad; Haigh, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067663 A1 2012-05-24

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-6-[(methylsulfonyl)amino]-3-benzofurancarbox...
C19H16ClNO5S
1331943-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 N 1.5400 3.0800 0.0 0
M  V30 5 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 3.0800 1.5400 0.0 0
M  V30 9 Cl 14.0710 4.6200 0.0 0
M  V30 10 C 5.5411 5.3900 0.0 0
M  V30 11 C 5.5411 3.8500 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 C 4.2074 6.1600 0.0 0
M  V30 14 O 7.0058 3.3741 0.0 0
M  V30 15 C 4.2074 3.0800 0.0 0
M  V30 16 C 7.9110 4.6200 0.0 0
M  V30 17 C 2.8738 5.3900 0.0 0
M  V30 18 C 2.8738 3.8500 0.0 0
M  V30 19 C 9.4510 4.6200 0.0 0
M  V30 20 C 10.2210 5.9536 0.0 0
M  V30 21 C 10.2210 3.2864 0.0 0
M  V30 22 C 11.7610 5.9536 0.0 0
M  V30 23 C 11.7610 3.2864 0.0 0
M  V30 24 C 12.5310 4.6200 0.0 0
M  V30 25 C 1.5400 6.1600 0.0 0
M  V30 26 C 0.7700 7.4936 0.0 0
M  V30 27 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Chlorophenyl)-5-cyclopropyl-N-methyl-6-[(methylsulfonyl)amino]benzofuran...
C20H19ClN2O4S
1331943-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0
M  V30 6 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 7 C 1.5400 9.9395 0.0 0
M  V30 8 O 0.0000 8.3995 0.0 0
M  V30 9 O 3.0800 8.3995 0.0 0
M  V30 10 Cl 14.0710 5.3195 0.0 0
M  V30 11 C 5.5411 4.5495 0.0 0
M  V30 12 C 7.0058 4.0736 0.0 0
M  V30 13 C 5.5411 6.0895 0.0 0
M  V30 14 C 4.2074 3.7795 0.0 0
M  V30 15 C 7.9110 5.3195 0.0 0
M  V30 16 O 7.0058 6.5655 0.0 0
M  V30 17 C 4.2074 6.8595 0.0 0
M  V30 18 C 2.8738 4.5495 0.0 0
M  V30 19 C 2.8738 6.0895 0.0 0
M  V30 20 C 9.4510 5.3195 0.0 0
M  V30 21 C 10.2210 3.9858 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 11.7610 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 12.5310 5.3195 0.0 0
M  V30 26 C 1.5400 3.7795 0.0 0
M  V30 27 C 0.0000 3.7795 0.0 0
M  V30 28 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 26
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1331943-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331943-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12460596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 11:
5-Cyclopropyl-2-(4-chlorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
A solution of
5-cyclopropyl-2-(4-chlorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic
acid (5 g, 11.52 mmol) in dry DMF (30 mL) was added with DIPEA (3.3 g,
25.34 mmol), HATU (5.15 g, 13.5 mmol) at 20 °C. After 15 minutes, 2M
Methylamine in THF(23.04 mL, 46.08 mmol) was added dropwise and the
mixture was stirred for another 2 hours before water (60 mL) was added.
The mixture was extracted with EA(3 × 200 mL), washed with water (2×200
mL), dried and concentrated to afford
5-Cyclopropyl-2-(4-chlorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide
as a brown solid (4.7 g, 97 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuranylaminoalkyl boronic acid derivatives
therapeutic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011103063 A1 2011-08-25

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-[4-(phenylmethoxy)phenyl]-4H-3,1-benzoxazin-4-one
C22H17NO4
1333520-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3349 0.0 0
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 O 13.8600 2.6674 0.0 0
M  V30 5 C 14.6300 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 N 6.9300 1.3338 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 O 6.9300 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 3.0800 0.0000 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 10.0100 1.3338 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 11.5500 1.3338 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 2.6674 0.0 0
M  V30 22 C 16.1700 4.0011 0.0 0
M  V30 23 C 16.9400 2.6674 0.0 0
M  V30 24 C 16.9400 5.3349 0.0 0
M  V30 25 C 18.4800 2.6674 0.0 0
M  V30 26 C 18.4800 5.3349 0.0 0
M  V30 27 C 19.2500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N-methyl-2-[[4-(phenylmethoxy)benzoyl]amino]benzamide
C23H22N2O4
1333520-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 6.6684 0.0 0
M  V30 3 O 6.9300 8.0021 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 N 4.6200 1.3336 0.0 0
M  V30 6 O 6.9300 2.6674 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 0.7700 5.3347 0.0 0
M  V30 9 C 0.0000 6.6684 0.0 0
M  V30 10 O 13.8600 6.6684 0.0 0
M  V30 11 C 14.6300 8.0021 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 6.6684 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 10.0100 8.0021 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 11.5500 8.0021 0.0 0
M  V30 23 C 12.3200 6.6684 0.0 0
M  V30 24 C 16.1700 8.0021 0.0 0
M  V30 25 C 16.9400 9.3358 0.0 0
M  V30 26 C 16.9400 6.6684 0.0 0
M  V30 27 C 18.4800 9.3358 0.0 0
M  V30 28 C 18.4800 6.6684 0.0 0
M  V30 29 C 19.2500 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 17
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 1 11 24
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333520-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333520-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14979743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro evaluation of derivatives of the β1-adrenergic
receptor antagonist HX-CH 44
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stephenson, Karin A.; Wilson, Alan A.; Houle, Sylvain; Vasdev, Neil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(18), 5506-5509

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitro-4-[(trichloromethyl)sulfonyl]benzene
C7H3Cl4NO4S
1334524-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0 VAL=6
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 3.4375 0.9764 0.0 0
M  V30 4 O 1.8975 3.6437 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 Cl 0.0000 0.7700 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 9 O 8.0023 0.7700 0.0 0
M  V30 10 O 9.3360 3.0801 0.0 0
M  V30 11 Cl 8.0023 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-4-[(trichloromethyl)sulfonyl]benzenamine
C8H7Cl3N2O4S
1334524-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 C 8.4700 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 Cl 9.2400 5.3347 0.0 0
M  V30 6 Cl 10.0100 4.0009 0.0 0
M  V30 7 Cl 9.2400 2.6673 0.0 0
M  V30 8 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 9 O 0.7700 1.3336 0.0 0
M  V30 10 O 3.0800 0.0000 0.0 0
M  V30 11 N 0.7700 4.0009 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 5.3900 4.0009 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 2.6673 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1334524-76-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1334524-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-71201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transformations of trichloromethyl-4-cholorophenyl sulfone into new
compounds with potential pesticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ochal, Zbigniew; Ochal, Izabela; Banach, Lukasz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polish Journal of Applied Chemistry (2010), 54(1-4), 49-61

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(1E)-1-(2,4-dichlorobenzoyl)-2-(dimethylamino)ethenyl]phosphonate
C15H20Cl2NO4P
1350374-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 4.4139 0.0 0
M  V30 2 P 4.6201 3.0801 0.0 0 VAL=5
M  V30 3 C 4.6201 5.7476 0.0 0
M  V30 4 C 2.3101 4.4139 0.0 0
M  V30 5 O 5.3901 1.7464 0.0 0
M  V30 6 O 3.2864 2.3101 0.0 0
M  V30 7 O 5.9538 3.8501 0.0 0
M  V30 8 O 3.8501 7.0812 0.0 0
M  V30 9 N 1.5400 5.7476 0.0 0
M  V30 10 C 6.9302 1.7464 0.0 0
M  V30 11 C 3.2864 0.7700 0.0 0
M  V30 12 C 2.3101 7.0812 0.0 0
M  V30 13 C 0.0000 5.7476 0.0 0
M  V30 14 C 7.7002 0.4127 0.0 0
M  V30 15 C 1.9526 0.0000 0.0 0
M  V30 16 Cl 6.1601 8.4151 0.0 0
M  V30 17 Cl 10.7802 5.7476 0.0 0
M  V30 18 C 6.1601 5.7476 0.0 0
M  V30 19 C 6.9302 7.0812 0.0 0
M  V30 20 C 6.9302 4.4139 0.0 0
M  V30 21 C 8.4702 7.0812 0.0 0
M  V30 22 C 8.4702 4.4139 0.0 0
M  V30 23 C 9.2402 5.7476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 2 3 8
M  V30 8 1 3 18
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 16 19
M  V30 17 1 17 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(1E)-1-(2,4-dichlorobenzoyl)-2-(methylamino)ethenyl]phosphonate
C14H18Cl2NO4P
1350374-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 3.8500 0.0 0
M  V30 2 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 3 C 6.1600 5.1836 0.0 0
M  V30 4 C 6.1600 2.5162 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 O 3.8500 2.3100 0.0 0
M  V30 7 O 3.8500 5.3900 0.0 0
M  V30 8 O 5.3900 6.5173 0.0 0
M  V30 9 N 7.7000 2.5162 0.0 0
M  V30 10 C 1.5400 5.1836 0.0 0
M  V30 11 C 2.5164 1.5400 0.0 0
M  V30 12 C 8.4700 1.1826 0.0 0
M  V30 13 C 0.0000 5.1836 0.0 0
M  V30 14 C 2.5164 0.0000 0.0 0
M  V30 15 Cl 7.7000 7.8509 0.0 0
M  V30 16 Cl 12.3200 5.1836 0.0 0
M  V30 17 C 7.7000 5.1836 0.0 0
M  V30 18 C 8.4700 6.5173 0.0 0
M  V30 19 C 8.4700 3.8500 0.0 0
M  V30 20 C 10.0100 6.5173 0.0 0
M  V30 21 C 10.0100 3.8500 0.0 0
M  V30 22 C 10.7800 5.1836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 2 3 8
M  V30 8 1 3 17
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 15 18
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350374-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350374-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10269330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient syntheses of 3-phosphorylquinolin-4-ones and
3-phosphoryl-1,8-naphthyridin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kedzia, Jacek; Modranka, Jakub; Janecki, Tomasz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(49), 6623-6626

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[9-[(5-chloro-4-oxo-4H-pyrrolo[1,2-d][1,3,4]oxad...
C22H24ClN7O6
1403942-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 5.3348 0.0 0
M  V30 2 C 6.1601 4.0010 0.0 0
M  V30 3 C 3.8501 5.3348 0.0 0
M  V30 4 O 5.3901 2.6673 0.0 0
M  V30 5 O 7.7002 4.0010 0.0 0
M  V30 6 O 3.0801 6.6685 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 C 6.1601 1.3337 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 4.8265 0.5637 0.0 0
M  V30 11 C 6.9302 0.0000 0.0 0
M  V30 12 C 7.4938 2.1037 0.0 0
M  V30 13 C 1.5400 5.1285 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 15 C 1.5400 8.2085 0.0 0
M  V30 16 C 11.1210 8.7124 0.0 0
M  V30 17 O 14.6907 4.7479 0.0 0
M  V30 18 Cl 17.8166 5.7901 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 8.4702 8.0022 0.0 0
M  V30 21 C 6.1601 6.6685 0.0 0
M  V30 22 N 8.7306 5.5239 0.0 0
M  V30 23 N 9.9766 7.6820 0.0 0
M  V30 24 N 7.7002 9.3358 0.0 0
M  V30 25 N 5.3901 8.0022 0.0 0
M  V30 26 C 10.1376 6.1504 0.0 0
M  V30 27 C 6.1601 9.3358 0.0 0
M  V30 28 C 12.5858 8.2366 0.0 0
M  V30 29 N 13.7302 9.2672 0.0 0
M  V30 30 O 12.9059 6.7303 0.0 0
M  V30 31 N 15.1949 8.7911 0.0 0
M  V30 32 C 14.3705 6.2544 0.0 0
M  V30 33 C 15.5151 7.2848 0.0 0
M  V30 34 C 16.5286 9.5611 0.0 0
M  V30 35 C 17.0466 7.1239 0.0 0
M  V30 36 C 17.6730 8.5307 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 16 23
M  V30 17 1 16 28
M  V30 18 2 17 32
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 32 33
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[9-[2-[[3-chloro-2-[(methylamino)carbonyl]-1H-pyrrol-1-yl...
C18H21ClN8O4
1403946-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 14.8307 4.1854 0.0 0
M  V30 2 C 16.1643 4.9554 0.0 0
M  V30 3 O 17.4979 4.1854 0.0 0
M  V30 4 O 16.1643 6.4954 0.0 0
M  V30 5 C 18.8317 4.9554 0.0 0
M  V30 6 C 19.6017 3.6216 0.0 0
M  V30 7 C 20.1654 5.7254 0.0 0
M  V30 8 C 18.0617 6.2891 0.0 0
M  V30 9 C 8.1788 4.2452 0.0 0
M  V30 10 C 7.1484 3.1006 0.0 0
M  V30 11 N 5.6421 3.4208 0.0 0
M  V30 12 O 7.6242 1.6361 0.0 0
M  V30 13 C 2.3100 3.7710 0.0 0
M  V30 14 N 0.7700 3.7710 0.0 0
M  V30 15 O 3.0800 5.1048 0.0 0
M  V30 16 C 0.0000 5.1048 0.0 0
M  V30 17 Cl 0.9473 0.7102 0.0 0
M  V30 18 C 12.1632 4.1854 0.0 0
M  V30 19 C 10.8296 4.9554 0.0 0
M  V30 20 C 13.4970 4.9554 0.0 0
M  V30 21 N 11.8431 2.6790 0.0 0
M  V30 22 N 9.6852 3.9248 0.0 0
M  V30 23 N 10.8296 6.4954 0.0 0
M  V30 24 N 13.4970 6.4954 0.0 0
M  V30 25 C 10.3115 2.5181 0.0 0
M  V30 26 C 12.1632 7.2654 0.0 0
M  V30 27 N 4.6115 2.2764 0.0 0
M  V30 28 C 3.0800 2.4374 0.0 0
M  V30 29 C 4.9317 0.7700 0.0 0
M  V30 30 C 2.4537 1.0306 0.0 0
M  V30 31 C 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 28
M  V30 17 1 14 16
M  V30 18 1 17 30
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403942-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403946-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-506918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: a) Methyl
3-iodo-1-(phenylsulfonyl)-1H-pyrrole-2-carboxylate A solution of methyl
3-bromo-1-(phenylsulfonyl)-1H-pyrrole-2-carboxylate2 (2.0 g, 5.8 mmol),
sodium iodide (3.5 g, 23 mmol), trans-1,2-bis(methylamino)cyclohexane
(0.83 g, 5.84 mmol) and copper iodide (0.55 g, 2.9 mmol) in 1,4-dioxane
(23 mL) was stirred under reflux during 3 days. At the end of this
period, the crude was allowed to reach room temperature and filtered
thought Celite® washing with ethyl acetate. The filtrate was concentrated
to dryness, suspended in 80 mL of HCl 1N and extracted with ethyl acetate
(3x). The organic mixture was washed with water and brine, dried (Mg2SO4)
and concentrated to give an oily residue that was purified by flash
chromatography silica (hexane/ethyl acetate). Concentration of the
fractions containing the compound afforded of the title compound. a)
Starting from di-tert-butyl
9-((5-chloro-4-oxo-4H-pyrrolo[1,2-d][1,3,4]oxadiazin-2-yl)methyl)-9H-purin-6-ylimidodicarbonate
(150 mg, 0.29 mmol) and following the experimental procedure described in
Example 26a but using tetrahydrofurane as solvent and stirring the
reaction mixture at room temperature during 2 hours were obtained 126 mg
(97% yield) of tert-butyl
9-(2-(3-chloro-2-(methylcarbamoyl)-1H-pyrrol-1-ylamino)-2-oxoethyl)-9H-purin-6-ylcarbamate.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolotriazinone derivatives as therapeutic PI3K
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernal Anchuela, Francisco Javier; Carrascal Riera, Marta; Caturla
Javaloyes, Juan Francisco; Gracia Ferrer, Jordi; Matassa, Victor Giulio;
Terricabras Belart, Emma; Taltavull Moll, Joan; Erra Sola, Montserrat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012146666 A1 2012-11-01

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[9-[(5-chloro-4-oxo-4H-pyrrolo[1,2-d][1,3,4]oxad...
C22H24ClN7O6
1403942-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 5.3348 0.0 0
M  V30 2 C 6.1601 4.0010 0.0 0
M  V30 3 C 3.8501 5.3348 0.0 0
M  V30 4 O 5.3901 2.6673 0.0 0
M  V30 5 O 7.7002 4.0010 0.0 0
M  V30 6 O 3.0801 6.6685 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 C 6.1601 1.3337 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 4.8265 0.5637 0.0 0
M  V30 11 C 6.9302 0.0000 0.0 0
M  V30 12 C 7.4938 2.1037 0.0 0
M  V30 13 C 1.5400 5.1285 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 15 C 1.5400 8.2085 0.0 0
M  V30 16 C 11.1210 8.7124 0.0 0
M  V30 17 O 14.6907 4.7479 0.0 0
M  V30 18 Cl 17.8166 5.7901 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 8.4702 8.0022 0.0 0
M  V30 21 C 6.1601 6.6685 0.0 0
M  V30 22 N 8.7306 5.5239 0.0 0
M  V30 23 N 9.9766 7.6820 0.0 0
M  V30 24 N 7.7002 9.3358 0.0 0
M  V30 25 N 5.3901 8.0022 0.0 0
M  V30 26 C 10.1376 6.1504 0.0 0
M  V30 27 C 6.1601 9.3358 0.0 0
M  V30 28 C 12.5858 8.2366 0.0 0
M  V30 29 N 13.7302 9.2672 0.0 0
M  V30 30 O 12.9059 6.7303 0.0 0
M  V30 31 N 15.1949 8.7911 0.0 0
M  V30 32 C 14.3705 6.2544 0.0 0
M  V30 33 C 15.5151 7.2848 0.0 0
M  V30 34 C 16.5286 9.5611 0.0 0
M  V30 35 C 17.0466 7.1239 0.0 0
M  V30 36 C 17.6730 8.5307 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 16 23
M  V30 17 1 16 28
M  V30 18 2 17 32
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 32 33
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[9-[2-[[3-chloro-2-[(methylamino)carbonyl]-1H-pyrrol-1-yl...
C18H21ClN8O4
1403946-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 14.8307 4.1854 0.0 0
M  V30 2 C 16.1643 4.9554 0.0 0
M  V30 3 O 17.4979 4.1854 0.0 0
M  V30 4 O 16.1643 6.4954 0.0 0
M  V30 5 C 18.8317 4.9554 0.0 0
M  V30 6 C 19.6017 3.6216 0.0 0
M  V30 7 C 20.1654 5.7254 0.0 0
M  V30 8 C 18.0617 6.2891 0.0 0
M  V30 9 C 8.1788 4.2452 0.0 0
M  V30 10 C 7.1484 3.1006 0.0 0
M  V30 11 N 5.6421 3.4208 0.0 0
M  V30 12 O 7.6242 1.6361 0.0 0
M  V30 13 C 2.3100 3.7710 0.0 0
M  V30 14 N 0.7700 3.7710 0.0 0
M  V30 15 O 3.0800 5.1048 0.0 0
M  V30 16 C 0.0000 5.1048 0.0 0
M  V30 17 Cl 0.9473 0.7102 0.0 0
M  V30 18 C 12.1632 4.1854 0.0 0
M  V30 19 C 10.8296 4.9554 0.0 0
M  V30 20 C 13.4970 4.9554 0.0 0
M  V30 21 N 11.8431 2.6790 0.0 0
M  V30 22 N 9.6852 3.9248 0.0 0
M  V30 23 N 10.8296 6.4954 0.0 0
M  V30 24 N 13.4970 6.4954 0.0 0
M  V30 25 C 10.3115 2.5181 0.0 0
M  V30 26 C 12.1632 7.2654 0.0 0
M  V30 27 N 4.6115 2.2764 0.0 0
M  V30 28 C 3.0800 2.4374 0.0 0
M  V30 29 C 4.9317 0.7700 0.0 0
M  V30 30 C 2.4537 1.0306 0.0 0
M  V30 31 C 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 28
M  V30 17 1 14 16
M  V30 18 1 17 30
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403942-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403946-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-6305018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: EXAMPLE 26.
2-((6-Amino-9H-purin-9-yl)methyl)-5-chloro-3-phenylpyrrolo[1,2-f][1,2,4]triazin-4(3H)-one.
a) To a solution of di-tert-butyl
9-((5-chloro-4-oxo-4H-pyrrolo[1,2-d][1,3,4]oxadiazin-2-yl)methyl)-9H-purin-6-ylimidodicarbonate
(125 mg, 0,2 mmol) in 2,5 mL of dry 1,4-dioxane under argon atmosphere
132 μL of aniline (1,45 mmol) were added and the mixture was heated to
reflux with stirring overnight. At the end of this period, the reaction
mixture was poured into 50 mL of a 4% aqueous solution of sodium
bicarbonate and extracted with ethyl acetate (2×40 mL). The organic
layers were mixed and washed with more 4% aqueous solution of sodium
bicarbonate, water and brine, and were dried (MgSO4) and concentrated
under reduced presure to give 187 mg of a solid that was purified by
flash chromatography silica (hexane/ethyl acetate). After purification
were obtained. a) Starting from di-tert-butyl
9-((5-chloro-4-oxo-4H-pyrrolo[1,2-d][1,3,4]oxadiazin-2-yl)methyl)-9H-purin-6-ylimidodicarbonate
(150 mg, 0,29 mmol) and following the experimental procedure described in
Example 26a but using tetrahydrofurane as solvent and stirring the
reaction mixture at room temperature during 2 hours were obtained 126 mg
(97% yield) of tert-butyl
9-(2-(3-chloro-2-(methylcarbamoyl)-1H-pyrrol-1-ylamino)-2-oxoethyl)-9H-purin-6-ylcarbamate.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolotriazinone derivatives as therapeutic PI3K
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernal Anchuela, Francisco Javier; Carrascal Riera, Marta; Caturla
Javaloyes, Juan Francisco; Gracia Ferrer, Jordi; Matassa, Victor Giulio;
Terricabras Belart, Emma
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2518070 A1 2012-10-31

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[(2-Nitrobenzoyl)amino]benzoyl]-D-proline phenylmethyl ester
C26H23N3O6
1404368-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 C 11.0630 4.4428 0.0 0
M  V30 4 O 12.5277 4.9187 0.0 0
M  V30 5 O 9.9186 5.4733 0.0 0
M  V30 6 C 12.8479 6.4250 0.0 0
M  V30 7 N 5.3348 4.6201 0.0 0
M  V30 8 C 4.0012 5.3901 0.0 0
M  V30 9 O 2.6675 4.6201 0.0 0
M  V30 10 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 11 O 0.0000 7.7002 0.0 0
M  V30 12 O 1.3337 5.3901 0.0 0
M  V30 13 N 9.3360 2.3101 0.0 0
M  V30 14 C 10.7428 2.9364 0.0 0 CFG=1
M  V30 15 C 9.4969 0.7785 0.0 0
M  V30 16 C 11.7734 1.7920 0.0 0
M  V30 17 C 11.0034 0.4583 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0012 2.3101 0.0 0
M  V30 22 C 5.3348 0.0000 0.0 0
M  V30 23 C 4.0012 0.7700 0.0 0
M  V30 24 C 14.3126 6.9010 0.0 0
M  V30 25 C 14.6328 8.4074 0.0 0
M  V30 26 C 15.4570 5.8705 0.0 0
M  V30 27 C 16.0974 8.8832 0.0 0
M  V30 28 C 16.9217 6.3465 0.0 0
M  V30 29 C 17.2419 7.8528 0.0 0
M  V30 30 C 4.0012 6.9302 0.0 0
M  V30 31 C 2.6675 7.7002 0.0 0
M  V30 32 C 5.3348 7.7002 0.0 0
M  V30 33 C 2.6675 9.2402 0.0 0
M  V30 34 C 5.3348 9.2402 0.0 0
M  V30 35 C 4.0012 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 14 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 19
M  V30 11 2 8 9
M  V30 12 1 8 30
M  V30 13 2 10 11
M  V30 14 2 10 12
M  V30 15 1 10 31
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-N-Methyl-1-[2-[(2-nitrobenzoyl)amino]benzoyl]-2-pyrrolidinecarboxamide
C20H20N4O5
1404368-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 C 1.9406 2.6091 0.0 0
M  V30 4 N 0.9100 1.4647 0.0 0
M  V30 5 O 3.4468 2.2889 0.0 0
M  V30 6 C 1.3859 0.0000 0.0 0
M  V30 7 N 6.9898 5.3196 0.0 0
M  V30 8 C 8.5298 5.3196 0.0 0
M  V30 9 O 9.2998 6.6533 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0 VAL=5
M  V30 11 O 13.1498 5.3196 0.0 0
M  V30 12 O 10.8398 6.6533 0.0 0
M  V30 13 N 2.3698 5.3196 0.0 0
M  V30 14 C 1.4645 4.0738 0.0 0 CFG=1
M  V30 15 C 1.4645 6.5655 0.0 0
M  V30 16 C 0.0000 4.5496 0.0 0
M  V30 17 C 0.0000 6.0897 0.0 0
M  V30 18 C 4.6798 6.6533 0.0 0
M  V30 19 C 6.2198 6.6533 0.0 0
M  V30 20 C 3.9098 7.9871 0.0 0
M  V30 21 C 6.9898 7.9871 0.0 0
M  V30 22 C 4.6798 9.3207 0.0 0
M  V30 23 C 6.2198 9.3207 0.0 0
M  V30 24 C 9.2998 3.9860 0.0 0
M  V30 25 C 10.8398 3.9860 0.0 0
M  V30 26 C 8.5298 2.6522 0.0 0
M  V30 27 C 11.6098 2.6522 0.0 0
M  V30 28 C 9.2998 1.3186 0.0 0
M  V30 29 C 10.8398 1.3186 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 14 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 2 8 9
M  V30 11 1 8 24
M  V30 12 2 10 11
M  V30 13 2 10 12
M  V30 14 1 10 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1404368-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1404368-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-972728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multifaceted folding in a foldamer featuring highly cooperative folds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Priya, Gowri; Kotmale, Amol S.; Gonnade, Rajesh G.;
Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(91),
11205-11207

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3S)-1-(2-chloro-4-pyrimidinyl)-3-pyrrolidinyl]carbamate
C13H19ClN4O2
1421048-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.6446 3.4580 0.0 0
M  V30 2 C 9.9783 2.6880 0.0 0
M  V30 3 O 11.3121 3.4580 0.0 0
M  V30 4 O 9.9783 1.1479 0.0 0
M  V30 5 C 12.6458 2.6880 0.0 0
M  V30 6 C 13.4158 4.0216 0.0 0
M  V30 7 C 13.9794 1.9179 0.0 0
M  V30 8 C 11.8757 1.3543 0.0 0
M  V30 9 Cl 0.0000 0.0000 0.0 0
M  V30 10 N 4.8736 2.1699 0.0 0
M  V30 11 C 5.9040 3.3143 0.0 0
M  V30 12 C 5.6436 0.8361 0.0 0
M  V30 13 C 7.3110 2.6880 0.0 0 CFG=1
M  V30 14 C 7.1500 1.1564 0.0 0
M  V30 15 C 3.3420 2.3308 0.0 0
M  V30 16 N 2.4368 1.0849 0.0 0
M  V30 17 C 2.7155 3.7376 0.0 0
M  V30 18 C 0.9052 1.2459 0.0 0
M  V30 19 C 1.1840 3.8987 0.0 0
M  V30 20 N 0.2787 2.6528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3S)-1-[2-(methylamino)-4-pyrimidinyl]-3-pyrrolidinyl]ca...
C14H23N5O2
1693765-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.7758 4.3425 0.0 0
M  V30 2 C 11.1826 3.7162 0.0 0
M  V30 3 O 12.4286 4.6213 0.0 0
M  V30 4 O 11.3437 2.1845 0.0 0
M  V30 5 C 13.8354 3.9949 0.0 0
M  V30 6 C 14.4618 5.4017 0.0 0
M  V30 7 C 15.2424 3.3686 0.0 0
M  V30 8 C 13.2091 2.5881 0.0 0
M  V30 9 N 1.5400 0.0000 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 N 6.1600 2.6673 0.0 0
M  V30 12 C 7.0652 3.9132 0.0 0
M  V30 13 C 7.0652 1.4214 0.0 0
M  V30 14 C 8.5299 3.4373 0.0 0 CFG=1
M  V30 15 C 8.5299 1.8973 0.0 0
M  V30 16 C 4.6200 2.6673 0.0 0
M  V30 17 N 3.8500 1.3336 0.0 0
M  V30 18 C 3.8500 4.0009 0.0 0
M  V30 19 C 2.3100 1.3336 0.0 0
M  V30 20 C 2.3100 4.0009 0.0 0
M  V30 21 N 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1421048-21-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693765-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13852763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrrolidinyl ureas as therapeutic inhibitors
of CDK8 and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bergeron, Philippe; Koehler, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015049325 A1 2015-04-09

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3a,8,8a-Tetrahydro-5-methoxy-3a,8-bis(3-methyl-2-buten-1-yl)-2H-furo[2,3-b]...
C21H27NO3
1425499-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 5.8941 0.0 0
M  V30 2 C 2.6528 6.5205 0.0 0
M  V30 3 C 1.4070 5.6153 0.0 0
M  V30 4 C 1.5679 4.0838 0.0 0
M  V30 5 C 0.0000 6.2417 0.0 0
M  V30 6 C 9.2621 7.2752 0.0 0
M  V30 7 C 9.5822 8.7816 0.0 0
M  V30 8 C 11.0468 9.2574 0.0 0
M  V30 9 C 11.3670 10.7637 0.0 0
M  V30 10 C 12.1913 8.2270 0.0 0
M  V30 11 O 3.6304 10.4151 0.0 0
M  V30 12 O 5.0115 1.3336 0.0 0
M  V30 13 C 5.7815 0.0000 0.0 0
M  V30 14 C 5.3056 6.7993 0.0 0
M  V30 15 C 5.7815 5.3347 0.0 0
M  V30 16 C 6.5515 7.7045 0.0 0
M  V30 17 C 4.0596 7.7045 0.0 0
M  V30 18 C 7.3215 5.3347 0.0 0
M  V30 19 C 5.0115 4.0009 0.0 0
M  V30 20 N 7.7974 6.7993 0.0 0
M  V30 21 O 6.0756 9.1692 0.0 0
M  V30 22 C 4.5356 9.1692 0.0 0
M  V30 23 C 8.0915 4.0009 0.0 0
M  V30 24 C 5.7815 2.6673 0.0 0
M  V30 25 C 7.3215 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 22
M  V30 12 1 12 13
M  V30 13 1 12 24
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 20
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 21 22
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3a,8,8a-Tetrahydro-5-methoxy-1-methyl-3a,8-bis(3-methyl-2-buten-1-yl)pyrrol...
C22H30N2O2
1425499-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 5.8942 0.0 0
M  V30 2 C 2.6528 6.5205 0.0 0
M  V30 3 C 1.4070 5.6153 0.0 0
M  V30 4 C 1.5679 4.0838 0.0 0
M  V30 5 C 0.0000 6.2418 0.0 0
M  V30 6 C 9.2619 7.2753 0.0 0
M  V30 7 C 10.4064 6.2447 0.0 0
M  V30 8 C 11.8710 6.7207 0.0 0
M  V30 9 C 13.0155 5.6902 0.0 0
M  V30 10 C 12.1912 8.2270 0.0 0
M  V30 11 C 6.9807 10.4151 0.0 0
M  V30 12 O 3.6304 10.4151 0.0 0
M  V30 13 O 5.0115 1.3336 0.0 0
M  V30 14 C 5.7815 0.0000 0.0 0
M  V30 15 C 5.3055 6.7993 0.0 0
M  V30 16 C 6.5515 7.7045 0.0 0
M  V30 17 C 5.7815 5.3347 0.0 0
M  V30 18 C 4.0596 7.7045 0.0 0
M  V30 19 N 7.7974 6.7993 0.0 0
M  V30 20 N 6.0755 9.1692 0.0 0
M  V30 21 C 7.3215 5.3347 0.0 0
M  V30 22 C 5.0115 4.0011 0.0 0
M  V30 23 C 4.5355 9.1692 0.0 0
M  V30 24 C 8.0915 4.0011 0.0 0
M  V30 25 C 5.7815 2.6673 0.0 0
M  V30 26 C 7.3215 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 20
M  V30 12 2 12 23
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 17 22
M  V30 22 1 18 23
M  V30 23 1 19 21
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1425499-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1425499-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13218789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of O-methyl substituted 2-oxofuro- and
2-oxopyrrolidinoindolines by reductive lactonization of oxindolylacetic
acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Lopez-Camacho, Perla
Y.; Perez-Rojas, Nadia A.; Suarez-Castillo, Oscar R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2012), 7(11), 1445-1451

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 4-acetylbenzenesulfonate
C18H13ClO6S
1427203-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 C 14.5750 2.2548 0.0 0
M  V30 9 C 15.9089 3.0248 0.0 0
M  V30 10 O 14.5750 0.7147 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 3.8501 4.0012 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 2.3101 1.3338 0.0 0
M  V30 19 C 1.5400 2.6675 0.0 0
M  V30 20 C 6.1601 5.3348 0.0 0
M  V30 21 C 10.5740 4.5648 0.0 0
M  V30 22 C 10.5740 3.0248 0.0 0
M  V30 23 C 11.9077 5.3348 0.0 0
M  V30 24 C 11.9077 2.2548 0.0 0
M  V30 25 C 13.2414 4.5648 0.0 0
M  V30 26 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 2 7 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 4-acetylb...
C19H17NO6S
1427203-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2890 3.9967 0.0 0
M  V30 2 C 2.6091 5.5030 0.0 0
M  V30 3 N 1.4647 6.5334 0.0 0
M  V30 4 O 4.0739 5.9789 0.0 0
M  V30 5 C 0.0000 6.0576 0.0 0
M  V30 6 O 9.5599 3.2863 0.0 0
M  V30 7 S 10.3299 4.6201 0.0 0 VAL=6
M  V30 8 O 11.0999 5.9538 0.0 0
M  V30 9 O 8.9963 5.3901 0.0 0
M  V30 10 C 15.6648 1.5400 0.0 0
M  V30 11 C 15.6648 0.0000 0.0 0
M  V30 12 O 16.9986 2.3101 0.0 0
M  V30 13 C 5.7098 1.9526 0.0 0
M  V30 14 C 4.9398 3.2863 0.0 0
M  V30 15 C 7.2499 1.9526 0.0 0
M  V30 16 O 4.6794 0.8082 0.0 0
M  V30 17 C 3.4335 2.9661 0.0 0
M  V30 18 C 5.7098 4.6201 0.0 0
M  V30 19 C 8.0199 3.2863 0.0 0
M  V30 20 C 3.2726 1.4345 0.0 0
M  V30 21 C 7.2499 4.6201 0.0 0
M  V30 22 C 11.6638 3.8501 0.0 0
M  V30 23 C 11.6638 2.3101 0.0 0
M  V30 24 C 12.9974 4.6201 0.0 0
M  V30 25 C 12.9974 1.5400 0.0 0
M  V30 26 C 14.3311 3.8501 0.0 0
M  V30 27 C 14.3311 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-84-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1471214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Acetylbenzenesulfonate (27). 27 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 20% → 90%). Yield: 97%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.63 (d, J = 4.7 Hz, 3H), 2.64 (s, 3H), 5.23
(d, J = 2.5 Hz, 2H), 5.85 (t, J = 2.5 Hz, 1H), 6.54 (dd, J1 = 2.2 Hz, J2
= 8.8 Hz, 1H), 6.69 (d, J = 2.2 Hz, 1H), 8.01-8.05 (m, 3H, 1 proton
disappears with D2O), 8.16 (d, J = 8.8 Hz, 2H), 8.83 (d, J = 8.8 Hz, 1H).
IC50 ± SD (nM), MAO-A: 29 ± 3.2. Calculated: C 58.91, H 4.42, N 3.62;
Found: C 59.14, H 4.52, N 3.76.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-8-methyl-2-oxo-2H-1-benzopyran-7-yl 4-methoxybenzenesulfonate
C18H15ClO6S
1427203-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 C 6.9302 1.3338 0.0 0
M  V30 4 O 8.4702 4.0012 0.0 0
M  V30 5 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 6 O 10.0102 6.6687 0.0 0
M  V30 7 O 7.9065 6.1048 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 O 14.5750 2.2548 0.0 0
M  V30 10 C 15.9089 3.0248 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 6.1601 2.6675 0.0 0
M  V30 16 O 3.8501 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 6.1601 5.3348 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 2.3101 1.3338 0.0 0
M  V30 21 C 10.5740 4.5648 0.0 0
M  V30 22 C 10.5740 3.0248 0.0 0
M  V30 23 C 11.9077 5.3348 0.0 0
M  V30 24 C 11.9077 2.2548 0.0 0
M  V30 25 C 13.2414 4.5648 0.0 0
M  V30 26 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 2 8 20
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-7-methyl-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl ...
C19H19NO6S
1427203-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2890 2.5369 0.0 0
M  V30 2 C 2.6091 1.0306 0.0 0
M  V30 3 N 1.4647 0.0000 0.0 0
M  V30 4 O 4.0739 0.5546 0.0 0
M  V30 5 C 0.0000 0.4759 0.0 0
M  V30 6 C 8.0199 5.9147 0.0 0
M  V30 7 O 9.5599 3.2472 0.0 0
M  V30 8 S 10.3299 1.9135 0.0 0 VAL=6
M  V30 9 O 11.0999 0.5798 0.0 0
M  V30 10 O 8.9963 1.1435 0.0 0
M  V30 11 O 15.6648 4.9936 0.0 0
M  V30 12 C 16.9986 4.2235 0.0 0
M  V30 13 C 4.9398 3.2472 0.0 0
M  V30 14 C 5.7098 4.5808 0.0 0
M  V30 15 C 3.4335 3.5673 0.0 0
M  V30 16 C 5.7098 1.9135 0.0 0
M  V30 17 C 7.2499 4.5808 0.0 0
M  V30 18 O 4.6794 5.7254 0.0 0
M  V30 19 C 3.2726 5.0991 0.0 0
M  V30 20 C 7.2499 1.9135 0.0 0
M  V30 21 C 8.0199 3.2472 0.0 0
M  V30 22 C 11.6638 2.6835 0.0 0
M  V30 23 C 11.6638 4.2235 0.0 0
M  V30 24 C 12.9974 1.9135 0.0 0
M  V30 25 C 12.9974 4.9936 0.0 0
M  V30 26 C 14.3311 2.6835 0.0 0
M  V30 27 C 14.3311 4.2235 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-658026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-7-Methyl-3-[2-(methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Methoxybenzenesulfonate (34). 34 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 30% → 90%). Yield: 97%. 1H
NMR (300 MHz, DMSO-d6) δ: 1.85 (s, 3H), 2.64 (d, J = 4.7 Hz, 3H), 3.86
(s, 3H), 5.24 (d, J = 2.5 Hz, 2H), 5.83 (t, J = 2.5 Hz, 1H), 6.48 (d, J =
8.5 Hz, 1H), 7.17 (d, J = 8.8 Hz, 2H), 7.80 (d, J = 8.8 Hz, 2H), 8.01 (br
q, J = 4.7 Hz, 1H, disappears with D2O), 8.68 (d, J = 8.5 Hz, 1H). IC50 ±
SD (nM), MAO-A: 7.0 ± 2.1. Calculated: C 58.60, H 4.92, N 3.60; Found: C
58.63, H 4.88, N 3.62.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 9-oxo-2-azaspiro[5.5]undecane-2-carboxylate
C15H25NO3
1434142-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 9.3360 2.3101 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 C 11.4397 1.7464 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 9.8996 4.4137 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 9-(methylamino)-2-azaspiro[5.5]undecane-2-carboxylate
C16H30N2O2
1793108-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 N 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1434142-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17119346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl derivatives for use in the treatment of
JAK-mediated disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Dai, Weilong; Li, Xiaobo; Wang,
Tingjin; Wu, Yanjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016190847 A1 2016-12-01

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 9-oxo-2-azaspiro[5.5]undecane-2-carboxylate
C15H25NO3
1434142-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 9.3360 2.3101 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 C 11.4397 1.7464 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 9.8996 4.4137 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 9-(methylamino)-2-azaspiro[5.5]undecane-2-carboxylate
C16H30N2O2
1793108-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 N 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1434142-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7670872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted heteroaryl compounds and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Wang, Tingjin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015094803 A1 2015-06-25

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[[4-(6-fluoro-2,3-dihydro-1H-indol-1-yl)-1-piperidinyl]carbonyl]ami...
C19H21FN4O3S
1443247-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.5546 5.7277 0.0 0
M  V30 2 C 9.7544 4.9318 0.0 0
M  V30 3 N 11.0881 4.1618 0.0 0
M  V30 4 O 9.7544 6.4718 0.0 0
M  V30 5 C 16.3907 5.2889 0.0 0
M  V30 6 O 17.2960 6.5348 0.0 0
M  V30 7 O 17.0172 3.8820 0.0 0
M  V30 8 C 18.8275 6.3739 0.0 0
M  V30 9 C 3.0126 2.4781 0.0 0
M  V30 10 N 4.4196 1.8517 0.0 0
M  V30 11 C 1.9822 1.3337 0.0 0
M  V30 12 C 2.5367 3.9428 0.0 0
M  V30 13 C 4.2587 0.3202 0.0 0
M  V30 14 C 2.7522 0.0000 0.0 0
M  V30 15 C 0.4759 1.6538 0.0 0
M  V30 16 C 1.0304 4.2630 0.0 0
M  V30 17 C 0.0000 3.1186 0.0 0
M  V30 18 C 5.7533 2.6218 0.0 0
M  V30 19 C 5.7533 4.1618 0.0 0
M  V30 20 C 7.0869 1.8517 0.0 0
M  V30 21 C 7.0869 4.9318 0.0 0
M  V30 22 C 8.4208 2.6218 0.0 0
M  V30 23 N 8.4208 4.1618 0.0 0
M  V30 24 C 12.4218 4.9318 0.0 0
M  V30 25 S 13.8287 4.3055 0.0 0
M  V30 26 N 12.5828 6.4634 0.0 0
M  V30 27 C 14.8592 5.4499 0.0 0
M  V30 28 C 14.0892 6.7835 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 23
M  V30 5 1 3 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 18
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(6-Fluoro-2,3-dihydro-1H-indol-1-yl)-N-[5-[(methylamino)carbonyl]-2-thiazol...
C19H22FN5O2S
1443247-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.5546 5.7277 0.0 0
M  V30 2 C 9.7544 4.9318 0.0 0
M  V30 3 N 11.0881 4.1618 0.0 0
M  V30 4 O 9.7544 6.4718 0.0 0
M  V30 5 C 16.3907 5.2889 0.0 0
M  V30 6 N 17.2960 6.5348 0.0 0
M  V30 7 O 17.0172 3.8820 0.0 0
M  V30 8 C 18.8275 6.3739 0.0 0
M  V30 9 C 3.0126 2.4781 0.0 0
M  V30 10 N 4.4196 1.8517 0.0 0
M  V30 11 C 1.9822 1.3337 0.0 0
M  V30 12 C 2.5367 3.9428 0.0 0
M  V30 13 C 4.2587 0.3202 0.0 0
M  V30 14 C 2.7522 0.0000 0.0 0
M  V30 15 C 0.4759 1.6538 0.0 0
M  V30 16 C 1.0304 4.2630 0.0 0
M  V30 17 C 0.0000 3.1186 0.0 0
M  V30 18 C 5.7533 2.6218 0.0 0
M  V30 19 C 7.0869 1.8517 0.0 0
M  V30 20 C 5.7533 4.1618 0.0 0
M  V30 21 C 8.4208 2.6218 0.0 0
M  V30 22 C 7.0869 4.9318 0.0 0
M  V30 23 N 8.4208 4.1618 0.0 0
M  V30 24 C 12.4218 4.9318 0.0 0
M  V30 25 S 13.8287 4.3055 0.0 0
M  V30 26 N 12.5828 6.4634 0.0 0
M  V30 27 C 14.8592 5.4499 0.0 0
M  V30 28 C 14.0892 6.7835 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 23
M  V30 5 1 3 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 18
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443247-74-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443247-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6127486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally
bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1:
Urea-based analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Shyh-Ming; Tang, Yuting; Zhang, Rui; Lu, Huajun; Kuo, Gee-Hong;
Gaul, Michael D.; Li, Yaxin; Ho, George; Conway, James G.; Liang, Yin;
Lenhard, James M.; Demarest, Keith T.; Murray, William V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(24), 6773-6776

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[[4-(6-fluoro-2,3-dihydro-1H-indol-1-yl)-1-piperidinyl]carbonyl]amin...
C20H23FN4O3S
1443247-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.5546 5.7277 0.0 0
M  V30 2 C 9.7544 4.9318 0.0 0
M  V30 3 N 11.0881 4.1618 0.0 0
M  V30 4 O 9.7544 6.4718 0.0 0
M  V30 5 C 16.3907 5.2889 0.0 0
M  V30 6 O 17.2960 6.5348 0.0 0
M  V30 7 O 17.0172 3.8821 0.0 0
M  V30 8 C 18.8277 6.3739 0.0 0
M  V30 9 C 19.7328 7.6198 0.0 0
M  V30 10 C 3.0128 2.4782 0.0 0
M  V30 11 N 4.4196 1.8517 0.0 0
M  V30 12 C 1.9822 1.3337 0.0 0
M  V30 13 C 2.5367 3.9428 0.0 0
M  V30 14 C 4.2587 0.3202 0.0 0
M  V30 15 C 2.7522 0.0000 0.0 0
M  V30 16 C 0.4759 1.6538 0.0 0
M  V30 17 C 1.0304 4.2630 0.0 0
M  V30 18 C 0.0000 3.1186 0.0 0
M  V30 19 C 5.7533 2.6218 0.0 0
M  V30 20 C 5.7533 4.1618 0.0 0
M  V30 21 C 7.0869 1.8517 0.0 0
M  V30 22 C 7.0869 4.9318 0.0 0
M  V30 23 C 8.4208 2.6218 0.0 0
M  V30 24 N 8.4208 4.1618 0.0 0
M  V30 25 C 12.4219 4.9318 0.0 0
M  V30 26 N 13.8287 4.3055 0.0 0
M  V30 27 S 12.5828 6.4634 0.0 0
M  V30 28 C 14.8592 5.4499 0.0 0
M  V30 29 C 14.0892 6.7837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 24
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 19
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(6-Fluoro-2,3-dihydro-1H-indol-1-yl)-N-[4-[(methylamino)carbonyl]-2-thiazol...
C19H22FN5O2S
1443247-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.5546 5.7277 0.0 0
M  V30 2 C 9.7544 4.9318 0.0 0
M  V30 3 N 11.0881 4.1618 0.0 0
M  V30 4 O 9.7544 6.4718 0.0 0
M  V30 5 C 16.3907 5.2889 0.0 0
M  V30 6 N 17.2960 6.5348 0.0 0
M  V30 7 O 17.0172 3.8820 0.0 0
M  V30 8 C 18.8275 6.3739 0.0 0
M  V30 9 C 3.0126 2.4781 0.0 0
M  V30 10 N 4.4196 1.8517 0.0 0
M  V30 11 C 1.9822 1.3337 0.0 0
M  V30 12 C 2.5367 3.9428 0.0 0
M  V30 13 C 4.2587 0.3202 0.0 0
M  V30 14 C 2.7522 0.0000 0.0 0
M  V30 15 C 0.4759 1.6538 0.0 0
M  V30 16 C 1.0304 4.2630 0.0 0
M  V30 17 C 0.0000 3.1186 0.0 0
M  V30 18 C 5.7533 2.6218 0.0 0
M  V30 19 C 7.0869 1.8517 0.0 0
M  V30 20 C 5.7533 4.1618 0.0 0
M  V30 21 C 8.4208 2.6218 0.0 0
M  V30 22 C 7.0869 4.9318 0.0 0
M  V30 23 N 8.4208 4.1618 0.0 0
M  V30 24 C 12.4218 4.9318 0.0 0
M  V30 25 N 13.8287 4.3055 0.0 0
M  V30 26 S 12.5828 6.4634 0.0 0
M  V30 27 C 14.8592 5.4499 0.0 0
M  V30 28 C 14.0892 6.7835 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 23
M  V30 5 1 3 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 18
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443247-84-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443247-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3989028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally
bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1:
Urea-based analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Shyh-Ming; Tang, Yuting; Zhang, Rui; Lu, Huajun; Kuo, Gee-Hong;
Gaul, Michael D.; Li, Yaxin; Ho, George; Conway, James G.; Liang, Yin;
Lenhard, James M.; Demarest, Keith T.; Murray, William V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(24), 6773-6776

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,3-difluoro-2-nitrobenzene
C6H2BrF2NO2
147808-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-fluoro-N-methyl-2-nitrobenzenamine
C7H6BrFN2O2
1396503-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 F 2.3101 6.6687 0.0 0
M  V30 7 Br 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147808-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396503-81-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31611412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Benzo[d]imidazole derivatives as TLR9 inhibitors for the treatment of
fibrosis and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, David S.; Regueiro-Ren, Alicia; Mandler, Michael; Posy, Shoshana L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022040260 A1 2022-02-24

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-[(5-bromopentyl)oxy]-2-fluorobenzene
C11H13Br2FO
1487606-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 F 0.0000 3.0801 0.0 0
M  V30 9 Br 0.0000 0.0000 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0010 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Bromo-3-fluorophenoxy)-N-methyl-1-pentanamine
C12H17BrFNO
1495896-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3358 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 N 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 F 0.0000 3.0801 0.0 0
M  V30 10 Br 0.0000 0.0000 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1487606-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1495896-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21547844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-substituted 1H-indazole derivatives CFTR modulator
compounds useful for treatment of cystic fibrosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Lianhal; Hwang, Tzyh-Chang; Zou, Xiaoqin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019136314 A1 2019-07-11

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R)-2-Methoxy-2-[2-(2-methylphenyl)ethynyl]cyclopropanecarboxylic acid
C14H14O3
1489390-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 O 7.9675 4.1839 0.0 0
M  V30 4 C 6.7878 5.1739 0.0 0
M  V30 5 C 10.6639 2.4081 0.0 0
M  V30 6 O 11.6537 1.2283 0.0 0
M  V30 7 O 11.1906 3.8551 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 7.7001 2.6673 0.0 0 CFG=2
M  V30 10 C 9.1471 2.1406 0.0 0 CFG=1
M  V30 11 C 7.9675 1.1507 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 C 2.3100 1.3337 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 0.7700 1.3337 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 9 3 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 10 5 CFG=1
M  V30 9 1 8 13
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-2-Methoxy-N-methyl-2-[2-(2-methylphenyl)ethynyl]cyclopropanecarbo...
C15H17NO2
1489390-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.5065 0.0 0
M  V30 2 C 4.6201 2.5065 0.0 0
M  V30 3 O 7.9675 0.9899 0.0 0
M  V30 4 C 6.7878 0.0000 0.0 0
M  V30 5 C 10.6639 2.7657 0.0 0
M  V30 6 N 11.6536 3.9455 0.0 0
M  V30 7 O 11.1906 1.3187 0.0 0
M  V30 8 C 13.1703 3.6780 0.0 0
M  V30 9 C 3.0800 5.1739 0.0 0
M  V30 10 C 7.7001 2.5065 0.0 0 CFG=2
M  V30 11 C 9.1471 3.0332 0.0 0 CFG=1
M  V30 12 C 7.9675 4.0232 0.0 0
M  V30 13 C 3.0800 2.5065 0.0 0
M  V30 14 C 2.3100 3.8402 0.0 0
M  V30 15 C 2.3100 1.1727 0.0 0
M  V30 16 C 0.7700 3.8402 0.0 0
M  V30 17 C 0.7700 1.1727 0.0 0
M  V30 18 C 0.0000 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 10 3 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 11 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 9 14
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1489390-21-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1489390-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15332080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective synthesis of oxepinones and azepinones by gold-catalyzed
cycloisomerization of functionalyzed cyclopropyl alkynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandez-Garcia, Jesus M.; Garcia-Garcia, Patricia; Fernandez-Rodriguez,
Manuel A.; Perez-Anes, Alexandra; Aguilar, Enrique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2013), 49(95),
11185-11187

$RFMT $RIREG SCHEME194 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Potassium cyanide
CKN
151-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 K 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(Methylamino)-1,4-dioxaspiro[4.5]decane-8-carbonitrile
C10H16N2O2
1002916-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6214 2.8943 0.0 0
M  V30 2 N 8.1380 3.1616 0.0 0
M  V30 3 N 5.6315 1.1798 0.0 0
M  V30 4 C 4.6416 0.0000 0.0 0
M  V30 5 C 2.4374 4.1669 0.0 0
M  V30 6 C 3.7710 4.9369 0.0 0
M  V30 7 C 2.4374 2.6269 0.0 0
M  V30 8 O 1.0306 3.5405 0.0 0
M  V30 9 O 2.2764 5.6985 0.0 0
M  V30 10 C 5.1048 4.1669 0.0 0
M  V30 11 C 3.7710 1.8569 0.0 0
M  V30 12 C 0.0000 4.6850 0.0 0
M  V30 13 C 0.7700 6.0186 0.0 0
M  V30 14 C 5.1048 2.6269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 151-50-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1002916-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-14473262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1:
8-Morpholino-1,4-dioxaspiro[4.5]decane-8-carbonitrile (31). Morpholine
(80.2 g, 0.92 mol), 1,4-dioxaspiro[4.5]decan-8-one (30.0 g, 0.192 mol)
and potassium cyanide (30.0 g, 0.46 mol) were added to a mixture of 4 N
hydrochloric acid (50 ml) and methanol (30 ml) under ice cooling. The
mixture was stirred for 74 h at room temperature and then, after addition
of water (80 ml), extracted with diethyl ether (4 × 100 ml). After volume
reduction, the residue was dissolved in dichloromethane (200 ml) and
dried overnight with magnesium sulfate. The organic phase was
concentrated and the ketal was obtained. Compound 25, Yield: 84-97%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist:
Cebranopadol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schunk, Stefan; Linz, Klaus; Hinze, Claudia; Frormann, Sven; Oberboersch,
Stefan; Sundermann, Bernd; Zemolka, Saskia; Englberger, Werner; Germann,
Tieno; Christoph, Thomas; Koegel, Babette-Y.; Schroeder, Wolfgang;
Harlfinger, Stephanie; Saunders, Derek; Kless, Achim; Schick, Hans;
Sonnenschein, Helmut
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(8), 857-862

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
6-Bromo-2-naphthalenol
C10H7BrO
15231-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6673 0.0 0
M  V30 2 O 8.4702 1.3337 0.0 0
M  V30 3 C 3.8501 1.3337 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 C 6.1601 2.6673 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 1.5400 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-naphthalenamine
C11H10BrN
305835-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Br 0.0000 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15231-91-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 305835-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-1487995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Bromo-N-methyl-2-naphthylamine (2a).- A mixture of 10.0 g (44.8 mmol)
of 1, 16.5 g (86.8 mmol) of Na2S2O5, 9.0 g (225 mmol) of NaOH and 40 mL
of H2O was placed in a pressure reactor. Then 15.0 g (222 mmol) of
methylamine hydrochloride were quickly mixed in with a stirring rod, and
the reactor was sealed and heated at 140° for 96 h. After cooling, the
reaction mixture was poured into 100 mL of 2 N NaOH, and the precipitate
was collected, washed with water and air-dried to constant mass. A dark
solid that gave a single peak under GLC analysis. (10.3 g; 97%). The
product was recrystallized twice from MeOH. A white solid. Mp 106-107°.
IR (KBr): 3400 (NH), 1610 and 1580 (aromatic C=C) cm-1. 1H NMR: δ 2.82
(s, 3 H, CH3), 3.92 (br s, 1Η, NH), 6.84 (d, J = 2.2 Hz, 1Η, 1-H), 6.93
(dd, J = 8.8, 2.2 Hz, 1Η, 3-H), 7.42 (dd, J = 8.9, 1.9 Hz, 1Η, 7-H), 7.48
(d, J = 8.9 Hz, 1Η, 8-H), 7.54 (d, J = 8.8 Hz, 1Η, 4-H), 7.81 (d, J = 1.9
Hz, 1Η, 5-H). Anal. Calcd. for C11H10BrN: C, 55.96; H, 4.27; N, 5.93.
Found: C, 55.71; H, 4.35; N, 6.21.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fluorescence probes with a 2,6-aminonaphthalene-carbonyl
chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balo, Carmen; Fernandez, Franco; Garcia-Mera, Xerardo; Lopez, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2000), 32(4), 367-372

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P,P,P′,P′-Tetraethyl P,P′-[10-[(methylsulfonyl)oxy]decylidene]bis[phosphonate]
C19H42O9P2S
1527504-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0
M  V30 2 P 4.0012 6.1601 0.0 0 VAL=5
M  V30 3 P 5.3348 3.8501 0.0 0 VAL=5
M  V30 4 C 6.6685 6.1601 0.0 0
M  V30 5 O 2.6673 6.9302 0.0 0
M  V30 6 O 4.7712 7.4938 0.0 0
M  V30 7 O 3.2311 4.8263 0.0 0
M  V30 8 O 5.3348 2.3101 0.0 0
M  V30 9 O 3.7948 3.8501 0.0 0
M  V30 10 O 6.8749 3.8501 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 C 4.0012 8.8275 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 C 3.0248 2.5163 0.0 0
M  V30 16 C 9.3360 6.1601 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 4.7712 10.1611 0.0 0
M  V30 19 C 6.6685 0.0000 0.0 0
M  V30 20 C 1.4847 2.5163 0.0 0
M  V30 21 C 10.6697 5.3901 0.0 0
M  V30 22 C 12.0033 6.1601 0.0 0
M  V30 23 C 13.3372 5.3901 0.0 0
M  V30 24 C 14.6708 6.1601 0.0 0
M  V30 25 C 16.0045 5.3901 0.0 0
M  V30 26 C 17.3382 6.1601 0.0 0
M  V30 27 O 18.6720 5.3901 0.0 0
M  V30 28 S 20.0057 6.1601 0.0 0 VAL=6
M  V30 29 C 20.7757 4.8263 0.0 0
M  V30 30 O 21.3393 6.9302 0.0 0
M  V30 31 O 19.2356 7.4938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 2 3 10
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 1 24 25
M  V30 25 1 25 26
M  V30 26 1 26 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 2 28 30
M  V30 30 2 28 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P,P,P′,P′-Tetraethyl P,P′-[10-(methylamino)decylidene]bis[phosphonate]
C19H43NO6P2
1527504-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0
M  V30 2 P 5.3348 3.8501 0.0 0 VAL=5
M  V30 3 P 4.0012 6.1601 0.0 0 VAL=5
M  V30 4 C 6.6685 6.1601 0.0 0
M  V30 5 O 5.3348 2.3101 0.0 0
M  V30 6 O 3.7948 3.8501 0.0 0
M  V30 7 O 6.8749 3.8501 0.0 0
M  V30 8 O 2.6675 6.9302 0.0 0
M  V30 9 O 4.7712 7.4938 0.0 0
M  V30 10 O 3.2311 4.8263 0.0 0
M  V30 11 C 8.0023 5.3901 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 3.0248 2.5163 0.0 0
M  V30 14 C 1.3337 6.1601 0.0 0
M  V30 15 C 4.0012 8.8275 0.0 0
M  V30 16 C 9.3360 6.1601 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 1.4847 2.5163 0.0 0
M  V30 19 C 0.0000 6.9302 0.0 0
M  V30 20 C 4.7712 10.1611 0.0 0
M  V30 21 C 10.6697 5.3901 0.0 0
M  V30 22 C 12.0033 6.1601 0.0 0
M  V30 23 C 13.3372 5.3901 0.0 0
M  V30 24 C 14.6708 6.1601 0.0 0
M  V30 25 C 16.0045 5.3901 0.0 0
M  V30 26 C 17.3382 6.1601 0.0 0
M  V30 27 N 18.6720 5.3901 0.0 0
M  V30 28 C 20.0057 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 2 3 10
M  V30 10 1 4 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 1 24 25
M  V30 25 1 25 26
M  V30 26 1 26 27
M  V30 27 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1527504-31-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1527504-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-556740
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Monomers for adhesive polymers: 11. Structure-adhesive properties
relationships of new hydrolytically stable acidic monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Fischer, Urs Karl; Moszner, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer International (2013), 62(12), 1717-1728

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 4-(hydroxymethyl)-, methyl ester
C10H12O3
155380-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Hydroxymethyl)-N-methylbenzeneacetamide
C10H13NO2
1976020-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155380-11-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1976020-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16454498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (methylamine)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Phenyl-3H-imidazo[4,5-b]pyridine derivatives as inhibitors or mammalian
tyrosine kinase ROR1 activity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mellstedt, Haakan; Bystroem, Styrbjoern; Vaagberg, Jan; Olsson, Elisabeth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016124553 A1 2016-08-11

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Glucofuranosiduronic acid, octyl, γ-lactone
C14H24O6
158603-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7113 6.6354 0.0 0
M  V30 2 O 3.0608 0.0000 0.0 0
M  V30 3 O 6.7721 5.2726 0.0 0
M  V30 4 C 8.1058 4.5026 0.0 0
M  V30 5 C 9.4396 5.2726 0.0 0
M  V30 6 C 10.7733 4.5026 0.0 0
M  V30 7 C 12.1070 5.2726 0.0 0
M  V30 8 C 13.4406 4.5026 0.0 0
M  V30 9 C 14.7745 5.2726 0.0 0
M  V30 10 C 16.1081 4.5026 0.0 0
M  V30 11 C 17.4418 5.2726 0.0 0
M  V30 12 O 0.0000 1.3628 0.0 0
M  V30 13 C 3.0011 3.9845 0.0 0 CFG=2
M  V30 14 C 3.7711 2.6509 0.0 0 CFG=1
M  V30 15 C 4.0315 5.1291 0.0 0 CFG=1
M  V30 16 O 1.4948 3.6644 0.0 0
M  V30 17 O 5.2774 2.9710 0.0 0
M  V30 18 C 2.7406 1.5063 0.0 0 CFG=2
M  V30 19 C 5.4385 4.5026 0.0 0 CFG=1
M  V30 20 C 1.3337 2.1328 0.0 0
M  V30 21 H 2.2310 5.3182 0.0 0
M  V30 22 H 4.5411 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 18 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 19 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 12 20
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 21 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 22 CFG=1
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 13 14 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Octyl N-methyl-α-D-glucofuranosiduronamide
C15H29NO6
2170991-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0432 3.8850 0.0 0 CFG=2
M  V30 2 C 2.5367 3.5649 0.0 0
M  V30 3 O 4.5191 5.3498 0.0 0
M  V30 4 N 1.5063 4.7094 0.0 0
M  V30 5 O 2.0609 2.1003 0.0 0
M  V30 6 C 0.0000 4.3892 0.0 0
M  V30 7 O 5.2173 0.0000 0.0 0
M  V30 8 O 8.8447 4.0287 0.0 0
M  V30 9 C 10.1785 3.2587 0.0 0
M  V30 10 C 11.5122 4.0287 0.0 0
M  V30 11 C 12.8459 3.2587 0.0 0
M  V30 12 C 14.1796 4.0287 0.0 0
M  V30 13 C 15.5134 3.2587 0.0 0
M  V30 14 C 16.8470 4.0287 0.0 0
M  V30 15 C 18.1807 3.2587 0.0 0
M  V30 16 C 19.5144 4.0287 0.0 0
M  V30 17 O 8.4945 0.6966 0.0 0
M  V30 18 C 5.0736 2.7406 0.0 0 CFG=2
M  V30 19 O 6.1042 3.8850 0.0 0
M  V30 20 C 5.8437 1.4070 0.0 0 CFG=2
M  V30 21 C 7.5111 3.2587 0.0 0 CFG=2
M  V30 22 C 7.3501 1.7271 0.0 0 CFG=1
M  V30 23 H 3.8278 1.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 20 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 21 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 22 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 23 CFG=3
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 158603-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170991-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18624767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Surfactant Properties of Nonionic Biosourced
Alkylglucuronamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lebeuf, Raphael; Liu, Chih-Yin; Pierlot, Christel; Nardello-Rataj,
Veronique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2018), 6(2), 2758-2766

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromo-3-nitropyridine
C5H2Br2N2O2
15862-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Br 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15862-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19996316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their
use as GluN2B receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chrovian, Christa C.; Letavic, Michael A.; Rech, Jason C.; Rudolph, Dale
A.; Johnson, Akinola Soyode; Stenne, Brice M.; Wall, Jessica L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018067786 A1 2018-04-12

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, (1R,2R,6S)-7-oxabicyclo[4.1.0]hept-2-yl-, phenylmethyl ester, ...
C14H17NO3
159324-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5412 3.0801 0.0 0
M  V30 2 C 6.8749 2.3101 0.0 0
M  V30 3 O 8.2085 3.0801 0.0 0
M  V30 4 O 6.8749 0.7700 0.0 0
M  V30 5 C 9.5422 2.3101 0.0 0
M  V30 6 C 2.8737 3.0801 0.0 0 CFG=2
M  V30 7 C 1.5400 2.3101 0.0 0 CFG=2
M  V30 8 C 4.2074 2.3101 0.0 0 CFG=2
M  V30 9 O 1.5400 3.8501 0.0 0
M  V30 10 C 1.5400 0.7700 0.0 0
M  V30 11 C 4.2074 0.7700 0.0 0
M  V30 12 C 2.8737 0.0000 0.0 0
M  V30 13 C 10.8760 3.0801 0.0 0
M  V30 14 C 12.2097 2.3101 0.0 0
M  V30 15 C 10.8760 4.6201 0.0 0
M  V30 16 C 13.5434 3.0801 0.0 0
M  V30 17 C 12.2097 5.3901 0.0 0
M  V30 18 C 13.5434 4.6201 0.0 0
M  V30 19 H 3.6437 4.4137 0.0 0
M  V30 20 H 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 19 CFG=1
M  V30 11 1 7 9
M  V30 12 1 7 10
M  V30 13 1 7 20 CFG=1
M  V30 14 1 8 11
M  V30 15 1 10 12
M  V30 16 1 11 12
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Phenylmethyl N-[(1R,2S,3R)-2-hydroxy-3-(methylamino)cyclohexyl]carbamate
C15H22N2O3
1929597-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 6 O 10.6697 0.7700 0.0 0
M  V30 7 N 13.3370 2.3101 0.0 0
M  V30 8 C 14.6707 3.0801 0.0 0
M  V30 9 C 9.3358 3.0801 0.0 0 CFG=1
M  V30 10 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 12.0033 3.0801 0.0 0 CFG=1
M  V30 13 C 10.6697 5.3901 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 1.3337 0.0000 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 1 10 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 12 7 CFG=3
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159324-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929597-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-16365158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds such as 2-phenylpyrimidines
derivatives as interleukin-1 receptor-associated kinases (IRAKs)
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jorand-Lebrun, Catherine; Jones, Reinaldo; Won, Annie Cho; Nguyen, Ngan;
Johnson, Theresa L.; Deselm, Lizbeth Celeste; Panda, Kausik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016081679 A1 2016-05-26

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethylthieno[2,3-b]thiophene-2-carboxaldehyde
C9H8OS2
159709-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6911 0.0000 0.0 0
M  V30 2 C 0.0000 1.1994 0.0 0
M  V30 3 C 6.4017 1.9694 0.0 0
M  V30 4 O 7.5460 2.9998 0.0 0
M  V30 5 C 2.4452 2.4452 0.0 0
M  V30 6 C 2.9211 3.9098 0.0 0
M  V30 7 C 3.6911 1.5400 0.0 0
M  V30 8 C 0.9052 2.4452 0.0 0
M  V30 9 S 4.4611 3.9098 0.0 0
M  V30 10 S 1.6752 4.8150 0.0 0
M  V30 11 C 4.9370 2.4452 0.0 0
M  V30 12 C 0.4294 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,4-Trimethylthieno[2,3-b]thiophene-2-methanamine
C10H13NS2
335033-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3611 0.0000 0.0 0
M  V30 2 C 0.0000 1.9404 0.0 0
M  V30 3 C 6.4219 1.3628 0.0 0
M  V30 4 N 7.7556 2.1328 0.0 0
M  V30 5 C 9.0893 1.3628 0.0 0
M  V30 6 C 2.6509 2.6509 0.0 0
M  V30 7 C 3.4209 3.9845 0.0 0
M  V30 8 C 3.6813 1.5063 0.0 0
M  V30 9 C 1.1444 2.9710 0.0 0
M  V30 10 S 4.9272 3.6644 0.0 0
M  V30 11 S 2.3903 5.1289 0.0 0
M  V30 12 C 5.0881 2.1328 0.0 0
M  V30 13 C 0.9835 4.5026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159709-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-08-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5493516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 92 Preparation
of (3,4-Dimethyl-thieno[2,3-b]thiophen-2-ylmethyl)methylamine [0847]
According to the procedure of Preparation 67, except substituting
3,4-dimethyl-thieno[2,3-b]thiophene-2-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (3.13 g, 97%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 7.07 (s, 1H), 3.78
(s, 2H), 2.42 (s, 3H), 2.35 (s, 3H), 2.30 (s, 3H), 2.19 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethylthieno[2,3-b]thiophene-2-carboxaldehyde
C9H8OS2
159709-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6911 0.0000 0.0 0
M  V30 2 C 0.0000 1.1994 0.0 0
M  V30 3 C 6.4017 1.9694 0.0 0
M  V30 4 O 7.5460 2.9998 0.0 0
M  V30 5 C 2.4452 2.4452 0.0 0
M  V30 6 C 2.9211 3.9098 0.0 0
M  V30 7 C 3.6911 1.5400 0.0 0
M  V30 8 C 0.9052 2.4452 0.0 0
M  V30 9 S 4.4611 3.9098 0.0 0
M  V30 10 S 1.6752 4.8150 0.0 0
M  V30 11 C 4.9370 2.4452 0.0 0
M  V30 12 C 0.4294 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,4-Trimethylthieno[2,3-b]thiophene-2-methanamine
C10H13NS2
335033-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3611 0.0000 0.0 0
M  V30 2 C 0.0000 1.9404 0.0 0
M  V30 3 C 6.4219 1.3628 0.0 0
M  V30 4 N 7.7556 2.1328 0.0 0
M  V30 5 C 9.0893 1.3628 0.0 0
M  V30 6 C 2.6509 2.6509 0.0 0
M  V30 7 C 3.4209 3.9845 0.0 0
M  V30 8 C 3.6813 1.5063 0.0 0
M  V30 9 C 1.1444 2.9710 0.0 0
M  V30 10 S 4.9272 3.6644 0.0 0
M  V30 11 S 2.3903 5.1289 0.0 0
M  V30 12 C 5.0881 2.1328 0.0 0
M  V30 13 C 0.9835 4.5026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159709-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-08-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12618076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethylthieno[2,3-b]thiophene-2-carboxaldehyde
C9H8OS2
159709-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6911 0.0000 0.0 0
M  V30 2 C 0.0000 1.1994 0.0 0
M  V30 3 C 6.4017 1.9694 0.0 0
M  V30 4 O 7.5460 2.9998 0.0 0
M  V30 5 C 2.4452 2.4452 0.0 0
M  V30 6 C 2.9211 3.9098 0.0 0
M  V30 7 C 3.6911 1.5400 0.0 0
M  V30 8 C 0.9052 2.4452 0.0 0
M  V30 9 S 4.4611 3.9098 0.0 0
M  V30 10 S 1.6752 4.8150 0.0 0
M  V30 11 C 4.9370 2.4452 0.0 0
M  V30 12 C 0.4294 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,4-Trimethylthieno[2,3-b]thiophene-2-methanamine
C10H13NS2
335033-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3611 0.0000 0.0 0
M  V30 2 C 0.0000 1.9404 0.0 0
M  V30 3 C 6.4219 1.3628 0.0 0
M  V30 4 N 7.7556 2.1328 0.0 0
M  V30 5 C 9.0893 1.3628 0.0 0
M  V30 6 C 2.6509 2.6509 0.0 0
M  V30 7 C 3.4209 3.9845 0.0 0
M  V30 8 C 3.6813 1.5063 0.0 0
M  V30 9 C 1.1444 2.9710 0.0 0
M  V30 10 S 4.9272 3.6644 0.0 0
M  V30 11 S 2.3903 5.1289 0.0 0
M  V30 12 C 5.0881 2.1328 0.0 0
M  V30 13 C 0.9835 4.5026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159709-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-08-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12901113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(3,4-Dimethyl-thieno[2,3-b]thiophen-2-ylmethyl)methylamine According to
the procedure of Preparation 1, except substituting
3,4-dimethylthieno[2,3-b]thiophene-2-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (3.13 g, 97%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 7.07 (s, 1H), 3.78
(s, 2H), 2.42 (s, 3H), 2.35 (s, 3H), 2.30 (s, 3H), 2.19 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-2-[[[(E)-[1-[5-(trifluoromethyl)benzo[b]thien-2-...
C22H19F3N2O4S
1607822-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 2.3100 0.0 0
M  V30 2 N 9.3358 3.0800 0.0 0
M  V30 3 C 10.6696 0.7700 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 3.0800 0.0 0
M  V30 6 C 18.2906 4.9317 0.0 0
M  V30 7 F 18.2906 3.3917 0.0 0
M  V30 8 F 19.8306 4.9317 0.0 0
M  V30 9 F 18.2906 6.4717 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 N 2.6674 5.3900 0.0 0
M  V30 13 O 5.3347 6.9300 0.0 0
M  V30 14 O 6.6685 4.6200 0.0 0
M  V30 15 O 1.3338 4.6200 0.0 0
M  V30 16 C 6.6685 7.7000 0.0 0
M  V30 17 C 0.0000 5.3900 0.0 0
M  V30 18 C 14.4406 3.5981 0.0 0
M  V30 19 C 13.6706 4.9317 0.0 0
M  V30 20 C 13.4100 2.4537 0.0 0
M  V30 21 C 15.9806 3.5981 0.0 0
M  V30 22 S 12.1642 4.6115 0.0 0
M  V30 23 C 14.4406 6.2655 0.0 0
M  V30 24 C 12.0032 3.0800 0.0 0
M  V30 25 C 16.7506 4.9317 0.0 0
M  V30 26 C 15.9806 6.2655 0.0 0
M  V30 27 C 5.3347 2.3100 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 5.3347 0.7700 0.0 0
M  V30 30 C 2.6674 2.3100 0.0 0
M  V30 31 C 4.0011 0.0000 0.0 0
M  V30 32 C 2.6674 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 1 23 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-N-methyl-2-[[[(E)-[1-[5-(trifluoromethyl)benzo[b]thien-...
C22H20F3N3O3S
1607822-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 2.3100 0.0 0
M  V30 2 N 9.3358 3.0800 0.0 0
M  V30 3 C 10.6696 0.7700 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 3.0800 0.0 0
M  V30 6 C 18.2906 4.9317 0.0 0
M  V30 7 F 18.2906 6.4717 0.0 0
M  V30 8 F 19.8306 4.9317 0.0 0
M  V30 9 F 18.2906 3.3917 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 N 2.6674 5.3900 0.0 0
M  V30 13 N 5.3347 6.9300 0.0 0
M  V30 14 O 6.6685 4.6200 0.0 0
M  V30 15 O 1.3338 4.6200 0.0 0
M  V30 16 C 6.6685 7.7000 0.0 0
M  V30 17 C 0.0000 5.3900 0.0 0
M  V30 18 C 14.4406 3.5981 0.0 0
M  V30 19 C 13.6706 4.9317 0.0 0
M  V30 20 C 13.4100 2.4537 0.0 0
M  V30 21 C 15.9806 3.5981 0.0 0
M  V30 22 S 12.1642 4.6115 0.0 0
M  V30 23 C 14.4406 6.2655 0.0 0
M  V30 24 C 12.0032 3.0800 0.0 0
M  V30 25 C 16.7506 4.9317 0.0 0
M  V30 26 C 15.9806 6.2655 0.0 0
M  V30 27 C 5.3347 2.3100 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 5.3347 0.7700 0.0 0
M  V30 30 C 2.6674 2.3100 0.0 0
M  V30 31 C 4.0011 0.0000 0.0 0
M  V30 32 C 2.6674 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 1 23 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1607822-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1607822-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9682468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and fungicidal activities of novel benzothiophene-substituted
oxime ether strobilurins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tu, Song; Xie, Ya-Qiang; Gui, Si-Zhe; Ye, Li-Yi; Huang, Zi-Long; Huang,
Yi-Bing; Che, Li-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(9), 2173-2176

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexyl N-[4-[2-[(methylsulfo...
C27H36N2O7S
1616457-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7800 5.3347 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 O 8.4700 6.6684 0.0 0
M  V30 4 O 10.7800 8.0020 0.0 0
M  V30 5 C 15.4000 8.0020 0.0 0
M  V30 6 C 16.9400 8.0020 0.0 0
M  V30 7 O 17.7100 9.3358 0.0 0
M  V30 8 S 19.2500 9.3358 0.0 0 VAL=6
M  V30 9 C 19.2500 7.7958 0.0 0
M  V30 10 O 20.7900 9.3358 0.0 0
M  V30 11 O 19.2500 10.8758 0.0 0
M  V30 12 N 5.3900 12.0031 0.0 0
M  V30 13 C 3.8500 12.0031 0.0 0
M  V30 14 O 3.0800 13.3367 0.0 0
M  V30 15 O 3.0800 10.6694 0.0 0
M  V30 16 C 1.5400 13.3367 0.0 0
M  V30 17 C 1.5400 14.8767 0.0 0
M  V30 18 C 0.0000 13.3367 0.0 0
M  V30 19 C 1.5400 11.7967 0.0 0
M  V30 20 C 12.3200 5.3347 0.0 0
M  V30 21 C 13.0900 4.0009 0.0 0
M  V30 22 C 13.0900 6.6684 0.0 0
M  V30 23 C 14.6300 4.0009 0.0 0
M  V30 24 C 14.6300 6.6684 0.0 0
M  V30 25 C 15.4000 5.3347 0.0 0
M  V30 26 C 12.3200 2.6673 0.0 0
M  V30 27 C 10.7800 2.6673 0.0 0
M  V30 28 C 13.0900 1.3336 0.0 0
M  V30 29 C 10.0100 1.3336 0.0 0
M  V30 30 C 12.3200 0.0000 0.0 0
M  V30 31 C 10.7800 0.0000 0.0 0
M  V30 32 C 7.7000 8.0020 0.0 0 CFG=2
M  V30 33 C 8.4700 9.3358 0.0 0
M  V30 34 C 6.1600 8.0020 0.0 0
M  V30 35 C 7.7000 10.6694 0.0 0
M  V30 36 C 5.3900 9.3358 0.0 0
M  V30 37 C 6.1600 10.6694 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 32 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 24
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 8 11
M  V30 13 1 12 13
M  V30 14 1 37 12 CFG=1
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 26
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 32 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
trans-4-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexyl N-[4-[2-(methylamino)...
C27H37N3O4
1616457-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7800 5.3347 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 O 8.4700 6.6684 0.0 0
M  V30 4 O 10.7800 8.0020 0.0 0
M  V30 5 C 15.4000 8.0020 0.0 0
M  V30 6 C 16.9400 8.0020 0.0 0
M  V30 7 N 17.7100 9.3356 0.0 0
M  V30 8 C 19.2500 9.3356 0.0 0
M  V30 9 N 5.3900 12.0031 0.0 0
M  V30 10 C 3.8500 12.0031 0.0 0
M  V30 11 O 3.0800 13.3367 0.0 0
M  V30 12 O 3.0800 10.6694 0.0 0
M  V30 13 C 1.5400 13.3367 0.0 0
M  V30 14 C 1.5400 14.8767 0.0 0
M  V30 15 C 0.0000 13.3367 0.0 0
M  V30 16 C 1.5400 11.7967 0.0 0
M  V30 17 C 13.0900 4.0009 0.0 0
M  V30 18 C 12.3200 5.3347 0.0 0
M  V30 19 C 14.6300 4.0009 0.0 0
M  V30 20 C 13.0900 6.6684 0.0 0
M  V30 21 C 15.4000 5.3347 0.0 0
M  V30 22 C 14.6300 6.6684 0.0 0
M  V30 23 C 12.3200 2.6673 0.0 0
M  V30 24 C 13.0900 1.3336 0.0 0
M  V30 25 C 10.7800 2.6673 0.0 0
M  V30 26 C 12.3200 0.0000 0.0 0
M  V30 27 C 10.0100 1.3336 0.0 0
M  V30 28 C 10.7800 0.0000 0.0 0
M  V30 29 C 7.7000 8.0020 0.0 0 CFG=2
M  V30 30 C 8.4700 9.3358 0.0 0
M  V30 31 C 6.1600 8.0020 0.0 0
M  V30 32 C 7.7000 10.6694 0.0 0
M  V30 33 C 5.3900 9.3358 0.0 0
M  V30 34 C 6.1600 10.6694 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 29 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 34 9 CFG=1
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616457-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616457-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12665293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New cyclohexyl and quinuclidinyl carbamate derivatives having beta2
adrenergic agonist and M3 muscarinic antagonist activity and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sole Feu, Laia; Carranco Moruno, Ines; Aiguade Bosch, Jose; Puig Duran,
Carlos; Fonquerna Pou, Silvia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014095920 A1 2014-06-26

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(5-Bromo-6-methoxy-2-benzofuranyl)carbonyl]-N-[(4-methoxyphenyl)methyl]gly...
C20H18BrNO6
1629383-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 6.6230 0.0 0
M  V30 2 N 7.6211 8.1630 0.0 0
M  V30 3 O 8.9547 5.8530 0.0 0
M  V30 4 C 8.9547 8.9330 0.0 0
M  V30 5 C 6.2873 8.9330 0.0 0
M  V30 6 C 6.2873 10.4730 0.0 0
M  V30 7 O 4.9536 11.2430 0.0 0
M  V30 8 O 7.6211 11.2430 0.0 0
M  V30 9 O 1.5400 1.3338 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 Br 0.0000 4.0011 0.0 0
M  V30 12 O 14.2895 5.8530 0.0 0
M  V30 13 C 15.6232 6.6230 0.0 0
M  V30 14 C 4.6201 4.0011 0.0 0
M  V30 15 C 3.8500 5.3348 0.0 0
M  V30 16 O 6.1263 4.3213 0.0 0
M  V30 17 C 3.8500 2.6675 0.0 0
M  V30 18 C 4.8805 6.4793 0.0 0
M  V30 19 C 2.3100 5.3348 0.0 0
M  V30 20 C 6.2873 5.8530 0.0 0
M  V30 21 C 2.3100 2.6675 0.0 0
M  V30 22 C 1.5400 4.0011 0.0 0
M  V30 23 C 10.2884 8.1630 0.0 0
M  V30 24 C 11.6222 8.9330 0.0 0
M  V30 25 C 10.2884 6.6230 0.0 0
M  V30 26 C 12.9559 8.1630 0.0 0
M  V30 27 C 11.6222 5.8530 0.0 0
M  V30 28 C 12.9559 6.6230 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 1 9 21
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-methoxy-N-[(4-methoxyphenyl)methyl]-N-[2-(methylamino)-2-oxoethyl]-...
C21H21BrN2O5
1629411-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6210 6.6229 0.0 0
M  V30 2 N 7.6210 8.1629 0.0 0
M  V30 3 O 8.9546 5.8529 0.0 0
M  V30 4 C 8.9546 8.9329 0.0 0
M  V30 5 C 6.2872 8.9329 0.0 0
M  V30 6 C 6.2872 10.4729 0.0 0
M  V30 7 N 4.9536 11.2429 0.0 0
M  V30 8 O 7.6210 11.2429 0.0 0
M  V30 9 C 4.9536 12.7829 0.0 0
M  V30 10 O 1.5400 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 Br 0.0000 4.0011 0.0 0
M  V30 13 O 14.2894 5.8529 0.0 0
M  V30 14 C 15.6230 6.6229 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 O 6.1263 4.3212 0.0 0
M  V30 18 C 3.8500 2.6674 0.0 0
M  V30 19 C 4.8804 6.4792 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 6.2872 5.8529 0.0 0
M  V30 22 C 2.3100 2.6674 0.0 0
M  V30 23 C 1.5400 4.0011 0.0 0
M  V30 24 C 10.2883 8.1629 0.0 0
M  V30 25 C 11.6221 8.9329 0.0 0
M  V30 26 C 10.2883 6.6229 0.0 0
M  V30 27 C 12.9557 8.1629 0.0 0
M  V30 28 C 11.6221 5.8529 0.0 0
M  V30 29 C 12.9557 6.6229 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 12 23
M  V30 14 1 13 14
M  V30 15 1 13 29
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 21
M  V30 24 1 20 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629383-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629411-11-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11446904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 3282-30-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies Towards the Total Synthesis of Aspirochlorine and Chloptosin
(Postdoctoral Thesis)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Knauer, Stephan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2007), (20140701), No pp.

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-2-oxo-3-[1-[(phenylmethoxy)carbonyl]-4-piperidinyl]-1(2H)-pyrimidi...
C19H25N3O5
164519-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3372 2.3101 0.0 0
M  V30 2 C 16.0045 3.8501 0.0 0
M  V30 3 C 17.3383 4.6201 0.0 0
M  V30 4 O 17.3383 6.1601 0.0 0
M  V30 5 O 18.6720 3.8501 0.0 0
M  V30 6 C 6.6687 1.5400 0.0 0
M  V30 7 O 5.3348 2.3101 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 N 12.0035 4.6201 0.0 0
M  V30 11 C 13.3372 3.8501 0.0 0
M  V30 12 C 12.0035 6.1601 0.0 0
M  V30 13 N 14.6708 4.6201 0.0 0
M  V30 14 C 13.3372 6.9302 0.0 0
M  V30 15 C 14.6708 6.1601 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 19 C 8.0023 3.8501 0.0 0
M  V30 20 C 9.3360 1.5400 0.0 0
M  V30 21 N 8.0023 2.3101 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 23 C 1.3337 1.5400 0.0 0
M  V30 24 C 2.6675 3.8501 0.0 0
M  V30 25 C 0.0000 2.3101 0.0 0
M  V30 26 C 1.3337 4.6201 0.0 0
M  V30 27 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 21
M  V30 9 1 7 9
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[tetrahydro-3-[2-(methylamino)-2-oxoethyl]-2-oxo-1(2H)-pyrimid...
C20H28N4O4
164519-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 2.3100 0.0 0
M  V30 2 C 16.0043 3.8500 0.0 0
M  V30 3 C 17.3380 4.6201 0.0 0
M  V30 4 N 18.6718 3.8500 0.0 0
M  V30 5 O 17.3380 6.1601 0.0 0
M  V30 6 C 20.0054 4.6201 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 O 5.3348 2.3100 0.0 0
M  V30 9 O 6.6684 0.0000 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 N 12.0032 4.6201 0.0 0
M  V30 12 C 13.3370 3.8500 0.0 0
M  V30 13 C 12.0032 6.1601 0.0 0
M  V30 14 N 14.6707 4.6201 0.0 0
M  V30 15 C 13.3370 6.9301 0.0 0
M  V30 16 C 14.6707 6.1601 0.0 0
M  V30 17 C 10.6695 3.8500 0.0 0
M  V30 18 C 10.6695 2.3100 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 9.3359 1.5400 0.0 0
M  V30 21 C 8.0022 3.8500 0.0 0
M  V30 22 N 8.0022 2.3100 0.0 0
M  V30 23 C 2.6675 2.3100 0.0 0
M  V30 24 C 1.3337 1.5400 0.0 0
M  V30 25 C 2.6675 3.8500 0.0 0
M  V30 26 C 0.0000 2.3100 0.0 0
M  V30 27 C 1.3337 4.6201 0.0 0
M  V30 28 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164519-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 164519-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7527840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 37a) Benzyl
4-[3-(methylcarbonylmethyl)-2-oxotetrahydropyrimidin-1(2H)-yl]piperidin-1-carboxylate
WSC (0.39 g) was added to a solution of
[3-{1-[(benzoyloxy)carbonyl]piperidin-4-yl}-2-oxotetrahydropyrimidin-1(2H)-yl]acetic
acid (0.70 g) obtained in Example 36a), a solution of methylamine in THF
(1.85 mL) and HOBt (0.31 g) in THF/dichloromethane (1/1, 30 mL) and the
mixture was stirred at room temperature overnight. The solvent were
distilled off under reduced pressure, and the residue was diluted with
ethyl acetate. The mixture was washed with an aqueous saturated sodium
bicarbonate solution and saturated saline solution, dried over anhydrous
magnesium sulfate and then concentrated under reduced pressure. The
residue was purified with basic silica gel column chromatography (ethyl
acetate) to obtain the title compound (0.70 g, 97%) as a white powder.
Benzyl
4-[3-(methylcarbonylmethyl)-2-oxotetrahydropyrimidin-1(2H)-yl]piperidin-1-carboxylate,
yield (0.70 g, 97%) NMR (CDCl3). δ: 1.53-1.70 (4H, m) , 1.89-2.01 (2H, m)
, 2.79 (3H, d, J= 5.2), 2.80-2.86 (2H, m) , 3.16 (2H, t, J= 6.0), 3.34
(2H, t, J= 6.0), 3.91 (2H, s), 4.25-4.31 (2H, m) , 4.39-4.55 (1H, m) ,
5.12 (2H, s), 6.63 (1H, brs), 7.30-7.38 (5H, m) .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic amides as activated blood coagulation factor
X inhibitors for use as antithrombotic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kubo, Keiji; Imaeda, Yasuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005113504 A1 2005-12-01

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Ethyl 6-[2-chloro-4-(6-methyl-2-pyrazinyl)phenyl]-2-(methylthio)-7-oxopyrido[...
C23H20ClN5O3S
1648865-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 4.6200 2.6673 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 O 7.7000 5.3347 0.0 0
M  V30 8 S 0.7700 9.3358 0.0 0
M  V30 9 C 0.0000 10.6694 0.0 0
M  V30 10 Cl 9.2400 10.6694 0.0 0
M  V30 11 C 16.9400 10.6694 0.0 0
M  V30 12 C 4.6200 8.0021 0.0 0
M  V30 13 N 5.3900 6.6684 0.0 0
M  V30 14 C 5.3900 9.3358 0.0 0
M  V30 15 N 3.0800 8.0021 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 4.6200 10.6694 0.0 0
M  V30 19 C 2.3100 9.3358 0.0 0
M  V30 20 C 7.7000 8.0020 0.0 0
M  V30 21 N 3.0800 10.6694 0.0 0
M  V30 22 C 9.2400 8.0020 0.0 0
M  V30 23 C 10.0100 9.3358 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 11.5500 9.3358 0.0 0
M  V30 26 C 11.5500 6.6684 0.0 0
M  V30 27 C 12.3200 8.0020 0.0 0
M  V30 28 C 13.8600 8.0020 0.0 0
M  V30 29 N 14.6300 9.3358 0.0 0
M  V30 30 C 14.6300 6.6684 0.0 0
M  V30 31 C 16.1700 9.3358 0.0 0
M  V30 32 N 16.1700 6.6684 0.0 0
M  V30 33 C 16.9400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 16
M  V30 8 1 8 9
M  V30 9 1 8 19
M  V30 10 1 10 23
M  V30 11 1 11 31
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-Chloro-4-(6-methyl-2-pyrazinyl)phenyl]-2-(methylamino)-7-oxopyrido[2,3-d...
C21H17ClN6O3
1648865-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 2.6674 0.0 0
M  V30 2 C 11.5500 1.3336 0.0 0
M  V30 3 O 12.3200 0.0000 0.0 0
M  V30 4 O 10.0100 1.3336 0.0 0
M  V30 5 O 9.2400 2.6674 0.0 0
M  V30 6 N 16.1700 6.6685 0.0 0
M  V30 7 C 16.9400 8.0021 0.0 0
M  V30 8 Cl 7.7000 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 C 12.3200 5.3347 0.0 0
M  V30 11 N 11.5500 4.0011 0.0 0
M  V30 12 C 11.5500 6.6685 0.0 0
M  V30 13 N 13.8600 5.3347 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 12.3200 8.0021 0.0 0
M  V30 17 C 14.6300 6.6685 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 N 13.8600 8.0021 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.9300 6.6685 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 5.3900 6.6685 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.0800 5.3347 0.0 0
M  V30 27 N 2.3100 6.6685 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 0.7700 6.6685 0.0 0
M  V30 30 N 0.7700 4.0011 0.0 0
M  V30 31 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 14
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 8 21
M  V30 9 1 9 29
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1648865-80-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1648865-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-12287715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (MCPBA) (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine-pyridinone serine/threonine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Drobnick, Joy; Gazzard, Lewis J.; Lee, Wendy;
Ndubaku, Chudi; Rudolph, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015011252 A1 2015-01-29

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2,5-difluoro-4-nitrobenzene
C6H2BrF2NO2
167415-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 5.3901 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-4-fluoro-N-methyl-2-nitrobenzenamine
C7H6BrFN2O2
1356483-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 F 5.3901 6.6687 0.0 0
M  V30 7 Br 6.9302 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 167415-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356483-97-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23346864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,3,4-oxadiazole derivatives as histone deacetylase 6
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Chang Sik; Oh, Jung Taek; Yun, Hokeun; Song, Hyeseung; Kim, Hyunjin
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020240492 A1 2020-12-03

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-methylbenzene
C10H13BrO
16929-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 C 9.2401 4.0010 0.0 0
M  V30 5 Br 10.7801 4.0010 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(4-methylphenoxy)-1-propanamine
C11H17NO
915923-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16929-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915923-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-148606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-(methylamino)-2-butenoate
C9H17NO2
36244-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 2.1037 2.6673 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 0.5637 0.0000 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 N 8.0023 0.5637 0.0 0
M  V30 11 C 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9 CFG=2
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36244-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13165353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Continuous flow synthesis of β-amino α, β-unsaturated esters in aqueous
medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joshi, Ramesh A.; Joshi, Rohini R.; Tibhe, Jagdish; Nivangune, Nayana T.;
Kulkarni, Amol A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Processing and Synthesis (2012), 1(2), 205-210

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1,2-dihydrofuro[3,2-f][1,7]naphthyridine
C10H7ClN2O
173540-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 2.6675 0.0 0
M  V30 5 C 2.3100 5.3349 0.0 0
M  V30 6 C 5.3900 2.6675 0.0 0
M  V30 7 C 5.6505 5.1456 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 0.7700 2.6675 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 N 4.6200 1.3338 0.0 0
M  V30 12 O 6.8963 2.9876 0.0 0
M  V30 13 C 7.0573 4.5192 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 8 11
M  V30 14 1 9 14
M  V30 15 2 10 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-N-methylfuro[3,2-f][1,7]naphthyridin-5-amine
C11H11N3O
1402084-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2873 4.0012 0.0 0
M  V30 2 C 7.0574 5.3348 0.0 0
M  V30 3 C 2.4373 2.6673 0.0 0
M  V30 4 C 3.9773 2.6673 0.0 0
M  V30 5 C 1.6672 4.0012 0.0 0
M  V30 6 C 1.6672 1.3337 0.0 0
M  V30 7 C 4.7473 4.0012 0.0 0
M  V30 8 N 4.7473 1.3337 0.0 0
M  V30 9 C 2.4373 5.3348 0.0 0
M  V30 10 C 0.1609 4.3213 0.0 0
M  V30 11 C 2.4373 0.0000 0.0 0
M  V30 12 N 3.9773 5.3348 0.0 0
M  V30 13 C 3.9773 0.0000 0.0 0
M  V30 14 O 1.4068 6.4792 0.0 0
M  V30 15 C 0.0000 5.8529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 12
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 2 11 13
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173540-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1402084-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3185059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polycyclic N-heterocyclic compounds. Part 71: Synthesis and
bronchodilator evaluation of 5-substituted
1,2-dihydrofuro[3,2-f][1,7]naphthyridines and related compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okuda, Kensuke; Matsushita, Tetsuo; Hirota, Takashi; Sasaki, Kenji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2012), 49(4), 742-747

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-phenyl-4(3H)-quinazolinone
C14H9ClN2O
1779036-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 0.0000 0.0 0
M  V30 2 Cl 11.5500 2.6674 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 6.9300 2.6674 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 9.2400 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 5.3900 5.3349 0.0 0
M  V30 10 C 10.0100 2.6674 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 N 9.2400 1.3338 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(3H)-Quinazolinone, 2-(methylamino)-6-phenyl-
C15H13N3O
3056123-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 0.0000 0.0 0
M  V30 2 N 11.5500 2.6674 0.0 0
M  V30 3 C 12.3200 1.3338 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 N 9.2400 4.0011 0.0 0
M  V30 7 C 6.9300 5.3349 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 7.7000 1.3338 0.0 0
M  V30 10 C 10.0100 2.6674 0.0 0
M  V30 11 C 5.3900 5.3349 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 N 9.2400 1.3338 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 15 1 12 14
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1779036-38-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056123-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38469215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoegenauer, Klemens; An, Shaojian; Axford, Jake; Benander, Christina;
Bergsdorf, Christian; Botsch, Josephine; Chau, Suzanne; Fernandez, Cesar;
Gleim, Scott; Hassiepen, Ulrich; Hunziker, Juerg; Joly, Emilie; Keller,
Aramis; Lopez Romero, Sandra; Maher, Robert; Mangold, Anne-Sophie;
Mickanin, Craig; Mihalic, Manuel; Neuner, Philippe; Patterson, Andrew W.;
Perruccio, Francesca; Roggo, Silvio; Scesa, Julien; Schroder, Martin;
Shkoza, Dojna; Thai, Binh; Vulpetti, Anna; Renatus, Martin; Reece-Hoyes,
John S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(12), 1631-1639

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylbenzenesulfonyl chloride
C8H7ClO3S
1788-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 C 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetyl-N-methylbenzenesulfonamide
C9H11NO3S
68793-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1788-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68793-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10667103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4-(N-methylsulfamoyl)phenethyl bromide To a
solution of 4-(chlorosulfonyl)phenethyl bromide (10.00 g, 35.2 mmol) in
tetrahydrofuran (200 ml) was added 40% aqueous methylamine solution (9.14
ml, 105.6 mmol) under stirring, and the resulting mixture was stirred at
room temperature for one hour. After evaporating the reaction mixture in
vacuo, water was added to the residue, and the resulting mixture was
extracted with dichloromethane. The extract was washed with water, dried
over anhydrous magnesium sulfate and evaporated in vacuo to afford the
title compound. 4-(N-Methylsulfamoyl)acetophenone was synthesized in a
yield of 97% as a white powder by conducting a reaction in a similar
manner to that described in Reference Example 8, using
4-(chlorosulfonyl)acetophenone instead of 4-(chlorosulfonyl)phenethyl
bromide.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic tertiary amine compounds that inhibit inflammatory
cytokine production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Shimozato, Takaichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070049620 A1 2007-03-01

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-(1,1-Dimethylethyl) (2R)-[1,4′-bipiperidine]-1′,2-dicarboxylate
C16H28N2O4
1803351-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 O 10.0100 5.3349 0.0 0
M  V30 6 O 10.0100 2.6674 0.0 0
M  V30 7 C 11.5500 5.3349 0.0 0
M  V30 8 C 11.5500 6.8749 0.0 0
M  V30 9 C 13.0900 5.3349 0.0 0
M  V30 10 C 11.5500 3.7949 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=1
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 C 5.3900 5.3349 0.0 0
M  V30 19 C 5.3900 2.6674 0.0 0
M  V30 20 C 6.9300 5.3349 0.0 0
M  V30 21 C 6.9300 2.6674 0.0 0
M  V30 22 N 7.7000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[(methylamino)carbonyl][1,4′-bipiperidine]-1′-carbox...
C17H31N3O3
1803351-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0
M  V30 3 O 4.6200 2.6674 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 O 10.0100 6.6685 0.0 0
M  V30 7 O 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 6.6685 0.0 0
M  V30 9 C 11.5500 8.2085 0.0 0
M  V30 10 C 13.0900 6.6685 0.0 0
M  V30 11 C 11.5500 5.1285 0.0 0
M  V30 12 N 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 5.3900 6.6685 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 6.9300 6.6685 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 N 7.7000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 23
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1803351-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803351-87-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12599458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic aza compounds as muscarinic M1 receptor agonists and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Giles Albert; Cansfield, Julie Elaine; Congreve, Miles Stuart;
O'Brien, Michael Alistair; Pickworth, Mark; Rackham, Mark David; Tehan,
Benjamin Gerald; Teobold, Barry John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015118342 A1 2015-08-13

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluoro-5-nitrobenzonitrile
C7H2ClFN2O2
183325-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 N 8.0021 0.7700 0.0 0
M  V30 7 Cl 6.6685 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(methylamino)-5-nitrobenzonitrile
C8H6ClN3O2
1380921-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 Cl 5.3900 6.6685 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 183325-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380921-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11465273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (b) 2-Chloro-4-(methylamino)-5-nitrobenzonitrile A solution of MeNH2 in
THF (14.9 mL, 2 M, 29.8 mmol) was added dropwise to a solution of
2-chloro-4-fluoro-5-nitrobenzonitrile (3.0 g, 15 mmol) in THF (100 mL)
at-20 °C. The mixture was stirred at -20 °C for 1 h and thereafter
concentrated, washed with brine and extracted with EtOAc. The organic
layer was dried over Na2SO4, filtered and concentrated. The resulting
residue was washed with PE to give the sub-title compound. Yield 3.07 g
(97%).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminobenzimidazole derivatives for use as
anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Kuelzer, Raimund; Mack, Juergen; Pfau, Roland;
Stenkamp, Dirk; Pelcman, Benjamin; Roenn, Robert; Lubriks, Dimitrijs;
Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012076672 A1 2012-06-14

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-10-chloro-4H-pyrido[3,2-...
C19H8BrCl2N5O2
1846567-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.0424 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.8369 0.0 0
M  V30 3 O 7.0036 7.8788 0.0 0
M  V30 4 Cl 9.6710 1.7187 0.0 0
M  V30 5 C 4.3361 3.2587 0.0 0
M  V30 6 N 2.9293 3.8850 0.0 0
M  V30 7 C 4.1752 1.7271 0.0 0
M  V30 8 N 1.8989 2.7406 0.0 0
M  V30 9 C 2.6689 1.4070 0.0 0
M  V30 10 C 5.6699 4.0287 0.0 0
M  V30 11 N 7.0036 3.2587 0.0 0
M  V30 12 O 5.6699 5.5688 0.0 0
M  V30 13 C 8.3373 4.0287 0.0 0
M  V30 14 C 7.0036 6.3388 0.0 0
M  V30 15 C 8.3373 5.5688 0.0 0
M  V30 16 C 9.6710 3.2587 0.0 0
M  V30 17 C 9.6710 6.3388 0.0 0
M  V30 18 C 11.0048 4.0287 0.0 0
M  V30 19 C 11.0048 5.5688 0.0 0
M  V30 20 N 12.3384 3.2587 0.0 0
M  V30 21 C 12.3384 6.3388 0.0 0
M  V30 22 C 13.6721 4.0287 0.0 0
M  V30 23 C 13.6721 5.5688 0.0 0
M  V30 24 C 2.6091 5.3915 0.0 0
M  V30 25 C 1.1444 5.8674 0.0 0
M  V30 26 N 3.7535 6.4219 0.0 0
M  V30 27 C 0.8242 7.3737 0.0 0
M  V30 28 C 3.4334 7.9284 0.0 0
M  V30 29 C 1.9688 8.4043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 25
M  V30 3 2 3 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[[[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]amino]-8-chlor...
C20H13BrCl2N6O2
927431-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 6.6685 0.0 0
M  V30 2 N 5.9256 5.3347 0.0 0
M  V30 3 O 5.9256 8.0022 0.0 0
M  V30 4 Cl 0.6496 10.2033 0.0 0
M  V30 5 Br 0.0000 4.9933 0.0 0
M  V30 6 C 7.4657 2.6674 0.0 0
M  V30 7 N 8.2357 1.3338 0.0 0
M  V30 8 O 5.9256 2.6674 0.0 0
M  V30 9 C 7.4657 0.0000 0.0 0
M  V30 10 Cl 7.4657 8.0022 0.0 0
M  V30 11 N 2.7104 7.9144 0.0 0
M  V30 12 C 3.6156 6.6685 0.0 0
M  V30 13 N 1.2459 7.4385 0.0 0
M  V30 14 C 2.7104 5.4227 0.0 0
M  V30 15 C 1.2459 5.8985 0.0 0
M  V30 16 C 3.1864 9.3790 0.0 0
M  V30 17 C 2.1559 10.5235 0.0 0
M  V30 18 N 4.6927 9.6993 0.0 0
M  V30 19 C 2.6317 11.9880 0.0 0
M  V30 20 C 5.1686 11.1638 0.0 0
M  V30 21 C 4.1382 12.3084 0.0 0
M  V30 22 C 7.4657 5.3347 0.0 0
M  V30 23 C 8.2357 4.0011 0.0 0
M  V30 24 C 8.2357 6.6685 0.0 0
M  V30 25 C 9.7757 4.0011 0.0 0
M  V30 26 C 9.7757 6.6685 0.0 0
M  V30 27 C 10.5457 5.3347 0.0 0
M  V30 28 N 10.5457 8.0022 0.0 0
M  V30 29 C 12.0857 5.3347 0.0 0
M  V30 30 C 12.0857 8.0022 0.0 0
M  V30 31 C 12.8557 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 22
M  V30 5 1 4 17
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 7 9
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1846567-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 927431-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12135730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic heterocyclic anthranilic diamides as ryanodine receptor
modulators with insecticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeanguenat, Andre; Durieux, Patricia; Edmunds, Andrew J. F.; Hall, Roger
G.; Hughes, Dave; Loiseleur, Olivier; Pabba, Jagadish; Stoller, Andre;
Trah, Stephan; Wenger, Jean; Dutton, Anna; Crossthwaite, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(3), 403-427

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-10-chloro-4H-pyrido[2,3-...
C19H8BrCl2N5O2
1846567-98-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.0424 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.8369 0.0 0
M  V30 3 O 7.0036 7.8788 0.0 0
M  V30 4 Cl 9.6710 1.7187 0.0 0
M  V30 5 C 4.3361 3.2587 0.0 0
M  V30 6 N 2.9293 3.8850 0.0 0
M  V30 7 C 4.1752 1.7271 0.0 0
M  V30 8 N 1.8989 2.7406 0.0 0
M  V30 9 C 2.6689 1.4070 0.0 0
M  V30 10 C 5.6699 4.0287 0.0 0
M  V30 11 N 7.0036 3.2587 0.0 0
M  V30 12 O 5.6699 5.5688 0.0 0
M  V30 13 C 8.3373 4.0287 0.0 0
M  V30 14 C 7.0036 6.3388 0.0 0
M  V30 15 C 8.3373 5.5688 0.0 0
M  V30 16 C 9.6710 3.2587 0.0 0
M  V30 17 C 9.6710 6.3388 0.0 0
M  V30 18 C 11.0048 4.0287 0.0 0
M  V30 19 C 11.0048 5.5688 0.0 0
M  V30 20 C 12.3384 3.2587 0.0 0
M  V30 21 N 12.3384 6.3388 0.0 0
M  V30 22 C 13.6721 4.0287 0.0 0
M  V30 23 C 13.6721 5.5688 0.0 0
M  V30 24 C 2.6091 5.3915 0.0 0
M  V30 25 C 1.1444 5.8674 0.0 0
M  V30 26 N 3.7535 6.4219 0.0 0
M  V30 27 C 0.8242 7.3737 0.0 0
M  V30 28 C 3.4334 7.9284 0.0 0
M  V30 29 C 1.9688 8.4043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 25
M  V30 3 2 3 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]amino]-5-chlor...
C20H13BrCl2N6O2
927431-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 6.6685 0.0 0
M  V30 2 N 5.9256 5.3347 0.0 0
M  V30 3 O 5.9256 8.0022 0.0 0
M  V30 4 Cl 0.6496 10.2033 0.0 0
M  V30 5 Br 0.0000 4.9933 0.0 0
M  V30 6 C 7.4657 2.6674 0.0 0
M  V30 7 N 8.2357 1.3338 0.0 0
M  V30 8 O 5.9256 2.6674 0.0 0
M  V30 9 C 7.4657 0.0000 0.0 0
M  V30 10 Cl 7.4657 8.0022 0.0 0
M  V30 11 N 2.7104 7.9144 0.0 0
M  V30 12 C 3.6156 6.6685 0.0 0
M  V30 13 N 1.2459 7.4385 0.0 0
M  V30 14 C 2.7104 5.4227 0.0 0
M  V30 15 C 1.2459 5.8985 0.0 0
M  V30 16 C 3.1864 9.3790 0.0 0
M  V30 17 C 2.1559 10.5235 0.0 0
M  V30 18 N 4.6927 9.6993 0.0 0
M  V30 19 C 2.6317 11.9880 0.0 0
M  V30 20 C 5.1686 11.1638 0.0 0
M  V30 21 C 4.1382 12.3084 0.0 0
M  V30 22 C 7.4657 5.3347 0.0 0
M  V30 23 C 8.2357 4.0011 0.0 0
M  V30 24 C 8.2357 6.6685 0.0 0
M  V30 25 C 9.7757 4.0011 0.0 0
M  V30 26 C 9.7757 6.6685 0.0 0
M  V30 27 C 10.5457 5.3347 0.0 0
M  V30 28 C 10.5457 8.0022 0.0 0
M  V30 29 N 12.0857 5.3347 0.0 0
M  V30 30 C 12.0857 8.0022 0.0 0
M  V30 31 C 12.8557 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 22
M  V30 5 1 4 17
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 7 9
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1846567-98-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 927431-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8730790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic heterocyclic anthranilic diamides as ryanodine receptor
modulators with insecticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeanguenat, Andre; Durieux, Patricia; Edmunds, Andrew J. F.; Hall, Roger
G.; Hughes, Dave; Loiseleur, Olivier; Pabba, Jagadish; Stoller, Andre;
Trah, Stephan; Wenger, Jean; Dutton, Anna; Crossthwaite, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(3), 403-427

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Zolpidic acid
C17H16N2O2
189005-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 2.6091 0.0 0
M  V30 2 C 4.9112 1.4645 0.0 0
M  V30 3 O 3.4048 1.7847 0.0 0
M  V30 4 O 5.3871 0.0000 0.0 0
M  V30 5 C 0.0000 3.7795 0.0 0
M  V30 6 C 12.5310 5.3195 0.0 0
M  V30 7 C 6.3710 5.3195 0.0 0
M  V30 8 C 5.4658 4.0736 0.0 0
M  V30 9 N 5.4658 6.5655 0.0 0
M  V30 10 N 4.0011 4.5495 0.0 0
M  V30 11 C 4.0011 6.0895 0.0 0
M  V30 12 C 2.6674 3.7795 0.0 0
M  V30 13 C 2.6674 6.8595 0.0 0
M  V30 14 C 1.3338 4.5495 0.0 0
M  V30 15 C 1.3338 6.0895 0.0 0
M  V30 16 C 7.9110 5.3195 0.0 0
M  V30 17 C 8.6810 3.9858 0.0 0
M  V30 18 C 8.6810 6.6533 0.0 0
M  V30 19 C 10.2210 3.9858 0.0 0
M  V30 20 C 10.2210 6.6533 0.0 0
M  V30 21 C 10.9910 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 6 21
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,6-Dimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide
C18H19N3O
82644-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 3.7534 0.0 0
M  V30 2 C 4.9112 2.6091 0.0 0
M  V30 3 N 5.3871 1.1444 0.0 0
M  V30 4 O 3.4048 2.9292 0.0 0
M  V30 5 C 4.3565 0.0000 0.0 0
M  V30 6 C 0.0000 4.9240 0.0 0
M  V30 7 C 12.5310 6.4640 0.0 0
M  V30 8 C 5.4658 5.2181 0.0 0
M  V30 9 C 6.3710 6.4640 0.0 0
M  V30 10 N 4.0011 5.6940 0.0 0
M  V30 11 N 5.4658 7.7099 0.0 0
M  V30 12 C 4.0011 7.2340 0.0 0
M  V30 13 C 2.6674 4.9240 0.0 0
M  V30 14 C 2.6674 8.0040 0.0 0
M  V30 15 C 1.3338 5.6940 0.0 0
M  V30 16 C 1.3338 7.2340 0.0 0
M  V30 17 C 7.9110 6.4640 0.0 0
M  V30 18 C 8.6810 7.7976 0.0 0
M  V30 19 C 8.6810 5.1304 0.0 0
M  V30 20 C 10.2210 7.7976 0.0 0
M  V30 21 C 10.2210 5.1304 0.0 0
M  V30 22 C 10.9910 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 22
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 12
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 189005-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82644-31-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3689186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and spectral characterization of process-related substances to
the hypnotic agent zolpidem
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sumalatha, Yasareni; Reddy, Padi Pratap; Reddy, Ranga; Satyanarayana,
Bollikonda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (7), 143-149

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[(Methylsulfonyl)oxy]methyl]cyclobutanecarbonitrile
C7H11NO3S
1909313-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 3.4375 0.0 0
M  V30 2 O 2.1037 3.4375 0.0 0
M  V30 3 S 1.3337 4.7712 0.0 0 VAL=6
M  V30 4 C 2.6673 5.5412 0.0 0
M  V30 5 O 0.5637 6.1050 0.0 0
M  V30 6 O 0.0000 4.0012 0.0 0
M  V30 7 C 5.7474 2.8739 0.0 0
M  V30 8 N 7.0811 3.6439 0.0 0
M  V30 9 C 4.4137 2.1038 0.0 0
M  V30 10 C 3.0801 1.3338 0.0 0
M  V30 11 C 5.1838 0.7700 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 3 7 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(Methylamino)methyl]cyclobutanecarbonitrile
C7H12N2
1904101-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 3.4374 0.0 0
M  V30 2 N 0.7700 3.4374 0.0 0
M  V30 3 C 0.0000 4.7710 0.0 0
M  V30 4 C 4.4137 2.8737 0.0 0
M  V30 5 N 5.7474 3.6437 0.0 0
M  V30 6 C 3.0801 2.1037 0.0 0
M  V30 7 C 3.8501 0.7700 0.0 0
M  V30 8 C 1.7462 1.3337 0.0 0
M  V30 9 C 2.5163 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1909313-54-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1904101-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22612179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1R,3S)-1-(2,4-dichlorophenyl)-6,7-difluoro-2,3,4,9-tetrahydro-1H-pyrid...
C20H16Cl2F2N2O2
1918181-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 8.8071 0.0 0
M  V30 2 O 10.6696 8.0371 0.0 0
M  V30 3 O 9.3359 10.3471 0.0 0
M  V30 4 C 12.0033 8.8071 0.0 0
M  V30 5 C 13.3369 8.0371 0.0 0
M  V30 6 Cl 5.3348 11.1171 0.0 0
M  V30 7 F 7.5323 0.3220 0.0 0
M  V30 8 F 4.4692 0.0000 0.0 0
M  V30 9 Cl 0.0000 11.1171 0.0 0
M  V30 10 C 5.3348 6.4971 0.0 0
M  V30 11 C 6.6685 5.7270 0.0 0
M  V30 12 C 5.3348 8.0371 0.0 0 CFG=1
M  V30 13 N 4.1903 5.4666 0.0 0
M  V30 14 C 6.3483 4.2206 0.0 0
M  V30 15 C 8.0021 6.4971 0.0 0
M  V30 16 N 6.6685 8.8071 0.0 0
M  V30 17 C 4.8167 4.0597 0.0 0
M  V30 18 C 7.2535 2.9747 0.0 0
M  V30 19 C 8.0021 8.0371 0.0 0 CFG=1
M  V30 20 C 4.1903 2.6528 0.0 0
M  V30 21 C 6.6270 1.5679 0.0 0
M  V30 22 C 5.0955 1.4070 0.0 0
M  V30 23 C 4.0010 8.8071 0.0 0
M  V30 24 C 4.0010 10.3471 0.0 0
M  V30 25 C 2.6673 8.0371 0.0 0
M  V30 26 C 2.6673 11.1171 0.0 0
M  V30 27 C 1.3337 8.8071 0.0 0
M  V30 28 C 1.3337 10.3471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 24
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 28
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=1
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dichlorophenyl)-6,7-difluoro-2,3,4,9-tetrahydro-N-methyl-1H-py...
C19H15Cl2F2N3O
1918182-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4464 2.3100 0.0 0
M  V30 2 N 5.1128 1.5400 0.0 0
M  V30 3 O 7.7802 1.5400 0.0 0
M  V30 4 C 5.1128 0.0000 0.0 0
M  V30 5 Cl 10.4475 4.6200 0.0 0
M  V30 6 F 0.0000 8.1144 0.0 0
M  V30 7 F 1.2528 10.9281 0.0 0
M  V30 8 Cl 13.1149 9.2400 0.0 0
M  V30 9 C 6.4464 6.9300 0.0 0
M  V30 10 C 5.1128 6.1600 0.0 0
M  V30 11 C 7.7802 6.1600 0.0 0 CFG=1
M  V30 12 N 6.1263 8.4364 0.0 0
M  V30 13 C 3.9684 7.1904 0.0 0
M  V30 14 C 5.1128 4.6200 0.0 0
M  V30 15 N 7.7802 4.6200 0.0 0
M  V30 16 C 4.5947 8.5974 0.0 0
M  V30 17 C 2.4367 7.0295 0.0 0
M  V30 18 C 6.4464 3.8500 0.0 0 CFG=1
M  V30 19 C 3.6895 9.8432 0.0 0
M  V30 20 C 1.5317 8.2753 0.0 0
M  V30 21 C 2.1580 9.6823 0.0 0
M  V30 22 C 9.1139 6.9300 0.0 0
M  V30 23 C 10.4475 6.1600 0.0 0
M  V30 24 C 9.1139 8.4700 0.0 0
M  V30 25 C 11.7812 6.9300 0.0 0
M  V30 26 C 10.4475 9.2400 0.0 0
M  V30 27 C 11.7812 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 20
M  V30 7 1 7 21
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 22 CFG=1
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918181-97-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15852362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-chloro-4,4,4-trifluoro-, ethyl ester
C6H6ClF3O2
197226-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.3337 0.0 0
M  V30 2 C 2.6675 2.1037 0.0 0
M  V30 3 C 5.3348 2.1037 0.0 0
M  V30 4 C 1.3337 1.3337 0.0 0
M  V30 5 Cl 2.6675 3.6437 0.0 0
M  V30 6 O 6.6685 1.3337 0.0 0
M  V30 7 O 5.3348 3.6437 0.0 0
M  V30 8 F 0.0000 0.5637 0.0 0
M  V30 9 F 2.1037 0.0000 0.0 0
M  V30 10 F 0.5637 2.6673 0.0 0
M  V30 11 C 8.0023 2.1037 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4,4,4-trifluoro-3-(methylamino)-, ethyl ester
C7H10F3NO2
121303-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 N 2.6675 0.7700 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 F 0.0000 3.8501 0.0 0
M  V30 7 F 2.1037 4.4137 0.0 0
M  V30 8 F 0.5637 1.7464 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 O 6.6685 3.0801 0.0 0
M  V30 11 O 5.3348 0.7700 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 197226-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121303-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5346595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1. Ethyl 3-methylamino-4,4,4-trifluorocrotonate (Step 5a) Ethyl
3-chloro-4,4,4-trifluorocrotonate (2.01 g, 9.93 mmol) was placed in a 90
cc glass pressure reactor containing a magnetic stir bar. The system was
freeze-thaw degassed and then anhydrous methylamine (5 g) was condensed
into the reactor at -70°C. The mixture was warmed to 15-20°C with
stirring for 90 minutes. Excess methylamine was vented; the methylamine
hydrochloride solid was filtered off, and rinsed with 1 mL of CH2Cl2. The
filtrate was distilled to yield 1.5 g of ethyl
3-methylamino-4,4,4-trifluorocrotonate. ethyl
3-methylamino-4,4,4-trifluorocrotonate, 1.5 g yield. bp 70°C at ca. 20 mm
Hg.
$DTYPE RXN:VAR(1):NOTES
$DATUM 15-20°, 90 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of halogenated α,β-unsaturated-β-aminocarboxylates and
-cyanocarboxylates from the corresponding β-halocarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Demmin, Timothy R.; Poss, Andrew Joseph; Bell, Robert Louis; Malec,
Ronald Theodor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002053518 A2 2002-07-11

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Phenylmethyl)-1-oxa-6-azaspiro[2.5]octane
C13H17NO
19867-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.6436 0.0 0
M  V30 2 C 8.0021 1.3336 0.0 0
M  V30 3 C 9.5421 1.3336 0.0 0
M  V30 4 O 8.7721 0.0000 0.0 0
M  V30 5 C 8.0021 2.8736 0.0 0
M  V30 6 C 6.6685 0.5636 0.0 0
M  V30 7 C 6.6685 3.6436 0.0 0
M  V30 8 C 5.3347 1.3336 0.0 0
M  V30 9 N 5.3347 2.8736 0.0 0
M  V30 10 C 2.6674 2.8736 0.0 0
M  V30 11 C 2.6674 1.3336 0.0 0
M  V30 12 C 1.3336 3.6436 0.0 0
M  V30 13 C 1.3336 0.5636 0.0 0
M  V30 14 C 0.0000 2.8736 0.0 0
M  V30 15 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 3 4
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylamino)methyl]-1-(phenylmethyl)-4-piperidinol
C14H22N2O
77211-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5187 1.7145 0.0 0
M  V30 2 N 10.5087 0.5347 0.0 0
M  V30 3 C 12.0252 0.8022 0.0 0
M  V30 4 O 8.5288 0.0000 0.0 0
M  V30 5 C 4.0011 3.7570 0.0 0
M  V30 6 C 8.0021 1.4470 0.0 0
M  V30 7 C 8.0021 2.9870 0.0 0
M  V30 8 C 6.6684 0.6770 0.0 0
M  V30 9 C 6.6684 3.7570 0.0 0
M  V30 10 C 5.3347 1.4470 0.0 0
M  V30 11 N 5.3347 2.9870 0.0 0
M  V30 12 C 2.6674 2.9870 0.0 0
M  V30 13 C 2.6674 1.4470 0.0 0
M  V30 14 C 1.3336 3.7570 0.0 0
M  V30 15 C 1.3336 0.6770 0.0 0
M  V30 16 C 0.0000 2.9870 0.0 0
M  V30 17 C 0.0000 1.4470 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 1 5 11
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19867-34-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 77211-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-15822299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(hetero)aryl substituted heterocycle derivatives useful
as dopamine transporter inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cremonesi, Susanna; Micheli, Fabrizio; Semeraro, Teresa; Tarsi, Luca;
Luker, Tim; Leslie, Colin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016042453 A1 2016-03-24

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,5S,9bS)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-3,3a,4,5-tetrahydro-8-...
C29H38O4Si
2056254-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5955 5.5336 0.0 0
M  V30 2 C 5.3494 6.4389 0.0 0
M  V30 3 O 5.5105 7.9704 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 4.0011 3.8501 0.0 0
M  V30 6 O 12.0034 3.8501 0.0 0
M  V30 7 Si 13.3371 4.6201 0.0 0
M  V30 8 C 14.6708 5.3901 0.0 0
M  V30 9 C 14.1071 3.2863 0.0 0
M  V30 10 C 12.5671 5.9538 0.0 0
M  V30 11 C 13.9008 6.7238 0.0 0
M  V30 12 C 16.0046 6.1601 0.0 0
M  V30 13 C 15.4408 4.0563 0.0 0
M  V30 14 O 5.3348 1.5400 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 C 8.0023 6.1601 0.0 0 CFG=1
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 9.3360 6.9301 0.0 0 CFG=1
M  V30 19 C 6.8579 7.1905 0.0 0
M  V30 20 C 9.3360 3.8501 0.0 0
M  V30 21 C 6.6686 3.8501 0.0 0
M  V30 22 C 10.6698 6.1601 0.0 0
M  V30 23 C 9.0158 8.4364 0.0 0
M  V30 24 C 7.4842 8.5974 0.0 0
M  V30 25 C 10.6698 4.6201 0.0 0 CFG=1
M  V30 26 C 9.3360 2.3100 0.0 0
M  V30 27 C 6.6686 2.3100 0.0 0
M  V30 28 C 8.0023 1.5400 0.0 0
M  V30 29 C 2.6675 4.6201 0.0 0
M  V30 30 C 2.6675 6.1601 0.0 0
M  V30 31 C 1.3338 3.8501 0.0 0
M  V30 32 C 1.3338 6.9301 0.0 0
M  V30 33 C 0.0000 4.6201 0.0 0
M  V30 34 C 0.0000 6.1601 0.0 0
M  V30 35 H 10.5818 7.8352 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 25 6 CFG=3
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 35 CFG=3
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 2 20 26
M  V30 28 1 21 27
M  V30 29 1 22 25
M  V30 30 1 23 24
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 18 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,5S,9bS)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-3,3a,4,5-tetrahydro-8-...
C30H43NO3Si
2056254-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5955 5.5338 0.0 0
M  V30 2 C 5.3494 6.4390 0.0 0
M  V30 3 N 5.5105 7.9705 0.0 0
M  V30 4 C 4.2645 8.8758 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 4.0011 3.8501 0.0 0
M  V30 7 O 12.0034 3.8501 0.0 0
M  V30 8 Si 13.3371 4.6201 0.0 0
M  V30 9 C 14.6707 5.3901 0.0 0
M  V30 10 C 14.1071 3.2864 0.0 0
M  V30 11 C 12.5670 5.9537 0.0 0
M  V30 12 C 13.9007 6.7237 0.0 0
M  V30 13 C 16.0045 6.1601 0.0 0
M  V30 14 C 15.4407 4.0564 0.0 0
M  V30 15 O 5.3348 1.5400 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 C 8.0023 6.1601 0.0 0 CFG=1
M  V30 18 C 8.0023 4.6201 0.0 0
M  V30 19 C 9.3359 6.9301 0.0 0 CFG=1
M  V30 20 C 6.8579 7.1907 0.0 0
M  V30 21 C 9.3359 3.8501 0.0 0
M  V30 22 C 6.6686 3.8501 0.0 0
M  V30 23 C 10.6697 6.1601 0.0 0
M  V30 24 C 9.0158 8.4365 0.0 0
M  V30 25 C 7.4842 8.5975 0.0 0
M  V30 26 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 27 C 9.3359 2.3100 0.0 0
M  V30 28 C 6.6686 2.3100 0.0 0
M  V30 29 C 8.0023 1.5400 0.0 0
M  V30 30 C 2.6675 4.6201 0.0 0
M  V30 31 C 2.6675 6.1601 0.0 0
M  V30 32 C 1.3338 3.8501 0.0 0
M  V30 33 C 1.3338 6.9301 0.0 0
M  V30 34 C 0.0000 4.6201 0.0 0
M  V30 35 C 0.0000 6.1601 0.0 0
M  V30 36 H 10.5818 7.8353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 1 26 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 15 16
M  V30 17 1 15 28
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 19 36 CFG=3
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 2 21 27
M  V30 29 1 22 28
M  V30 30 1 23 26
M  V30 31 1 24 25
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 19 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2056254-87-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2056254-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16618817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Synthesis and Racemization of (-)-Sinoracutine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Volpin, Giulio; Veprek, Nynke A.; Bellan, Andreas B.; Trauner, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(3), 897-901

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[4-(2-Methylpropyl)phenyl]sulfonyl]-5-oxo-L-proline
C15H19NO5S
2095255-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.5254 3.3320 0.0 0 VAL=6
M  V30 2 O 5.2954 1.9983 0.0 0
M  V30 3 O 3.7554 4.6658 0.0 0
M  V30 4 C 1.4646 4.6948 0.0 0
M  V30 5 O 0.0000 5.1707 0.0 0
M  V30 6 O 2.6091 5.7252 0.0 0
M  V30 7 O 4.1752 0.0000 0.0 0
M  V30 8 C 9.8602 6.4121 0.0 0
M  V30 9 C 11.1939 5.6421 0.0 0
M  V30 10 C 11.1939 4.1020 0.0 0
M  V30 11 C 12.5276 6.4121 0.0 0
M  V30 12 N 3.1917 2.5620 0.0 0
M  V30 13 C 1.7847 3.1885 0.0 0 CFG=2
M  V30 14 C 3.0306 1.0304 0.0 0
M  V30 15 C 0.7543 2.0439 0.0 0
M  V30 16 C 1.5243 0.7103 0.0 0
M  V30 17 C 5.8591 4.1020 0.0 0
M  V30 18 C 7.1927 3.3320 0.0 0
M  V30 19 C 5.8591 5.6421 0.0 0
M  V30 20 C 8.5266 4.1020 0.0 0
M  V30 21 C 7.1927 6.4121 0.0 0
M  V30 22 C 8.5266 5.6421 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 13 4 CFG=1
M  V30 8 2 7 14
M  V30 9 1 8 9
M  V30 10 1 8 22
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-N2-[[4-(2-methylpropyl)phenyl]sulfonyl]-L-glutamine
C16H24N2O5S
2095255-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 6.1601 0.0 0 VAL=6
M  V30 2 N 4.0010 6.9302 0.0 0
M  V30 3 O 6.1048 7.4938 0.0 0
M  V30 4 O 4.5648 4.8265 0.0 0
M  V30 5 C 2.6673 6.1601 0.0 0 CFG=2
M  V30 6 C 2.6673 4.6201 0.0 0
M  V30 7 C 1.3337 6.9302 0.0 0
M  V30 8 C 1.3337 3.8501 0.0 0
M  V30 9 O 1.3337 8.4702 0.0 0
M  V30 10 O 0.0000 6.1601 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 N 0.0000 1.5400 0.0 0
M  V30 13 O 2.6673 1.5400 0.0 0
M  V30 14 C 0.0000 0.0000 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 12.0033 3.8501 0.0 0
M  V30 17 C 13.3370 3.0801 0.0 0
M  V30 18 C 12.0033 5.3901 0.0 0
M  V30 19 C 6.6685 5.3901 0.0 0
M  V30 20 C 6.6685 3.8501 0.0 0
M  V30 21 C 8.0022 6.1601 0.0 0
M  V30 22 C 8.0022 3.0801 0.0 0
M  V30 23 C 9.3360 5.3901 0.0 0
M  V30 24 C 9.3360 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 24
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095255-46-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095255-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-17089346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Possible anticancer agents: synthesis, pharmacological activity, and
molecular modeling studies on some 5-N-Substituted-2-N-(substituted
benzenesulphonyl)-L(+)Glutamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jha, Tarun; Basu, Soumya; Halder, Amit Kumar; Adhikari, Nilanjan;
Samanta, Soma
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2017), 26(7), 1437-1458

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-1H-imidazole-2-carboxy...
C13H21N3O4
2097417-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0319 3.4208 0.0 0
M  V30 2 O 12.5384 3.1006 0.0 0
M  V30 3 O 10.5561 4.8855 0.0 0
M  V30 4 C 13.5688 4.2450 0.0 0
M  V30 5 C 15.0751 3.9248 0.0 0
M  V30 6 C 7.7000 3.7710 0.0 0
M  V30 7 C 6.1600 3.7710 0.0 0
M  V30 8 N 5.3900 5.1048 0.0 0
M  V30 9 C 3.8500 5.1048 0.0 0
M  V30 10 O 3.0800 6.4384 0.0 0
M  V30 11 O 3.0800 3.7710 0.0 0
M  V30 12 C 1.5400 6.4384 0.0 0
M  V30 13 C 1.5400 7.9784 0.0 0
M  V30 14 C 0.0000 6.4384 0.0 0
M  V30 15 C 1.5400 4.8984 0.0 0
M  V30 16 C 10.0015 2.2764 0.0 0
M  V30 17 N 8.4700 2.4374 0.0 0
M  V30 18 N 10.3217 0.7700 0.0 0
M  V30 19 C 7.8435 1.0306 0.0 0
M  V30 20 C 8.9881 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H20N4O3
2377665-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 3.7710 0.0 0
M  V30 2 C 6.1600 3.7710 0.0 0
M  V30 3 N 5.3900 5.1048 0.0 0
M  V30 4 C 3.8500 5.1048 0.0 0
M  V30 5 O 3.0800 6.4384 0.0 0
M  V30 6 O 3.0800 3.7710 0.0 0
M  V30 7 C 1.5400 6.4384 0.0 0
M  V30 8 C 1.5400 4.8984 0.0 0
M  V30 9 C 0.0000 6.4384 0.0 0
M  V30 10 C 1.5400 7.9784 0.0 0
M  V30 11 C 11.0321 3.4208 0.0 0
M  V30 12 N 12.5384 3.1006 0.0 0
M  V30 13 O 10.5562 4.8855 0.0 0
M  V30 14 C 13.5689 4.2450 0.0 0
M  V30 15 N 8.4700 2.4374 0.0 0
M  V30 16 C 10.0017 2.2764 0.0 0
M  V30 17 C 7.8437 1.0306 0.0 0
M  V30 18 N 10.3218 0.7700 0.0 0
M  V30 19 C 8.9881 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097417-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377665-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21841916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazopiperazines as inhibitors of transcription activating proteins and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le, Kang; Soth, Michael J.; Jones, Philip; Cross, Jason; Carroll,
Christopher L.; McAfoos, Timothy J.; Mandal, Pijus K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019191667 A1 2019-10-03

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(3-amino-6-imidazo[1,2-a]pyridin-3-yl-5-methyl-2-pyrazinyl)-1-methyl-...
C18H18N8O2
2101737-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4196 5.7680 0.0 0
M  V30 2 N 9.7544 5.7680 0.0 0
M  V30 3 C 8.7710 0.1258 0.0 0
M  V30 4 C 13.7234 2.3308 0.0 0
M  V30 5 O 14.6286 1.0850 0.0 0
M  V30 6 O 14.3499 3.7378 0.0 0
M  V30 7 C 16.1602 1.2459 0.0 0
M  V30 8 C 17.0654 0.0000 0.0 0
M  V30 9 C 4.4196 2.6880 0.0 0
M  V30 10 N 3.0128 3.3143 0.0 0
M  V30 11 C 4.2587 1.1564 0.0 0
M  V30 12 C 1.9822 2.1699 0.0 0
M  V30 13 C 2.5369 4.7790 0.0 0
M  V30 14 N 2.7522 0.8362 0.0 0
M  V30 15 C 0.4759 2.4901 0.0 0
M  V30 16 C 1.0304 5.0992 0.0 0
M  V30 17 C 0.0000 3.9548 0.0 0
M  V30 18 C 5.7534 3.4580 0.0 0
M  V30 19 N 7.0871 2.6880 0.0 0
M  V30 20 C 5.7534 4.9980 0.0 0
M  V30 21 C 8.4208 3.4580 0.0 0
M  V30 22 N 7.0871 5.7680 0.0 0
M  V30 23 C 8.4208 4.9980 0.0 0
M  V30 24 C 9.7544 2.6880 0.0 0
M  V30 25 N 11.1614 3.3143 0.0 0
M  V30 26 N 9.9155 1.1564 0.0 0
M  V30 27 C 12.1918 2.1699 0.0 0
M  V30 28 N 11.4218 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 23
M  V30 3 1 3 26
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 27
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Amino-6-imidazo[1,2-a]pyridin-3-yl-5-methyl-2-pyrazinyl)-N,1-dimethyl-1H...
C17H17N9O
2101744-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4196 5.6421 0.0 0
M  V30 2 N 9.7544 5.6421 0.0 0
M  V30 3 C 8.7709 0.0000 0.0 0
M  V30 4 C 13.7234 2.2049 0.0 0
M  V30 5 N 14.6286 0.9590 0.0 0
M  V30 6 O 14.3498 3.6118 0.0 0
M  V30 7 C 16.1601 1.1201 0.0 0
M  V30 8 C 4.4196 2.5620 0.0 0
M  V30 9 N 3.0128 3.1885 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 C 1.9822 2.0439 0.0 0
M  V30 12 C 2.5369 4.6530 0.0 0
M  V30 13 N 2.7522 0.7103 0.0 0
M  V30 14 C 0.4759 2.3641 0.0 0
M  V30 15 C 1.0304 4.9732 0.0 0
M  V30 16 C 0.0000 3.8288 0.0 0
M  V30 17 C 5.7532 3.3320 0.0 0
M  V30 18 N 7.0871 2.5620 0.0 0
M  V30 19 C 5.7532 4.8720 0.0 0
M  V30 20 C 8.4207 3.3320 0.0 0
M  V30 21 N 7.0871 5.6421 0.0 0
M  V30 22 C 8.4207 4.8720 0.0 0
M  V30 23 C 9.7544 2.5620 0.0 0
M  V30 24 N 11.1614 3.1885 0.0 0
M  V30 25 N 9.9153 1.0304 0.0 0
M  V30 26 C 12.1918 2.0439 0.0 0
M  V30 27 N 11.4218 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 22
M  V30 3 1 3 25
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 26
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101737-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101744-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17623953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlaam, Bernard; Cosulich, Sabina; Fitzek, Martina; Germain, Herve;
Green, Stephen; Hanson, Lyndsey L.; Harris, Craig S.; Hancox, Urs;
Hudson, Kevin; Lambert-van der Brempt, Christine; Lamorlette, Maryannick;
Magnien, Francoise; Ouvry, Gilles; Page, Ken; Ruston, Linette; Ward,
Lara; Delouvrie, Benedicte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(13), 3030-3035

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(3-amino-6-imidazo[1,2-a]pyridin-3-yl-2-pyrazinyl)-1-methyl-1H-1,2,4-...
C17H16N8O2
2101741-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7544 0.0000 0.0 0
M  V30 2 C 8.7709 5.6422 0.0 0
M  V30 3 C 13.7233 3.4372 0.0 0
M  V30 4 O 14.6286 4.6831 0.0 0
M  V30 5 O 14.3498 2.0302 0.0 0
M  V30 6 C 16.1601 4.5221 0.0 0
M  V30 7 C 17.0654 5.7680 0.0 0
M  V30 8 C 4.4196 3.0801 0.0 0
M  V30 9 N 3.0128 2.4537 0.0 0
M  V30 10 C 4.2586 4.6116 0.0 0
M  V30 11 C 1.9822 3.5981 0.0 0
M  V30 12 C 2.5369 0.9890 0.0 0
M  V30 13 N 2.7522 4.9318 0.0 0
M  V30 14 C 0.4759 3.2779 0.0 0
M  V30 15 C 1.0304 0.6688 0.0 0
M  V30 16 C 0.0000 1.8132 0.0 0
M  V30 17 C 5.7532 2.3100 0.0 0
M  V30 18 N 7.0871 3.0801 0.0 0
M  V30 19 C 5.7532 0.7700 0.0 0
M  V30 20 C 8.4207 2.3100 0.0 0
M  V30 21 N 7.0871 0.0000 0.0 0
M  V30 22 C 8.4207 0.7700 0.0 0
M  V30 23 C 9.7544 3.0801 0.0 0
M  V30 24 N 11.1614 2.4537 0.0 0
M  V30 25 N 9.9155 4.6116 0.0 0
M  V30 26 C 12.1918 3.5981 0.0 0
M  V30 27 N 11.4218 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 26
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Amino-6-imidazo[1,2-a]pyridin-3-yl-2-pyrazinyl)-N,1-dimethyl-1H-1,2,4-tr...
C16H15N9O
2101982-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7544 0.0000 0.0 0
M  V30 2 C 8.7709 5.6420 0.0 0
M  V30 3 C 13.7233 3.4372 0.0 0
M  V30 4 N 14.6285 4.6831 0.0 0
M  V30 5 O 14.3498 2.0302 0.0 0
M  V30 6 C 16.1601 4.5220 0.0 0
M  V30 7 C 4.4196 3.0800 0.0 0
M  V30 8 N 3.0127 2.4536 0.0 0
M  V30 9 C 4.2586 4.6116 0.0 0
M  V30 10 C 1.9822 3.5981 0.0 0
M  V30 11 C 2.5369 0.9890 0.0 0
M  V30 12 N 2.7522 4.9318 0.0 0
M  V30 13 C 0.4759 3.2779 0.0 0
M  V30 14 C 1.0304 0.6688 0.0 0
M  V30 15 C 0.0000 1.8132 0.0 0
M  V30 16 C 5.7532 2.3100 0.0 0
M  V30 17 N 7.0870 3.0800 0.0 0
M  V30 18 C 5.7532 0.7700 0.0 0
M  V30 19 C 8.4207 2.3100 0.0 0
M  V30 20 N 7.0870 0.0000 0.0 0
M  V30 21 C 8.4207 0.7700 0.0 0
M  V30 22 C 9.7544 3.0800 0.0 0
M  V30 23 N 11.1613 2.4536 0.0 0
M  V30 24 N 9.9153 4.6116 0.0 0
M  V30 25 C 12.1918 3.5981 0.0 0
M  V30 26 N 11.4217 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 24
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 25
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 14 1 10 13
M  V30 15 2 11 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101741-72-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101982-98-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17623954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlaam, Bernard; Cosulich, Sabina; Fitzek, Martina; Germain, Herve;
Green, Stephen; Hanson, Lyndsey L.; Harris, Craig S.; Hancox, Urs;
Hudson, Kevin; Lambert-van der Brempt, Christine; Lamorlette, Maryannick;
Magnien, Francoise; Ouvry, Gilles; Page, Ken; Ruston, Linette; Ward,
Lara; Delouvrie, Benedicte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(13), 3030-3035

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1,3-bis(2-methylphenyl)-2,4(1H,3H)-pyrimidinedione
C18H15ClN2O2
2107417-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 0.7700 0.0 0
M  V30 2 Cl 2.6673 5.3900 0.0 0
M  V30 3 C 1.3336 4.6200 0.0 0
M  V30 4 O 8.0021 5.3900 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 N 6.6684 3.0800 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 1.3336 3.0800 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3336 0.0000 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 C 9.3358 3.0800 0.0 0
M  V30 20 C 8.0021 0.7700 0.0 0
M  V30 21 C 10.6694 2.3100 0.0 0
M  V30 22 C 9.3358 0.0000 0.0 0
M  V30 23 C 10.6694 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 13
M  V30 4 2 4 11
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)-1,3-bis(2-methylphenyl)-2,4(1H,3H)-pyrimidinedione
C19H19N3O2
2107417-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.1600 0.0 0
M  V30 2 N 2.6673 1.5400 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 C 1.3336 2.3100 0.0 0
M  V30 5 O 8.0021 1.5400 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 5.3347 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 N 6.6684 3.8500 0.0 0
M  V30 11 C 5.3347 1.5400 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0
M  V30 13 C 2.6673 4.6200 0.0 0
M  V30 14 C 1.3336 3.8500 0.0 0
M  V30 15 C 2.6673 6.1600 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 17 C 1.3336 6.9300 0.0 0
M  V30 18 C 0.0000 6.1600 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 22 C 10.6694 4.6200 0.0 0
M  V30 23 C 9.3358 6.9300 0.0 0
M  V30 24 C 10.6694 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 14
M  V30 5 2 5 12
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 10 19
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2107417-82-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2107417-85-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17459077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational Analysis and Absolute Configuration of Axially Chiral
1-Aryl and 1,3-Bisaryl-xanthines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mancinelli, Michele; Perticarari, Sofia; Prati, Luca; Mazzanti, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(13), 6874-6885

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Chlorodifluoromethoxy)phenyl]-6′-fluoro-2-(1-methyl-1H-pyrazol-5-yl)[3,...
C22H15ClF3N5O2
2144405-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.6421 0.0 0
M  V30 2 N 10.6697 4.8721 0.0 0
M  V30 3 O 9.3360 7.1821 0.0 0
M  V30 4 C 4.9846 0.0000 0.0 0
M  V30 5 F 0.0000 7.9521 0.0 0
M  V30 6 O 16.0045 7.9521 0.0 0
M  V30 7 C 17.3383 7.1821 0.0 0
M  V30 8 Cl 17.3383 5.6421 0.0 0
M  V30 9 F 18.6720 6.4121 0.0 0
M  V30 10 F 18.6720 7.9521 0.0 0
M  V30 11 C 5.3348 4.8721 0.0 0
M  V30 12 C 5.3348 3.3320 0.0 0
M  V30 13 C 6.6685 5.6421 0.0 0
M  V30 14 N 6.6685 2.5620 0.0 0
M  V30 15 C 8.0023 4.8721 0.0 0
M  V30 16 C 8.0023 3.3320 0.0 0
M  V30 17 C 4.0012 5.6421 0.0 0
M  V30 18 C 4.0012 7.1821 0.0 0
M  V30 19 C 2.6675 4.8721 0.0 0
M  V30 20 C 2.6675 7.9521 0.0 0
M  V30 21 N 1.3337 5.6421 0.0 0
M  V30 22 C 1.3337 7.1821 0.0 0
M  V30 23 C 4.0012 2.5620 0.0 0
M  V30 24 N 3.8402 1.0304 0.0 0
M  V30 25 C 2.5943 3.1885 0.0 0
M  V30 26 N 2.3338 0.7103 0.0 0
M  V30 27 C 1.5638 2.0439 0.0 0
M  V30 28 C 12.0035 5.6421 0.0 0
M  V30 29 C 12.0035 7.1821 0.0 0
M  V30 30 C 13.3372 4.8721 0.0 0
M  V30 31 C 13.3372 7.9521 0.0 0
M  V30 32 C 14.6708 5.6421 0.0 0
M  V30 33 C 14.6708 7.1821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 28
M  V30 5 1 4 24
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 1 12 23
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Chlorodifluoromethoxy)phenyl]-6′-(methylamino)-2-(1-methyl-1H-pyrazol-5...
C23H19ClF2N6O2
2144405-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.6421 0.0 0
M  V30 2 N 10.6697 4.8721 0.0 0
M  V30 3 O 9.3360 7.1821 0.0 0
M  V30 4 C 4.9846 0.0000 0.0 0
M  V30 5 N 0.0000 7.9521 0.0 0
M  V30 6 C 0.0000 9.4922 0.0 0
M  V30 7 O 16.0045 7.9521 0.0 0
M  V30 8 C 17.3383 7.1821 0.0 0
M  V30 9 Cl 18.6720 7.9521 0.0 0
M  V30 10 F 18.6720 6.4121 0.0 0
M  V30 11 F 17.3383 5.6421 0.0 0
M  V30 12 C 5.3348 4.8721 0.0 0
M  V30 13 C 5.3348 3.3320 0.0 0
M  V30 14 C 6.6685 5.6421 0.0 0
M  V30 15 N 6.6685 2.5620 0.0 0
M  V30 16 C 8.0023 4.8721 0.0 0
M  V30 17 C 8.0023 3.3320 0.0 0
M  V30 18 C 4.0012 5.6421 0.0 0
M  V30 19 C 4.0012 7.1821 0.0 0
M  V30 20 C 2.6675 4.8721 0.0 0
M  V30 21 C 2.6675 7.9521 0.0 0
M  V30 22 N 1.3337 5.6421 0.0 0
M  V30 23 C 1.3337 7.1821 0.0 0
M  V30 24 C 4.0012 2.5620 0.0 0
M  V30 25 N 3.8402 1.0304 0.0 0
M  V30 26 C 2.5943 3.1885 0.0 0
M  V30 27 N 2.3338 0.7103 0.0 0
M  V30 28 C 1.5638 2.0439 0.0 0
M  V30 29 C 12.0035 5.6421 0.0 0
M  V30 30 C 12.0035 7.1821 0.0 0
M  V30 31 C 13.3372 4.8721 0.0 0
M  V30 32 C 13.3372 7.9521 0.0 0
M  V30 33 C 14.6708 5.6421 0.0 0
M  V30 34 C 14.6708 7.1821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 29
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 7 8
M  V30 9 1 7 34
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 1 13 24
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2144405-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2144405-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19628834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel heterocyclic compounds as tyrosine kinase BCR-ABL
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Lianhai; Yu, Chunrong; Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017186148 A1 2017-11-02

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
S-Phenyl (3R)-3-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]-2,3-dihydro-2-oxo-1-...
C39H36N2O3S2
2149021-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.7648 0.0 0
M  V30 2 O 6.5894 3.0544 0.0 0
M  V30 3 C 9.9860 4.4936 0.0 0
M  V30 4 C 11.1482 5.5038 0.0 0
M  V30 5 S 12.6043 5.0025 0.0 0
M  V30 6 O 10.8544 7.0155 0.0 0
M  V30 7 N 8.8501 3.4886 0.0 0
M  V30 8 S 10.3146 3.0127 0.0 0 CFG=1 VAL=4
M  V30 9 C 10.6349 1.5063 0.0 0
M  V30 10 O 11.4591 4.0431 0.0 0
M  V30 11 C 9.1285 1.1861 0.0 0
M  V30 12 C 10.9551 0.0000 0.0 0
M  V30 13 C 12.1412 1.8264 0.0 0
M  V30 14 N 6.1600 5.7648 0.0 0
M  V30 15 C 7.0652 7.0107 0.0 0
M  V30 16 C 7.0652 4.5190 0.0 0
M  V30 17 C 8.5299 6.5348 0.0 0
M  V30 18 C 6.7450 8.5171 0.0 0
M  V30 19 C 8.5299 4.9948 0.0 0 CFG=1
M  V30 20 C 9.6743 7.5654 0.0 0
M  V30 21 C 7.8896 9.5475 0.0 0
M  V30 22 C 9.3541 9.0717 0.0 0
M  V30 23 C 4.6200 7.3048 0.0 0
M  V30 24 C 3.2864 8.0748 0.0 0
M  V30 25 C 5.9538 8.0748 0.0 0
M  V30 26 C 3.2864 9.6148 0.0 0
M  V30 27 C 5.9538 9.6148 0.0 0
M  V30 28 C 4.6200 10.3848 0.0 0
M  V30 29 C 3.0800 5.7648 0.0 0
M  V30 30 C 2.3100 7.0986 0.0 0
M  V30 31 C 2.3100 4.4312 0.0 0
M  V30 32 C 0.7700 7.0986 0.0 0
M  V30 33 C 0.7700 4.4312 0.0 0
M  V30 34 C 0.0000 5.7648 0.0 0
M  V30 35 C 4.6200 4.2248 0.0 0
M  V30 36 C 3.2864 3.4548 0.0 0
M  V30 37 C 5.9538 3.4548 0.0 0
M  V30 38 C 3.2864 1.9148 0.0 0
M  V30 39 C 5.9538 1.9148 0.0 0
M  V30 40 C 4.6200 1.1448 0.0 0
M  V30 41 C 13.7665 6.0128 0.0 0
M  V30 42 C 15.2227 5.5114 0.0 0
M  V30 43 C 13.4727 7.5244 0.0 0
M  V30 44 C 16.3850 6.5217 0.0 0
M  V30 45 C 14.6349 8.5348 0.0 0
M  V30 46 C 16.0912 8.0334 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 2 2 16
M  V30 6 1 3 4
M  V30 7 1 19 3 CFG=3
M  V30 8 1 4 5
M  V30 9 2 4 6
M  V30 10 1 5 41
M  V30 11 1 7 8
M  V30 12 1 19 7 CFG=1
M  V30 13 1 8 9 CFG=1
M  V30 14 2 8 10
M  V30 15 1 9 11
M  V30 16 1 9 12
M  V30 17 1 9 13
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 15 18
M  V30 22 1 16 19
M  V30 23 1 17 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-3-[[(S)-(1,1-Dimethylethyl)sulfinyl]amino]-2,3-dihydro-N-methyl-2-oxo-1-...
C34H35N3O3S
2149021-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.5894 7.3306 0.0 0
M  V30 3 N 9.9860 5.8914 0.0 0
M  V30 4 S 11.1482 4.8810 0.0 0 CFG=1 VAL=4
M  V30 5 C 12.6043 5.3825 0.0 0
M  V30 6 O 10.8544 3.3694 0.0 0
M  V30 7 C 12.1030 6.8385 0.0 0
M  V30 8 C 14.0605 5.8839 0.0 0
M  V30 9 C 13.1057 3.9264 0.0 0
M  V30 10 C 8.8501 6.8964 0.0 0
M  V30 11 C 10.3148 7.3723 0.0 0
M  V30 12 N 10.6349 8.8786 0.0 0
M  V30 13 O 11.4591 6.3419 0.0 0
M  V30 14 C 12.0995 9.3546 0.0 0
M  V30 15 N 6.1600 4.6200 0.0 0
M  V30 16 C 7.0652 3.3741 0.0 0
M  V30 17 C 7.0652 5.8660 0.0 0
M  V30 18 C 8.5299 3.8500 0.0 0
M  V30 19 C 6.7450 1.8679 0.0 0
M  V30 20 C 8.5299 5.3900 0.0 0 CFG=2
M  V30 21 C 9.6743 2.8196 0.0 0
M  V30 22 C 7.8896 0.8373 0.0 0
M  V30 23 C 9.3541 1.3133 0.0 0
M  V30 24 C 4.6200 6.1600 0.0 0
M  V30 25 C 5.9538 6.9300 0.0 0
M  V30 26 C 3.2864 6.9300 0.0 0
M  V30 27 C 5.9538 8.4700 0.0 0
M  V30 28 C 3.2864 8.4700 0.0 0
M  V30 29 C 4.6200 9.2400 0.0 0
M  V30 30 C 3.0800 4.6200 0.0 0
M  V30 31 C 2.3100 3.2864 0.0 0
M  V30 32 C 2.3100 5.9538 0.0 0
M  V30 33 C 0.7700 3.2864 0.0 0
M  V30 34 C 0.7700 5.9538 0.0 0
M  V30 35 C 0.0000 4.6200 0.0 0
M  V30 36 C 4.6200 3.0800 0.0 0
M  V30 37 C 3.2864 2.3100 0.0 0
M  V30 38 C 5.9538 2.3100 0.0 0
M  V30 39 C 3.2864 0.7700 0.0 0
M  V30 40 C 5.9538 0.7700 0.0 0
M  V30 41 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 1 36
M  V30 5 2 2 17
M  V30 6 1 3 4
M  V30 7 1 20 3 CFG=3
M  V30 8 1 4 5 CFG=3
M  V30 9 2 4 6
M  V30 10 1 5 7
M  V30 11 1 5 8
M  V30 12 1 5 9
M  V30 13 1 10 11
M  V30 14 1 20 10 CFG=1
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 12 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2149021-70-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2149021-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17908789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An asymmetric acetate-Mannich reaction of chiral isatin derived ketimines
and its applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hajra, Saumen; Bhosale, Suhas Shivajirao; Hazra, Atanu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(43), 9217-9225

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carboxylic acid
C14H12O5
216581-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 1.3338 0.0 0
M  V30 4 O 7.7000 0.0000 0.0 0
M  V30 5 O 5.3900 1.3338 0.0 0
M  V30 6 O 6.9300 6.6685 0.0 0
M  V30 7 C 11.5500 4.0011 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.7000 2.6674 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 O 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 6 10
M  V30 8 1 7 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-1,6-dimethyl-4-oxo-3-(phenylmethoxy)-2-pyridinecarboxylic acid
C15H15NO4
850346-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 O 6.1600 1.3338 0.0 0
M  V30 4 O 6.1600 4.0011 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 O 4.6200 6.6685 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 N 2.3100 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.7800 4.0011 0.0 0
M  V30 19 C 10.7800 6.6685 0.0 0
M  V30 20 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 15
M  V30 7 1 6 11
M  V30 8 2 7 12
M  V30 9 1 8 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216581-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850346-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5428923
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
3-(benzyloxy)-1,6-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid. 2
M Methylamine solution in Methanol (5.8 ml, 11.5 mmol) was added to a
suspension of the 3-(benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carboxylic acid
(1.0 g, 3.84 mmol) in Methanol (3 ml) at room temperature. The resulting
solution was sealed, and then heated at 70 °C for overnight. A clear
yellow solution was observed. The titled compound was obtained as a light
yellow solid after solvent was removed by reducing pressure. The yellow
solid was directly used for the next step reaction without further
purification. (1.74 g, yield 97%).
3-(benzyloxy)-1,6-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid,
yield (1.74 g, 97%). 1H NMR (D MSO) δ: 7.70 (br, 1H,), 7.49 (m, 2H), 7.30
(M, 3H), 6.01 (S, 1H), 4.90 (s, 3H, CH2), 3.47 (S, 3H, NMe), 2.2 (S, 3H,
CH3), MS: 274 (M + 1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carboxylic acid derivatives of
3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimian, Khashayar; Tam, Tim Fat; Li, Wanren; Wang, Yingsheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2379370 A1 2003-09-28

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrobenzonitrile
C7H3FN2O2
218632-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 3-(methylamino)-4-nitro-
C8H7N3O2
64910-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 218632-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38477186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Leucettinibs, a class of DYRK/CLK kinase inhibitors inspired by the
marine sponge natural product Leucettamine B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deau, Emmanuel; Lindberg, Mattias F.; Miege, Frederic; Roche, Didier;
George, Nicolas; George, Pascal; Kramer, Andreas; Knapp, Stefan; Meijer,
Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(15), 10694-10714

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrobenzonitrile
C7H3FN2O2
218632-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 3-(methylamino)-4-nitro-
C8H7N3O2
64910-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 218632-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36786371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM methanol solvent may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolone derivative as inhibitor of protein kinases in
particular DYRK1A, CLK1 and/or CLK4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deau, Emmanuel; George, Pascal; Meijer, Laurent; Miege, Frederic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023072966 A1 2023-05-04

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrobenzonitrile
C7H3FN2O2
218632-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 3-(methylamino)-4-nitro-
C8H7N3O2
64910-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 218632-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36785616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, MeOH solvent may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolone derivative as inhibitor of protein kinases in
particular DYRK1A, CLK1 and/or CLK4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deau, Emmanuel; George, Pascal; Meijer, Laurent; Miege, Frederic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4173675 A1 2023-05-03

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-methyl-β-oxobenzenepropanoate
C11H12O3
22027-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 O 3.8501 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 2.6673 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 10.7802 2.6673 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 8.4702 4.0010 0.0 0
M  V30 13 C 8.4702 1.3337 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-(4-methylphenyl)-2-propenoate
C12H15NO2
2304416-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 O 1.5400 2.6674 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 10.7800 2.6674 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 8.4700 1.3338 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22027-51-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,6-Dichlorophenyl)-7-fluoro-1-methyl-1,6-naphthyridin-2(1H)-one
C15H9Cl2FN2O
220822-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 Cl 3.0800 5.3349 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 F 11.5500 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 N 6.9300 1.3338 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3349 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 N 9.2400 5.3349 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.7700 1.3338 0.0 0
M  V30 21 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 17
M  V30 3 1 3 18
M  V30 4 1 4 10
M  V30 5 1 5 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,6-Dichlorophenyl)-1-methyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one
C16H13Cl2N3O
220816-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 5.3349 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 11.5500 4.0011 0.0 0
M  V30 6 C 12.3200 5.3347 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 5.3900 1.3338 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 N 6.9300 1.3338 0.0 0
M  V30 18 C 7.7000 2.6674 0.0 0
M  V30 19 C 7.7000 5.3349 0.0 0
M  V30 20 C 9.2400 2.6674 0.0 0
M  V30 21 N 9.2400 5.3349 0.0 0
M  V30 22 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 15
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 18
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 220822-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220816-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2946623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(2,6-Dichlorophenyl)-1-methy7-(methylamino)-1,6-naphthyridin-2(1H)-one
(7b). Similar treatment of 17 with excess 40% aqueous methylamine (180
equiv) in 2-propanol at 100 °C (pressure vessel) for 5 h gave 7b. Yield
97%. mp (CH2Cl2/light petroleum) 252-253.5 °C; 1H NMR [(CD3)2SO] δ 8.42
(s, 1 H, H-5), 7.76 (s, 1 H, H-4), 7.56 (d, J = 8.0 Hz, 2 H, H-3',5'),
7.43 (dd, J = 8.7, 7.3 Hz, 1 H, H-4'), 7.15 (br q, J = 4.8 Hz, 1 H,
NHCH3), 6.20 (s, 1 H, H-8), 3.53 (s, 3 H, NCH3), 2.88 (d, J = 4.9 Hz, 3
H, NHCH3); 13C NMR δ 160.76, 159.77 (2 s, C-2,7), 150.71 (d, C-5), 146.15
(s, C-8a), 138.32 (d, C-4), 135.05 (s, 2 C, C-2',6'), 135.04 (s, C-1'),
130.19 (d, C-4'), 127.93 (d, 2 C, C-3',5'), 122.03 (s, C-3), 108.03 (s,
C-4a), 86.98 (br d, C-8), 28.82, 28.23 (2 q, 2NCH3). Anal. (C16H13Cl2N3O)
C, H, N. Elemental analyses: Found: C 57.5; H 4; N 12.6; Calculated: C
57.5; H 3.9; N 12.6
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Structure-Activity Relationships of 7-Substituted
3-(2,6-Dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as Selective
Inhibitors of pp60c-src
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thompson, Andrew M.; Rewcastle, Gordon W.; Boushelle, Stacey L.; Hartl,
Brian G.; Kraker, Alan J.; Lu, Gina H.; Batley, Brian L.; Panek, Robert
L.; Showalter, H. D. Hollis; Denny, William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(16), 3134-3147

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)sulfonyl]-α-methoxy-N-methylbenzeneacetamide
C16H16BrNO4S
2242699-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 O 4.0010 0.7700 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 O 8.7722 1.7464 0.0 0
M  V30 10 O 7.2322 4.4137 0.0 0
M  V30 11 Br 13.3370 6.1601 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 23 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 7 18
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Methoxy-N-methylbenzeneacetamide
C10H13NO2
158664-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 N 6.6685 2.3100 0.0 0
M  V30 5 O 5.3347 4.6200 0.0 0
M  V30 6 C 5.3347 0.0000 0.0 0
M  V30 7 C 8.0021 3.0800 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 1.3336 5.3900 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242699-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 158664-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19092376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of α-alkoxy amides via scandium-catalyzed oxidative
reaction between ynamides and alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zhi-Xin; Zhu, Bo-Han; Xie, Pei-Xi; Tang, Jia-Qi; Li, Xin-Ling;
Zhu, Chunyin; Yin, Ying-Wu; Ye, Long-Wu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(33), 18308-18315

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethyl 2,7-dihydro-9-(3-methoxypropoxy)-2-oxospiro[6H-benzo[a]quinolizine-6,...
C24H27NO7
2243414-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 7.7002 0.0 0
M  V30 2 O 2.6675 6.9302 0.0 0
M  V30 3 O 4.0012 9.2402 0.0 0
M  V30 4 C 1.3337 7.7002 0.0 0
M  V30 5 C 0.0000 6.9302 0.0 0
M  V30 6 O 4.0012 4.6201 0.0 0
M  V30 7 O 13.3372 2.3101 0.0 0
M  V30 8 C 14.6708 3.0801 0.0 0
M  V30 9 C 16.0045 2.3101 0.0 0
M  V30 10 C 17.3382 3.0801 0.0 0
M  V30 11 O 18.6720 2.3101 0.0 0
M  V30 12 C 20.0057 3.0801 0.0 0
M  V30 13 C 10.6697 0.7700 0.0 0
M  V30 14 O 12.0033 0.0000 0.0 0
M  V30 15 O 9.3360 0.0000 0.0 0
M  V30 16 C 9.3360 7.7002 0.0 0
M  V30 17 N 8.0023 6.9302 0.0 0
M  V30 18 C 10.6697 6.9302 0.0 0
M  V30 19 C 10.4250 8.7891 0.0 0
M  V30 20 C 8.2470 8.7891 0.0 0
M  V30 21 C 8.0023 5.3901 0.0 0
M  V30 22 C 6.6685 7.7002 0.0 0
M  V30 23 C 10.6697 5.3901 0.0 0
M  V30 24 C 9.3360 9.8781 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 6.6685 4.6201 0.0 0
M  V30 27 C 5.3348 6.9302 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 9.3360 3.0801 0.0 0
M  V30 30 C 5.3348 5.3901 0.0 0
M  V30 31 C 12.0033 3.0801 0.0 0
M  V30 32 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 30
M  V30 7 1 7 8
M  V30 8 1 7 31
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 32
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 2 22 27
M  V30 28 1 23 25
M  V30 29 2 23 28
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,7-dihydro-9-(3-methoxypropoxy)-10-[(methylamino)carbonyl]-2-oxospiro[...
C25H30N2O6
2243414-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 9.2402 0.0 0
M  V30 2 O 2.6675 8.4702 0.0 0
M  V30 3 O 4.0012 10.7802 0.0 0
M  V30 4 C 1.3337 9.2402 0.0 0
M  V30 5 C 0.0000 8.4702 0.0 0
M  V30 6 O 4.0012 6.1601 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 N 9.3360 1.5400 0.0 0
M  V30 9 O 12.0033 1.5400 0.0 0
M  V30 10 C 9.3360 0.0000 0.0 0
M  V30 11 O 13.3372 3.8501 0.0 0
M  V30 12 C 14.6708 4.6201 0.0 0
M  V30 13 C 16.0045 3.8501 0.0 0
M  V30 14 C 17.3382 4.6201 0.0 0
M  V30 15 O 18.6720 3.8501 0.0 0
M  V30 16 C 20.0057 4.6201 0.0 0
M  V30 17 N 8.0023 8.4702 0.0 0
M  V30 18 C 9.3360 9.2402 0.0 0
M  V30 19 C 8.0023 6.9302 0.0 0
M  V30 20 C 6.6685 9.2402 0.0 0
M  V30 21 C 10.6697 8.4702 0.0 0
M  V30 22 C 8.2470 10.3292 0.0 0
M  V30 23 C 10.4249 10.3292 0.0 0
M  V30 24 C 9.3360 6.1601 0.0 0
M  V30 25 C 6.6685 6.1601 0.0 0
M  V30 26 C 5.3348 8.4702 0.0 0
M  V30 27 C 10.6697 6.9302 0.0 0
M  V30 28 C 9.3360 11.4181 0.0 0
M  V30 29 C 9.3360 4.6201 0.0 0
M  V30 30 C 5.3348 6.9302 0.0 0
M  V30 31 C 12.0033 6.1601 0.0 0
M  V30 32 C 10.6697 3.8501 0.0 0
M  V30 33 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 30
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 32
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 33
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 2 19 25
M  V30 25 2 20 26
M  V30 26 1 21 27
M  V30 27 1 22 28
M  V30 28 1 23 28
M  V30 29 1 24 27
M  V30 30 2 24 29
M  V30 31 1 25 30
M  V30 32 1 26 30
M  V30 33 2 27 31
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243414-55-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243414-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20474135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolizinones as antivirals for inhibition of HBe and HBs
antigens and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catalano, John G.; Dickson, Hamilton D.; Kazmierski, Wieslaw Mieczyslaw;
Leivers, Martin R.; Weatherhead, John Gordon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018154466 A1 2018-08-30

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-alanyl-L-proline methyl ester
C17H22N2O5
22610-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8456 3.3450 0.0 0
M  V30 2 C 6.1792 4.1150 0.0 0 CFG=2
M  V30 3 O 4.8456 1.8049 0.0 0
M  V30 4 N 7.5131 3.3450 0.0 0
M  V30 5 C 6.1792 5.6550 0.0 0
M  V30 6 C 8.8467 4.1150 0.0 0
M  V30 7 O 10.1804 3.3450 0.0 0
M  V30 8 O 8.8467 5.6550 0.0 0
M  V30 9 C 11.5142 4.1150 0.0 0
M  V30 10 C 1.7847 1.9822 0.0 0
M  V30 11 O 0.3202 1.5063 0.0 0
M  V30 12 O 2.9293 0.9517 0.0 0
M  V30 13 C 0.0000 0.0000 0.0 0
M  V30 14 N 3.5119 4.1150 0.0 0
M  V30 15 C 2.1051 3.4886 0.0 0 CFG=2
M  V30 16 C 3.3510 5.6465 0.0 0
M  V30 17 C 1.0745 4.6330 0.0 0
M  V30 18 C 1.8445 5.9667 0.0 0
M  V30 19 C 12.8479 3.3450 0.0 0
M  V30 20 C 12.8479 1.8049 0.0 0
M  V30 21 C 14.1816 4.1150 0.0 0
M  V30 22 C 14.1816 1.0349 0.0 0
M  V30 23 C 15.5152 3.3450 0.0 0
M  V30 24 C 15.5152 1.8049 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 15 10 CFG=3
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-alanyl-N-methyl-L-prolinamide
C17H23N3O4
66383-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8456 3.3450 0.0 0
M  V30 2 C 6.1792 4.1150 0.0 0 CFG=2
M  V30 3 O 4.8456 1.8049 0.0 0
M  V30 4 N 7.5131 3.3450 0.0 0
M  V30 5 C 6.1792 5.6550 0.0 0
M  V30 6 C 8.8467 4.1150 0.0 0
M  V30 7 O 10.1804 3.3450 0.0 0
M  V30 8 O 8.8467 5.6550 0.0 0
M  V30 9 C 11.5142 4.1150 0.0 0
M  V30 10 C 1.7847 1.9822 0.0 0
M  V30 11 N 0.3202 1.5063 0.0 0
M  V30 12 O 2.9293 0.9517 0.0 0
M  V30 13 C 0.0000 0.0000 0.0 0
M  V30 14 N 3.5119 4.1150 0.0 0
M  V30 15 C 2.1051 3.4886 0.0 0 CFG=2
M  V30 16 C 3.3510 5.6465 0.0 0
M  V30 17 C 1.0745 4.6330 0.0 0
M  V30 18 C 1.8445 5.9667 0.0 0
M  V30 19 C 12.8479 3.3450 0.0 0
M  V30 20 C 12.8479 1.8049 0.0 0
M  V30 21 C 14.1816 4.1150 0.0 0
M  V30 22 C 14.1816 1.0349 0.0 0
M  V30 23 C 15.5152 3.3450 0.0 0
M  V30 24 C 15.5152 1.8049 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 15 10 CFG=3
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22610-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66383-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Preparation of Dipeptide Derivatives with
C-Terminal Amide Groups. Method A. The corresponding dipeptide methyl
ester (4.22 mmol) was dissolved in MeNH2 • EtOH (10 mL, 8 M). After 2 h
of reaction the solvent was evaporated to dryness, and when necessary,
the residue waspurified by flash chromatography or centrifugal circular
thinlayer chromatography, using the system of eluents indicated in each
case Z-Ala-Pro-NHMe (7a): Solid 97% yield (From 3a, Method A). (mp
126-128 ºC). Eluent: MeOH:CH2Cl2 (1:30). HPLC: tR= 2.51 min (Novapak,
A:B=40:60). [α]D= -112.3 (c=0.98, CHCl3). 1H NMR (CDCl3): Trans/cis
isomers ratio 6:1. Trans isomer: δ 7.30 (m, 5H, Ph), 6.74 (br s, 1H,
NH-CH3), 5.65 (m, 1H, NH-Ala), 5.09 (s, 2H, CH2-Z), 4.62-4.50 (m, 2H,
α-H, Pro, α-H, Ala), 3.62 (m, 2H, δ-H, Pro), 2.77 (d, 3H, J=4.9, CH3-NH),
2.38 (m, 1H, β-H, Pro), 2.13 (m, 1H, γ-H, Pro), 2.02 (m, 1H, γ-H, Pro),
1.89 (m, 1H, β-H, Pro), 1.35 (d, 3H, J=6.8, β- H, Ala). cis isomer: δ
7.30 (m, 5H, Ph), 7.17 (br s, 1H, NH-CH3), 5.65 (m, 1H, NH-Ala), 5.14 (d,
1H, J=12.4, CH2-Z), 5.02 (d, 1H, J=12.4, CH2-Z), 4.28 (m, 1H, α-H, Pro),
4.12 (q, 1H, J=6.8, α-H, Ala), 3.62 (m, 2H, δ-H, Pro), 2.81 (d, 3H,
J=4.9, CH3-NH), 2.50 (m, 1H, β- H, Pro), 2.20-1.75 (m, 3H, β-H, Pro, γ-H,
Pro), 1.28 (d, 3H, J=6.8, β-H, Ala). 1H NMR (400 MHz, DMSO-d 6):
Trans/cis isomers ratio 5.3:1. Trans isomer: δ 7.69 (c, 1H, J=4.6,
NHCH3), 7.50 (d, 1H, J=7.3, NH-Ala), 7.33 (m, 5H, Ph), 5.00 (s, 2H,
CH2-Z), 4.31 (q, 1H, J=7.3, α-H, Ala), 4.21 (dd, 1H, J=8.2, 3.8, α-H,
Pro), 3.58 (m, 2H, δ-H, Pro), 2.55 (d, 3H, J=4.6, CH3-NH), 2.01 (m, 1H,
β-H, Pro), 2.00-1.71 (m, 3H, β-H, Pro, γ-H, Pro), 1.19 (d, 3H, J=7.3,
β-H, Ala). cis isomer: δ 8.03 (c, 1H, J=4.6, NH-CH3), 7.33 (m, 5H, Ph),
7.16 (m, 1H, NHAla), 5.01 (d, 1H, J=12.7, CH2-Z), 4.98 (d, 1H, J=12.7,
CH2-Z), 4.20-4.02 (m, 2H, α-H, Pro, α-H, Ala), 3.58 (m, 2H, δ-H, Pro),
2.58 (d, 3H, J=4.6, CH3-NH), 2.01 (m, 1H, β-H, Pro), 2.00-1.71 (m, 3H,
β-H, Pro, γ-H, Pro), 1.16 (d, 3H, J=6.9, β-H, Ala). 13C NMR (CDCl3):
Trans isomer: δ 172.6 (CO-Ala), 171.4 (CO-Pro), 155.6 (CO-Z), 136.3
(C-Ph), 128.5, 128.1, 128.0 (CH-Ph), 66.8 (CH2-Z), 59.8 (α-C, Pro), 48.2
(α-C, Ala), 47.2 (δ-C, Pro), 27.2 (β-C, Pro), 26.2 (CH3-NH), 25.1 (γ-C,
Pro), 18.4 (β-C, Ala). cis isomer: δ 172.1 (CO-Ala), 171.0 (CO-Pro),
156.4 (CO-Z), 136.3 (C-Ph), 128.5, 128.1, 128.0 (CH-Ph), 67.0 (CH2-Z),
60.9 (α-C, Pro), 49.0 (α-C, Ala), 46.9 (δ-C, Pro), 31.6 (β-C, Pro), 26.5
(CH3-NH), 22.0 (γ-C, Pro), 17.0 (β-C, Ala). ES-MS: 334.2 [M+1]+, 356.0
[M+Na]+. Anal. Calcd. for C17H23N3O4: C, 61.25; H, 6.95; N, 12.60. Found:
C, 61.24; H, 7.00; N, 12.53.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further Evidence for 2-Alkyl-2-carboxyazetidines as γ-Turn Inducers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Thompson, Kevin; Perez de
Vega, M. Jesus; Infantes, Lourdes; Garcia-Lopez, M. Teresa;
Gonzalez-Muniz, Rosario; Martin-Martinez, Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8203-8211

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
2-(Methylthio)-4-[[3-(trifluoromethyl)phenyl]amino]-5-pyrimidinecarboxylic acid
C13H10F3N3O2S
227449-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 O 6.1600 1.3338 0.0 0
M  V30 5 S 1.5400 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 10.7800 6.6685 0.0 0
M  V30 8 F 10.7800 5.1285 0.0 0
M  V30 9 F 12.3200 6.6685 0.0 0
M  V30 10 F 10.7800 8.2085 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 N 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 N 1.5400 4.0011 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.1600 6.6685 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(methylthio)-4-[[3-(trifluoromethyl)phenyl]amino]-5-pyrimidinecarb...
C14H13F3N4OS
863029-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 3.8500 1.3336 0.0 0
M  V30 3 O 6.1600 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 N 6.1600 5.3347 0.0 0
M  V30 6 S 1.5400 8.0021 0.0 0
M  V30 7 C 0.0000 8.0021 0.0 0
M  V30 8 C 10.7800 8.0021 0.0 0
M  V30 9 F 10.7800 9.5421 0.0 0
M  V30 10 F 12.3200 8.0021 0.0 0
M  V30 11 F 10.7800 6.4621 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 N 3.8500 6.6685 0.0 0
M  V30 16 N 1.5400 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 8.4700 6.6685 0.0 0
M  V30 20 C 6.1600 8.0021 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 6.9300 9.3358 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 21
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 227449-41-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863029-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10111108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and
structure-activity relationships of pyrimidine-5-carboxamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hisamichi, Hiroyuki; Naito, Ryo; Toyoshima, Akira; Kawano, Noriyuki;
Ichikawa, Atsushi; Orita, Akiko; Orita, Masaya; Hamada, Noritaka;
Takeuchi, Makoto; Ohta, Mitsuaki; Tsukamoto, Shin-ichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2005), 13(16), 4936-4951

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethoxymethyl)-6-(4-methyl-1-piperazinyl)-2-(methylsulfonyl)pyrimidine
C13H22N4O4S
2304751-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 O 1.3336 5.3900 0.0 0
M  V30 3 O 2.6673 7.7000 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 C 1.3336 8.4700 0.0 0
M  V30 6 S 5.3347 1.5400 0.0 0 VAL=6
M  V30 7 C 5.3347 0.0000 0.0 0
M  V30 8 O 3.7947 1.5400 0.0 0
M  V30 9 O 6.8747 1.5400 0.0 0
M  V30 10 C 12.0031 8.4700 0.0 0
M  V30 11 C 6.6684 5.3900 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 N 6.6684 3.8500 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 5.3347 3.0800 0.0 0
M  V30 16 N 4.0011 3.8500 0.0 0
M  V30 17 N 8.0020 6.1600 0.0 0
M  V30 18 C 8.0020 7.7000 0.0 0
M  V30 19 C 9.3358 5.3900 0.0 0
M  V30 20 C 9.3358 8.4700 0.0 0
M  V30 21 C 10.6694 6.1600 0.0 0
M  V30 22 N 10.6694 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 15
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethoxymethyl)-N-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinamine
C13H23N5O2
2304752-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 5.3901 0.0 0
M  V30 2 O 2.6673 6.9302 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 1.3337 7.7002 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 N 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 12.0033 7.7002 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 5.3901 0.0 0
M  V30 11 N 6.6685 3.0801 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 N 4.0012 3.0801 0.0 0
M  V30 15 N 8.0022 5.3901 0.0 0
M  V30 16 C 8.0022 6.9302 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 9.3360 7.7002 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 20 N 10.6697 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304751-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304752-14-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24030709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural optimization of aminopyrimidine-based CXCR4 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Fang; Wang, Yujie; Du, Qian; Ge, Wenxiang; Li, Zhanhui; Wang, Xu;
Fu, Chunyan; Luo, Lusong; Tian, Sheng; Ma, Haikuo; Zheng, Jiyue; Zhang,
Yi; Sun, Xiaotian; He, Sudan; Zhang, Xiaohu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 187111914

$RFMT $RIREG SCHEME239 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,7-Nonadiene-4,6-dione
C9H12O2
2307827-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 2.6675 1.5400 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 C 9.3359 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6 CFG=2
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10 CFG=2
M  V30 10 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H30N2O8
3047659-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 5.3348 0.0 0
M  V30 2 O 1.5400 6.6685 0.0 0
M  V30 3 O 1.5400 4.0012 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 O 4.6201 1.3337 0.0 0
M  V30 7 O 2.3101 2.6673 0.0 0
M  V30 8 C 3.8501 0.0000 0.0 0
M  V30 9 C 3.8501 8.0022 0.0 0
M  V30 10 C 6.9302 2.6673 0.0 0
M  V30 11 C 6.9302 8.0022 0.0 0
M  V30 12 C 8.4702 10.6697 0.0 0
M  V30 13 C 11.5503 10.6697 0.0 0
M  V30 14 O 10.7802 12.0033 0.0 0
M  V30 15 O 13.0903 10.6697 0.0 0
M  V30 16 C 11.5503 13.3370 0.0 0
M  V30 17 C 11.5503 5.3348 0.0 0
M  V30 18 C 13.0903 8.0022 0.0 0
M  V30 19 O 13.8603 6.6685 0.0 0
M  V30 20 O 13.8603 9.3358 0.0 0
M  V30 21 C 15.4003 6.6685 0.0 0
M  V30 22 C 3.8501 5.3348 0.0 0
M  V30 23 C 4.6201 4.0010 0.0 0
M  V30 24 N 4.6201 6.6685 0.0 0
M  V30 25 C 6.1601 4.0010 0.0 0
M  V30 26 C 6.1601 6.6685 0.0 0
M  V30 27 C 6.9302 5.3348 0.0 0
M  V30 28 C 8.4702 8.0022 0.0 0
M  V30 29 N 9.2402 9.3360 0.0 0
M  V30 30 C 9.2402 6.6685 0.0 0
M  V30 31 C 10.7802 9.3360 0.0 0
M  V30 32 C 10.7802 6.6685 0.0 0
M  V30 33 C 11.5503 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 23
M  V30 8 1 6 8
M  V30 9 1 9 24
M  V30 10 1 10 25
M  V30 11 1 11 26
M  V30 12 1 11 28
M  V30 13 1 12 29
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 31
M  V30 17 1 14 16
M  V30 18 1 17 32
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 33
M  V30 22 1 19 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 29 1 28 29
M  V30 30 2 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2307827-66-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047659-32-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40794641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14219-31-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated magnetite-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, silica-coated magnetic nanoparticles
functionalized copper catalyst used in stage 2, reusable catalyst in
stage 2, solid-supported catalyst in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One pot multicomponent reaction of curcumin: Green synthesis of novel
1,4-dihydropyridine-2,3-dicarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Motamed, Nasim Khoshlahjeh; Larijani, Kambiz; Pournamdari, Elham;
Saeidian, Hamid; Hargalani, Fariba Zamani
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2024), 61(8), 1306-1313

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[4-(hydroxymethyl)phenyl]-4-nitro-1H-pyrazole-3-carboxylate
C12H11N3O5
2357109-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 4.1475 0.0 0
M  V30 2 O 1.5316 5.5544 0.0 0
M  V30 3 O 1.2528 2.9016 0.0 0
M  V30 4 C 0.0000 5.7154 0.0 0
M  V30 5 N 3.8333 1.2459 0.0 0 VAL=5
M  V30 6 O 4.7384 0.0000 0.0 0
M  V30 7 O 2.3016 1.0850 0.0 0
M  V30 8 C 11.4619 7.5847 0.0 0
M  V30 9 O 12.7955 6.8146 0.0 0
M  V30 10 N 6.1270 4.5046 0.0 0
M  V30 11 N 4.7200 5.1309 0.0 0
M  V30 12 C 5.9659 2.9730 0.0 0
M  V30 13 C 3.6896 3.9865 0.0 0
M  V30 14 C 4.4596 2.6529 0.0 0
M  V30 15 C 7.4607 5.2746 0.0 0
M  V30 16 C 8.7944 4.5046 0.0 0
M  V30 17 C 7.4607 6.8146 0.0 0
M  V30 18 C 10.1280 5.2746 0.0 0
M  V30 19 C 8.7944 7.5847 0.0 0
M  V30 20 C 10.1280 6.8146 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Hydroxymethyl)phenyl]-N-methyl-4-nitro-1H-pyrazole-3-carboxamide
C12H12N4O4
2357111-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 4.1475 0.0 0
M  V30 2 N 1.5316 5.5544 0.0 0
M  V30 3 O 1.2528 2.9016 0.0 0
M  V30 4 C 0.0000 5.7154 0.0 0
M  V30 5 N 3.8333 1.2459 0.0 0 VAL=5
M  V30 6 O 2.3016 1.0850 0.0 0
M  V30 7 O 4.7384 0.0000 0.0 0
M  V30 8 C 11.4619 7.5847 0.0 0
M  V30 9 O 12.7955 6.8146 0.0 0
M  V30 10 N 6.1270 4.5046 0.0 0
M  V30 11 N 4.7200 5.1309 0.0 0
M  V30 12 C 5.9659 2.9730 0.0 0
M  V30 13 C 3.6896 3.9865 0.0 0
M  V30 14 C 4.4596 2.6529 0.0 0
M  V30 15 C 7.4607 5.2746 0.0 0
M  V30 16 C 8.7944 4.5046 0.0 0
M  V30 17 C 7.4607 6.8146 0.0 0
M  V30 18 C 10.1280 5.2746 0.0 0
M  V30 19 C 8.7944 7.5847 0.0 0
M  V30 20 C 10.1280 6.8146 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2357109-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2357111-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20995414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide conjugates as IRAK4 protein kinase degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20190192668 A1 2019-06-27

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-[2-(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]pyrimid...
C19H16ClN7
2364536-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.9132 7.5823 0.0 0
M  V30 2 C 7.5332 4.9149 0.0 0
M  V30 3 C 8.3032 6.2487 0.0 0
M  V30 4 C 13.5468 9.3287 0.0 0
M  V30 5 C 16.2140 4.7087 0.0 0
M  V30 6 C 3.6832 3.5813 0.0 0
M  V30 7 C 2.6528 2.4369 0.0 0
M  V30 8 N 2.9132 4.9149 0.0 0
M  V30 9 N 5.2232 3.5813 0.0 0
M  V30 10 C 1.2459 3.0632 0.0 0
M  V30 11 C 2.8137 0.9052 0.0 0
M  V30 12 N 1.4068 4.5947 0.0 0
M  V30 13 C 3.6832 6.2487 0.0 0
M  V30 14 C 5.9932 4.9149 0.0 0
M  V30 15 C 0.0000 2.1580 0.0 0
M  V30 16 C 1.5679 0.0000 0.0 0
M  V30 17 C 5.2232 6.2487 0.0 0
M  V30 18 C 0.1609 0.6265 0.0 0
M  V30 19 C 9.8432 6.2487 0.0 0
M  V30 20 N 10.7484 5.0027 0.0 0
M  V30 21 N 10.7484 7.4946 0.0 0
M  V30 22 C 12.2130 5.4787 0.0 0
M  V30 23 N 12.2130 7.0187 0.0 0
M  V30 24 N 13.5468 4.7087 0.0 0
M  V30 25 C 13.5468 7.7887 0.0 0
M  V30 26 C 14.8804 5.4787 0.0 0
M  V30 27 C 14.8804 7.0187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 19
M  V30 5 1 4 25
M  V30 6 1 5 26
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 2 9 14
M  V30 15 2 10 12
M  V30 16 1 10 15
M  V30 17 2 11 16
M  V30 18 2 13 17
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrimido[1,2-b]indazol-4-amine, 2-[2-(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrim...
C20H20N8
3055291-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.9132 7.5823 0.0 0
M  V30 2 C 3.6832 8.9160 0.0 0
M  V30 3 C 7.5332 4.9149 0.0 0
M  V30 4 C 8.3032 6.2487 0.0 0
M  V30 5 C 13.5468 9.3287 0.0 0
M  V30 6 C 16.2140 4.7087 0.0 0
M  V30 7 C 3.6832 3.5813 0.0 0
M  V30 8 N 2.9132 4.9149 0.0 0
M  V30 9 C 2.6528 2.4369 0.0 0
M  V30 10 N 5.2232 3.5813 0.0 0
M  V30 11 C 3.6832 6.2487 0.0 0
M  V30 12 N 1.4068 4.5947 0.0 0
M  V30 13 C 1.2459 3.0632 0.0 0
M  V30 14 C 2.8137 0.9052 0.0 0
M  V30 15 C 5.9932 4.9149 0.0 0
M  V30 16 C 5.2232 6.2487 0.0 0
M  V30 17 C 0.0000 2.1580 0.0 0
M  V30 18 C 1.5679 0.0000 0.0 0
M  V30 19 C 0.1609 0.6265 0.0 0
M  V30 20 C 9.8432 6.2487 0.0 0
M  V30 21 N 10.7484 5.0027 0.0 0
M  V30 22 N 10.7484 7.4946 0.0 0
M  V30 23 C 12.2130 5.4787 0.0 0
M  V30 24 N 12.2130 7.0187 0.0 0
M  V30 25 N 13.5468 4.7087 0.0 0
M  V30 26 C 13.5468 7.7887 0.0 0
M  V30 27 C 14.8804 5.4787 0.0 0
M  V30 28 C 14.8804 7.0187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 20
M  V30 6 1 5 26
M  V30 7 1 6 27
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 2 11 16
M  V30 17 2 12 13
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 16
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2364536-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055291-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41634203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based discovery of Pyrimido[1,2-b]indazole PDE10A inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chino, Ayaka; Seo, Ryushi; Amano, Yasushi; Namatame, Ichiji; Hamaguchi,
Wataru; Honbou, Kazuya; Mihara, Takuma; Yamazaki, Mayako; Tomishima,
Masaki; Masuda, Naoyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2018), 66(3), 286-294

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,4R)-1-[4-[2-(2-Bromoethoxy)ethoxy]-2-(3-methyl-5-isoxazolyl)-1-oxobutyl]-...
C29H37BrN4O6S
2378262-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3722 5.3025 0.0 0
M  V30 2 C 15.9122 5.3025 0.0 0 CFG=3
M  V30 3 O 13.6022 3.9689 0.0 0
M  V30 4 C 16.6822 6.6363 0.0 0
M  V30 5 C 18.2222 6.6363 0.0 0
M  V30 6 O 18.9922 7.9700 0.0 0
M  V30 7 C 20.5322 7.9700 0.0 0
M  V30 8 C 21.3022 9.3036 0.0 0
M  V30 9 O 22.8422 9.3036 0.0 0
M  V30 10 C 23.6122 10.6374 0.0 0
M  V30 11 C 25.1522 10.6374 0.0 0
M  V30 12 Br 25.9222 11.9710 0.0 0
M  V30 13 C 11.0403 5.6529 0.0 0
M  V30 14 N 9.5338 5.9730 0.0 0
M  V30 15 O 11.5161 4.1882 0.0 0
M  V30 16 C 8.5034 4.8285 0.0 0 CFG=2
M  V30 17 C 8.9793 3.3640 0.0 0
M  V30 18 O 13.2452 10.6052 0.0 0
M  V30 19 C 17.0393 0.0000 0.0 0
M  V30 20 C 1.4946 3.5472 0.0 0
M  V30 21 N 13.6022 6.6363 0.0 0
M  V30 22 C 12.0707 6.7973 0.0 0 CFG=2
M  V30 23 C 14.2287 8.0431 0.0 0
M  V30 24 C 11.7505 8.3037 0.0 0
M  V30 25 C 13.0841 9.0735 0.0 0 CFG=2
M  V30 26 C 16.6822 3.9689 0.0 0
M  V30 27 O 18.2139 3.8080 0.0 0
M  V30 28 C 16.0559 2.5621 0.0 0
M  V30 29 N 18.5341 2.3015 0.0 0
M  V30 30 C 17.2004 1.5315 0.0 0
M  V30 31 C 6.9971 5.1487 0.0 0
M  V30 32 C 5.9666 4.0043 0.0 0
M  V30 33 C 6.5213 6.6134 0.0 0
M  V30 34 C 4.4603 4.3245 0.0 0
M  V30 35 C 5.0149 6.9335 0.0 0
M  V30 36 C 3.9844 5.7892 0.0 0
M  V30 37 C 2.4780 6.1093 0.0 0
M  V30 38 C 1.3336 5.0788 0.0 0
M  V30 39 S 1.8517 7.5161 0.0 0
M  V30 40 N 0.0000 5.8488 0.0 0
M  V30 41 C 0.3202 7.3552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 26
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 22 13 CFG=3
M  V30 17 1 14 16
M  V30 18 1 16 17 CFG=1
M  V30 19 1 16 31
M  V30 20 1 25 18 CFG=1
M  V30 21 1 19 30
M  V30 22 1 20 38
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 39 1 36 37
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 22 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,4R)-4-Hydroxy-1-[4-[2-[2-(methylamino)ethoxy]ethoxy]-2-(3-methyl-5-isoxaz...
C30H41N5O6S
2378262-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3722 5.3025 0.0 0
M  V30 2 C 15.9122 5.3025 0.0 0 CFG=3
M  V30 3 O 13.6022 3.9689 0.0 0
M  V30 4 C 16.6822 6.6363 0.0 0
M  V30 5 C 18.2222 6.6363 0.0 0
M  V30 6 O 18.9922 7.9700 0.0 0
M  V30 7 C 20.5322 7.9700 0.0 0
M  V30 8 C 21.3022 9.3036 0.0 0
M  V30 9 O 22.8422 9.3036 0.0 0
M  V30 10 C 23.6122 10.6372 0.0 0
M  V30 11 C 25.1522 10.6372 0.0 0
M  V30 12 N 25.9222 11.9710 0.0 0
M  V30 13 C 27.4622 11.9710 0.0 0
M  V30 14 C 11.0403 5.6529 0.0 0
M  V30 15 N 9.5338 5.9730 0.0 0
M  V30 16 O 11.5161 4.1882 0.0 0
M  V30 17 C 8.5034 4.8285 0.0 0 CFG=2
M  V30 18 C 8.9793 3.3640 0.0 0
M  V30 19 O 13.2452 10.6052 0.0 0
M  V30 20 C 17.0393 0.0000 0.0 0
M  V30 21 C 1.4946 3.5472 0.0 0
M  V30 22 N 13.6022 6.6363 0.0 0
M  V30 23 C 12.0707 6.7973 0.0 0 CFG=2
M  V30 24 C 14.2287 8.0431 0.0 0
M  V30 25 C 11.7505 8.3035 0.0 0
M  V30 26 C 13.0841 9.0735 0.0 0 CFG=2
M  V30 27 C 16.6822 3.9689 0.0 0
M  V30 28 O 18.2139 3.8080 0.0 0
M  V30 29 C 16.0559 2.5621 0.0 0
M  V30 30 N 18.5341 2.3015 0.0 0
M  V30 31 C 17.2004 1.5315 0.0 0
M  V30 32 C 6.9971 5.1487 0.0 0
M  V30 33 C 6.5213 6.6134 0.0 0
M  V30 34 C 5.9666 4.0043 0.0 0
M  V30 35 C 5.0149 6.9335 0.0 0
M  V30 36 C 4.4603 4.3245 0.0 0
M  V30 37 C 3.9844 5.7892 0.0 0
M  V30 38 C 2.4780 6.1093 0.0 0
M  V30 39 C 1.3336 5.0788 0.0 0
M  V30 40 S 1.8517 7.5161 0.0 0
M  V30 41 N 0.0000 5.8488 0.0 0
M  V30 42 C 0.3202 7.3552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 27
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 23 14 CFG=3
M  V30 18 1 15 17
M  V30 19 1 17 18 CFG=1
M  V30 20 1 17 32
M  V30 21 1 26 19 CFG=1
M  V30 22 1 20 31
M  V30 23 1 21 39
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 1 37 38
M  V30 41 2 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 23 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378262-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378262-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21620593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as modulators of proteolysis useful
for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crew, Andrew P.; Hornberger, Keith R.; Wang, Jing; Dong, Hanqing; Berlin,
Michael; Crews, Craig M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195609 A2 2019-10-10

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-5-methoxy-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxy...
C15H13N3O4
2378817-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3854 0.0000 0.0 0
M  V30 2 O 0.4759 4.1490 0.0 0
M  V30 3 C 0.0000 5.6137 0.0 0
M  V30 4 C 11.7367 5.6421 0.0 0
M  V30 5 O 13.0705 4.8720 0.0 0
M  V30 6 O 11.7367 7.1821 0.0 0
M  V30 7 C 14.4042 5.6421 0.0 0
M  V30 8 N 6.4019 2.5620 0.0 0
M  V30 9 C 4.9951 3.1885 0.0 0
M  V30 10 C 6.2410 1.0304 0.0 0
M  V30 11 C 3.9647 2.0439 0.0 0
M  V30 12 C 4.5192 4.6530 0.0 0
M  V30 13 N 4.7347 0.7103 0.0 0
M  V30 14 C 2.4582 2.3641 0.0 0
M  V30 15 C 3.0128 4.9732 0.0 0
M  V30 16 C 1.9823 3.8288 0.0 0
M  V30 17 C 7.7357 3.3320 0.0 0
M  V30 18 C 9.0694 2.5620 0.0 0
M  V30 19 C 7.7357 4.8720 0.0 0
M  V30 20 C 10.4031 3.3320 0.0 0
M  V30 21 N 9.0694 5.6421 0.0 0
M  V30 22 C 10.4031 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-5-methoxy-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarbo...
C15H14N4O3
2378817-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3854 0.0000 0.0 0
M  V30 2 O 0.4759 4.1490 0.0 0
M  V30 3 C 0.0000 5.6137 0.0 0
M  V30 4 C 11.7367 5.6421 0.0 0
M  V30 5 N 13.0705 4.8720 0.0 0
M  V30 6 O 11.7367 7.1821 0.0 0
M  V30 7 C 14.4042 5.6421 0.0 0
M  V30 8 N 6.4019 2.5620 0.0 0
M  V30 9 C 4.9951 3.1885 0.0 0
M  V30 10 C 6.2410 1.0304 0.0 0
M  V30 11 C 3.9645 2.0439 0.0 0
M  V30 12 C 4.5192 4.6530 0.0 0
M  V30 13 N 4.7345 0.7103 0.0 0
M  V30 14 C 2.4582 2.3641 0.0 0
M  V30 15 C 3.0128 4.9732 0.0 0
M  V30 16 C 1.9823 3.8288 0.0 0
M  V30 17 C 7.7357 3.3320 0.0 0
M  V30 18 C 7.7357 4.8720 0.0 0
M  V30 19 C 9.0694 2.5620 0.0 0
M  V30 20 C 9.0694 5.6421 0.0 0
M  V30 21 N 10.4031 3.3320 0.0 0
M  V30 22 C 10.4031 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378817-94-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378817-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860289
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,2-difluoro-2-phenoxyacetate
C9H8F2O3
24253-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.5637 0.0 0
M  V30 2 C 5.3348 1.3337 0.0 0
M  V30 3 C 6.6685 2.1037 0.0 0
M  V30 4 F 6.1048 0.0000 0.0 0
M  V30 5 F 4.5648 2.6673 0.0 0
M  V30 6 O 8.0023 1.3337 0.0 0
M  V30 7 O 6.6685 3.6437 0.0 0
M  V30 8 C 9.3360 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 1.3337 0.5637 0.0 0
M  V30 11 C 2.6675 2.8737 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 14 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, 2,2-difluoro-N-methyl-2-phenoxy-
C9H9F2NO2
24210-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.5637 0.0 0
M  V30 2 C 5.3348 1.3337 0.0 0
M  V30 3 C 6.6685 2.1037 0.0 0
M  V30 4 F 6.1048 0.0000 0.0 0
M  V30 5 F 4.5648 2.6673 0.0 0
M  V30 6 N 8.0023 1.3337 0.0 0
M  V30 7 O 6.6685 3.6437 0.0 0
M  V30 8 C 9.3360 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 1.3337 0.5637 0.0 0
M  V30 11 C 2.6675 2.8737 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 14 C 0.0000 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24253-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24210-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35498421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Placing CF2 in the Center: Major Physicochemical Changes Upon a Minor
Structural Alteration in Gem-Difunctional Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saphier, Sigal; Katalan, Shahaf; Yacov, Guy; Berliner, Anat; Redy-Keisar,
Orit; Fridkin, Gil; Ghindes-Azaria, Lee; Columbus, Ishay; Pevzner,
Alexander; Drug, Eyal; Prihed, Hagit; Gershonov, Eytan; Eichen, Yoav;
Elias, Shlomi; Parvari, Galit; Zafrani, Yossi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(7), e202202939

$RFMT $RIREG SCHEME245 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dibromo-3-(bromomethyl)isothiazole
C4H2Br3NS
4576-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.3628 0.0 0
M  V30 2 Br 6.6363 2.1328 0.0 0
M  V30 3 Br 2.2418 0.0000 0.0 0
M  V30 4 Br 0.0000 2.4899 0.0 0
M  V30 5 C 3.9690 2.1328 0.0 0
M  V30 6 C 2.5620 1.5065 0.0 0
M  V30 7 N 3.8079 3.6644 0.0 0
M  V30 8 C 1.5316 2.6509 0.0 0
M  V30 9 S 2.3016 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4,5-dibromo-3-isothiazolyl)methyl]-N-methylcarbamate
C10H14Br2N2O2S
1454848-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.6218 0.0 0
M  V30 2 N 5.3348 1.8517 0.0 0
M  V30 3 C 4.0012 2.6218 0.0 0
M  V30 4 C 5.3348 0.3117 0.0 0
M  V30 5 O 2.6675 1.8517 0.0 0
M  V30 6 O 4.0012 4.1618 0.0 0
M  V30 7 C 1.3338 2.6218 0.0 0
M  V30 8 C 0.5638 1.2881 0.0 0
M  V30 9 C 0.0000 3.3918 0.0 0
M  V30 10 C 2.1038 3.9554 0.0 0
M  V30 11 Br 9.7293 3.9845 0.0 0
M  V30 12 Br 11.9713 1.4946 0.0 0
M  V30 13 C 8.0023 1.8517 0.0 0
M  V30 14 C 9.4091 2.4782 0.0 0
M  V30 15 N 8.1633 0.3202 0.0 0
M  V30 16 C 10.4397 1.3337 0.0 0
M  V30 17 S 9.6697 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 14
M  V30 12 1 12 16
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4576-99-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454848-27-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1568722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3: A solution of the mixture obtained from step 2 (50 g, calculated
to contain 28 g, 83 mmol of pure compound 31) in THF (20 mL) was added
slowly to a solution of CH3NH2 (33% in EtOH, 200 mL, 2.1 mol) diluted
with additional EtOH (200 mL) at 0 °C over 10 minutes. After complete
addition, the reaction was stirred at 0 °C for 25 minutes. The reaction
was then concentrated in vacuo to approximately 300 mL volume. Ethanol
(150 mL) was added and the mixture was again concentrated to
approximately 300 mL in volume. The resulting solution was then cooled to
0 °C and (BOC)2O (33 g, 150 mmol) was added portion-wise over 5 minutes
(CO2 evolution). After complete addition the mixture was left to stir at
20 °C overnight. The reaction mixture was concentrated in vacuo and the
residue was purified by column chromatography over silica gel, which was
eluted with 10% EtOAc in heptanes. Compound 51 as a cream colored solid
(32 g, 97% yield). TLC (Rf = 0.30, 10% EtOAc in heptanes). 1H NMR (400
MHz, CDCl3) δ 4.50 - 4.60 (m, 2 H), 2.90 - 2.99 (m, 3 H), 1.35 - 1.55 (m,
9 H). LCMS ES m/z 287 ES [M-Boc]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,3′,3′-Tetrakis(4-hydroxyphenyl)[4,5′-biisobenzofuran]-1′,3(1H,3′H)-dione
C40H26O8
2452061-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7261 9.7907 0.0 0
M  V30 2 O 5.5161 0.0000 0.0 0
M  V30 3 O 0.0000 6.1264 0.0 0
M  V30 4 O 12.9967 13.7918 0.0 0
M  V30 5 O 20.7228 10.1275 0.0 0
M  V30 6 O 15.2068 4.0011 0.0 0
M  V30 7 C 6.1601 6.1264 0.0 0
M  V30 8 C 7.6664 5.8062 0.0 0
M  V30 9 O 5.9990 7.6579 0.0 0
M  V30 10 C 8.4364 7.1399 0.0 0
M  V30 11 C 8.4364 4.4725 0.0 0
M  V30 12 C 7.4060 8.2844 0.0 0
M  V30 13 C 9.9764 7.1399 0.0 0
M  V30 14 C 9.9764 4.4725 0.0 0
M  V30 15 C 10.7464 5.8062 0.0 0
M  V30 16 C 5.9990 4.5948 0.0 0
M  V30 17 C 7.2449 3.6896 0.0 0
M  V30 18 C 4.5922 3.9683 0.0 0
M  V30 19 C 7.0839 2.1580 0.0 0
M  V30 20 C 4.4311 2.4368 0.0 0
M  V30 21 C 5.6771 1.5316 0.0 0
M  V30 22 C 4.6201 6.1264 0.0 0
M  V30 23 C 3.8501 4.7927 0.0 0
M  V30 24 C 3.8501 7.4600 0.0 0
M  V30 25 C 2.3100 4.7927 0.0 0
M  V30 26 C 2.3100 7.4600 0.0 0
M  V30 27 C 1.5400 6.1264 0.0 0
M  V30 28 C 10.7464 8.4735 0.0 0
M  V30 29 C 12.2865 8.4735 0.0 0
M  V30 30 C 9.9764 9.8073 0.0 0
M  V30 31 C 13.0565 9.8073 0.0 0
M  V30 32 C 10.7464 11.1410 0.0 0
M  V30 33 C 14.5628 10.1275 0.0 0
M  V30 34 C 12.2865 11.1410 0.0 0
M  V30 35 O 14.7238 11.6590 0.0 0
M  V30 36 C 13.3169 12.2854 0.0 0
M  V30 37 C 16.1028 10.1275 0.0 0
M  V30 38 C 16.8728 8.7938 0.0 0
M  V30 39 C 16.8728 11.4612 0.0 0
M  V30 40 C 18.4128 8.7938 0.0 0
M  V30 41 C 18.4128 11.4612 0.0 0
M  V30 42 C 19.1828 10.1275 0.0 0
M  V30 43 C 14.7238 8.5959 0.0 0
M  V30 44 C 16.1307 7.9695 0.0 0
M  V30 45 C 13.4780 7.6907 0.0 0
M  V30 46 C 16.2916 6.4379 0.0 0
M  V30 47 C 13.6389 6.1590 0.0 0
M  V30 48 C 15.0457 5.5327 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 21
M  V30 3 1 3 27
M  V30 4 2 4 36
M  V30 5 1 5 42
M  V30 6 1 6 48
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 7 22
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 1 13 28
M  V30 19 2 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 31 34
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 33 37
M  V30 41 1 33 43
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 44 2 37 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 2 39 41
M  V30 48 2 40 42
M  V30 49 1 41 42
M  V30 50 2 43 44
M  V30 51 1 43 45
M  V30 52 1 44 46
M  V30 53 2 45 47
M  V30 54 2 46 48
M  V30 55 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C42H32N2O6
2452061-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6653 8.4279 0.0 0
M  V30 2 O 7.7261 9.7907 0.0 0
M  V30 3 O 0.0000 6.1264 0.0 0
M  V30 4 O 5.5161 0.0000 0.0 0
M  V30 5 C 16.0575 12.4291 0.0 0
M  V30 6 O 12.9967 13.7918 0.0 0
M  V30 7 O 20.7228 10.1275 0.0 0
M  V30 8 O 15.2068 4.0011 0.0 0
M  V30 9 C 6.1601 6.1264 0.0 0
M  V30 10 C 7.6664 5.8062 0.0 0
M  V30 11 N 5.9990 7.6579 0.0 0
M  V30 12 C 8.4364 7.1399 0.0 0
M  V30 13 C 8.4364 4.4725 0.0 0
M  V30 14 C 7.4060 8.2844 0.0 0
M  V30 15 C 9.9764 7.1399 0.0 0
M  V30 16 C 9.9764 4.4725 0.0 0
M  V30 17 C 10.7464 5.8062 0.0 0
M  V30 18 C 4.6201 6.1264 0.0 0
M  V30 19 C 3.8501 7.4600 0.0 0
M  V30 20 C 3.8501 4.7927 0.0 0
M  V30 21 C 2.3100 7.4600 0.0 0
M  V30 22 C 2.3100 4.7927 0.0 0
M  V30 23 C 1.5400 6.1264 0.0 0
M  V30 24 C 5.9990 4.5948 0.0 0
M  V30 25 C 7.2449 3.6896 0.0 0
M  V30 26 C 4.5922 3.9683 0.0 0
M  V30 27 C 7.0839 2.1580 0.0 0
M  V30 28 C 4.4311 2.4368 0.0 0
M  V30 29 C 5.6771 1.5316 0.0 0
M  V30 30 C 10.7464 8.4735 0.0 0
M  V30 31 C 12.2865 8.4735 0.0 0
M  V30 32 C 9.9764 9.8073 0.0 0
M  V30 33 C 13.0565 9.8073 0.0 0
M  V30 34 C 10.7464 11.1410 0.0 0
M  V30 35 C 14.5628 10.1275 0.0 0
M  V30 36 C 12.2865 11.1410 0.0 0
M  V30 37 N 14.7238 11.6590 0.0 0
M  V30 38 C 13.3169 12.2854 0.0 0
M  V30 39 C 16.1028 10.1275 0.0 0
M  V30 40 C 16.8728 11.4612 0.0 0
M  V30 41 C 16.8728 8.7938 0.0 0
M  V30 42 C 18.4128 11.4612 0.0 0
M  V30 43 C 18.4128 8.7938 0.0 0
M  V30 44 C 19.1828 10.1275 0.0 0
M  V30 45 C 14.7238 8.5959 0.0 0
M  V30 46 C 13.4780 7.6907 0.0 0
M  V30 47 C 16.1307 7.9695 0.0 0
M  V30 48 C 13.6389 6.1592 0.0 0
M  V30 49 C 16.2916 6.4379 0.0 0
M  V30 50 C 15.0457 5.5327 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 14
M  V30 3 1 3 23
M  V30 4 1 4 29
M  V30 5 1 5 37
M  V30 6 2 6 38
M  V30 7 1 7 44
M  V30 8 1 8 50
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 1 15 30
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 33 36
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 35 39
M  V30 43 1 35 45
M  V30 44 1 36 38
M  V30 45 1 37 38
M  V30 46 2 39 40
M  V30 47 1 39 41
M  V30 48 1 40 42
M  V30 49 2 41 43
M  V30 50 2 42 44
M  V30 51 1 43 44
M  V30 52 2 45 46
M  V30 53 1 45 47
M  V30 54 1 46 48
M  V30 55 2 47 49
M  V30 56 2 48 50
M  V30 57 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2452061-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2452061-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22586909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a novel epoxy resin having cardo structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tokoro, Yuichiro; Yaginuma, Yudai; Oyama, Toshiyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Photopolymer Science and Technology (2019), 32(3), 463-467

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (1R,2R,5S)-2-fluoro-3-oxo-9-azabicyclo[3.3.1]nonane-9-c...
C13H20FNO3
2470190-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8940 3.0657 0.0 0
M  V30 2 O 7.6640 1.7320 0.0 0
M  V30 3 O 7.6640 4.3993 0.0 0
M  V30 4 C 9.2040 1.7320 0.0 0
M  V30 5 C 9.2040 3.2720 0.0 0
M  V30 6 C 10.7440 1.7320 0.0 0
M  V30 7 C 9.2040 0.1920 0.0 0
M  V30 8 F 2.2427 0.0000 0.0 0
M  V30 9 O 0.0000 3.3339 0.0 0
M  V30 10 N 5.3540 3.0657 0.0 0
M  V30 11 C 3.9549 2.5242 0.0 0 CFG=1
M  V30 12 C 4.1481 3.5323 0.0 0 CFG=2
M  V30 13 C 2.4306 1.5285 0.0 0 CFG=2
M  V30 14 C 3.0418 4.0394 0.0 0
M  V30 15 C 2.6912 2.5452 0.0 0
M  V30 16 C 3.2894 4.9918 0.0 0
M  V30 17 C 1.3835 2.6579 0.0 0
M  V30 18 C 1.8967 4.4451 0.0 0
M  V30 19 H 4.6577 1.1539 0.0 0
M  V30 20 H 5.1450 4.7061 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 13 8 CFG=3
M  V30 9 2 9 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 19 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 20 CFG=3
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (1R,2R,5S)-2-fluoro-3-(methylimino)-9-azabicyclo[3.3.1]...
C14H23FN2O2
2474023-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 3.0657 0.0 0
M  V30 2 O 3.0800 1.7320 0.0 0
M  V30 3 O 3.0800 4.3993 0.0 0
M  V30 4 C 1.5400 1.7320 0.0 0
M  V30 5 C 1.5400 0.1920 0.0 0
M  V30 6 C 0.0000 1.7320 0.0 0
M  V30 7 C 1.5400 3.2720 0.0 0
M  V30 8 F 8.5013 0.0000 0.0 0
M  V30 9 N 10.7441 3.3339 0.0 0
M  V30 10 C 12.0215 2.4739 0.0 0
M  V30 11 N 5.3900 3.0657 0.0 0
M  V30 12 C 6.7892 2.5242 0.0 0 CFG=1
M  V30 13 C 6.5960 3.5323 0.0 0 CFG=2
M  V30 14 C 8.3135 1.5285 0.0 0 CFG=2
M  V30 15 C 7.7022 4.0394 0.0 0
M  V30 16 C 8.0530 2.5452 0.0 0
M  V30 17 C 7.4547 4.9918 0.0 0
M  V30 18 C 9.3606 2.6579 0.0 0
M  V30 19 C 8.8473 4.4451 0.0 0
M  V30 20 H 6.0864 1.1539 0.0 0
M  V30 21 H 5.5990 4.7061 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 14 8 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 18 CFG=2
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 20 CFG=3
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 21 CFG=1
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2470190-41-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2474023-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22829115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thiadiazoles as small molecule splicing
modulator compounds for modulating splicing of mRNA
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luzzio, Michael; Lucas, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020163323 A1 2020-08-13

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL

C24H28N6O6
2489324-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.0776 7.0961 0.0 0
M  V30 2 C 10.8476 5.7623 0.0 0
M  V30 3 C 10.8476 8.4297 0.0 0
M  V30 4 O 12.3876 5.7623 0.0 0
M  V30 5 O 10.0776 4.4287 0.0 0
M  V30 6 C 13.1575 4.4287 0.0 0
M  V30 7 C 11.8239 3.6587 0.0 0
M  V30 8 C 13.9275 3.0950 0.0 0
M  V30 9 C 14.4912 5.1986 0.0 0
M  V30 10 O 4.3983 11.9838 0.0 0
M  V30 11 C 3.2882 7.3197 0.0 0
M  V30 12 C 4.7504 1.4918 0.0 0
M  V30 13 O 4.3680 0.0000 0.0 0
M  V30 14 O 6.2334 1.9066 0.0 0
M  V30 15 N 7.7589 8.4515 0.0 0 CFG=3
M  V30 16 C 6.1848 8.4334 0.0 0
M  V30 17 C 8.5376 7.0961 0.0 0
M  V30 18 N 8.1904 9.9601 0.0 0
M  V30 19 C 5.6660 9.8397 0.0 0
M  V30 20 N 5.4129 7.1019 0.0 0
M  V30 21 C 7.7582 5.7393 0.0 0
M  V30 22 C 6.8905 10.8353 0.0 0
M  V30 23 C 4.3192 10.4458 0.0 0
M  V30 24 C 6.1938 5.7476 0.0 0
M  V30 25 N 2.9176 9.9810 0.0 0
M  V30 26 N 5.5279 4.3778 0.0 0
M  V30 27 C 2.3449 8.5369 0.0 0 CFG=2
M  V30 28 C 4.0335 4.0854 0.0 0
M  V30 29 C 0.8039 8.3427 0.0 0
M  V30 30 C 3.6496 2.5688 0.0 0
M  V30 31 C 2.9212 5.1785 0.0 0
M  V30 32 O 0.0000 7.1065 0.0 0
M  V30 33 C 2.1421 2.1520 0.0 0
M  V30 34 C 1.4271 4.7608 0.0 0
M  V30 35 C 0.2273 5.6505 0.0 0
M  V30 36 C 1.0256 3.2470 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 23
M  V30 11 1 27 11 CFG=3
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 30
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 1 28 31
M  V30 33 1 29 32
M  V30 34 1 30 33
M  V30 35 2 31 34
M  V30 36 1 32 35
M  V30 37 2 33 36
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H31N7O5
2489324-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.0776 8.1729 0.0 0
M  V30 2 C 10.8476 6.8393 0.0 0
M  V30 3 C 10.8476 9.5067 0.0 0
M  V30 4 O 12.3875 6.8393 0.0 0
M  V30 5 O 10.0776 5.5057 0.0 0
M  V30 6 C 13.1575 5.5057 0.0 0
M  V30 7 C 14.4911 6.2757 0.0 0
M  V30 8 C 13.9275 4.1721 0.0 0
M  V30 9 C 11.8239 4.7357 0.0 0
M  V30 10 O 4.3983 13.0608 0.0 0
M  V30 11 C 3.2881 8.3965 0.0 0
M  V30 12 C 4.7503 2.5688 0.0 0
M  V30 13 N 4.3680 1.0771 0.0 0
M  V30 14 O 6.2333 2.9835 0.0 0
M  V30 15 C 5.4687 0.0000 0.0 0
M  V30 16 C 6.1848 9.5102 0.0 0
M  V30 17 N 7.7588 9.5286 0.0 0 CFG=3
M  V30 18 C 5.6660 10.9165 0.0 0
M  V30 19 N 5.4128 8.1789 0.0 0
M  V30 20 C 8.5376 8.1729 0.0 0
M  V30 21 N 8.1903 11.0371 0.0 0
M  V30 22 C 6.8904 11.9123 0.0 0
M  V30 23 C 4.3192 11.5228 0.0 0
M  V30 24 C 6.1938 6.8247 0.0 0
M  V30 25 C 7.7582 6.8162 0.0 0
M  V30 26 N 2.9176 11.0579 0.0 0
M  V30 27 N 5.5279 5.4549 0.0 0
M  V30 28 C 2.3449 9.6139 0.0 0 CFG=2
M  V30 29 C 4.0335 5.1624 0.0 0
M  V30 30 C 0.8039 9.4197 0.0 0
M  V30 31 C 3.6496 3.6457 0.0 0
M  V30 32 C 2.9212 6.2554 0.0 0
M  V30 33 O 0.0000 8.1834 0.0 0
M  V30 34 C 2.1421 3.2290 0.0 0
M  V30 35 C 1.4271 5.8377 0.0 0
M  V30 36 C 0.2273 6.7275 0.0 0
M  V30 37 C 1.0256 4.3239 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 23
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 31
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 2 20 25
M  V30 25 2 21 22
M  V30 26 1 23 26
M  V30 27 1 24 25
M  V30 28 2 24 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 1 29 32
M  V30 34 1 30 33
M  V30 35 1 31 34
M  V30 36 2 32 35
M  V30 37 1 33 36
M  V30 38 2 34 37
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2489324-93-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489324-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23123242
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocycles as TYK2 inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Bohan; Dong, Qing; Hung, Gene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020185755 A1 2020-09-17

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[(6R)-7-(3,4-dichlorobenzoyl)-5,6,7,8-tetrahydro-6-methyl-2-[(1-meth...
C25H25Cl2N5O4
2489339-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 2.6674 0.0 0
M  V30 2 C 10.7800 1.3336 0.0 0
M  V30 3 C 11.5500 0.0000 0.0 0
M  V30 4 C 9.2400 1.3336 0.0 0
M  V30 5 O 11.5500 8.0021 0.0 0
M  V30 6 C 17.7100 5.3347 0.0 0
M  V30 7 O 18.4800 6.6684 0.0 0
M  V30 8 O 18.4800 4.0011 0.0 0
M  V30 9 C 20.0200 6.6684 0.0 0
M  V30 10 C 6.1600 9.3358 0.0 0
M  V30 11 C 4.6200 6.6684 0.0 0
M  V30 12 O 3.8500 8.0021 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 1.5400 1.3336 0.0 0
M  V30 15 N 11.5500 5.3347 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 6.6684 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 C 8.4700 8.0021 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 6.9300 8.0021 0.0 0 CFG=1
M  V30 24 N 6.1600 6.6684 0.0 0
M  V30 25 C 13.0900 5.3347 0.0 0
M  V30 26 C 13.8600 6.6684 0.0 0
M  V30 27 C 13.8600 4.0011 0.0 0
M  V30 28 C 15.4000 6.6684 0.0 0
M  V30 29 N 15.4000 4.0011 0.0 0
M  V30 30 C 16.1700 5.3347 0.0 0
M  V30 31 C 3.8500 5.3347 0.0 0
M  V30 32 C 2.3100 5.3347 0.0 0
M  V30 33 C 4.6200 4.0011 0.0 0
M  V30 34 C 1.5400 4.0011 0.0 0
M  V30 35 C 3.8500 2.6674 0.0 0
M  V30 36 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 30
M  V30 9 1 7 9
M  V30 10 1 23 10 CFG=3
M  V30 11 2 11 12
M  V30 12 1 11 24
M  V30 13 1 11 31
M  V30 14 1 13 34
M  V30 15 1 14 36
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(6R)-7-(3,4-Dichlorobenzoyl)-5,6,7,8-tetrahydro-6-methyl-2-[(1-methylethyl...
C25H26Cl2N6O3
2489339-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 2.6674 0.0 0
M  V30 2 C 10.7800 1.3336 0.0 0
M  V30 3 C 11.5500 0.0000 0.0 0
M  V30 4 C 9.2400 1.3336 0.0 0
M  V30 5 O 11.5500 8.0021 0.0 0
M  V30 6 C 17.7100 5.3347 0.0 0
M  V30 7 N 18.4800 6.6684 0.0 0
M  V30 8 O 18.4800 4.0011 0.0 0
M  V30 9 C 20.0200 6.6684 0.0 0
M  V30 10 C 6.1600 9.3358 0.0 0
M  V30 11 C 4.6200 6.6684 0.0 0
M  V30 12 O 3.8500 8.0021 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 1.5400 1.3336 0.0 0
M  V30 15 N 11.5500 5.3347 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 6.6684 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 C 8.4700 8.0021 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 6.9300 8.0021 0.0 0 CFG=1
M  V30 24 N 6.1600 6.6684 0.0 0
M  V30 25 C 13.0900 5.3347 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 13.8600 6.6684 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 N 15.4000 6.6684 0.0 0
M  V30 30 C 16.1700 5.3347 0.0 0
M  V30 31 C 3.8500 5.3347 0.0 0
M  V30 32 C 2.3100 5.3347 0.0 0
M  V30 33 C 4.6200 4.0011 0.0 0
M  V30 34 C 1.5400 4.0011 0.0 0
M  V30 35 C 3.8500 2.6674 0.0 0
M  V30 36 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 30
M  V30 9 1 7 9
M  V30 10 1 23 10 CFG=3
M  V30 11 2 11 12
M  V30 12 1 11 24
M  V30 13 1 11 31
M  V30 14 1 13 34
M  V30 15 1 14 36
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2489339-02-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489339-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23147593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused ring pyrimidone derivatives for use in the treatment
of HBV infection or of HBV-induced diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grosse, Sandrine Celine; Berke, Jan Martin; Hsiao, Meng-Yang; Hu, Lili;
Jacoby, Edgar; Jonckers, Tim Hugo Maria; Kesteleyn, Bart Rudolf Romanie;
Last, Stefaan Julien; Martinez Lamenca, Carolina; Perrier, Mathieu;
Pieters, Serge Maria Aloysius; Raboisson, Pierre Jean-Marie Bernard;
Tahri, Abdellah; Vandyck, Koen; Verschueren, Wim Gaston
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020182990 A1 2020-09-17

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-2-(methylthio)-5,7-diphenyl-4H-pyrano[2,3-b]pyridin-4-one
C23H17NO3S
2489550-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 6.6685 0.0 0
M  V30 2 C 0.7700 4.0012 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 S 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 6.9302 6.6685 0.0 0
M  V30 12 N 6.9302 4.0012 0.0 0
M  V30 13 O 4.6201 2.6673 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 3.0801 2.6673 0.0 0
M  V30 17 C 4.6201 8.0023 0.0 0
M  V30 18 C 3.0801 8.0023 0.0 0
M  V30 19 C 5.3901 9.3360 0.0 0
M  V30 20 C 2.3101 9.3360 0.0 0
M  V30 21 C 4.6201 10.6697 0.0 0
M  V30 22 C 3.0801 10.6697 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 10.0102 4.0012 0.0 0
M  V30 26 C 11.5503 6.6685 0.0 0
M  V30 27 C 11.5503 4.0012 0.0 0
M  V30 28 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 1 15 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-2-(methylamino)-5,7-diphenyl-4H-pyrano[2,3-b]pyridin-4-one
C23H18N2O3
2489549-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 6.6685 0.0 0
M  V30 2 C 0.7700 4.0012 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 N 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 6.9302 6.6685 0.0 0
M  V30 12 N 6.9302 4.0012 0.0 0
M  V30 13 O 4.6201 2.6673 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 3.0801 2.6673 0.0 0
M  V30 17 C 4.6201 8.0023 0.0 0
M  V30 18 C 3.0801 8.0023 0.0 0
M  V30 19 C 5.3901 9.3360 0.0 0
M  V30 20 C 2.3101 9.3360 0.0 0
M  V30 21 C 4.6201 10.6697 0.0 0
M  V30 22 C 3.0801 10.6697 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 10.0102 4.0012 0.0 0
M  V30 26 C 11.5503 6.6685 0.0 0
M  V30 27 C 11.5503 4.0012 0.0 0
M  V30 28 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 1 15 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2489550-18-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489549-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26252866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, toxic methanethiol release during reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(Substituted amino)-8-azachromones from 4,6-Diaryl-2-pyridones: A
Synthetic Strategy toward Compounds of Broad Structural Diversity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Ghoteimi, Rayane; Mathe, Christophe; Peyrottes, Suzanne;
Uttaro, Jean-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(18), 11778-11793

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-5-methyl-3-(1-methyl-1-phenylethyl)benzaldehyde
C17H18O2
263172-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 2.6673 5.3900 0.0 0
M  V30 3 C 4.0011 6.1600 0.0 0
M  V30 4 O 6.6684 6.1600 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 O 10.6694 3.8500 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3336 1.5400 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 5 11
M  V30 8 1 7 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-[(methylimino)methyl]-6-(1-methyl-1-phenylethyl)phenol
C18H21NO
479508-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 2.6673 5.3901 0.0 0
M  V30 3 C 4.0012 6.1601 0.0 0
M  V30 4 O 6.6685 6.1601 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 6.6685 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 4 10
M  V30 6 2 5 6 CFG=2
M  V30 7 1 5 12
M  V30 8 1 6 7
M  V30 9 1 8 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 263172-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479508-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19996709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zirconium complexes having phenoxy/cycloalkylimine chelate ligands for
production of low molecular weight polyethylenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishii, Seiichi; Mitani, Makoto; Saito, Junji; Matsuura, Sadahiko;
Matsukawa, Naoto; Tsuru, Kazutaka; Fujita, Terunori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1270603 A2 2003-01-02

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[[(1,1-Dimethylethoxy)carbonyl][3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-...
C25H23N3O7
267648-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5957 5.3901 0.0 0
M  V30 2 C 7.5957 3.8500 0.0 0
M  V30 3 O 6.2620 3.0800 0.0 0
M  V30 4 O 8.9295 3.0800 0.0 0
M  V30 5 C 6.2620 1.5400 0.0 0
M  V30 6 C 7.8020 1.5400 0.0 0
M  V30 7 C 6.2620 0.0000 0.0 0
M  V30 8 C 4.7220 1.5400 0.0 0
M  V30 9 O 12.9304 5.3901 0.0 0
M  V30 10 C 12.9304 3.8500 0.0 0
M  V30 11 C 1.5315 8.3338 0.0 0
M  V30 12 O 0.0000 8.4947 0.0 0
M  V30 13 O 2.1579 6.9268 0.0 0
M  V30 14 C 6.2620 6.1601 0.0 0
M  V30 15 O 6.1011 7.6916 0.0 0
M  V30 16 N 4.8552 5.5336 0.0 0
M  V30 17 C 4.5946 8.0118 0.0 0
M  V30 18 C 3.8246 6.6781 0.0 0
M  V30 19 C 8.9295 6.1601 0.0 0
M  V30 20 C 10.2631 5.3901 0.0 0
M  V30 21 C 8.9295 7.7001 0.0 0
M  V30 22 C 11.5968 6.1601 0.0 0
M  V30 23 C 10.2631 8.4701 0.0 0
M  V30 24 C 11.5968 7.7001 0.0 0
M  V30 25 C 3.9683 9.4186 0.0 0
M  V30 26 C 2.4368 9.5797 0.0 0
M  V30 27 C 4.8735 10.6646 0.0 0
M  V30 28 C 1.8103 10.9865 0.0 0
M  V30 29 C 4.2472 12.0714 0.0 0
M  V30 30 C 2.7155 12.2323 0.0 0
M  V30 31 C 12.9304 8.4701 0.0 0
M  V30 32 C 13.0915 10.0016 0.0 0
M  V30 33 O 14.3374 7.8436 0.0 0
M  V30 34 N 14.5978 10.3218 0.0 0
M  V30 35 C 15.3678 8.9881 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 19
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 26
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 17 25
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 31
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [3-methoxy-4-(5-oxazolyl)phenyl][5-[2-[(methylamino)carbonyl]p...
C26H26N4O6
267648-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7722 5.3901 0.0 0
M  V30 2 C 7.7722 3.8501 0.0 0
M  V30 3 O 9.1058 3.0800 0.0 0
M  V30 4 O 6.4384 3.0800 0.0 0
M  V30 5 C 9.1058 1.5400 0.0 0
M  V30 6 C 10.6459 1.5400 0.0 0
M  V30 7 C 9.1058 0.0000 0.0 0
M  V30 8 C 7.5658 1.5400 0.0 0
M  V30 9 O 2.4374 5.3901 0.0 0
M  V30 10 C 2.4374 3.8501 0.0 0
M  V30 11 C 13.8363 8.3338 0.0 0
M  V30 12 N 15.3679 8.4948 0.0 0
M  V30 13 O 13.2100 6.9269 0.0 0
M  V30 14 C 16.2731 7.2489 0.0 0
M  V30 15 C 9.1058 6.1601 0.0 0
M  V30 16 O 9.2668 7.6916 0.0 0
M  V30 17 N 10.5127 5.5336 0.0 0
M  V30 18 C 10.7732 8.0118 0.0 0
M  V30 19 C 11.5432 6.6782 0.0 0
M  V30 20 C 6.4384 6.1601 0.0 0
M  V30 21 C 5.1047 5.3901 0.0 0
M  V30 22 C 6.4384 7.7001 0.0 0
M  V30 23 C 3.7711 6.1601 0.0 0
M  V30 24 C 5.1047 8.4701 0.0 0
M  V30 25 C 3.7711 7.7001 0.0 0
M  V30 26 C 11.3995 9.4186 0.0 0
M  V30 27 C 12.9311 9.5797 0.0 0
M  V30 28 C 10.4943 10.6647 0.0 0
M  V30 29 C 13.5576 10.9865 0.0 0
M  V30 30 C 11.1208 12.0715 0.0 0
M  V30 31 C 12.6524 12.2324 0.0 0
M  V30 32 C 2.4374 8.4701 0.0 0
M  V30 33 C 1.0304 7.8436 0.0 0
M  V30 34 O 2.2763 10.0017 0.0 0
M  V30 35 N 0.0000 8.9882 0.0 0
M  V30 36 C 0.7700 10.3218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 23
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 27
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 18 26
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 32
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 267648-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 267648-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14956248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 83 Part G,
[3-Methoxy-4-(5-oxazolyl)phenyl][5-[2-[(methylamino)carbonyl]phenyl]-2-oxazolyl]carbamic
acid 1,1-dimethylethyl ester To a mixture of 83F (50 mg, 0.105 mmol)
methylamine (2M in THF, 65 μl, 1.3 mmol)1-hydroxyy-7-azabenzotriaole
(18.5 mg, 0.136 mmol) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide
hydrochloride ( 26 mg, 0.136 mmol) in THF (1 ml) was added N,
N-diisopropylethylamine (55 μl, 0.315 mmol). The mixture was stirred at
50 °C for 18 hours diluted with dichloromethane (4 ml) and successively
washed with 1N HCl (2 ml), 10 % NaOH (2 ml)and brine. The dichloromethane
layer was dried over sodium sulfate and concentrated in vacuo to afford
83G. Yellow solid, yield (51 mg, 97 %). (LC/MS retention time = 3.70
min.; M+ = 491.30 Column: YMC S5 ODS 4.6 x 5.0 mm Ballistic. Solvent A =
10% MeOH, 90% H2O, 0.1% TFA; Solvent B = 90% MeOH, 10% H2O, 0.1% TFA).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of compounds derived from an amine nucleus as inhibitors of
IMPDH enzyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Chunjian; Dhar, T. G. Murali; Gu, Henry H.; Iwanowicz, Edwin J.;
Leftheris, Katerina; Pitts, William John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000025780 A1 2000-05-11

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(7-bromo-5-fluoro-4-oxo-3(4H)-quinazolinyl)-1-piperidinec...
C18H21BrFN3O3
2724264-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 1.3338 0.0 0
M  V30 2 F 4.6200 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6674 0.0 0
M  V30 4 C 13.0900 4.0011 0.0 0
M  V30 5 O 13.8600 5.3349 0.0 0
M  V30 6 O 13.8600 2.6674 0.0 0
M  V30 7 C 15.4000 5.3349 0.0 0
M  V30 8 C 15.4000 6.8749 0.0 0
M  V30 9 C 16.9400 5.3349 0.0 0
M  V30 10 C 15.4000 3.7949 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0
M  V30 15 N 4.6200 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 N 6.9300 4.0011 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 6.1600 5.3349 0.0 0
M  V30 20 C 1.5400 2.6674 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 9.2400 2.6674 0.0 0
M  V30 23 C 9.2400 5.3349 0.0 0
M  V30 24 C 10.7800 2.6674 0.0 0
M  V30 25 C 10.7800 5.3349 0.0 0
M  V30 26 N 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 26
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[7-bromo-5-(methylamino)-4-oxo-3(4H)-quinazoli...
C19H25BrN4O3
2923457-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 N 4.6200 1.3338 0.0 0
M  V30 3 C 3.8500 0.0000 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 C 13.0900 5.3347 0.0 0
M  V30 6 O 13.8600 6.6685 0.0 0
M  V30 7 O 13.8600 4.0011 0.0 0
M  V30 8 C 15.4000 6.6685 0.0 0
M  V30 9 C 15.4000 5.1285 0.0 0
M  V30 10 C 16.9400 6.6685 0.0 0
M  V30 11 C 15.4000 8.2085 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 N 4.6200 6.6685 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 N 6.9300 5.3347 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 6.1600 6.6685 0.0 0
M  V30 21 C 1.5400 4.0011 0.0 0
M  V30 22 C 8.4700 5.3347 0.0 0
M  V30 23 C 9.2400 4.0011 0.0 0
M  V30 24 C 9.2400 6.6685 0.0 0
M  V30 25 C 10.7800 4.0011 0.0 0
M  V30 26 C 10.7800 6.6685 0.0 0
M  V30 27 N 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 1 18 22
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2724264-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2923457-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36872676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and methods for modulating nucleic
acid splicing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reynolds, Dominic; Seiler, Michael W.; Agrawal, Anant A.; Vaillancourt,
Frederic; Smith, Peter; Prajapati, Sudeep; Hopper, Allen T.; Vyskocil,
Stepan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023064880 A1 2023-04-20

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carboxaldehyde, 1-methyl-2-(1-naphthalenyl)-, (2S)-
C20H15NO
2758192-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0620 0.9473 0.0 0
M  V30 2 O 8.5266 0.4714 0.0 0
M  V30 3 C 4.3514 5.6421 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 C 6.7418 2.4536 0.0 0
M  V30 6 N 5.4958 4.6116 0.0 0
M  V30 7 C 7.7722 3.5981 0.0 0
M  V30 8 C 7.0022 4.9318 0.0 0
M  V30 9 C 9.3123 3.5981 0.0 0
M  V30 10 C 7.7722 6.2655 0.0 0
M  V30 11 C 10.0823 4.9318 0.0 0
M  V30 12 C 9.3123 6.2655 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 0.7700 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6675 4.6201 0.0 0
M  V30 18 C 2.6675 0.0000 0.0 0
M  V30 19 C 1.3337 0.7700 0.0 0
M  V30 20 C 0.0000 3.0801 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 2 18 19
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-methanamine, N,1-dimethyl-2-(1-naphthalenyl)-, (2S)-
C21H20N2
2758193-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 5.7308 0.0 0
M  V30 2 N 9.4584 5.4106 0.0 0
M  V30 3 C 10.4889 6.5550 0.0 0
M  V30 4 C 3.2574 3.0202 0.0 0
M  V30 5 C 5.3900 4.7474 0.0 0
M  V30 6 C 6.9217 4.5864 0.0 0
M  V30 7 N 4.7637 3.3406 0.0 0
M  V30 8 C 7.2419 3.0800 0.0 0
M  V30 9 C 5.9081 2.3100 0.0 0
M  V30 10 C 8.5755 2.3100 0.0 0
M  V30 11 C 5.9081 0.7700 0.0 0
M  V30 12 C 8.5755 0.7700 0.0 0
M  V30 13 C 7.2419 0.0000 0.0 0
M  V30 14 C 4.6200 6.0810 0.0 0
M  V30 15 C 3.0800 6.0810 0.0 0
M  V30 16 C 5.3900 7.4148 0.0 0
M  V30 17 C 2.3100 7.4148 0.0 0
M  V30 18 C 2.3100 4.7474 0.0 0
M  V30 19 C 4.6200 8.7484 0.0 0
M  V30 20 C 3.0800 8.7484 0.0 0
M  V30 21 C 0.7700 7.4148 0.0 0
M  V30 22 C 0.7700 4.7474 0.0 0
M  V30 23 C 0.0000 6.0810 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 20
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2758192-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2758193-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29439856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cobalt-Catalyzed Enantioselective C-H Arylation of Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jacob, Nicolas; Zaid, Yassir; Oliveira, Joao C. A.; Ackermann, Lutz;
Wencel-Delord, Joanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2022), 144(2), 798-806

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
(3β,4α)-3-(Acetyloxy)-23-oxoolean-12-en-28-oic acid
C32H48O5
27706-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4729 1.1333 0.0 0
M  V30 2 C 9.7829 5.5352 0.0 0
M  V30 3 C 6.4657 1.1799 0.0 0
M  V30 4 C 11.9596 1.1508 0.0 0
M  V30 5 O 13.1393 0.1609 0.0 0
M  V30 6 C 13.6741 2.1408 0.0 0
M  V30 7 O 14.5370 4.0011 0.0 0
M  V30 8 C 15.3070 5.3349 0.0 0
M  V30 9 C 14.5370 6.6685 0.0 0
M  V30 10 O 16.8470 5.3349 0.0 0
M  V30 11 C 2.2170 1.3338 0.0 0
M  V30 12 O 2.9871 0.0000 0.0 0
M  V30 13 O 0.6770 1.3338 0.0 0
M  V30 14 C 1.7145 6.8515 0.0 0
M  V30 15 C 0.0000 5.8615 0.0 0
M  V30 16 C 8.3770 4.0011 0.0 0 CFG=2
M  V30 17 C 7.6070 2.6674 0.0 0 CFG=2
M  V30 18 C 9.9170 4.0011 0.0 0 CFG=2
M  V30 19 C 7.6070 5.3349 0.0 0
M  V30 20 C 6.0670 2.6674 0.0 0 CFG=1
M  V30 21 C 8.3770 1.3338 0.0 0
M  V30 22 C 10.6870 2.6674 0.0 0 CFG=2
M  V30 23 C 10.6870 5.3349 0.0 0
M  V30 24 C 6.0670 5.3347 0.0 0
M  V30 25 C 5.2970 4.0011 0.0 0
M  V30 26 C 5.2970 1.3338 0.0 0
M  V30 27 C 9.9170 1.3338 0.0 0
M  V30 28 C 12.2270 2.6674 0.0 0 CFG=2
M  V30 29 C 12.2270 5.3349 0.0 0
M  V30 30 C 3.7570 4.0011 0.0 0 CFG=2
M  V30 31 C 3.7570 1.3338 0.0 0
M  V30 32 C 12.9970 4.0011 0.0 0 CFG=1
M  V30 33 C 2.9870 2.6674 0.0 0 CFG=1
M  V30 34 C 2.9870 5.3347 0.0 0
M  V30 35 C 1.4470 2.6674 0.0 0
M  V30 36 C 1.4470 5.3347 0.0 0
M  V30 37 C 0.6770 4.0011 0.0 0
M  V30 38 H 8.7757 5.4887 0.0 0
M  V30 39 H 11.4570 1.3338 0.0 0
M  V30 40 H 4.5270 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 18 2 CFG=3
M  V30 3 1 20 3 CFG=1
M  V30 4 2 4 5
M  V30 5 1 28 4 CFG=1
M  V30 6 1 28 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 32 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 33 11 CFG=3
M  V30 14 1 14 36
M  V30 15 1 15 36
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 38 CFG=1
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 22 27
M  V30 29 1 22 28
M  V30 30 1 22 39 CFG=1
M  V30 31 1 23 29
M  V30 32 2 24 25
M  V30 33 1 25 30
M  V30 34 1 26 31
M  V30 35 1 28 32
M  V30 36 1 29 32
M  V30 37 1 30 33
M  V30 38 1 30 34
M  V30 39 1 30 40 CFG=3
M  V30 40 1 31 33
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 1 35 37
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 16 17 18 20 22 28 30 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β,4α)-3-(Acetyloxy)-N-methyl-23-oxoolean-12-en-28-amide
C33H51NO4
2588333-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 5.0298 0.0 0
M  V30 2 N 1.3338 4.2598 0.0 0
M  V30 3 O 2.6674 6.5698 0.0 0
M  V30 4 C 0.0000 5.0298 0.0 0
M  V30 5 C 6.0176 7.1955 0.0 0
M  V30 6 C 3.0112 0.0000 0.0 0
M  V30 7 C 4.9910 0.0000 0.0 0
M  V30 8 C 7.1188 7.8312 0.0 0
M  V30 9 C 11.3204 5.1739 0.0 0
M  V30 10 C 12.9931 10.0594 0.0 0
M  V30 11 O 12.4663 11.5066 0.0 0
M  V30 12 C 11.0133 10.0594 0.0 0
M  V30 13 O 14.6705 8.8798 0.0 0
M  V30 14 C 16.0041 8.1098 0.0 0
M  V30 15 C 17.3379 8.8798 0.0 0
M  V30 16 O 16.0041 6.5698 0.0 0
M  V30 17 C 4.0011 4.2598 0.0 0 CFG=1
M  V30 18 C 5.3347 3.4898 0.0 0 CFG=1
M  V30 19 C 4.0011 5.7998 0.0 0
M  V30 20 C 2.6674 3.4898 0.0 0
M  V30 21 C 6.6685 4.2598 0.0 0
M  V30 22 C 5.3347 1.9498 0.0 0
M  V30 23 C 5.3347 6.5698 0.0 0
M  V30 24 C 2.6674 1.9498 0.0 0
M  V30 25 C 6.6685 5.7998 0.0 0 CFG=1
M  V30 26 C 8.0021 3.4898 0.0 0
M  V30 27 C 4.0011 1.1798 0.0 0
M  V30 28 C 8.0021 6.5698 0.0 0 CFG=1
M  V30 29 C 9.3358 4.2598 0.0 0
M  V30 30 C 9.3358 5.7998 0.0 0 CFG=1
M  V30 31 C 8.0021 8.1098 0.0 0
M  V30 32 C 10.6694 6.5698 0.0 0 CFG=2
M  V30 33 C 9.3358 8.8798 0.0 0
M  V30 34 C 10.6694 8.1098 0.0 0 CFG=2
M  V30 35 C 12.0032 5.7998 0.0 0
M  V30 36 C 12.0032 8.8798 0.0 0 CFG=2
M  V30 37 C 13.3369 6.5698 0.0 0
M  V30 38 C 13.3369 8.1098 0.0 0 CFG=1
M  V30 39 H 6.6685 2.7198 0.0 0
M  V30 40 H 10.2191 4.5382 0.0 0
M  V30 41 H 10.6694 9.6498 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 25 5 CFG=3
M  V30 6 1 6 27
M  V30 7 1 7 27
M  V30 8 1 28 8 CFG=1
M  V30 9 1 32 9 CFG=1
M  V30 10 2 10 11
M  V30 11 1 36 10 CFG=3
M  V30 12 1 36 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 38 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 18 39 CFG=1
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 1 22 27
M  V30 28 1 23 25
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 1 30 32
M  V30 36 1 30 40 CFG=3
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 33 34
M  V30 41 1 34 36
M  V30 42 1 34 41 CFG=3
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 17 18 25 28 30 32 34 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27706-38-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2588333-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23287357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of gypsogenin and gypsogenic acid derivatives with antitumor
activity by damaging cell membranes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Guiying; Chu, Haiping; Wang, Jilei; Mu, Yanling; Sun, Jingyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2019), 43(47), 18898-18914

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(E)-(2-Benzothiazolylimino)hydroxymethyl]-L-alanine methyl ester
C12H13N3O3S
2770660-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.0811 1.5400 0.0 0
M  V30 2 C 7.4148 2.3101 0.0 0
M  V30 3 N 8.7485 1.5400 0.0 0
M  V30 4 O 7.4148 3.8501 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0 CFG=1
M  V30 6 C 11.4160 1.5400 0.0 0
M  V30 7 C 10.0823 3.8501 0.0 0
M  V30 8 O 12.7496 2.3101 0.0 0
M  V30 9 O 11.4160 0.0000 0.0 0
M  V30 10 C 14.0833 1.5400 0.0 0
M  V30 11 C 2.3101 2.8281 0.0 0
M  V30 12 C 3.0801 4.1618 0.0 0
M  V30 13 N 3.3405 1.6836 0.0 0
M  V30 14 C 0.7700 2.8281 0.0 0
M  V30 15 S 4.5864 3.8416 0.0 0
M  V30 16 C 2.3101 5.4955 0.0 0
M  V30 17 C 4.7473 2.3101 0.0 0
M  V30 18 C 0.0000 4.1618 0.0 0
M  V30 19 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=1
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C12H14N4O2S
2770660-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.0811 1.5400 0.0 0
M  V30 2 C 7.4148 2.3101 0.0 0
M  V30 3 N 8.7485 1.5400 0.0 0
M  V30 4 O 7.4148 3.8501 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0 CFG=1
M  V30 6 C 11.4160 1.5400 0.0 0
M  V30 7 C 10.0823 3.8501 0.0 0
M  V30 8 N 12.7496 2.3101 0.0 0
M  V30 9 O 11.4160 0.0000 0.0 0
M  V30 10 C 14.0833 1.5400 0.0 0
M  V30 11 C 2.3101 2.8281 0.0 0
M  V30 12 C 3.0801 4.1618 0.0 0
M  V30 13 N 3.3405 1.6836 0.0 0
M  V30 14 C 0.7700 2.8281 0.0 0
M  V30 15 S 4.5864 3.8416 0.0 0
M  V30 16 C 2.3101 5.4955 0.0 0
M  V30 17 C 4.7473 2.3101 0.0 0
M  V30 18 C 0.0000 4.1618 0.0 0
M  V30 19 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=1
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2770660-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2770660-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32438665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isothioureas, ureas, and their N-methyl amides from 2-aminobenzothiazole
and chiral amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padilla-Martinez, Itzia I.; Gonzalez-Encarnacion, Jose Miguel;
Garcia-Baez, Efren V.; Cruz, Alejandro; Ramos-Organillo, Angel Andres
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(18), 3391

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromo-3-fluoro-5-methyl-2-nitrophenyl)-N-methylacetamide
C10H10BrFN2O3
2858643-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 O 6.1600 1.3338 0.0 0
M  V30 4 N 6.1600 4.0011 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 8.4700 5.3347 0.0 0
M  V30 8 O 6.1600 6.6685 0.0 0
M  V30 9 F 1.5400 1.3338 0.0 0
M  V30 10 Br 0.0000 4.0011 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 3.8500 5.3347 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 14
M  V30 10 1 10 16
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Bromo-5-methyl-3-(methylamino)-2-nitrophenyl]-N-methylacetamide
C11H14BrN3O3
2858644-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9301 0.0 0
M  V30 3 O 2.6675 6.9301 0.0 0
M  V30 4 N 6.6684 4.6201 0.0 0
M  V30 5 C 8.0022 3.8500 0.0 0
M  V30 6 C 6.6684 6.1601 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 O 8.0022 2.3100 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 Br 1.3337 1.5400 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 11 17
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2858643-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2858644-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35058676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, incremental addition of methylamine in THF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecules as inhibitors of KRAS G12C mutant and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shibata, Kazuaki; Asakura, Hiroki; Akemoto, Kei; Sakamoto, Toshihiro;
Kondo, Hitomi; Yamamoto, Tomohiro; Miura, Risako; Schoepf, Patrick; Del
Pozo, Juan; Giambusu, George Madalin; Graham, Thomas H.; Han, Yongxin;
Hennessy, Elisabeth T.; Palani, Anandan; Ryan, Michael; Sloman, David L.;
Howard, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022232318 A1 2022-11-03

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
1,3-Benzodioxole-5-acetic acid
C9H8O4
2861-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 7.7047 0.7700 0.0 0
M  V30 4 O 9.0383 3.0800 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 O 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,3-benzodioxole-5-acetamide
C10H11NO3
127901-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 O 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2861-28-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127901-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6000065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[6-(methoxycarbonyl)-3-pyridinyl]-3,6-diazabicyclo[3.1.1]...
C17H23N3O4
2868276-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8700 2.8379 0.0 0
M  V30 2 O 3.0797 1.5161 0.0 0
M  V30 3 O 3.1205 4.1833 0.0 0
M  V30 4 C 1.5398 1.5397 0.0 0
M  V30 5 C 1.5634 3.0795 0.0 0
M  V30 6 C 0.0000 1.5633 0.0 0
M  V30 7 C 1.5163 0.0000 0.0 0
M  V30 8 C 15.0008 4.1894 0.0 0
M  V30 9 O 15.7708 5.5231 0.0 0
M  V30 10 O 15.7708 2.8558 0.0 0
M  V30 11 C 17.3108 5.5231 0.0 0
M  V30 12 N 8.8408 4.1894 0.0 0
M  V30 13 C 7.6402 3.7270 0.0 0
M  V30 14 C 7.4508 4.7249 0.0 0
M  V30 15 C 6.4435 5.4956 0.0 0
M  V30 16 C 6.8051 2.2724 0.0 0
M  V30 17 C 6.5521 3.2181 0.0 0
M  V30 18 N 5.4099 2.8144 0.0 0
M  V30 19 C 10.3808 4.1894 0.0 0
M  V30 20 C 11.1508 2.8558 0.0 0
M  V30 21 C 11.1508 5.5231 0.0 0
M  V30 22 C 12.6908 2.8558 0.0 0
M  V30 23 N 12.6908 5.5231 0.0 0
M  V30 24 C 13.4608 4.1894 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 19
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[6-[(methylamino)carbonyl]-3-pyridinyl]-3,6-diazabicyclo[...
C17H24N4O3
2868276-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8700 2.8379 0.0 0
M  V30 2 O 3.0797 1.5161 0.0 0
M  V30 3 O 3.1205 4.1833 0.0 0
M  V30 4 C 1.5398 1.5397 0.0 0
M  V30 5 C 1.5634 3.0795 0.0 0
M  V30 6 C 0.0000 1.5633 0.0 0
M  V30 7 C 1.5163 0.0000 0.0 0
M  V30 8 C 15.0008 4.1894 0.0 0
M  V30 9 N 15.7708 5.5231 0.0 0
M  V30 10 O 15.7708 2.8558 0.0 0
M  V30 11 C 17.3108 5.5231 0.0 0
M  V30 12 N 8.8408 4.1894 0.0 0
M  V30 13 C 7.6402 3.7270 0.0 0
M  V30 14 C 7.4508 4.7249 0.0 0
M  V30 15 C 6.4435 5.4956 0.0 0
M  V30 16 C 6.8051 2.2724 0.0 0
M  V30 17 C 6.5521 3.2181 0.0 0
M  V30 18 N 5.4099 2.8144 0.0 0
M  V30 19 C 10.3808 4.1894 0.0 0
M  V30 20 C 11.1508 5.5231 0.0 0
M  V30 21 C 11.1508 2.8558 0.0 0
M  V30 22 C 12.6908 5.5231 0.0 0
M  V30 23 N 12.6908 2.8558 0.0 0
M  V30 24 C 13.4608 4.1894 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 19
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-5,8-dimethyl-2-(methylsulfonyl)pyrido[2,3-d]pyrimidin-7(8H)-one
C10H10BrN3O3S
2891866-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 0.0000 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 4 C 10.0100 4.0009 0.0 0
M  V30 5 O 8.4700 5.5409 0.0 0
M  V30 6 O 8.4700 2.4609 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 Br 0.0000 2.6673 0.0 0
M  V30 9 C 4.6200 2.6673 0.0 0
M  V30 10 C 3.8500 4.0009 0.0 0
M  V30 11 N 6.1600 2.6673 0.0 0
M  V30 12 N 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 4.0009 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.9300 4.0009 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 1.5400 2.6673 0.0 0
M  V30 18 N 6.1600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 15
M  V30 7 2 7 16
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-5,8-dimethyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
C10H11BrN4O
2891866-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 6.1601 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 8.0023 4.6201 0.0 0
M  V30 5 C 9.3360 3.8501 0.0 0
M  V30 6 Br 0.0000 1.5400 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 N 2.6675 4.6201 0.0 0
M  V30 10 N 5.3348 4.6201 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 N 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891866-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2891866-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35624380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-(4-fluorophenyl)-1H-pyrazole-3-carboxamides
as modulators of protein kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Gary A.; Galatsis, Paul; Huntsman, Andrew C.; Huynh, Khoi; Werner,
Doug
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023283369 A1 2023-01-12

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3,4-dichlorophenoxy)benzaldehyde
C13H7BrCl2O2
289718-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Br 10.7800 4.0011 0.0 0
M  V30 5 Cl 0.0000 6.6684 0.0 0
M  V30 6 Cl 1.5400 9.3358 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 8.4700 2.6674 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 16
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-Bromo-2-(3,4-dichlorophenoxy)benzyl]methylamine
C14H12BrCl2NO
289717-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 10.0100 8.0021 0.0 0
M  V30 7 Cl 11.5500 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 289718-03-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 289717-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3564331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step B:
[5-Bromo-2-(3,4-dichloro-phenoxy)-benzyl]-methyl-amine. To a mixture of
5-bromo-2-(3,4-dichloro-phenoxy)-benzaldehyde (4.74 g, 13.8 mmol) in MeOH
(250 mL) was added MeNH2 (40% aq.; 20 mL, 260 mmol), and the 15 resulting
mixture was stirred at rt until homogeneous. The mixture was cooled to 0
°C and treated with NaBH4 (1.05 g, 27.8 mmol) portionwise. After 24 h,
the mixture was concentrated and the residue was diluted with 1 N NaOH
and extracted with DCM. The combined organic layers were dried (Na2SO4)
and concentrated. The crude product was purified by FCC to provide the
desired product. (4.80 g, 97%). MS (ESI): mass calcd. for C14H12BrCl2NO,
358.95; m/z found, 360.1 [M+H]+. 1H NMR (CDCl3): 7.61 (d,J= 2.5, 1H),
7.40-7.37 (m, 2H), 7.03 (d,J= 2.8, 1H), 6.82-6.79 (m, 2H), 3.72 (s, 2H),
2.44 (s, 3H), 1.30-1.21 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenoxy benzylamine compounds as histamine H3 receptor
and/or serotonin transporter modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allison, Brett; Curtis, Michael P.; Grice, Cheryl A.; Keith, John M.;
Letavic, Michael A.; Miller, Jennifer M. B.; Stocking, Emily M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008002820 A2 2008-01-03

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3,4-dichlorophenoxy)benzaldehyde
C13H7BrCl2O2
289718-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Br 10.7800 4.0011 0.0 0
M  V30 5 Cl 0.0000 6.6684 0.0 0
M  V30 6 Cl 1.5400 9.3358 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 8.4700 2.6674 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 16
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-Bromo-2-(3,4-dichlorophenoxy)benzyl]methylamine
C14H12BrCl2NO
289717-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 10.0100 8.0021 0.0 0
M  V30 7 Cl 11.5500 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 289718-03-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 289717-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10676960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B: [5-Bromo-2-(3,4-dichloro-phenoxy)-benzyl]-methyl-amine. To a
mixture of 5-bromo-2-(3,4-dichloro-phenoxy)-benzaldehyde (4.74 g, 13.8
mmol) in MeOH (250 ml.) was added MeNH2 (40% aq.; 20 mL, 260 mmol), and
the resulting mixture was stirred at rt until homogeneous. The mixture
was cooled to 0 °C and treated with NaBH4 (1.05 g, 27.8 mmol)
portionwise. After 24 h, the mixture was concentrated and the residue was
diluted with 1 N NaOH and extracted with DCM. The combined organic layers
were dried (Na2SO4) and concentrated. The crude product was purified by
FCC. The desired product (4.80 g, 97%). MS (ESI): mass calcd. for
C14H12BrCl2NO, 358.95; m/z found, 360.1 [M+H]+. 1H NMR (CDCl3): 7.61 (d,
J = 2.5, 1H), 7.40-7.37 (m,2H), 7.03 (d, J = 2.8, 1H), 6.82-6.79 (m, 2H),
3.72 (s, 2H), 2.44 (s, 3H), 1.30-1.21 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of butyl and butynyl benzylamine compounds as histamine H3
receptor and/or serotonin transporter modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, John M.; Letavic, Michael A.; Stocking, Emily M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008002817 A1 2008-01-03

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3,4-dichlorophenoxy)benzaldehyde
C13H7BrCl2O2
289718-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Br 10.7800 4.0011 0.0 0
M  V30 5 Cl 0.0000 6.6684 0.0 0
M  V30 6 Cl 1.5400 9.3358 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 8.4700 2.6674 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 16
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-Bromo-2-(3,4-dichlorophenoxy)benzyl]methylamine
C14H12BrCl2NO
289717-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 10.0100 8.0021 0.0 0
M  V30 7 Cl 11.5500 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 289718-03-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 289717-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7146359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B: [5-Bromo-2-(3,4-dichloro-phenoxy)-benzyl]-methyl-amine. To a
mixture of 5-bromo-2-(3,4-dichloro-phenoxy)-benzaldehyde (4.74 g, 13.8
mmol) in MeOH (250 ml.) was added MeNH2 (40% aq.; 20 mL, 260 mmol), and
the 10 resulting mixture was stirred at rt until homogeneous. The mixture
was cooled to 0 °C and treated with NaBH4 (1.05 g, 27.8 mmol)
portionwise. After 24 h, the mixture was concentrated and the residue was
diluted with 1N NaOH and extracted with DCM. The combined organic layers
were dried (Na2SO4) and concentrated. The crude product was purified by
FCC to provide the desired product (4.80 g, 97%). MS (ESI): mass calcd.
for C14H12BrCl2NO, 358.95; m/z found, 360.1 [M+H]+. 1H NMR (CDCl3): 7.61
(d, J = 2.5, 1H), 7.40-7.37 (m, 2H), 7.03 (d, J = 2.8, 1H), 6.82-6.79 (m,
2H), 3.72 (s, 2H), 2.44 (s, 3H), 1.30-1.21 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted aminomethyl benzamides as histamine H3
receptor and serotonin transporter modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allison, Brett; Carruthers, Nicholas I.; Curtis, Michael P.; Keith, John
M.; Letavic, Michael A.; Stocking, Emily M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008002818 A1 2008-01-03

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3,4-dichlorophenoxy)benzaldehyde
C13H7BrCl2O2
289718-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 1.3336 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Br 10.7800 4.0011 0.0 0
M  V30 5 Cl 0.0000 6.6684 0.0 0
M  V30 6 Cl 1.5400 9.3358 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 8.4700 2.6674 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 16
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-Bromo-2-(3,4-dichlorophenoxy)benzyl]methylamine
C14H12BrCl2NO
289717-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 10.0100 8.0021 0.0 0
M  V30 7 Cl 11.5500 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 289718-03-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 289717-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5241204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME262 STEP1
$RXN



  3  1
$MOL
4-Nitrophenyl chloroformate
C7H4ClNO4
7693-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 Cl 8.0023 2.3101 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-3-acetic acid, 3′-[[[(1R,2R,3S,4R,7Z)-7-(cyclopropylmethylene...
C39H39F5N2O6
2924773-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.3204 7.8678 0.0 0
M  V30 2 N 5.1860 6.5942 0.0 0
M  V30 3 O 2.7845 7.7551 0.0 0
M  V30 4 N 7.5826 8.1979 0.0 0
M  V30 5 C 8.9163 8.9679 0.0 0
M  V30 6 O 8.9163 10.5079 0.0 0
M  V30 7 C 1.2403 8.9067 0.0 0
M  V30 8 O 8.9163 5.8878 0.0 0
M  V30 9 C 8.9163 4.3478 0.0 0
M  V30 10 C 5.5767 1.2738 0.0 0
M  V30 11 F 6.8505 2.1393 0.0 0
M  V30 12 F 6.4424 0.0000 0.0 0
M  V30 13 F 4.3030 0.4081 0.0 0
M  V30 14 F 2.5050 1.0481 0.0 0
M  V30 15 F 12.9174 11.2779 0.0 0
M  V30 16 C 18.2522 8.1979 0.0 0 CFG=3
M  V30 17 C 19.5859 8.9679 0.0 0
M  V30 18 O 18.2522 6.6578 0.0 0
M  V30 19 O 20.9196 8.1979 0.0 0
M  V30 20 O 19.5859 10.5079 0.0 0
M  V30 21 C 22.2534 8.9679 0.0 0
M  V30 22 C 21.4834 10.3015 0.0 0
M  V30 23 C 23.5870 9.7379 0.0 0
M  V30 24 C 23.0234 7.6341 0.0 0
M  V30 25 C 4.9908 9.2545 0.0 0 CFG=2
M  V30 26 C 3.9474 10.0924 0.0 0 CFG=1
M  V30 27 C 6.2490 8.9679 0.0 0 CFG=2
M  V30 28 C 2.6841 9.4425 0.0 0
M  V30 29 C 4.3339 11.6198 0.0 0
M  V30 30 C 5.2398 10.0564 0.0 0 CFG=2
M  V30 31 C 5.5013 11.4319 0.0 0
M  V30 32 C 4.5158 5.2076 0.0 0
M  V30 33 C 5.3815 3.9340 0.0 0
M  V30 34 C 2.9800 5.0949 0.0 0
M  V30 35 C 4.7111 2.5474 0.0 0
M  V30 36 C 2.3096 3.7084 0.0 0
M  V30 37 C 3.1752 2.4346 0.0 0
M  V30 38 C 0.9824 7.3884 0.0 0
M  V30 39 C 0.0000 6.2025 0.0 0
M  V30 40 C 1.5183 5.9447 0.0 0
M  V30 41 C 10.2500 8.1979 0.0 0
M  V30 42 C 11.5838 8.9679 0.0 0
M  V30 43 C 10.2500 6.6578 0.0 0
M  V30 44 C 12.9174 8.1979 0.0 0
M  V30 45 C 11.5838 5.8878 0.0 0
M  V30 46 C 12.9174 6.6578 0.0 0
M  V30 47 C 14.2511 8.9679 0.0 0
M  V30 48 C 15.5848 8.1979 0.0 0
M  V30 49 C 14.2511 10.5079 0.0 0
M  V30 50 C 16.9186 8.9679 0.0 0
M  V30 51 C 15.5848 11.2779 0.0 0
M  V30 52 C 16.9186 10.5079 0.0 0
M  V30 53 H 2.7420 11.0508 0.0 0
M  V30 54 H 6.7199 10.4817 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 25 1 CFG=1
M  V30 4 1 2 32
M  V30 5 1 4 5
M  V30 6 1 27 4 CFG=1
M  V30 7 2 5 6
M  V30 8 1 5 41
M  V30 9 2 7 28
M  V30 10 1 7 38
M  V30 11 1 8 9
M  V30 12 1 8 43
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 35
M  V30 17 1 14 37
M  V30 18 1 15 49
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 50
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 53 CFG=1
M  V30 33 1 27 30
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 37 1 30 54 CFG=3
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 44 1 38 39
M  V30 45 1 38 40
M  V30 46 1 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 44 47
M  V30 53 1 45 46
M  V30 54 2 47 48
M  V30 55 1 47 49
M  V30 56 1 48 50
M  V30 57 2 49 51
M  V30 58 2 50 52
M  V30 59 1 51 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 25 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-3-acetic acid, 3′-[[[(1R,2R,3S,4R,7Z)-7-(cyclopropylmethylene...
C41H42F5N3O7
2924773-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.9720 10.6694 0.0 0
M  V30 2 C 9.5120 10.6694 0.0 0
M  V30 3 O 10.2820 12.0031 0.0 0
M  V30 4 C 4.9821 12.0148 0.0 0
M  V30 5 N 5.0948 10.4789 0.0 0
M  V30 6 O 3.5956 12.6851 0.0 0
M  V30 7 C 2.8339 14.4544 0.0 0
M  V30 8 O 7.9720 8.0021 0.0 0
M  V30 9 C 7.2020 6.6684 0.0 0
M  V30 10 C 2.7729 5.6760 0.0 0
M  V30 11 F 4.3088 5.7887 0.0 0
M  V30 12 F 2.8857 4.1401 0.0 0
M  V30 13 F 1.2371 5.5633 0.0 0
M  V30 14 F 0.0000 7.0165 0.0 0
M  V30 15 F 14.1320 10.6694 0.0 0
M  V30 16 C 17.2120 5.3347 0.0 0 CFG=3
M  V30 17 C 16.4420 4.0011 0.0 0
M  V30 18 O 18.7520 5.3347 0.0 0
M  V30 19 O 17.2120 2.6674 0.0 0
M  V30 20 O 14.9020 4.0011 0.0 0
M  V30 21 C 19.5220 6.6684 0.0 0
M  V30 22 C 16.4420 1.3336 0.0 0
M  V30 23 N 21.0620 6.6684 0.0 0
M  V30 24 O 18.7520 8.0021 0.0 0
M  V30 25 C 15.1083 2.1036 0.0 0
M  V30 26 C 15.6720 0.0000 0.0 0
M  V30 27 C 17.7758 0.5636 0.0 0
M  V30 28 C 21.8320 8.0021 0.0 0
M  V30 29 C 7.2020 12.0031 0.0 0 CFG=1
M  V30 30 C 6.8724 13.4504 0.0 0 CFG=2
M  V30 31 C 6.2558 12.8804 0.0 0 CFG=1
M  V30 32 C 4.3522 14.1966 0.0 0
M  V30 33 C 7.7865 14.5108 0.0 0
M  V30 34 C 5.7712 14.1277 0.0 0 CFG=1
M  V30 35 C 6.8696 15.2572 0.0 0
M  V30 36 C 10.2820 9.3358 0.0 0
M  V30 37 C 11.8220 9.3358 0.0 0
M  V30 38 C 9.5120 8.0021 0.0 0
M  V30 39 C 12.5920 8.0021 0.0 0
M  V30 40 C 10.2820 6.6684 0.0 0
M  V30 41 C 11.8220 6.6684 0.0 0
M  V30 42 C 1.8515 13.2685 0.0 0
M  V30 43 C 0.4078 12.7327 0.0 0
M  V30 44 C 1.5937 11.7502 0.0 0
M  V30 45 C 3.8210 9.6133 0.0 0
M  V30 46 C 3.9339 8.0775 0.0 0
M  V30 47 C 2.4346 10.2837 0.0 0
M  V30 48 C 2.6602 7.2118 0.0 0
M  V30 49 C 1.1609 9.4180 0.0 0
M  V30 50 C 1.2736 7.8822 0.0 0
M  V30 51 C 14.1320 8.0021 0.0 0
M  V30 52 C 14.9020 6.6684 0.0 0
M  V30 53 C 14.9020 9.3358 0.0 0
M  V30 54 C 16.4420 6.6684 0.0 0
M  V30 55 C 16.4420 9.3358 0.0 0
M  V30 56 C 17.2120 8.0021 0.0 0
M  V30 57 H 8.3668 13.0788 0.0 0
M  V30 58 H 5.2064 15.5605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 29 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 36
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 31 4 CFG=1
M  V30 8 1 5 45
M  V30 9 2 7 32
M  V30 10 1 7 42
M  V30 11 1 8 9
M  V30 12 1 8 38
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 48
M  V30 17 1 14 50
M  V30 18 1 15 53
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 54
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 22 26
M  V30 30 1 22 27
M  V30 31 1 23 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 57 CFG=3
M  V30 37 1 31 34
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 41 1 34 58 CFG=1
M  V30 42 2 36 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 40
M  V30 46 2 39 41
M  V30 47 1 39 51
M  V30 48 1 40 41
M  V30 49 1 42 43
M  V30 50 1 42 44
M  V30 51 1 43 44
M  V30 52 2 45 46
M  V30 53 1 45 47
M  V30 54 1 46 48
M  V30 55 2 47 49
M  V30 56 2 48 50
M  V30 57 1 49 50
M  V30 58 2 51 52
M  V30 59 1 51 53
M  V30 60 1 52 54
M  V30 61 2 53 55
M  V30 62 2 54 56
M  V30 63 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 29 30 31 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7693-46-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2924773-30-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2924773-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36855761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Norbornyl benzamide derivatives as RXFP1 agonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Shun; Bilder, Donna M.; Clarke, Adam James; Finlay, Heather; Friends,
Todd J.; Mathur, Arvind; Myers, Michael C.; Lawrence, R. Michael; Li,
Jianqing; Pinto, Donald J.P.; Orwat, Michael J.; Pabbisetty, Kumar
Balashanmuga; Shaw, Scott A.; Smith, Leon M., II; Tora, George O.;
Vokits, Benjamin P.; O'Malley, Daniel; Wurtz, Nicholas R.; Bhogadi,
Vikram; Pasunoori, Laxman; Srinivas, Pitani Veera Venkata; Kumar,
Sreekantha Ratna; Potturi, Hima Kiran; Hegde, Subramanya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023076626 A1 2023-05-04

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purine-9-butanol, 6-amino-8-bromo-, 9-(4-methylbenzenesulfonate)
C16H18BrN5O3S
302908-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5190 3.7827 0.0 0
M  V30 2 C 7.2890 5.1163 0.0 0
M  V30 3 C 8.8290 5.1163 0.0 0
M  V30 4 C 9.5990 6.4500 0.0 0
M  V30 5 O 11.1390 6.4500 0.0 0
M  V30 6 S 11.9090 7.7838 0.0 0 VAL=6
M  V30 7 O 12.6790 9.1174 0.0 0
M  V30 8 O 10.5752 8.5538 0.0 0
M  V30 9 N 0.0000 2.4581 0.0 0
M  V30 10 Br 4.5496 6.4933 0.0 0
M  V30 11 C 17.2437 4.7038 0.0 0
M  V30 12 C 4.0738 2.5368 0.0 0
M  V30 13 C 2.6091 3.0127 0.0 0
M  V30 14 N 4.9790 3.7827 0.0 0
M  V30 15 N 4.3939 1.0304 0.0 0
M  V30 16 N 2.6091 4.5527 0.0 0
M  V30 17 C 1.4647 1.9823 0.0 0
M  V30 18 C 4.0738 5.0286 0.0 0
M  V30 19 C 3.2496 0.0000 0.0 0
M  V30 20 N 1.7849 0.4759 0.0 0
M  V30 21 C 13.2426 7.0138 0.0 0
M  V30 22 C 13.2426 5.4738 0.0 0
M  V30 23 C 14.5763 7.7838 0.0 0
M  V30 24 C 14.5763 4.7038 0.0 0
M  V30 25 C 15.9099 7.0138 0.0 0
M  V30 26 C 15.9099 5.4738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 9 17
M  V30 11 1 10 18
M  V30 12 1 11 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,8,9,10-Tetrahydro-6-methyl-6H-[1,3]diazepino[1,2-e]purin-4-amine
C10H14N6
302908-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.5425 0.0 0
M  V30 2 C 5.8614 0.0000 0.0 0
M  V30 3 C 3.0801 4.2098 0.0 0
M  V30 4 N 4.5864 3.8897 0.0 0
M  V30 5 C 2.3101 2.8762 0.0 0
M  V30 6 N 2.3101 5.5435 0.0 0
M  V30 7 C 4.7473 2.3581 0.0 0
M  V30 8 C 5.6835 4.9705 0.0 0
M  V30 9 N 3.3405 1.7316 0.0 0
M  V30 10 C 0.7700 2.8762 0.0 0
M  V30 11 C 0.7700 5.5435 0.0 0
M  V30 12 N 6.0452 1.5289 0.0 0
M  V30 13 C 7.2124 4.7866 0.0 0
M  V30 14 N 0.0000 4.2098 0.0 0
M  V30 15 C 7.5026 2.0267 0.0 0
M  V30 16 C 8.0220 3.4765 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 302908-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302908-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5285141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of acyclic adenine 8,N-anhydronucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meszarosova, Katerina; Holy, Antonin; Masojidkova, Milena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Collection of Czechoslovak Chemical Communications (2000), 65(7),
1109-1125

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-chloro-2-[[[(Z)-[1-(4-fluorophenyl)-2-methoxyethylidene...
C20H20ClFN2O5
3036384-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1601 0.0 0
M  V30 2 C 5.3348 6.9301 0.0 0
M  V30 3 N 2.6675 6.9301 0.0 0
M  V30 4 O 5.3348 8.4701 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 O 1.3338 6.1601 0.0 0
M  V30 7 C 6.6686 9.2401 0.0 0
M  V30 8 C 0.0000 6.9301 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 3.8500 0.0 0
M  V30 11 N 9.3359 4.6201 0.0 0
M  V30 12 C 10.6697 3.8500 0.0 0
M  V30 13 C 10.6697 2.3100 0.0 0
M  V30 14 O 12.0034 1.5400 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 Cl 6.6686 1.5400 0.0 0
M  V30 17 F 16.0045 6.9301 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 2.6675 3.8500 0.0 0
M  V30 21 C 5.3348 2.3100 0.0 0
M  V30 22 C 2.6675 2.3100 0.0 0
M  V30 23 C 4.0011 1.5400 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 13.3370 3.8500 0.0 0
M  V30 26 C 12.0034 6.1601 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 13.3370 6.9301 0.0 0
M  V30 29 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 16 21
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 3-chloro-2-[[[(Z)-[1-(4-fluorophenyl)-2-methoxyethylidene]a...
C20H21ClFN3O4
3036385-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1601 0.0 0
M  V30 2 C 5.3348 6.9301 0.0 0
M  V30 3 N 2.6675 6.9301 0.0 0
M  V30 4 N 5.3348 8.4701 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 O 1.3338 6.1601 0.0 0
M  V30 7 C 6.6686 9.2401 0.0 0
M  V30 8 C 0.0000 6.9301 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 3.8500 0.0 0
M  V30 11 N 9.3359 4.6201 0.0 0
M  V30 12 C 10.6697 3.8500 0.0 0
M  V30 13 C 10.6697 2.3100 0.0 0
M  V30 14 O 12.0034 1.5400 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 Cl 6.6686 1.5400 0.0 0
M  V30 17 F 16.0045 6.9301 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 2.6675 3.8500 0.0 0
M  V30 21 C 5.3348 2.3100 0.0 0
M  V30 22 C 2.6675 2.3100 0.0 0
M  V30 23 C 4.0011 1.5400 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 13.3370 3.8500 0.0 0
M  V30 26 C 12.0034 6.1601 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 13.3370 6.9301 0.0 0
M  V30 29 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 16 21
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036384-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036385-00-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40779235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and use of strobilurin-type compounds for combating
phytopathogenic fungi containing an amino acid substitution F129L in the
mitochondrial cytochrome b protein conferring resistance to Qo inhibitors
XV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Chandan; Das, Saikat; Dietz, Jochen; Ludwig, Lydia; Khanna, Smriti;
Kulkarni, Sarang; Fehr, Marcus; Koch, Andreas; Le Vezouet, Ronan; Rath,
Rakesh; Grammenos, Wassilios; Siepe, Isabella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024088792 A1 2024-05-02

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-chloro-2-[[[(Z)-[1-(4-fluorophenyl)-2-methoxyethylidene...
C20H20ClFN2O5
3036384-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1601 0.0 0
M  V30 2 C 5.3348 6.9301 0.0 0
M  V30 3 N 2.6675 6.9301 0.0 0
M  V30 4 O 5.3348 8.4701 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 O 1.3338 6.1601 0.0 0
M  V30 7 C 6.6686 9.2401 0.0 0
M  V30 8 C 0.0000 6.9301 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 3.8500 0.0 0
M  V30 11 N 9.3359 4.6201 0.0 0
M  V30 12 C 10.6697 3.8500 0.0 0
M  V30 13 C 10.6697 2.3100 0.0 0
M  V30 14 O 12.0034 1.5400 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 Cl 6.6686 1.5400 0.0 0
M  V30 17 F 16.0045 6.9301 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 2.6675 3.8500 0.0 0
M  V30 21 C 5.3348 2.3100 0.0 0
M  V30 22 C 2.6675 2.3100 0.0 0
M  V30 23 C 4.0011 1.5400 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 13.3370 3.8500 0.0 0
M  V30 26 C 12.0034 6.1601 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 13.3370 6.9301 0.0 0
M  V30 29 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 16 21
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 3-chloro-2-[[[(Z)-[1-(4-fluorophenyl)-2-methoxyethylidene]a...
C20H21ClFN3O4
3036385-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1601 0.0 0
M  V30 2 C 5.3348 6.9301 0.0 0
M  V30 3 N 2.6675 6.9301 0.0 0
M  V30 4 N 5.3348 8.4701 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 O 1.3338 6.1601 0.0 0
M  V30 7 C 6.6686 9.2401 0.0 0
M  V30 8 C 0.0000 6.9301 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0022 3.8500 0.0 0
M  V30 11 N 9.3359 4.6201 0.0 0
M  V30 12 C 10.6697 3.8500 0.0 0
M  V30 13 C 10.6697 2.3100 0.0 0
M  V30 14 O 12.0034 1.5400 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 Cl 6.6686 1.5400 0.0 0
M  V30 17 F 16.0045 6.9301 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 3.8500 0.0 0
M  V30 20 C 2.6675 3.8500 0.0 0
M  V30 21 C 5.3348 2.3100 0.0 0
M  V30 22 C 2.6675 2.3100 0.0 0
M  V30 23 C 4.0011 1.5400 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 13.3370 3.8500 0.0 0
M  V30 26 C 12.0034 6.1601 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 13.3370 6.9301 0.0 0
M  V30 29 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 16 21
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036384-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036385-00-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40803662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and use of strobilurin-type compounds for combating
phytopathogenic fungi containing an amino acid substitution F129L in the
mitochondrial cytochrome b protein conferring resistance to Qo inhibitors
XV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Chandan; Das, Saikat; Dietz, Jochen; Ludwig, Lydia; Khanna, Smriti;
Kulkarni, Sarang; Fehr, Marcus; Koch, Andreas; Le Vezouet, Ronan; Rath,
Rakesh; Grammenos, Wassilios; Siepe, Isabella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4361126 A1 2024-05-01

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3R)-2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-1H-pyrido[3,4-b]indole-...
C20H20N2O3
303984-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 O 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=1
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=2
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 7.5823 8.4701 0.0 0
M  V30 22 C 8.9160 6.1601 0.0 0
M  V30 23 C 8.9160 9.2401 0.0 0
M  V30 24 C 10.2498 6.9301 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3R)-2,3,4,9-Tetrahydro-1-(4-methoxyphenyl)-N-methyl-1H-pyrido[3,4-b]indol...
C20H21N3O2
2254177-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 N 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=1
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=2
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 8.9160 6.1601 0.0 0
M  V30 22 C 7.5823 8.4701 0.0 0
M  V30 23 C 10.2498 6.9301 0.0 0
M  V30 24 C 8.9160 9.2401 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 303984-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254177-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19425561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of all stereoisomers of
1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Onda, Momoko; Higashida, Ayaka; Hirano, Takako; Nishio, Toshiyuki;
Hakamata, Wataru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molbank (2018), (1), M973/1-M973/6

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-4-carboxaldehyde, 1-(3-chloro-2-pyridinyl)-5-(trifluoromethyl)-
C10H5ClF3N3O
3040200-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 1.4647 0.0 0
M  V30 2 F 3.5847 1.9406 0.0 0
M  V30 3 F 4.5733 0.0000 0.0 0
M  V30 4 F 6.5139 0.9887 0.0 0
M  V30 5 C 8.2358 2.5000 0.0 0
M  V30 6 O 9.6426 3.1264 0.0 0
M  V30 7 Cl 3.0800 6.8425 0.0 0
M  V30 8 C 5.5252 2.9292 0.0 0
M  V30 9 N 4.6200 4.1751 0.0 0
M  V30 10 C 6.9898 3.4051 0.0 0
M  V30 11 N 5.5252 5.4211 0.0 0
M  V30 12 C 6.9898 4.9451 0.0 0
M  V30 13 C 3.0800 4.1751 0.0 0
M  V30 14 C 2.3100 5.5089 0.0 0
M  V30 15 N 2.3100 2.8415 0.0 0
M  V30 16 C 0.7700 5.5089 0.0 0
M  V30 17 C 0.7700 2.8415 0.0 0
M  V30 18 C 0.0000 4.1751 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 9 13
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-4-methanamine, 1-(3-chloro-2-pyridinyl)-N-methyl-5-(trifluorometh...
C11H10ClF3N4
3040200-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 1.4647 0.0 0
M  V30 2 F 3.5847 1.9406 0.0 0
M  V30 3 F 4.5733 0.0000 0.0 0
M  V30 4 F 6.5139 0.9887 0.0 0
M  V30 5 C 8.2356 2.5000 0.0 0
M  V30 6 N 9.6426 3.1264 0.0 0
M  V30 7 C 10.8884 2.2211 0.0 0
M  V30 8 Cl 3.0800 6.8425 0.0 0
M  V30 9 C 5.5252 2.9292 0.0 0
M  V30 10 N 4.6200 4.1751 0.0 0
M  V30 11 C 6.9898 3.4051 0.0 0
M  V30 12 N 5.5252 5.4211 0.0 0
M  V30 13 C 6.9898 4.9451 0.0 0
M  V30 14 C 3.0800 4.1751 0.0 0
M  V30 15 C 2.3100 5.5089 0.0 0
M  V30 16 N 2.3100 2.8415 0.0 0
M  V30 17 C 0.7700 5.5089 0.0 0
M  V30 18 C 0.7700 2.8415 0.0 0
M  V30 19 C 0.0000 4.1751 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 10 14
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3040200-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxylic acid, 3-(4-bromophenyl)-2,2-difluoro-1-methyl-, (1R,3S...
C11H9BrF2O2
3047245-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0433 1.1797 0.0 0
M  V30 2 O 1.0534 0.0000 0.0 0
M  V30 3 O 3.5599 0.9123 0.0 0
M  V30 4 C 0.0000 2.3595 0.0 0
M  V30 5 F 0.0000 4.4343 0.0 0
M  V30 6 F 2.0433 5.6140 0.0 0
M  V30 7 Br 9.0104 3.3968 0.0 0
M  V30 8 C 2.8503 3.3968 0.0 0 CFG=1
M  V30 9 C 1.5166 2.6268 0.0 0 CFG=1
M  V30 10 C 1.5166 4.1668 0.0 0
M  V30 11 C 4.3903 3.3968 0.0 0
M  V30 12 C 5.1603 4.7305 0.0 0
M  V30 13 C 5.1603 2.0632 0.0 0
M  V30 14 C 6.7003 4.7305 0.0 0
M  V30 15 C 6.7003 2.0632 0.0 0
M  V30 16 C 7.4704 3.3968 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 9 4 CFG=3
M  V30 5 1 5 10
M  V30 6 1 6 10
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxamide, 3-(4-bromophenyl)-2,2-difluoro-N,1-dimethyl-, (1R,3S...
C12H12BrF2NO
3047245-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0433 2.6269 0.0 0
M  V30 2 N 1.0534 1.4471 0.0 0
M  V30 3 O 3.5599 2.3594 0.0 0
M  V30 4 C 1.5800 0.0000 0.0 0
M  V30 5 C 0.0000 3.8066 0.0 0
M  V30 6 F 0.0000 5.8814 0.0 0
M  V30 7 F 2.0433 7.0612 0.0 0
M  V30 8 Br 9.0102 4.8441 0.0 0
M  V30 9 C 1.5166 4.0741 0.0 0 CFG=1
M  V30 10 C 2.8502 4.8441 0.0 0 CFG=1
M  V30 11 C 1.5166 5.6141 0.0 0
M  V30 12 C 4.3902 4.8441 0.0 0
M  V30 13 C 5.1602 6.1777 0.0 0
M  V30 14 C 5.1602 3.5103 0.0 0
M  V30 15 C 6.7002 6.1777 0.0 0
M  V30 16 C 6.7002 3.5103 0.0 0
M  V30 17 C 7.4702 4.8441 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 9 5 CFG=3
M  V30 6 1 6 11
M  V30 7 1 7 11
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3047245-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047245-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41893433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolopyridine derivatives as MALT1 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mowat, Jeffrey Stuart; Thuring, Johannes Wilhelmus J.; Hulpia, Fabian;
Lepri, Susan; Peschiulli, Aldo; Van Roosbroeck, Yves Emiel Maria; Velter,
Adriana-Ingrid; Muuronen, Mikko Juhani Artturi; Wroblowski, Berthold;
Renders, Evelien; Tona, Veronica
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024133859 A1 2024-06-27

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
2-Azidobenzoic acid
C7H5N3O2
31162-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0 CHG=1 VAL=4
M  V30 6 N 7.7000 4.0011 0.0 0 CHG=-1
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-N-methylbenzamide
C8H8N4O
32709-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0 CHG=1 VAL=4
M  V30 3 N 8.4700 4.0011 0.0 0 CHG=-1
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 O 3.0800 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 31162-13-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32709-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36891559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent cyclization of 2-(5-iodo-1,2,3-triazolyl)benzamides toward
triazole-fused lactams and cyclic imidates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotovshchikov, Yury N.; Tatevosyan, Stepan S.; Latyshev, Gennadij V.;
Kugusheva, Zoya R.; Lukashev, Nikolay V.; Beletskaya, Irina P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2023), 47(26), 12239-12247

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Fluoro-4-[4-(2-fluoro-5-nitrobenzoyl)-1-piperazinyl]phenyl]ethanone
C19H17F2N3O4
330636-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.6697 6.1601 0.0 0
M  V30 2 C 4.0010 6.9302 0.0 0
M  V30 3 O 4.0010 8.4702 0.0 0
M  V30 4 C 13.3370 1.5400 0.0 0
M  V30 5 C 13.3370 0.0000 0.0 0
M  V30 6 O 14.6707 2.3101 0.0 0
M  V30 7 F 1.3337 8.4702 0.0 0
M  V30 8 N 1.3337 2.3101 0.0 0 VAL=5
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 2.6673 1.5400 0.0 0
M  V30 11 N 8.0022 4.6201 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 N 5.3348 6.1601 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 9.3358 2.3101 0.0 0
M  V30 20 C 12.0033 3.8501 0.0 0
M  V30 21 C 10.6697 1.5400 0.0 0
M  V30 22 C 12.0033 2.3101 0.0 0
M  V30 23 C 2.6673 6.1601 0.0 0
M  V30 24 C 2.6673 4.6201 0.0 0
M  V30 25 C 1.3337 6.9302 0.0 0
M  V30 26 C 1.3337 3.8501 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 2 2 3
M  V30 3 1 2 16
M  V30 4 1 2 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 7 25
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Fluoro-4-[4-[2-(methylamino)-5-nitrobenzoyl]-1-piperazinyl]phenyl]ethanone
C20H21FN4O4
847968-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0
M  V30 2 O 3.8500 8.0021 0.0 0
M  V30 3 N 1.5400 6.6684 0.0 0
M  V30 4 C 0.0000 6.6684 0.0 0
M  V30 5 N 4.6200 1.3336 0.0 0 VAL=5
M  V30 6 O 6.1600 1.3336 0.0 0
M  V30 7 O 3.8500 0.0000 0.0 0
M  V30 8 F 10.7800 9.3358 0.0 0
M  V30 9 C 15.4000 6.6684 0.0 0
M  V30 10 C 16.1700 8.0021 0.0 0
M  V30 11 O 16.1700 5.3347 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 N 6.1600 6.6684 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 8.4700 8.0021 0.0 0
M  V30 22 C 8.4700 5.3347 0.0 0
M  V30 23 N 9.2400 6.6684 0.0 0
M  V30 24 C 10.7800 6.6684 0.0 0
M  V30 25 C 11.5500 8.0021 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 13.0900 8.0021 0.0 0
M  V30 28 C 13.0900 5.3347 0.0 0
M  V30 29 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 29
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330636-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847968-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6370547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of benzoylpiperazines as a novel class of potent and selective
GlyT1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pinard, Emmanuel; Alberati, Daniela; Borroni, Edilio; Fischer, Holger;
Hainzl, Dominik; Jolidon, Synese; Moreau, Jean-Luc; Narquizian, Robert;
Nettekoven, Matthias; Norcross, Roger D.; Stalder, Henri; Thomas, Andrew
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(18), 5134-5139

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dichlorophenyl)-1-(methylsulfonyl)-N-[3-(4-oxo-1-piperidinyl)propyl]-4...
C21H29Cl2N3O4S
333993-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9538 5.3348 0.0 0
M  V30 2 C 4.4137 5.3348 0.0 0
M  V30 3 C 6.7238 6.6685 0.0 0
M  V30 4 O 3.6437 4.0012 0.0 0
M  V30 5 C 8.2638 6.6685 0.0 0
M  V30 6 C 9.0338 8.0022 0.0 0
M  V30 7 Cl 5.9538 0.0000 0.0 0
M  V30 8 Cl 9.0338 0.0000 0.0 0
M  V30 9 S 1.3337 10.6697 0.0 0 VAL=6
M  V30 10 C 0.5637 12.0033 0.0 0
M  V30 11 O 0.0000 9.8996 0.0 0
M  V30 12 O 2.6673 11.4397 0.0 0
M  V30 13 O 15.1940 8.0022 0.0 0
M  V30 14 C 6.7238 4.0012 0.0 0
M  V30 15 C 5.9538 2.6673 0.0 0
M  V30 16 C 8.2638 4.0012 0.0 0
M  V30 17 C 6.7238 1.3337 0.0 0
M  V30 18 C 9.0338 2.6673 0.0 0
M  V30 19 C 8.2638 1.3337 0.0 0
M  V30 20 C 3.6437 6.6685 0.0 0
M  V30 21 C 2.1037 6.6685 0.0 0
M  V30 22 C 4.4137 8.0022 0.0 0
M  V30 23 C 1.3337 8.0022 0.0 0
M  V30 24 C 3.6437 9.3360 0.0 0
M  V30 25 N 2.1037 9.3360 0.0 0
M  V30 26 N 10.5739 8.0022 0.0 0
M  V30 27 C 11.3439 9.3360 0.0 0
M  V30 28 C 11.3439 6.6685 0.0 0
M  V30 29 C 12.8839 9.3360 0.0 0
M  V30 30 C 12.8839 6.6685 0.0 0
M  V30 31 C 13.6539 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 20
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 26
M  V30 9 1 7 17
M  V30 10 1 8 19
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 9 12
M  V30 14 1 9 25
M  V30 15 2 13 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dichlorophenyl)-N-[3-[4-(methylamino)-1-piperidinyl]propyl]-1-(methyls...
C22H34Cl2N4O3S
333993-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9537 5.3348 0.0 0
M  V30 2 C 4.4137 5.3348 0.0 0
M  V30 3 C 6.7237 6.6684 0.0 0
M  V30 4 O 3.6437 4.0011 0.0 0
M  V30 5 C 8.2637 6.6684 0.0 0
M  V30 6 C 9.0337 8.0021 0.0 0
M  V30 7 Cl 5.9537 0.0000 0.0 0
M  V30 8 Cl 9.0337 0.0000 0.0 0
M  V30 9 S 1.3337 10.6695 0.0 0 VAL=6
M  V30 10 C 0.5636 12.0032 0.0 0
M  V30 11 O 2.6673 11.4396 0.0 0
M  V30 12 O 0.0000 9.8995 0.0 0
M  V30 13 N 15.1938 8.0021 0.0 0
M  V30 14 C 15.9638 9.3359 0.0 0
M  V30 15 C 6.7237 4.0011 0.0 0
M  V30 16 C 5.9537 2.6673 0.0 0
M  V30 17 C 8.2637 4.0011 0.0 0
M  V30 18 C 6.7237 1.3337 0.0 0
M  V30 19 C 9.0337 2.6673 0.0 0
M  V30 20 C 8.2637 1.3337 0.0 0
M  V30 21 C 3.6437 6.6684 0.0 0
M  V30 22 C 2.1037 6.6684 0.0 0
M  V30 23 C 4.4137 8.0021 0.0 0
M  V30 24 C 1.3337 8.0021 0.0 0
M  V30 25 C 3.6437 9.3359 0.0 0
M  V30 26 N 2.1037 9.3359 0.0 0
M  V30 27 N 10.5738 8.0021 0.0 0
M  V30 28 C 11.3438 9.3359 0.0 0
M  V30 29 C 11.3438 6.6684 0.0 0
M  V30 30 C 12.8838 9.3359 0.0 0
M  V30 31 C 12.8838 6.6684 0.0 0
M  V30 32 C 13.6538 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 27
M  V30 9 1 7 18
M  V30 10 1 8 20
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 9 12
M  V30 14 1 9 26
M  V30 15 1 13 14
M  V30 16 1 13 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333993-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333993-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6090359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Acetyl-N-(3,4-dichlorophenyl)-N-{3-[4-(methylamino)-1-piperidinyl]propyl}-4-piperidinecarboxamide
To a solution of the compound obtained in Example 208 (454mg, 1.00mmol)
in 1,2-dicholoroethane (10mL) were added a solution of 2.0M-methylamine
in THF (2.0mL, 4.0mmol), acetic acid (0.057mL, 1.0mmol), sodium
triacetoxyborohydridesodium triacetoxyborohydride (424mg, 2.00mmol),
successively, and the mixture was stirred at room temperature for 1.5
hours. To the mixture was added aqueous solution of 1N-sodium hydroxide
(15mL), and the mixture was stirred at room temperature for 30 minutes
and extracted with dichloromethane (15mL, 10mLx2). The organic layer was
dried over anhydrous sodium sulfate and concentrated under reduced
pressure to give the titled compound. (466mg, 0.99mmol, Yield 99%) as a
colorless oily substance.
N-(3,4-Dichlorophenyl)-N-{3-[4-(methylamino)-1-piperidinyl]propyl}-1-(methylsulfonyl)-4-piperidinecarboxamide
The title compound was prepared using a similar procedure to that
described for example 196 from the title compound of example 322, yield
97%. 1H NMR (CDCl3) δ 1.45-2.05 (12H, m), 2.1-2.4 (3H, m), 2.45-2.95 (5H,
m), 2.51 (3H, s), 2.74 (3H, s), 3.6-3.8 (4H, m), 4.2 (1H, br), 7.06 (1H,
dd, J=2.5, 8.4Hz), 7.32 (1H, d, J=2.5Hz), 7.54 (1H, d, J=8.4Hz)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl-N-(heterocyclylalkyl)piperidinecarboxamides as CCR5
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imamura, Shinichi; Baba, Masanori; Sugihara, Yoshihiro; Kanzaki, Naoyuki;
Nishimura, Osamu; Hattori, Taeko; Hashiguchi, Shohei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2608807 A1 2001-04-12

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 10-fluoro-4-methoxybenzo[a]phenazine-11-carboxylate
C19H13FN2O3
346690-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0033 4.6201 0.0 0
M  V30 2 C 13.3370 3.8501 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 1.5400 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 N 5.3348 3.8501 0.0 0
M  V30 12 C 9.3360 4.6201 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 N 5.3348 6.9302 0.0 0
M  V30 15 C 8.0022 6.9302 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 9.3360 1.5400 0.0 0
M  V30 20 C 4.0010 6.1601 0.0 0
M  V30 21 C 2.6673 3.8501 0.0 0
M  V30 22 C 10.6697 2.3101 0.0 0
M  V30 23 C 2.6673 6.9302 0.0 0
M  V30 24 C 1.3337 4.6201 0.0 0
M  V30 25 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 2 13 19
M  V30 19 2 14 20
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 2 17 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-methoxy-10-(methylamino)benzo[a]phenazine-11-carboxylate
C20H17N3O3
346690-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 N 1.3337 3.8501 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 O 13.3370 4.6201 0.0 0
M  V30 8 C 14.6707 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 N 6.6685 3.8501 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 N 6.6685 6.9302 0.0 0
M  V30 15 C 4.0010 6.9302 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3358 3.8501 0.0 0
M  V30 20 C 9.3358 6.9302 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 9.3358 2.3101 0.0 0
M  V30 23 C 10.6697 6.1601 0.0 0
M  V30 24 C 12.0033 3.8501 0.0 0
M  V30 25 C 10.6697 1.5400 0.0 0
M  V30 26 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 26 1 21 24
M  V30 27 2 22 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 346690-83-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346690-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14179843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The 10-fluoro-4-methoxybenzo[a]phenazine-11-carboxylic acid methyl ester
(0.1 g, 0.29 mmol) was dissolved in a 2 M solution of methylamine in
tetrahydrofuran (5 mL). The reaction was stirred for 15 h at room
temperature. The solvent and methylamine were removed in vacuo to give
the crude product obtained (0.10 g, 97%).
4-Methoxy-10-methylamino-benzo[a]phenazine-11-carboxylic Acid Methyl
Ester, Yield (0.10 g, 97%). 1H NMR (CDCl3) δ 4.05 (s, 3H), 4.18 (s, 3H),
7.18 (d, 1H), 7.50 (d, 1H), 7.70 (t, 1H), 7.87 (d, 1H), 8.18 (d, 1H),
8.36 (br. s, 1H), 8.40 (d, 1H), 8.95 (d, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Angular Benzophenazines: Dual Topoisomerase I and Topoisomerase II
Inhibitors as Potential Anticancer Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vicker, Nigel; Burgess, Luke; Chuckowree, Irina S.; Dodd, Rory; Folkes,
Adrian J.; Hardick, David J.; Hancox, Timothy C.; Miller, Warren; Milton,
John; Sohal, Sukhjit; Wang, Shouming; Wren, Stephen P.; Charlton, Peter
A.; Dangerfield, Wendy; Liddle, Chris; Mistry, Prakash; Stewart, Alistair
J.; Denny, William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(3), 721-739

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,4S)-3-[3-(cyclopentyloxy)-4-methoxyphenyl]-4-[(1R)-1-hydroxyethyl]...
C22H31NO6
347845-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5016 8.4543 0.0 0 CFG=2
M  V30 2 C 5.1680 7.6843 0.0 0
M  V30 3 O 6.5016 9.9943 0.0 0
M  V30 4 C 8.4616 9.0911 0.0 0
M  V30 5 C 10.5458 4.7632 0.0 0
M  V30 6 C 11.9526 5.3896 0.0 0
M  V30 7 O 10.3847 3.2317 0.0 0
M  V30 8 O 13.1985 4.4843 0.0 0
M  V30 9 O 12.1135 6.9211 0.0 0
M  V30 10 C 14.6054 5.1108 0.0 0
M  V30 11 O 2.3100 3.7710 0.0 0
M  V30 12 O 0.7700 6.4385 0.0 0
M  V30 13 C 0.0000 7.7721 0.0 0
M  V30 14 C 6.9300 6.4385 0.0 0 CFG=2
M  V30 15 C 7.8353 7.6843 0.0 0 CFG=2
M  V30 16 C 7.8353 5.1926 0.0 0
M  V30 17 C 9.3000 7.2085 0.0 0
M  V30 18 N 9.3000 5.6685 0.0 0
M  V30 19 C 5.3900 6.4385 0.0 0
M  V30 20 C 4.6200 5.1047 0.0 0
M  V30 21 C 4.6200 7.7721 0.0 0
M  V30 22 C 3.0800 5.1047 0.0 0
M  V30 23 C 3.0800 7.7721 0.0 0
M  V30 24 C 2.3100 6.4385 0.0 0
M  V30 25 C 3.0800 2.4374 0.0 0
M  V30 26 C 2.4537 1.0304 0.0 0
M  V30 27 C 4.6116 2.2764 0.0 0
M  V30 28 C 3.5981 0.0000 0.0 0
M  V30 29 C 4.9319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 15 4 CFG=1
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,4S)-3-[3-(Cyclopentyloxy)-4-methoxyphenyl]-4-[(1R)-1-hydroxyethyl]-N,4-di...
C22H32N2O5
347845-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5016 8.4543 0.0 0 CFG=2
M  V30 2 C 5.1680 7.6843 0.0 0
M  V30 3 O 6.5016 9.9943 0.0 0
M  V30 4 C 8.4616 9.0911 0.0 0
M  V30 5 C 10.5458 4.7632 0.0 0
M  V30 6 C 11.9526 5.3896 0.0 0
M  V30 7 O 10.3847 3.2317 0.0 0
M  V30 8 N 13.1985 4.4843 0.0 0
M  V30 9 O 12.1135 6.9211 0.0 0
M  V30 10 C 14.6054 5.1108 0.0 0
M  V30 11 O 2.3100 3.7710 0.0 0
M  V30 12 O 0.7700 6.4385 0.0 0
M  V30 13 C 0.0000 7.7721 0.0 0
M  V30 14 C 6.9300 6.4385 0.0 0 CFG=2
M  V30 15 C 7.8353 7.6843 0.0 0 CFG=2
M  V30 16 C 7.8353 5.1926 0.0 0
M  V30 17 C 9.3000 7.2085 0.0 0
M  V30 18 N 9.3000 5.6685 0.0 0
M  V30 19 C 5.3900 6.4385 0.0 0
M  V30 20 C 4.6200 5.1047 0.0 0
M  V30 21 C 4.6200 7.7721 0.0 0
M  V30 22 C 3.0800 5.1047 0.0 0
M  V30 23 C 3.0800 7.7721 0.0 0
M  V30 24 C 2.3100 6.4385 0.0 0
M  V30 25 C 3.0800 2.4374 0.0 0
M  V30 26 C 4.6116 2.2764 0.0 0
M  V30 27 C 2.4537 1.0304 0.0 0
M  V30 28 C 4.9319 0.7700 0.0 0
M  V30 29 C 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 15 4 CFG=1
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347845-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 347845-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1911638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[3-((1R)-1-Hydroxyethyl)(3S,4S)-4-(3-cyclopentyloxy-4-methoxyphenyl)-3-methylpyrrolidinyl]-N-methyl-2-oxoacetamide
Example 72 (17.3 mg, 0.0427 mmol) was dissolved in THF (0.8 mL).
Methylamine (40% in water, 0.5 mL) was added, and the apparatus was
sealed and stirred for 1 hour at room temperature. TLC (3:1
EtOAc:hexanes) showed complete consumption of starting material. The
reaction was diluted with EtOAc (20 mL), and the organic layers were
washed with brine (2×15 mL). The organic layer was dried over Na2SO4 and
concentrated in vacuo. A clear, colorless oil (16.9 mg, 97%). 1H NMR (400
MHz, CDCl3) δ: 7.59 (br s, 1H), 6.80-6.79 (m, 3H), 4.75-4.73 (m, 1H),
4.47-3.46 (c, 10H), 2.89-2.87 (dd, 3H), 1.91-1.57 (m, 8H), 1.18-1.16 (dd,
3H), 0.76-0.73 (d, 3H). LRMS (Electrospray, positive): Da/e 405.1 (m+1).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed apparatus
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylpyrrolidines as inhibitors of cyclic AMP-specific
phosphodiesterase and as inhibitors of tumor necrosis factor release.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martins, Timothy J.; Fowler, Kerry W.; Odingo, Joshua; Kesicki, Edward
A.; Oliver, Amy; Burgess, Laurence E.; Gaudino, John J.; Jones, Zachary
S.; Newhouse, Bradley J.; Schlachter, Stephen T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6423710 B1 2002-07-23

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,4S)-3-[3-(cyclopentyloxy)-4-methoxyphenyl]-4-[(1R)-1-hydroxyethyl]...
C22H31NO6
347845-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5016 8.4543 0.0 0 CFG=2
M  V30 2 C 5.1680 7.6843 0.0 0
M  V30 3 O 6.5016 9.9943 0.0 0
M  V30 4 C 8.4616 9.0911 0.0 0
M  V30 5 C 10.5458 4.7632 0.0 0
M  V30 6 C 11.9526 5.3896 0.0 0
M  V30 7 O 10.3847 3.2317 0.0 0
M  V30 8 O 13.1985 4.4843 0.0 0
M  V30 9 O 12.1135 6.9211 0.0 0
M  V30 10 C 14.6054 5.1108 0.0 0
M  V30 11 O 2.3100 3.7710 0.0 0
M  V30 12 O 0.7700 6.4385 0.0 0
M  V30 13 C 0.0000 7.7721 0.0 0
M  V30 14 C 6.9300 6.4385 0.0 0 CFG=2
M  V30 15 C 7.8353 7.6843 0.0 0 CFG=2
M  V30 16 C 7.8353 5.1926 0.0 0
M  V30 17 C 9.3000 7.2085 0.0 0
M  V30 18 N 9.3000 5.6685 0.0 0
M  V30 19 C 5.3900 6.4385 0.0 0
M  V30 20 C 4.6200 5.1047 0.0 0
M  V30 21 C 4.6200 7.7721 0.0 0
M  V30 22 C 3.0800 5.1047 0.0 0
M  V30 23 C 3.0800 7.7721 0.0 0
M  V30 24 C 2.3100 6.4385 0.0 0
M  V30 25 C 3.0800 2.4374 0.0 0
M  V30 26 C 2.4537 1.0304 0.0 0
M  V30 27 C 4.6116 2.2764 0.0 0
M  V30 28 C 3.5981 0.0000 0.0 0
M  V30 29 C 4.9319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 15 4 CFG=1
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,4S)-3-[3-(Cyclopentyloxy)-4-methoxyphenyl]-4-[(1R)-1-hydroxyethyl]-N,4-di...
C22H32N2O5
347845-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5016 8.4543 0.0 0 CFG=2
M  V30 2 C 5.1680 7.6843 0.0 0
M  V30 3 O 6.5016 9.9943 0.0 0
M  V30 4 C 8.4616 9.0911 0.0 0
M  V30 5 C 10.5458 4.7632 0.0 0
M  V30 6 C 11.9526 5.3896 0.0 0
M  V30 7 O 10.3847 3.2317 0.0 0
M  V30 8 N 13.1985 4.4843 0.0 0
M  V30 9 O 12.1135 6.9211 0.0 0
M  V30 10 C 14.6054 5.1108 0.0 0
M  V30 11 O 2.3100 3.7710 0.0 0
M  V30 12 O 0.7700 6.4385 0.0 0
M  V30 13 C 0.0000 7.7721 0.0 0
M  V30 14 C 6.9300 6.4385 0.0 0 CFG=2
M  V30 15 C 7.8353 7.6843 0.0 0 CFG=2
M  V30 16 C 7.8353 5.1926 0.0 0
M  V30 17 C 9.3000 7.2085 0.0 0
M  V30 18 N 9.3000 5.6685 0.0 0
M  V30 19 C 5.3900 6.4385 0.0 0
M  V30 20 C 4.6200 5.1047 0.0 0
M  V30 21 C 4.6200 7.7721 0.0 0
M  V30 22 C 3.0800 5.1047 0.0 0
M  V30 23 C 3.0800 7.7721 0.0 0
M  V30 24 C 2.3100 6.4385 0.0 0
M  V30 25 C 3.0800 2.4374 0.0 0
M  V30 26 C 4.6116 2.2764 0.0 0
M  V30 27 C 2.4537 1.0304 0.0 0
M  V30 28 C 4.9319 0.7700 0.0 0
M  V30 29 C 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 15 4 CFG=1
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347845-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 347845-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11753296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[3-((1R)-1-Hydroxyethyl)(3S,4S)-4-(3-cyclopentyloxy-4-methoxyphenyl)-3-methylpyrrolidinyl]-N-methy2-oxoacetaiiiide
Example 72 (17.3 mg, 0.0427 mmol} was dissolved in THF (0.8 mL).
Methylamine (40% in water, 0.5 mL) was added, and the apparatus was
sealed and stirred for 1 hour at room temperature. TLC (3:1
EtOAc:hexanes) showed complete consumption of starting material. The
reaction was diluted with EtOAc (20 .mL), and the organic layers were
washed with brine (2 x 15 mL). The organic layer was dried over Na2SO4
and concentrated in vacuo. Colorless oil, yield (16.9 mg, 97%). 1H NMR
(400 MHz, CDCl3) δ: 7.59 (br s, 1H) , 6.80- 6.79 (m, 3H) , 4.75-4.73 (m,
1H) , 4.47-3.46 (c, 10H) , 2.89-2.37 (dd, 3H), 1.91-1.57 (m, 8H),
1.18-1.16 (dd, 3H) , 0:76-0.73 (d, 3H) . LRMS (Electrospray, positive):
Da/e 405.1 (m+1).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed apparatus
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolidine derivatives as cyclic AMP-specific
phosphodiesterase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martins, Timothy J.; Fowler, Kerry W.; Odingo, Joshua; Kesicki, Edward
A.; Oliver, Amy; Burgess, Laurence E.; Gaudino, John J.; Jones, Zachary
S.; Newhouse, Bradley J.; Schlachter, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001047905 A1 2001-07-05

$RFMT $RIREG SCHEME273 STEP1
$RXN



  3  1
$MOL
Sodium thiocyanate
CHNS.Na
540-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 0.0000 1.5400 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 Na 1.5400 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chlorophenyl)benzenecarboximidoyl chloride
C13H9Cl2N
34918-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 4.0012 4.6201 0.0 0
M  V30 4 Cl 10.6697 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 8.0023 5.3901 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chlorophenyl)-N′-[(methylamino)thioxomethyl]benzenecarboximidamide
C15H14ClN3S
666175-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 5.3347 0.0 0
M  V30 5 N 9.2400 5.3347 0.0 0
M  V30 6 S 6.9300 6.6685 0.0 0
M  V30 7 C 10.0100 6.6685 0.0 0
M  V30 8 Cl 0.0000 8.0021 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 540-72-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34918-77-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 666175-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30702053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of the
Thioureas.12 The appropriate benzimidoyl chloride was dissolved in
acetone p.a. (1 mmol/3 mL). At -15 °C, a solution of NaSCN (1.1 equiv) in
acetone (1 mmol/2 mL) was added dropwise. The mixture was stirred on the
cooling bath until 0 °C was reached. The precipitate (NaCl) was removed
by filtration over a glass filter with Hyflo. The filtrate was stirred on
an ice bath, and appropriate amine (1.1 equiv) was added. After it was
stirred to room temperature, the solvent was removed by evaporation and
the residue was triturated with a diethyl ether/n-pentane (usually 1:4)
mixture, collected on a glass filter, washed once more, and dried in
vacuo to give the thiourea. This product was then used in the next step
without further purification.
1-[(3-Chlorophenylimino)phenylmethyl]-3-methyl-thiourea (5h). Scale: 4.2
mmol. Yield: 1.25 g (97%). 1H NMR (CDCl3): δ 3.26 (d, 3H, J = 4.4 Hz,
NCH3); 6.50 (d, 1H, J = 7.3 Hz, arom); 6.76 (s, 1H, arom); 7.00 (m, 2H,
arom); 7.29 (m, 5H, arom); 8.08 (s, 1H, NH); 11.63 (broad s, 1H, NH). 13C
NMR (CDCl3): δ 31.9, 120.4, 122.4, 123.5, 127.8, 128.6, 129.5, 130.5,
131.3, 134.0, 147.8, 156.0, 180.8.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 2,3,5-substituted
[1,2,4]thiadiazoles as allosteric modulators of adenosine receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van den Nieuwendijk, Adrianus M. C. H.; Pietra, Daniele; Heitman, Laura;
Goeblyoes, Aniko; IJzerman, Adriaan P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(3), 663-672

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tryptophan, 1-[(4-methylphenyl)sulfonyl]-, methyl ester, mono(trifluoroacet...
C19H20N2O4S.C2HF3O2
352352-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 10.4146 0.0 0 VAL=6
M  V30 2 O 4.5648 9.0809 0.0 0
M  V30 3 O 6.1048 11.7483 0.0 0
M  V30 4 C 10.6375 9.2874 0.0 0
M  V30 5 C 11.2638 10.6944 0.0 0 CFG=2
M  V30 6 C 12.7955 10.8554 0.0 0
M  V30 7 N 10.3587 11.9403 0.0 0
M  V30 8 O 13.4219 12.2623 0.0 0
M  V30 9 O 13.7006 9.6095 0.0 0
M  V30 10 C 14.9534 12.4233 0.0 0
M  V30 11 C 0.0000 13.4947 0.0 0
M  V30 12 N 6.6685 9.6446 0.0 0
M  V30 13 C 6.8294 8.1130 0.0 0
M  V30 14 C 8.0755 10.2711 0.0 0
M  V30 15 C 8.3359 7.7928 0.0 0
M  V30 16 C 5.7990 6.9686 0.0 0
M  V30 17 C 9.1059 9.1265 0.0 0
M  V30 18 C 8.8118 6.3281 0.0 0
M  V30 19 C 6.2749 5.5039 0.0 0
M  V30 20 C 7.7813 5.1837 0.0 0
M  V30 21 C 4.0012 11.1846 0.0 0
M  V30 22 C 2.6673 10.4146 0.0 0
M  V30 23 C 4.0012 12.7246 0.0 0
M  V30 24 C 1.3337 11.1846 0.0 0
M  V30 25 C 2.6673 13.4947 0.0 0
M  V30 26 C 1.3337 12.7246 0.0 0
M  V30 27 C 6.8099 2.3101 0.0 0
M  V30 28 C 8.1435 1.5400 0.0 0
M  V30 29 F 7.5799 3.6437 0.0 0
M  V30 30 F 5.4762 3.0801 0.0 0
M  V30 31 F 6.0399 0.9764 0.0 0
M  V30 32 O 9.4772 2.3101 0.0 0
M  V30 33 O 8.1435 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 21
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=3
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 11 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 1 27 31
M  V30 33 1 28 32
M  V30 34 2 28 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methyl-1-[(4-methylphenyl)sulfonyl]-1H-indole-3-propanamide
C19H21N3O3S
2287239-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.2309 0.0 0 VAL=6
M  V30 2 O 4.5648 3.8972 0.0 0
M  V30 3 O 6.1048 6.5645 0.0 0
M  V30 4 C 10.6375 4.1037 0.0 0
M  V30 5 C 11.2638 5.5107 0.0 0 CFG=2
M  V30 6 C 12.7955 5.6716 0.0 0
M  V30 7 N 10.3587 6.7566 0.0 0
M  V30 8 N 13.4219 7.0786 0.0 0
M  V30 9 O 13.7006 4.4257 0.0 0
M  V30 10 C 14.9534 7.2395 0.0 0
M  V30 11 C 0.0000 8.3109 0.0 0
M  V30 12 N 6.6685 4.4609 0.0 0
M  V30 13 C 6.8294 2.9293 0.0 0
M  V30 14 C 8.0755 5.0873 0.0 0
M  V30 15 C 8.3359 2.6091 0.0 0
M  V30 16 C 5.7990 1.7849 0.0 0
M  V30 17 C 9.1059 3.9428 0.0 0
M  V30 18 C 8.8118 1.1444 0.0 0
M  V30 19 C 6.2749 0.3202 0.0 0
M  V30 20 C 7.7813 0.0000 0.0 0
M  V30 21 C 4.0012 6.0009 0.0 0
M  V30 22 C 2.6673 5.2309 0.0 0
M  V30 23 C 4.0012 7.5409 0.0 0
M  V30 24 C 1.3337 6.0009 0.0 0
M  V30 25 C 2.6673 8.3109 0.0 0
M  V30 26 C 1.3337 7.5409 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 21
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=3
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 11 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 352352-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287239-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19828961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric and geometry-selective α-alkenylation of α-amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abas, Hossay; Mas-Rosello, Josep; Amer, Mostafa Mahmoud; Durand, Derek
J.; Groleau, Robin R.; Fey, Natalie; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(8), 2418-2422

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Trifluoromethyl)oxirane
C3H3F3O
359-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 1.5400 0.0 0
M  V30 2 F 2.8736 3.0800 0.0 0
M  V30 3 F 4.4136 1.5400 0.0 0
M  V30 4 F 2.8736 0.0000 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,1-Trifluoro-3-(methylamino)-2-propanol
C4H8F3NO
400838-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3338 2.3101 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 F 2.1038 3.6437 0.0 0
M  V30 7 F 0.5638 0.9764 0.0 0
M  V30 8 N 5.3348 1.5400 0.0 0
M  V30 9 C 6.6687 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 359-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 400838-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-6523015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (R and S) 1-N-Methylamino-3,3,3-trifluoro-2-propanol (R and
S)-(trifluoromethyl)oxirane (2.40 g, 21.4 mmol (P. V. Ramachandran, B.
Long and H. C. Brown, J. Org. Chem., 1995, 60 4146) was cooled to −20°C.
and treated dropwise with cold anhydrous methylamine (15 ml). The
reaction flask was sealed and the resulting mixture was allowed to warm
up to 22°C. and stirred for 2 h. The reaction mixture was cooled again to
−20°C., carefully opened and the excess methylamine was allowed to
evaporate. White needles (2.97 g, 97%) mp 53-54°C. (ether-hexane); Anal.
Calcd. for C4H8F3NO: C 33.57, H 5.63, N 9.79. Found: C 33.35, H 5.39, N
9.74.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of O-substituted
4-(4-hydroxyphenyl)-1,1,1-trifluoro-2-butanones as selective cPLA2
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banville, Jacques; Gai, Yonghua; Johnson, Graham; Zusi, Fred Christopher;
Burke, James R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6350892 B1 2002-02-26

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[4-(trifluoromethyl)phenoxy]benzaldehyde
C14H8BrF3O2
364323-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3349 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 Br 1.5400 0.0000 0.0 0
M  V30 5 C 10.7800 5.3349 0.0 0
M  V30 6 F 10.7800 3.7949 0.0 0
M  V30 7 F 12.3200 5.3349 0.0 0
M  V30 8 F 10.7800 6.8749 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 6.1600 5.3349 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 8.4700 6.6685 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 9.2400 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 1 2 10
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-[4-(trifluoromethyl)phenoxy]benzenemethanamine
C15H13BrF3NO
951137-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 C 2.3100 5.3349 0.0 0
M  V30 3 N 0.7700 5.3349 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 11.5500 5.3349 0.0 0
M  V30 7 F 11.5500 3.7949 0.0 0
M  V30 8 F 13.0900 5.3349 0.0 0
M  V30 9 F 11.5500 6.8749 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 3.0800 1.3338 0.0 0
M  V30 16 C 6.9300 5.3349 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 10.0100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 3 4
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364323-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951137-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13796398
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[4-(methylthio)phenoxy]benzaldehyde
C14H11BrO2S
364323-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 Br 0.0000 5.3901 0.0 0
M  V30 5 S 10.6697 5.3901 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 5.3901 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-[4-(methylthio)phenoxy]benzenemethanamine
C15H16BrNOS
364321-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 S 11.5500 5.3347 0.0 0
M  V30 7 C 12.3200 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 3.0800 1.3338 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 7.7000 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364323-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 364321-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3113940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-phenoxybenzaldehyde
C13H9BrO2
364354-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 2.3100 0.0 0
M  V30 2 C 2.6674 0.7700 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Br 0.0000 5.3900 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 5.3900 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 6.6684 3.0800 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 8.0021 5.3900 0.0 0
M  V30 15 C 9.3358 3.0800 0.0 0
M  V30 16 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 6
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-phenoxybenzenemethanamine
C14H14BrNO
951136-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 1 3 4
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364354-23-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951136-99-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11656021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl vinyl sulfone
C3H6O2S
3680-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 C 0.0000 0.5637 0.0 0
M  V30 4 O 2.1037 0.0000 0.0 0
M  V30 5 O 0.5637 2.6673 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(methylsulfonyl)ethanamine
C4H11NO2S
202198-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0
M  V30 2 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 O 0.5638 2.6673 0.0 0
M  V30 6 O 2.1038 0.0000 0.0 0
M  V30 7 N 5.3348 2.1037 0.0 0
M  V30 8 C 6.6687 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3680-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 202198-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34480251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of the Brigatinib analogues as potent
inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and
EGFRL858R/T790M/C797S)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Haotian; Wu, Yingming; Xiao, Qitao; He, Dongbo; Zhou, Tongrui; Liu,
Wenzhong; Yang, Chun-Hao; Xie, Yuli
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 72128729

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Aconitane-4-carboxaldehyde, 20-ethyl-1,6,14,16-tetramethoxy-7,8-[methylenebis...
C26H39NO7
372190-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1959 1.5399 0.0 0
M  V30 2 C 7.1959 0.0000 0.0 0
M  V30 3 C 3.2410 0.6977 0.0 0
M  V30 4 C 1.7033 0.6131 0.0 0
M  V30 5 O 2.8210 6.5931 0.0 0
M  V30 6 C 2.4739 8.0935 0.0 0
M  V30 7 C 1.5384 6.4464 0.0 0
M  V30 8 O 0.0000 6.3781 0.0 0
M  V30 9 O 9.6964 8.1773 0.0 0
M  V30 10 C 11.1450 8.6996 0.0 0
M  V30 11 O 12.4851 6.9632 0.0 0
M  V30 12 C 13.5740 5.8743 0.0 0
M  V30 13 C 5.8627 3.8508 0.0 0 CFG=2
M  V30 14 C 7.1963 3.0808 0.0 0 CFG=2
M  V30 15 C 4.5291 4.6208 0.0 0 CFG=1
M  V30 16 C 7.2901 4.4136 0.0 0 CFG=2
M  V30 17 C 5.8623 2.3099 0.0 0 CFG=1
M  V30 18 C 5.3367 7.2722 0.0 0 CFG=1
M  V30 19 N 4.2840 2.7588 0.0 0
M  V30 20 C 4.2938 6.1435 0.0 0 CFG=2
M  V30 21 C 3.1949 3.8499 0.0 0 CFG=2
M  V30 22 C 7.7461 5.8810 0.0 0 CFG=2
M  V30 23 C 8.5570 3.5282 0.0 0
M  V30 24 C 4.5282 1.5392 0.0 0
M  V30 25 C 6.8726 7.1617 0.0 0 CFG=1
M  V30 26 O 4.9669 8.7671 0.0 0
M  V30 27 C 1.7055 4.2473 0.0 0
M  V30 28 C 3.1946 2.3091 0.0 0
M  V30 29 C 9.2883 5.9037 0.0 0 CFG=1
M  V30 30 C 9.7811 4.4574 0.0 0 CFG=2
M  V30 31 C 8.3530 8.1703 0.0 0
M  V30 32 O 7.4523 8.5884 0.0 0
M  V30 33 C 6.2745 9.5806 0.0 0
M  V30 34 C 10.9977 6.5645 0.0 0 CFG=1
M  V30 35 H 8.5316 2.3136 0.0 0
M  V30 36 H 3.1403 5.2862 0.0 0
M  V30 37 H 8.0148 2.2204 0.0 0
M  V30 38 H 8.4555 7.2479 0.0 0
M  V30 39 H 10.9362 3.4390 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 2 7 8
M  V30 8 1 21 7 CFG=3
M  V30 9 1 9 10
M  V30 10 1 29 9 CFG=1
M  V30 11 1 11 12
M  V30 12 1 34 11 CFG=3
M  V30 13 1 13 14 CFG=1
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 35 CFG=3
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 15 36 CFG=3
M  V30 23 1 16 22
M  V30 24 1 16 23
M  V30 25 1 16 37 CFG=3
M  V30 26 1 17 24
M  V30 27 1 18 20
M  V30 28 1 18 25
M  V30 29 1 18 26 CFG=1
M  V30 30 1 19 27
M  V30 31 1 21 27
M  V30 32 1 21 28
M  V30 33 1 22 25
M  V30 34 1 22 29
M  V30 35 1 22 38 CFG=3
M  V30 36 1 30 23 CFG=1
M  V30 37 1 24 28
M  V30 38 1 25 31 CFG=1
M  V30 39 1 25 32
M  V30 40 1 26 33
M  V30 41 1 29 30
M  V30 42 1 30 34
M  V30 43 1 30 39 CFG=3
M  V30 44 1 31 34
M  V30 45 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(13 13 14 15 16 17 18 20 21 22 25 29 30 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[(1α,6β,14α,16β)-20-ethyl-1,6,14,16-tetramethoxy-7,8-[methyle...
C27H42N2O6
464880-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.3516 4.4742 0.0 0
M  V30 2 C 3.5816 3.1404 0.0 0
M  V30 3 C 6.5229 1.1471 0.0 0
M  V30 4 C 7.5503 0.0000 0.0 0
M  V30 5 O 10.6670 6.6629 0.0 0
M  V30 6 C 11.7177 7.7886 0.0 0
M  V30 7 C 11.4162 6.3474 0.0 0
M  V30 8 N 12.8385 5.7571 0.0 0
M  V30 9 C 14.0607 6.6937 0.0 0
M  V30 10 O 0.8870 8.9522 0.0 0
M  V30 11 C 0.0000 10.2110 0.0 0
M  V30 12 O 2.4826 11.8153 0.0 0
M  V30 13 C 2.8811 13.3028 0.0 0
M  V30 14 C 6.6615 5.8089 0.0 0 CFG=2
M  V30 15 C 5.1216 5.8089 0.0 0 CFG=2
M  V30 16 C 8.2015 5.8087 0.0 0 CFG=1
M  V30 17 C 5.7068 7.0100 0.0 0 CFG=2
M  V30 18 C 5.8916 4.4742 0.0 0 CFG=1
M  V30 19 C 8.8278 8.5087 0.0 0 CFG=1
M  V30 20 N 7.4826 4.0736 0.0 0
M  V30 21 C 9.1666 7.0099 0.0 0 CFG=2
M  V30 22 C 8.9715 4.4740 0.0 0 CFG=2
M  V30 23 C 6.0456 8.5089 0.0 0 CFG=2
M  V30 24 C 4.1668 6.8765 0.0 0
M  V30 25 C 6.6614 3.1397 0.0 0
M  V30 26 C 7.4425 9.1811 0.0 0 CFG=1
M  V30 27 O 9.8955 9.6186 0.0 0
M  V30 28 C 10.4600 4.0736 0.0 0
M  V30 29 C 8.2013 3.1395 0.0 0
M  V30 30 C 4.7212 9.2995 0.0 0 CFG=1
M  V30 31 C 3.5713 8.2933 0.0 0 CFG=2
M  V30 32 C 6.6646 10.7948 0.0 0
M  V30 33 O 7.6537 10.7065 0.0 0
M  V30 34 C 9.1698 10.9768 0.0 0
M  V30 35 C 3.5715 10.7264 0.0 0 CFG=1
M  V30 36 H 3.5816 5.8121 0.0 0
M  V30 37 H 9.7368 5.6906 0.0 0
M  V30 38 H 3.9825 5.4729 0.0 0
M  V30 39 H 7.8529 7.0702 0.0 0
M  V30 40 H 2.0617 7.9890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 2 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 30 10 CFG=3
M  V30 12 1 12 13
M  V30 13 1 35 12 CFG=1
M  V30 14 1 14 15 CFG=3
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 15 20
M  V30 20 1 15 36 CFG=1
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 16 37 CFG=1
M  V30 24 1 17 23
M  V30 25 1 17 24
M  V30 26 1 17 38 CFG=1
M  V30 27 1 18 25
M  V30 28 1 19 21
M  V30 29 1 19 26
M  V30 30 1 19 27 CFG=3
M  V30 31 1 20 28
M  V30 32 1 22 28
M  V30 33 1 22 29
M  V30 34 1 23 26
M  V30 35 1 23 30
M  V30 36 1 23 39 CFG=1
M  V30 37 1 31 24 CFG=3
M  V30 38 1 25 29
M  V30 39 1 26 32 CFG=3
M  V30 40 1 26 33
M  V30 41 1 27 34
M  V30 42 1 30 31
M  V30 43 1 31 35
M  V30 44 1 31 40 CFG=1
M  V30 45 1 32 35
M  V30 46 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(13 14 15 16 17 18 19 21 22 23 26 30 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 372190-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 464880-81-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2720794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of imines (3-6) (general procedure). A solution ofelatidal 1
(0.239 g, 0.50 mmol) in 0.6 mL of MeOH was added to primary amine (0.50
mmol). The mixture was refluxed for 30 min and the solvent was removed in
vacuo. Chloroform (1 mL) was added to the residue, and the traces of
moisture were removed by distillation as an azeotrope. The residue was
dried at 50 °C (3 Torr).
18(E)-Methylimino-7,8-methylenedioxy-1α,6β,14α,16β-tetramethoxy-20-ethylaconitane
(3) was prepared by the abovedesctibed general procedure. A 29% aqueous
solution of MeNH2 was used. Colourless crystals. m.p. 143-144 °C, [α]20
578 -2.3 (c 6.9, MeOH). Found, m/z: 490.3073 [M]+. C27H42N2O6.
Calculated: M = 490.3043. 1H NMR, 8: 0.99 (t, 3 H, NCH2CH3, J= 7 Hz);
3.11, 3.19, 3.26 and 3.34 (all s, each 3 Η, 1-, 6-, 14-, and 16-OMe);
3.21 (d, 3 H, NMe, J= 1.4 Hz); 4.93 and 4.96 (both s, each 1H, OCH2O);
7,35 (q, 1H, C(18)H, J= 1.4 Hz). IR (KBr), v/cm-1: 934, 956, 978, 989,
1009, 1036, 1088, 1115, 1146, 1450, 1669 (C=N), 2816, 2858, 2907, 2963.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of alkaloids of the Siberian and Altai flora. 7. Synthesis of
18-amino-18-deoxy derivatives of elatidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ganbaatar, J.; Batsuren, D.; Osadchii, S. A.; Shults, E. E.; Tolstikov,
G. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2002), 51(3), 531-534

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[2-(4-benzoyl-1-piperazinyl)-2-oxoacetyl]-4-fluoro-1H-indole-7-carbo...
C23H20FN3O5
389628-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.8501 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3358 6.1601 0.0 0
M  V30 5 F 12.8556 1.3845 0.0 0
M  V30 6 C 16.9776 5.9624 0.0 0
M  V30 7 O 18.4839 5.6422 0.0 0
M  V30 8 O 16.5016 7.4270 0.0 0
M  V30 9 C 19.5144 6.7866 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 C 13.4102 3.9936 0.0 0
M  V30 13 C 14.4407 5.1382 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 13.8862 2.5290 0.0 0
M  V30 16 C 15.9470 4.8178 0.0 0
M  V30 17 N 13.6707 6.4718 0.0 0
M  V30 18 C 12.1643 6.1517 0.0 0
M  V30 19 C 15.3925 2.2087 0.0 0
M  V30 20 C 16.4229 3.3533 0.0 0
M  V30 21 N 8.0022 3.8501 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 8.0022 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0
M  V30 26 N 5.3348 2.3101 0.0 0
M  V30 27 C 2.6673 2.3101 0.0 0
M  V30 28 C 1.3337 1.5400 0.0 0
M  V30 29 C 2.6673 3.8501 0.0 0
M  V30 30 C 0.0000 2.3101 0.0 0
M  V30 31 C 1.3337 4.6201 0.0 0
M  V30 32 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 10 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(4-Benzoyl-1-piperazinyl)-2-oxoacetyl]-4-fluoro-N-methyl-1H-indole-7-car...
C23H21FN4O4
389629-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.8501 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3358 6.1601 0.0 0
M  V30 5 F 12.8556 1.3845 0.0 0
M  V30 6 C 16.9776 5.9624 0.0 0
M  V30 7 N 18.4839 5.6422 0.0 0
M  V30 8 O 16.5016 7.4270 0.0 0
M  V30 9 C 19.5144 6.7866 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 C 13.4102 3.9936 0.0 0
M  V30 13 C 14.4407 5.1382 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 13.8862 2.5290 0.0 0
M  V30 16 C 15.9470 4.8178 0.0 0
M  V30 17 N 13.6707 6.4718 0.0 0
M  V30 18 C 12.1643 6.1517 0.0 0
M  V30 19 C 15.3925 2.2087 0.0 0
M  V30 20 C 16.4229 3.3533 0.0 0
M  V30 21 N 8.0022 3.8501 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 8.0022 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0
M  V30 26 N 5.3348 2.3101 0.0 0
M  V30 27 C 2.6673 2.3101 0.0 0
M  V30 28 C 2.6673 3.8501 0.0 0
M  V30 29 C 1.3337 1.5400 0.0 0
M  V30 30 C 1.3337 4.6201 0.0 0
M  V30 31 C 0.0000 2.3101 0.0 0
M  V30 32 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 10 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 389628-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 389629-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3343613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and antiviral activity of substituted
piperazinyloxoacetylindole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallace, Owen B.; Wang, Tao; Yeung, Kap-Sun; Pearce, Bradley C.;
Meanwell, Nicholas A.; Qiu, Zhilei; Fang, Haiquan; Xue, Qiufen May; Yin,
Zhiwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030069245 A1 2003-04-10

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[2-(4-benzoyl-1-piperazinyl)-2-oxoacetyl]-4-fluoro-1H-indole-7-carbo...
C23H20FN3O5
389628-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.8501 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3358 6.1601 0.0 0
M  V30 5 F 12.8556 1.3845 0.0 0
M  V30 6 C 16.9776 5.9624 0.0 0
M  V30 7 O 18.4839 5.6422 0.0 0
M  V30 8 O 16.5016 7.4270 0.0 0
M  V30 9 C 19.5144 6.7866 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 C 13.4102 3.9936 0.0 0
M  V30 13 C 14.4407 5.1382 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 13.8862 2.5290 0.0 0
M  V30 16 C 15.9470 4.8178 0.0 0
M  V30 17 N 13.6707 6.4718 0.0 0
M  V30 18 C 12.1643 6.1517 0.0 0
M  V30 19 C 15.3925 2.2087 0.0 0
M  V30 20 C 16.4229 3.3533 0.0 0
M  V30 21 N 8.0022 3.8501 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 8.0022 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0
M  V30 26 N 5.3348 2.3101 0.0 0
M  V30 27 C 2.6673 2.3101 0.0 0
M  V30 28 C 1.3337 1.5400 0.0 0
M  V30 29 C 2.6673 3.8501 0.0 0
M  V30 30 C 0.0000 2.3101 0.0 0
M  V30 31 C 1.3337 4.6201 0.0 0
M  V30 32 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 10 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(4-Benzoyl-1-piperazinyl)-2-oxoacetyl]-4-fluoro-N-methyl-1H-indole-7-car...
C23H21FN4O4
389629-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.8501 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3358 6.1601 0.0 0
M  V30 5 F 12.8556 1.3845 0.0 0
M  V30 6 C 16.9776 5.9624 0.0 0
M  V30 7 N 18.4839 5.6422 0.0 0
M  V30 8 O 16.5016 7.4270 0.0 0
M  V30 9 C 19.5144 6.7866 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 C 13.4102 3.9936 0.0 0
M  V30 13 C 14.4407 5.1382 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 13.8862 2.5290 0.0 0
M  V30 16 C 15.9470 4.8178 0.0 0
M  V30 17 N 13.6707 6.4718 0.0 0
M  V30 18 C 12.1643 6.1517 0.0 0
M  V30 19 C 15.3925 2.2087 0.0 0
M  V30 20 C 16.4229 3.3533 0.0 0
M  V30 21 N 8.0022 3.8501 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 8.0022 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0
M  V30 26 N 5.3348 2.3101 0.0 0
M  V30 27 C 2.6673 2.3101 0.0 0
M  V30 28 C 2.6673 3.8501 0.0 0
M  V30 29 C 1.3337 1.5400 0.0 0
M  V30 30 C 1.3337 4.6201 0.0 0
M  V30 31 C 0.0000 2.3101 0.0 0
M  V30 32 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 10 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 389628-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 389629-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11069660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Alternatively, the compound of this example can be prepared as shown and
described below. To the methyl ester intermediate 22, (60 mg, 0.137 mmol)
was added a solution of methylamine in water (1.5 ml, 18 mmol, 40% aq.)
and the resulting mixture stirred at rt for 52 h. Evaporation of the
excess reagent in vacuo gave the product. White solid, yield 58 mg, 97%
1H NMR (CD3OD) δ 8.17 (s, 1H), 7.71 (dd, J = 8.1, 4.0, 1H), 7.45 (b, s,
5H), 7.01 (app t, J= 9.2, 1H), 3.95 - 3.40 (b m, 8H), 2.96 (s, 3H); LC/MS
(ES+) m/z (M+H)+ = 437, HPLC Rt = 1.123.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted indoleoxoacetylpiperazines with antiviral
activity against HIV-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallace, Owen B.; Wang, Tao; Yeung, Kap-Sun; Pearce, Bradley C.;
Meanwell, Nicholas A.; Qiu, Zhilei; Fang, Haiquan; Xue, Qiufen May; Yin,
Zhiwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002004440 A1 2002-01-17

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitroquinoline
C9H5ClN2O2
39061-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 8.0021 2.3100 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-quinolinamine
C10H9N3O2
99009-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 N 6.6686 2.3100 0.0 0 VAL=5
M  V30 4 O 6.6686 0.7700 0.0 0
M  V30 5 O 8.0022 3.0800 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3337 2.3100 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 N 4.0011 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39061-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99009-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34299526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Dehydrogenative Synthesis of Imidazoquinolines in
Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakayama, Taku; Harada, Shogo; Kikkawa, Shoko; Hikawa, Hidemasa; Azumaya,
Isao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(10), e202200510

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[2,3-O-(1-methylethylidene)-β-D-ribofuranosyl]-9H-purine
C13H15ClN4O4
39824-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2969 1.0304 0.0 0
M  V30 2 O 6.1524 0.0000 0.0 0
M  V30 3 C 11.1809 5.2128 0.0 0
M  V30 4 C 10.1504 6.9977 0.0 0
M  V30 5 Cl 0.0000 8.0725 0.0 0
M  V30 6 C 5.7309 4.6948 0.0 0 CFG=2
M  V30 7 C 7.2372 5.0149 0.0 0 CFG=2
M  V30 8 O 5.5698 3.1632 0.0 0
M  V30 9 C 8.0072 3.6813 0.0 0 CFG=2
M  V30 10 O 8.2676 6.1595 0.0 0
M  V30 11 C 6.9768 2.5369 0.0 0 CFG=2
M  V30 12 O 9.5136 4.0014 0.0 0
M  V30 13 C 9.6746 5.5331 0.0 0
M  V30 14 N 4.5863 5.7253 0.0 0
M  V30 15 C 3.0800 5.4052 0.0 0
M  V30 16 C 4.7473 7.2569 0.0 0
M  V30 17 C 2.3100 6.7388 0.0 0
M  V30 18 N 2.3100 4.0714 0.0 0
M  V30 19 N 3.3405 7.8832 0.0 0
M  V30 20 C 0.7700 6.7388 0.0 0
M  V30 21 C 0.7700 4.0714 0.0 0
M  V30 22 N 0.0000 5.4052 0.0 0
M  V30 23 H 6.4672 6.3487 0.0 0
M  V30 24 H 8.7772 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 3 13
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 14 CFG=1
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 23 CFG=1
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 9 24 CFG=1
M  V30 16 1 10 13
M  V30 17 1 12 13
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 15 18
M  V30 22 2 16 19
M  V30 23 1 17 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-2′,3′-O-(1-methylethylidene)adenosine
C14H19N5O4
4566-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 1.0304 0.0 0
M  V30 2 O 5.0284 0.0000 0.0 0
M  V30 3 C 0.0000 5.2128 0.0 0
M  V30 4 C 1.0304 6.9977 0.0 0
M  V30 5 N 11.1808 8.0724 0.0 0
M  V30 6 C 12.7208 8.0724 0.0 0
M  V30 7 C 5.4499 4.6947 0.0 0 CFG=2
M  V30 8 C 3.9437 5.0149 0.0 0 CFG=2
M  V30 9 O 5.6110 3.1632 0.0 0
M  V30 10 C 3.1737 3.6812 0.0 0 CFG=2
M  V30 11 O 2.9132 6.1594 0.0 0
M  V30 12 C 4.2041 2.5369 0.0 0 CFG=2
M  V30 13 O 1.6672 4.0014 0.0 0
M  V30 14 C 1.5063 5.5331 0.0 0
M  V30 15 N 6.5945 5.7253 0.0 0
M  V30 16 C 8.1008 5.4051 0.0 0
M  V30 17 C 6.4336 7.2568 0.0 0
M  V30 18 C 8.8708 6.7388 0.0 0
M  V30 19 N 8.8708 4.0713 0.0 0
M  V30 20 N 7.8404 7.8832 0.0 0
M  V30 21 C 10.4108 6.7388 0.0 0
M  V30 22 C 10.4108 4.0713 0.0 0
M  V30 23 N 11.1808 5.4051 0.0 0
M  V30 24 H 4.7137 6.3487 0.0 0
M  V30 25 H 2.4036 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15 CFG=3
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 24 CFG=3
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 25 CFG=3
M  V30 17 1 11 14
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 2 17 20
M  V30 24 1 18 20
M  V30 25 2 18 21
M  V30 26 1 19 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39824-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4566-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8593216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SAH derived potent and selective EZH2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kung, Pei-Pei; Huang, Buwen; Zehnder, Luke; Tatlock, John; Bingham,
Patrick; Krivacic, Cody; Gajiwala, Ketan; Diehl, Wade; Yu, Xiu; Maegley,
Karen A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(7), 1532-1537

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[3-methyl-4-(methylthio)phenoxy]benzaldehyde
C15H13BrO2S
402911-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 Br 1.5400 0.0000 0.0 0
M  V30 5 C 9.2400 8.0021 0.0 0
M  V30 6 S 10.7800 5.3347 0.0 0
M  V30 7 C 11.5500 4.0011 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 1 4 13
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-[3-methyl-4-(methylthio)phenoxy]benzenemethanamine
C16H18BrNOS
402910-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 10.0100 8.0021 0.0 0
M  V30 7 S 11.5500 5.3347 0.0 0
M  V30 8 C 12.3200 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 3.0800 1.3336 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 7.7000 6.6685 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402911-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402910-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7378123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Gluconimidic acid, N-[(methylsulfonyl)oxy]-2,3,4,6-tetrakis-O-(phenylmethyl...
C35H37NO8S
404022-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 9.3358 0.0 0
M  V30 2 C 5.3901 9.3358 0.0 0
M  V30 3 O 10.0102 9.3358 0.0 0
M  V30 4 C 9.2402 10.6697 0.0 0
M  V30 5 O 5.3901 6.6685 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 C 11.5503 6.6685 0.0 0
M  V30 8 O 12.3203 8.0022 0.0 0
M  V30 9 C 13.8603 8.0022 0.0 0
M  V30 10 N 6.9302 4.0010 0.0 0
M  V30 11 O 7.7002 2.6673 0.0 0
M  V30 12 S 6.9302 1.3337 0.0 0 VAL=6
M  V30 13 C 8.2638 0.5637 0.0 0
M  V30 14 O 6.1601 0.0000 0.0 0
M  V30 15 O 5.5965 2.1037 0.0 0
M  V30 16 C 7.7002 8.0022 0.0 0 CFG=2
M  V30 17 C 9.2402 8.0022 0.0 0 CFG=2
M  V30 18 C 6.9302 6.6685 0.0 0 CFG=1
M  V30 19 C 10.0102 6.6685 0.0 0 CFG=1
M  V30 20 C 7.7002 5.3348 0.0 0
M  V30 21 O 9.2402 5.3348 0.0 0
M  V30 22 C 4.6201 10.6697 0.0 0
M  V30 23 C 5.3901 12.0033 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 4.6201 13.3370 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 3.0801 13.3370 0.0 0
M  V30 28 C 10.0102 12.0033 0.0 0
M  V30 29 C 11.5503 12.0033 0.0 0
M  V30 30 C 9.2402 13.3370 0.0 0
M  V30 31 C 12.3203 13.3370 0.0 0
M  V30 32 C 10.0102 14.6707 0.0 0
M  V30 33 C 11.5503 14.6707 0.0 0
M  V30 34 C 3.0801 5.3348 0.0 0
M  V30 35 C 2.3101 6.6685 0.0 0
M  V30 36 C 2.3101 4.0010 0.0 0
M  V30 37 C 0.7700 6.6685 0.0 0
M  V30 38 C 0.7700 4.0010 0.0 0
M  V30 39 C 0.0000 5.3348 0.0 0
M  V30 40 C 14.6303 6.6685 0.0 0
M  V30 41 C 16.1704 6.6685 0.0 0
M  V30 42 C 13.8603 5.3348 0.0 0
M  V30 43 C 16.9404 5.3348 0.0 0
M  V30 44 C 14.6303 4.0010 0.0 0
M  V30 45 C 16.1704 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 17 3 CFG=3
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 18 5 CFG=3
M  V30 9 1 6 34
M  V30 10 1 7 8
M  V30 11 1 19 7 CFG=1
M  V30 12 1 8 9
M  V30 13 1 9 40
M  V30 14 1 10 11
M  V30 15 2 10 20 CFG=2
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 2 12 14
M  V30 19 2 12 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,5R,6R,7S,8R)-1-Methyl-6,7,8-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]...
C35H38N2O5
620946-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0102 0.0 0
M  V30 2 C 5.3348 11.5503 0.0 0
M  V30 3 C 10.1060 12.1139 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 C 4.0012 7.7002 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 O 12.0035 7.7002 0.0 0
M  V30 8 C 13.3372 6.9302 0.0 0
M  V30 9 O 8.0023 5.3901 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 8.0023 10.0102 0.0 0 CFG=2
M  V30 12 C 6.6687 9.2402 0.0 0 CFG=2
M  V30 13 N 8.7723 11.3439 0.0 0
M  V30 14 N 7.2323 11.3439 0.0 0
M  V30 15 O 9.3360 9.2402 0.0 0
M  V30 16 C 6.6687 7.7002 0.0 0 CFG=1
M  V30 17 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 18 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 19 C 4.0012 12.3203 0.0 0
M  V30 20 C 4.0012 13.8603 0.0 0
M  V30 21 C 2.6675 11.5503 0.0 0
M  V30 22 C 2.6675 14.6303 0.0 0
M  V30 23 C 1.3338 12.3203 0.0 0
M  V30 24 C 1.3338 13.8603 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 26 C 2.6675 5.3901 0.0 0
M  V30 27 C 1.3338 7.7002 0.0 0
M  V30 28 C 1.3338 4.6201 0.0 0
M  V30 29 C 0.0000 6.9302 0.0 0
M  V30 30 C 0.0000 5.3901 0.0 0
M  V30 31 C 9.3360 3.0801 0.0 0
M  V30 32 C 8.0023 2.3101 0.0 0
M  V30 33 C 10.6697 2.3101 0.0 0
M  V30 34 C 8.0023 0.7700 0.0 0
M  V30 35 C 10.6697 0.7700 0.0 0
M  V30 36 C 9.3360 0.0000 0.0 0
M  V30 37 C 14.6708 7.7002 0.0 0
M  V30 38 C 16.0045 6.9302 0.0 0
M  V30 39 C 14.6708 9.2402 0.0 0
M  V30 40 C 17.3383 7.7002 0.0 0
M  V30 41 C 16.0045 10.0102 0.0 0
M  V30 42 C 17.3383 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 19
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 1 17 6 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 37
M  V30 12 1 9 10
M  V30 13 1 18 9 CFG=1
M  V30 14 1 10 31
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 14 CFG=1
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 404022-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620946-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29077803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-methylbenzenesulfonyl chloride
C7H6Cl2O2S
42413-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N,4-dimethylbenzenesulfonamide
C8H10ClNO2S
1196703-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Cl 1.5400 0.0000 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42413-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1196703-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-652828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of substituted nicotinamides as inhibitors of
soluble epoxide hydrolase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Steven J.; Soleymanzadeh, Fariba; Eldrup, Anne B.; Farrow, Neil
A.; Muegge, Ingo; Kukulka, Alison; Kabcenell, Alisa K.; DeLombaert,
Stephane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5864-5868

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-4-methoxybenzaldehyde
C10H12O3
42924-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 O 3.8500 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-4-methoxy-N-methylbenzenemethanamine
C11H17NO2
1079652-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 1.3338 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 N 7.7000 6.6685 0.0 0
M  V30 6 C 9.2400 6.6685 0.0 0
M  V30 7 O 0.7700 5.3347 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 5.3900 5.3347 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42924-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1079652-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6619624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 133:
1-(4-ethoxy-2-methoxyphenyl)-N-methylmethanamine To a solution of
4-ethoxy-2-methoxybenzaldehyde (Intermediate 132, 0.3 g, 1.66 mmol) was
added methanamine (0.717 mL, 8.32 mmol) followed by sodium
triacetoxyhydroborate (0.353 g, 1.66 mmol) and acetic acid (10.00 mg,
0.17 mmol) at rt. The reaction mixture was stirred at rt for 16 h. Water
was added and the mixture was extracted with DCM. The aqueous layer was
evaporated under reduced pressure and DMF (20 mL) was added, filtered and
concentrated under reduced pressure to give title compound, which was
used without further purification. Intermediate 136:
1-(2-ethoxy-4-methoxyphenyl)-N-methylmethanamine Following a procedure
similar to that described for the preparation of Intermediate 133,
starting from 2-ethoxy-4-methoxybenzaldehyde (Intermediate 135), the
title compound (0.190 g, 97 %) was obtained as an oil, which was used
without further purification. MS [M + H]+ 195.98 (ESI).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5,6-dihydro-7H-pyrrolo[3,4-d]pyrimidin-7-one derivatives
as P2X3 receptor antagonists for treating especially pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bayrakdarian, Malken; Buon, Christophe; Cantin, Louis-David; Hu, Yun-Jin;
Luo, Xuehong; Santhakumar, Vijayaratnam; Tomaszewski, Miroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008136756 A1 2008-11-13

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Decafluorobiphenyl
C12F10
434-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 0.0000 0.0 0
M  V30 2 F 4.6200 5.3349 0.0 0
M  V30 3 F 6.1600 5.3349 0.0 0
M  V30 4 F 6.1600 0.0000 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 F 9.2400 5.3349 0.0 0
M  V30 8 F 9.2400 0.0000 0.0 0
M  V30 9 F 0.0000 2.6674 0.0 0
M  V30 10 F 10.7800 2.6674 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 1.5400 2.6674 0.0 0
M  V30 17 C 6.1600 2.6674 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.9300 1.3338 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 8.4700 1.3338 0.0 0
M  V30 22 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 18
M  V30 4 1 4 19
M  V30 5 1 5 14
M  V30 6 1 6 15
M  V30 7 1 7 20
M  V30 8 1 8 21
M  V30 9 1 9 16
M  V30 10 1 10 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′,3,3′,4′,5,5′,6,6′-Nonafluoro-N-methyl[1,1′-biphenyl]-4-amine
C13H4F9N
67986-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.1600 5.3349 0.0 0
M  V30 2 F 6.1600 0.0000 0.0 0
M  V30 3 F 4.6200 0.0000 0.0 0
M  V30 4 F 4.6200 5.3349 0.0 0
M  V30 5 F 9.2400 5.3349 0.0 0
M  V30 6 F 9.2400 0.0000 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 F 1.5400 5.3349 0.0 0
M  V30 9 N 10.7800 2.6674 0.0 0
M  V30 10 C 11.5500 4.0011 0.0 0
M  V30 11 F 0.0000 2.6674 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 1.3338 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.8500 1.3338 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 21 C 2.3100 1.3338 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 19
M  V30 4 1 4 20
M  V30 5 1 5 15
M  V30 6 1 6 16
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 11 23
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67986-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2768848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on reaction conditions-stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Decafluorobiphenyl
C12F10
434-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 0.0000 0.0 0
M  V30 2 F 4.6200 5.3349 0.0 0
M  V30 3 F 6.1600 5.3349 0.0 0
M  V30 4 F 6.1600 0.0000 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 F 9.2400 5.3349 0.0 0
M  V30 8 F 9.2400 0.0000 0.0 0
M  V30 9 F 0.0000 2.6674 0.0 0
M  V30 10 F 10.7800 2.6674 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 1.5400 2.6674 0.0 0
M  V30 17 C 6.1600 2.6674 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.9300 1.3338 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 8.4700 1.3338 0.0 0
M  V30 22 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 18
M  V30 4 1 4 19
M  V30 5 1 5 14
M  V30 6 1 6 15
M  V30 7 1 7 20
M  V30 8 1 8 21
M  V30 9 1 9 16
M  V30 10 1 10 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4,4′-diamine, 2,2′,3,3′,5,5′,6,6′-octafluoro-N4,N4′-dimethyl-
C14H8F8N2
67986-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3900 0.0000 0.0 0
M  V30 2 F 5.3900 5.3349 0.0 0
M  V30 3 F 6.9300 5.3349 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 F 2.3100 5.3349 0.0 0
M  V30 7 F 10.0100 5.3349 0.0 0
M  V30 8 F 10.0100 0.0000 0.0 0
M  V30 9 N 0.7700 2.6674 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 N 11.5500 2.6674 0.0 0
M  V30 12 C 12.3200 1.3338 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.0800 1.3338 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 2.3100 2.6674 0.0 0
M  V30 19 C 6.9300 2.6674 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 7.7000 1.3338 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 9.2400 1.3338 0.0 0
M  V30 24 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 20
M  V30 4 1 4 21
M  V30 5 1 5 16
M  V30 6 1 6 17
M  V30 7 1 7 22
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 24
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67986-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6697765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on reaction conditions-stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-cyano-N′-(imidazo[1,2-a]pyridin-2-ylmethyl)carbamimidate
C16H13N5O
452967-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 5.3349 0.0 0
M  V30 2 N 7.3470 4.0011 0.0 0
M  V30 3 C 8.8870 4.0011 0.0 0
M  V30 4 O 9.6570 5.3349 0.0 0
M  V30 5 N 9.6570 2.6674 0.0 0
M  V30 6 C 8.8870 1.3338 0.0 0
M  V30 7 N 8.1170 0.0000 0.0 0
M  V30 8 C 2.6673 4.5649 0.0 0
M  V30 9 N 2.6673 6.1049 0.0 0
M  V30 10 N 4.1320 4.0889 0.0 0
M  V30 11 C 1.3336 3.7949 0.0 0
M  V30 12 C 4.1320 6.5807 0.0 0
M  V30 13 C 1.3336 6.8749 0.0 0
M  V30 14 C 5.0370 5.3349 0.0 0
M  V30 15 C 0.0000 4.5649 0.0 0
M  V30 16 C 0.0000 6.1049 0.0 0
M  V30 17 C 11.1970 5.3349 0.0 0
M  V30 18 C 11.9670 4.0011 0.0 0
M  V30 19 C 11.9670 6.6685 0.0 0
M  V30 20 C 13.5070 4.0011 0.0 0
M  V30 21 C 13.5070 6.6685 0.0 0
M  V30 22 C 14.2770 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 3 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 14
M  V30 17 2 13 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-(imidazo[1,2-a]pyridin-2-ylmethyl)-N′′-methylguanidine
C11H12N6
452967-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5771 4.0010 0.0 0
M  V30 2 N 7.3471 2.6673 0.0 0
M  V30 3 C 8.8871 2.6673 0.0 0
M  V30 4 N 9.6571 4.0010 0.0 0
M  V30 5 N 9.6571 1.3337 0.0 0
M  V30 6 C 11.1972 4.0010 0.0 0
M  V30 7 C 8.8871 0.0000 0.0 0
M  V30 8 N 12.7372 4.0010 0.0 0
M  V30 9 C 2.6673 3.2310 0.0 0
M  V30 10 N 2.6673 4.7710 0.0 0
M  V30 11 N 4.1320 2.7551 0.0 0
M  V30 12 C 1.3337 2.4609 0.0 0
M  V30 13 C 4.1320 5.2470 0.0 0
M  V30 14 C 1.3337 5.5410 0.0 0
M  V30 15 C 5.0371 4.0010 0.0 0
M  V30 16 C 0.0000 3.2310 0.0 0
M  V30 17 C 0.0000 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 15
M  V30 17 2 14 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 452967-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 452967-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17617818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine derivatives of imidazo[1,2-a]pyridine useful as antagonists of
gonadotropin releasing hormone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dossetter, Alexander Graham; Kenny, Peter; McKerrecher, Darren;
Wardleworth, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002066478 A1 2002-08-29

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-cyano-N′-(imidazo[1,2-a]pyridin-2-ylmethyl)carbamimidate
C16H13N5O
452967-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 5.3349 0.0 0
M  V30 2 N 7.3470 4.0011 0.0 0
M  V30 3 C 8.8870 4.0011 0.0 0
M  V30 4 O 9.6570 5.3349 0.0 0
M  V30 5 N 9.6570 2.6674 0.0 0
M  V30 6 C 8.8870 1.3338 0.0 0
M  V30 7 N 8.1170 0.0000 0.0 0
M  V30 8 C 2.6673 4.5649 0.0 0
M  V30 9 N 2.6673 6.1049 0.0 0
M  V30 10 N 4.1320 4.0889 0.0 0
M  V30 11 C 1.3336 3.7949 0.0 0
M  V30 12 C 4.1320 6.5807 0.0 0
M  V30 13 C 1.3336 6.8749 0.0 0
M  V30 14 C 5.0370 5.3349 0.0 0
M  V30 15 C 0.0000 4.5649 0.0 0
M  V30 16 C 0.0000 6.1049 0.0 0
M  V30 17 C 11.1970 5.3349 0.0 0
M  V30 18 C 11.9670 4.0011 0.0 0
M  V30 19 C 11.9670 6.6685 0.0 0
M  V30 20 C 13.5070 4.0011 0.0 0
M  V30 21 C 13.5070 6.6685 0.0 0
M  V30 22 C 14.2770 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 3 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 14
M  V30 17 2 13 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-(imidazo[1,2-a]pyridin-2-ylmethyl)-N′′-methylguanidine
C11H12N6
452967-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5771 4.0010 0.0 0
M  V30 2 N 7.3471 2.6673 0.0 0
M  V30 3 C 8.8871 2.6673 0.0 0
M  V30 4 N 9.6571 4.0010 0.0 0
M  V30 5 N 9.6571 1.3337 0.0 0
M  V30 6 C 11.1972 4.0010 0.0 0
M  V30 7 C 8.8871 0.0000 0.0 0
M  V30 8 N 12.7372 4.0010 0.0 0
M  V30 9 C 2.6673 3.2310 0.0 0
M  V30 10 N 2.6673 4.7710 0.0 0
M  V30 11 N 4.1320 2.7551 0.0 0
M  V30 12 C 1.3337 2.4609 0.0 0
M  V30 13 C 4.1320 5.2470 0.0 0
M  V30 14 C 1.3337 5.5410 0.0 0
M  V30 15 C 5.0371 4.0010 0.0 0
M  V30 16 C 0.0000 3.2310 0.0 0
M  V30 17 C 0.0000 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 15
M  V30 17 2 14 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 452967-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 452967-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9350293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D2: Preparation of
N-Cyano-N'-(imidazo[1,2-a]pyridin-2-ylmethyl)-N''-methyl-guanidine A
mixture of 1-imidazo[1,2-a] pyridin-2-ylmethyl-3-cyano-2-phenyl-isourea
(1.00 g, 3.40 mmol) and excess methylamine in 33% aq. ethanol (5 mL) in
IPA were warmed to 70 °C for 2 h. The reaction was concentrated in vacuo,
and the residue triturated with ethyl acetate and filtered. The resulting
solid was washed with ether and dried. The title compound as a white
solid (0.75 g, 97%). Mass Spectrum: 229 [MH]+ 1H NMR spectrum (DMSO-d6):
2. 72 (3H, s); 4.40 (2H, s); 6.82 (1H, t); 7.17 (1H, brs), 7.19 (1H, t);
7.40 (1H, br s); 7.48 (1H, d); 7.78 (1H, s); 8.48 (1H, d).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazopyridines for antagonizing gonadotropin
releasing hormone activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dossetter, Alexander Graham; Kenny, Peter; McKerrecher, Darren;
Wardleworth, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002066477 A2 2002-08-29

$RFMT $RIREG SCHEME291 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Curcumin
C21H20O6
458-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 C 10.6695 1.5400 0.0 0
M  V30 7 C 12.0034 2.3100 0.0 0
M  V30 8 O 10.6695 0.0000 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 O 18.6718 1.5400 0.0 0
M  V30 14 C 18.6718 0.0000 0.0 0
M  V30 15 O 18.6718 4.6201 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.6675 1.5400 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 1.3337 2.3100 0.0 0
M  V30 20 C 2.6675 4.6201 0.0 0
M  V30 21 C 1.3337 3.8500 0.0 0
M  V30 22 C 14.6707 2.3100 0.0 0
M  V30 23 C 16.0043 1.5400 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 17.3381 2.3100 0.0 0
M  V30 26 C 16.0043 4.6201 0.0 0
M  V30 27 C 17.3381 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 19
M  V30 13 1 12 21
M  V30 14 1 13 14
M  V30 15 1 13 25
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H38N2O12
3047659-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6694 13.0900 0.0 0
M  V30 2 O 9.3358 13.8600 0.0 0
M  V30 3 O 12.0032 13.8600 0.0 0
M  V30 4 C 9.3358 15.4000 0.0 0
M  V30 5 C 8.0021 11.5500 0.0 0
M  V30 6 O 8.0021 13.0900 0.0 0
M  V30 7 O 6.6684 10.7800 0.0 0
M  V30 8 C 6.6684 13.8600 0.0 0
M  V30 9 C 10.6694 6.9300 0.0 0
M  V30 10 C 8.0021 8.4700 0.0 0
M  V30 11 O 17.3379 10.7800 0.0 0
M  V30 12 C 18.6716 11.5500 0.0 0
M  V30 13 O 17.3379 13.8600 0.0 0
M  V30 14 C 10.6694 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 O 9.3358 1.5400 0.0 0
M  V30 17 O 6.6684 1.5400 0.0 0
M  V30 18 C 9.3358 0.0000 0.0 0
M  V30 19 C 5.3347 3.8500 0.0 0
M  V30 20 O 5.3347 2.3100 0.0 0
M  V30 21 O 4.0011 4.6200 0.0 0
M  V30 22 C 4.0011 1.5400 0.0 0
M  V30 23 O 1.3336 6.1600 0.0 0
M  V30 24 C 0.0000 6.9300 0.0 0
M  V30 25 O 1.3336 9.2400 0.0 0
M  V30 26 C 12.0031 10.7800 0.0 0
M  V30 27 C 10.6694 11.5500 0.0 0
M  V30 28 C 12.0032 9.2400 0.0 0
M  V30 29 C 9.3358 10.7800 0.0 0
M  V30 30 C 10.6694 8.4700 0.0 0
M  V30 31 N 9.3358 9.2400 0.0 0
M  V30 32 C 13.3369 11.5500 0.0 0
M  V30 33 C 14.6705 10.7800 0.0 0
M  V30 34 C 13.3369 13.0900 0.0 0
M  V30 35 C 16.0041 11.5500 0.0 0
M  V30 36 C 14.6705 13.8600 0.0 0
M  V30 37 C 16.0041 13.0900 0.0 0
M  V30 38 C 9.3358 6.1600 0.0 0
M  V30 39 C 8.0021 6.9300 0.0 0
M  V30 40 N 9.3358 4.6200 0.0 0
M  V30 41 C 6.6684 6.1600 0.0 0
M  V30 42 C 8.0021 3.8500 0.0 0
M  V30 43 C 6.6684 4.6200 0.0 0
M  V30 44 C 5.3347 6.9300 0.0 0
M  V30 45 C 4.0011 6.1600 0.0 0
M  V30 46 C 5.3347 8.4700 0.0 0
M  V30 47 C 2.6674 6.9300 0.0 0
M  V30 48 C 4.0011 9.2400 0.0 0
M  V30 49 C 2.6674 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 29
M  V30 8 1 6 8
M  V30 9 1 9 30
M  V30 10 1 9 38
M  V30 11 1 10 31
M  V30 12 1 11 12
M  V30 13 1 11 35
M  V30 14 1 13 37
M  V30 15 1 14 40
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 42
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 43
M  V30 23 1 20 22
M  V30 24 1 23 24
M  V30 25 1 23 47
M  V30 26 1 25 49
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 32
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 1 41 44
M  V30 46 2 42 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 458-37-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047659-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40794637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14219-31-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated magnetite-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, optimization study, optimized on solvent,
catalyst and time, silica-coated magnetic nanoparticles functionalized
copper catalyst used in stage 2, reusable catalyst in stage 2,
solid-supported catalyst in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One pot multicomponent reaction of curcumin: Green synthesis of novel
1,4-dihydropyridine-2,3-dicarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Motamed, Nasim Khoshlahjeh; Larijani, Kambiz; Pournamdari, Elham;
Saeidian, Hamid; Hargalani, Fariba Zamani
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2024), 61(8), 1306-1313

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-fluoro-3-nitrobenzamide
C11H13FN2O3
474018-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 F 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-(methylamino)-3-nitrobenzamide
C12H17N3O3
474019-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 C 10.6695 3.8500 0.0 0
M  V30 7 C 9.3359 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 9 O 0.0000 3.8500 0.0 0
M  V30 10 O 1.3337 6.1601 0.0 0
M  V30 11 N 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 4.0011 4.6201 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 2.6673 3.8500 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 474018-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 474019-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13382943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel benzimidazole derivatives as selective CB2 inverse agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Page, D.; Brochu, M.-C.; Yang, H.; Brown, W.; St-Onge, S.; Martin, E.;
Salois, D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2006), 3(5), 298-303

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Stearyl acrylate
C21H40O2
4813-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 1.5400 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 6.6687 2.3101 0.0 0
M  V30 4 C 10.6697 1.5400 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 12.0035 2.3101 0.0 0
M  V30 7 O 4.0012 2.3101 0.0 0
M  V30 8 C 13.3372 1.5400 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 14.6708 2.3101 0.0 0
M  V30 11 C 1.3338 2.3101 0.0 0
M  V30 12 O 2.6675 0.0000 0.0 0
M  V30 13 C 16.0045 1.5400 0.0 0
M  V30 14 C 0.0000 1.5400 0.0 0
M  V30 15 C 17.3383 2.3101 0.0 0
M  V30 16 C 18.6720 1.5400 0.0 0
M  V30 17 C 20.0057 2.3101 0.0 0
M  V30 18 C 21.3393 1.5400 0.0 0
M  V30 19 C 22.6731 2.3101 0.0 0
M  V30 20 C 24.0068 1.5400 0.0 0
M  V30 21 C 25.3405 2.3101 0.0 0
M  V30 22 C 26.6742 1.5400 0.0 0
M  V30 23 C 28.0080 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[3-(octadecyloxy)-3-oxopropyl]-β-alanine octadecyl ester
C43H85NO4
166334-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 29.3416 1.5400 0.0 0
M  V30 2 C 30.6753 2.3101 0.0 0
M  V30 3 C 28.0080 2.3101 0.0 0
M  V30 4 C 29.3416 0.0000 0.0 0
M  V30 5 C 32.0091 1.5400 0.0 0
M  V30 6 C 26.6743 1.5400 0.0 0
M  V30 7 C 33.3428 2.3101 0.0 0
M  V30 8 C 25.3405 2.3101 0.0 0
M  V30 9 O 34.6765 1.5400 0.0 0
M  V30 10 O 33.3428 3.8501 0.0 0
M  V30 11 O 24.0068 1.5400 0.0 0
M  V30 12 O 25.3405 3.8501 0.0 0
M  V30 13 C 36.0101 2.3101 0.0 0
M  V30 14 C 22.6731 2.3101 0.0 0
M  V30 15 C 37.3440 1.5400 0.0 0
M  V30 16 C 21.3393 1.5400 0.0 0
M  V30 17 C 38.6776 2.3101 0.0 0
M  V30 18 C 20.0057 2.3101 0.0 0
M  V30 19 C 40.0113 1.5400 0.0 0
M  V30 20 C 18.6720 1.5400 0.0 0
M  V30 21 C 41.3450 2.3101 0.0 0
M  V30 22 C 17.3383 2.3101 0.0 0
M  V30 23 C 42.6788 1.5400 0.0 0
M  V30 24 C 16.0045 1.5400 0.0 0
M  V30 25 C 44.0125 2.3101 0.0 0
M  V30 26 C 14.6708 2.3101 0.0 0
M  V30 27 C 45.3461 1.5400 0.0 0
M  V30 28 C 13.3372 1.5400 0.0 0
M  V30 29 C 46.6798 2.3101 0.0 0
M  V30 30 C 12.0035 2.3101 0.0 0
M  V30 31 C 48.0136 1.5400 0.0 0
M  V30 32 C 10.6697 1.5400 0.0 0
M  V30 33 C 49.3473 2.3101 0.0 0
M  V30 34 C 9.3360 2.3101 0.0 0
M  V30 35 C 50.6810 1.5400 0.0 0
M  V30 36 C 8.0023 1.5400 0.0 0
M  V30 37 C 52.0146 2.3101 0.0 0
M  V30 38 C 6.6687 2.3101 0.0 0
M  V30 39 C 53.3485 1.5400 0.0 0
M  V30 40 C 5.3348 1.5400 0.0 0
M  V30 41 C 54.6821 2.3101 0.0 0
M  V30 42 C 4.0012 2.3101 0.0 0
M  V30 43 C 56.0158 1.5400 0.0 0
M  V30 44 C 2.6675 1.5400 0.0 0
M  V30 45 C 57.3495 2.3101 0.0 0
M  V30 46 C 1.3338 2.3101 0.0 0
M  V30 47 C 58.6833 1.5400 0.0 0
M  V30 48 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 1 37 39
M  V30 39 1 38 40
M  V30 40 1 39 41
M  V30 41 1 40 42
M  V30 42 1 41 43
M  V30 43 1 42 44
M  V30 44 1 43 45
M  V30 45 1 44 46
M  V30 46 1 45 47
M  V30 47 1 46 48
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4813-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166334-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11628201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound 4g
Product CH3N(CH2CH2COOC18H37)2 Yield 97.0 %. Bp [°C/mmHg] or mp 30-31 °C
Molecular formula C43H85NO4 Elemental analysis calcd. (wt%): C, 75.93; H,
12.60; N, 2.06. found (wt%): C, 75.91; H, 12.64; N, 2.02.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-Methyl-2-phenyl-5-(1H-pyrrol-1-yl)thieno[2,3-d]pyrimidin-6-yl]ethanone
C19H15N3OS
487004-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9261 1.5400 0.0 0
M  V30 2 C 0.5925 2.3101 0.0 0
M  V30 3 O 1.9261 0.0000 0.0 0
M  V30 4 C 4.9272 6.8293 0.0 0
M  V30 5 C 3.4209 3.8418 0.0 0
M  V30 6 C 4.9272 4.1619 0.0 0
M  V30 7 C 3.2598 2.3101 0.0 0
M  V30 8 C 5.6972 2.8283 0.0 0
M  V30 9 C 5.6972 5.4956 0.0 0
M  V30 10 S 4.6668 1.6837 0.0 0
M  V30 11 N 7.2372 2.8283 0.0 0
M  V30 12 N 7.2372 5.4956 0.0 0
M  V30 13 C 8.0073 4.1619 0.0 0
M  V30 14 N 2.2763 4.8722 0.0 0
M  V30 15 C 0.7700 4.5520 0.0 0
M  V30 16 C 2.4374 6.4038 0.0 0
M  V30 17 C 0.0000 5.8857 0.0 0
M  V30 18 C 1.0304 7.0303 0.0 0
M  V30 19 C 9.5473 4.1619 0.0 0
M  V30 20 C 10.3173 2.8283 0.0 0
M  V30 21 C 10.3173 5.4956 0.0 0
M  V30 22 C 11.8573 2.8283 0.0 0
M  V30 23 C 11.8573 5.4956 0.0 0
M  V30 24 C 12.6274 4.1619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 13 19
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[4-Methyl-2-phenyl-5-(1H-pyrrol-1-yl)thieno[2,3-d]pyrimidin-6-yl]ethylid...
C20H18N4S
877204-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.2024 0.0 0
M  V30 2 N 1.5400 6.5361 0.0 0
M  V30 3 C 1.5400 3.8686 0.0 0
M  V30 4 C 0.0000 6.5361 0.0 0
M  V30 5 C 7.5535 2.1224 0.0 0
M  V30 6 C 4.7552 3.9564 0.0 0
M  V30 7 C 6.2199 4.4324 0.0 0
M  V30 8 C 3.8500 5.2024 0.0 0
M  V30 9 C 6.2199 5.9724 0.0 0
M  V30 10 C 7.5535 3.6624 0.0 0
M  V30 11 S 4.7552 6.4483 0.0 0
M  V30 12 N 7.5535 6.7424 0.0 0
M  V30 13 N 8.8872 4.4324 0.0 0
M  V30 14 C 8.8872 5.9724 0.0 0
M  V30 15 N 4.2794 2.4919 0.0 0
M  V30 16 C 2.8147 2.0160 0.0 0
M  V30 17 C 5.1846 1.2460 0.0 0
M  V30 18 C 2.8147 0.4760 0.0 0
M  V30 19 C 4.2794 0.0000 0.0 0
M  V30 20 C 10.2208 6.7424 0.0 0
M  V30 21 C 10.2208 8.2824 0.0 0
M  V30 22 C 11.5546 5.9724 0.0 0
M  V30 23 C 11.5546 9.0524 0.0 0
M  V30 24 C 12.8883 6.7424 0.0 0
M  V30 25 C 12.8883 8.2824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 14 20
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487004-87-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877204-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7709614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of
6-acetyl-4-methyl-5-(1-pyrrolyl)-2-phenylthieno[2,3-d]pyrimidine in
heterocyclic synthesis. Convenient route to some Schiff's bases,
chalcones, pyridines, pyridin-2(1H)-ones and 2H-pyran-2-one derivatives
incorporating a 5-(1-pyrrolyl)-2-phenylthieno[2,3-d]pyrimidine moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Yuh-Wen; Yao, Wei-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chinese Chemical Society (Taipei, Taiwan) (2005), 52(2),
313-325

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-fluorophenyl)-6-(1-methylethyl)-2-[(methylsulfonyl)oxy]-5-pyrimid...
C16H17FN2O5S
488798-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 5.3900 1.3336 0.0 0
M  V30 3 O 7.7000 2.6674 0.0 0
M  V30 4 C 6.1600 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 1.5400 2.6674 0.0 0
M  V30 7 C 3.8500 1.3336 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 10 C 1.5400 6.4621 0.0 0
M  V30 11 O 0.0000 8.0021 0.0 0
M  V30 12 O 1.5400 9.5421 0.0 0
M  V30 13 F 12.3200 5.3347 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 N 5.3900 6.6685 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 6.6685 0.0 0
M  V30 19 N 3.0800 5.3347 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 8.4700 6.6685 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 10.0100 6.6685 0.0 0
M  V30 24 C 10.0100 4.0011 0.0 0
M  V30 25 C 10.7800 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 9 12
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-fluorophenyl)-2-(methylamino)-6-(1-methylethyl)-5-pyrimidinecarbo...
C16H18FN3O2
160009-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 O 3.8500 1.3336 0.0 0
M  V30 3 O 6.1600 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 0.0000 2.6674 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 N 1.5400 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 F 10.7800 5.3347 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 N 3.8500 6.6685 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 N 1.5400 5.3347 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 8.4700 6.6685 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 488798-39-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160009-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6381716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [Example 23] Preparation of
(4-(4-fluorophenyl)-6-isopropyl-5-methoxycarbonyl-2-N-methylaminopyrimidine
In a 50 mL-volume glass flask equipped with a stirrer, a thermometer and
a dropping funnel was placed 6.00 g (16.3 mmol.) of
4-(4-fluorophenyl)-6-isopropyl-5-methoxycarbonyl-2-methanesulfonyloxypyrimidine.
Into the flask was slowly dropped under ice-chilling 5.06 g (65.2 mmol)
of aqueous 40 wt.% methylamine solution. The resulting mixture was
stirred for one hour at the same temperature for carrying out reaction.
After the reaction was complete, 16 mL of water was added to the reaction
mixture. The aqueous mixture was then subjected to extraction with
toluene. The toluene portion was separated, washed with a saturated
aqueous sodium chloride solution, and dried over anhydrous magnesium
sulfate. The dried toluene portion was filtered and concentrated under
reduced pressure to give 4.81 g of
4-(4-fluorophenyl)-6-isopropyl-5-methoxycarbonyl-2-N-methylaminopyrimidine.
The yield was 97% (based on the amount of
4-(4-fluorophenyl)-6-isopropyl-5-methoxycarbonyl-2-methanesulfonyloxypyrimidine)
.
(4-(4-fluorophenyl)-6-isopropyl-5-methoxycarbonyl-2-N-methylaminopyrimidine
, Yield 97%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing aminopyrimidine compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsushita, Akio; Oda, Mizuho; Kawachi, Yasuhiro; Chika, Junichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003006439 A1 2003-01-23

$RFMT $RIREG SCHEME296 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Binaphthalene]-2,2′,7,7′-tetrol
C20H14O4
66478-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 4.6201 0.0 0
M  V30 2 O 2.6673 3.0801 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 O 10.6697 3.0801 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0012 5.3901 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 C 4.0012 6.9302 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 6.6685 6.9302 0.0 0
M  V30 11 C 5.3348 7.7002 0.0 0
M  V30 12 C 2.6673 7.7002 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 8.0023 3.0801 0.0 0
M  V30 20 C 4.0012 0.7700 0.0 0
M  V30 21 C 5.3348 0.0000 0.0 0
M  V30 22 C 8.0023 0.0000 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 9.3360 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 3 13
M  V30 4 1 4 23
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 11
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 2 20 21
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′,3,3′-Tetrahydro-2,2′-dimethyl[10,10′-bi-1H-naphth[1,2-e][1,3]oxazine]-9,...
C26H24N2O4
1381799-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 1.1550 0.0 0
M  V30 2 O 6.0015 7.7000 0.0 0
M  V30 3 C 5.3347 8.8550 0.0 0
M  V30 4 C 6.0015 0.0000 0.0 0
M  V30 5 C 2.6673 4.2350 0.0 0
M  V30 6 C 4.0011 3.4650 0.0 0
M  V30 7 C 2.6673 5.7750 0.0 0
M  V30 8 C 1.3336 3.4650 0.0 0
M  V30 9 C 4.0011 1.9250 0.0 0
M  V30 10 C 1.3336 6.5450 0.0 0
M  V30 11 C 4.0011 6.5450 0.0 0
M  V30 12 C 0.0000 4.2350 0.0 0
M  V30 13 C 1.3336 1.9250 0.0 0
M  V30 14 C 2.6673 1.1550 0.0 0
M  V30 15 C 0.0000 5.7750 0.0 0
M  V30 16 O 1.3336 8.0850 0.0 0
M  V30 17 N 4.0011 8.0850 0.0 0
M  V30 18 C 2.6673 8.8550 0.0 0
M  V30 19 C 7.3352 5.3900 0.0 0
M  V30 20 C 8.6690 4.6200 0.0 0
M  V30 21 C 7.3352 6.9300 0.0 0
M  V30 22 C 8.6690 3.0800 0.0 0
M  V30 23 C 10.0026 5.3900 0.0 0
M  V30 24 C 8.6690 7.7000 0.0 0
M  V30 25 C 10.0026 2.3100 0.0 0
M  V30 26 C 7.3352 2.3100 0.0 0
M  V30 27 C 11.3362 4.6200 0.0 0
M  V30 28 C 10.0026 6.9300 0.0 0
M  V30 29 C 11.3362 3.0800 0.0 0
M  V30 30 O 10.0026 0.7700 0.0 0
M  V30 31 N 7.3352 0.7700 0.0 0
M  V30 32 C 8.6690 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 21
M  V30 3 1 3 17
M  V30 4 1 4 31
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 19
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 15
M  V30 19 2 13 14
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 22 26
M  V30 29 2 23 27
M  V30 30 1 23 28
M  V30 31 2 24 28
M  V30 32 2 25 29
M  V30 33 1 25 30
M  V30 34 1 26 31
M  V30 35 1 27 29
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 66478-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1381799-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-7074799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,2'-Dimethyl-2,3,2',3'-tetrahydro-1H,1'H-[10,10']bi[naphtho[1,2-e][1,3]oxazinyl]-9,9'-diol:
Intermediate of compound (12) A solution of 37% w/v formaldehyde solution
(0.45 g, 1.22 mL, 15.0 mmol) and 40% w/v methylamine solution (0.215 g,
0.536 mL, 6.91 mmol) in methanol stirred for 30 min under nitrogen
atmosphere, to this solution 7,7'-dihydroxy-2,2'-binaphthol 7 (1.00 g,
3.14 mmol) was added in one portion. Then the solution was stirred for 48
h at 60 °C. The white precipitate was separated out filter the solid
washed with methanol (3x10mL) the solid was dried under vacuum. Yield =
0.775 g (57.57%). The mother liquor and washings are combined together
and concentrated to obtained brown solid. The crude product was purified
by column chromatography on silica gel using gradient petroleum ether:
ethyl acetate 100:0 to 50:50 as eluent to obtain a white solid dried in
vacuum. Yield = 0.525 g (39%). Yield = 1.3 g, (96.75%). M.p. 209-210 °C.
1H NMR (CDCl3, 400 MHz): δ 7.85-7.83 (d, J = 8.4 Hz, 2H), 7.69-7.67 (d, J
= 8.8 Hz, 2H), 7.15- 7.13 (d, J = 8.8 Hz, 2H), 6.96-6.94 (d, J = 8.8 Hz),
5.06 (s, 2H, -OH), 4.75-4.73 (d, J = 9.2 Hz, 2H), 4.62-4.59 (d, J = 9.2
Hz, 2H), 3.65-3.61 (d, J = 16.8 Hz, 2H), 3.22-3.17 (d, J = 16.8 Hz, 2H),
2.82 (s, 6H). 13C NMR (CDCl3, 100 MHz): δ 153.97 (Cq), 153.60 (Cq),
133.16 (CH), 132.92 (Cq), 129.80 (CH), 125.82 (Cq), 117.03 (CH), 114.33
(CH), 111.88 (Cq), 111.32 (Cq), 82.36 (OCH2N), 50.85 (ArCH2N), 39.25
(NCH3). MS (EI): m/z, (%) 429 (15), 428 (53), 427 (13), 385 (13), 384
(13), 370 (13), 369 (17), 368 (31), 325 (22), 324 (13), 314 (14), 313
(34), 297 (24), 295 (14), 271 (14), 239 (27), 226 (21), 213 (19), 58
(100), 57 (34). Anal. Calcd. for C26H24N2O4: C 72.88, H 5.64; N 6.54.
Found: C 72.78, H 5.40, N 6.64. IR (KBr): 3464, 2891, 1613, 1519, 1455,
1345, 1302, 1250, 1087, 1021, 938, 878, 861, 815, 756, 700, 598 cm.-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Chiral Helical 1,3-Oxazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Talele, Harish R.; Sahoo, Sibaprasad; Bedekar, Ashutosh V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(12), 3166-3169

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4,5-dimethoxybenzenesulfonyl chloride
C8H8BrClO4S
51072-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 4.0011 0.0 0
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 O 6.1600 1.3338 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 Br 3.0800 6.6685 0.0 0
M  V30 6 S 1.5400 4.0011 0.0 0 VAL=6
M  V30 7 Cl 0.0000 4.0011 0.0 0
M  V30 8 O 1.5400 5.5411 0.0 0
M  V30 9 O 1.5400 2.4611 0.0 0
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4,5-dimethoxy-N-methylbenzenesulfonamide
C9H12BrNO4S
923126-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 5.3901 0.0 0 VAL=6
M  V30 2 N 1.3337 6.1601 0.0 0
M  V30 3 O 1.8975 4.0564 0.0 0
M  V30 4 O 3.4375 6.7238 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 Br 5.3348 6.9302 0.0 0
M  V30 7 O 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 8.0023 2.3101 0.0 0
M  V30 10 C 9.3360 3.0801 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51072-64-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 923126-56-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31526288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Environmentally friendly catechol-based synthesis of dibenzosultams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liljenberg, Sara; Nain-Perez, Amalyn; Nilsson, Oscar; Matic, Josipa;
Groetli, Morten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2022), 46(12), 5593-5605

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
6-Phenoxynicotinic acid
C12H9NO3
51362-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 C 9.3360 1.5400 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3360 0.0000 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 5.3348 2.3101 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-phenoxy-3-pyridinecarboxamide
C13H12N2O2
595576-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 C 9.3360 1.5400 0.0 0
M  V30 3 N 10.6697 2.3101 0.0 0
M  V30 4 O 9.3360 0.0000 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 N 5.3348 2.3101 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 51362-38-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 595576-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5979837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cycloauration of substituted 2-phenoxypyridine derivatives and X-ray
crystal structure of gold,
dichloro[2-[[5-[(cyclopentylamino)carbonyl]-2-pyridinyl-κN]oxy]phenyl-κC]-,
(SP-4-3)-
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Yongbao; Cameron, Beth R.; Skerlj, Renato T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2003), 677(1-2), 57-72

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl squarate
C8H10O4
5231-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9014 2.2960 0.0 0
M  V30 2 C 7.2351 3.0661 0.0 0
M  V30 3 C 8.5687 2.2960 0.0 0
M  V30 4 O 2.3101 1.3337 0.0 0
M  V30 5 C 0.7700 1.3337 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 O 4.9390 5.8872 0.0 0
M  V30 8 O 1.3478 4.9250 0.0 0
M  V30 9 C 4.5676 3.0661 0.0 0
M  V30 10 C 3.0801 2.6673 0.0 0
M  V30 11 C 4.1690 4.5536 0.0 0
M  V30 12 C 2.6815 4.1550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 7 11
M  V30 8 2 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-4-(methylamino)-3-cyclobutene-1,2-dione
C5H5NO3
876131-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.2579 2.6290 0.0 0
M  V30 2 C 6.0279 3.9626 0.0 0
M  V30 3 O 2.6290 5.2579 0.0 0
M  V30 4 O 2.6290 0.0000 0.0 0
M  V30 5 O 0.0000 2.6290 0.0 0
M  V30 6 C 3.7179 2.6290 0.0 0
M  V30 7 C 2.6290 3.7179 0.0 0
M  V30 8 C 2.6290 1.5400 0.0 0
M  V30 9 C 1.5400 2.6290 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 1 4 8
M  V30 5 2 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5231-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876131-58-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-4584333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 11114-15-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dowex 50wx8(H+) used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and properties of new nucleotide analogs possessing squaramide
moieties as new phosphate isosters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seio, Kohji; Miyashita, Takuhei; Sato, Kousuke; Sekine, Mitsuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2005), (24), 5163-5170

$RFMT $RIREG SCHEME300 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-1-[2′-(trifluoromethoxy)[1,1′-biphenyl]-3-yl]-1H-pyrazole-3-methanol
C18H15F3N2O2
784141-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 4.0011 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 F 0.7700 5.3347 0.0 0
M  V30 4 F 0.0000 4.0011 0.0 0
M  V30 5 F 0.7700 2.6674 0.0 0
M  V30 6 C 10.4394 8.0453 0.0 0
M  V30 7 C 13.6258 3.6595 0.0 0
M  V30 8 O 15.0326 4.2860 0.0 0
M  V30 9 C 6.1600 4.0011 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 C 8.4700 5.3347 0.0 0
M  V30 13 C 6.1600 6.6684 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 5.3900 2.6674 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 6.1600 1.3336 0.0 0
M  V30 18 C 3.0800 1.3336 0.0 0
M  V30 19 C 5.3900 0.0000 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 N 10.0101 5.3347 0.0 0
M  V30 22 N 10.9153 4.0889 0.0 0
M  V30 23 C 10.9153 6.5806 0.0 0
M  V30 24 C 12.3798 4.5647 0.0 0
M  V30 25 C 12.3798 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 21
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-methanol, 5-methyl-1-[2′-(trifluoromethoxy)[1,1′-biphenyl]-3-yl...
C20H18F3N3O3
784141-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 4.0442 0.0 0
M  V30 2 C 1.5400 4.0442 0.0 0
M  V30 3 F 0.7700 2.7106 0.0 0
M  V30 4 F 0.0000 4.0442 0.0 0
M  V30 5 F 0.7700 5.3779 0.0 0
M  V30 6 C 10.4394 0.0000 0.0 0
M  V30 7 C 13.6258 4.3858 0.0 0
M  V30 8 O 15.0326 3.7593 0.0 0
M  V30 9 C 16.2785 4.6645 0.0 0
M  V30 10 N 17.6855 4.0382 0.0 0
M  V30 11 O 16.1176 6.1961 0.0 0
M  V30 12 C 18.9313 4.9434 0.0 0
M  V30 13 C 6.1600 4.0442 0.0 0
M  V30 14 C 7.7000 4.0442 0.0 0
M  V30 15 C 5.3900 2.7106 0.0 0
M  V30 16 C 8.4700 2.7106 0.0 0
M  V30 17 C 6.1600 1.3769 0.0 0
M  V30 18 C 7.7000 1.3769 0.0 0
M  V30 19 C 5.3900 5.3779 0.0 0
M  V30 20 C 3.8500 5.3779 0.0 0
M  V30 21 C 6.1600 6.7117 0.0 0
M  V30 22 C 3.0800 6.7117 0.0 0
M  V30 23 C 5.3900 8.0453 0.0 0
M  V30 24 C 3.8500 8.0453 0.0 0
M  V30 25 N 10.0101 2.7106 0.0 0
M  V30 26 N 10.9153 3.9564 0.0 0
M  V30 27 C 10.9153 1.4647 0.0 0
M  V30 28 C 12.3798 3.4806 0.0 0
M  V30 29 C 12.3800 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 27
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 16 25
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 784141-23-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 784141-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-12890119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM {5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3
-yl]-1H-pyrazol-3-yl}methyl methylcarbamate To the solution of the
alcohol from EXAMPLE 123 (0.050g, 0.14mmol) in dry dichloromethane (3mL)
was added 1,1'-carbonyldiimidazole (0.023g, 0.14mmol). The reaction
solution was stirred at room temperature for one hour before the
methylamine was added. The reaction was then stirred at the same
temperature for overnight. The reaction was quenched with 10% HCl
aqueous, and extracted with dichloromethane (3 times). The combined
organic layer was washed with brine, and dried over anhydrous sodium
sulfate. The product was purified via a column chromatography on silica
gel. The carbamate was obtained. White solid, yield 0.0565g, 97%. 1H NMR
(CDCl3) (δ, ppm): 7.56-7.37 (m, 10H), 6.37 (s, 1H), 5.59 (s, 2H), 2.36
(s, 3H). MS (ESI): m/e 428.0 (M+Na)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl-substituted pyrazoles as sodium channel blockers, and their
preparation, pharmaceutical compositions, and use in the treatment of
pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chakravarty, Prasun K.; Fisher, Michael H.; Parsons, William H.;
Tyagarajan, Sriram; Zhou, Bishan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004092140 A1 2004-10-28

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41455678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details,intermediate from stage 1 added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the preparation of intermediates of
chlorantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tripati, Awinesh; Jampani, Amarnath; Sanaka, Ganapathi; Arudra, Veeraiah;
Samatham, Radha Rani; Madalapu, Veerababu; Muddasani, Pulla Reddy;
Nannapaneni, Venkaiah Chowdary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024116196 A1 2024-06-06

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42880486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, stage 1 intermediate added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the preparation of intermediates of
chlorantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tripati, Awinesh; Jampani, Amarnath; Sanaka, Ganapathi; Arudra, Veeraiah;
Samatham, Radha Rani; Madalapu, Veerababu; Muddasani, Pulla Reddy;
Nannapaneni, Venkaiah Chowdary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202241068895 A 2024-05-31

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42481592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, stage 1 intermediate added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the preparation of intermediate of
cyantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tripati, Awinesh; Jampani, Amarnath; Arudra, Veeraiah; Samatham, Radha
Rani; Madalapu, Veerababu; Muddasani, Pulla Reddy; Nannapaneni, Venkaiah
Chowdary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202241068896 A 2024-05-31

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3-Fluoro-4-nitrophenyl)methyl]morpholine
C11H13FN2O3
552883-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 F 9.3360 4.6201 0.0 0
M  V30 3 N 9.3360 1.5400 0.0 0 VAL=5
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 8.0023 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 N 2.6673 3.8501 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 O 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(4-morpholinylmethyl)-2-nitrobenzenamine
C12H17N3O3
552883-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 1.3337 4.6201 0.0 0
M  V30 3 C 1.3337 6.1601 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 8.0023 3.8501 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 O 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552883-91-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 552883-99-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4998705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The design and development of 2-aryl-2-hydroxy ethylamine substituted
1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human
cytomegalovirus polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanis, Steven P.; Strohbach, Joseph W.; Parker, Timothy T.; Moon, Malcom
W.; Thaisrivongs, Suvit; Perrault, William R.; Hopkins, Todd A.;
Knechtel, Mary L.; Oien, Nancee L.; Wieber, Janet L.; Stephanski, Kevin
J.; Wathen, Michael W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(6), 1994-2000

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
(2R)-1-[(1R)-1-(Dimethylamino)ethyl]-2-(diphenylphosphino)ferrocene
C26H28FeNP
55700-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 8.1784 12.8450 0.0 0
M  V30 2 C 3.4063 16.1265 0.0 0 CFG=1
M  V30 3 N 4.6315 16.8366 0.0 0
M  V30 4 C 2.1812 16.8366 0.0 0
M  V30 5 C 5.8567 16.1265 0.0 0
M  V30 6 C 4.6315 18.2491 0.0 0
M  V30 7 Fe 3.4063 7.3238 0.0 0 CHG=2 VAL=10
M  V30 8 C 6.7932 12.5524 0.0 0 CHG=-1 CFG=1 VAL=4
M  V30 9 C 3.4063 14.7140 0.0 0 CFG=2 VAL=5
M  V30 10 C 4.6628 11.3194 0.0 0 CFG=2 VAL=5
M  V30 11 C 0.0780 12.5524 0.0 0 CFG=1 VAL=5
M  V30 12 C 2.2007 11.3194 0.0 0 CFG=2 VAL=5
M  V30 13 C 0.0000 2.1655 0.0 0 CHG=-1 VAL=4
M  V30 14 C 6.7190 2.1655 0.0 0 VAL=5
M  V30 15 C 4.5886 3.3985 0.0 0 VAL=5
M  V30 16 C 2.1226 3.3985 0.0 0 VAL=5
M  V30 17 C 3.3322 0.0000 0.0 0 VAL=5
M  V30 18 C 9.4035 13.5552 0.0 0
M  V30 19 C 9.4035 15.0886 0.0 0
M  V30 20 C 10.7341 12.7865 0.0 0
M  V30 21 C 10.7341 15.8573 0.0 0
M  V30 22 C 12.0646 13.5552 0.0 0
M  V30 23 C 12.0646 15.0886 0.0 0
M  V30 24 C 8.1784 11.4325 0.0 0
M  V30 25 C 6.8439 10.6639 0.0 0
M  V30 26 C 9.5050 10.6639 0.0 0
M  V30 27 C 6.8439 9.1265 0.0 0
M  V30 28 C 9.5050 9.1265 0.0 0
M  V30 29 C 8.1784 8.3578 0.0 0
M  V30 30 H 4.2960 12.6850 0.0 0
M  V30 31 H 2.5674 12.6850 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 2 3 CFG=1
M  V30 5 1 2 4
M  V30 6 1 2 9
M  V30 7 1 3 5
M  V30 8 1 3 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 13
M  V30 15 1 7 14
M  V30 16 1 7 15
M  V30 17 1 7 16
M  V30 18 1 7 17
M  V30 19 1 8 9
M  V30 20 1 8 10
M  V30 21 2 9 11
M  V30 22 2 10 12
M  V30 23 1 10 30 CFG=1
M  V30 24 1 11 12
M  V30 25 1 12 31 CFG=1
M  V30 26 1 13 16
M  V30 27 1 13 17
M  V30 28 1 14 15
M  V30 29 2 14 17
M  V30 30 2 15 16
M  V30 31 2 18 19
M  V30 32 1 18 20
M  V30 33 1 19 21
M  V30 34 2 20 22
M  V30 35 2 21 23
M  V30 36 1 22 23
M  V30 37 2 24 25
M  V30 38 1 24 26
M  V30 39 1 25 27
M  V30 40 2 26 28
M  V30 41 2 27 29
M  V30 42 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 8 9 10 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-1-(Diphenylphosphino)-2-[(1R)-1-(methylamino)ethyl]ferrocene
C25H26FeNP
406681-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 8.1045 12.7328 0.0 0
M  V30 2 C 3.3756 15.9847 0.0 0 CFG=1
M  V30 3 N 4.5897 16.6845 0.0 0
M  V30 4 C 2.1615 16.6845 0.0 0
M  V30 5 C 5.9237 15.9151 0.0 0
M  V30 6 Fe 3.3756 7.2615 0.0 0 CHG=2 VAL=10
M  V30 7 C 6.7318 12.4428 0.0 0 CHG=-1 CFG=1 VAL=4
M  V30 8 C 3.3756 14.5811 0.0 0 CFG=2 VAL=5
M  V30 9 C 4.6206 11.2210 0.0 0 CFG=2 VAL=5
M  V30 10 C 0.0773 12.4428 0.0 0 CFG=1 VAL=5
M  V30 11 C 2.1808 11.2210 0.0 0 CFG=2 VAL=5
M  V30 12 C 0.0000 2.1460 0.0 0 CHG=-1 VAL=4
M  V30 13 C 6.6584 2.1460 0.0 0 VAL=5
M  V30 14 C 4.5472 3.3717 0.0 0 VAL=5
M  V30 15 C 2.1035 3.3717 0.0 0 VAL=5
M  V30 16 C 3.3021 0.0000 0.0 0 VAL=5
M  V30 17 C 9.3186 13.4327 0.0 0
M  V30 18 C 9.3186 14.9562 0.0 0
M  V30 19 C 10.6371 12.6710 0.0 0
M  V30 20 C 10.6371 15.7179 0.0 0
M  V30 21 C 11.9556 13.4327 0.0 0
M  V30 22 C 11.9556 14.9562 0.0 0
M  V30 23 C 8.1045 11.3292 0.0 0
M  V30 24 C 6.7821 10.5675 0.0 0
M  V30 25 C 9.4191 10.5675 0.0 0
M  V30 26 C 6.7821 9.0479 0.0 0
M  V30 27 C 9.4191 9.0479 0.0 0
M  V30 28 C 8.1045 8.2862 0.0 0
M  V30 29 H 4.2572 12.5743 0.0 0
M  V30 30 H 2.5442 12.5743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3 CFG=1
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 1 7 9
M  V30 20 2 8 10
M  V30 21 2 9 11
M  V30 22 1 9 29 CFG=1
M  V30 23 1 10 11
M  V30 24 1 11 30 CFG=1
M  V30 25 1 12 15
M  V30 26 1 12 16
M  V30 27 1 13 14
M  V30 28 2 13 16
M  V30 29 2 14 15
M  V30 30 2 17 18
M  V30 31 1 17 19
M  V30 32 1 18 20
M  V30 33 2 19 21
M  V30 34 2 20 22
M  V30 35 1 21 22
M  V30 36 2 23 24
M  V30 37 1 23 25
M  V30 38 1 24 26
M  V30 39 2 25 27
M  V30 40 2 26 28
M  V30 41 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 7 8 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55700-44-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 406681-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-18097905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl R-1-(S-2-Diphenylphosphino)ferrocenyl ethylamine (R,S-4b).
Dimethylamino compound R,S-2 (99.9 g; 0.23 mol) was combined with acetic
anhydride (72.8 mL; 0.77 mol; 3.35 equiv), and the heterogeneous mixture
was heated under nitrogen to 90 °C during which time it became
homogeneous. The reaction mixture was held at 90 °C for 3.5 h, at which
point TLC analysis indicated no 2 but much 3 (1:4 EtOAc/heptane, Et3N
deactivated). The mixture was cooled to ambient temperature. Aqueous
methylamine (359.5 g; 4.63 mol; 20.1 equiv) was dissolved in 2-propanol
(463 mL) in a separate flask and cooled to 20 °C. The mixture containing
3 was added over 25 min to the amine mixture with an attendant minor
exotherm (maximum temperature was 26.0 °C) and washed in with 116 mL of
warm (40-50 °C) 2-propanol. The mixture was heated to 50 °C overnight (17
h) to afford a homogeneous solution which had no remaining 3 according to
TLC analysis (1:4 EtOAc/heptane, Et3N deactivated). The mixture was
cooled to 24 °C, and water (1158 mL) was added. This resulted in a
moderate exotherm (maximum temperature 32 °C) and an orange precipitate.
The mixture was stirred at ambient temperature for 30 min and the solid
was filtered, washed with water, and dried in a nitrogen-purged vacuum
oven at 40 °C for 2 days to afford 93.8 g (95% overall) of R,S- 4b as an
orange solid which was pure by 1H NMR analysis. An analytical sample
could be obtained by recrystallization from 2-propanol. Mp: 112-113 °C.
1H NMR (CDCl3) δ: 7.55 (m, 2H); 7.37 (m, 3 H); 7.26 (m, 5H); 4.463 (br s,
1H); 4.286 (m, 1H); 4.028 (s, 5H); 3.94 (m, 1H); 3.78 (m, 1H); 1.943 (s,
3H); 1.445 (d, 3H, J = 6.59 Hz). 13C NMR (CDCl3) δ: 140.0 (d, J C-P = 10
Hz); 137.1 (d,J C-P = 9 Hz); 134.9 (d, J C-P = 21 Hz); 132.9 (d, J C-P =
19 Hz); 129.2 (s); 128.6 (s); 128.5 (d,J C-P = 6 Hz); 128.3 (d, J C-P = 7
Hz); 97.5 (d, J C-P = 24 Hz); 75.5 (d, J C-P = 7 Hz); 71.3 (d, J C-P = 4
Hz); 69.8 (s); 69.5 (d, J C-P = 4 Hz); 69.1 (s); 52.5 (d, J C-P = 10 Hz);
32.8 (s); 18.8 (s). 31P NMR (acetone-d 6) δ: -26.0 (s). FDMS: m/z 427
(M+). [α]24 D = -309 (c 1.55, ethanol). Anal. Calcd for C25H26FeNP: C,
70.27; H, 6.13; N, 3.28. Found: C, 70.64; H, 6.37; N, 3.16.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and application of phosphinoferrocenylaminophosphine ligands
for asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boaz, Neil W.; Mackenzie, Elaine B.; Debenham, Sheryl D.; Large, Shannon
E.; Ponasik, James A. Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(5), 1872-1880

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Glycine
C2H5NO2
56-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylglycinamide
C3H8N2O
22356-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 N 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22356-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19668214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bioinspired Radical Stetter Reaction: Radical Umpolung Enabled by
Ion-Pair Photocatalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morack, Tobias; Mueck-Lichtenfeld, Christian; Gilmour, Ryan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(4), 1208-1212

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
3-(Cyanomethyl)benzoic acid
C9H7NO2
5689-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 3 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Cyanomethyl)-N-methylbenzamide
C10H10N2O
791717-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 1.5400 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 N 10.6697 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 3 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5689-33-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 791717-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11242313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) 3-(Cyanomethyl)-N-methylbenzamide Thionyl chloride (0.4 ml, 5.55 mmol)
was added dropwise to a stirred and cooled (0 °C) solution of
3-(cyanomethyl)benzoic acid (745 mg, 4.62 mmol) and DMF (0.3 ml) in
anhydrous dichloromethane (5 ml). The resulting mixture was refluxed for
1.5 h. The reaction mixture was then cooled to ambient temperature and
added dropwise to methylamine (1.43 ml, 16.6 mmol, 40% solution in water)
at 0 °C, and the resulting mixture was stirred at 0 °C for 1 h. The
reaction mixture was then partitioned between water and dichloromethane,
and the water phase was extracted with dichloromethane. The combined
organic phases were dried (Na2SO4) and concentrated in vacuo to give the
title compound. Yield 778 mg, 97%. 1H NMR (DMSO-d6): δ 8.49 (1H, br s),
7.83 (1H, s), 7.78 (1H, m), 7.49 (2H, m), 4.10 (2H, s), 2.79 (3H, d,
J=4.55 Hz); MS (ESI) m/z 175 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of [1,2,4]triazole-3-thiones as inhibitors of myeloperoxidase
for the treatment of neuroinflammatory disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Svensson, Mats; Tiden, Anna-Karin; Turek, Dominika
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096781 A1 2004-11-11

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloroacetanilide
C8H8ClNO
587-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 Cl 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-phenylacetamide
C9H12N2O
31110-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-65-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31110-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8552606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME307 STEP1
$RXN



  3  1
$MOL
3-Bromoaniline
C6H6BrN
591-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(3-Bromophenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H9BrN2O2
920874-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 4.0286 0.0 0
M  V30 2 O 2.2420 5.3914 0.0 0
M  V30 3 C 0.0000 2.9016 0.0 0
M  V30 4 O 1.6752 0.0000 0.0 0
M  V30 5 Br 10.6376 4.0286 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0
M  V30 7 C 2.5622 3.8850 0.0 0
M  V30 8 C 3.8080 1.7270 0.0 0
M  V30 9 N 1.5317 2.7405 0.0 0
M  V30 10 C 2.3017 1.4068 0.0 0
M  V30 11 C 6.6365 3.2586 0.0 0
M  V30 12 C 7.9701 4.0286 0.0 0
M  V30 13 C 6.6365 1.7185 0.0 0
M  V30 14 C 9.3038 3.2586 0.0 0
M  V30 15 C 7.9701 0.9485 0.0 0
M  V30 16 C 9.3038 1.7185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 591-19-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920874-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7996770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-(trifluoromethyl)benzaldehyde
C8H4F4O
60611-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 F 4.5648 4.4137 0.0 0
M  V30 3 F 6.6687 3.8501 0.0 0
M  V30 4 F 6.1048 1.7464 0.0 0
M  V30 5 C 2.6675 4.6201 0.0 0
M  V30 6 O 1.3338 5.3901 0.0 0
M  V30 7 F 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-6-(trifluoromethyl)benzenemethanamine
C9H9F4N
958863-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3338 0.0 0
M  V30 2 F 4.4137 2.1038 0.0 0
M  V30 3 F 3.8501 0.0000 0.0 0
M  V30 4 F 1.7464 0.5638 0.0 0
M  V30 5 C 4.6201 4.0012 0.0 0
M  V30 6 N 5.3901 5.3348 0.0 0
M  V30 7 C 6.9302 5.3348 0.0 0
M  V30 8 F 3.0801 6.6687 0.0 0
M  V30 9 C 2.3101 2.6675 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 C 0.7700 2.6675 0.0 0
M  V30 12 C 2.3101 5.3348 0.0 0
M  V30 13 C 0.0000 4.0012 0.0 0
M  V30 14 C 0.7700 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60611-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958863-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-fluorobenzaldehyde
C7H4ClFO
61072-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 Cl 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chloro-2-fluorophenyl)methylene]methanamine
C8H7ClFN
1289570-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 C 8.4702 4.0010 0.0 0
M  V30 4 F 4.6201 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61072-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289570-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7825991
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of intermediate
[1-(4-chloro-phenyl)-meth-(E)-ylidene]-methyl-amine A mixture of
4-chloro-2-fluoro-benzoaldehyde (Matrix Sci, 3.17 g, 20.0 mmol) and
methyl amine (2.0 M in THF, Aldrich, 15 mL, 15.0 mmol) in CH2Cl2 (20 mL)
was stirred at rt overnight. The reaction mixture was concentrated and
the residue was dried under reduced pressure to aflbrd
[[1-(4-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methylamine (3.32 g,
97.0%) as colorless oil which was used in the next step without further
purification.
[1-(4-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methylamine, yield (3.32
g, 97.0%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartkovitz, David Joseph; Chu, Xin-Jie; Liu, Jin-Jun; Morgan Ross, Tina;
Zhang, Zhuming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110086854 A1 2011-04-14

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-iodobenzene
C6H4ClI
615-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 2.6673 0.0 0
M  V30 2 I 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzenamine
C7H8ClN
932-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 932-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2792677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
4-Iodobenzoic acid
C7H5IO2
619-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methylbenzamide
C8H8INO
89976-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89976-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3664481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed synthesis of phosphonium salts from aryl halides and
triphenylphosphine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marcoux, David; Charette, Andre B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2008), 350(18), 2967-2974

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzoic acid
C7H5NO4
62-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-nitrobenzoate
C8H7NO4
619-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-9163462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl glycolate
C4H8O3
623-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methylacetamide
C3H7NO2
5415-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5415-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10555585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Aqueous methylamine (40 wt %, 825 mL, 10630.00 mmol) was added to THF (1
L), and the solution was cooled to 10 °C. Ethyl glycolate (500 g, 4800.00
mmol) was added slowly with stirring at a rate so as to maintain the
internal temperature between 15 and 20 °C (ca. 1 h). The reaction mixture
was concentrated under reduced pressure to an oil. The oil was
coevaporated with anhydrous acetonitrile. Diethyl ether (1 L) was added
to the oil, which caused a white solid to form exothermically (Caution:
add slowly to prevent ether from boiling over). After stirring, the
slurry was filtered and the resulting solid was washed with diethyl ether
(500 mL) and then hexanes (2 x 500 mL) and then dried. Product, yield 417
g, 97%. White irregular crystals. mp 64-66 °C; 1H NMR (200 MHz, DMSO-d6)
δ 2.80 (d, J = 37 Hz, 2 H), 4.00 (s, 3 H), 4.4 (br s, 1 H), 7.0 (br s, 1
H); 13C NMR (75 MHz, DMSO-d6) δ 25.6, 61.9, 173.4; HRMS (EI) m/z calcd
for C3H7NO2+ 89.0477, found 89.0477.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Comparing In Vitro and In Vivo Activity of
2'-O-[2-(Methylamino)-2-oxoethyl]- and 2'-O-Methoxyethyl-Modified
Antisense Oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prakash, Thazha P.; Kawasaki, Andrew M.; Wancewicz, Edward V.; Shen,
Lijiang; Monia, Brett P.; Ross, Bruce S.; Bhat, Balkrishen; Manoharan,
Muthiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(9), 2766-2776

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluorobenzenesulfonyl chloride
C6H3BrClFO2S
631912-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 F 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluoro-N-methylbenzenesulfonamide
C7H7BrFNO2S
1864395-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 631912-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1864395-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35591914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocyclic YAP/TAZ-TEAD modulators and KRAS inhibitors for
use in combination chemotherapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Anwesha; Evangelista, Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022246459 A1 2022-11-24

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluorobenzenesulfonyl chloride
C6H3BrClFO2S
631912-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 F 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluoro-N-methylbenzenesulfonamide
C7H7BrFNO2S
1864395-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 631912-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1864395-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-21356659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzosulfonyl compounds as anticancer agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konradi, Andrei W.; Lin, Tracy Tzu-Ling Tang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019040380 A1 2019-02-28

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methyl-3-nitro-N-phenylbenzenesulfonamide
C13H11ClN2O4S
6409-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 2.3101 0.0 0 VAL=6
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 O 6.1048 0.9764 0.0 0
M  V30 4 O 4.5648 3.6437 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0 VAL=5
M  V30 7 O 12.0033 3.0801 0.0 0
M  V30 8 O 10.6697 0.7700 0.0 0
M  V30 9 Cl 10.6697 5.3901 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 5.3901 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 16
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 13
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(methylamino)-3-nitro-N-phenylbenzenesulfonamide
C14H15N3O4S
1095501-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0022 5.3901 0.0 0
M  V30 3 O 7.4385 3.2864 0.0 0
M  V30 4 O 5.8985 5.9538 0.0 0
M  V30 5 C 8.0022 6.9302 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 9.3360 3.0801 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 2 17
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6409-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1095501-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9333805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3. N-methyl-4-(methylamino)-3-nitro-N-phenylbenzene sulfonamide. A
solution of 4-chloro-N-methyl-3-nitro-N-phenylbenzoyl sulfonamide (9.4 g,
0.029 mol) in ethanol (50 ml) was combined with 25 ml of an aqueous
solution of 40% methylamine. The reaction mixture was heated to 70°C and
stirred at this temperature for 1 h. After cooling and filtering, the
filter cake was washed with ethanol and dried at 60°C. The yield of
N-methyl-4-(methylamino)-3-nitro-N-phenylbenzoyl sulfonamide was 9.0 g
(97%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylsulfonyloxy- and arylsulfamoyl-alkylammonium salts as thrombin
inhibitors and their preparation, and pharmaceutical compositions and use
in the treatment of thromboembolic disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sinauridze, Elena Ivanovna; Ataullakhanov, Fazoil Inoyatovich; Butylin,
Andrey Alexandrovich; Sulimov, Vladimir Borisovich; Romanov, Alexey
Nickolayevich; Bogolyubov, Alexey Alexeevich; Kuznetsov, Yury
Vladimirovich; Gribkova, Irina Vladimirovna; Gorbatenko, Alexander
Sergeevich; Kondakova, Olga Anatolievna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009002228 A2 2008-12-31

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methyl-3-nitro-N-phenylbenzenesulfonamide
C13H11ClN2O4S
6409-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 2.3101 0.0 0 VAL=6
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 O 6.1048 0.9764 0.0 0
M  V30 4 O 4.5648 3.6437 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0 VAL=5
M  V30 7 O 12.0033 3.0801 0.0 0
M  V30 8 O 10.6697 0.7700 0.0 0
M  V30 9 Cl 10.6697 5.3901 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 5.3901 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 16
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 13
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(methylamino)-3-nitro-N-phenylbenzenesulfonamide
C14H15N3O4S
1095501-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0022 5.3901 0.0 0
M  V30 3 O 7.4385 3.2864 0.0 0
M  V30 4 O 5.8985 5.9538 0.0 0
M  V30 5 C 8.0022 6.9302 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 9.3360 3.0801 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 2 17
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6409-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1095501-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10626680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3. N-methyl-4-(methylarnino)-3-nitro-N-phenylbenzene sulfonamide. A
solution of 4-chloro-N-methyl-3-nitro-N-phenylbenzoyl sulfonamide (9.4 g,
0.029 mol) in ethanol (50 ml) was combined with 25 ml of an aqueous
solution of 40% methylamine. The reaction mixture was heated to 70°C and
stirred at this temperature for 1 h. After cooling and filtering, the
filter cake was washed with ethanol and dried at 60°C. The yield of
N-methyl-4-(methylamino)-3-nitro-N-phenylbenzoyl sulfonamide was 9.0 g
(97%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzenesulfonic acid esters and related compounds as
anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sinauridze, Elena Ivanovna; Ataullakhanov, Fazoil Inoyatovich; Butylin,
Andrey Alexandrovich; Sulimov, Vladimir Borisovich; Romanov, Alexey
Nickolaevich; Bogolyubov, Alexey Alexeevich; Kuznetsov, Yury
Vladimirovich; Gribkova, Irina Vladimirovna; Gorbatenko, Alexander
Sergeevich; Kondakova, Olga Anatolievna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009002229 A2 2008-12-31

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Nitrophenyl)methylene]methanamine
C8H8N2O2
1637328-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1637328-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22950090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Isoxazolemethanol, 5-(3-chlorophenyl)-α-methyl-, 3-methanesulfonate
C12H12ClNO4S
657424-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9685 3.4370 0.0 0
M  V30 2 O 3.0633 4.6831 0.0 0
M  V30 3 C 3.3420 2.0302 0.0 0
M  V30 4 S 1.5317 4.5220 0.0 0 VAL=6
M  V30 5 C 1.3706 6.0535 0.0 0
M  V30 6 O 0.0000 4.3610 0.0 0
M  V30 7 O 1.6926 2.9904 0.0 0
M  V30 8 Cl 13.2722 3.0800 0.0 0
M  V30 9 C 7.9374 3.0800 0.0 0
M  V30 10 C 6.5305 2.4536 0.0 0
M  V30 11 O 7.7763 4.6116 0.0 0
M  V30 12 C 5.5000 3.5981 0.0 0
M  V30 13 N 6.2700 4.9318 0.0 0
M  V30 14 C 9.2711 2.3100 0.0 0
M  V30 15 C 10.6047 3.0800 0.0 0
M  V30 16 C 9.2711 0.7700 0.0 0
M  V30 17 C 11.9384 2.3100 0.0 0
M  V30 18 C 10.6047 0.0000 0.0 0
M  V30 19 C 11.9384 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 17
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Chlorophenyl)-N,α-dimethyl-3-isoxazolemethanamine
C12H13ClN2O
1147756-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3037 3.4372 0.0 0
M  V30 2 N 10.2090 4.6831 0.0 0
M  V30 3 C 9.9301 2.0302 0.0 0
M  V30 4 C 11.7405 4.5220 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 5.3348 3.0800 0.0 0
M  V30 7 C 6.7416 2.4536 0.0 0
M  V30 8 O 5.4957 4.6116 0.0 0
M  V30 9 C 7.7722 3.5981 0.0 0
M  V30 10 N 7.0022 4.9318 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 657424-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147756-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7008810
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1.1:
N-{[5-(3-Chlorophenyl)isoxazol-3-yl]methyl}cyclopropanamine
[5-(3-Chlorophenyl)isoxazol-3-yl]methyl methanesulfonate (WO 2004/014881)
(1.45 g, 5.04 mmol) was dissolved in THF (30 mL) and cyclopropylamine
(2.0 mL, 25 mmol) was added. The reaction mixture was stirred at rt
overnight. The next day, more cyclopropylamine (2.0 mL, 25 mmol) was
added and the reaction mixture was heated at 40 °C with reflux condenser
for 3 h. The solvent was evaporated and the residue was dissolved in DCM
(80 mL), washed with saturated NaHCO3 solution (50 mL) and dried (MgSO4).
The crude title compound (yield 90%) was used in the next step without
further purification.
1-[5-(3-Chlorophenyl)isoxazol-3-yl]-N-methylethanamine, yield 97% 1-1 g.
1H NMR (400 MHz, CDCl3): δ 7.39 (s, 1H), 7.63 (m, 1H), 7.37 (m, 2H), 7.51
(s, 1H), 3.92 (q, 1H), 2.38 (s, 3H), 1.43 (d, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino 1,2,4-triazole derivatives as modulators of mGluR5
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Waallberg, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009054794 A1 2009-04-30

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-methoxy-6-nitro-3-benzofurancarboxylic acid
C16H10FNO6
691857-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 1.1444 0.0 0
M  V30 2 O 6.2449 0.0000 0.0 0
M  V30 3 O 8.7817 0.8242 0.0 0
M  V30 4 O 1.3338 2.3149 0.0 0
M  V30 5 C 1.3338 0.7749 0.0 0
M  V30 6 N 1.3338 5.3949 0.0 0 VAL=5
M  V30 7 O 1.3338 6.9349 0.0 0
M  V30 8 O 0.0000 4.6249 0.0 0
M  V30 9 F 13.8647 3.8549 0.0 0
M  V30 10 C 5.3347 3.0849 0.0 0
M  V30 11 C 5.3347 4.6249 0.0 0
M  V30 12 C 6.7994 2.6091 0.0 0
M  V30 13 C 4.0011 2.3149 0.0 0
M  V30 14 O 6.7994 5.1008 0.0 0
M  V30 15 C 4.0011 5.3949 0.0 0
M  V30 16 C 7.7046 3.8549 0.0 0
M  V30 17 C 2.6674 3.0849 0.0 0
M  V30 18 C 2.6674 4.6249 0.0 0
M  V30 19 C 9.2446 3.8549 0.0 0
M  V30 20 C 10.0146 2.5213 0.0 0
M  V30 21 C 10.0146 5.1886 0.0 0
M  V30 22 C 11.5546 2.5213 0.0 0
M  V30 23 C 11.5546 5.1886 0.0 0
M  V30 24 C 12.3247 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-methoxy-N-methyl-6-nitro-3-benzofurancarboxamide
C17H13FN2O5
691857-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 2.6091 0.0 0
M  V30 2 N 6.2449 1.4645 0.0 0
M  V30 3 O 8.7817 2.2889 0.0 0
M  V30 4 C 6.7207 0.0000 0.0 0
M  V30 5 O 1.3338 3.7795 0.0 0
M  V30 6 C 1.3338 2.2395 0.0 0
M  V30 7 N 1.3338 6.8595 0.0 0 VAL=5
M  V30 8 O 0.0000 6.0895 0.0 0
M  V30 9 O 1.3338 8.3995 0.0 0
M  V30 10 F 13.8646 5.3195 0.0 0
M  V30 11 C 6.7994 4.0736 0.0 0
M  V30 12 C 5.3347 4.5495 0.0 0
M  V30 13 C 7.7046 5.3195 0.0 0
M  V30 14 C 5.3347 6.0895 0.0 0
M  V30 15 C 4.0011 3.7795 0.0 0
M  V30 16 O 6.7994 6.5655 0.0 0
M  V30 17 C 4.0011 6.8595 0.0 0
M  V30 18 C 2.6674 4.5495 0.0 0
M  V30 19 C 2.6674 6.0895 0.0 0
M  V30 20 C 9.2446 5.3195 0.0 0
M  V30 21 C 10.0146 3.9858 0.0 0
M  V30 22 C 10.0146 6.6533 0.0 0
M  V30 23 C 11.5546 3.9858 0.0 0
M  V30 24 C 11.5546 6.6533 0.0 0
M  V30 25 C 12.3246 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 13 20
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 691857-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691857-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-151840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran compounds for treatment and prophylaxis of
hepatitis C viral infections and associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burns, Christopher J.; Del Vecchio, Alfred M.; Bailey, Thomas R.;
Kulkarni, Bheemashankar A.; Faitg, Thomas H.; Sherk, Susan R.;
Blackledge, Charles W.; Rys, David J.; Lessen, Thomas A.; Swestock, John;
Deng, Yijun; Nitz, Theodore J.; Reinhardt, Jason A.; Feng, Hao; Saha,
Ashis K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004041201 A2 2004-05-21

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
3-Thiopheneacetic acid
C6H6O2S
6964-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 C 5.1049 1.8517 0.0 0
M  V30 3 O 5.1049 0.3117 0.0 0
M  V30 4 O 6.4385 2.6217 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 C 1.0306 2.4782 0.0 0
M  V30 7 C 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 S 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-thiopheneacetamide
C7H9NOS
853918-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 2.6217 0.0 0
M  V30 2 C 5.1047 1.8517 0.0 0
M  V30 3 N 6.4385 2.6217 0.0 0
M  V30 4 O 5.1047 0.3117 0.0 0
M  V30 5 C 7.7722 1.8517 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0
M  V30 7 C 1.0304 2.4782 0.0 0
M  V30 8 C 2.2765 0.3202 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 10 S 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6964-21-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853918-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10257394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R)-3-Chloro-1-phenylpropoxy]-2-iodobenzene
C15H14ClIO
696613-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 2 O 4.6201 5.3348 0.0 0
M  V30 3 C 4.6201 2.6675 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 Cl 4.6201 0.0000 0.0 0
M  V30 6 I 3.0801 8.0023 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 C 7.7002 2.6675 0.0 0
M  V30 9 C 7.7002 5.3348 0.0 0
M  V30 10 C 9.2402 2.6675 0.0 0
M  V30 11 C 9.2402 5.3348 0.0 0
M  V30 12 C 10.0102 4.0012 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 2.3101 6.6687 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 0.7700 6.6687 0.0 0
M  V30 17 C 0.7700 4.0012 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(2-Iodophenoxy)-N-methylbenzenepropanamine
C16H18INO
145294-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 O 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 I 3.0801 9.3360 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 7.7002 4.0012 0.0 0
M  V30 10 C 7.7002 6.6685 0.0 0
M  V30 11 C 9.2402 4.0012 0.0 0
M  V30 12 C 9.2402 6.6685 0.0 0
M  V30 13 C 10.0102 5.3348 0.0 0
M  V30 14 C 3.0801 6.6685 0.0 0
M  V30 15 C 2.3101 8.0023 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 8.0023 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696613-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 145294-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11688395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Embodiment 3. Synthesis of
(R)-(-)-N-Methyl-3-(2-iodophenoxy)-3-phenylpropanamine (MIPP). Compound
1-A (2.68 g, 7.2 mmole) was dissolved in an aqueous solution of ethanol
(80 ml) and methylamine (160 ml), and heated to reflux for 30 h. After
cooling, the solution was extracted with chloroform (100 ml, twice), and
an organic layer was decanted. The organic layer was dried over anhydrous
sodium sulfate, and dried by evaporation under vacuum. the product as oil
(2.75 g, 97.4%). The chemical structure of the oil product was analysed.
1H and 13C NMR spectra: 1H NMR (CDCl3) δ 7.73 (dd, J = 8.1 and 1.5 Hz,
1H, Ph), 7.31 (m, 5H, Ph), 7.06 (td, J = 7.8 and 1.5 Hz, 1H, Ph), 6.60
(m, 2H, Ph), 5.32 (dd, J = 8.3 and 4.7 Hz, H3), 2.83 (m, 2H, H2), 2.43
(s, 3H, H3), 2.23 (m, 1H, H1), 2.05 (m, 1H, H1), 1.66 (s, 1H, NH). 13C
NMR (CDCl3) δ 156.30, 141.01, 139.30, 129.11, 128.63, 127.62, 125.80,
122.34, 113.74 and 87.0 (Ph), 79.52 (CH), 48.33 and 38.59 (CH2CH2N),
36.49 (CH3). MS: m/z is 367 (M+), 240 (M+-1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for preparation of
N-methyl-3-(2-tributylstannylphenoxy)-3-phenylpropanamine, and use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Show-Wen; Lin, Cheng-Hsien; Lin, Tsyh-Lang; Hsu, Cheng-Fang; Chang,
Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110313183 A1 2011-12-22

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
701-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 F 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methylbenzenesulfonamide
C7H8FNO2S
953899-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 F 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 701-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 953899-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-939911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Regio- and Chemo-selective Reactions of 2-Bromobenzyl
Bromides: Expanding the Scope for the Synthesis of Biaryls Fused to a
Seven-Membered Sultam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Sharma, Shubhra; Dayal, Neetu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(36), 7885-7891

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3,5-dimethoxybenzene
C8H9ClO2
7051-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 Cl 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxy-N-methylbenzenamine
C9H13NO2
118684-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0011 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 O 1.5400 6.6686 0.0 0
M  V30 4 C 0.0000 6.6686 0.0 0
M  V30 5 O 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 5.3348 0.0 0
M  V30 9 C 3.8500 2.6675 0.0 0
M  V30 10 C 2.3100 5.3348 0.0 0
M  V30 11 C 2.3100 2.6675 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7051-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118684-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22797078
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2495200-16-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Pd-Catalyzed Monoarylation of Small Primary Alkyl Amines
through Backbone-Modification in Ylide-Functionalized Phosphines (YPhos)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodstein, Ilja; Prendes, Daniel Sowa; Wickert, Leon; Paassen, Maurice;
Gessner, Viktoria H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(22), 14674-14683

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3,5-dimethoxybenzene
C8H9ClO2
7051-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 Cl 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxy-N-methylbenzenamine
C9H13NO2
118684-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0011 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 O 1.5400 6.6686 0.0 0
M  V30 4 C 0.0000 6.6686 0.0 0
M  V30 5 O 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 5.3348 0.0 0
M  V30 9 C 3.8500 2.6675 0.0 0
M  V30 10 C 2.3100 5.3348 0.0 0
M  V30 11 C 2.3100 2.6675 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7051-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118684-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4003046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1070663-78-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1070663-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure D: An oven-dried Schlenk tube, which
was equipped with a magnetic stir bar was charged with the precatalyst
(0.003 or 0.001 equiv.), BrettPhos (0.003 or 0.001 equiv.), and NaOt-Bu
(120 mg, 1.2 mmol). The vessel was evacuated and backfilled with argon
(this process was repeated a total of 3 times) and then the aryl chloride
(1.0 mmol), 2M methylamine solution in THF (1 mL, 2.0 mmol), and t-BuOH
(1mL) were added in succession via syringe (aryl chlorides that were
solids at room temperature were added with the precatalyst and base). The
Schlenk tube was sealed with a Teflon stopper and heated to 80 °C for 12
h. The reaction mixture was then diluted with ethyl acetate, washed with
aqueous NH4Cl, dried over Na2SO4, concentrated in vacuo, and purified via
column chromatography on silica gel. (80 °C, 0.3% Pd): Following general
procedure D, a mixture of 3,5-dimethoxychlorobenzene (173 mg, 1.0 mmol),
2M methylamine (1 mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2 mmol), BrettPhos
precatalyst (2.4 mg, 0.003 mmol), BrettPhos (1.5 mg, 0.003 mmol), and
t-BuOH (1 mL) was stirred at 80 °C for 12h. The crude product was
purified via column chromatography (80:20 to 50:50 Hexanes/EtOAc
gradient) to provide the title compound as a pale yellow liquid (162 mg,
97%). 1H NMR (400 MHz, CDCl3) δ: 5.89 (t, J = 2.2 Hz, 1H), 5.80 (t, J =
2.2 Hz, 2H), 3.76 (s, 7H), 2.81 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ:
161.9, 151.5, 91.4, 89.7, 55.3, 30.9 ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Active Catalyst for Pd-Catalyzed Amination Reactions:
Cross-Coupling Reactions Using Aryl Mesylates and the Highly Selective
Monoarylation of Primary Amines Using Aryl Chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fors, Brett P.; Watson, Donald A.; Biscoe, Mark R.; Buchwald, Stephen L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(41), 13552-13554

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Propanediol, 3-[(4-methoxyphenyl)methoxy]-, 1-(4-methylbenzenesulfonate),...
C18H22O6S
713100-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4137 4.5648 0.0 0
M  V30 3 O 1.7462 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7474 5.3348 0.0 0
M  V30 6 C 7.0811 4.5648 0.0 0 CFG=1
M  V30 7 C 8.4149 5.3348 0.0 0
M  V30 8 O 7.0811 3.0248 0.0 0
M  V30 9 O 9.7486 4.5648 0.0 0
M  V30 10 C 11.0822 5.3348 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 O 16.4171 2.2548 0.0 0
M  V30 13 C 17.7507 3.0248 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 0.7700 4.0012 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 0.0000 2.6675 0.0 0
M  V30 18 C 2.3101 1.3338 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 12.4159 4.5648 0.0 0
M  V30 21 C 13.7497 5.3348 0.0 0
M  V30 22 C 12.4159 3.0248 0.0 0
M  V30 23 C 15.0834 4.5648 0.0 0
M  V30 24 C 13.7497 2.2548 0.0 0
M  V30 25 C 15.0834 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 20
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-1-[(4-Methoxyphenyl)methoxy]-3-(methylamino)-2-propanol
C12H19NO3
713100-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 O 10.6697 0.7700 0.0 0
M  V30 7 N 13.3370 2.3101 0.0 0
M  V30 8 C 14.6707 3.0801 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 0.0000 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 713100-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713100-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6373763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2R)-1-(Methylamine)-3-(4-methoxybenzyloxy)-propan-2-ol (4a). Tosylate 27
(480 mg, 1.31 mmol), methylamine (5 mL, 40 w% in water) and THF (10 mL)
were heated in a sealed tube at 75 °C for 3h. The reaction mixture was
allowed to cool to room temperature, and then THF was evaporated under
reduced pressure. The residue was redissolved in CH2Cl2 (10 mL) and
extracted with NaOH (2 M, 2 mL). The water phase was extracted twice with
CH2Cl2 (2 mL) and the organic phases dried (MgSO4). Evaporation of the
solvent gave 4a in 97% yield (285 mg, 1.27 mmol). The product was used
without further purification. 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J=8.5,
2H), 6.88 (d, J=8.5, 2H), 4.48 (s, 2H), 3.92-3.85 (m, 1H), 3.80 (s, 3H),
3.48 (AB-dd, J=9.7, 4.1 Hz, 1H), 3.43 (AB-d, J=9.7, 6.3 Hz, 1H),
2.69-2.60 (m, 2H), 2.43 (s, 3H), 2.26 (br s, 2H); 13C NMR (100 MHz,
CDCl3) δ 159.7, 130.6, 129.8, 114.2, 73.5, 73.1, 69.0, 55.7, 54.7, 36.7;
IR (neat): 3313 (br), 2840 cm-1; HRMS (FAB+) calcd for C12H20NO3 (M+H):
226.1443, found: 226.1447.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective Synthesis of Polyhydroxyl Surfactants. Stereochemical
Influence on Langmuir Monolayers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neimert-Andersson, Kristina; Blomberg, Eva; Somfai, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(11), 3746-3752

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-oxo-2-[(phenylmethyl)amino]acetate
C11H13NO3
7142-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 O 8.0022 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 1.5400 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-N2-(phenylmethyl)ethanediamide
C10H12N2O2
7666-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7142-72-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7666-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18461383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine
Receptor Ligands Leads to Increased M2R Affinity and Selectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM She, Xueke; Pegoli, Andrea; Mayr, Judith; Huebner, Harald; Bernhardt,
Guenther; Gmeiner, Peter; Keller, Max
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(10), 6741-6754

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-6-Chloro-α-(nitromethylene)-3-pyridineethanamine
C8H8ClN3O2
717106-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 N 6.1600 1.3338 0.0 0
M  V30 5 N 9.2400 1.3338 0.0 0 VAL=5
M  V30 6 O 8.4700 0.0000 0.0 0
M  V30 7 O 10.7800 1.3338 0.0 0
M  V30 8 Cl 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 N 2.3100 5.3349 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-6-Chloro-N-methyl-α-(nitromethylene)-3-pyridineethanamine
C9H10ClN3O2
717106-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 2.6674 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 O 1.3336 6.1600 0.0 0
M  V30 9 Cl 9.3358 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 N 8.0021 2.3100 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 717106-22-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 717106-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-12261387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of insecticidal, acaricidal and nematocidal pyridine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benko, Zoltan Laszlo; Deamicis, Carl Vincent; Demeter, David Anthony;
Markley, Lowell Dean; Samaritoni, Jack Geno; Schmidt, Carrie Lynn Rau;
Zhu, Yuamning; Erickson, W. Randal; Anzeveno, Peter Biagio; Pechacek,
James Todd; Watson, Gerald Bryan; Deboer, Gerrit Jan; Sheets, Joel Jay;
Zabik, Susan Erhardt; Yerkes, Carla Nanette; Schobert, Christian Thomas;
Dripps, James Edwin; Dintenfass, Leonard Paul; Karr, Laura Lee; Neese,
Paul Allen; Huang, Jim Xinpei; Gifford, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004057960 A2 2004-07-15

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-cyano-8-methyl-4H-3,1-...
C18H9BrClN5O2
736995-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.0424 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.8369 0.0 0
M  V30 3 O 7.0036 7.8788 0.0 0
M  V30 4 C 9.6710 1.7187 0.0 0
M  V30 5 C 12.3384 6.3388 0.0 0
M  V30 6 N 13.6721 7.1088 0.0 0
M  V30 7 C 4.3361 3.2587 0.0 0
M  V30 8 N 2.9293 3.8850 0.0 0
M  V30 9 C 4.1752 1.7271 0.0 0
M  V30 10 N 1.8989 2.7406 0.0 0
M  V30 11 C 2.6689 1.4070 0.0 0
M  V30 12 C 5.6699 4.0287 0.0 0
M  V30 13 N 7.0036 3.2587 0.0 0
M  V30 14 O 5.6699 5.5688 0.0 0
M  V30 15 C 8.3373 4.0287 0.0 0
M  V30 16 C 7.0036 6.3388 0.0 0
M  V30 17 C 8.3373 5.5688 0.0 0
M  V30 18 C 9.6710 3.2587 0.0 0
M  V30 19 C 9.6710 6.3388 0.0 0
M  V30 20 C 11.0048 4.0287 0.0 0
M  V30 21 C 11.0048 5.5688 0.0 0
M  V30 22 C 2.6091 5.3915 0.0 0
M  V30 23 C 1.1444 5.8674 0.0 0
M  V30 24 N 3.7535 6.4219 0.0 0
M  V30 25 C 0.8242 7.3737 0.0 0
M  V30 26 C 3.4334 7.9284 0.0 0
M  V30 27 C 1.9688 8.4043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 23
M  V30 3 2 3 16
M  V30 4 1 4 18
M  V30 5 3 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 8 22
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 17
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyantraniliprole
C19H14BrClN6O2
736994-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 4.6201 0.0 0
M  V30 2 N 7.0036 3.8501 0.0 0
M  V30 3 O 5.6699 6.1601 0.0 0
M  V30 4 Cl 0.0000 5.4283 0.0 0
M  V30 5 Br 2.0424 0.5914 0.0 0
M  V30 6 C 9.6709 2.3101 0.0 0
M  V30 7 N 11.0048 1.5400 0.0 0
M  V30 8 O 8.3373 1.5400 0.0 0
M  V30 9 C 11.0048 0.0000 0.0 0
M  V30 10 C 7.0036 6.9302 0.0 0
M  V30 11 C 12.3384 6.9302 0.0 0
M  V30 12 N 13.6721 7.7002 0.0 0
M  V30 13 N 2.9293 4.4764 0.0 0
M  V30 14 C 4.3361 3.8501 0.0 0
M  V30 15 N 1.8989 3.3320 0.0 0
M  V30 16 C 4.1752 2.3185 0.0 0
M  V30 17 C 2.6689 1.9983 0.0 0
M  V30 18 C 2.6091 5.9829 0.0 0
M  V30 19 C 1.1444 6.4587 0.0 0
M  V30 20 N 3.7535 7.0133 0.0 0
M  V30 21 C 0.8242 7.9652 0.0 0
M  V30 22 C 3.4334 8.5198 0.0 0
M  V30 23 C 1.9688 8.9956 0.0 0
M  V30 24 C 8.3373 4.6201 0.0 0
M  V30 25 C 9.6709 3.8501 0.0 0
M  V30 26 C 8.3373 6.1601 0.0 0
M  V30 27 C 11.0048 4.6201 0.0 0
M  V30 28 C 9.6709 6.9302 0.0 0
M  V30 29 C 11.0048 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 24
M  V30 5 1 4 19
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 25
M  V30 10 1 7 9
M  V30 11 1 10 26
M  V30 12 3 11 12
M  V30 13 1 11 29
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736995-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 736994-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30630455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield,alternative preparation
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of solid state forms of Cyantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suez, Gal; Forckosh, Hagit; Golub, Yanai; Lie, Jie; Chen, Bob; Parnes,
Regev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021249395 A1 2021-12-16

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzoic acid
C7H5ClO2
74-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12475677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 11C-labelled amides by palladium-mediated carboxamination
using [11C]carbon monoxide, in situ activated amines and
1,2,2,6,6-pentamethylpiperidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karimi, Farhad; Langstroem, Bengt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2003), (11), 2132-2137

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylthiuram disulfide
C4H8N2S4
2438-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 S 4.0012 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0
M  V30 4 S 2.6675 3.8501 0.0 0
M  V30 5 S 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0
M  V30 9 S 6.6685 0.0000 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2438-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28590828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 142-82-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dimethylthiarum disulfide. New sulfur transfer reagent in
phosphorothioates oligonucleotide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhiwei; Song, Quanlai; Sanghvi, Yogesh S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Methods in Molecular Biology (Totowa, NJ, United States) (2005), 28851-63

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylthiuram disulfide
C4H8N2S4
2438-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 S 4.0012 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0
M  V30 4 S 2.6675 3.8501 0.0 0
M  V30 5 S 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0
M  V30 9 S 6.6685 0.0000 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2438-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30781819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM aPreparation of dimethylthiuram disulfide (4): NaOH (80 g, 2 mol) was
dissolved in water (500 mL) and the solution was cooled to 0°C. THF (200
mL), methylamine (40% in water, 170mL, 2mol) and carbon disulfide (120mL,
2mol) were added over a period of 30min to aq. NaOH solution while
stirring at 0°C. Crushed ice (1.5-Kg) was added to the reaction mixture,
followed by acetic acid (300mL). Hydrogen peroxide (30%, 100 mL, 1 mol)
was added gradually while stirring over 15 min while maintaining the
reaction temperature below 5°C. Heptane (800 mL) was added to the
reaction mixture and stirred for additional 30 min. The product was
filtered off and washed with aq. acetic acid (2%, 5x200mL) and heptanes
(2x200mL). The product was air dried until constant weight (~1 day).
Off-white solid (205 g, 97%). M.p. 98-100°C (dec.)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Short, Novel, and Cheaper Procedure for Oligonucleotide Synthesis Using
Automated Solid Phase Synthesizer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Quanlai; Wang, Zhiwei; Sanghvi, Yogesh S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2003), 22(5-8), 629-633

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylthiuram disulfide
C4H8N2S4
2438-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 S 4.0012 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0
M  V30 4 S 2.6675 3.8501 0.0 0
M  V30 5 S 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0
M  V30 9 S 6.6685 0.0000 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2438-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27573112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes for the preparation of oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanghvi, Yogesh S.; Song, Quanlai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002014340 A1 2002-02-21

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-8-(4-morpholinylsulfonyl)furo[3,4-c]quinoline-1,3-dione
C16H14N2O6S
753482-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.4292 0.0 0
M  V30 2 S 9.3194 3.0801 0.0 0 VAL=6
M  V30 3 O 8.5493 1.7464 0.0 0
M  V30 4 O 10.0894 4.4137 0.0 0
M  V30 5 C 1.3170 6.1601 0.0 0
M  V30 6 O 0.0000 3.1398 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 C 3.9845 3.0801 0.0 0
M  V30 9 C 5.3182 5.3901 0.0 0
M  V30 10 C 6.6519 3.0801 0.0 0
M  V30 11 C 2.6507 3.8501 0.0 0
M  V30 12 C 3.6644 1.5738 0.0 0
M  V30 13 N 3.9845 6.1601 0.0 0
M  V30 14 C 6.6519 6.1601 0.0 0
M  V30 15 C 7.9855 3.8501 0.0 0
M  V30 16 C 2.6507 5.3901 0.0 0
M  V30 17 C 1.5063 2.8196 0.0 0
M  V30 18 O 2.1326 1.4127 0.0 0
M  V30 19 C 7.9855 5.3901 0.0 0
M  V30 20 N 10.6530 2.3101 0.0 0
M  V30 21 C 10.6530 0.7700 0.0 0
M  V30 22 C 11.9867 3.0801 0.0 0
M  V30 23 C 11.9867 0.0000 0.0 0
M  V30 24 C 13.3204 2.3101 0.0 0
M  V30 25 O 13.3204 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 2 20
M  V30 6 1 5 16
M  V30 7 2 6 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 2 13 16
M  V30 20 1 14 19
M  V30 21 2 15 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl-8-(4-morpholinylsulfonyl)-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione
C17H17N3O5S
745046-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.4292 0.0 0
M  V30 2 O 0.0000 3.1398 0.0 0
M  V30 3 C 1.3170 6.1601 0.0 0
M  V30 4 C 1.3626 0.0790 0.0 0
M  V30 5 S 9.3194 3.0801 0.0 0 VAL=6
M  V30 6 O 8.5493 1.7464 0.0 0
M  V30 7 O 10.0894 4.4137 0.0 0
M  V30 8 C 3.9845 3.0801 0.0 0
M  V30 9 C 5.3182 3.8501 0.0 0
M  V30 10 C 2.6507 3.8501 0.0 0
M  V30 11 C 3.6644 1.5738 0.0 0
M  V30 12 C 5.3182 5.3901 0.0 0
M  V30 13 C 6.6519 3.0801 0.0 0
M  V30 14 C 1.5063 2.8196 0.0 0
M  V30 15 C 2.6507 5.3901 0.0 0
M  V30 16 N 2.1326 1.4127 0.0 0
M  V30 17 N 3.9845 6.1601 0.0 0
M  V30 18 C 6.6519 6.1601 0.0 0
M  V30 19 C 7.9855 3.8501 0.0 0
M  V30 20 C 7.9855 5.3901 0.0 0
M  V30 21 N 10.6530 2.3101 0.0 0
M  V30 22 C 10.6530 0.7700 0.0 0
M  V30 23 C 11.9867 3.0801 0.0 0
M  V30 24 C 11.9867 0.0000 0.0 0
M  V30 25 C 13.3204 2.3101 0.0 0
M  V30 26 O 13.3204 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 5 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 753482-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745046-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-6728386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
Synthesis and SAR of 2-substituted
4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kravchenko, Dmitri V.; Kysil, Volodymyr M.; Tkachenko, Sergey E.;
Maliarchouk, Sergey; Okun, Ilya M.; Ivachtchenko, Alexandre V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2005), 40(12), 1377-1383

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzeneethanesulfonyl chloride
C8H8Cl2O2S
76653-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 3.0800 0.0 0
M  V30 7 Cl 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 1.5400 0.0 0
M  V30 10 C 6.1600 4.2073 0.0 0
M  V30 11 C 7.7000 1.5400 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzeneethanesulfonamide
C9H12ClNO2S
260542-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8736 0.0 0
M  V30 2 C 3.8500 1.5400 0.0 0
M  V30 3 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 4 N 0.7700 1.5400 0.0 0
M  V30 5 O 2.3100 3.0800 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 0.2062 0.0 0
M  V30 8 Cl 10.7800 2.8736 0.0 0
M  V30 9 C 6.1600 2.8736 0.0 0
M  V30 10 C 6.9300 4.2073 0.0 0
M  V30 11 C 6.9300 1.5400 0.0 0
M  V30 12 C 8.4700 4.2073 0.0 0
M  V30 13 C 8.4700 1.5400 0.0 0
M  V30 14 C 9.2400 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76653-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 260542-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15828179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Towards Uniform Iodine Catalysis: Intramolecular C-H Amination of Arenes
under Visible Light
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez, Claudio; Bosnidou, Alexandra E.; Allmendinger, Simon; Muniz,
Kilian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(29), 9929-9932

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenyl chloroformate
C7H4ClNO4
7693-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 Cl 8.0023 2.3101 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, 4-nitrophenyl ester
C8H8N2O4
5819-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 N 9.3359 4.6201 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7693-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5819-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31870267
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused ring pyrimidone derivatives for the treatment of HBV
infection or of HBV-induced diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Lianzhu; Deng, Gang; Lu, Chunliang; Liu, Zhiguo; Grosse, Sandrine
Celine; Vandyck, Koen; Jacoby, Edgar; Jonckers, Tim Hugo Maria;
Raboisson, Pierre Jean-Marie Bernard; Last, Stefaan Julien; Pieters,
Serge Maria Aloysius; Perrier, Mathieu; Verschueren, Wim Gaston; Martinez
Lamenca, Carolina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022053010 A1 2022-03-17

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34701278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selectivity of a bromoacridine-containing fluorophore for triplex DNA
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Sanjeev Kumar; Fraser, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2021), 152(8), 1013-1016

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Carbamic acid, diethyl-, 6,6′-bis[(phenylmethyl)thio][8,8′-biquinoline]-7,7′-...
C42H42N4O4S2
829666-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 8.4700 0.0 0
M  V30 2 C 6.6684 9.2400 0.0 0
M  V30 3 N 6.6684 10.7800 0.0 0
M  V30 4 O 5.3347 8.4700 0.0 0
M  V30 5 C 8.0021 11.5500 0.0 0
M  V30 6 C 5.3347 11.5500 0.0 0
M  V30 7 C 8.0021 13.0900 0.0 0
M  V30 8 C 5.3347 13.0900 0.0 0
M  V30 9 O 12.0031 4.6200 0.0 0
M  V30 10 C 13.3369 3.8500 0.0 0
M  V30 11 N 13.3369 2.3100 0.0 0
M  V30 12 O 14.6705 4.6200 0.0 0
M  V30 13 C 12.0031 1.5400 0.0 0
M  V30 14 C 14.6705 1.5400 0.0 0
M  V30 15 C 12.0031 0.0000 0.0 0
M  V30 16 C 14.6705 0.0000 0.0 0
M  V30 17 S 5.3347 6.9300 0.0 0
M  V30 18 C 4.0011 6.1600 0.0 0
M  V30 19 S 14.6705 6.1600 0.0 0
M  V30 20 C 16.0041 6.9300 0.0 0
M  V30 21 C 9.3358 6.1600 0.0 0
M  V30 22 C 8.0021 6.9300 0.0 0
M  V30 23 C 9.3358 4.6200 0.0 0
M  V30 24 C 6.6684 6.1600 0.0 0
M  V30 25 C 8.0021 3.8500 0.0 0
M  V30 26 N 10.6694 3.8500 0.0 0
M  V30 27 C 6.6684 4.6200 0.0 0
M  V30 28 C 8.0021 2.3100 0.0 0
M  V30 29 C 10.6694 2.3100 0.0 0
M  V30 30 C 9.3358 1.5400 0.0 0
M  V30 31 C 10.6694 6.9300 0.0 0
M  V30 32 C 12.0031 6.1600 0.0 0
M  V30 33 C 10.6694 8.4700 0.0 0
M  V30 34 C 13.3369 6.9300 0.0 0
M  V30 35 C 12.0031 9.2400 0.0 0
M  V30 36 N 9.3358 9.2400 0.0 0
M  V30 37 C 13.3369 8.4700 0.0 0
M  V30 38 C 12.0031 10.7800 0.0 0
M  V30 39 C 9.3358 10.7800 0.0 0
M  V30 40 C 10.6694 11.5500 0.0 0
M  V30 41 C 2.6674 6.9300 0.0 0
M  V30 42 C 2.6674 8.4700 0.0 0
M  V30 43 C 1.3336 6.1600 0.0 0
M  V30 44 C 1.3336 9.2400 0.0 0
M  V30 45 C 0.0000 6.9300 0.0 0
M  V30 46 C 0.0000 8.4700 0.0 0
M  V30 47 C 17.3378 6.1600 0.0 0
M  V30 48 C 18.6716 6.9300 0.0 0
M  V30 49 C 17.3378 4.6200 0.0 0
M  V30 50 C 20.0052 6.1600 0.0 0
M  V30 51 C 18.6716 3.8500 0.0 0
M  V30 52 C 20.0052 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 32
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 24
M  V30 19 1 18 41
M  V30 20 1 19 20
M  V30 21 1 19 34
M  V30 22 1 20 47
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 21 31
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 1 23 26
M  V30 29 2 24 27
M  V30 30 1 25 27
M  V30 31 1 25 28
M  V30 32 2 26 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 1 33 36
M  V30 40 2 34 37
M  V30 41 1 35 37
M  V30 42 1 35 38
M  V30 43 2 36 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 52 2 47 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 2 49 51
M  V30 56 2 50 52
M  V30 57 1 51 52
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, diethyl-, 6,6′-bis[(methylamino)sulfonyl][8,8′-biquinoline]-7,...
C30H36N6O8S2
829666-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 C 4.0012 7.7002 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 O 4.0012 9.2402 0.0 0
M  V30 5 C 2.6675 5.3901 0.0 0
M  V30 6 C 1.3338 7.7002 0.0 0
M  V30 7 C 1.3338 4.6201 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 O 10.6698 5.3901 0.0 0
M  V30 10 C 12.0035 4.6201 0.0 0
M  V30 11 N 13.3372 5.3901 0.0 0
M  V30 12 O 12.0035 3.0801 0.0 0
M  V30 13 C 13.3372 6.9302 0.0 0
M  V30 14 C 14.6708 4.6201 0.0 0
M  V30 15 C 14.6708 7.7002 0.0 0
M  V30 16 C 16.0046 5.3901 0.0 0
M  V30 17 S 5.3348 10.0102 0.0 0 VAL=6
M  V30 18 N 4.0012 10.7802 0.0 0
M  V30 19 O 6.1048 11.3439 0.0 0
M  V30 20 O 4.5648 8.6765 0.0 0
M  V30 21 C 4.0012 12.3203 0.0 0
M  V30 22 S 10.6698 2.3101 0.0 0 VAL=6
M  V30 23 N 12.0035 1.5400 0.0 0
M  V30 24 O 11.4398 3.6437 0.0 0
M  V30 25 O 9.8998 0.9764 0.0 0
M  V30 26 C 12.0035 0.0000 0.0 0
M  V30 27 C 8.0023 6.9302 0.0 0
M  V30 28 C 6.6687 7.7002 0.0 0
M  V30 29 C 9.3360 7.7002 0.0 0
M  V30 30 C 6.6687 9.2402 0.0 0
M  V30 31 C 9.3360 9.2402 0.0 0
M  V30 32 N 10.6698 6.9302 0.0 0
M  V30 33 C 8.0023 10.0102 0.0 0
M  V30 34 C 10.6698 10.0102 0.0 0
M  V30 35 C 12.0035 7.7002 0.0 0
M  V30 36 C 12.0035 9.2402 0.0 0
M  V30 37 C 8.0023 5.3901 0.0 0
M  V30 38 C 9.3360 4.6201 0.0 0
M  V30 39 C 6.6687 4.6201 0.0 0
M  V30 40 C 9.3360 3.0801 0.0 0
M  V30 41 C 6.6687 3.0801 0.0 0
M  V30 42 N 5.3348 5.3901 0.0 0
M  V30 43 C 8.0023 2.3101 0.0 0
M  V30 44 C 5.3348 2.3101 0.0 0
M  V30 45 C 4.0012 4.6201 0.0 0
M  V30 46 C 4.0012 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 38
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 2 17 20
M  V30 20 1 17 30
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 2 22 25
M  V30 25 1 22 40
M  V30 26 1 23 26
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 27 37
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 1 29 32
M  V30 33 2 30 33
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 2 32 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 1 39 42
M  V30 44 2 40 43
M  V30 45 1 41 43
M  V30 46 1 41 44
M  V30 47 2 42 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 829666-55-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 829666-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25446069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-50-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A steady stream of Cl2 gas was bubbled through a stirred biphasic mixture
of bisthioether 20 (1.20 g, 1.64 mmol) in CH2Cl2-AcOH-H2O (4:2:1, 28 mL)
at 0 °C for 15 min. After this time, the mixture was sparged with N2 for
2 min and then 40 wt.% aq. MeNH2 (45 mL) was added. The reaction mixture
was allowed to warm to rt and stirred for a further 4 h before CH2Cl2
(100 mL) and H2O (100 mL) were added. The pH of the aqueous layer was
adjusted to 7 (with 2M aq. HCl) and the layers were well shaken and
separated. The aqueous layer was extracted (2x100 mL CH2Cl2) and the
combined organic phases were washed with brine (100 mL), dried (Na2SO4),
and concentrated in vacuo. The residue was purified by column
chromatography (eluting with 5% MeOH in CH2Cl2) to yield bissulfonamide
21 (1.07 g, 1.59 mmol, 97%) as a pale yellow solid. mp 245 °C dec (THF);
IR (neat) 3247, 2945, 1711, 1606, 1434, 1344, 1261, 1212, 1164, 1069,
785, 750, 546 cm-1; 1H NMR (500 MHz, d6-DMSO, T = 373 K) δ 8.74 (2H, dd,
J = 4.1, 1.7 Hz), 8.64 (2H, s), 8.57 (2H, dd, J = 8.3, 1.7 Hz), 7.54 (2H,
dd, J = 8.3, 4.1 Hz), 6.71 (2H, br s), 3.06-2.95 (4H, m), 2.87-2.77 (4H,
m), 2.67 (6H, br s), 0.70-0.63 (12H, m) ppm; 13C NMR (125 MHz, d6- DMSO,
T = 373 K) δ 151.6 (2C, 1), 151.2 (2C, 0), 148.2 (2C, 0), 145.3 (2C, 0),
136.2 (2C, 1), 132.2 (2C, 0), 130.1 (2C, 1), 128.6 (2C, 0), 124.1 (2C,
0), 121.0 (2C, 1), 40.6 (4C, 2), 28.3 (2C, 3), 12.0 (4C, 3) ppm; MS (ES+)
m/z 673 (M+H)+; HRMS (ES+) m/z 673.2128 (calcd. for C30H37N6O832S2:
673.2114); Anal. calcd. for C30H36N6O8S2: C, 53.56; H, 5.39; N, 12.49.
Found: C, 53.30; H, 5.40; N, 12.50.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Harnessing Anionic Rearrangements on the Benzenoid Ring of Quinoline for
the Synthesis of 6,6'-Disubstituted 7,7'-Dihydroxy-8,8'-biquinolyls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blakemore, Paul R.; Kilner, Colin; Milicevic, Selena D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(1), 373-376

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,3-dihydro-7-hydroxy-5-oxo-1H,5H-benzo[ij]quinolizine-6-carboxylate
C15H15NO4
84088-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 O 4.0011 6.9301 0.0 0
M  V30 3 C 6.6684 5.3901 0.0 0
M  V30 4 O 8.0022 4.6201 0.0 0
M  V30 5 O 6.6684 6.9301 0.0 0
M  V30 6 C 9.3359 5.3901 0.0 0
M  V30 7 C 10.6695 4.6201 0.0 0
M  V30 8 C 2.6673 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 N 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 4.0011 5.3901 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0800 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 2 13 19
M  V30 19 1 14 18
M  V30 20 1 15 20
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-7-hydroxy-N-methyl-5-oxo-1H,5H-benzo[ij]quinolizine-6-carboxamide
C14H14N2O3
376381-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 O 4.0011 6.9300 0.0 0
M  V30 3 C 6.6684 5.3900 0.0 0
M  V30 4 N 8.0021 4.6200 0.0 0
M  V30 5 O 6.6684 6.9300 0.0 0
M  V30 6 C 9.3358 5.3900 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 1.3336 0.7700 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 17
M  V30 19 1 14 19
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84088-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 376381-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9606562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Refluxing ester 2 for 20 h with a 40% excess of the corresponding amine
in bromobenzene [6] has previously been used for the preparation of
1-hydroxy-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic
acid alkylamides 1. We have meanwhile accumulated practical experience of
the synthesis of 4-hydroxy-2-oxoquinoline-3-carboxamides and this infers
that such rigorous conditions are clearly excessive. In fact, carrying
out further experiments has shown that ester 2 is readily amidated by
alkylamines in just refluxing ethanol. The reaction is complete after 2-4
h and its success needs only a 10% excess of the alkylamine. Compound 1a,
yield 97%. Empirical formula: C14H14N2O3; mp, °С (ethanol): 147-149
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Hydroxy-2-quinolones. Part 194.
1-Hydroxy-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic
acid alkylamides. Synthesis, structure, and biological properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Golik, N. Yu.; Andreeva, K. V.; Gorokhova, O. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2011),
46(12), 1459-1466

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,11-Bis(chloromethyl)-25,26,27,28-tetrakis(2-ethoxyethoxy)pentacyclo[19.3.1....
C46H58Cl2O8
842171-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9993 8.7812 0.0 0
M  V30 2 C 7.7693 10.1148 0.0 0
M  V30 3 C 6.9993 11.4485 0.0 0
M  V30 4 O 7.7693 12.7822 0.0 0
M  V30 5 C 6.9993 14.1159 0.0 0
M  V30 6 C 7.7693 15.4495 0.0 0
M  V30 7 C 1.2389 10.7492 0.0 0
M  V30 8 Cl 1.1046 12.2833 0.0 0
M  V30 9 O 8.7812 8.4502 0.0 0
M  V30 10 C 10.1148 7.6803 0.0 0
M  V30 11 C 11.4485 8.4502 0.0 0
M  V30 12 O 12.7822 7.6803 0.0 0
M  V30 13 C 14.1159 8.4502 0.0 0
M  V30 14 C 15.4495 7.6803 0.0 0
M  V30 15 C 10.7492 14.2106 0.0 0
M  V30 16 Cl 12.2833 14.3449 0.0 0
M  V30 17 O 6.6683 6.9993 0.0 0
M  V30 18 C 5.3347 7.7693 0.0 0
M  V30 19 C 4.0009 6.9993 0.0 0
M  V30 20 O 2.6673 7.7693 0.0 0
M  V30 21 C 1.3336 6.9993 0.0 0
M  V30 22 C 0.0000 7.7693 0.0 0
M  V30 23 O 8.4502 6.6683 0.0 0
M  V30 24 C 7.6803 5.3347 0.0 0
M  V30 25 C 8.4502 4.0009 0.0 0
M  V30 26 O 7.6803 2.6673 0.0 0
M  V30 27 C 8.4502 1.3336 0.0 0
M  V30 28 C 7.6803 0.0000 0.0 0
M  V30 29 C 5.3227 10.3243 0.0 0
M  V30 30 C 5.4593 8.7812 0.0 0
M  V30 31 C 6.4078 11.3433 0.0 0
M  V30 32 C 3.9117 10.9946 0.0 0
M  V30 33 C 4.1894 7.8939 0.0 0
M  V30 34 C 7.8939 11.2601 0.0 0
M  V30 35 C 2.6346 10.0984 0.0 0
M  V30 36 C 4.1062 6.4078 0.0 0
M  V30 37 C 2.7689 8.5439 0.0 0
M  V30 38 C 8.7812 9.9902 0.0 0
M  V30 39 C 8.5439 12.6806 0.0 0
M  V30 40 C 5.1253 5.3227 0.0 0
M  V30 41 C 10.3243 10.1268 0.0 0
M  V30 42 C 10.0984 12.8149 0.0 0
M  V30 43 C 6.6683 5.4593 0.0 0
M  V30 44 C 4.4549 3.9117 0.0 0
M  V30 45 C 11.3433 9.0418 0.0 0
M  V30 46 C 10.9946 11.5378 0.0 0
M  V30 47 C 7.5555 4.1894 0.0 0
M  V30 48 C 5.3512 2.6346 0.0 0
M  V30 49 C 11.2601 7.5555 0.0 0
M  V30 50 C 9.0418 4.1062 0.0 0
M  V30 51 C 6.9056 2.7689 0.0 0
M  V30 52 C 9.9902 6.6683 0.0 0
M  V30 53 C 12.6806 6.9056 0.0 0
M  V30 54 C 10.1268 5.1253 0.0 0
M  V30 55 C 12.8149 5.3512 0.0 0
M  V30 56 C 11.5378 4.4549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 35
M  V30 9 1 9 10
M  V30 10 1 9 38
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 42
M  V30 17 1 17 18
M  V30 18 1 17 43
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 23 24
M  V30 24 1 23 52
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 2 29 32
M  V30 32 2 30 33
M  V30 33 1 31 34
M  V30 34 1 32 35
M  V30 35 1 33 36
M  V30 36 1 33 37
M  V30 37 1 34 38
M  V30 38 2 34 39
M  V30 39 2 35 37
M  V30 40 1 36 40
M  V30 41 2 38 41
M  V30 42 1 39 42
M  V30 43 1 40 43
M  V30 44 2 40 44
M  V30 45 1 41 45
M  V30 46 1 41 46
M  V30 47 2 42 46
M  V30 48 2 43 47
M  V30 49 1 44 48
M  V30 50 1 45 49
M  V30 51 1 47 50
M  V30 52 1 47 51
M  V30 53 2 48 51
M  V30 54 1 49 52
M  V30 55 2 49 53
M  V30 56 1 50 54
M  V30 57 2 52 54
M  V30 58 1 53 55
M  V30 59 1 54 56
M  V30 60 2 55 56
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
25,26,27,28-Tetrakis(2-ethoxyethoxy)-N5,N11-dimethylpentacyclo[19.3.1.13,7.19...
C48H66N2O8
842171-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2642 8.3901 0.0 0
M  V30 2 C 8.8042 8.3901 0.0 0
M  V30 3 C 9.5742 7.0564 0.0 0
M  V30 4 O 11.1142 7.0564 0.0 0
M  V30 5 C 11.8842 5.7226 0.0 0
M  V30 6 C 13.4242 5.7226 0.0 0
M  V30 7 C 6.0884 2.4175 0.0 0
M  V30 8 N 7.3500 1.5341 0.0 0
M  V30 9 C 7.2157 0.0000 0.0 0
M  V30 10 O 7.8686 10.0987 0.0 0
M  V30 11 C 7.8686 11.6387 0.0 0
M  V30 12 C 9.2023 12.4087 0.0 0
M  V30 13 O 9.2023 13.9487 0.0 0
M  V30 14 C 10.5361 14.7187 0.0 0
M  V30 15 C 10.5361 16.2587 0.0 0
M  V30 16 C 13.8412 8.9229 0.0 0
M  V30 17 N 14.7246 10.1843 0.0 0
M  V30 18 C 16.2587 10.0502 0.0 0
M  V30 19 O 5.5555 8.9945 0.0 0
M  V30 20 C 5.5555 7.4545 0.0 0
M  V30 21 C 4.2219 6.6845 0.0 0
M  V30 22 O 4.2219 5.1445 0.0 0
M  V30 23 C 2.8883 4.3745 0.0 0
M  V30 24 C 2.8883 2.8345 0.0 0
M  V30 25 O 6.1600 10.7032 0.0 0
M  V30 26 C 4.6200 10.7032 0.0 0
M  V30 27 C 3.8500 12.0368 0.0 0
M  V30 28 O 2.3100 12.0368 0.0 0
M  V30 29 C 1.5400 13.3704 0.0 0
M  V30 30 C 0.0000 13.3704 0.0 0
M  V30 31 C 7.7624 6.1666 0.0 0
M  V30 32 C 6.4942 7.0564 0.0 0
M  V30 33 C 9.1873 6.5967 0.0 0
M  V30 34 C 7.6373 4.6094 0.0 0
M  V30 35 C 5.0909 6.4002 0.0 0
M  V30 36 C 9.8585 7.9255 0.0 0
M  V30 37 C 6.2227 3.9516 0.0 0
M  V30 38 C 3.7622 7.0714 0.0 0
M  V30 39 C 4.9436 4.8451 0.0 0
M  V30 40 C 9.2023 9.3287 0.0 0
M  V30 41 C 11.4136 7.7781 0.0 0
M  V30 42 C 3.3321 8.4963 0.0 0
M  V30 43 C 10.0921 10.5967 0.0 0
M  V30 44 C 12.3071 9.0570 0.0 0
M  V30 45 C 4.2219 9.7645 0.0 0
M  V30 46 C 1.7750 8.6214 0.0 0
M  V30 47 C 9.6620 12.0219 0.0 0
M  V30 48 C 11.6493 10.4718 0.0 0
M  V30 49 C 3.5659 11.1678 0.0 0
M  V30 50 C 1.1171 10.0360 0.0 0
M  V30 51 C 8.3332 12.6928 0.0 0
M  V30 52 C 4.2368 12.4965 0.0 0
M  V30 53 C 2.0106 11.3151 0.0 0
M  V30 54 C 6.9300 12.0368 0.0 0
M  V30 55 C 8.4806 14.2481 0.0 0
M  V30 56 C 5.6620 12.9266 0.0 0
M  V30 57 C 7.2017 15.1416 0.0 0
M  V30 58 C 5.7869 14.4837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 32
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 37
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 40
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 44
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 45
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 25 26
M  V30 26 1 25 54
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 31 32
M  V30 32 1 31 33
M  V30 33 2 31 34
M  V30 34 2 32 35
M  V30 35 1 33 36
M  V30 36 1 34 37
M  V30 37 1 35 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 2 36 41
M  V30 41 2 37 39
M  V30 42 1 38 42
M  V30 43 2 40 43
M  V30 44 1 41 44
M  V30 45 1 42 45
M  V30 46 2 42 46
M  V30 47 1 43 47
M  V30 48 1 43 48
M  V30 49 2 44 48
M  V30 50 2 45 49
M  V30 51 1 46 50
M  V30 52 1 47 51
M  V30 53 1 49 52
M  V30 54 1 49 53
M  V30 55 2 50 53
M  V30 56 1 51 54
M  V30 57 2 51 55
M  V30 58 1 52 56
M  V30 59 2 54 56
M  V30 60 1 55 57
M  V30 61 1 56 58
M  V30 62 2 57 58
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 842171-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 842171-99-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10999107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,11-Bis[(N-methyl)aminomethyl]-25,26,27,28-tetrakis-
(2-ethoxyethoxy)calix[4]arene (10). A 33% methylamine solution in EtOH
(10 mL) was added to a round-bottomed flask containing the
bischloromethyl calixarene 9 (260 mg, 0.32 mmol). The solution was
stirred ca. 48 h at room temperature, until completion was confirmed by
TLC (Al2O3,CH2Cl2/MeOH 9/1). The solvent was evaporated under vacuum; the
crude was dissolved in CH2Cl2 (30 mL) and washed with a 10% NaHCO3
solution (30 mL). The organic phase was dried over Na2SO4, filtered, and
evaporated under vacuum to give 10 (252 mg, 0.32 mmol) as colorless oil.
Yield 97% 5,11-Bis[(N-methyl)aminomethyl]-25,26,27,28-tetrakis-
(2-ethoxyethoxy)calix[4]arene (10), Yield 252 mg, 0.32 mmol, 97% 1H NMR
(300 MHz; CDCl3) δ 7.18 (d, J = 1.6 Hz, 2H), 6.86 (dd, J = 7.4 Hz, J =
1.2 Hz, 2H), 6.73 (d, J = 1.6 Hz, 2H), 6.68 (d, J = 7.4 Hz, 2H), 6.58 (t,
J = 7.4 Hz, 2H), 4.51 (d, J = 13.1 Hz, 1H), 4.50 (d, J = 13.1 Hz, 2H),
4.47 (d, J = 13.1 Hz, 1H), 4.16-4.07 (m, 8H), 3.94 (d, J = 13.4 Hz, 2H),
3.82 (t, J = 5.5 Hz, 8H), 3.62 (d, J = 13.4 Hz, 2H), 3.53 (q, J = 7.0 Hz,
4H), 3.51 (q, J = 7.0 Hz, 4H), 3.24 (d, J = 13.1 Hz, 1H), 3.14 (d, J =
13.1 Hz, 3H), 2.28 (s, 6H), 1.19 (t, J = 7.0 Hz, 12H). 13C NMR (75 MHz;
CDCl3) δ 156.7, 155.9, 135.8, 135.6, 134.9, 134.3, 130.4, 129.6, 128.5,
128.3, 124.4, 122.6, 73.5, 73.2, 69.6, 69.5, 66.3, 51.6, 30.8, 30.7,
30.5, 15.2. MS (CI) m/z (%) 799.4 [M + H]+ (75), 767.5 [M - NHCH3]+
(100). Anal. Calcd for C48H66N2O8 (799.06): C, 72.15; H, 8.33; N, 3.51.
Found: C, 72.32; H, 8.41; N, 3.44
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Di- and Trinuclear Zn2+ Complexes of Calix[4]arene Based Ligands as
Catalysts of Acyl and Phosphoryl Transfer Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cacciapaglia, Roberta; Casnati, Alessandro; Mandolini, Luigi; Reinhoudt,
David N.; Salvio, Riccardo; Sartori, Andrea; Ungaro, Rocco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(2), 624-630

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-2H...
C25H26F2N2O3
843654-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 5.3348 0.0000 0.0 0
M  V30 3 O 6.6684 2.3100 0.0 0
M  V30 4 F 0.0000 4.6200 0.0 0
M  V30 5 N 6.6684 6.9301 0.0 0
M  V30 6 C 8.0021 6.1601 0.0 0
M  V30 7 C 9.3357 6.9301 0.0 0
M  V30 8 C 10.6695 6.1601 0.0 0
M  V30 9 F 15.8682 3.0542 0.0 0
M  V30 10 C 4.0010 3.8500 0.0 0
M  V30 11 C 2.6673 4.6200 0.0 0
M  V30 12 C 5.3348 4.6200 0.0 0
M  V30 13 C 4.0010 2.3100 0.0 0
M  V30 14 O 2.6673 6.1601 0.0 0
M  V30 15 C 1.3337 3.8500 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 4.0010 6.9301 0.0 0
M  V30 19 C 1.3337 2.3100 0.0 0
M  V30 20 C 6.6684 8.4701 0.0 0
M  V30 21 C 7.7574 9.5590 0.0 0
M  V30 22 C 5.5795 9.5590 0.0 0
M  V30 23 C 6.6684 10.6480 0.0 0
M  V30 24 C 12.0032 6.9301 0.0 0
M  V30 25 C 13.4100 6.3037 0.0 0
M  V30 26 C 12.1641 8.4616 0.0 0
M  V30 27 C 14.4406 7.4481 0.0 0
M  V30 28 C 13.8860 4.8390 0.0 0
M  V30 29 N 13.6706 8.7818 0.0 0
M  V30 30 C 15.9469 7.1280 0.0 0
M  V30 31 C 15.3923 4.5189 0.0 0
M  V30 32 C 16.4227 5.6633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 24
M  V30 11 1 9 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 1 27 29
M  V30 33 2 27 30
M  V30 34 1 28 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-N-...
C26H29F2N3O2
843654-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 N 5.3348 0.7700 0.0 0
M  V30 3 O 6.6684 3.0800 0.0 0
M  V30 4 C 6.6684 0.0000 0.0 0
M  V30 5 F 0.0000 5.3901 0.0 0
M  V30 6 N 6.6684 7.7001 0.0 0
M  V30 7 C 8.0021 6.9301 0.0 0
M  V30 8 C 9.3357 7.7001 0.0 0
M  V30 9 C 10.6695 6.9301 0.0 0
M  V30 10 F 15.8682 3.8242 0.0 0
M  V30 11 C 4.0010 4.6200 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 4.0010 3.0800 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 O 2.6673 6.9301 0.0 0
M  V30 16 C 1.3337 4.6200 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 5.3348 6.9301 0.0 0
M  V30 19 C 4.0010 7.7001 0.0 0
M  V30 20 C 1.3337 3.0800 0.0 0
M  V30 21 C 6.6684 9.2401 0.0 0
M  V30 22 C 5.5795 10.3290 0.0 0
M  V30 23 C 7.7574 10.3290 0.0 0
M  V30 24 C 6.6684 11.4180 0.0 0
M  V30 25 C 12.0032 7.7001 0.0 0
M  V30 26 C 13.4100 7.0738 0.0 0
M  V30 27 C 12.1641 9.2316 0.0 0
M  V30 28 C 14.4406 8.2181 0.0 0
M  V30 29 C 13.8860 5.6090 0.0 0
M  V30 30 N 13.6706 9.5518 0.0 0
M  V30 31 C 15.9469 7.8980 0.0 0
M  V30 32 C 15.3923 5.2889 0.0 0
M  V30 33 C 16.4227 6.4333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 25
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 19
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 1 28 30
M  V30 34 2 28 31
M  V30 35 1 29 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 843654-80-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 843654-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5495112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure D (Amide Functionalization). 3-{Cyclobutyl[
3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluoro-N-methylchromane-
5-carboxamide (35f). To 39 (0.1 g, 0.227 mmol) in anhydrous THF (8 mL)
was added 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride
(EDC, 0.087 g, 0.454 mmol), 1-hydroxybenzotriazole hydrate (HOBt, 0.061
g, 0.454 mmol), and methylamine (2 M/THF, 0.45 mL, 0.908 mmol). The
mixture was stirred at room temperature overnight. It was concentrated
and the residue taken up in CH2Cl2/H2O. The aqueous layer was extracted
one more time with CH2Cl2, and the organic extracts were treated with
brine, dried over anhydrous MgSO4, filtered, and concentrated.
Chromatography (6:3:1 hexanes-EtOAc-MeOH (1% NH4OH) afforded 0.1 g (97%)
of 35f. Conversion to the mono-HCl salt generated a white solid. white
solid: mp 132 °C/dec; 1H NMR (400 MHz, DMSO-d6) δ 1.49-1.78 (m, 2H),
1.91-2.44 (m, 5H), 2.63-2.81 (m, 5H), 3.05-3.23 (m, 2H), 3.32 (s, 3H),
3.85-4.16 (m, 2H), 4.30-4.44 (m, 1H), 4.49-4.64 (m, 1H), 6.85-6.95 (m,
1H), 7.03-7.12 (m, 1H), 7.15-7.27 (m, 2H), 7.28-7.37 (m, 2H), 8.21-8.37
(m, 1H), 10.29-10.60 (m, 1H), 10.93 (s, 1H); MS (ES) m/z 454.2 ([M +
H]+). Anal. (C26H29F2N3O2 • 1.2HCl • 0.25H2O) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advances toward New Antidepressants with Dual Serotonin Transporter and
5-HT1A Receptor Affinity within a Class of 3-Aminochroman Derivatives.
Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatzenbuhler, Nicole T.; Baudy, Reinhardt; Evrard, Deborah A.; Failli,
Amedeo; Harrison, Boyd L.; Lenicek, Steven; Mewshaw, Richard E.; Saab,
Annmarie; Shah, Uresh; Sze, Jean; Zhang, Minsheng; Zhou, Dahui; Chlenov,
Michael; Kagan, Michael; Golembieski, Jeannette; Hornby, Geoffrey; Lai,
Margaret; Smith, Deborah L.; Sullivan, Kelly M.; Schechter, Lee E.;
Andree, Terrance H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(21), 6980-7004

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-2H...
C25H26F2N2O3
843654-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 5.3348 0.0000 0.0 0
M  V30 3 O 6.6684 2.3100 0.0 0
M  V30 4 F 0.0000 4.6200 0.0 0
M  V30 5 N 6.6684 6.9301 0.0 0
M  V30 6 C 8.0021 6.1601 0.0 0
M  V30 7 C 9.3357 6.9301 0.0 0
M  V30 8 C 10.6695 6.1601 0.0 0
M  V30 9 F 15.8682 3.0542 0.0 0
M  V30 10 C 4.0010 3.8500 0.0 0
M  V30 11 C 2.6673 4.6200 0.0 0
M  V30 12 C 5.3348 4.6200 0.0 0
M  V30 13 C 4.0010 2.3100 0.0 0
M  V30 14 O 2.6673 6.1601 0.0 0
M  V30 15 C 1.3337 3.8500 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 4.0010 6.9301 0.0 0
M  V30 19 C 1.3337 2.3100 0.0 0
M  V30 20 C 6.6684 8.4701 0.0 0
M  V30 21 C 7.7574 9.5590 0.0 0
M  V30 22 C 5.5795 9.5590 0.0 0
M  V30 23 C 6.6684 10.6480 0.0 0
M  V30 24 C 12.0032 6.9301 0.0 0
M  V30 25 C 13.4100 6.3037 0.0 0
M  V30 26 C 12.1641 8.4616 0.0 0
M  V30 27 C 14.4406 7.4481 0.0 0
M  V30 28 C 13.8860 4.8390 0.0 0
M  V30 29 N 13.6706 8.7818 0.0 0
M  V30 30 C 15.9469 7.1280 0.0 0
M  V30 31 C 15.3923 4.5189 0.0 0
M  V30 32 C 16.4227 5.6633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 24
M  V30 11 1 9 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 1 27 29
M  V30 33 2 27 30
M  V30 34 1 28 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-N-...
C26H29F2N3O2
843654-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 N 5.3348 0.7700 0.0 0
M  V30 3 O 6.6684 3.0800 0.0 0
M  V30 4 C 6.6684 0.0000 0.0 0
M  V30 5 F 0.0000 5.3901 0.0 0
M  V30 6 N 6.6684 7.7001 0.0 0
M  V30 7 C 8.0021 6.9301 0.0 0
M  V30 8 C 9.3357 7.7001 0.0 0
M  V30 9 C 10.6695 6.9301 0.0 0
M  V30 10 F 15.8682 3.8242 0.0 0
M  V30 11 C 4.0010 4.6200 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 4.0010 3.0800 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 O 2.6673 6.9301 0.0 0
M  V30 16 C 1.3337 4.6200 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 5.3348 6.9301 0.0 0
M  V30 19 C 4.0010 7.7001 0.0 0
M  V30 20 C 1.3337 3.0800 0.0 0
M  V30 21 C 6.6684 9.2401 0.0 0
M  V30 22 C 5.5795 10.3290 0.0 0
M  V30 23 C 7.7574 10.3290 0.0 0
M  V30 24 C 6.6684 11.4180 0.0 0
M  V30 25 C 12.0032 7.7001 0.0 0
M  V30 26 C 13.4100 7.0738 0.0 0
M  V30 27 C 12.1641 9.2316 0.0 0
M  V30 28 C 14.4406 8.2181 0.0 0
M  V30 29 C 13.8860 5.6090 0.0 0
M  V30 30 N 13.6706 9.5518 0.0 0
M  V30 31 C 15.9469 7.8980 0.0 0
M  V30 32 C 15.3923 5.2889 0.0 0
M  V30 33 C 16.4227 6.4333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 25
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 19
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 1 28 30
M  V30 34 2 28 31
M  V30 35 1 29 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 843654-80-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 843654-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13092371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 167:
3-{cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluoro-N-methylchromane-5-carboxamide
("Compound 59"). To
3-{cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxylic
acid (0.1g, 0.23mmol) in anhydrous THF (8mL), under nitrogen at room
temperature, was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
hydrochloride (EDC, 0.087g, 0.45mmol), 1-hydroxybenzotriazole hydrate
(HOBt, 0.06g, 0.45mmol) and methylamine (2M/THF, 0.45mL, 0.91mmol). The
reaction mixture was stirred at room temperature overnight. The reaction
mixture was concentrated under vacuum on a rota vap, the residue taken up
in dichloromethane/H2O), the organic layer separated, dried over
magnesium sulfate, filtered and concentrated. Chromatography on Biotage
Quad using silica gel column and ((6:3:1) Hex-BtOAc-MeOH (1% NH4OH)) as
elution solvent afforded 0.1g (97%) of desired product which was
converted to the HCl salt to generate
3-{cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluoro-N-methylchromane-5-carboxamide
hydrochloride salt as a white solid:. mp 132°C/dec; MS (ES) m/z 454.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of 3-aminochroman and 2-aminotetralin derivatives, useful
in the treatment of serotonin-mediated disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatzenbuhler, Nicole Theriault; Evrard, Deborah Ann; Mewshaw, Richard
Eric; Zhou, Dahui; Shah, Uresh Shantilal; Inghrim, Jennifer Ann; Lenicek,
Steven Edward; Baudy, Reinhardt Bernhard; Butera, John Anthony; Sabb,
Annmarie L.; Failli, Amedeo Arturo; Ramamoorthy, Pudukkaraipudur
Sivaramakrishnan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005012291 A1 2005-02-10

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitrobenzaldehyde
C7H4BrNO3
84459-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 Br 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-nitrobenzenemethanamine
C8H9BrN2O2
1037082-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84459-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16054033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Potent, Selective, and Orally Bioavailable
Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor
Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Johnson, James A.; Jiang, Wen;
Jacutin-Porte, Swanee; Ladziata, Vladimir; Zou, Yan; Phillips, Monique
S.; Wurtz, Nicholas R.; Parkhurst, Brandon; Rendina, Alan R.; Harper,
Timothy M.; Cheney, Daniel L.; Luettgen, Joseph M.; Wong, Pancras C.;
Seiffert, Dietmar; Wexler, Ruth R.; Priestley, E. Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(15), 7125-7137

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (5aS,9aS)-1-formyl-6,7-dihydro-4-methoxy-9a(5aH)-dibenzofuranacetate
C18H20O5
869369-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2404 4.0936 0.0 0
M  V30 2 C 7.7049 3.6178 0.0 0
M  V30 3 O 8.8495 4.6482 0.0 0
M  V30 4 O 8.0251 2.1113 0.0 0
M  V30 5 C 10.3140 4.1723 0.0 0
M  V30 6 C 11.4586 5.2027 0.0 0
M  V30 7 C 6.9300 5.8614 0.0 0
M  V30 8 O 7.7000 7.1952 0.0 0
M  V30 9 O 0.7700 5.8616 0.0 0
M  V30 10 C 0.0000 7.1952 0.0 0
M  V30 11 C 5.0959 3.0632 0.0 0 CFG=1
M  V30 12 C 4.6200 4.5278 0.0 0
M  V30 13 C 3.8500 2.1580 0.0 0 CFG=2
M  V30 14 C 6.5028 2.4367 0.0 0
M  V30 15 C 3.0800 4.5278 0.0 0
M  V30 16 C 5.3900 5.8616 0.0 0
M  V30 17 O 2.6041 3.0632 0.0 0
M  V30 18 C 4.0109 0.6265 0.0 0
M  V30 19 C 6.6638 0.9052 0.0 0
M  V30 20 C 2.3100 5.8616 0.0 0
M  V30 21 C 4.6200 7.1952 0.0 0
M  V30 22 C 5.4179 0.0000 0.0 0
M  V30 23 C 3.0800 7.1952 0.0 0
M  V30 24 H 2.5164 1.3880 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 24 CFG=1
M  V30 19 2 14 19
M  V30 20 1 15 17
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4aS,8aS)-4a,5,11,12-Tetrahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2...
C17H19NO3
869369-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8719 0.0 0
M  V30 2 O 9.0005 3.5017 0.0 0
M  V30 3 C 10.2343 4.4231 0.0 0
M  V30 4 C 0.8656 6.5934 0.0 0
M  V30 5 C 3.9107 2.6675 0.0 0 CFG=1
M  V30 6 C 4.9425 3.7984 0.0 0
M  V30 7 C 4.6807 1.3338 0.0 0 CFG=2
M  V30 8 C 2.3676 2.7910 0.0 0
M  V30 9 C 2.3707 2.6675 0.0 0
M  V30 10 C 6.3509 3.1857 0.0 0
M  V30 11 C 4.7543 5.3206 0.0 0
M  V30 12 O 6.1885 1.6509 0.0 0
M  V30 13 C 3.9107 0.0000 0.0 0
M  V30 14 C 1.5258 4.0797 0.0 0
M  V30 15 C 1.6007 1.3338 0.0 0
M  V30 16 C 7.5855 4.1095 0.0 0
M  V30 17 C 5.9899 6.2440 0.0 0
M  V30 18 C 3.4224 6.1085 0.0 0
M  V30 19 C 2.3707 0.0000 0.0 0
M  V30 20 N 1.9914 5.5424 0.0 0
M  V30 21 C 7.4059 5.6389 0.0 0
M  V30 22 H 5.5846 0.0869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9 CFG=1
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 22 CFG=3
M  V30 14 1 8 14
M  V30 15 2 9 15
M  V30 16 1 10 12
M  V30 17 2 10 16
M  V30 18 1 11 17
M  V30 19 1 11 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 19
M  V30 23 1 16 21
M  V30 24 2 17 21
M  V30 25 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869369-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869369-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8802965
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM deoxy-galanthamide 80 To a solution of compound 85 (219mg, 0.693mmol) in
methanol (7mL) was added methyl amine (1.4mL of 2.0M solution in
methanol) and 4Å molecular sieves. The solution was stirred at room
temperature for 3h. The reaction mixture was cooled to 0°C and sodium
boronhydride (52mg, 1.39mmol) was added to the reaction flask in several
portions. The reaction was allowed to warm to room temperature and
stirred for 8h. The solution was heated to 70°C for 1h. The solvent was
removed under vacuum. Flash chromatography (pure ethyl acetate) yielded
the product (190mg, 97%) as a white solid. white solid. IR (film) 3014,
2827, 2840, 1651, 1508, 1438, 1391, 1283, 1219, 1165, 1072, 1038, 899,
793, 711, 663 cm-1. 1H NMR (300MHz, CDCl3) δ 6.66 (d, J=8.1Hz, 1H), 6.62
(d, J=8.1Hz, 1H), 5.81 (m, 1H), 5.40 (m, 1H), 4.70 (m, 1H), 4.46 (d,
J=15.9, 1H), 4.25 (d, J=15.6, 1H), 3.85 (s, 1H), 2.99 (s, 3H), 2.82 (s,
1H), 2.81 (s, 1H), 2.50-2.30 (m, 2H), 2.20-1.95 (m, 1H), 1.95-1.80 (m,
1H). 13C NMR (75MHz, CDCl3) δ 166.76, 142.86, 139.79, 127.51, 123.22,
122.69, 120.45, 114.29, 106.51, 83.53, 72.47, 51.21, 47.26, 38.57, 38.34,
30.98, 16.21, 14.58. Anal. Calc’d for C17H19NO3: C, 71.56%; H, 6.71%; N,
4.91%. Found: C, 71.38%; H, 6.87%; N, 4.83%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent Enantioselective Synthesis of (-)-Galanthamine and (-)-Morphine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trost, Barry M.; Tang, Weiping; Toste, F. Dean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2005), 127(42), 14785-14803

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,6-Dimethyl-4-[3-methyl-4-(2-pyridinylmethoxy)phenyl]-4H-pyrimido[4,5,6-ef][...
C25H22N4O3
871019-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3831 0.5282 0.0 0
M  V30 2 C 1.6657 0.4820 0.0 0
M  V30 3 C 3.5374 0.0000 0.0 0
M  V30 4 C 9.6829 0.4643 0.0 0
M  V30 5 O 11.2229 3.1317 0.0 0
M  V30 6 C 11.9929 4.4654 0.0 0
M  V30 7 C 2.9315 4.9480 0.0 0
M  V30 8 C 4.4293 4.5119 0.0 0
M  V30 9 C 1.7459 3.9341 0.0 0
M  V30 10 C 2.6057 6.4615 0.0 0
M  V30 11 N 5.0629 3.1317 0.0 0
M  V30 12 N 5.5499 5.5569 0.0 0
M  V30 13 O 1.7367 2.4155 0.0 0
M  V30 14 C 0.2946 4.4253 0.0 0
M  V30 15 N 3.7246 7.5115 0.0 0
M  V30 16 C 1.1535 6.9579 0.0 0
M  V30 17 C 4.4192 1.7291 0.0 0
M  V30 18 C 5.1960 7.0563 0.0 0
M  V30 19 C 2.9006 1.4022 0.0 0
M  V30 20 C 0.0000 5.9373 0.0 0
M  V30 21 C 6.6029 3.1317 0.0 0
M  V30 22 C 7.3729 1.7981 0.0 0
M  V30 23 C 7.3729 4.4654 0.0 0
M  V30 24 C 8.9129 1.7981 0.0 0
M  V30 25 C 8.9129 4.4654 0.0 0
M  V30 26 C 9.6829 3.1317 0.0 0
M  V30 27 C 13.5329 4.4654 0.0 0
M  V30 28 C 14.3029 3.1317 0.0 0
M  V30 29 N 14.3029 5.7992 0.0 0
M  V30 30 C 15.8429 3.1317 0.0 0
M  V30 31 C 15.8429 5.7992 0.0 0
M  V30 32 C 16.6129 4.4654 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 19
M  V30 3 1 3 19
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 26
M  V30 7 1 6 27
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 11 21
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 2 15 18
M  V30 23 2 16 20
M  V30 24 1 17 19
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-2-[[4-[[3-methyl-4-(2-pyridinylmethoxy)phenyl]amino]-5-quinazoli...
C26H27N5O3
871019-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 5.7476 0.0 0
M  V30 2 O 3.0801 4.4139 0.0 0
M  V30 3 C 2.3101 3.0801 0.0 0
M  V30 4 C 3.6437 2.3101 0.0 0
M  V30 5 C 0.9764 3.8501 0.0 0
M  V30 6 C 1.5400 1.7464 0.0 0
M  V30 7 N 3.6437 0.7700 0.0 0
M  V30 8 O 4.9775 3.0801 0.0 0
M  V30 9 C 4.9775 0.0000 0.0 0
M  V30 10 C 10.0102 3.0801 0.0 0
M  V30 11 O 11.5503 5.7476 0.0 0
M  V30 12 C 12.3203 7.0812 0.0 0
M  V30 13 C 3.0801 7.0812 0.0 0
M  V30 14 C 4.6201 7.0812 0.0 0
M  V30 15 C 2.3101 5.7476 0.0 0
M  V30 16 C 2.3101 8.4149 0.0 0
M  V30 17 N 5.3901 8.4149 0.0 0
M  V30 18 C 0.7700 5.7476 0.0 0
M  V30 19 C 0.7700 8.4149 0.0 0
M  V30 20 N 3.0801 9.7487 0.0 0
M  V30 21 C 4.6201 9.7487 0.0 0
M  V30 22 C 0.0000 7.0812 0.0 0
M  V30 23 C 6.9302 5.7476 0.0 0
M  V30 24 C 7.7002 4.4139 0.0 0
M  V30 25 C 7.7002 7.0812 0.0 0
M  V30 26 C 9.2402 4.4139 0.0 0
M  V30 27 C 9.2402 7.0812 0.0 0
M  V30 28 C 10.0102 5.7476 0.0 0
M  V30 29 C 13.8603 7.0812 0.0 0
M  V30 30 C 14.6303 5.7476 0.0 0
M  V30 31 N 14.6303 8.4149 0.0 0
M  V30 32 C 16.1704 5.7476 0.0 0
M  V30 33 C 16.1704 8.4149 0.0 0
M  V30 34 C 16.9404 7.0812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 4 7
M  V30 9 2 4 8
M  V30 10 1 7 9
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 28
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 2 20 21
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 871019-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871019-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-464475
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example 43.
2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N,2-dimethylpropanamide.
To a solution of
4-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-6,6-dimethyl-4H-[1,4]oxazepino[5,6,7-de]quinazolin-5(6H)-one
(70 mg, 0.157 mmol) in THF (2 ml) was added a solution of 2M methylamine
in THF (2.0 ml, 2.0 mmol). The reaction was stirred at room temperature
for 1 hour and then the solvents and excess amine were removed in vacuo
to give a solid which was crystallised from ethyl acetate to give the
title compound. Example 50.
N,2-Dimethyl-2-[(4-{[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]propanamide.
The procedure described in Example 43 was repeated using
4-[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]-6,6-dimethyl-4H-[1,4]oxazepino[5,6,7-de]quinazolin-5(6H)-one
(obtained as described in Example 49, preparation of starting materials,
30 mg, 0.07 mmol) and 2M methylamine in THF (5.0 ml, 5.0 mmol). The
reaction was stirred at room temperature for 16 hours and then the
solvents and excess amine were removed in vacuo to give a solid which was
crystallised from ethyl acetate / isohexane to give the title compound as
a white solid (31 mg, 97%). NMR spectrum: 1.72 (s, 6H), 2.31 (s, 3H),
2.67 (d, 3H), 5.22 (s, 2H), 6.72 (d, 1H), 7.06 (d, 1H), 7.36 (m, 2H),
7.56, (d, 1H), 7.66 (m, 3H), 7.87 (td, 1H), 8.43 (q, 1H), 8.49 (s, 1H),
8.60 (d, 1H), 10.14 (s, 1H); Mass spectrum: MH+ 458.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-anilino-5-carbamoylmethoxyquinazolines as selective
erbB2 receptor tyrosine kinase inhibitors for use against tumors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradbury, Robert Hugh; Kettle, Jason Grant; Scott, James Stewart;
Barlaam, Bernard Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005118572 A1 2005-12-15

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (4R)-5-[(1,1-dimethylethoxy)carbonyl]-1-oxo-2,5-diazaspiro[3.4]octane-...
C14H22N2O5
873840-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 3.7710 0.0 0
M  V30 2 O 2.1037 3.7710 0.0 0
M  V30 3 O 4.4137 5.1048 0.0 0
M  V30 4 C 1.3337 5.1048 0.0 0
M  V30 5 C 2.6675 5.8749 0.0 0
M  V30 6 C 0.5636 6.4385 0.0 0
M  V30 7 C 0.0000 4.3348 0.0 0
M  V30 8 O 8.6276 1.3266 0.0 0
M  V30 9 C 8.4331 5.0394 0.0 0
M  V30 10 C 9.9394 4.7192 0.0 0
M  V30 11 O 10.9700 5.8636 0.0 0
M  V30 12 O 10.4153 3.2545 0.0 0
M  V30 13 C 12.4763 5.5434 0.0 0
M  V30 14 C 5.9452 2.2765 0.0 0 CFG=2
M  V30 15 N 4.4137 2.4374 0.0 0
M  V30 16 C 7.4832 2.3570 0.0 0
M  V30 17 C 5.8647 3.8143 0.0 0
M  V30 18 C 6.2656 0.7700 0.0 0
M  V30 19 C 3.7874 1.0306 0.0 0
M  V30 20 N 7.4026 3.8949 0.0 0
M  V30 21 C 4.9318 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16 CFG=3
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (4R)-2-[2-(methylamino)-2-oxoethyl]-1-oxo-2,5-diazaspiro[3....
C14H23N3O4
873840-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 3.7710 0.0 0
M  V30 2 O 2.1037 3.7710 0.0 0
M  V30 3 O 4.4137 5.1048 0.0 0
M  V30 4 C 1.3337 5.1048 0.0 0
M  V30 5 C 2.6675 5.8749 0.0 0
M  V30 6 C 0.5636 6.4385 0.0 0
M  V30 7 C 0.0000 4.3348 0.0 0
M  V30 8 O 8.6276 1.3266 0.0 0
M  V30 9 C 8.4331 5.0394 0.0 0
M  V30 10 C 9.9394 4.7192 0.0 0
M  V30 11 N 10.9700 5.8636 0.0 0
M  V30 12 O 10.4153 3.2545 0.0 0
M  V30 13 C 12.4763 5.5434 0.0 0
M  V30 14 C 5.9452 2.2765 0.0 0 CFG=2
M  V30 15 N 4.4137 2.4374 0.0 0
M  V30 16 C 7.4832 2.3570 0.0 0
M  V30 17 C 5.8647 3.8143 0.0 0
M  V30 18 C 6.2656 0.7700 0.0 0
M  V30 19 C 3.7874 1.0306 0.0 0
M  V30 20 N 7.4026 3.8949 0.0 0
M  V30 21 C 4.9318 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17 CFG=1
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 873840-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 873840-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4047847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (R)-2-(5-tert-Butoxycarbonyl-1-oxo-2,5-diazaspiro[3.4]oct-2-yl)-N-methylacetamide
(2). 11a (16.0 mg, 0.0536 mmol) was dissolved in methylamine solution (8
M in ethanol, 2 mL) while cooling with an ice bath. The mixture was
stirred at this temperature for 40 min, whereupon the solvent was removed
at low temperature under reduced pressure. The residue was purified by
column chromatography (100% ethyl acetate). 2 as colorless oil, yield
15.4 mg, 97%. Rf 0.22 (CH2Cl2/methanol 95:5); [α]23D 72.8° (c 0.25,
CHCl3); IR (neat) 3483 (w), 3338 (s), 2976, 1767, 1680 cm-1; IR (CHCl3, 2
mM) 3338 cm-1; 1H NMR (600 MHz, CDCl3) δ 1.48 (s, 9H), 1.81-1.89 (m, 1H),
1.96-2.01 (m, 1H), 2.16 (ddd, 1H, J = 12.9, 6.7, 4.4 Hz), 2.36 (ddd, 1H,
J = 12.9, 10.2, 6.8 Hz), 2.82 (d, 3H, J = 4.9 Hz), 3.25 (d, 1H, J = 4.9
Hz), 3.44 und 3.41-3.49 (d and m, 3H, J = 17.8 Hz), 3.82 (d, 1H, J = 4.9
Hz), 4.45 (d, 1H, J = 17.8 Hz), 8.24 (bs, 1H); 13C NMR (150 MHz, CDCl3) δ
23.3, 26.0, 28.4, 33.2, 45.2, 47.9, 54.4, 74.1, 81.3, 153.9, 168.0,
169.1; EIMS 298 (M + 1), 297 (M+). Anal. Calcd for C14H23N3O4 x 0.5H2O:
C, 54.89; H, 7.90; N, 13.72; Found: C, 54.70; H, 7.45; N, 13.56.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chirospecific Synthesis of Spirocyclic β-Lactams and Their
Characterization as Potent Type II β-Turn Inducing Peptide Mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bittermann, Holger; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2006), 71(1), 97-102

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
2,5-Dimethyl 2,5-pyridinedicarboxylate
C9H9NO4
881-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 N 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[(methylamino)carbonyl]-3-pyridinecarboxylate
C9H10N2O3
173371-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 N 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 N 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 881-86-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 173371-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10488855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused 1,4-dihydrodioxin derivatives as inhibitors of heat
shock transcription factor 1 for therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Keith; Rye, Carl; Chessum, Nicola; Cheeseman, Matthew; Pasqua,
Adele Elisa; Pike, Kurt Gordon; Faulder, Paul Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015049535 A1 2015-04-09

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-4-carboxylic acid, 5-(chlorosulfonyl)-1-methyl-, ethyl ester
C7H9ClN2O4S
88398-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.8691 0.0 0
M  V30 2 O 6.6363 3.6391 0.0 0
M  V30 3 O 5.3026 1.3290 0.0 0
M  V30 4 C 7.9700 2.8691 0.0 0
M  V30 5 C 9.3037 3.6391 0.0 0
M  V30 6 S 2.2418 1.5063 0.0 0 VAL=6
M  V30 7 Cl 1.9217 0.0000 0.0 0
M  V30 8 O 0.7354 1.8265 0.0 0
M  V30 9 O 3.7481 1.1861 0.0 0
M  V30 10 C 0.0000 3.9962 0.0 0
M  V30 11 C 3.9688 3.6391 0.0 0
M  V30 12 C 2.5620 3.0128 0.0 0
M  V30 13 C 3.8079 5.1707 0.0 0
M  V30 14 N 1.5316 4.1572 0.0 0
M  V30 15 N 2.3016 5.4908 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 12
M  V30 10 1 10 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-5-[(methylamino)sulfonyl]-1H-pyrazole-4-carboxylate
C8H13N3O4S
2041076-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 3.7710 0.0 0 VAL=6
M  V30 2 N 1.5400 5.1048 0.0 0
M  V30 3 O 3.6437 4.5410 0.0 0
M  V30 4 O 0.9762 3.0010 0.0 0
M  V30 5 C 0.0000 5.1048 0.0 0
M  V30 6 C 5.6420 3.4208 0.0 0
M  V30 7 O 7.1484 3.1007 0.0 0
M  V30 8 O 5.1661 4.8855 0.0 0
M  V30 9 C 8.1789 4.2452 0.0 0
M  V30 10 C 9.6851 3.9249 0.0 0
M  V30 11 C 0.9473 0.7104 0.0 0
M  V30 12 C 3.0800 2.4374 0.0 0
M  V30 13 C 4.6116 2.2764 0.0 0
M  V30 14 N 2.4535 1.0306 0.0 0
M  V30 15 C 4.9317 0.7700 0.0 0
M  V30 16 N 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 14
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88398-82-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2041076-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-16645513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives useful as 5-lipoxygenase activating
protein (FLAP) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Broddefalk, Johan Olof; Emtenaes, Hans Fredrik; Granberg, Kenneth Lars;
Lemurell, Malin Anita; Pettersen, Daniel Tor; Plowright, Alleyn Thomas;
Ulander, Lars Johan Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016177703 A1 2016-11-10

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-(3-bromophenyl)-1-methyl-2-oxoethyl]carbamate
C14H18BrNO3
887913-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.6673 0.0 0
M  V30 2 N 6.6685 1.8973 0.0 0
M  V30 3 C 4.5648 1.3337 0.0 0
M  V30 4 C 6.1048 4.0012 0.0 0
M  V30 5 C 8.0022 2.6673 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 O 9.3360 1.8973 0.0 0
M  V30 8 O 8.0022 4.2074 0.0 0
M  V30 9 C 10.6697 2.6673 0.0 0
M  V30 10 C 11.4397 1.3337 0.0 0
M  V30 11 C 12.0033 3.4374 0.0 0
M  V30 12 C 9.8996 4.0012 0.0 0
M  V30 13 Br 0.0000 2.6673 0.0 0
M  V30 14 C 4.0012 3.4374 0.0 0
M  V30 15 C 2.6673 2.6673 0.0 0
M  V30 16 C 4.0012 4.9774 0.0 0
M  V30 17 C 1.3337 3.4374 0.0 0
M  V30 18 C 2.6673 5.7474 0.0 0
M  V30 19 C 1.3337 4.9774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-(3-bromophenyl)-1-methyl-2-(methylamino)ethyl]carbamate
C15H23BrN2O2
887913-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.0010 0.0 0
M  V30 2 N 6.6685 3.2310 0.0 0
M  V30 3 C 4.5648 2.6673 0.0 0
M  V30 4 C 6.1048 5.3348 0.0 0
M  V30 5 C 8.0022 4.0010 0.0 0
M  V30 6 N 5.3348 1.3337 0.0 0
M  V30 7 O 9.3360 3.2310 0.0 0
M  V30 8 O 8.0022 5.5410 0.0 0
M  V30 9 C 4.5648 0.0000 0.0 0
M  V30 10 C 10.6697 4.0010 0.0 0
M  V30 11 C 11.4397 2.6673 0.0 0
M  V30 12 C 12.0033 4.7710 0.0 0
M  V30 13 C 9.8996 5.3348 0.0 0
M  V30 14 Br 0.0000 4.0010 0.0 0
M  V30 15 C 4.0012 4.7710 0.0 0
M  V30 16 C 2.6673 4.0010 0.0 0
M  V30 17 C 4.0012 6.3111 0.0 0
M  V30 18 C 1.3337 4.7710 0.0 0
M  V30 19 C 2.6673 7.0811 0.0 0
M  V30 20 C 1.3337 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 887913-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887913-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4618016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
rac-[1-(3-bromo-phenyl)-1-methyl-2-methylamino-ethyl]-carbamic acid
tert-butyl ester Methylamine 2 M in THF (6.09 mL, 12.19 mmol) was added
to a solution of rac-[1-(3-bromo-phenyl)-1-methyl-2-oxo-ethyl]-carbamic
acid tert-butyl ester (2 g, 6.09 mmol) in a mixture of DCM (110 mL) and
AcOH (2.01 mL). The mixture was stirred at room temperature for 1 hour.
Then sodium triacetoxyborohydride (3.62 g, 17.06 mmol) was added and the
mixture was stirred at room temperature for 5 hours. The mixture was
diluted with DCM and poured into NaHCO3 (aqueous sat. soltn.). The
organic layer was separated and the aqueous layer was further extracted
with DCM. The combined organic layers were separated, dried (MgSO4),
filtered and the solvents evaporated in vacuo to yield
rac-[1-(3-bromo-phenyl)-1-methyl-2-methylamino-ethyl]-carbamic acid
tert-butyl ester that was used in the next step without further
purification. Yield 2 g, 97%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-amino-5,6-dihydro-1H-pyrazin-2-one derivatives as
β-secretase inhibitors useful for the treatment of Alzheimer's disease
and other forms of dementia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trabanco-Suarez, Andres Avelino; Delgado-Jimenez, Francisca; Tresadern,
Gary John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012000933 A1 2012-01-05

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5aS,6R,8S,8aS)-8-(Azidomethyl)-6-[(benzoyloxy)methyl]-5a,6,8,8a-tetrahydro-3...
C18H17N5O5
900513-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0293 8.9921 0.0 0
M  V30 2 O 9.5693 8.9921 0.0 0
M  V30 3 C 10.3393 10.3257 0.0 0
M  V30 4 O 9.5693 11.6595 0.0 0
M  V30 5 C 6.9021 3.6895 0.0 0
M  V30 6 N 8.3089 3.0632 0.0 0
M  V30 7 N 8.4700 1.5315 0.0 0 CHG=1 VAL=4
M  V30 8 N 8.6309 0.0000 0.0 0 CHG=-1
M  V30 9 C 2.2889 11.7561 0.0 0
M  V30 10 O 0.0000 9.6951 0.0 0
M  V30 11 C 5.7276 7.4975 0.0 0 CFG=2
M  V30 12 C 5.4074 5.9911 0.0 0 CFG=2
M  V30 13 N 4.3939 8.2675 0.0 0
M  V30 14 C 7.2593 7.6584 0.0 0 CFG=2
M  V30 15 C 6.7412 5.2211 0.0 0 CFG=2
M  V30 16 O 3.8759 5.8301 0.0 0
M  V30 17 C 3.2496 7.2369 0.0 0
M  V30 18 C 4.0738 9.7738 0.0 0
M  V30 19 O 7.8856 6.2516 0.0 0
M  V30 20 N 1.7849 7.7129 0.0 0
M  V30 21 C 2.6091 10.2496 0.0 0
M  V30 22 C 1.4647 9.2192 0.0 0
M  V30 23 C 11.8793 10.3257 0.0 0
M  V30 24 C 12.6493 11.6595 0.0 0
M  V30 25 C 12.6493 8.9921 0.0 0
M  V30 26 C 14.1893 11.6595 0.0 0
M  V30 27 C 14.1893 8.9921 0.0 0
M  V30 28 C 14.9593 10.3257 0.0 0
M  V30 29 H 6.0477 9.0038 0.0 0
M  V30 30 H 5.0872 4.4848 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 1 15 5 CFG=1
M  V30 8 2 6 7
M  V30 9 2 7 8
M  V30 10 1 9 21
M  V30 11 2 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 29 CFG=3
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 12 30 CFG=3
M  V30 19 1 13 17
M  V30 20 1 13 18
M  V30 21 1 14 19
M  V30 22 1 15 19
M  V30 23 1 16 17
M  V30 24 2 17 20
M  V30 25 2 18 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Altritol, 1-azido-2,5-anhydro-1,4-dideoxy-4-[5-methyl-2-(methylamino)-4-oxo...
C12H18N6O4
900513-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5892 1.1444 0.0 0
M  V30 2 O 7.6198 0.0000 0.0 0
M  V30 3 O 6.5892 6.5654 0.0 0
M  V30 4 N 4.6200 6.5222 0.0 0
M  V30 5 C 3.8500 7.8559 0.0 0
M  V30 6 C 9.7757 5.5302 0.0 0
M  V30 7 N 11.1826 4.9037 0.0 0
M  V30 8 N 12.4285 5.8089 0.0 0 CHG=1 VAL=4
M  V30 9 N 13.6743 6.7141 0.0 0 CHG=-1
M  V30 10 C 1.5400 1.1875 0.0 0
M  V30 11 O 0.0000 3.8549 0.0 0
M  V30 12 C 6.1600 3.8549 0.0 0 CFG=2
M  V30 13 C 7.0652 2.6091 0.0 0 CFG=2
M  V30 14 C 7.0652 5.1008 0.0 0 CFG=2
M  V30 15 O 8.5298 3.0849 0.0 0
M  V30 16 C 8.5298 4.6250 0.0 0 CFG=2
M  V30 17 N 4.6200 3.8549 0.0 0
M  V30 18 C 3.8500 5.1886 0.0 0
M  V30 19 C 3.8500 2.5211 0.0 0
M  V30 20 N 2.3100 5.1886 0.0 0
M  V30 21 C 2.3100 2.5211 0.0 0
M  V30 22 C 1.5400 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 14 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 6 7
M  V30 7 1 16 6 CFG=3
M  V30 8 2 7 8
M  V30 9 2 8 9
M  V30 10 1 10 21
M  V30 11 2 11 22
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 900513-64-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900513-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11036572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on time and amt. of reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-step synthesis of novel tricyclic isomeric azidonucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Zong-Sheng; Qiao, Ren-Ping; Yang, Zhen-Jun; Zhang, Liang-Ren; Zhang,
Li-He
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2006), 17(7), 1056-1061

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Chlorophenyl)(1-hydroxycyclopentyl)methanone
C12H13ClO2
90717-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 O 2.4917 1.3338 0.0 0
M  V30 3 Cl 4.8017 0.0000 0.0 0
M  V30 4 O 3.8987 4.6274 0.0 0
M  V30 5 C 4.8017 2.6674 0.0 0
M  V30 6 C 5.5717 1.3338 0.0 0
M  V30 7 C 5.5717 4.0011 0.0 0
M  V30 8 C 7.1117 1.3338 0.0 0
M  V30 9 C 7.1117 4.0011 0.0 0
M  V30 10 C 7.8817 2.6674 0.0 0
M  V30 11 C 2.4917 4.0011 0.0 0
M  V30 12 C 1.2459 3.0959 0.0 0
M  V30 13 C 2.0159 5.4658 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentanol
C13H16ClNO
6740-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 N 2.4917 1.3338 0.0 0
M  V30 3 C 0.9517 1.3338 0.0 0
M  V30 4 O 3.8987 4.6274 0.0 0
M  V30 5 Cl 4.8017 0.0000 0.0 0
M  V30 6 C 4.8017 2.6674 0.0 0
M  V30 7 C 5.5717 1.3338 0.0 0
M  V30 8 C 5.5717 4.0011 0.0 0
M  V30 9 C 7.1117 1.3338 0.0 0
M  V30 10 C 7.1117 4.0011 0.0 0
M  V30 11 C 7.8817 2.6674 0.0 0
M  V30 12 C 2.4917 4.0011 0.0 0
M  V30 13 C 1.2459 3.0959 0.0 0
M  V30 14 C 2.0159 5.4658 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 12
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90717-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6740-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20926552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on temperature, optimized on time,
alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of arylcycloalkylamine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Monbaliu, Jean-Christophe; Kassin, Victor-Emmanuel; Collin, Diego
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3505509 A1 2019-07-03

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Chlorophenyl)(1-hydroxycyclopentyl)methanone
C12H13ClO2
90717-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 O 2.4917 1.3338 0.0 0
M  V30 3 Cl 4.8017 0.0000 0.0 0
M  V30 4 O 3.8987 4.6274 0.0 0
M  V30 5 C 4.8017 2.6674 0.0 0
M  V30 6 C 5.5717 1.3338 0.0 0
M  V30 7 C 5.5717 4.0011 0.0 0
M  V30 8 C 7.1117 1.3338 0.0 0
M  V30 9 C 7.1117 4.0011 0.0 0
M  V30 10 C 7.8817 2.6674 0.0 0
M  V30 11 C 2.4917 4.0011 0.0 0
M  V30 12 C 1.2459 3.0959 0.0 0
M  V30 13 C 2.0159 5.4658 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentanol
C13H16ClNO
6740-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 N 2.4917 1.3338 0.0 0
M  V30 3 C 0.9517 1.3338 0.0 0
M  V30 4 O 3.8987 4.6274 0.0 0
M  V30 5 Cl 4.8017 0.0000 0.0 0
M  V30 6 C 4.8017 2.6674 0.0 0
M  V30 7 C 5.5717 1.3338 0.0 0
M  V30 8 C 5.5717 4.0011 0.0 0
M  V30 9 C 7.1117 1.3338 0.0 0
M  V30 10 C 7.1117 4.0011 0.0 0
M  V30 11 C 7.8817 2.6674 0.0 0
M  V30 12 C 2.4917 4.0011 0.0 0
M  V30 13 C 1.2459 3.0959 0.0 0
M  V30 14 C 2.0159 5.4658 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 12
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90717-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6740-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20771140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on temperature, optimized on time,
alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of arylcycloalkylamine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Toupy, Thomas; Gerardy, Romaric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019129815 A1 2019-07-04

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[2-C-[(phenylmethoxy)methyl]-5-O-(phenylmethyl)-β-D-ribofuranosyl]...
C25H25ClN4O5
908836-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0904 6.9300 0.0 0
M  V30 2 O 6.0904 5.3900 0.0 0
M  V30 3 C 4.7566 4.6200 0.0 0
M  V30 4 O 8.0504 6.2932 0.0 0
M  V30 5 O 10.1346 7.2708 0.0 0
M  V30 6 C 10.1346 10.6211 0.0 0
M  V30 7 O 11.5414 9.9948 0.0 0
M  V30 8 C 12.7873 10.9000 0.0 0
M  V30 9 Cl 0.0000 10.2706 0.0 0
M  V30 10 C 6.5189 8.9461 0.0 0 CFG=2
M  V30 11 C 7.4241 7.7000 0.0 0 CFG=1
M  V30 12 O 7.4241 10.1919 0.0 0
M  V30 13 C 8.8886 8.1761 0.0 0 CFG=2
M  V30 14 C 8.8886 9.7161 0.0 0 CFG=2
M  V30 15 N 4.9788 8.9461 0.0 0
M  V30 16 C 4.0736 10.1919 0.0 0
M  V30 17 C 4.0736 7.7000 0.0 0
M  V30 18 C 2.6091 9.7161 0.0 0
M  V30 19 N 4.3938 11.6982 0.0 0
M  V30 20 N 2.6091 8.1761 0.0 0
M  V30 21 C 1.4645 10.7465 0.0 0
M  V30 22 C 3.2494 12.7288 0.0 0
M  V30 23 N 1.7847 12.2528 0.0 0
M  V30 24 C 4.7566 3.0800 0.0 0
M  V30 25 C 3.4230 2.3100 0.0 0
M  V30 26 C 6.0904 2.3100 0.0 0
M  V30 27 C 3.4230 0.7700 0.0 0
M  V30 28 C 6.0904 0.7700 0.0 0
M  V30 29 C 4.7566 0.0000 0.0 0
M  V30 30 C 14.1943 10.2737 0.0 0
M  V30 31 C 15.4401 11.1788 0.0 0
M  V30 32 C 14.3552 8.7420 0.0 0
M  V30 33 C 16.8469 10.5524 0.0 0
M  V30 34 C 15.7620 8.1157 0.0 0
M  V30 35 C 17.0078 9.0209 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 24
M  V30 5 1 11 4 CFG=1
M  V30 6 1 13 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 14 6 CFG=3
M  V30 9 1 7 8
M  V30 10 1 8 30
M  V30 11 1 9 21
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 15 CFG=3
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 2 17 20
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, N-methyl-2′-C-[(phenylmethoxy)methyl]-5′-O-(phenylmethyl)-
C26H29N5O5
908836-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2348 6.9300 0.0 0
M  V30 2 O 7.2348 5.3900 0.0 0
M  V30 3 C 5.9012 4.6200 0.0 0
M  V30 4 O 9.1949 6.2932 0.0 0
M  V30 5 O 11.2790 7.2708 0.0 0
M  V30 6 C 11.2790 10.6211 0.0 0
M  V30 7 O 12.6860 9.9948 0.0 0
M  V30 8 C 13.9318 10.9000 0.0 0
M  V30 9 N 1.1444 10.2706 0.0 0
M  V30 10 C 0.0000 11.3010 0.0 0
M  V30 11 C 7.6634 8.9461 0.0 0 CFG=2
M  V30 12 C 8.5686 7.7000 0.0 0 CFG=1
M  V30 13 O 8.5686 10.1919 0.0 0
M  V30 14 C 10.0332 8.1761 0.0 0 CFG=2
M  V30 15 C 10.0332 9.7161 0.0 0 CFG=2
M  V30 16 N 6.1234 8.9461 0.0 0
M  V30 17 C 5.2182 10.1919 0.0 0
M  V30 18 C 5.2182 7.7000 0.0 0
M  V30 19 C 3.7535 9.7161 0.0 0
M  V30 20 N 5.5383 11.6982 0.0 0
M  V30 21 N 3.7535 8.1761 0.0 0
M  V30 22 C 2.6091 10.7465 0.0 0
M  V30 23 C 4.3938 12.7288 0.0 0
M  V30 24 N 2.9292 12.2528 0.0 0
M  V30 25 C 5.9012 3.0800 0.0 0
M  V30 26 C 4.5675 2.3100 0.0 0
M  V30 27 C 7.2348 2.3100 0.0 0
M  V30 28 C 4.5675 0.7700 0.0 0
M  V30 29 C 7.2348 0.7700 0.0 0
M  V30 30 C 5.9012 0.0000 0.0 0
M  V30 31 C 15.3386 10.2737 0.0 0
M  V30 32 C 16.5845 11.1788 0.0 0
M  V30 33 C 15.4997 8.7420 0.0 0
M  V30 34 C 17.9914 10.5524 0.0 0
M  V30 35 C 16.9065 8.1157 0.0 0
M  V30 36 C 18.1524 9.0209 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 25
M  V30 5 1 12 4 CFG=1
M  V30 6 1 14 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 8
M  V30 10 1 8 31
M  V30 11 1 9 10
M  V30 12 1 9 22
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 16 CFG=3
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908836-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908836-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5016366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent
anti-hepatitis C virus (HCV) agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoo, Byul Nae; Kim, Hea Ok; Moon, Hyung Ryong; Seol, Su Kyung; Jang, Sung
Key; Lee, Kang Man; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(16), 4190-4194

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
(3,4-Dimethoxyphenyl)acetic acid
C10H12O4
93-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 C 7.7001 5.3348 0.0 0
M  V30 7 O 6.9301 6.6686 0.0 0
M  V30 8 O 9.2401 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 3.0800 2.6675 0.0 0
M  V30 11 C 3.0800 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzeneacetamide
C11H15NO3
3340-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 N 9.2400 5.3347 0.0 0
M  V30 8 O 6.9300 6.6685 0.0 0
M  V30 9 C 10.0100 6.6685 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93-40-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3340-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1753276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38281918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidine derivative as TYK2 inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Masse, Craig E.; Phadke, Avinash S.; Lawson, Jon P.; Levy, Stuart; Yang,
Xiaowei; Wu, Guisheng; Fan, Shufeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023183908 A1 2023-09-28

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(4-chlorophenoxy)benzaldehyde
C13H8BrClO2
951136-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 Br 1.5400 0.0000 0.0 0
M  V30 5 Cl 10.7800 5.3347 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 1.5400 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 4 11
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(4-chlorophenoxy)-N-methylbenzenemethanamine
C14H13BrClNO
951136-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 11.5500 5.3347 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951136-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951136-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9535790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[4-chloro-3-(trifluoromethyl)phenoxy]benzaldehyde
C14H7BrClF3O2
951136-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 O 8.4700 0.0000 0.0 0
M  V30 4 Br 12.3200 4.0011 0.0 0
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 F 1.5400 5.1284 0.0 0
M  V30 7 F 0.0000 6.6684 0.0 0
M  V30 8 F 1.5400 8.2084 0.0 0
M  V30 9 Cl 3.0800 9.3358 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 8.4700 2.6674 0.0 0
M  V30 12 C 8.4700 5.3347 0.0 0
M  V30 13 C 10.0100 2.6674 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 10.7800 4.0011 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 6.1600 6.6684 0.0 0
M  V30 19 C 3.0800 6.6684 0.0 0
M  V30 20 C 5.3900 8.0021 0.0 0
M  V30 21 C 3.8500 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 2 11
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 19
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-[4-chloro-3-(trifluoromethyl)phenoxy]-N-methylbenzenemethanamine
C15H12BrClF3NO
951137-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.3347 0.0 0
M  V30 2 C 7.7000 2.6673 0.0 0
M  V30 3 N 8.4700 1.3336 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 Br 12.3200 5.3347 0.0 0
M  V30 6 C 1.5400 8.0021 0.0 0
M  V30 7 F 1.5400 9.5421 0.0 0
M  V30 8 F 0.0000 8.0021 0.0 0
M  V30 9 F 1.5400 6.4621 0.0 0
M  V30 10 Cl 3.0800 10.6694 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 8.4700 6.6684 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 10.0100 6.6684 0.0 0
M  V30 16 C 10.7800 5.3347 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 3.8500 6.6684 0.0 0
M  V30 19 C 6.1600 8.0021 0.0 0
M  V30 20 C 3.0800 8.0021 0.0 0
M  V30 21 C 5.3900 9.3358 0.0 0
M  V30 22 C 3.8500 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 20
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951136-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951137-05-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-367606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3-fluorophenoxy)benzaldehyde
C13H8BrFO2
951136-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 1.3336 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 F 10.7800 6.6685 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 4 11
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3-fluorophenoxy)-N-methylbenzenemethanamine
C14H13BrFNO
951137-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.3347 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 3.8500 1.3336 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 Br 0.0000 5.3347 0.0 0
M  V30 6 F 10.7800 8.0021 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 6.6684 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 1 5 12
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951136-81-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951137-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2538763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3-chlorophenoxy)benzaldehyde
C13H8BrClO2
951136-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 1.3336 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 Cl 10.7800 6.6685 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 4 11
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(3-chlorophenoxy)-N-methylbenzenemethanamine
C14H13BrClNO
951137-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.3347 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 3.8500 1.3336 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 Br 0.0000 5.3347 0.0 0
M  V30 6 Cl 10.7800 8.0021 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 6.6684 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 1 5 12
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951136-84-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951137-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11936776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(2-chloro-4-fluorophenoxy)benzaldehyde
C13H7BrClFO2
951136-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 Br 1.5400 0.0000 0.0 0
M  V30 5 Cl 6.1600 8.0021 0.0 0
M  V30 6 F 10.7800 5.3347 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 12
M  V30 6 1 5 14
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(2-chloro-4-fluorophenoxy)-N-methylbenzenemethanamine
C14H12BrClFNO
951137-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 N 0.7700 5.3347 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 Cl 6.9300 8.0021 0.0 0
M  V30 7 F 11.5500 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 13
M  V30 7 1 6 15
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951136-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951137-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14066914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Stocking, Emily M.; Barbier, Ann J.; Bonaventure,
Pascal; Boggs, Jamin D.; Lord, Brian; Miller, Kirsten L.; Wilson, Sandy
J.; Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(17), 4799-4803

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
3,4,5-Trimethoxyphenylacetic acid
C11H14O5
951-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 5.3901 0.0 0
M  V30 2 C 1.3337 6.9301 0.0 0
M  V30 3 O 1.3337 2.3100 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 6.6684 5.3901 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 O 9.3359 5.3901 0.0 0
M  V30 10 O 8.0022 3.0800 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxy-N-methylbenzeneacetamide
C12H17NO4
408508-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 N 9.3360 5.3901 0.0 0
M  V30 4 O 8.0023 3.0801 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 5.3901 0.0 0
M  V30 9 C 1.3337 6.9302 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 951-82-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 408508-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3882758
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM acid cation resin used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antitumor activity of novel 4-chloro-3-arylmaleimide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guiqing; He, Qiaojun; Yang, Bo; Hu, Yongzhou
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2009), 6(1), 51-55

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxaldehyde
C8H5ClN2O
958230-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 1.5400 0.0 0
M  V30 3 O 7.7047 2.3100 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 C 0.9052 1.8341 0.0 0
M  V30 8 N 3.7036 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-1H-pyrrolo[2,3-b]pyridine-5-carboxaldehyde
C9H9N3O
926663-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7036 0.7700 0.0 0
M  V30 2 C 2.3699 0.0000 0.0 0
M  V30 3 C 6.3709 2.3100 0.0 0
M  V30 4 O 7.7047 3.0800 0.0 0
M  V30 5 C 2.3699 3.0800 0.0 0
M  V30 6 C 3.7036 2.3100 0.0 0
M  V30 7 C 2.3699 4.6200 0.0 0
M  V30 8 C 0.9052 2.6042 0.0 0
M  V30 9 C 5.0372 3.0800 0.0 0
M  V30 10 N 3.7036 5.3900 0.0 0
M  V30 11 N 0.9052 5.0959 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 5.0372 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 958230-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926663-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15496001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted tricyclic compounds as FGFR inhibitors for
treatment of cancer and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Liangxing; Zhang, Colin; He, Chunhong; Sun, Yaping; Lu, Liang; Qian,
Ding-Quan; Xu, Meizhong; Zhuo, Jincong; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130338134 A1 2013-12-19

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2,4-dichloroquinazoline
C8H3BrCl2N2
959237-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6685 3.8500 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2-chloro-N-methyl-4-quinazolinamine
C9H7BrClN3
1603398-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 5.3349 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 Cl 1.5400 0.0000 0.0 0
M  V30 4 Br 8.4700 4.0011 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 N 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 N 1.5400 2.6674 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 959237-68-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603398-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20834445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinediamine derivatives for use as antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manetsch, Roman; Van Horn, Kurt S.; Burda, Whittney; Shaw, Lindsey N.;
Fleeman, Renee; Barber, Megan; Flanigan, David Lawrence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US10323007 B1 2019-06-18

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2,4-dichloroquinazoline
C8H3BrCl2N2
959237-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6685 3.8500 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2-chloro-N-methyl-4-quinazolinamine
C9H7BrClN3
1603398-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 5.3349 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 Cl 1.5400 0.0000 0.0 0
M  V30 4 Br 8.4700 4.0011 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 N 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 N 1.5400 2.6674 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 959237-68-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603398-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17729930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characterizing the antimicrobial activity of N2,N4-disubstituted
quinazoline-2,4-diamines toward multidrug-resistant Acinetobacter
baumannii
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fleeman, Renee; Van Horn, Kurt S.; Barber, Megan M.; Burda, Whittney N.;
Flanigan, David L.; Manetsch, Roman; Shaw, Lindsey N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Antimicrobial Agents and Chemotherapy (2017), 61(6), e00059/1-e00059/11

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Amino-1-methyl-4-[3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]p...
C25H21F3N6O3
960070-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4679 1.4472 0.0 0
M  V30 2 O 1.4780 2.6268 0.0 0
M  V30 3 O 1.9412 0.0000 0.0 0
M  V30 4 C 0.0000 6.2748 0.0 0
M  V30 5 N 4.6948 8.9854 0.0 0
M  V30 6 N 10.6530 5.5646 0.0 0
M  V30 7 C 11.9868 6.3346 0.0 0
M  V30 8 N 13.3204 5.5646 0.0 0
M  V30 9 O 11.9868 7.8746 0.0 0
M  V30 10 C 18.6552 5.5646 0.0 0
M  V30 11 F 17.8852 4.2309 0.0 0
M  V30 12 F 19.9889 4.7946 0.0 0
M  V30 13 F 19.4253 6.8984 0.0 0
M  V30 14 C 3.9845 1.7145 0.0 0
M  V30 15 C 5.5011 1.4472 0.0 0
M  V30 16 C 4.5112 0.2673 0.0 0
M  V30 17 C 3.9845 3.2545 0.0 0
M  V30 18 C 5.3182 4.0245 0.0 0
M  V30 19 N 2.6508 4.0245 0.0 0
M  V30 20 C 5.3182 5.5646 0.0 0
M  V30 21 C 2.6508 5.5646 0.0 0
M  V30 22 C 3.9845 6.3346 0.0 0
M  V30 23 N 1.5063 6.5952 0.0 0
M  V30 24 C 3.6643 7.8410 0.0 0
M  V30 25 N 2.1328 8.0020 0.0 0
M  V30 26 C 6.6520 6.3346 0.0 0
M  V30 27 C 7.9856 5.5646 0.0 0
M  V30 28 C 6.6520 7.8746 0.0 0
M  V30 29 C 9.3193 6.3346 0.0 0
M  V30 30 C 7.9856 8.6446 0.0 0
M  V30 31 C 9.3193 7.8746 0.0 0
M  V30 32 C 14.6541 6.3346 0.0 0
M  V30 33 C 15.9878 5.5646 0.0 0
M  V30 34 C 14.6541 7.8746 0.0 0
M  V30 35 C 17.3216 6.3346 0.0 0
M  V30 36 C 15.9878 8.6446 0.0 0
M  V30 37 C 17.3216 7.8746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 23
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 35
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 26
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Amino-1-methyl-4-[3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]p...
C26H24F3N7O2
960070-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6268 5.8615 0.0 0
M  V30 2 N 1.4472 4.8715 0.0 0
M  V30 3 O 2.3595 7.3781 0.0 0
M  V30 4 C 0.0000 5.3982 0.0 0
M  V30 5 C 2.9034 11.2763 0.0 0
M  V30 6 N 8.3246 11.2763 0.0 0
M  V30 7 N 11.7740 5.3348 0.0 0
M  V30 8 C 13.3141 5.3348 0.0 0
M  V30 9 N 14.0841 4.0011 0.0 0
M  V30 10 O 14.0841 6.6684 0.0 0
M  V30 11 C 18.7041 1.3337 0.0 0
M  V30 12 F 20.0378 2.1037 0.0 0
M  V30 13 F 19.4741 0.0000 0.0 0
M  V30 14 F 17.3705 0.5636 0.0 0
M  V30 15 C 4.0740 5.3348 0.0 0
M  V30 16 C 3.8066 3.8182 0.0 0
M  V30 17 C 5.2536 4.3448 0.0 0
M  V30 18 C 4.8440 6.6684 0.0 0
M  V30 19 C 6.3840 6.6684 0.0 0
M  V30 20 N 4.0740 8.0021 0.0 0
M  V30 21 C 7.1540 8.0021 0.0 0
M  V30 22 C 4.8440 9.3359 0.0 0
M  V30 23 C 6.3840 9.3359 0.0 0
M  V30 24 N 4.3681 10.8004 0.0 0
M  V30 25 C 6.8598 10.8004 0.0 0
M  V30 26 N 5.6140 11.7057 0.0 0
M  V30 27 C 8.6940 8.0021 0.0 0
M  V30 28 C 9.4640 6.6684 0.0 0
M  V30 29 C 9.4640 9.3359 0.0 0
M  V30 30 C 11.0040 6.6684 0.0 0
M  V30 31 C 11.0040 9.3359 0.0 0
M  V30 32 C 11.7740 8.0021 0.0 0
M  V30 33 C 15.6241 4.0011 0.0 0
M  V30 34 C 16.3941 2.6673 0.0 0
M  V30 35 C 16.3941 5.3348 0.0 0
M  V30 36 C 17.9341 2.6673 0.0 0
M  V30 37 C 17.9341 5.3348 0.0 0
M  V30 38 C 18.7041 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 6 25
M  V30 7 1 7 8
M  V30 8 1 7 30
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 33
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 36
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 27
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960070-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960070-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1319353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The carboxylic acid (1 eq.) was suspended in
DCM and treated with the amine (1.3 eq.) and 4- ethylmorpholine (5 eq.).
The suspension was stirred for 10 minutes at room temperature and then
cooled with ice. 2,4,6-tripropyl- [1,3,5,2,4,6]trioxatriphosphinane
2,4,6-trioxide (T3P; 2 eq.) was added and the solution stirred over night
at room temperature. The mixture was concentrated in vacuo, taken up in
sodium bicarbonate solution and stirred. The precipitate was filtered
off, washed with water and dried to yield the amide. In some cases
additional purification steps (flash column chromatography and/or
preparative HPLC) were necessary. 1 -(3-Amino-1
-methyl-4-(3-[3-(3-trifluoromethyl-phenyl)-ureido]- phenyl}-I
H-pyrazolo[3,4-b]pyridin-6-yl)- cyclopropanecarboxylic acid methylamide,
yield 200 mg, 97% . 1 H-NMR (d6-DMSO; 400 MHz): 9.14 (s, 1 H); 9.06 (s, 1
H); 8.01 (s, 1 H); 7.72 (s, 1 H);7.60(d, 1 H); 7.55 (d,1 H); 7.52 (t, 1
H); 7.50(d, 1 H); 7.48(d, 1 H); 7.32 (d, 1 H); 7.20 (d, 1 H); 6.88 (s, 1
H); 4.78 (br. s, 2 H); 3.80 (s, 3 H); 2.58 (d, 3 H); 1.38 (m, 2H); 1.29
(m, 2 H). MS (ESI): [M+H]+ = 524.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted aminopyrazolopyridines and salts thereof, their preparations
and pharmaceutical compositions comprising them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartung, Ingo; Ince, Stuart; Kettschau, Georg; Thierauch, Karl-Heinz;
Briem, Hans; Schwede, Wolfgang; Ter Laak, Antonius M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007144202 A1 2007-12-21

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-pyridinecarbonitrile
C6H3FN2
97509-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 6.1601 2.6673 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-2-pyridinecarbonitrile
C7H7N3
1211520-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 N 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97509-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1211520-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31095819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peroxidase catalyzed conversion of dihydrotetrazines into a tetrazines
for use in bioorthogonal chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fox, Joseph M.; Thorpe, Colin; Tallon, Amanda M.; Xie, Yixin; Trout,
William; Cantrel, Ashlyn S.; Rosenberger, Julia E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210164005 A1 2021-06-03

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-pyridinecarbonitrile
C6H3FN2
97509-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 6.1601 2.6673 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-2-pyridinecarbonitrile
C7H7N3
1211520-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 N 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97509-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1211520-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18535653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for inducing bioorthogonal reactivity through enzymatic or long
wavelength photocatalytic activation of tetrazine ligation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fox, Joseph; Jia, Xinqiao; Thorpe, Colin; Rosenthal, Joel; Zhang, Han;
Fang, Yinshi; Trout, Will; Liu, Shuang; Xie, Yixin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017106427 A1 2017-06-22

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-(trifluoromethyl)benzene
C7H4ClF3
98-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenamine
C8H8F3N
22864-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22864-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16445894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12131-44-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1219080-77-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-[Bis(1-adamantantyl)phosphino]-N,N-dimethylaniline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lundgren, Rylan J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2014), 1-2

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-(trifluoromethyl)benzene
C7H4ClF3
98-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenamine
C8H8F3N
22864-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22864-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-539632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 415941-58-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative cinnamyl palladium catalyst gave similar yield, alternative
diadamantyl ligand gave similar yield, Buchwald-Hartwig coupling, in-situ
generated catalyst, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Versatile Catalyst System for the Cross-Coupling of Aryl
Chlorides and Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lundgren, Rylan J.; Sappong-Kumankumah, Antonia; Stradiotto, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(6), 1983-1991,
S1983/1-S1983/198

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)methylene]methanamine
C8H8BrN
35003-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35003-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12629384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-4-bromobenzimine (1). 4-Bromobenzaldehyde (48 g, 0.26 mol) was
added to an aqueous solution (40% w/w, 26 mL) of methylamine cooled to 0
°C. The resulting milky white emulsion was stirred at room temperature
for 1 h. The crude mixture was then extracted with 150 mL of
dichloromethane. The organic phase was separated, washed with 100 mL of
water, dried over sodium sulfate, and filtered, and the solvent was
evaporated under reduced pressure. The desired imine was obtained as a
white solid (49.3 g) in 96% yield. N-Methyl-4-bromobenzimine (1), yield
49.3 g, 96% 1H NMR (200 MHz, CDCl3): δ 3.50 (3H, d, 4J = 1.7 Hz), 7.55
(4H, m), 8.22 (1H, q, 4J = 1.7 Hz). 13C NMR (50 MHz, CDCl3): δ 48.2,
124.9-129.3-131.8-135.1, 161.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a new water-soluble C2-symmetric chiral diamine: preliminary
investigation of its catalytic properties for asymmetric hydrogenation
under biphasic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maillet, Celine; Praveen, Thoniyot; Janvier, Pascal; Minguet, Sebastien;
Evain, Michel; Saluzzo, Christine; Tommasino, M. Lorraine; Bujoli, Bruno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2002), 67(23), 8191-8196

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11629539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 91 Preparation
of (3,4-Dimethoxy-benzyl)methylamine [0846] According to the procedure of
Preparation 67, except substituting 3,4-dimethoxy-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.10 g, 96%) was
prepared as a light yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.92-6.80 (m,
3H), 3.72 (d, J=4.5 Hz, 6H), 3.54 (s, 2H), 2.71 (br s, 1H), 2.23 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10494816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10769998
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(3,4-Dimethoxy-benzyl)methylamine According to the procedure of
Preparation 1, except substituting 3,4-dimethoxybenzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.10 g, 96%) was
prepared as a light yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.92-6.80 (m,
3H), 3.72 (d, J = 4.5 Hz, 6H), 3.54 (s, 2H), 2.71 (br s, 1H), 2.23 (s,
3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37025144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused 1,2,3,4-tetrahydropyridine-2,4-dione multicyclic compounds as PARP1
inhibitors and their preparation, pharmaceutical compositions and use in
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paliwal, Sunil; Samatar, Ahmed Abdi; Cripe, Lawrence Saunders
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023096915 A1 2023-06-01

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-(3-methylphenyl)-2,4-dinitrobenzenamine
C13H10ClN3O4
1000054-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 2.3100 0.0 0
M  V30 2 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 4.0011 6.9300 0.0 0
M  V30 6 N 1.3336 5.3900 0.0 0 VAL=5
M  V30 7 O 0.0000 4.6200 0.0 0
M  V30 8 O 1.3336 6.9300 0.0 0
M  V30 9 C 12.0031 2.3100 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6673 3.0800 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 8.0020 3.0800 0.0 0
M  V30 17 C 9.3358 2.3100 0.0 0
M  V30 18 C 8.0020 4.6200 0.0 0
M  V30 19 C 10.6694 3.0800 0.0 0
M  V30 20 C 9.3358 5.3900 0.0 0
M  V30 21 C 10.6694 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 5 14
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-N3-(3-methylphenyl)-4,6-dinitro-1,3-benzenediamine
C14H14N4O4
1000054-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 5.3900 0.0 0
M  V30 2 N 4.0011 6.9300 0.0 0 VAL=5
M  V30 3 O 2.6673 7.7000 0.0 0
M  V30 4 O 5.3347 7.7000 0.0 0
M  V30 5 N 4.0011 0.7700 0.0 0
M  V30 6 C 5.3347 0.0000 0.0 0
M  V30 7 N 1.3336 2.3100 0.0 0 VAL=5
M  V30 8 O 0.0000 3.0800 0.0 0
M  V30 9 O 1.3336 0.7700 0.0 0
M  V30 10 C 12.0031 5.3900 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 5.3900 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 2.6673 4.6200 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6673 3.0800 0.0 0
M  V30 17 C 8.0020 4.6200 0.0 0
M  V30 18 C 9.3358 5.3900 0.0 0
M  V30 19 C 8.0020 3.0800 0.0 0
M  V30 20 C 10.6694 4.6200 0.0 0
M  V30 21 C 9.3358 2.3100 0.0 0
M  V30 22 C 10.6694 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000054-32-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000054-38-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-514251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methylamino-5-(3-methylphenyl)amino-2,4-dinitrobenzene (S8).
Chloroarene (2.00 g, 6.50 mmol), methylamine (40 wt% in H2O, 2.02 g, 26.0
mmol), and EtOH (15 mL) were combined in a vial, which was later sealed
with a Teflon-lined screw-cap. The mixture was vigorously stirred at 70
°C for 24 h. After pouring the cooled reaction mixture into H2O (50 mL),
precipitated solids were collected by vacuum filtration, rinsed with H2O,
and dried under vacuum.
1-Methylamino-5-(3-methylphenyl)amino-2,4-dinitrobenzene as a yellow
powder, yield 1.89 g, 96%. 1H NMR (300 MHz, CDCl3): δ 9.80 (brs, 1H),
9.29 (s, 1H), 8.25 (br s, 1H), 7.38-7.33 (m, 1H), 7.15-7.13 (m, 3H), 6.14
(s, 1H), 2.84 (d, J = 5.1 Hz, 3H), 2.41 (s, 3H); 13C NMR (75 MHz, CDCl3):
δ 149.3, 147.5, 140.1, 137.4, 129.7, 129.4, 127.7, 125.8, 122.1, 92.4,
29.8, 21.3; HRMS m/z calcd for C14H15N4O4 [M+H+] 303.1084, found
303.1088.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phase-tunable fluorophores based upon benzobis(imidazolium) salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boydston, Andrew J.; Pecinovsky, Cory S.; Chao, Steven T.; Bielawski,
Christopher W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2007), 129(47), 14550-14551

$RFMT $RIREG SCHEME364 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3-Methyl-5-(phenylmethylene)-2-thioxo-4-thiazolidinone
C11H9NOS2
948016-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.3628 0.0 0
M  V30 2 O 7.0618 0.0000 0.0 0
M  V30 3 C 9.3037 2.4898 0.0 0
M  V30 4 S 7.6286 5.3913 0.0 0
M  V30 5 C 5.3348 2.1328 0.0 0
M  V30 6 C 6.7417 1.5063 0.0 0
M  V30 7 S 5.4958 3.6644 0.0 0
M  V30 8 N 7.7721 2.6509 0.0 0
M  V30 9 C 7.0021 3.9845 0.0 0
M  V30 10 C 2.6673 2.1328 0.0 0
M  V30 11 C 2.6673 3.6728 0.0 0
M  V30 12 C 1.3337 1.3628 0.0 0
M  V30 13 C 1.3337 4.4428 0.0 0
M  V30 14 C 0.0000 2.1328 0.0 0
M  V30 15 C 0.0000 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 1 10
M  V30 3 2 2 6
M  V30 4 1 3 8
M  V30 5 2 4 9
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 948016-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-1358579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 284049-75-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective, no solvent, Knoevenagel condensation,
optimization study, optimized on catalyst, time and stoichiometry of
catalyst, ionic liquid used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Butyl-3-methylimidazolium acetate catalyzed synthesis of
N-substituted-5-arylidene-rhodanines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Sarangthem Joychandra; Ahmad, Sohail; Chauhan, S. M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2014), 51(S1), E129-E139

$RFMT $RIREG SCHEME365 STEP1
$RXN



  4  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-yl 2,3-dihydro-1H-pyrrole-1-carboxylate
C8H11NO2
110910-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2-Propen-1-yl (3aR,9bR)-2,3,3a,4,5,9b-hexahydro-8-[(methylamino)carbonyl]...
C23H25N3O3
862432-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3192 7.6403 0.0 0
M  V30 2 O 10.3498 8.7849 0.0 0
M  V30 3 O 9.7951 6.1758 0.0 0
M  V30 4 C 11.8561 8.4647 0.0 0
M  V30 5 C 12.8865 9.6091 0.0 0
M  V30 6 C 14.3930 9.2889 0.0 0
M  V30 7 C 9.3359 2.3100 0.0 0
M  V30 8 N 9.3359 0.7700 0.0 0
M  V30 9 O 10.6695 3.0800 0.0 0
M  V30 10 C 10.6695 0.0000 0.0 0
M  V30 11 C 6.6684 6.9301 0.0 0 CFG=2
M  V30 12 C 5.3348 7.7001 0.0 0 CFG=1
M  V30 13 C 6.6684 5.3901 0.0 0
M  V30 14 N 7.8130 7.9605 0.0 0
M  V30 15 C 4.0011 6.9301 0.0 0 CFG=3
M  V30 16 C 5.6549 9.2064 0.0 0
M  V30 17 C 5.3348 4.6200 0.0 0
M  V30 18 C 8.0022 4.6200 0.0 0
M  V30 19 C 7.1865 9.3674 0.0 0
M  V30 20 N 4.0011 5.3901 0.0 0
M  V30 21 C 5.3348 3.0800 0.0 0
M  V30 22 C 8.0022 3.0800 0.0 0
M  V30 23 C 6.6684 2.3100 0.0 0
M  V30 24 C 2.6675 7.7001 0.0 0
M  V30 25 C 1.3337 6.9301 0.0 0
M  V30 26 C 2.6675 9.2401 0.0 0
M  V30 27 C 0.0000 7.7001 0.0 0
M  V30 28 C 1.3337 10.0101 0.0 0
M  V30 29 C 0.0000 9.2401 0.0 0
M  V30 30 H 8.0754 6.3037 0.0 0
M  V30 31 H 4.0889 8.6053 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 30 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 31 CFG=1
M  V30 18 1 13 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 24
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 18 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110910-76-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862432-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14934039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure:
Ethyl4-aminobenzoate (1 equiv.), aldehyde (1.1 equiv.), in dry toluene
was added a drop of TFA. The solution was refluxed for overnight, while
water was removed by Dean Stark trap. After removal of the solvent, the
resulted Schiffbase was used for next step directly. To the residue was
added allyI 2,3-dihydro-1H-pyrrole-1-carboxylate or other reactant as
shown in above scheme (1.1 equivalent) in acetonitrile. The reaction
mixture was stirred at room temperature for 16 hours. The solvent was
removed to give a residue, which was purified by silica gel column
chromatography giving the desired compound at approximately 1:1 ratio. A
mixture of carboxylic acid (1 equiv.), HATU (1.1 equiv.), DIPEA (1.1
equiv.) in DMF was stirred for 5 minutes. Then, a primary or secondary
amine was added to the solution. The reaction mixture was stirred at room
temperature for 4 hours. The solvent was removed in vacuo. The residue
was purified by flash column chromatography.The titled compounds of
Example 2 are made using the titled compounds made in Example 1 as the
starting materials. Tert-Butyl
8-[(4-methylpiperazin-l-yl)carbonyll-4-phenyl-2,3,3a,4,5,9b-hexahydro-
1H-pyrrolo[3,2-c]quinoline-l-carboxylate. The titled compound (235.1mg,
97% yield) was obtained by following the general procedure 5.
Allyl(3aS,9bS)-8-[(methylamino)carbonyl]-4-phenyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,2-c]quinoline-1-carboxylate.
The titled compound(1.283g; yield, 96%)was obtained by following the
general procedure 5. (ESI) (M+H)+ = 392.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinecarboxamides and
piperidoquinolinecarboxamides as B2 Bradykinin receptor modulators for
pain management and other uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Yun-Jin; Tomaszewski, Miroslaw; Walpole, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075476 A1 2005-08-18

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
NBD-Cl
C6H2ClN3O3
10199-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 3.7035 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3698 0.0 0
M  V30 3 O 0.0000 5.0371 0.0 0
M  V30 4 Cl 6.9302 3.7035 0.0 0
M  V30 5 C 3.0801 2.3698 0.0 0
M  V30 6 C 4.6201 2.3698 0.0 0
M  V30 7 C 2.3101 3.7035 0.0 0
M  V30 8 N 2.6042 0.9051 0.0 0
M  V30 9 C 5.3901 3.7035 0.0 0
M  V30 10 N 5.0960 0.9051 0.0 0
M  V30 11 C 3.0801 5.0371 0.0 0
M  V30 12 O 3.8501 0.0000 0.0 0
M  V30 13 C 4.6201 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-amino-7-nitrobenzofurazan
C7H6N4O3
18378-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 N 1.5229 4.8805 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 N 3.6810 6.1264 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 O 2.1494 6.2873 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10199-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18378-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10284383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole
(NBD), rhodamine and bodipy as new fluorescent probes for the polyamine
transport system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guminski, Yves; Grousseaud, Martial; Cugnasse, Sandrine; Brel, Viviane;
Annereau, Jean-Philippe; Vispe, Stephane; Guilbaud, Nicolas; Barret,
Jean-Marc; Bailly, Christian; Imbert, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2474-2477

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,3,4,6-Tetramethyl (1R,2α,3aβ,4R,5β,6aβ)-octahydro-2,5-dihydroxy-1,3,4,6...
C16H22O10
1025024-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 6.6814 0.0 0
M  V30 2 O 1.3337 5.9114 0.0 0
M  V30 3 O 2.6675 8.2214 0.0 0
M  V30 4 C 0.0000 6.6814 0.0 0
M  V30 5 C 5.5516 9.2783 0.0 0
M  V30 6 O 6.4569 10.5244 0.0 0
M  V30 7 O 4.0201 9.4394 0.0 0
M  V30 8 C 5.8304 11.9312 0.0 0
M  V30 9 C 9.1790 5.2498 0.0 0
M  V30 10 O 10.5128 6.0198 0.0 0
M  V30 11 O 9.1790 3.7098 0.0 0
M  V30 12 C 11.8465 5.2498 0.0 0
M  V30 13 C 6.2949 2.6528 0.0 0
M  V30 14 O 5.3896 1.4068 0.0 0
M  V30 15 O 7.8264 2.4918 0.0 0
M  V30 16 C 6.0161 0.0000 0.0 0
M  V30 17 O 3.0177 3.3494 0.0 0
M  V30 18 O 8.8288 8.5818 0.0 0
M  V30 19 C 5.4079 6.5379 0.0 0 CFG=1
M  V30 20 C 6.4385 5.3933 0.0 0 CFG=1
M  V30 21 C 4.0011 5.9114 0.0 0 CFG=2
M  V30 22 C 6.1780 7.8715 0.0 0 CFG=3
M  V30 23 C 7.8453 6.0198 0.0 0 CFG=2
M  V30 24 C 5.6685 4.0597 0.0 0 CFG=3
M  V30 25 C 4.1621 4.3798 0.0 0 CFG=1
M  V30 26 C 7.6844 7.5514 0.0 0 CFG=2
M  V30 27 H 4.3775 7.6823 0.0 0
M  V30 28 H 7.4690 4.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 23 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 24
M  V30 16 1 14 16
M  V30 17 1 25 17 CFG=3
M  V30 18 1 26 18 CFG=3
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 27 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 28 CFG=1
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(6 19 20 21 23 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2α,3S,3aβ,4R,5α,6S,6aβ)-Octahydro-2,5-dihydroxy-N1,N3,N4,N6-tetrameth...
C16H26N4O6
1025024-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 6.6814 0.0 0
M  V30 2 N 1.3337 5.9114 0.0 0
M  V30 3 O 2.6675 8.2214 0.0 0
M  V30 4 C 0.0000 6.6814 0.0 0
M  V30 5 C 5.5516 9.2783 0.0 0
M  V30 6 N 6.4569 10.5244 0.0 0
M  V30 7 O 4.0201 9.4394 0.0 0
M  V30 8 C 5.8304 11.9312 0.0 0
M  V30 9 C 9.1790 5.2498 0.0 0
M  V30 10 N 10.5128 6.0198 0.0 0
M  V30 11 O 9.1790 3.7098 0.0 0
M  V30 12 C 11.8465 5.2498 0.0 0
M  V30 13 C 6.2949 2.6528 0.0 0
M  V30 14 N 5.3896 1.4068 0.0 0
M  V30 15 O 7.8264 2.4918 0.0 0
M  V30 16 C 6.0161 0.0000 0.0 0
M  V30 17 O 3.0177 3.3494 0.0 0
M  V30 18 O 8.8288 8.5818 0.0 0
M  V30 19 C 5.4079 6.5379 0.0 0 CFG=1
M  V30 20 C 6.4385 5.3933 0.0 0 CFG=1
M  V30 21 C 4.0011 5.9114 0.0 0 CFG=2
M  V30 22 C 6.1780 7.8715 0.0 0 CFG=1
M  V30 23 C 7.8453 6.0198 0.0 0 CFG=2
M  V30 24 C 5.6685 4.0597 0.0 0 CFG=1
M  V30 25 C 4.1621 4.3798 0.0 0 CFG=1
M  V30 26 C 7.6844 7.5514 0.0 0 CFG=2
M  V30 27 H 4.3775 7.6823 0.0 0
M  V30 28 H 7.4690 4.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 23 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 16
M  V30 17 1 25 17 CFG=3
M  V30 18 1 26 18 CFG=3
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 27 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 28 CFG=1
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(8 19 20 21 22 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1025024-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1025024-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11200664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A rigid bicyclo[3.3.0]octane (octahydropentalene): a heavily constrained
novel aliphatic template for molecular self-assembly
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kendhale, Amol M.; Gonnade, Rajesh; Rajamohanan, P. R.; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(19), 3056-3059

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1-Benzothiazine, 3-(3-bromopropyl)-6-chloro-1-(2-fluorophenyl)-3,4-dihyd...
C17H16BrClFNO2S
1033629-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 Br 12.0033 6.1601 0.0 0
M  V30 8 Cl 4.0012 0.0000 0.0 0
M  V30 9 N 4.0012 6.1601 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 6.6685 6.1601 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 2.6673 8.4702 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 23 C 1.3337 9.2402 0.0 0
M  V30 24 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1-Benzothiazine-3-propanamine, 6-chloro-1-(2-fluorophenyl)-3,4-dihydro-N...
C18H20ClFN2O2S
1033627-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 N 12.0033 6.1601 0.0 0
M  V30 8 C 13.3370 6.9302 0.0 0
M  V30 9 Cl 4.0010 0.0000 0.0 0
M  V30 10 N 4.0010 6.1601 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 6.6685 6.1601 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 4.0010 1.5400 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 24 C 1.3337 9.2402 0.0 0
M  V30 25 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033629-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033627-57-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7217093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-[6-chloro-1-(2-fluorophenyl)-2,2-dioxido-3,4-dihydro-1H-2,1-benzothiazin-3-yl]-Nmethylpropan-1-amine.
Step 1: A solution of 2-bromo-5-chlorophenylacetic acid (1.0 g, 4.0 mmol)
in tetrahydrofuran (16 mL) was cooled to 0°C and was treated with 1.0 M
borane tetrahydrofuran complex solution (6 mL, 6.0 mmol) and then warmed
to room temperature for 2 h. The reaction mixture was slowly quenched
with H2O (10 mL) and then diluted with ethyl acetate (30 mL) and washed
with 2N HCl (3 × 15 mL). The organic layer was isolated, dried with MgSO4
and evaporated to provide 2-(2-bromo-5-chlorophenyl)ethanol (0.91 g, 96%)
as a yellow solid. HPLC Retention time 8.7 min.; Xterra RP18, 3.5 μ, 150
× 4.6 mm column, 1.2 mL/min, 85/15-5/95 (Ammon. Form. Buff.
Ph=3.5/ACN+MeOH) for 10min, hold 4min. HRMS: calcd for C8H8BrCIO,
233.94470; found (EI, M+*), 233.9448;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic sulfonamide derivatives as monoamine reuptake inhibitors, their
preparation, pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel Adam; McComas, Casey Cameron; Mann,
Charles William; Melenski, Edward George; Sabatucci, Joseph P.;
Woodworth, Richard Page, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073956 A2 2008-06-19

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-chloropropyl)-1-(3-fluorophenyl)-3,4-dihydro-...
C16H16ClFN2O2S
1034028-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 F 0.0000 4.6201 0.0 0
M  V30 8 N 5.3348 4.6201 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 2.6673 7.7002 0.0 0
M  V30 23 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(3-fluorophenyl)-1,4-dihydro-N-met...
C17H20FN3O2S
1034027-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 4.0010 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 7.7002 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-76-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7546036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-chloropropyl)-3,4-dihydro-1-(3-methoxyphenyl)...
C17H19ClN2O3S
1034028-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.9921 6.5698 0.0 0
M  V30 2 O 7.0122 6.5698 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 C 12.0033 4.6201 0.0 0
M  V30 5 C 13.3370 5.3901 0.0 0
M  V30 6 Cl 14.6707 4.6201 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 N 6.6685 4.6201 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 S 8.0022 5.3901 0.0 0 VAL=6
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 N 9.3358 4.6201 0.0 0
M  V30 15 C 9.3358 3.0801 0.0 0
M  V30 16 C 8.0022 0.7700 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 4.0010 4.6201 0.0 0
M  V30 21 C 5.3348 6.9302 0.0 0
M  V30 22 C 2.6673 5.3901 0.0 0
M  V30 23 C 4.0010 7.7002 0.0 0
M  V30 24 C 2.6673 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1,4-dihydro-1-(3-methoxyphenyl)-N-me...
C18H23N3O3S
1034027-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.9923 6.5698 0.0 0
M  V30 2 O 7.0124 6.5698 0.0 0
M  V30 3 C 10.6698 5.3901 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 5.3901 0.0 0
M  V30 6 N 14.6708 4.6201 0.0 0
M  V30 7 C 16.0046 5.3901 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 N 6.6687 4.6201 0.0 0
M  V30 11 C 6.6687 3.0801 0.0 0
M  V30 12 S 8.0023 5.3901 0.0 0 VAL=6
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 N 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 C 8.0023 0.7700 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 6.6687 0.0000 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 23
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11806073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 1-(4-chlorophenyl)-3-(3-chloropropyl)-3,4-dihydro-...
C16H16Cl2N2O2S
1034028-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 Cl 0.0000 7.7002 0.0 0
M  V30 8 N 5.3348 4.6201 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 2.6673 7.7002 0.0 0
M  V30 23 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(4-chlorophenyl)-1,4-dihydro-N-met...
C17H20ClN3O2S
1034027-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 Cl 0.0000 7.7002 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 4.0010 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 7.7002 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4810045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 1-(3-chloro-4-fluorophenyl)-3-(3-chloropropyl)-3,4...
C16H15Cl2FN2O2S
1034028-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 Cl 0.0000 4.6201 0.0 0
M  V30 8 F 0.0000 7.7002 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 4.0010 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 7.7002 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 22
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(3-chloro-4-fluorophenyl)-1,4-dihy...
C17H19ClFN3O2S
1034027-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 Cl 0.0000 4.6201 0.0 0
M  V30 9 F 0.0000 7.7002 0.0 0
M  V30 10 N 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 N 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 6.6685 0.7700 0.0 0
M  V30 18 C 4.0010 0.7700 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 4.0010 6.9302 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 2.6673 7.7002 0.0 0
M  V30 25 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 23
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-830285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-chloropropyl)-1-(4-fluorophenyl)-3,4-dihydro-...
C16H16ClFN2O2S
1034028-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 F 0.0000 7.7002 0.0 0
M  V30 8 N 5.3348 4.6201 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 2.6673 7.7002 0.0 0
M  V30 23 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(4-fluorophenyl)-1,4-dihydro-N-met...
C17H20FN3O2S
1034027-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 F 0.0000 7.7002 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 4.0010 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 7.7002 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13943478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-chloropropyl)-3,4-dihydro-1-(4-methoxyphenyl)...
C17H19ClN2O3S
1034028-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8927 6.8514 0.0 0
M  V30 2 O 7.6072 5.8614 0.0 0
M  V30 3 C 3.8500 6.6686 0.0 0
M  V30 4 C 2.3100 6.6686 0.0 0
M  V30 5 C 1.5400 8.0022 0.0 0
M  V30 6 Cl 0.0000 8.0022 0.0 0
M  V30 7 O 13.0901 4.0011 0.0 0
M  V30 8 C 13.8601 5.3348 0.0 0
M  V30 9 N 6.9301 4.0011 0.0 0
M  V30 10 C 6.1600 2.6675 0.0 0
M  V30 11 S 6.1600 5.3348 0.0 0 VAL=6
M  V30 12 C 4.6200 2.6675 0.0 0
M  V30 13 C 6.9301 1.3337 0.0 0
M  V30 14 N 4.6200 5.3348 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.8500 1.3337 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 18 C 4.6200 0.0000 0.0 0
M  V30 19 C 8.4701 4.0011 0.0 0
M  V30 20 C 9.2401 2.6675 0.0 0
M  V30 21 C 9.2401 5.3348 0.0 0
M  V30 22 C 10.7801 2.6675 0.0 0
M  V30 23 C 10.7801 5.3348 0.0 0
M  V30 24 C 11.5501 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1,4-dihydro-1-(4-methoxyphenyl)-N-me...
C18H23N3O3S
1034027-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.9923 6.5698 0.0 0
M  V30 2 O 7.0124 6.5698 0.0 0
M  V30 3 C 10.6698 5.3901 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 5.3901 0.0 0
M  V30 6 N 14.6708 4.6201 0.0 0
M  V30 7 C 16.0046 5.3901 0.0 0
M  V30 8 O 1.3338 7.7002 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 N 6.6687 4.6201 0.0 0
M  V30 11 C 6.6687 3.0801 0.0 0
M  V30 12 S 8.0023 5.3901 0.0 0 VAL=6
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 N 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 C 8.0023 0.7700 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 6.6687 0.0000 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2686030
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-chloropropyl)-1-(3,4-difluorophenyl)-3,4-dihy...
C16H15ClF2N2O2S
1034028-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 F 0.0000 4.6201 0.0 0
M  V30 8 F 0.0000 7.7002 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 4.0010 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 7.7002 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 22
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(3,4-difluorophenyl)-1,4-dihydro-N...
C17H19F2N3O2S
1034027-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6584 6.5698 0.0 0
M  V30 2 O 5.6786 6.5698 0.0 0
M  V30 3 C 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 F 0.0000 7.7002 0.0 0
M  V30 10 N 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 S 6.6685 5.3901 0.0 0 VAL=6
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 N 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 6.6685 0.7700 0.0 0
M  V30 18 C 4.0010 0.7700 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 4.0010 6.9302 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 2.6673 7.7002 0.0 0
M  V30 25 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 23
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6943268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(2-bromoethyl)-1-(2-fluorophenyl)-3,4-dihydro-, ...
C15H14BrFN2O2S
1034028-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0023 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 Br 10.6697 5.3901 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 N 6.6685 4.6201 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 4.0012 0.0000 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 1.3337 7.7002 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 9
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-ethanamine, 1-(2-fluorophenyl)-1,4-dihydro-N-meth...
C16H18FN3O2S
1034027-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 10.6697 5.3901 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 N 4.0012 4.6201 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 6.6685 4.6201 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6673 5.3901 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4754500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-bromopropyl)-1-(2-fluorophenyl)-3,4-dihydro-,...
C16H16BrFN2O2S
1034028-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 Br 12.0033 4.6201 0.0 0
M  V30 8 N 4.0012 4.6201 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 6.6685 4.6201 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6673 5.3901 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 1-(2-fluorophenyl)-1,4-dihydro-N-met...
C17H20FN3O2S
1034027-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 N 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 5.3901 0.0 0
M  V30 9 N 4.0010 4.6201 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 N 6.6685 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 18 C 4.0010 0.0000 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-75-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6896137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(4-bromobutyl)-1-(2-fluorophenyl)-3,4-dihydro-, ...
C17H18BrFN2O2S
1034028-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 Br 13.3370 5.3901 0.0 0
M  V30 9 N 4.0010 4.6201 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 N 6.6685 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 18 C 4.0010 0.0000 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-butanamine, 1-(2-fluorophenyl)-1,4-dihydro-N-meth...
C18H22FN3O2S
1034027-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 F 1.3337 3.0801 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 N 13.3370 5.3901 0.0 0
M  V30 9 C 14.6707 4.6201 0.0 0
M  V30 10 N 4.0010 4.6201 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 N 6.6685 4.6201 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 4.0010 0.0000 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 1.3337 7.7002 0.0 0
M  V30 25 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9017084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(2-bromoethyl)-6-fluoro-1-(2-fluorophenyl)-3,4-d...
C15H13BrF2N2O2S
1034028-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0023 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 Br 10.6697 6.9302 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 N 4.0012 6.1601 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 N 6.6685 6.1601 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 1.3337 9.2402 0.0 0
M  V30 23 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-ethanamine, 6-fluoro-1-(2-fluorophenyl)-1,4-dihyd...
C16H17F2N3O2S
1034027-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 N 10.6697 6.9302 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 F 4.0012 0.0000 0.0 0
M  V30 9 N 4.0012 6.1601 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 6.6685 6.1601 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 2.6673 8.4702 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 23 C 1.3337 9.2402 0.0 0
M  V30 24 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-77-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11152858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(3-bromopropyl)-6-fluoro-1-(2-fluorophenyl)-3,4-...
C16H15BrF2N2O2S
1034028-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 Br 12.0033 6.1601 0.0 0
M  V30 8 F 4.0012 0.0000 0.0 0
M  V30 9 N 4.0012 6.1601 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 6.6685 6.1601 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 2.6673 8.4702 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 23 C 1.3337 9.2402 0.0 0
M  V30 24 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-propanamine, 6-fluoro-1-(2-fluorophenyl)-1,4-dihy...
C17H19F2N3O2S
1034027-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 N 12.0033 6.1601 0.0 0
M  V30 8 C 13.3370 6.9302 0.0 0
M  V30 9 F 4.0010 0.0000 0.0 0
M  V30 10 N 4.0010 6.1601 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 6.6685 6.1601 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 4.0010 1.5400 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 24 C 1.3337 9.2402 0.0 0
M  V30 25 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13284517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(4-bromobutyl)-6-fluoro-1-(2-fluorophenyl)-3,4-d...
C17H17BrF2N2O2S
1034028-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 Br 13.3370 6.9302 0.0 0
M  V30 9 F 4.0010 0.0000 0.0 0
M  V30 10 N 4.0010 6.1601 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 6.6685 6.1601 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 4.0010 1.5400 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 24 C 1.3337 9.2402 0.0 0
M  V30 25 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-butanamine, 6-fluoro-1-(2-fluorophenyl)-1,4-dihyd...
C18H21F2N3O2S
1034027-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3246 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3358 6.1601 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 N 13.3370 6.9302 0.0 0
M  V30 9 C 14.6707 6.1601 0.0 0
M  V30 10 F 4.0010 0.0000 0.0 0
M  V30 11 N 4.0010 6.1601 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 N 6.6685 6.1601 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 23 C 2.6673 8.4702 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 25 C 1.3337 9.2402 0.0 0
M  V30 26 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 13
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 21
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15413180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 28-96% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of norepinephrine reuptake inhibitors
with benzothiadiazine dioxide or dihydrosulfostyril cores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel; McComas, Casey C.; Trybulski, Eugene J.;
Woodworth, Richard P.; Deecher, Darlene C.; Whiteside, Garth T.; Zhang,
Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(5), 1555-1558

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Phenylmethyl)thio]acetic acid
C9H10O2S
103-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 S 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 9.3359 3.0800 0.0 0
M  V30 6 O 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 1.3337 3.0800 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(phenylmethyl)thio]acetate
C10H12O2S
17277-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 S 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17277-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29375601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorophenyl isocyanate
C7H4ClNO
104-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 1.5400 0.0 0
M  V30 4 Cl 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-N′-methylurea
C8H9ClN2O
5352-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5352-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-3209932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-(2,4-Dichlorophenyl)-N'-methyl-urea (7). A
cooled (0 °C) solution of methylamine in EtOH (50 mL, 400 mmol, 8.0 M)
was dissolved in anhydrous THF (300 mL) and was treated with
2,4-dichlorophenyl isocyanate (25.0 g, 133 mmol). The cooling bath was
removed, and the mixture was warmed to 65 °C for 20 min. The reaction
mixture was then cooled to 0 °C. The solid was collected on a Buchner
funnel, washed with cold ether and dried under vacuum to afford
N-(2,4-dichlorophenyl)-N'-methyl-urea (21.7 g, 74% yield) as a colorless
solid. Yield 74-96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione
derivatives as corticotropin-releasing factor1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartz, Richard A.; Nanda, Kausik K.; Ingalls, Charles L.; Ahuja, Vijay
T.; Molski, Thaddeus F.; Zhang, Ge; Wong, Harvey; Peng, Yong; Kelley,
Michelle; Lodge, Nicholas J.; Zaczek, Robert; Gilligan, Paul J.; Trainor,
George L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(19), 4741-4754

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-3-oxo-1-[(phenylthio)methyl]propyl]carbamate
C15H21NO3S
1044598-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 S 8.4700 5.3347 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 6.1600 1.3338 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 O 5.3900 0.0000 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 1.5400 5.1285 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 10.7800 6.6685 0.0 0
M  V30 18 C 12.3200 4.0011 0.0 0
M  V30 19 C 12.3200 6.6685 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-3-(methylamino)-1-[(phenylthio)methyl]propyl]carbamate
C16H26N2O2S
2101566-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0 CFG=1
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 N 5.3900 6.6685 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 S 8.4700 6.6685 0.0 0
M  V30 6 C 3.8500 6.6685 0.0 0
M  V30 7 C 6.1600 2.6674 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 O 3.0800 5.3347 0.0 0
M  V30 10 N 5.3900 1.3336 0.0 0
M  V30 11 C 1.5400 8.0021 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 1.5400 9.5421 0.0 0
M  V30 14 C 0.0000 8.0021 0.0 0
M  V30 15 C 1.5400 6.4621 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 10.7800 5.3347 0.0 0
M  V30 18 C 10.7800 8.0021 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 20 C 12.3200 8.0021 0.0 0
M  V30 21 C 13.0900 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 16
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1044598-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101566-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-18787847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acylsulfonamide phosphonate derivatives for treating
senescence-associated diseases and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Backes, Bradley; W. Von Geldern, Thomas; Chen, Bing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017101851 A1 2017-06-22

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Cinnamaldehyde
C9H8O
104-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2E)-3-Phenyl-2-propen-1-ylidene]methanamine
C10H11N
196703-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-55-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 196703-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22952409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, reaction carried out with various reaction condition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME386 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2′-amino-1,2,5′,6′,7′,8′-hexahydro-1′-methyl-2-oxospiro[3H-indole-3,4′(...
C20H23N3O3
917506-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8690 3.9843 0.0 0
M  V30 2 O 7.7523 2.7228 0.0 0
M  V30 3 O 7.5198 5.3801 0.0 0
M  V30 4 C 9.2863 2.8571 0.0 0
M  V30 5 C 10.1697 1.5955 0.0 0
M  V30 6 O 1.2266 5.7130 0.0 0
M  V30 7 N 6.6685 1.5400 0.0 0
M  V30 8 C 4.0011 0.0000 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 5.2470 5.5253 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.7551 5.5253 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 4.7711 6.9899 0.0 0
M  V30 17 C 6.7533 5.2051 0.0 0
M  V30 18 C 5.3348 2.3100 0.0 0
M  V30 19 N 3.2311 6.9899 0.0 0
M  V30 20 N 4.0011 1.5400 0.0 0
M  V30 21 C 1.3337 1.5400 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 23 C 5.8016 8.1344 0.0 0
M  V30 24 C 7.7837 6.3495 0.0 0
M  V30 25 C 0.0000 2.3100 0.0 0
M  V30 26 C 7.3079 7.8142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 13
M  V30 7 1 7 18
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 16 19
M  V30 23 2 16 23
M  V30 24 1 17 24
M  V30 25 1 18 20
M  V30 26 1 21 25
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 917506-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29796406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1318-93-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reactions run in the absence of montmorillonite K10 gave lower yields, no
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four component and solvent-free synthesis of some new
spiro-1,4-dihydropyridines on solid support montmorillonite K10
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azizian, Javad; Hatamjafari, Farhad; Karimi, Ali Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2006), 43(5), 1349-1352

$RFMT $RIREG SCHEME387 STEP1
$RXN



  3  1
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Bromophenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H9BrN2O2
920941-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 O 1.6752 5.3914 0.0 0
M  V30 5 Br 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 C 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 7.9701 1.3628 0.0 0
M  V30 13 C 6.6365 3.6728 0.0 0
M  V30 14 C 9.3038 2.1328 0.0 0
M  V30 15 C 7.9701 4.4428 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920941-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1885397
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Bis(4-nitrophenoxy)pyrimidine
C16H10N4O6
1069112-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0035 4.6201 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 N 17.3383 1.5400 0.0 0 VAL=5
M  V30 4 O 17.3383 0.0000 0.0 0
M  V30 5 O 18.6720 2.3101 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 10.6697 3.8501 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 N 10.6697 2.3101 0.0 0
M  V30 12 C 8.0023 3.8501 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 N 8.0023 2.3101 0.0 0
M  V30 15 C 13.3372 3.8501 0.0 0
M  V30 16 C 14.6708 4.6201 0.0 0
M  V30 17 C 13.3372 2.3101 0.0 0
M  V30 18 C 16.0045 3.8501 0.0 0
M  V30 19 C 14.6708 1.5400 0.0 0
M  V30 20 C 16.0045 2.3101 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 4.0012 4.6201 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6675 3.8501 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 12
M  V30 4 1 2 21
M  V30 5 2 3 4
M  V30 6 2 3 5
M  V30 7 1 3 20
M  V30 8 2 6 7
M  V30 9 2 6 8
M  V30 10 1 6 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-(4-nitrophenoxy)-4-pyrimidinamine
C11H10N4O3
1069112-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 N 12.0033 4.6201 0.0 0
M  V30 3 C 13.3370 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 N 8.0022 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 4.0010 1.5400 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1069112-51-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1069112-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10210246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl-[6-(4-nitrophenoxy)pyrimidin-4-yl]amine(34). Compound 33 (96 g,
0.27 mol), tetrahydrofuran (330 mL), and methylamine (105 g, 40 wt % in
water, 1.35 mol) were charged to a 2-L flask equipped with a mechanical
stirrer, thermocouple, heating/cooling capacity, addition funnel, and a
nitrogen inlet/ outlet. The mixture was heated to 30 °C and stirred for
an additional 16 h. A solution of sodium hydroxide (11.0 g) and water (1
L) was charged over 30 min while maintaining the batch temperature below
25 °C. The mixture was cooled to 0 °C and stirred for an additional 1 h.
Product was collected by filtration, rinsed with water (800 mL), and
dried at 50 °C under vacuum (5 mmHg) for 16 h to obtain 34 (64 g, 96%
yield) as an off-white solid:. mp 164-166 °C; HPLC purity 99%; 1H NMR
(300 MHz, DMSO-d6) δ 8.26 (d, J = 7.0 Hz, 2H), 8.17 (s, b, 1H), 7.50 (d,
J = 4.7 Hz, 1H), 7.38 (d, J = 7.1 Hz, 2H), 6.02 (s, 1H), 2.80 (s, b, 3H).
13C NMR (75 MHz, DMSO-d6) δ 165.7, 158.9, 158.5, 144.2, 126.7, 125.8,
122.1, 120.1, 27.8. HPLC for 33 (tR = 13.3 min); 34 (tR = 8.8 min):
Alltech Inertsil ODS-2 5 μm C-18 150 mm × 4.6 mm, flow rate = 1.0 mL/
min, 40 °C, gradient elution from 10:90 A:B to 65:35 A:B over 15 min; A =
acetonitrile; B = 0.05 M NaH2PO4 (pH 2.5).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of a Triad of Flt3 Kinase Inhibitors: From Bench to Pilot Plant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shieh, Wen-Chung; McKenna, Joe; Sclafani, Joseph A.; Xue, Song; Girgis,
Michael; Vivelo, James; Radetich, Branko; Prasad, Kapa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2008), 12(6), 1146-1155

$RFMT $RIREG SCHEME389 STEP1
$RXN



  4  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glyoxal
C2H2O2
107-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 O 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethylimidazolium acetate
C5H9N2.C2H3O2
78643-53-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 6.4718 0.0 0
M  V30 2 C 5.3026 5.3447 0.0 0
M  V30 3 C 2.7406 6.3283 0.0 0
M  V30 4 N 1.3337 5.7018 0.0 0 CHG=1
M  V30 5 N 3.7711 5.1837 0.0 0
M  V30 6 C 1.4946 4.1702 0.0 0
M  V30 7 C 3.0011 3.8501 0.0 0
M  V30 8 C 2.6513 1.5400 0.0 0
M  V30 9 C 1.3177 2.3101 0.0 0
M  V30 10 O 3.9850 2.3101 0.0 0 CHG=-1
M  V30 11 O 2.6513 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 107-22-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 78643-53-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-6108794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chlorine-free alternatives to the synthesis of ionic liquids for biomass
processing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gurau, Gabriela; Wang, Hui; Qiao, Yun; Lu, Xingmei; Zhang, Suojiang;
Rogers, Robin D.IUPAC Commission
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pure and Applied Chemistry (2012), 84(3), 745-754

$RFMT $RIREG SCHEME390 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-formylbenzoate
C9H8O3
1571-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isopropyl chloroformate
C4H7ClO2
108-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 Cl 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[methyl[(1-methylethoxy)carbonyl]amino]methyl]benzoate
C14H19NO4
1520080-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 2.6673 3.8501 0.0 0
M  V30 6 O 4.0010 6.1601 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 1.3337 6.1601 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 O 13.3370 2.3101 0.0 0
M  V30 12 O 12.0033 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 9.3358 4.6201 0.0 0
M  V30 17 C 9.3358 1.5400 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1571-08-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520080-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7276630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for Synthesis of
Carbamates: Method B. Preparation of carbamates 5b, 6b, 7b, S1, S4, 10b,
11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. To a stirred solution of
aldehyde (2.10 mmol) in MeOH (10.5 mL) was added at rt a 40% MeOH
solution of MeNH2 (0.429 mL, 4.20 mmol). After 1 h at rt, NaBH4 (159 mg,
4.20 mmol) was added at 0°C and the mixture was stirred at rt for 30 min.
The reaction mixture was quenched with acetone (20 mL) at 0°C and the new
mixture was concentrated under reduced pressure. The residual white
solids were used for the next step without purification. To a stirred
solution of the residue in a mixture of 1:1:1 THF-acetone-H2O (10.0 mL)
was added at 0°C ClCO2R (3.78 mmol) or FmocOSu (1.28 g, 3.78 mmol, for
17g and S15). After 2 h at rt, saturated aqueous NaHCO3 (10 mL) was added
at 0°C and the mixture was extracted with EtOAc (10 mL x 3). The extracts
were washed with saturated aqueous NaCl (10 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by column
chromatography on silica gel to afford carbamates 5b, 6b, 7b, S1, S4,
10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. From
3-methoxybenzaldehyde. From methyl 4-formylbenzoate. Methyl
4-(((isopropoxycarbonyl)methyl)amino)methyl)benzoate (14b) as a colorless
syrup, yield 96%. Rf = 0.39 (2:1 hexane-EtOAc); IR (neat, cm-1) 2981,
1724, 1697, 1436, 1397, 1280, 1242, 1179, 1147, 1109; 1H NMR (500 MHz,
(CD3)2SO, 80°C, solvent residual peak = 2.50) δ 1.20 (6H, d, J = 6.3 Hz),
2.83 (3H, s), 3.86 (3H, s), 4.49 (2H, s), 4.83 (1H, sept, J = 6.3 Hz),
7.36 (2H, d, J = 8.3 Hz), 7.94 (2H, d, J = 8.3 Hz); 13C NMR (125 MHz,
80°C, (CD3)2SO) δ 21.5, 33.6, 51.1, 51.5, 67.8, 127.0, 128.4, 129.0,
143.2, 155.1, 165.7; LRMS (EI) m/z (M)+ 265.2; HRMS (EI) m/z (M)+ calcd
for C14H19NO4 265.1314, found 265.1332.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-1-methyl-1H-pyrazole-5-carboxaldehyde
C9H14N2O
1087163-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.0287 0.0 0
M  V30 2 C 2.1037 5.3624 0.0 0
M  V30 3 C 0.0000 4.7987 0.0 0
M  V30 4 C 0.5637 2.6951 0.0 0
M  V30 5 C 6.6365 2.9016 0.0 0
M  V30 6 O 7.2628 4.3084 0.0 0
M  V30 7 C 4.9612 0.0000 0.0 0
M  V30 8 C 2.6675 3.2587 0.0 0
M  V30 9 C 4.0743 3.8850 0.0 0
M  V30 10 N 2.8284 1.7271 0.0 0
M  V30 11 C 5.1048 2.7406 0.0 0
M  V30 12 N 4.3347 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-N,1-dimethyl-1H-pyrazole-5-methanamine
C10H19N3
1454851-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.0287 0.0 0
M  V30 2 C 2.1038 5.3624 0.0 0
M  V30 3 C 0.0000 4.7987 0.0 0
M  V30 4 C 0.5638 2.6951 0.0 0
M  V30 5 C 6.6365 2.9016 0.0 0
M  V30 6 N 7.2628 4.3084 0.0 0
M  V30 7 C 8.7945 4.4695 0.0 0
M  V30 8 C 4.9612 0.0000 0.0 0
M  V30 9 C 2.6675 3.2587 0.0 0
M  V30 10 C 4.0743 3.8850 0.0 0
M  V30 11 N 2.8284 1.7271 0.0 0
M  V30 12 C 5.1049 2.7406 0.0 0
M  V30 13 N 4.3349 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1087163-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454851-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11148553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: Compound 492 (2000 mg, 12.03 mmol) in MeOH (50 mL) was stirred
under nitrogen with 33% methylamine in EtOH (1.80 mL. 5.09 mmol).
Anhydrous MgSO4 (3000 mg) was added, and the reaction stirred for a
further 1 .5 hours. The reaction flask was cooled in an ice-bath and
NaBH4 (546 mg, 14.40 mmol) added. The reaction was stirred for 14 hours,
concentrated and partitioned between water and DCM. The organic was
separated, and the aqueous further extracted with DCM (2 x). The combined
organics were dried (Na2SO4), and concentrated. Compound 493 as a
colorless oil (2100 mg, 96%). LCMS APCI m/z 182 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl 4-methyl 2-hydroxy-3-methylenebutanedioate
C8H12O5
108735-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 C 4.0011 0.0000 0.0 0
M  V30 7 O 8.0022 2.3100 0.0 0
M  V30 8 O 6.6684 0.0000 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8500 0.0 0
M  V30 11 C 9.3359 1.5400 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-hydroxy-1-methyl-5-oxo-3-pyrrolidinecarboxylate
C7H11NO4
1219926-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 O 2.2418 5.3915 0.0 0
M  V30 6 O 0.0000 2.9016 0.0 0
M  V30 7 C 1.6751 0.0000 0.0 0
M  V30 8 C 3.9690 3.2587 0.0 0
M  V30 9 C 2.5620 3.8850 0.0 0
M  V30 10 C 3.8079 1.7271 0.0 0
M  V30 11 C 1.5316 2.7406 0.0 0
M  V30 12 N 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108735-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1219926-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7814824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and polymerization of new multifunctional pyrrolidinone
methacrylate monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morizur, Jean-Francois; Zhou, Hui; Hoyle, Charles E.; Mathias, Lon J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer (2010), 51(4), 848-853

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylammonium acetate
C2H4O2.CH5N
6998-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.5637 3.8501 0.0 0
M  V30 2 N 2.1037 3.8501 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 2.6673 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 2 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-9-[2,5-di-O-benzoyl-3-deoxy-3-(methoxycarbonyl)-β-D-ribofuranosy...
C26H20Cl2N4O7
1108175-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5000 7.9888 0.0 0
M  V30 2 C 4.5948 6.7429 0.0 0
M  V30 3 O 5.2212 5.3361 0.0 0
M  V30 4 C 7.7418 10.4787 0.0 0
M  V30 5 O 8.8863 11.5091 0.0 0
M  V30 6 O 6.2772 10.9545 0.0 0
M  V30 7 C 8.5661 13.0155 0.0 0
M  V30 8 C 10.8025 9.1159 0.0 0
M  V30 9 O 12.1362 8.3459 0.0 0
M  V30 10 C 13.4700 9.1159 0.0 0
M  V30 11 O 13.4700 10.6559 0.0 0
M  V30 12 Cl 6.3601 0.0000 0.0 0
M  V30 13 Cl 11.4338 1.6486 0.0 0
M  V30 14 C 7.8015 6.4942 0.0 0 CFG=2
M  V30 15 C 7.0315 7.8279 0.0 0 CFG=2
M  V30 16 O 9.3080 6.8144 0.0 0
M  V30 17 C 8.0621 8.9722 0.0 0 CFG=2
M  V30 18 C 9.4689 8.3459 0.0 0 CFG=2
M  V30 19 N 7.1752 5.0873 0.0 0
M  V30 20 C 7.9452 3.7536 0.0 0
M  V30 21 C 5.6688 4.7671 0.0 0
M  V30 22 C 6.9148 2.6091 0.0 0
M  V30 23 N 9.4515 3.4334 0.0 0
M  V30 24 N 5.5078 3.2356 0.0 0
M  V30 25 C 7.3907 1.1445 0.0 0
M  V30 26 C 9.9275 1.9687 0.0 0
M  V30 27 N 8.8969 0.8244 0.0 0
M  V30 28 C 3.0632 6.9039 0.0 0
M  V30 29 C 2.1580 5.6580 0.0 0
M  V30 30 C 2.4369 8.3108 0.0 0
M  V30 31 C 0.6265 5.8189 0.0 0
M  V30 32 C 0.9052 8.4717 0.0 0
M  V30 33 C 0.0000 7.2259 0.0 0
M  V30 34 C 14.8036 8.3459 0.0 0
M  V30 35 C 14.8036 6.8059 0.0 0
M  V30 36 C 16.1373 9.1159 0.0 0
M  V30 37 C 16.1373 6.0359 0.0 0
M  V30 38 C 17.4709 8.3459 0.0 0
M  V30 39 C 17.4711 6.8059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=3
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 18 8 CFG=1
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 34
M  V30 14 1 12 25
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 20 23
M  V30 26 2 21 24
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 2-chloro-3′-deoxy-3′-(methoxycarbonyl)-N-methyl-, 2′,5′-dibenzoate
C27H24ClN5O7
1108175-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5000 9.4534 0.0 0
M  V30 2 C 4.5948 8.2075 0.0 0
M  V30 3 O 5.2213 6.8007 0.0 0
M  V30 4 C 7.7418 11.9433 0.0 0
M  V30 5 O 8.8864 12.9738 0.0 0
M  V30 6 O 6.2773 12.4192 0.0 0
M  V30 7 C 8.5662 14.4802 0.0 0
M  V30 8 C 10.8026 10.5806 0.0 0
M  V30 9 O 12.1363 9.8106 0.0 0
M  V30 10 C 13.4701 10.5806 0.0 0
M  V30 11 O 13.4701 12.1206 0.0 0
M  V30 12 N 6.3601 1.4647 0.0 0
M  V30 13 C 6.8362 0.0000 0.0 0
M  V30 14 Cl 11.4339 3.1132 0.0 0
M  V30 15 C 7.8016 7.9588 0.0 0 CFG=2
M  V30 16 C 7.0316 9.2925 0.0 0 CFG=2
M  V30 17 O 9.3080 8.2790 0.0 0
M  V30 18 C 8.0622 10.4370 0.0 0 CFG=2
M  V30 19 C 9.4690 9.8106 0.0 0 CFG=2
M  V30 20 N 7.1753 6.5519 0.0 0
M  V30 21 C 7.9453 5.2182 0.0 0
M  V30 22 C 5.6688 6.2317 0.0 0
M  V30 23 C 6.9149 4.0738 0.0 0
M  V30 24 N 9.4516 4.8980 0.0 0
M  V30 25 N 5.5079 4.7001 0.0 0
M  V30 26 C 7.3907 2.6091 0.0 0
M  V30 27 C 9.9276 3.4333 0.0 0
M  V30 28 N 8.8970 2.2889 0.0 0
M  V30 29 C 3.0633 8.3686 0.0 0
M  V30 30 C 2.1580 7.1226 0.0 0
M  V30 31 C 2.4369 9.7754 0.0 0
M  V30 32 C 0.6265 7.2837 0.0 0
M  V30 33 C 0.9052 9.9364 0.0 0
M  V30 34 C 0.0000 8.6905 0.0 0
M  V30 35 C 14.8038 9.8106 0.0 0
M  V30 36 C 14.8038 8.2705 0.0 0
M  V30 37 C 16.1374 10.5806 0.0 0
M  V30 38 C 16.1374 7.5005 0.0 0
M  V30 39 C 17.4712 9.8106 0.0 0
M  V30 40 C 17.4711 8.2705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 19 8 CFG=1
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 35
M  V30 14 1 12 13
M  V30 15 1 12 26
M  V30 16 1 14 27
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 20 CFG=1
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 2 22 25
M  V30 28 1 23 25
M  V30 29 2 23 26
M  V30 30 1 24 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6998-30-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1108175-07-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1108175-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2210218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Chloro-N6-methyl-9-(3-C-methylcarbamoyl-3-deoxy-β-D-ribofuranosyl)adenine
(3b). To a solution of 15 (33 mg, 0.058 mmol) in anhydrous THF (2 mL) was
added anhydrous 0.642M MeNH2-AcOH (2.16 mL, 1.39 mmol), and then the
reaction mixture was stirred overnight. Solvents were removed under
reduced pressure and the residue was purified by silica gel column
chromatography (hexane : ethyl acetate = 1:1) to afford a product. Methyl
derivative. Yield: (31.5 mg, 96%). UV (MeOH) λmax 268 nm (pH 7);[α]25D
4.80° (c 1.0, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 8.04-7.86 (m, 4H), 7.79
(s, 1H), 7.66-7.37 (m, 6H), 6.27 (d, 1H,J = 6.2 Hz), 6.05 (d, 1H,J = 1.3
Hz), 5.13-5.07 (m, 1H), 4.91-4.77 (m, 1H), 4.71-4.63 (m, 1H), 4.58-4.53
(m, 1H), 3.73 (s, 3H), 3.16 (s, 3H); IR (neat) 2925, 1725 cm-1; MS (FAB)
m/z 566 (M+H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3'-Acetamidoadenosine Derivatives as Potential A3 Adenosine
Receptor Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chun, Moon Woo; Choi, Sung Wook; Kang, Tae Kyung; Choi, Won Jun; Kim, Hea
Ok; Gao, Zhan-Guo; Jacobson, Kenneth A.; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2008), 27(4), 408-420

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
3-(1H-Imidazol-1-ylcarbonyl)-4-methyl-2(1H)-quinolinone
C14H11N3O2
1133823-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 N 8.0022 2.3101 0.0 0
M  V30 16 C 8.1633 3.8416 0.0 0
M  V30 17 C 9.4091 1.6837 0.0 0
M  V30 18 C 9.6696 4.1618 0.0 0
M  V30 19 N 10.4396 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 11
M  V30 4 1 2 15
M  V30 5 2 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-N,4-dimethyl-2-oxo-3-quinolinecarboxamide
C12H12N2O2
1186103-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1133823-83-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1186103-98-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-9305487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Methylamide (4a). A
stream of dry HCl gas was passed for 15 min through a suspension of
finely powdered imidazolide 2 (2.53 g, 0.01 mol) in anhydrous CCl4 (70
ml) cooled to -20°C. The product was tightly sealed and left at about 5°C
for 3 days. The main amount of excessive HCl was removed from the
reaction mixture by bubbling through dry argon, after which the reaction
vessel with the acid chloride 3 obtained was placed in an ice bath and
saturated with gaseous methylamine. After 3-4 h the solvent was
evaporated to dryness in vacuo. The residue was treated with cold water
and acidified with dilute (1:1) HCl to pH 5. The precipitated methylamide
4a was filtered off, washed with cold water, dried, and crystallized from
ethanol. Yield 96%. Empirical formula: C12H12N2O2; Found, %: C 66.76; H
5.68; N 13.03; Calculated, %: C 66.65; H 5.59; N 12.95; mp: 297-299 °C
$DTYPE RXN:VAR(1):NOTES
$DATUM MeNH2-gas used, sealed container used in substage 3, HCl-gas used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Hydroxy-2-quinolones. Part 150. Efficient synthesis, structure, and
biological activities of 4-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic
acid alkyl amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Bereznyakova, N. L.; Parshikov, V. A.; Gorokhova, O. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2008),
44(12), 1493-1499

$RFMT $RIREG SCHEME395 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenyltin dichloride
C12H10Cl2Sn
1135-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 4.6201 1.5400 0.0 0
M  V30 2 Cl 4.6201 0.0000 0.0 0
M  V30 3 Cl 4.6201 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 C 2.3100 2.8737 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 0.7700 2.8737 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 6.1601 1.5400 0.0 0
M  V30 11 C 6.9301 0.2064 0.0 0
M  V30 12 C 6.9301 2.8737 0.0 0
M  V30 13 C 8.4701 0.2064 0.0 0
M  V30 14 C 8.4701 2.8737 0.0 0
M  V30 15 C 9.2401 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H18N2S4Sn
1448221-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3501 6.6137 0.0 0
M  V30 2 C 0.0000 5.8333 0.0 0
M  V30 3 N 8.9119 6.6137 0.0 0
M  V30 4 C 10.2581 5.8333 0.0 0
M  V30 5 Sn 5.1310 5.9036 0.0 0 CHG=4 VAL=6
M  V30 6 S 3.8512 4.6276 0.0 0 CHG=-1 VAL=2
M  V30 7 S 6.4069 4.6276 0.0 0 CHG=-1 VAL=2
M  V30 8 S 6.4069 7.1834 0.0 0 VAL=3
M  V30 9 S 3.8512 7.1834 0.0 0 VAL=3
M  V30 10 C 2.5752 5.9036 0.0 0
M  V30 11 C 7.6867 5.9036 0.0 0
M  V30 12 C 5.1310 3.0747 0.0 0 CHG=-1 VAL=4
M  V30 13 C 3.7965 2.3060 0.0 0
M  V30 14 C 6.4576 2.3060 0.0 0
M  V30 15 C 3.7965 0.7687 0.0 0
M  V30 16 C 6.4576 0.7687 0.0 0
M  V30 17 C 5.1310 0.0000 0.0 0
M  V30 18 C 5.1310 8.7363 0.0 0 CHG=-1 VAL=4
M  V30 19 C 3.7965 9.5011 0.0 0
M  V30 20 C 6.4576 9.5011 0.0 0
M  V30 21 C 3.7965 11.0384 0.0 0
M  V30 22 C 6.4576 11.0384 0.0 0
M  V30 23 C 5.1310 11.8071 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 12
M  V30 10 1 5 18
M  V30 11 1 6 10
M  V30 12 1 7 11
M  V30 13 2 8 11
M  V30 14 2 9 10
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1135-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448221-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-15082545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, properties and spectroscopic characterization of some
diorganotin(IV) dithiocarbamates complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jain, Disha; Chaturvedi, Alok; Upadhyay, Rajesh Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research Journal of Pharmaceutical, Biological and Chemical Sciences
(2012), 3(3), 1311-1318

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxylic acid, 4-bromo-3-methyl-5-(phenylsulfonyl)-, methyl ester
C13H11BrO4S2
1138033-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.0287 0.0 0 VAL=6
M  V30 2 O 4.7712 5.3624 0.0 0
M  V30 3 O 3.2311 2.6951 0.0 0
M  V30 4 Br 4.3514 0.6966 0.0 0
M  V30 5 C 9.3038 2.9016 0.0 0
M  V30 6 O 9.9303 4.3086 0.0 0
M  V30 7 O 10.2090 1.6557 0.0 0
M  V30 8 C 11.4619 4.4695 0.0 0
M  V30 9 C 7.6286 0.0000 0.0 0
M  V30 10 C 5.3348 3.2587 0.0 0
M  V30 11 S 6.7418 3.8850 0.0 0
M  V30 12 C 5.4959 1.7271 0.0 0
M  V30 13 C 7.7722 2.7406 0.0 0
M  V30 14 C 7.0022 1.4070 0.0 0
M  V30 15 C 2.6675 4.7987 0.0 0
M  V30 16 C 2.6675 6.3388 0.0 0
M  V30 17 C 1.3337 4.0287 0.0 0
M  V30 18 C 1.3337 7.1088 0.0 0
M  V30 19 C 0.0000 4.7987 0.0 0
M  V30 20 C 0.0000 6.3388 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 15
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 6 8
M  V30 10 1 9 14
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,3-dimethyl-5-(phenylsulfonyl)-2-thiophenecarboxamide
C13H12BrNO3S2
1138033-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.0287 0.0 0 VAL=6
M  V30 2 O 3.2311 2.6951 0.0 0
M  V30 3 O 4.7712 5.3624 0.0 0
M  V30 4 Br 4.3514 0.6966 0.0 0
M  V30 5 C 9.3038 2.9016 0.0 0
M  V30 6 N 9.9303 4.3086 0.0 0
M  V30 7 O 10.2090 1.6557 0.0 0
M  V30 8 C 11.4619 4.4695 0.0 0
M  V30 9 C 7.6286 0.0000 0.0 0
M  V30 10 C 5.3348 3.2587 0.0 0
M  V30 11 S 6.7418 3.8850 0.0 0
M  V30 12 C 5.4959 1.7271 0.0 0
M  V30 13 C 7.7722 2.7406 0.0 0
M  V30 14 C 7.0022 1.4070 0.0 0
M  V30 15 C 2.6675 4.7987 0.0 0
M  V30 16 C 2.6675 6.3388 0.0 0
M  V30 17 C 1.3337 4.0287 0.0 0
M  V30 18 C 1.3337 7.1088 0.0 0
M  V30 19 C 0.0000 4.7987 0.0 0
M  V30 20 C 0.0000 6.3388 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 15
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 6 8
M  V30 10 1 9 14
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138033-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138033-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9745008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 16
4-bromo-N,3-dimethyl-5-(phenylsulfonyl)thiophene-2-carboxamide To methyl
4-bromo-3-methyl-5-(phenylsulfonyl)thiophene-2-carboxylate (470 mg) was
added 40% methylamine-methanol solution (7 mL). After stirring at room
temperature for 3 hr, the mixture was concentrated under reduced
pressure. The residue was purified by silica gel column chromatography
(eluent: hexane-ethyl acetate=3:1&#x2192;1:3) and basic silica gel column
chromatography (eluent: hexane-ethyl acetate=7:3&#x2192;35:65) to give
the title compound as a colorless solid (451 mg, yield 96%). 1H-NMR
(CDCl3) &#x03B4; : 2.40 (3H, s), 3.00 (3H, d, J=4.9 Hz), 5.90 (1H, brs),
7.51-7.59 (2H, m), 7.60-7.69 (1H, m), 8.02-8.10 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Hydrazine, acetate (1:1)
C2H4O2.H4N2
7335-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.5637 3.8501 0.0 0
M  V30 2 N 2.1037 3.8501 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 2.6673 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 2 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[[(4-chlorophenyl)methyl]amino]thioxomethyl]-1-pyrr...
C17H23ClN2O2S
1140495-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0132 3.7710 0.0 0
M  V30 2 N 8.5532 3.7710 0.0 0
M  V30 3 S 6.2432 5.1048 0.0 0
M  V30 4 C 9.3232 5.1048 0.0 0
M  V30 5 C 3.6812 3.4208 0.0 0
M  V30 6 O 2.1748 3.1006 0.0 0
M  V30 7 O 4.1571 4.8855 0.0 0
M  V30 8 C 1.1444 4.2450 0.0 0
M  V30 9 C 0.0000 3.2146 0.0 0
M  V30 10 C 0.1140 5.3895 0.0 0
M  V30 11 C 2.2889 5.2756 0.0 0
M  V30 12 Cl 15.4832 5.1048 0.0 0
M  V30 13 C 6.2432 2.4374 0.0 0 CFG=1
M  V30 14 N 4.7116 2.2764 0.0 0
M  V30 15 C 6.8696 1.0306 0.0 0
M  V30 16 C 4.3915 0.7700 0.0 0
M  V30 17 C 5.7251 0.0000 0.0 0
M  V30 18 C 10.8632 5.1048 0.0 0
M  V30 19 C 11.6332 6.4384 0.0 0
M  V30 20 C 11.6332 3.7710 0.0 0
M  V30 21 C 13.1732 6.4384 0.0 0
M  V30 22 C 13.1732 3.7710 0.0 0
M  V30 23 C 13.9432 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 23
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-4H-1,2,4-triazo...
C19H25ClN4O2
1140495-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 2.6674 0.0 0
M  V30 2 O 2.1036 2.6674 0.0 0
M  V30 3 O 4.4136 1.3336 0.0 0
M  V30 4 C 1.3336 1.3336 0.0 0
M  V30 5 C 0.0000 2.1036 0.0 0
M  V30 6 C 0.5636 0.0000 0.0 0
M  V30 7 C 2.6674 0.5636 0.0 0
M  V30 8 C 9.2773 4.5122 0.0 0
M  V30 9 C 10.6400 1.4516 0.0 0
M  V30 10 Cl 15.4373 4.5122 0.0 0
M  V30 11 C 5.9452 4.1620 0.0 0 CFG=1
M  V30 12 N 4.4136 4.0011 0.0 0
M  V30 13 C 6.2655 5.6684 0.0 0
M  V30 14 C 3.7873 5.4079 0.0 0
M  V30 15 C 4.9317 6.4384 0.0 0
M  V30 16 C 6.9757 3.0176 0.0 0
M  V30 17 N 8.5073 3.1786 0.0 0
M  V30 18 N 6.6556 1.5112 0.0 0
M  V30 19 C 9.1336 1.7718 0.0 0
M  V30 20 N 7.9892 0.7412 0.0 0
M  V30 21 C 10.8173 4.5122 0.0 0
M  V30 22 C 11.5873 3.1786 0.0 0
M  V30 23 C 11.5873 5.8460 0.0 0
M  V30 24 C 13.1273 3.1786 0.0 0
M  V30 25 C 13.1273 5.8460 0.0 0
M  V30 26 C 13.8973 4.5122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 17
M  V30 9 1 8 21
M  V30 10 1 9 19
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16 CFG=3
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7335-65-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1140495-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1140495-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10326679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1600-27-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel pyrrolidine heterocycles as CCR1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Merritt, J. Robert; James, Ray; Paradkar, Vidyadhar M.; Zhang, Chongwu;
Liu, Ruiyan; Liu, Jinqi; Jacob, Biji; Chiriac, Camelia; Ohlmeyer, Michael
J.; Quadros, Elizabeth; Wines, Pamela; Postelnek, Jennifer; Hicks,
Catherine M.; Chen, Weiqing; Kimble, Earl F.; O'Brien, Linda; White,
Nicole; Desai, Hema; Appell, Kenneth C.; Webb, Maria L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(18), 5477-5479

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R)-3-Chloro-1-phenylpropoxy]-2-methylbenzene
C16H17ClO
114446-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 2 O 4.6201 5.3348 0.0 0
M  V30 3 C 4.6201 2.6675 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 Cl 4.6201 0.0000 0.0 0
M  V30 6 C 3.0801 8.0023 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 C 7.7002 2.6675 0.0 0
M  V30 9 C 7.7002 5.3348 0.0 0
M  V30 10 C 9.2402 2.6675 0.0 0
M  V30 11 C 9.2402 5.3348 0.0 0
M  V30 12 C 10.0102 4.0012 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 2.3101 6.6687 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 0.7700 6.6687 0.0 0
M  V30 17 C 0.7700 4.0012 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-N,N-Dimethyl-γ-(2-methylphenoxy)benzenepropanamine
C18H23NO
299435-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 O 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 5.3901 0.0000 0.0 0
M  V30 8 C 3.0801 9.3360 0.0 0
M  V30 9 C 6.9302 5.3348 0.0 0
M  V30 10 C 7.7002 4.0012 0.0 0
M  V30 11 C 7.7002 6.6685 0.0 0
M  V30 12 C 9.2402 4.0012 0.0 0
M  V30 13 C 9.2402 6.6685 0.0 0
M  V30 14 C 10.0102 5.3348 0.0 0
M  V30 15 C 3.0801 6.6685 0.0 0
M  V30 16 C 2.3101 8.0023 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 0.7700 8.0023 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114446-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 299435-85-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25757292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric reduction of prochiral ketones using in situ generated
oxazaborolidine derived from
(1S,2S,3R,4R)-3-amino-7,7-dimethoxynorbornan-2-ol. An efficient synthesis
of enantiopure (R)-tomoxetine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lapis, Alexandre A. M.; De Fatima, Angelo; Martins, Jose E. D.; Costa,
Valentim E. U.; Pilli, Ronaldo A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2005), 46(3), 495-498

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-[(1,1-dimethylethoxy)carbonyl]-D-phenylalanine
C14H17Cl2NO4
114873-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 4.0012 0.0 0
M  V30 2 C 5.9538 2.6675 0.0 0 CFG=2
M  V30 3 N 4.4137 2.6675 0.0 0
M  V30 4 C 6.7238 1.3338 0.0 0
M  V30 5 C 3.6437 4.0012 0.0 0
M  V30 6 O 8.2638 1.3338 0.0 0
M  V30 7 O 5.9538 0.0000 0.0 0
M  V30 8 O 2.1037 4.0012 0.0 0
M  V30 9 O 4.4137 5.3348 0.0 0
M  V30 10 C 1.3337 5.3348 0.0 0
M  V30 11 C 0.0000 4.5648 0.0 0
M  V30 12 C 0.5637 6.6687 0.0 0
M  V30 13 C 2.6673 6.1048 0.0 0
M  V30 14 Cl 8.2638 6.6687 0.0 0
M  V30 15 Cl 12.8839 4.0012 0.0 0
M  V30 16 C 8.2638 4.0012 0.0 0
M  V30 17 C 9.0338 5.3348 0.0 0
M  V30 18 C 9.0338 2.6675 0.0 0
M  V30 19 C 10.5739 5.3348 0.0 0
M  V30 20 C 10.5739 2.6675 0.0 0
M  V30 21 C 11.3439 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 17
M  V30 15 1 15 21
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C15H20Cl2N2O3
2554611-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 5.3347 0.0 0
M  V30 2 C 5.9536 4.0011 0.0 0 CFG=2
M  V30 3 N 4.4136 4.0011 0.0 0
M  V30 4 C 6.7236 2.6674 0.0 0
M  V30 5 C 3.6436 5.3347 0.0 0
M  V30 6 N 5.9536 1.3336 0.0 0
M  V30 7 O 8.2636 2.6674 0.0 0
M  V30 8 O 2.1036 5.3347 0.0 0
M  V30 9 O 4.4136 6.6685 0.0 0
M  V30 10 C 6.7236 0.0000 0.0 0
M  V30 11 C 1.3336 6.6685 0.0 0
M  V30 12 C 2.6673 7.4385 0.0 0
M  V30 13 C 0.5636 8.0021 0.0 0
M  V30 14 C 0.0000 5.8985 0.0 0
M  V30 15 Cl 8.2636 8.0021 0.0 0
M  V30 16 Cl 12.8836 5.3347 0.0 0
M  V30 17 C 8.2636 5.3347 0.0 0
M  V30 18 C 9.0336 6.6685 0.0 0
M  V30 19 C 9.0336 4.0011 0.0 0
M  V30 20 C 10.5736 6.6685 0.0 0
M  V30 21 C 10.5736 4.0011 0.0 0
M  V30 22 C 11.3436 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 18
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114873-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2554611-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24045045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and
scope of an isoindolin-2-yl linker with an α-amino amide as the
zinc-binding unit
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenwood, Simon O. R.; Chan, A. W. Edith; Hansen, D. Flemming; Marson,
Charles M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(5), 126926

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[5-(2,2-dibromoethenyl)-2-methoxyphenoxy]methyl]-α-(methoxyimi...
C20H19Br2NO5
1159342-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 N 10.6697 3.8501 0.0 0
M  V30 4 O 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 O 12.0033 4.6201 0.0 0
M  V30 7 C 9.3360 1.5400 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 C 6.6685 6.1601 0.0 0
M  V30 10 O 5.3348 6.9302 0.0 0
M  V30 11 O 2.6673 8.4702 0.0 0
M  V30 12 C 1.3337 9.2402 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 Br 1.3337 0.0000 0.0 0
M  V30 16 Br 0.0000 2.3101 0.0 0
M  V30 17 C 9.3360 6.1601 0.0 0
M  V30 18 C 8.0022 6.9302 0.0 0
M  V30 19 C 10.6697 6.9302 0.0 0
M  V30 20 C 8.0022 8.4702 0.0 0
M  V30 21 C 10.6697 8.4702 0.0 0
M  V30 22 C 9.3360 9.2402 0.0 0
M  V30 23 C 4.0010 6.1601 0.0 0
M  V30 24 C 2.6673 6.9302 0.0 0
M  V30 25 C 4.0010 4.6201 0.0 0
M  V30 26 C 1.3337 6.1601 0.0 0
M  V30 27 C 2.6673 3.8501 0.0 0
M  V30 28 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 27
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[5-(2,2-Dibromoethenyl)-2-methoxyphenoxy]methyl]-α-(methoxyimino)-N-m...
C20H20Br2N2O4
1159342-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 N 10.6697 3.8501 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 O 12.0033 4.6201 0.0 0
M  V30 7 C 9.3360 1.5400 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 C 6.6685 6.1601 0.0 0
M  V30 10 O 5.3348 6.9302 0.0 0
M  V30 11 O 2.6673 8.4702 0.0 0
M  V30 12 C 1.3337 9.2402 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 Br 1.3337 0.0000 0.0 0
M  V30 16 Br 0.0000 2.3101 0.0 0
M  V30 17 C 9.3360 6.1601 0.0 0
M  V30 18 C 8.0022 6.9302 0.0 0
M  V30 19 C 10.6697 6.9302 0.0 0
M  V30 20 C 8.0022 8.4702 0.0 0
M  V30 21 C 10.6697 8.4702 0.0 0
M  V30 22 C 9.3360 9.2402 0.0 0
M  V30 23 C 4.0010 6.1601 0.0 0
M  V30 24 C 2.6673 6.9302 0.0 0
M  V30 25 C 4.0010 4.6201 0.0 0
M  V30 26 C 1.3337 6.1601 0.0 0
M  V30 27 C 2.6673 3.8501 0.0 0
M  V30 28 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 27
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-65-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10185741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 72: Preparation of
(E)-2-(2-((5-(2,2-dibromovinyl)-2-methoxyphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((5-(2,2-dibromovinyl)-2-methoxyphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.513g,
1mmol) obtained in Example 71 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.492g, 96%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.88(d, 3H), 3.86(s, 3H), 3.97(s, 3H), 5.11(s, 2H), 6.78(s, 1H),
6.97-7.55(m, 8H) MS : 509.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME401 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-(4-nitrophenyl)-4(1H)-quinazolinone
C15H13N3O3
1352072-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 N 11.5500 2.6674 0.0 0 VAL=5
M  V30 4 O 12.3200 1.3338 0.0 0
M  V30 5 O 12.3200 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 7.7000 1.3338 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352072-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21401337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Ethyl 2-[(1S)-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]-3-methylbutyl]-1,3-d...
C15H29NO3S3
1203455-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 5.3348 0.0 0 CFG=2
M  V30 2 N 4.6201 4.0010 0.0 0
M  V30 3 C 2.3100 5.3348 0.0 0
M  V30 4 S 3.8501 2.6673 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 6.6685 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 C 2.3100 8.0021 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 3.2864 0.5637 0.0 0
M  V30 11 C 5.3901 0.0000 0.0 0
M  V30 12 C 5.9539 2.1037 0.0 0
M  V30 13 C 5.8661 5.7632 0.0 0
M  V30 14 O 7.2729 6.3896 0.0 0
M  V30 15 O 5.7050 4.2317 0.0 0
M  V30 16 C 8.5188 5.4843 0.0 0
M  V30 17 C 9.9258 6.1108 0.0 0
M  V30 18 C 4.6201 6.6685 0.0 0
M  V30 19 S 5.6507 7.8129 0.0 0
M  V30 20 S 3.2133 7.2948 0.0 0
M  V30 21 C 4.8807 9.1465 0.0 0
M  V30 22 C 3.3742 8.8264 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1S)-1-[[(S)-(1,1-Dimethylethyl)sulfinyl]amino]-3-methylbutyl]-N-methyl-1,...
C14H28N2O2S3
1203455-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8117 4.6688 0.0 0 CFG=2
M  V30 2 N 5.1456 3.8987 0.0 0
M  V30 3 C 3.8117 6.2088 0.0 0
M  V30 4 S 6.4792 4.6688 0.0 0 CFG=1 VAL=4
M  V30 5 C 2.4781 6.9788 0.0 0
M  V30 6 C 7.8129 3.8987 0.0 0
M  V30 7 O 6.4792 6.2088 0.0 0
M  V30 8 C 1.1444 6.2088 0.0 0
M  V30 9 C 2.4781 8.5189 0.0 0
M  V30 10 C 8.5829 5.2324 0.0 0
M  V30 11 C 9.1466 3.1287 0.0 0
M  V30 12 C 7.0429 2.5651 0.0 0
M  V30 13 C 3.3833 2.6529 0.0 0
M  V30 14 N 2.7570 1.2459 0.0 0
M  V30 15 O 4.9149 2.8138 0.0 0
M  V30 16 C 3.6622 0.0000 0.0 0
M  V30 17 C 2.4781 3.8987 0.0 0
M  V30 18 S 1.3337 2.8683 0.0 0
M  V30 19 S 1.8517 5.3056 0.0 0
M  V30 20 C 0.0000 3.6383 0.0 0
M  V30 21 C 0.3202 5.1446 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=1
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 17
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1203455-94-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1203455-92-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13152330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Beyond the chiral pool: a general approach to β-amino-α-keto amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Cristian L.; Krawiec, Mariusz; Forslund, Raymond E.; Nugent,
William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(1), 41-47

$RFMT $RIREG SCHEME403 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7,8,10-Tetrahydro-10-(4-methoxyphenyl)-5,7,7-trimethyl-5H-indeno[1,2-b]quin...
C26H25NO3
916755-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.1685 4.3799 0.0 0
M  V30 2 O 5.5177 9.7102 0.0 0
M  V30 3 C 1.5166 4.3202 0.0 0
M  V30 4 C 0.9899 10.3873 0.0 0
M  V30 5 C 0.0000 8.6727 0.0 0
M  V30 6 O 10.8524 9.7102 0.0 0
M  V30 7 C 12.1861 8.9402 0.0 0
M  V30 8 C 5.5177 6.6302 0.0 0
M  V30 9 C 5.5177 5.0902 0.0 0
M  V30 10 C 4.1840 7.4002 0.0 0
M  V30 11 C 4.1840 4.3202 0.0 0
M  V30 12 C 6.6621 4.0596 0.0 0
M  V30 13 C 2.8502 6.6302 0.0 0
M  V30 14 C 4.1840 8.9402 0.0 0
M  V30 15 C 4.5042 2.8137 0.0 0
M  V30 16 N 2.8502 5.0902 0.0 0
M  V30 17 C 6.0357 2.6528 0.0 0
M  V30 18 C 1.5166 7.4002 0.0 0
M  V30 19 C 2.8502 9.7102 0.0 0
M  V30 20 C 3.5990 1.5679 0.0 0
M  V30 21 C 6.6621 1.2460 0.0 0
M  V30 22 C 1.5166 8.9402 0.0 0
M  V30 23 C 4.2253 0.1611 0.0 0
M  V30 24 C 5.7568 0.0000 0.0 0
M  V30 25 C 6.8513 7.4002 0.0 0
M  V30 26 C 6.8513 8.9402 0.0 0
M  V30 27 C 8.1850 6.6302 0.0 0
M  V30 28 C 8.1850 9.7102 0.0 0
M  V30 29 C 9.5188 7.4002 0.0 0
M  V30 30 C 9.5188 8.9402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 16
M  V30 4 1 4 22
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 25
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 17
M  V30 22 2 15 20
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 1 19 22
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916755-99-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-6548526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, TiO2 nanoparticles used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple route to indeno[1,2-b]quinoline derivatives via a coupling
reaction catalyzed by TiO2 nanoparticles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdolmohammadi, Shahrzad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2013), 24(4), 318-320

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-4-(Methylamino)-3-penten-2-one
C6H11NO
23652-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 N 1.5400 2.6673 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 6.1601 2.6673 0.0 0
M  V30 8 O 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23652-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14965316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of enaminones and their reaction with dimethyl acetylene
dicarboxylate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moradi, Shahram; Rajabi Mehr, Farhad; Baharvand, Afrooz; Rostami, Cobra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Iranian Journal of Chemistry & Chemical Engineering (2008), 27(1), 17-23

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
2-(1,1-Dimethylethyl) (3R)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indole-2,3-dica...
C17H20N2O4
123910-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4000 1.3338 0.0 0
M  V30 2 O 8.9400 1.3338 0.0 0
M  V30 3 O 6.6300 0.0000 0.0 0
M  V30 4 C 8.9400 4.0011 0.0 0
M  V30 5 O 9.7100 5.3349 0.0 0
M  V30 6 O 9.7100 2.6674 0.0 0
M  V30 7 C 11.2500 5.3349 0.0 0
M  V30 8 C 11.2500 3.7949 0.0 0
M  V30 9 C 12.7900 5.3349 0.0 0
M  V30 10 C 11.2500 6.8749 0.0 0
M  V30 11 C 4.3200 4.0011 0.0 0
M  V30 12 C 5.0900 5.3349 0.0 0
M  V30 13 C 2.8137 4.3212 0.0 0
M  V30 14 C 5.0900 2.6674 0.0 0
M  V30 15 C 6.6300 5.3349 0.0 0
M  V30 16 N 4.0596 6.4792 0.0 0
M  V30 17 C 2.6526 5.8529 0.0 0
M  V30 18 C 1.5679 3.4162 0.0 0
M  V30 19 C 6.6300 2.6674 0.0 0 CFG=2
M  V30 20 N 7.4000 4.0011 0.0 0
M  V30 21 C 1.2459 6.4792 0.0 0
M  V30 22 C 0.1609 4.0425 0.0 0
M  V30 23 C 0.0000 5.5740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 17
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-1,3,4,9-tetrahydro-3-[(methylamino)carbonyl]-2H-pyrido...
C18H23N3O3
1448014-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4000 2.6674 0.0 0
M  V30 2 N 6.6300 1.3338 0.0 0
M  V30 3 O 8.9400 2.6674 0.0 0
M  V30 4 C 7.4000 0.0000 0.0 0
M  V30 5 C 8.9400 5.3347 0.0 0
M  V30 6 O 9.7100 6.6685 0.0 0
M  V30 7 O 9.7100 4.0011 0.0 0
M  V30 8 C 11.2500 6.6685 0.0 0
M  V30 9 C 11.2500 8.2085 0.0 0
M  V30 10 C 12.7900 6.6685 0.0 0
M  V30 11 C 11.2500 5.1285 0.0 0
M  V30 12 C 4.3200 5.3347 0.0 0
M  V30 13 C 2.8137 5.6549 0.0 0
M  V30 14 C 5.0900 6.6685 0.0 0
M  V30 15 C 5.0900 4.0011 0.0 0
M  V30 16 C 2.6526 7.1866 0.0 0
M  V30 17 C 1.5679 4.7498 0.0 0
M  V30 18 C 6.6300 6.6685 0.0 0
M  V30 19 N 4.0596 7.8129 0.0 0
M  V30 20 C 6.6300 4.0011 0.0 0 CFG=2
M  V30 21 C 1.2459 7.8129 0.0 0
M  V30 22 C 0.1609 5.3761 0.0 0
M  V30 23 N 7.4000 5.3347 0.0 0
M  V30 24 C 0.0000 6.9077 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 20 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 23
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 19
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123910-26-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448014-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8553798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of (R)-tert-butyl
3-(methylcarbamoyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate
(4-A) To a solution of
(R)-2-(tert-butoxycarbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic
acid (SM2-A, 10 g, 32 mmol) in dimethylformamide (DMF, 100 ml) was added
2-(7-aza-1H -benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate (HATU, 15.5 g, 42 mmol), followed by
diisopropylethylamine (DIEA, 12.4 g, 96 mmol) while the temperature was
maintained below 0 °C. After stirring at this temperature for 2 hours
(h), methylamine (32 mL, 63 mmol, 2 M in THF) was added. The reaction
mixture was warmed to rt and stirred at rt for 16 h. The solution was
diluted with ethyl acetate (500 mL); washed with water (200 mL), 0.1 M of
hydrochloride (100 mL), saturated NaHCO3 (100 mL), and then brine (100
mL); dried over Na2SO4 and concentrated and purified by column
chromatograph (CC, dichloromethane (DCM ): MeOH = 200:1) to give product
(4-A). White solid, Yield 10 g, 96 %. LC-MS (M+H)+ = 330
$DTYPE RXN:VAR(1):NOTES
$DATUM temperature less than or equal to zero degree Celsius (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tryptoline derivatives having kinase inhibitory activity and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keefe, Anthony D.; Wagner, Richard W.; Clark, Matthew; Zhang, Ying;
Gikunju, Diana; Cuozzo, John; Thomson, Heather
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013106414 A1 2013-07-18

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
(TB-5-23)-Methyl[tris[2-(diphenylphosphino-κP)phenyl]silyl-κSi]iron
C55H45FeP3Si
1240529-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 71 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8287 14.4721 0.0 0 CHG=-1 VAL=4
M  V30 2 Fe 6.4758 10.7527 0.0 0 CHG=2 VAL=5
M  V30 3 Si 6.4758 8.8852 0.0 0 CHG=-1 VAL=4
M  V30 4 P 4.8734 11.6884 0.0 0 VAL=4
M  V30 5 P 8.0782 11.6884 0.0 0 VAL=4
M  V30 6 P 6.4758 12.6241 0.0 0 VAL=4
M  V30 7 C 1.6063 13.8912 0.0 0
M  V30 8 C 9.6806 8.8852 0.0 0
M  V30 9 C 3.2710 8.8852 0.0 0
M  V30 10 C 3.2710 10.7527 0.0 0
M  V30 11 C 9.6806 10.7527 0.0 0
M  V30 12 C 3.2048 14.8269 0.0 0
M  V30 13 C 0.0000 14.8269 0.0 0
M  V30 14 C 11.2829 7.9495 0.0 0
M  V30 15 C 1.6687 7.9495 0.0 0
M  V30 16 C 1.6687 11.6884 0.0 0
M  V30 17 C 11.2829 11.6884 0.0 0
M  V30 18 C 3.2048 16.6944 0.0 0
M  V30 19 C 0.0000 16.6944 0.0 0
M  V30 20 C 12.8814 8.8852 0.0 0
M  V30 21 C 0.0663 8.8852 0.0 0
M  V30 22 C 0.0663 10.7527 0.0 0
M  V30 23 C 12.8814 10.7527 0.0 0
M  V30 24 C 1.6063 17.6301 0.0 0
M  V30 25 C 4.8734 8.1328 0.0 0
M  V30 26 C 5.6454 6.8033 0.0 0
M  V30 27 C 3.3373 8.1289 0.0 0
M  V30 28 C 4.8734 5.4738 0.0 0
M  V30 29 C 2.5732 6.8033 0.0 0
M  V30 30 C 3.3412 5.4738 0.0 0
M  V30 31 C 3.5634 19.1272 0.0 0
M  V30 32 C 4.3315 20.4567 0.0 0
M  V30 33 C 2.0312 19.1272 0.0 0
M  V30 34 C 3.5673 21.7861 0.0 0
M  V30 35 C 1.2632 20.4567 0.0 0
M  V30 36 C 2.0273 21.7861 0.0 0
M  V30 37 C 11.5247 12.9438 0.0 0
M  V30 38 C 11.5247 14.4760 0.0 0
M  V30 39 C 12.8580 12.1757 0.0 0
M  V30 40 C 12.8580 15.2441 0.0 0
M  V30 41 C 14.1836 12.9438 0.0 0
M  V30 42 C 14.1836 14.4760 0.0 0
M  V30 43 C 7.0918 0.0000 0.0 0
M  V30 44 C 5.7623 0.7642 0.0 0
M  V30 45 C 8.4213 0.7681 0.0 0
M  V30 46 C 5.7623 2.3042 0.0 0
M  V30 47 C 8.4213 2.3003 0.0 0
M  V30 48 C 7.0918 3.0683 0.0 0
M  V30 49 C 5.6649 13.7781 0.0 0
M  V30 50 C 4.3354 14.5462 0.0 0
M  V30 51 C 6.9943 14.5501 0.0 0
M  V30 52 C 4.3393 16.0823 0.0 0
M  V30 53 C 6.9943 16.0823 0.0 0
M  V30 54 C 5.6649 16.8503 0.0 0
M  V30 55 C 4.8461 21.8758 0.0 0
M  V30 56 C 6.1795 22.6399 0.0 0
M  V30 57 C 3.5206 22.6399 0.0 0
M  V30 58 C 6.1795 24.1761 0.0 0
M  V30 59 C 3.5206 24.1761 0.0 0
M  V30 60 C 4.8461 24.9441 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 4 25
M  V30 11 1 4 31
M  V30 12 1 5 11
M  V30 13 1 5 37
M  V30 14 1 5 43
M  V30 15 1 6 12
M  V30 16 1 6 49
M  V30 17 1 6 55
M  V30 18 1 7 12
M  V30 19 2 7 13
M  V30 20 1 8 11
M  V30 21 2 8 14
M  V30 22 1 9 10
M  V30 23 2 9 15
M  V30 24 2 10 16
M  V30 25 2 11 17
M  V30 26 2 12 18
M  V30 27 1 13 19
M  V30 28 1 14 20
M  V30 29 1 15 21
M  V30 30 1 16 22
M  V30 31 1 17 23
M  V30 32 1 18 24
M  V30 33 2 19 24
M  V30 34 2 20 23
M  V30 35 2 21 22
M  V30 36 2 25 26
M  V30 37 1 25 27
M  V30 38 1 26 28
M  V30 39 2 27 29
M  V30 40 2 28 30
M  V30 41 1 29 30
M  V30 42 2 31 32
M  V30 43 1 31 33
M  V30 44 1 32 34
M  V30 45 2 33 35
M  V30 46 2 34 36
M  V30 47 1 35 36
M  V30 48 2 37 38
M  V30 49 1 37 39
M  V30 50 1 38 40
M  V30 51 2 39 41
M  V30 52 2 40 42
M  V30 53 1 41 42
M  V30 54 2 43 44
M  V30 55 1 43 45
M  V30 56 1 44 46
M  V30 57 2 45 47
M  V30 58 2 46 48
M  V30 59 1 47 48
M  V30 60 2 49 50
M  V30 61 1 49 51
M  V30 62 1 50 52
M  V30 63 2 51 53
M  V30 64 2 52 54
M  V30 65 1 53 54
M  V30 66 2 55 56
M  V30 67 1 55 57
M  V30 68 1 56 58
M  V30 69 2 57 59
M  V30 70 2 58 60
M  V30 71 1 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonic acid, 1,1,1-trifluoro-, compd. with hydrazine (1:1)
CHF3O3S.H4N2
1240530-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 3.0800 0.0 0
M  V30 2 S 3.0800 3.0800 0.0 0 VAL=6
M  V30 3 F 0.7700 4.4136 0.0 0
M  V30 4 F 0.0000 3.0800 0.0 0
M  V30 5 F 0.7700 1.7464 0.0 0
M  V30 6 O 3.0800 4.6200 0.0 0
M  V30 7 O 3.0800 1.5400 0.0 0
M  V30 8 O 4.6200 3.0800 0.0 0
M  V30 9 N 1.5400 0.0000 0.0 0
M  V30 10 N 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 2 2 7
M  V30 7 1 2 8
M  V30 8 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron(1+), (hydrazine-κN1)[tris[2-(diphenylphosphino-κP)phenyl]silyl-κSi]-, (T...
C54H46FeN2P3Si.CF3O3S
1240529-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  69 79 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.0801 18.2968 0.0 0 VAL=4
M  V30 2 N 7.0801 19.7627 0.0 0
M  V30 3 Fe 6.4758 27.4627 0.0 0 CHG=2 VAL=5
M  V30 4 Si 6.4758 25.5952 0.0 0 CHG=-1 VAL=4
M  V30 5 P 4.8734 28.3984 0.0 0 VAL=4
M  V30 6 P 8.0782 28.3984 0.0 0 VAL=4
M  V30 7 P 6.4758 29.3341 0.0 0 VAL=4
M  V30 8 C 1.6063 30.6012 0.0 0
M  V30 9 C 9.6806 25.5952 0.0 0
M  V30 10 C 3.2710 25.5952 0.0 0
M  V30 11 C 3.2710 27.4627 0.0 0
M  V30 12 C 9.6806 27.4627 0.0 0
M  V30 13 C 3.2048 31.5369 0.0 0
M  V30 14 C 0.0000 31.5369 0.0 0
M  V30 15 C 11.2829 24.6595 0.0 0
M  V30 16 C 1.6687 24.6595 0.0 0
M  V30 17 C 1.6687 28.3984 0.0 0
M  V30 18 C 11.2829 28.3984 0.0 0
M  V30 19 C 3.2048 33.4044 0.0 0
M  V30 20 C 0.0000 33.4044 0.0 0
M  V30 21 C 12.8814 25.5952 0.0 0
M  V30 22 C 0.0663 25.5952 0.0 0
M  V30 23 C 0.0663 27.4627 0.0 0
M  V30 24 C 12.8814 27.4627 0.0 0
M  V30 25 C 1.6063 34.3401 0.0 0
M  V30 26 C 4.8734 24.8427 0.0 0
M  V30 27 C 5.6454 23.5133 0.0 0
M  V30 28 C 3.3373 24.8388 0.0 0
M  V30 29 C 4.8734 22.1838 0.0 0
M  V30 30 C 2.5732 23.5133 0.0 0
M  V30 31 C 3.3412 22.1838 0.0 0
M  V30 32 C 3.5634 35.8372 0.0 0
M  V30 33 C 4.3315 37.1666 0.0 0
M  V30 34 C 2.0312 35.8372 0.0 0
M  V30 35 C 3.5673 38.4961 0.0 0
M  V30 36 C 1.2632 37.1666 0.0 0
M  V30 37 C 2.0273 38.4961 0.0 0
M  V30 38 C 11.5247 29.6538 0.0 0
M  V30 39 C 11.5247 31.1860 0.0 0
M  V30 40 C 12.8580 28.8857 0.0 0
M  V30 41 C 12.8580 31.9540 0.0 0
M  V30 42 C 14.1836 29.6538 0.0 0
M  V30 43 C 14.1836 31.1860 0.0 0
M  V30 44 C 7.0918 11.5247 0.0 0
M  V30 45 C 5.7623 12.2888 0.0 0
M  V30 46 C 8.4213 12.2927 0.0 0
M  V30 47 C 5.7623 13.8288 0.0 0
M  V30 48 C 8.4213 13.8249 0.0 0
M  V30 49 C 7.0918 14.5930 0.0 0
M  V30 50 C 6.2068 5.3881 0.0 0
M  V30 51 C 6.2068 6.9203 0.0 0
M  V30 52 C 7.5363 4.6200 0.0 0
M  V30 53 C 7.5363 7.6883 0.0 0
M  V30 54 C 8.8657 5.3881 0.0 0
M  V30 55 C 8.8657 6.9203 0.0 0
M  V30 56 C 4.8461 38.5858 0.0 0
M  V30 57 C 6.1795 39.3499 0.0 0
M  V30 58 C 3.5206 39.3499 0.0 0
M  V30 59 C 6.1795 40.8860 0.0 0
M  V30 60 C 3.5206 40.8860 0.0 0
M  V30 61 C 4.8461 41.6541 0.0 0
M  V30 62 C 6.3218 1.5400 0.0 0
M  V30 63 S 7.8618 1.5400 0.0 0 VAL=6
M  V30 64 F 5.5518 2.8736 0.0 0
M  V30 65 F 4.7818 1.5400 0.0 0
M  V30 66 F 5.5518 0.2064 0.0 0
M  V30 67 O 7.8618 3.0800 0.0 0
M  V30 68 O 7.8618 0.0000 0.0 0
M  V30 69 O 9.4018 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 26
M  V30 12 1 5 32
M  V30 13 1 6 12
M  V30 14 1 6 38
M  V30 15 1 6 44
M  V30 16 1 7 13
M  V30 17 1 7 50
M  V30 18 1 7 56
M  V30 19 1 8 13
M  V30 20 2 8 14
M  V30 21 1 9 12
M  V30 22 2 9 15
M  V30 23 1 10 11
M  V30 24 2 10 16
M  V30 25 2 11 17
M  V30 26 2 12 18
M  V30 27 2 13 19
M  V30 28 1 14 20
M  V30 29 1 15 21
M  V30 30 1 16 22
M  V30 31 1 17 23
M  V30 32 1 18 24
M  V30 33 1 19 25
M  V30 34 2 20 25
M  V30 35 2 21 24
M  V30 36 2 22 23
M  V30 37 2 26 27
M  V30 38 1 26 28
M  V30 39 1 27 29
M  V30 40 2 28 30
M  V30 41 2 29 31
M  V30 42 1 30 31
M  V30 43 2 32 33
M  V30 44 1 32 34
M  V30 45 1 33 35
M  V30 46 2 34 36
M  V30 47 2 35 37
M  V30 48 1 36 37
M  V30 49 2 38 39
M  V30 50 1 38 40
M  V30 51 1 39 41
M  V30 52 2 40 42
M  V30 53 2 41 43
M  V30 54 1 42 43
M  V30 55 2 44 45
M  V30 56 1 44 46
M  V30 57 1 45 47
M  V30 58 2 46 48
M  V30 59 2 47 49
M  V30 60 1 48 49
M  V30 61 2 50 51
M  V30 62 1 50 52
M  V30 63 1 51 53
M  V30 64 2 52 54
M  V30 65 2 53 55
M  V30 66 1 54 55
M  V30 67 2 56 57
M  V30 68 1 56 58
M  V30 69 1 57 59
M  V30 70 2 58 60
M  V30 71 2 59 61
M  V30 72 1 60 61
M  V30 73 1 62 63
M  V30 74 1 62 64
M  V30 75 1 62 65
M  V30 76 1 62 66
M  V30 77 2 63 67
M  V30 78 2 63 68
M  V30 79 1 63 69
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1240529-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1240530-10-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240529-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-1256121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triggering N2 uptake via redox-induced expulsion of coordinated NH3 and
N2 silylation at trigonal bipyramidal iron
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Yunho; Mankad, Neal P.; Peters, Jonas C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemistry (2010), 2(7), 558-565

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-5,6-dihydro-7(4H)-benzothiazolone
C9H11NOS
1247386-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 C 7.4150 3.1854 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 4.5865 1.6538 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 S 3.3406 3.8119 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 4.7475 3.1854 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-4,5,6,7-tetrahydro-N-methyl-7-benzothiazolamine
C10H16N2S
1247417-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6211 3.9554 0.0 0
M  V30 4 C 8.9550 3.1854 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 S 4.8807 3.8119 0.0 0
M  V30 9 N 6.1265 1.6538 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 1.5400 1.3337 0.0 0
M  V30 12 C 6.2875 3.1854 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1247386-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1247417-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22801892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine reactant and reagent stoichiometry dependent product
formation, incremental addition of agent in 3 portions stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Versatile approaches to a library of building blocks based on
5-acylthiazole skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulyk, Olesia G.; Biloborodov, Dmytro A.; Cherevatenko, Maksim A.;
Shyriakin, Yevhen Y.; Lyapunov, Alexander Yu.; Mazepa, Alexander V.;
Vashchenko, Valerii V.; Orlov, Valeriy D.; Kolosov, Maksim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2020), 50(23), 3616-3628

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Dimethyl (2R,2′R)-2,2′-[(2-iodo-1,3-phenylene)bis(oxy)]bis[propanoate]
C14H17IO6
1255651-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6696 3.0800 0.0 0
M  V30 2 C 12.0032 2.3100 0.0 0 CFG=2
M  V30 3 C 13.3369 3.0800 0.0 0
M  V30 4 C 12.0032 0.7700 0.0 0
M  V30 5 O 14.6705 2.3100 0.0 0
M  V30 6 O 13.3369 4.6200 0.0 0
M  V30 7 C 16.0043 3.0800 0.0 0
M  V30 8 I 8.0021 4.6200 0.0 0
M  V30 9 O 5.3347 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 O 1.3338 2.3100 0.0 0
M  V30 14 O 2.6674 4.6200 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 9.3358 2.3100 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 9.3358 0.7700 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 8.0021 0.0000 0.0 0
M  V30 21 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C14H19IN2O4
2459908-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 3.0800 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 3 C 2.6674 3.0800 0.0 0
M  V30 4 C 4.0011 0.7700 0.0 0
M  V30 5 N 1.3338 2.3100 0.0 0
M  V30 6 O 2.6674 4.6200 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0
M  V30 8 I 8.0021 4.6200 0.0 0
M  V30 9 O 10.6696 3.0800 0.0 0
M  V30 10 C 12.0032 2.3100 0.0 0 CFG=2
M  V30 11 C 13.3369 3.0800 0.0 0
M  V30 12 C 12.0032 0.7700 0.0 0
M  V30 13 N 14.6705 2.3100 0.0 0
M  V30 14 O 13.3369 4.6200 0.0 0
M  V30 15 C 16.0043 3.0800 0.0 0
M  V30 16 C 6.6685 2.3100 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 9.3358 2.3100 0.0 0
M  V30 20 C 8.0021 0.0000 0.0 0
M  V30 21 C 9.3358 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1255651-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2459908-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22442234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hypervalent Iodine(III)-Catalysed Enantioselective α-Acetoxylation of
Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hokamp, Tobias; Wirth, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(46), 10417-10421

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
3-Iodo-1-(phenylmethyl)-1H-indole-2-carboxylic acid
C16H12INO2
1263209-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.7533 0.0 0
M  V30 2 C 7.9523 5.4031 0.0 0
M  V30 3 O 9.4586 5.0829 0.0 0
M  V30 4 O 7.4762 6.8678 0.0 0
M  V30 5 I 8.6488 2.1259 0.0 0
M  V30 6 C 4.7638 3.0126 0.0 0
M  V30 7 N 5.3901 4.4196 0.0 0
M  V30 8 C 5.9082 1.9822 0.0 0
M  V30 9 C 3.2991 2.5367 0.0 0
M  V30 10 C 6.9217 4.2587 0.0 0
M  V30 11 C 7.2419 2.7522 0.0 0
M  V30 12 C 5.5880 0.4759 0.0 0
M  V30 13 C 2.9789 1.0304 0.0 0
M  V30 14 C 4.1233 0.0000 0.0 0
M  V30 15 C 3.0801 5.7533 0.0 0
M  V30 16 C 2.3101 7.0869 0.0 0
M  V30 17 C 2.3101 4.4196 0.0 0
M  V30 18 C 0.7700 7.0869 0.0 0
M  V30 19 C 0.7700 4.4196 0.0 0
M  V30 20 C 0.0000 5.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N-methyl-1-(phenylmethyl)-1H-indole-2-carboxamide
C17H15IN2O
1913308-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6420 5.7309 0.0 0
M  V30 2 C 2.3100 6.0811 0.0 0
M  V30 3 N 0.7700 6.0811 0.0 0
M  V30 4 O 3.0800 7.4149 0.0 0
M  V30 5 C 0.0000 7.4149 0.0 0
M  V30 6 I 0.9473 3.0204 0.0 0
M  V30 7 N 4.6116 4.5865 0.0 0
M  V30 8 C 4.9318 3.0800 0.0 0
M  V30 9 C 3.0800 4.7474 0.0 0
M  V30 10 C 3.5981 2.3100 0.0 0
M  V30 11 C 6.2654 2.3100 0.0 0
M  V30 12 C 2.4536 3.3406 0.0 0
M  V30 13 C 3.5981 0.7700 0.0 0
M  V30 14 C 6.2654 0.7700 0.0 0
M  V30 15 C 4.9318 0.0000 0.0 0
M  V30 16 C 7.1485 5.4107 0.0 0
M  V30 17 C 8.1789 6.5553 0.0 0
M  V30 18 C 7.6244 3.9462 0.0 0
M  V30 19 C 9.6852 6.2351 0.0 0
M  V30 20 C 9.1306 3.6258 0.0 0
M  V30 21 C 10.1611 4.7704 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 9
M  V30 6 1 3 5
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1263209-59-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1913308-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6255383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivity of alkynylindole-2-carboxamides in [Pd]-catalysed C-H
activation and phase transfer catalysis: formation of pyrrolo-diindolones
vs. β-carbolinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tulichala, R. N. Prasad; Swamy, K. C. Kumara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(19), 4519-4533

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-5-fluoro-1-methyl-4-(phenylmethoxy)-1H-indole-3-acetic acid
C18H15BrFNO3
1265219-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6948 2.6091 0.0 0
M  V30 2 C 4.2189 1.1444 0.0 0
M  V30 3 O 2.7125 0.8242 0.0 0
M  V30 4 O 5.2494 0.0000 0.0 0
M  V30 5 O 6.6519 5.2598 0.0 0
M  V30 6 C 7.9857 6.0298 0.0 0
M  V30 7 C 0.0000 5.3196 0.0 0
M  V30 8 Br 1.3170 8.3399 0.0 0
M  V30 9 F 6.6519 8.3399 0.0 0
M  V30 10 C 3.9845 5.2598 0.0 0
M  V30 11 C 2.6509 6.0298 0.0 0
M  V30 12 C 3.6644 3.7535 0.0 0
M  V30 13 C 5.3182 6.0298 0.0 0
M  V30 14 N 1.5063 4.9994 0.0 0
M  V30 15 C 2.6509 7.5699 0.0 0
M  V30 16 C 2.1326 3.5926 0.0 0
M  V30 17 C 5.3182 7.5699 0.0 0
M  V30 18 C 3.9845 8.3399 0.0 0
M  V30 19 C 9.3194 5.2598 0.0 0
M  V30 20 C 9.3194 3.7198 0.0 0
M  V30 21 C 10.6530 6.0298 0.0 0
M  V30 22 C 10.6530 2.9498 0.0 0
M  V30 23 C 11.9867 5.2598 0.0 0
M  V30 24 C 11.9867 3.7198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 19
M  V30 8 1 7 14
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-5-fluoro-N,1-dimethyl-4-(phenylmethoxy)-1H-indole-3-acetamide
C19H18BrFN2O2
1265219-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6519 6.7247 0.0 0
M  V30 2 C 7.9857 7.4947 0.0 0
M  V30 3 C 4.6948 4.0739 0.0 0
M  V30 4 C 4.2189 2.6091 0.0 0
M  V30 5 N 5.2494 1.4647 0.0 0
M  V30 6 O 2.7125 2.2890 0.0 0
M  V30 7 C 4.7735 0.0000 0.0 0
M  V30 8 C 0.0000 6.7845 0.0 0
M  V30 9 Br 1.3170 9.8048 0.0 0
M  V30 10 F 6.6519 9.8048 0.0 0
M  V30 11 C 3.9845 6.7247 0.0 0
M  V30 12 C 2.6509 7.4947 0.0 0
M  V30 13 C 5.3182 7.4947 0.0 0
M  V30 14 C 3.6644 5.2183 0.0 0
M  V30 15 N 1.5063 6.4641 0.0 0
M  V30 16 C 2.6509 9.0348 0.0 0
M  V30 17 C 5.3182 9.0348 0.0 0
M  V30 18 C 2.1326 5.0573 0.0 0
M  V30 19 C 3.9845 9.8048 0.0 0
M  V30 20 C 9.3194 6.7247 0.0 0
M  V30 21 C 10.6530 7.4947 0.0 0
M  V30 22 C 9.3194 5.1847 0.0 0
M  V30 23 C 11.9867 6.7247 0.0 0
M  V30 24 C 10.6530 4.4147 0.0 0
M  V30 25 C 11.9867 5.1847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 15
M  V30 10 1 9 16
M  V30 11 1 10 17
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1265219-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1265219-01-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5494479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 105.
1-ethyl-6-fluoro-3-(2-(isoindolin-2-yl)ethyl)-1H-indol-4-ol (31-4). Step
1: 2-(4-(benzyloxy)-1-ethyl-6-fluoro-1H-indol-3-yl)-1-(isoindolin-2-yl)
ethanone (31-2). A mixture of 31-1 (100 mg, 0.306 mmol), isoindoline (47
mg, 0.398 mmol) and HATU (232 mg, 0.611 mmol) in THF (10 mL) was stirred
for 10 min at room temperature. DIPEA (99 mg, 0.764 mmol) was added and
the reaction mixture was stirred overnight. The volatiles were evaporated
and the resulting residue was partitioned between ethyl acetate (10 mL)
and water (10 mL). The organic layer was separated and washed with brine
(3 × 10 mL), dried over Na2SO4 and concentrated under vacuum. The
resulting residue was purified on silica gel column chromatography
eluting with dichloromethane/methanol (100: 1).
2-(4-(benzyloxy)-7-bromo-5-fluoro-1-methyl-1H-indol-3-yl)-N-methyl
acetamide (33-5). Following the procedure (step 1, scheme 31) used to
prepare compound 31-2, compound 33-4 gave compound 33-5 in 96% yield as a
yellow solid. LRMS: calc 404.0 and found: 405.0 [M+1].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indole derivatives as serotonin receptor modulators and their preparation
and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elder, Amy; Harriman, Geraldine; Leit, Silvana; Li, Jie; Sard, Howard;
Zhang, Yiliang; Wilson, Doug
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011019738 A1 2011-02-17

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
S-(1,1-Dimethylethyl) (3R)-2,3-dihydro-3-hydroxy-1-[(4-methoxyphenyl)methyl]-...
C22H25NO4S
1266333-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.1107 0.0 0
M  V30 2 C 4.0012 3.3406 0.0 0
M  V30 3 S 2.6673 4.1107 0.0 0
M  V30 4 O 4.0012 1.8006 0.0 0
M  V30 5 C 1.3337 3.3406 0.0 0
M  V30 6 C 0.5637 4.6743 0.0 0
M  V30 7 C 0.0000 2.5706 0.0 0
M  V30 8 C 2.1037 2.0068 0.0 0
M  V30 9 O 5.7633 2.0948 0.0 0
M  V30 10 C 9.8570 5.7309 0.0 0
M  V30 11 O 6.5248 6.0811 0.0 0
M  V30 12 O 15.8825 4.4502 0.0 0
M  V30 13 C 16.9130 5.5946 0.0 0
M  V30 14 C 7.8131 2.3101 0.0 0
M  V30 15 C 9.1467 3.0801 0.0 0
M  V30 16 C 6.6685 3.3406 0.0 0 CFG=2
M  V30 17 C 7.8131 0.7700 0.0 0
M  V30 18 N 8.8265 4.5865 0.0 0
M  V30 19 C 10.4804 2.3101 0.0 0
M  V30 20 C 7.2948 4.7475 0.0 0
M  V30 21 C 9.1467 0.0000 0.0 0
M  V30 22 C 10.4804 0.7700 0.0 0
M  V30 23 C 11.3633 5.4108 0.0 0
M  V30 24 C 11.8393 3.9462 0.0 0
M  V30 25 C 12.3939 6.5553 0.0 0
M  V30 26 C 13.3456 3.6260 0.0 0
M  V30 27 C 13.9002 6.2351 0.0 0
M  V30 28 C 14.3761 4.7704 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 16 9 CFG=1
M  V30 10 1 10 18
M  V30 11 1 10 23
M  V30 12 2 11 20
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-2,3-Dihydro-3-hydroxy-1-[(4-methoxyphenyl)methyl]-N-methyl-2-oxo-1H-indo...
C19H20N2O4
1266333-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1105 4.0010 0.0 0
M  V30 2 C 3.3405 2.6673 0.0 0
M  V30 3 N 4.1105 1.3337 0.0 0
M  V30 4 O 1.8005 2.6673 0.0 0
M  V30 5 C 3.3405 0.0000 0.0 0
M  V30 6 O 2.0946 4.4296 0.0 0
M  V30 7 C 5.7309 8.5232 0.0 0
M  V30 8 O 6.0811 5.1911 0.0 0
M  V30 9 O 11.5895 6.6197 0.0 0
M  V30 10 C 12.7339 7.6501 0.0 0
M  V30 11 C 2.3101 6.4792 0.0 0
M  V30 12 C 3.0801 7.8129 0.0 0
M  V30 13 C 3.3405 5.3348 0.0 0 CFG=2
M  V30 14 C 0.7700 6.4792 0.0 0
M  V30 15 N 4.5864 7.4927 0.0 0
M  V30 16 C 2.3101 9.1466 0.0 0
M  V30 17 C 4.7473 5.9612 0.0 0
M  V30 18 C 0.0000 7.8129 0.0 0
M  V30 19 C 0.7700 9.1466 0.0 0
M  V30 20 C 7.1955 8.0473 0.0 0
M  V30 21 C 7.5157 6.5410 0.0 0
M  V30 22 C 8.3401 9.0779 0.0 0
M  V30 23 C 8.9804 6.0651 0.0 0
M  V30 24 C 9.8046 8.6019 0.0 0
M  V30 25 C 10.1248 7.0956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 13 6 CFG=3
M  V30 7 1 7 15
M  V30 8 1 7 20
M  V30 9 2 8 17
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1266333-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266333-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9521779
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Enantioselective Ene and Aldol Reactions with
Isatins, Keto Esters, and Diketones: Reliable Approach to Chiral Tertiary
Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aikawa, Kohsuke; Mimura, Shunsuke; Numata, Yukinobu; Mikami, Koichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), (1), 62-65, S62/1-S62/56

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-3-cyclopropyl-1-phenyl-2,4(1H,3H)-pyrimidinedione
C13H11ClN2O2
1279693-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.7700 0.0 0
M  V30 2 Cl 2.6675 5.3901 0.0 0
M  V30 3 O 8.0022 5.3901 0.0 0
M  V30 4 N 4.0011 3.0800 0.0 0
M  V30 5 C 5.3348 2.3100 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 N 6.6686 3.0800 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 8.0022 2.3100 0.0 0
M  V30 17 C 8.7722 0.9764 0.0 0
M  V30 18 C 9.5423 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyclopropyl-6-(methylamino)-1-phenyl-2,4(1H,3H)-pyrimidinedione
C14H15N3O2
1279693-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.1600 0.0 0
M  V30 2 N 2.6674 1.5400 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 O 8.0021 1.5400 0.0 0
M  V30 5 N 4.0011 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 N 6.6685 3.8500 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 6.6685 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 6.1600 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 1.3336 6.9300 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 0.0000 6.1600 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 9.5421 4.6200 0.0 0
M  V30 19 C 8.7721 5.9536 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1279693-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1279693-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13440933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a suspension of 3.4 (194 mg, 0.74 mmol) in ethanol (0.74 mL) was added
methyl amine in methanol (1.13 mL, 11.1 mmol, 40 wt %). The mixture was
heated in an 80 °C bath for 2 h and concentrated at reduced pressure. The
crude residue was diluted with chloroform, washed with water and brine
successively, dried over sodium sulfate, and concentrated at reduced
pressure to afford 3.5 (183 mg, 96%) as a white solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212
(JTP-74057 DMSO Solvate)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abe, Hiroyuki; Kikuchi, Shinichi; Hayakawa, Kazuhide; Iida, Tetsuya;
Nagahashi, Noboru; Maeda, Katsuya; Sakamoto, Johei; Matsumoto, Noriaki;
Miura, Tomoya; Matsumura, Koji; Seki, Noriyoshi; Inaba, Takashi;
Kawasaki, Hisashi; Yamaguchi, Takayuki; Kakefuda, Reina; Nanayama,
Toyomichi; Kurachi, Hironori; Hori, Yoshikazu; Yoshida, Takayuki;
Kakegawa, Junya; Watanabe, Yoshihiro; Gilmartin, Aidan G.; Richter, Mark
C.; Moss, Katherine G.; Laquerre, Sylvie G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2011), 2(4), 320-324

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-ethyl-9H-purin-2-amine
C7H8ClN5
130584-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 4.5603 0.0 0
M  V30 2 C 7.6826 5.7047 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 N 2.6675 0.0000 0.0 0
M  V30 5 C 4.0011 3.8501 0.0 0
M  V30 6 C 2.6675 4.6201 0.0 0
M  V30 7 N 5.1457 4.8805 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8501 0.0 0
M  V30 10 N 2.9877 6.1264 0.0 0
M  V30 11 C 4.5192 6.2873 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Ethyl-N6-methyl-9H-purine-2,6-diamine
C8H12N6
2377767-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 C 7.9857 4.5603 0.0 0
M  V30 4 C 9.0163 5.7047 0.0 0
M  V30 5 N 4.0012 0.0000 0.0 0
M  V30 6 C 4.0012 4.6201 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 N 4.3213 6.1264 0.0 0
M  V30 10 N 6.4794 4.8805 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 N 2.6675 2.3101 0.0 0
M  V30 13 C 5.8529 6.2873 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 130584-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377767-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21522393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed steel vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New A2A adenosine receptor antagonists: a structure-based upside-down
interaction in the receptor cavity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lambertucci, Catia; Spinaci, Andrea; Buccioni, Michela; Dal Ben, Diego;
Ngouadjeu Ngnintedem, Michael Alliance; Kachler, Sonja; Marucci,
Gabriella; Klotz, Karl-Norbert; Volpini, Rosaria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2019), 92103183

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[[(6-Bromo-3-pyridazinyl)methylamino]methyl]cyclohexyl]glycine met...
C15H23BrN4O2
1313366-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 O 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 N 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[trans-4-[[(6-Bromo-3-pyridazinyl)methylamino]methyl]cyclohexyl]amino]-N-m...
C15H24BrN5O
1313366-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 N 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 N 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313366-38-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313366-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1082278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 132.2:
2-(4-{[(5-Iodo-pyridin-2-yl)-methyl-amino]-methyl}-trans-cyclohexyl-amino)-N-methyl-acetamide.
The mixture of intermediate 130.3 (12.9 g, 30.6 mmol) and methylamine
(33% in EtOH) (191 mL, 1.53 mol) was stirred 16 hours at 80° C. The
mixture was concentrated to dryness and the residue was purified by
normal phase column chromatography, eluting with DCM-MeOH-aq. 30% NH4OH
(200:20:1). Intermediate 153.2:
2-(4-{[(6-Bromo-pyridazin-3-yl)-methyl-amino]-methyl}-trans-cyclohexyl-amino)-N-methyl-acetamide.
The title intermediate (200 mg, 0.513 mmol, 96%) was obtained as a beige
foam from Intermediate 144.3 (200 mg, 0.533 mmol) analogously to
Intermediate 132.2. HPLC: Dt Ret =0.49 min; LC-MS: m/z 370/372 [M]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isoquinolinone and quinazolinone derivatives as MDM2 and MDM4 inhibitors
and their preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berghausen, Joerg; Buschmann, Nicole; Furet, Pascal; Gessier, Francois;
Hergovich Lisztwan, Joanna; Holzer, Philipp; Jacoby, Edgar; Kallen,
Joerg; Masuya, Keiichi; Pissot Soldermann, Carole; Ren, Haixia; Stutz,
Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011076786 A1 2011-06-30

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
3,7-Anhydro-2,4,5-trideoxy-8-O-[(1,1-dimethylethyl)diphenylsilyl]-6-O-methyl-...
C25H36O4Si
1318256-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 5.3349 0.0 0
M  V30 2 O 6.1600 5.3349 0.0 0
M  V30 3 C 4.6200 6.8749 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 6.8749 0.0 0
M  V30 6 C 4.6200 8.4149 0.0 0
M  V30 7 C 6.1600 6.8749 0.0 0
M  V30 8 O 8.4700 1.3338 0.0 0
M  V30 9 C 9.2400 0.0000 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 13.0900 6.6685 0.0 0
M  V30 12 O 13.8600 8.0021 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 5.3349 0.0 0
M  V30 19 C 4.6200 3.7949 0.0 0
M  V30 20 C 5.9536 3.0249 0.0 0
M  V30 21 C 3.2864 3.0249 0.0 0
M  V30 22 C 5.9536 1.4849 0.0 0
M  V30 23 C 3.2864 1.4849 0.0 0
M  V30 24 C 4.6200 0.7149 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0 CFG=1
M  V30 26 C 9.2400 2.6674 0.0 0 CFG=1
M  V30 27 O 9.2400 5.3349 0.0 0
M  V30 28 C 10.7800 2.6674 0.0 0
M  V30 29 C 10.7800 5.3349 0.0 0 CFG=2
M  V30 30 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 25 4 CFG=1
M  V30 10 1 8 9
M  V30 11 1 26 8 CFG=3
M  V30 12 1 10 11
M  V30 13 1 29 10 CFG=3
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Anhydro-1,2,4,5-tetradeoxy-8-O-[(1,1-dimethylethyl)diphenylsilyl]-6-O-met...
C26H39NO3Si
1318256-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 5.3349 0.0 0
M  V30 2 O 6.1600 5.3349 0.0 0
M  V30 3 C 4.6200 6.8749 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 6.8749 0.0 0
M  V30 6 C 4.6200 8.4149 0.0 0
M  V30 7 C 6.1600 6.8749 0.0 0
M  V30 8 O 8.4700 1.3338 0.0 0
M  V30 9 C 9.2400 0.0000 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 13.0900 6.6685 0.0 0
M  V30 12 N 13.8600 8.0021 0.0 0
M  V30 13 C 15.4000 8.0021 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 0.0000 5.3349 0.0 0
M  V30 20 C 4.6200 3.7949 0.0 0
M  V30 21 C 3.2864 3.0249 0.0 0
M  V30 22 C 5.9536 3.0249 0.0 0
M  V30 23 C 3.2864 1.4849 0.0 0
M  V30 24 C 5.9536 1.4849 0.0 0
M  V30 25 C 4.6200 0.7149 0.0 0
M  V30 26 C 8.4700 4.0011 0.0 0 CFG=1
M  V30 27 C 9.2400 2.6674 0.0 0 CFG=1
M  V30 28 O 9.2400 5.3349 0.0 0
M  V30 29 C 10.7800 2.6674 0.0 0
M  V30 30 C 10.7800 5.3349 0.0 0 CFG=2
M  V30 31 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 26 4 CFG=1
M  V30 10 1 8 9
M  V30 11 1 27 8 CFG=3
M  V30 12 1 10 11
M  V30 13 1 30 10 CFG=3
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1318256-65-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1318256-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8333089
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-76-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based domain shuffling approach for the synthesis of pyran-based
macrocyclic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Comer, Eamon; Liu, Haibo; Joliton, Adrien; Clabaut, Alexandre; Johnson,
Christopher; Akella, Lakshmi B.; Marcaurelle, Lisa A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2011), 108(17), 6751-6756, S6751/1-S6751/60

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
3-[6-[[(1,1-Dimethylethoxy)carbonyl][[trans-3-fluoro-1-(3-fluoro-2-pyridinyl)...
C26H25F3N4O4
1344145-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 6.1600 0.0 0
M  V30 2 N 5.7473 5.3900 0.0 0
M  V30 3 C 5.7473 3.8500 0.0 0
M  V30 4 O 7.0809 3.0800 0.0 0
M  V30 5 O 4.4136 3.0800 0.0 0
M  V30 6 C 7.0809 1.5400 0.0 0
M  V30 7 C 5.5409 1.5400 0.0 0
M  V30 8 C 7.0809 0.0000 0.0 0
M  V30 9 C 8.6209 1.5400 0.0 0
M  V30 10 F 0.0000 5.3900 0.0 0
M  V30 11 F 2.1177 1.7987 0.0 0
M  V30 12 F 9.7484 10.7800 0.0 0
M  V30 13 C 15.0831 7.7000 0.0 0
M  V30 14 O 16.4167 8.4700 0.0 0
M  V30 15 O 15.0831 6.1600 0.0 0
M  V30 16 C 3.0800 5.3900 0.0 0 CFG=2
M  V30 17 C 1.7462 4.6200 0.0 0
M  V30 18 C 3.8500 4.0564 0.0 0
M  V30 19 C 2.5162 3.2864 0.0 0 CFG=1
M  V30 20 C 2.3100 6.7236 0.0 0
M  V30 21 C 0.7700 6.7236 0.0 0
M  V30 22 N 3.0800 8.0574 0.0 0
M  V30 23 C 0.0000 8.0574 0.0 0
M  V30 24 C 2.3100 9.3911 0.0 0
M  V30 25 C 0.7700 9.3911 0.0 0
M  V30 26 C 7.0809 6.1600 0.0 0
M  V30 27 C 8.4147 5.3900 0.0 0
M  V30 28 N 7.0809 7.7000 0.0 0
M  V30 29 C 9.7484 6.1600 0.0 0
M  V30 30 N 8.4147 8.4700 0.0 0
M  V30 31 C 9.7484 7.7000 0.0 0
M  V30 32 C 11.0820 8.4700 0.0 0
M  V30 33 C 12.4158 7.7000 0.0 0
M  V30 34 C 11.0820 10.0100 0.0 0
M  V30 35 C 13.7494 8.4700 0.0 0
M  V30 36 C 12.4158 10.7800 0.0 0
M  V30 37 C 13.7494 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 26
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 21
M  V30 12 1 19 11 CFG=3
M  V30 13 1 12 34
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 35
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 31 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl]methy...
C27H28F3N5O3
1344145-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 6.1600 0.0 0
M  V30 2 N 5.7473 5.3900 0.0 0
M  V30 3 C 5.7473 3.8500 0.0 0
M  V30 4 O 7.0809 3.0800 0.0 0
M  V30 5 O 4.4136 3.0800 0.0 0
M  V30 6 C 7.0809 1.5400 0.0 0
M  V30 7 C 5.5409 1.5400 0.0 0
M  V30 8 C 7.0809 0.0000 0.0 0
M  V30 9 C 8.6209 1.5400 0.0 0
M  V30 10 F 0.0000 5.3900 0.0 0
M  V30 11 F 2.1177 1.7987 0.0 0
M  V30 12 F 9.7484 10.7800 0.0 0
M  V30 13 C 15.0831 7.7000 0.0 0
M  V30 14 N 16.4167 8.4700 0.0 0
M  V30 15 O 15.0831 6.1600 0.0 0
M  V30 16 C 17.7503 7.7000 0.0 0
M  V30 17 C 3.0800 5.3900 0.0 0 CFG=2
M  V30 18 C 3.8500 4.0564 0.0 0
M  V30 19 C 1.7462 4.6200 0.0 0
M  V30 20 C 2.5162 3.2864 0.0 0 CFG=1
M  V30 21 C 2.3100 6.7236 0.0 0
M  V30 22 C 0.7700 6.7236 0.0 0
M  V30 23 N 3.0800 8.0574 0.0 0
M  V30 24 C 0.0000 8.0574 0.0 0
M  V30 25 C 2.3100 9.3911 0.0 0
M  V30 26 C 0.7700 9.3911 0.0 0
M  V30 27 C 7.0809 6.1600 0.0 0
M  V30 28 C 8.4147 5.3900 0.0 0
M  V30 29 N 7.0809 7.7000 0.0 0
M  V30 30 C 9.7484 6.1600 0.0 0
M  V30 31 N 8.4147 8.4700 0.0 0
M  V30 32 C 9.7484 7.7000 0.0 0
M  V30 33 C 11.0820 8.4700 0.0 0
M  V30 34 C 12.4156 7.7000 0.0 0
M  V30 35 C 11.0820 10.0100 0.0 0
M  V30 36 C 13.7494 8.4700 0.0 0
M  V30 37 C 12.4156 10.7800 0.0 0
M  V30 38 C 13.7494 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 22
M  V30 12 1 20 11 CFG=1
M  V30 13 1 12 35
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 36
M  V30 17 1 14 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 32 33
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1344145-42-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1344145-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5926017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM t-Butyl
((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl(6-(2-fluoro-5-(methylcarbamoyl)phenyl)pyridazin-3-yl)carbamate.
To
3-(6-(t-butoxycarbonyl(((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyridazin-3-yl)-4-fluorobenzoic
acid (29 g, 55.7 mmol, 1 equiv) in DCM (200 mL) was added oxalyl chloride
(19.4 mL, 222 mmol, 4 equiv). The reaction was stirred for 1 h,
concentrated, and azeotroped twice with toluene. The crude product was
then dissolved in DCM and cooled to 0 °C. To this mixture was added NH2Me
(2 M/THF, 278 mL, 556.8 mmol). The mixture was warmed to rt and stirred
at rt for 30 min. The solid was filtered off and the filtrate was
concentrated. The crude product was purified on silica gel to provide the
title compound. Yield 28.1 g, 96%, pale yellow solid LRMS (M+H+) m/z
528.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminopyridazine derivatives for use in treatment of
neuromuscular diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashcraft, Luke W.; Bergnes, Gustave; Collibee, Scott; Chuang, Chihyuan;
Gardina, Jeff; Morgan, Bradley P.; Muci, Alex R.; Qian, Xiangping;
Warrington, Jeffrey; Yang, Zhe; Lu, Pu-Ping; Romero, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011133882 A1 2011-10-27

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-oxo-4-(2-propen-1-yloxy)butanoate
C9H14O4
134989-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 8 O 9.3360 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 13 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(methylamino)-4-(2-propen-1-yloxy)-2-butenoate
C10H17NO3
1240195-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 N 4.6200 1.3338 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 O 7.7000 4.0011 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 2.3100 5.3347 0.0 0
M  V30 9 O 2.3100 2.6674 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 10.0100 5.3347 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134989-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2520777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (E/Z)-Ethyl 4-allyloxy-3-(methylamino)but-2-enoate. A solution of
methylamine (25% w/v in H2O; 1.86 mL, 15 mmol) was added in a single
portion to a stirred suspension of silica gel (1.0 g) and ethyl
4-allyloxy-3-oxobutanoate (2.79 g, 15 mmol) at room temperature, and the
resulting mixture was stirred at room temperature for 15 h. The mixture
was diluted with dichloromethane (20 mL), dried (MgSO4), filtered and
concentrated in vacuo to give the title compound as a pale brown oil
(2.88 g, 96%; 1.5:1 E:Z). (Found: M+Na+, 222.1106. C10H17NO3Na requires
222.1101); νmax (CHCl3)/cm-1 3430, 3008, 2984, 1674, 1656, 1592, 1153; δH
(400 MHz; CDCl3) E isomer: 5.96-5.92 (m, 1H, CH), 5.74 (1H, br s, NH),
5.31 (1H, d, J17.2, CH), 5.23 (1H, d, J10.4, CH), 4.78 (2H, s, OCH2),
4.52 (1H, s, CH), 4.14-4.02 (m, 4H, 2 × OCH2), 2.77 (3H, d, J5.2, NMe),
1.27 (3H, t, J7.0, CH3); Z isomer: 8.25 (1H, br s, NH), 5.96-5.92 (m, 1H,
CH), 5.31 (1H, d, J17.2, CH), 5.23 (1H, d, J10.4, CH), 4.66 (1H, s, CH),
4.14-4.02 (m, 6H, 3 × CH2), 2.97 (3H, d, J5.2, NMe), 1.27 (3H, t, J7.0,
CH3); δC (75 MHz; CDCl3) mixture: 170.7, 168.9, 160.7, 160.2, 134.0 (CH),
133.9 (CH), 117.8 (CH2), 117.7 (CH2), 82.9 (CH), 79.1 (CH), 72.2 (CH2),
71.1 (CH2), 68.8 (CH2), 68.3 (CH2), 58.6 (CH2), 58.4 (CH2), 29.6 (Me),
29.5 (Me), 14.7 (Me), 14.6 (Me); m/z (EI) 421 (2M+Na+, 100%), 222 (M+Na+,
55).
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indolequinones from Bromoquinones and Enamines Mediated by
Cu(OAc)2·H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(17), 6023-6026

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3R)-6-bromo-2,3-dihydro-3-hydroxy-1-(3-methyl-2-buten-1-yl)-2-oxo-1H-...
C16H18BrNO4
1351337-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.6557 6.7993 0.0 0
M  V30 2 C 9.1957 6.7993 0.0 0
M  V30 3 O 9.9657 8.1331 0.0 0
M  V30 4 O 9.9657 5.4656 0.0 0
M  V30 5 C 11.5057 8.1331 0.0 0
M  V30 6 O 8.2925 4.8393 0.0 0
M  V30 7 C 2.9292 5.9415 0.0 0
M  V30 8 C 2.6091 7.4479 0.0 0
M  V30 9 C 1.1444 7.9238 0.0 0
M  V30 10 C 0.8242 9.4301 0.0 0
M  V30 11 C 0.0000 6.8934 0.0 0
M  V30 12 O 5.6398 7.9109 0.0 0
M  V30 13 Br 4.0998 0.0000 0.0 0
M  V30 14 C 6.4098 4.0009 0.0 0
M  V30 15 C 4.8698 4.0009 0.0 0
M  V30 16 C 6.8857 5.4656 0.0 0 CFG=2
M  V30 17 C 7.1798 2.6673 0.0 0
M  V30 18 N 4.3940 5.4656 0.0 0
M  V30 19 C 4.0998 2.6673 0.0 0
M  V30 20 C 5.6398 6.3709 0.0 0
M  V30 21 C 6.4098 1.3336 0.0 0
M  V30 22 C 4.8698 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 16 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 12 20
M  V30 13 1 13 22
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 1 19 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-6-Bromo-2,3-dihydro-3-hydroxy-N-methyl-1-(3-methyl-2-buten-1-yl)-2-oxo-1...
C16H19BrN2O3
1351337-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.6557 6.7993 0.0 0
M  V30 2 C 9.1957 6.7993 0.0 0
M  V30 3 N 9.9657 8.1331 0.0 0
M  V30 4 O 9.9657 5.4656 0.0 0
M  V30 5 C 11.5057 8.1331 0.0 0
M  V30 6 O 8.2925 4.8393 0.0 0
M  V30 7 C 2.9292 5.9415 0.0 0
M  V30 8 C 2.6091 7.4479 0.0 0
M  V30 9 C 1.1444 7.9238 0.0 0
M  V30 10 C 0.8242 9.4301 0.0 0
M  V30 11 C 0.0000 6.8934 0.0 0
M  V30 12 O 5.6398 7.9109 0.0 0
M  V30 13 Br 4.0998 0.0000 0.0 0
M  V30 14 C 6.4098 4.0009 0.0 0
M  V30 15 C 4.8698 4.0009 0.0 0
M  V30 16 C 6.8857 5.4656 0.0 0 CFG=2
M  V30 17 C 7.1798 2.6673 0.0 0
M  V30 18 N 4.3940 5.4656 0.0 0
M  V30 19 C 4.0998 2.6673 0.0 0
M  V30 20 C 5.6398 6.3709 0.0 0
M  V30 21 C 6.4098 1.3336 0.0 0
M  V30 22 C 4.8698 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 16 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 12 20
M  V30 13 1 13 22
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 1 19 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351337-20-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351337-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4255058
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Enantioselective Decarboxylative Addition of Malonic
Acids Half Thioesters to Isatins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hara, Noriyuki; Nakamura, Shuichi; Funahashi, Yasuhiro; Shibata, Norio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2011), 353(16), 2976-2980

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[4-chloro-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-triazin...
C22H31ClN6O2
1352804-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 10.6697 1.5400 0.0 0
M  V30 3 Cl 8.0023 6.1601 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 O 17.3382 3.8501 0.0 0
M  V30 9 O 16.0045 6.1601 0.0 0
M  V30 10 C 18.6720 4.6201 0.0 0
M  V30 11 C 17.9020 5.9538 0.0 0
M  V30 12 C 20.0057 5.3901 0.0 0
M  V30 13 C 19.4420 3.2864 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 N 8.0023 1.5400 0.0 0
M  V30 16 N 6.6685 3.8501 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0
M  V30 19 N 9.3360 3.8501 0.0 0
M  V30 20 C 4.0012 2.3101 0.0 0
M  V30 21 C 2.6675 1.5400 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 2.6675 4.6201 0.0 0
M  V30 25 C 1.3337 3.8501 0.0 0
M  V30 26 C 12.0033 2.3101 0.0 0
M  V30 27 C 13.3372 1.5400 0.0 0
M  V30 28 C 12.0033 3.8501 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 13.3372 4.6201 0.0 0
M  V30 31 N 14.6708 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 17
M  V30 4 1 2 26
M  V30 5 1 3 18
M  V30 6 1 4 21
M  V30 7 1 5 22
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 31
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[4-(methylamino)-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-...
C23H35N7O2
1352804-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 5.3348 4.6201 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 10.6697 1.5400 0.0 0
M  V30 6 N 8.0023 6.1601 0.0 0
M  V30 7 C 9.3360 6.9302 0.0 0
M  V30 8 C 16.0045 4.6201 0.0 0
M  V30 9 O 17.3382 3.8501 0.0 0
M  V30 10 O 16.0045 6.1601 0.0 0
M  V30 11 C 18.6720 4.6201 0.0 0
M  V30 12 C 17.9020 5.9538 0.0 0
M  V30 13 C 20.0057 5.3901 0.0 0
M  V30 14 C 19.4420 3.2864 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 1.5400 0.0 0
M  V30 17 C 4.0012 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 2.6675 4.6201 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 6.6685 2.3101 0.0 0
M  V30 22 N 8.0023 1.5400 0.0 0
M  V30 23 N 6.6685 3.8501 0.0 0
M  V30 24 C 9.3360 2.3101 0.0 0
M  V30 25 C 8.0023 4.6201 0.0 0
M  V30 26 N 9.3360 3.8501 0.0 0
M  V30 27 C 12.0033 2.3101 0.0 0
M  V30 28 C 13.3372 1.5400 0.0 0
M  V30 29 C 12.0033 3.8501 0.0 0
M  V30 30 C 14.6708 2.3101 0.0 0
M  V30 31 C 13.3372 4.6201 0.0 0
M  V30 32 N 14.6708 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 17
M  V30 5 1 4 20
M  V30 6 1 5 24
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 32
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352804-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352804-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8081650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, anti-HIV evaluation and molecular modeling of
piperidine-linked amino-triazine derivatives as potent non-nucleoside
reverse transcriptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Xuwang; Zhan, Peng; Liu, Xin; Cheng, Ziheng; Meng, Caicai; Shao,
Siyuan; Pannecouque, Christophe; Clercq, Erik De; Liu, Xinyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(12), 3856-3864

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[4-chloro-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-triazin...
C22H31ClN6O2
1352804-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 N 10.6697 1.5400 0.0 0
M  V30 3 Cl 8.0023 6.1601 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 O 17.3382 3.8501 0.0 0
M  V30 9 O 16.0045 6.1601 0.0 0
M  V30 10 C 18.6720 4.6201 0.0 0
M  V30 11 C 17.9020 5.9538 0.0 0
M  V30 12 C 20.0057 5.3901 0.0 0
M  V30 13 C 19.4420 3.2864 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 N 8.0023 1.5400 0.0 0
M  V30 16 N 6.6685 3.8501 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0
M  V30 19 N 9.3360 3.8501 0.0 0
M  V30 20 C 4.0012 2.3101 0.0 0
M  V30 21 C 2.6675 1.5400 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 2.6675 4.6201 0.0 0
M  V30 25 C 1.3337 3.8501 0.0 0
M  V30 26 C 12.0033 2.3101 0.0 0
M  V30 27 C 13.3372 1.5400 0.0 0
M  V30 28 C 12.0033 3.8501 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 13.3372 4.6201 0.0 0
M  V30 31 N 14.6708 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 17
M  V30 4 1 2 26
M  V30 5 1 3 18
M  V30 6 1 4 21
M  V30 7 1 5 22
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 31
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[4-(methylamino)-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-...
C23H35N7O2
1352804-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 5.3348 4.6201 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 10.6697 1.5400 0.0 0
M  V30 6 N 8.0023 6.1601 0.0 0
M  V30 7 C 9.3360 6.9302 0.0 0
M  V30 8 C 16.0045 4.6201 0.0 0
M  V30 9 O 17.3382 3.8501 0.0 0
M  V30 10 O 16.0045 6.1601 0.0 0
M  V30 11 C 18.6720 4.6201 0.0 0
M  V30 12 C 17.9020 5.9538 0.0 0
M  V30 13 C 20.0057 5.3901 0.0 0
M  V30 14 C 19.4420 3.2864 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 1.5400 0.0 0
M  V30 17 C 4.0012 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 2.6675 4.6201 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 6.6685 2.3101 0.0 0
M  V30 22 N 8.0023 1.5400 0.0 0
M  V30 23 N 6.6685 3.8501 0.0 0
M  V30 24 C 9.3360 2.3101 0.0 0
M  V30 25 C 8.0023 4.6201 0.0 0
M  V30 26 N 9.3360 3.8501 0.0 0
M  V30 27 C 12.0033 2.3101 0.0 0
M  V30 28 C 13.3372 1.5400 0.0 0
M  V30 29 C 12.0033 3.8501 0.0 0
M  V30 30 C 14.6708 2.3101 0.0 0
M  V30 31 C 13.3372 4.6201 0.0 0
M  V30 32 N 14.6708 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 17
M  V30 5 1 4 20
M  V30 6 1 5 24
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 32
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352804-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352804-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6679626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of piperidine-substituted triazine
derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Xuwang; Zhan, Peng; Pannecouque, Christophe; Balzarini, Jan; De
Clercq, Erik; Liu, Xinyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2012), 5160-66

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-[2,3-dihydro-1-methyl-2-oxo-3-(triphenylmethyl)...
C39H24F5N3O3
1355152-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 56 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5190 4.5190 0.0 0
M  V30 2 O 5.8818 1.4582 0.0 0
M  V30 3 C 9.2139 1.8084 0.0 0
M  V30 4 C 15.1721 6.7693 0.0 0
M  V30 5 O 16.5057 7.5393 0.0 0
M  V30 6 O 15.1721 5.2293 0.0 0
M  V30 7 F 16.5057 4.4593 0.0 0
M  V30 8 F 19.1732 9.0793 0.0 0
M  V30 9 F 19.1732 2.9193 0.0 0
M  V30 10 F 21.8405 7.5393 0.0 0
M  V30 11 F 21.8405 4.4593 0.0 0
M  V30 12 N 6.0255 4.1989 0.0 0
M  V30 13 C 7.1699 5.2293 0.0 0
M  V30 14 C 6.6518 2.7921 0.0 0
M  V30 15 C 8.5037 4.4593 0.0 0
M  V30 16 N 7.1699 6.7693 0.0 0
M  V30 17 N 8.1833 2.9530 0.0 0
M  V30 18 C 9.8373 5.2293 0.0 0
M  V30 19 C 8.5037 7.5393 0.0 0
M  V30 20 C 9.8373 6.7693 0.0 0
M  V30 21 C 4.8392 6.0255 0.0 0
M  V30 22 C 6.3039 6.5013 0.0 0
M  V30 23 C 3.6948 7.0559 0.0 0
M  V30 24 C 6.6241 8.0076 0.0 0
M  V30 25 C 4.0150 8.5622 0.0 0
M  V30 26 C 5.4797 9.0382 0.0 0
M  V30 27 C 3.0127 4.8392 0.0 0
M  V30 28 C 2.5369 6.3039 0.0 0
M  V30 29 C 1.9823 3.6948 0.0 0
M  V30 30 C 1.0304 6.6241 0.0 0
M  V30 31 C 0.4759 4.0150 0.0 0
M  V30 32 C 0.0000 5.4795 0.0 0
M  V30 33 C 4.1989 3.0127 0.0 0
M  V30 34 C 2.7343 2.5367 0.0 0
M  V30 35 C 5.3434 1.9822 0.0 0
M  V30 36 C 2.4141 1.0304 0.0 0
M  V30 37 C 5.0232 0.4759 0.0 0
M  V30 38 C 3.5585 0.0000 0.0 0
M  V30 39 C 11.1710 7.5393 0.0 0
M  V30 40 C 12.5046 6.7693 0.0 0
M  V30 41 C 11.1710 9.0793 0.0 0
M  V30 42 C 13.8384 7.5393 0.0 0
M  V30 43 C 12.5046 9.8493 0.0 0
M  V30 44 C 13.8384 9.0793 0.0 0
M  V30 45 C 17.8394 6.7693 0.0 0
M  V30 46 C 17.8394 5.2293 0.0 0
M  V30 47 C 19.1732 7.5393 0.0 0
M  V30 48 C 19.1732 4.4593 0.0 0
M  V30 49 C 20.5069 6.7693 0.0 0
M  V30 50 C 20.5069 5.2293 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 21
M  V30 3 1 1 27
M  V30 4 1 1 33
M  V30 5 2 2 14
M  V30 6 1 3 17
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 1 4 42
M  V30 10 1 5 45
M  V30 11 1 7 46
M  V30 12 1 8 47
M  V30 13 1 9 48
M  V30 14 1 10 49
M  V30 15 1 11 50
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 13 16
M  V30 20 1 14 17
M  V30 21 1 15 17
M  V30 22 2 15 18
M  V30 23 1 16 19
M  V30 24 1 18 20
M  V30 25 2 19 20
M  V30 26 1 20 39
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 39 2 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 2 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,3-Dihydro-1-methyl-2-oxo-1H-imidazo[4,5-b]pyridin-6-yl)-N-methylbenzamide
C15H14N4O2
1355152-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9692 1.1395 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 C 11.9120 3.0800 0.0 0
M  V30 4 N 13.2456 2.3100 0.0 0
M  V30 5 O 11.9120 4.6200 0.0 0
M  V30 6 C 14.5793 3.0800 0.0 0
M  V30 7 C 3.9098 3.0800 0.0 0
M  V30 8 C 3.9098 4.6200 0.0 0
M  V30 9 C 5.2434 2.3100 0.0 0
M  V30 10 N 2.4452 2.6042 0.0 0
M  V30 11 N 5.2434 5.3900 0.0 0
M  V30 12 N 2.4452 5.0959 0.0 0
M  V30 13 C 6.5772 3.0800 0.0 0
M  V30 14 C 1.5400 3.8500 0.0 0
M  V30 15 C 6.5772 4.6200 0.0 0
M  V30 16 C 7.9109 2.3100 0.0 0
M  V30 17 C 9.2445 3.0800 0.0 0
M  V30 18 C 7.9109 0.7700 0.0 0
M  V30 19 C 10.5782 2.3100 0.0 0
M  V30 20 C 9.2445 0.0000 0.0 0
M  V30 21 C 10.5782 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1355152-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1355152-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12340469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure B for the Synthesis of the Substituted Benzamide
Analogues (19, 20, and 30-53) in Scheme 3. To a solution of 28 (0.1 M)
and diisopropylethyl amine (ca. 3 equiv) was added the appropriate
primary amine (1.2 equiv) at 0 °C. The reaction mixture was warmed to the
ambient temperature and stirred for 1 h. The solvent was removed by
reduced pressure. The crude product was diluted with ethyl acetate (30
mL) and washed with saturated aqueous NaHCO3 (10 mL) and brine (10 mL).
The organic layer was dried over magnesium sulfate, filtered, and
concentrated in vacuo. Purification of the crude product by flash
chromatography eluting with a linear gradient ranging from 25 to 100%
EtOAc-hexane provided trityl protected benzamide analogues 29. To a
solution of 29 in CH2Cl2 (5 mL) was added trifluoroacetic acid (1 mL) at
room temperature. The reaction mixture was stirred for 30 min. After the
solvent and trifluoroacetic acid were removed in vacuo, the desired
product (19, 20, and 30-53) was purified by flash chromatography eluting
with a linear gradient ranging from 0 to 20% MeOH/EtOAc.
N-Methyl-3-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]-pyridin-6-yl)benzamide
(19). The general procedure B was followed using 28 (216 mg, 318 μmol)
and methylamine to provide 19 as a white solid (86 mg, 305 μmol, 96%). 1H
NMR (400 MHz, DMSO-d6): δ 11.64 (s, 1H), 8.59 (d, J= 4.4 Hz, 1H), 8.29
(d, J= 2.0 Hz, 1H), 8.14 (t, J= 1.6 Hz, 1H), 7.86-7.81 (m, 3H), 7.55 (t,
J= 8.0 Hz, 1H), 3.37 (s, 3H), 2.82 (d, J= 4.8 Hz, 3H). 13C NMR (100 MHz,
DMSO-d6): δ 166.49, 154.11, 143.33, 138.27, 138.07, 135.29, 129.14,
129.01, 128.94, 126.10, 125.46, 125.12, 112.23, 26.43, 26.23. MS (ESI)
283.0 m/z [M + H]+. HRMS (ESI) calcd for C15H15N4O2 [M + H]+, 283.1195;
found, 283.1194. Purity (≥, tr = 5.28 min).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure Guided Development of Novel Thymidine Mimetics Targeting
Pseudomonas aeruginosa Thymidylate Kinase: From Hit to Lead Generation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Jun Yong; Plummer, Mark S.; Starr, Jeremy; Desbonnet, Charlene R.;
Soutter, Holly; Chang, Jeanne; Miller, J. Richard; Dillman, Keith;
Miller, Alita A.; Roush, William R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(2), 852-870

$RFMT $RIREG SCHEME421 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-(2-chloroacetyl)-, methyl ester
C4H6ClNO3
13558-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 Cl 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylrhodanine
C4H5NOS2
4807-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 S 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 S 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13558-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4807-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-22743562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise approach to N-substituted rhodanines through a base-assisted
one-pot coupling and cyclization process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Yongxi; Tang, Mei-Lin; Huo, Zhipeng; Zhang, Chenchen; Sun, Xun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(5), 1138

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(4-formylphenoxy)hexanoate
C14H18O4
135934-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 C 13.3372 2.3101 0.0 0
M  V30 7 C 14.6708 1.5400 0.0 0
M  V30 8 O 16.0045 2.3101 0.0 0
M  V30 9 O 14.6708 0.0000 0.0 0
M  V30 10 C 17.3383 1.5400 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 12 O 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[4-[(methylamino)methyl]phenoxy]hexanoate
C15H23NO3
2454241-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 1.5400 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 1.5400 0.0 0
M  V30 4 C 12.0035 2.3101 0.0 0
M  V30 5 C 13.3372 1.5400 0.0 0
M  V30 6 C 14.6708 2.3101 0.0 0
M  V30 7 C 16.0045 1.5400 0.0 0
M  V30 8 O 17.3383 2.3101 0.0 0
M  V30 9 O 16.0045 0.0000 0.0 0
M  V30 10 C 18.6720 1.5400 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 N 1.3337 3.8501 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0012 2.3101 0.0 0
M  V30 19 C 4.0012 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135934-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454241-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]benzoyl]-L-proline methyl e...
C19H26N2O5
1374822-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 5.8691 0.0 0
M  V30 2 O 5.1047 5.0991 0.0 0
M  V30 3 C 3.4209 2.5369 0.0 0
M  V30 4 O 3.1005 1.0306 0.0 0
M  V30 5 O 4.8854 3.0128 0.0 0
M  V30 6 C 4.2451 0.0000 0.0 0
M  V30 7 C 6.4384 7.4091 0.0 0
M  V30 8 N 7.7721 8.1791 0.0 0
M  V30 9 C 9.1059 7.4091 0.0 0
M  V30 10 O 10.4396 8.1791 0.0 0
M  V30 11 O 9.1059 5.8691 0.0 0
M  V30 12 C 11.7732 7.4091 0.0 0
M  V30 13 C 12.5433 8.7428 0.0 0
M  V30 14 C 13.1069 6.6391 0.0 0
M  V30 15 C 11.0032 6.0753 0.0 0
M  V30 16 N 2.4373 5.0991 0.0 0
M  V30 17 C 2.2763 3.5673 0.0 0 CFG=2
M  V30 18 C 1.0304 5.7254 0.0 0
M  V30 19 C 0.7700 3.2472 0.0 0
M  V30 20 C 0.0000 4.5810 0.0 0
M  V30 21 C 3.7711 7.4091 0.0 0
M  V30 22 C 5.1047 8.1791 0.0 0
M  V30 23 C 2.4373 8.1791 0.0 0
M  V30 24 C 5.1047 9.7192 0.0 0
M  V30 25 C 2.4373 9.7192 0.0 0
M  V30 26 C 3.7711 10.4892 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 17 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[2-[[(2S)-2-[(methylamino)carbonyl]-1-pyrrolidinyl]carbo...
C19H27N3O4
1374822-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 5.8691 0.0 0
M  V30 2 O 5.1047 5.0991 0.0 0
M  V30 3 C 3.4209 2.5369 0.0 0
M  V30 4 N 3.1005 1.0306 0.0 0
M  V30 5 O 4.8854 3.0128 0.0 0
M  V30 6 C 4.2451 0.0000 0.0 0
M  V30 7 C 6.4384 7.4091 0.0 0
M  V30 8 N 7.7721 8.1791 0.0 0
M  V30 9 C 9.1059 7.4091 0.0 0
M  V30 10 O 10.4396 8.1791 0.0 0
M  V30 11 O 9.1059 5.8691 0.0 0
M  V30 12 C 11.7732 7.4091 0.0 0
M  V30 13 C 12.5433 8.7428 0.0 0
M  V30 14 C 13.1069 6.6391 0.0 0
M  V30 15 C 11.0032 6.0753 0.0 0
M  V30 16 N 2.4373 5.0991 0.0 0
M  V30 17 C 2.2763 3.5673 0.0 0 CFG=2
M  V30 18 C 1.0304 5.7254 0.0 0
M  V30 19 C 0.7700 3.2472 0.0 0
M  V30 20 C 0.0000 4.5810 0.0 0
M  V30 21 C 3.7711 7.4091 0.0 0
M  V30 22 C 5.1047 8.1791 0.0 0
M  V30 23 C 2.4373 8.1791 0.0 0
M  V30 24 C 5.1047 9.7192 0.0 0
M  V30 25 C 2.4373 9.7192 0.0 0
M  V30 26 C 3.7711 10.4892 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 17 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1374822-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374822-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14845929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expanding the structural repertoire of β/α Ant-Pro (anthranilic
acid-proline) oligomers into γ/α 2-Amb-Pro (2-aminomethyl benzoic
acid-proline) oligomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Priya, Gowri; Rajamohanan, P. R.; Hofmann,
Hans-Jorg; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(23), 4399-4405

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-oxo-4-phenyl-1H-2-benzopyran-3-carboxylic acid
C16H9ClO4
142256-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 1.3337 3.0801 0.0 0
M  V30 3 O 0.0000 5.3901 0.0 0
M  V30 4 O 4.0012 9.2402 0.0 0
M  V30 5 Cl 9.3360 4.6201 0.0 0
M  V30 6 C 4.0012 4.6201 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 C 2.6675 5.3901 0.0 0
M  V30 9 C 5.3348 6.9302 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 O 2.6675 6.9302 0.0 0
M  V30 12 C 4.0012 7.7002 0.0 0
M  V30 13 C 6.6685 7.7002 0.0 0
M  V30 14 C 8.0023 5.3901 0.0 0
M  V30 15 C 8.0023 6.9302 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1,2-dihydro-2-methyl-1-oxo-4-phenyl-3-isoquinolinecarboxylic acid
C17H12ClNO3
142256-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 1.3337 3.0800 0.0 0
M  V30 3 O 0.0000 5.3901 0.0 0
M  V30 4 C 1.3337 7.7001 0.0 0
M  V30 5 O 4.0011 9.2401 0.0 0
M  V30 6 Cl 9.3359 4.6201 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 2.6675 5.3901 0.0 0
M  V30 10 C 5.3348 6.9301 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 N 2.6675 6.9301 0.0 0
M  V30 13 C 4.0011 7.7001 0.0 0
M  V30 14 C 6.6684 7.7001 0.0 0
M  V30 15 C 8.0022 5.3901 0.0 0
M  V30 16 C 8.0022 6.9301 0.0 0
M  V30 17 C 4.0011 3.0800 0.0 0
M  V30 18 C 5.3348 2.3100 0.0 0
M  V30 19 C 2.6675 2.3100 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 12
M  V30 5 2 5 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 142256-41-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 142256-43-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8290417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A
new class of potent, selective, and orally active non-peptide dipeptidyl
peptidase IV inhibitors that form a unique interaction with Lys554
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banno, Yoshihiro; Miyamoto, Yasufumi; Sasaki, Mitsuru; Oi, Satoru;
Asakawa, Tomoko; Kataoka, Osamu; Takeuchi, Koji; Suzuki, Nobuhiro; Ikedo,
Koji; Kosaka, Takuo; Tsubotani, Shigetoshi; Tani, Akiyoshi; Funami,
Miyuki; Tawada, Michiko; Yamamoto, Yoshio; Aertgeerts, Kathleen; Yano,
Jason; Maezaki, Hironobu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(16), 4953-4970

